hgnc_symbol	description	keep_in_list (CORRECTED DATA)	keep_in_list (INCORRECT DATA. IGNORE THIS COLUMN)	comments	ensembl_gene_ids	uniprot_gn_ids	Protein.families	consensus_score	generic_categories	all_categories	ligand_uniprot	ligand_symbol	ligand_references	GO_cellular_component	GO_molecular_function	GO_biological_process	genecards_url	islet_tpm	islet_tpm_rank	islet_proteomics	islet_proteomics_rank	islet_specificity	islet_specificity_rank	Immune	Duct	Endothelial	Pericytes	Acinar	INS/SST	INS/GCG	PPY	Delta	Beta	Alpha	delta_rank	beta_rank	alpha_rank	mean_scRNAseq	delta_specificity	beta_specificity	alpha_specificity	delta_specificity_rank	beta_specificity_rank	alpha_specificity_rank	Islet, Beta Rank of Ranks
EGFR	epidermal growth factor receptor	Yes	Yes		ENSG00000146648	P00533	Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily	23	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand_regulator, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14544, O14828, O14944, O14965, O60674, O60716, O94832, O94898, O95630, P00519, P00995, P01100, P01133, P01135, P01137, P03950, P03971, P04083, P04626, P04637, P04792, P04899, P05230, P05362, P05556, P05771, P06493, P07355, P07585, P07900, P07948, P08069, P08253, P08581, P08631, P09211, P09769, P0DP23, P0DP24, P0DP25, P10275, P10276, P12830, P12931, P13611, P13688, P14174, P14555, P14923, P15514, P15692, P15907, P16144, P16885, P17252, P17275, P17612, P17706, P17936, P17948, P18031, P18085, P18146, P18433, P19174, P19784, P20936, P21754, P22681, P23458, P23470, P24666, P24821, P24941, P25098, P25445, P26441, P26447, P27361, P28482, P28799, P29279, P29317, P29350, P30304, P30530, P31749, P31751, P32004, P35070, P35221, P35222, P35790, P40199, P40763, P40818, P41240, P42566, P42574, P42684, P42685, P43119, P43378, P49913, P51451, P51452, P52735, P56975, P62987, P62993, P78545, Q02156, Q02297, Q02750, Q03135, Q05209, Q05513, Q05655, Q06124, Q07912, Q08830, Q12805, Q12913, Q13153, Q13191, Q13332, Q13546, Q13555, Q13641, Q13671, Q13882, Q14289, Q15139, Q15262, Q15303, Q15645, Q15759, Q16512, Q16539, Q6S5L8, Q6UW88, Q8IZV2, Q8WUM4, Q8WWG1, Q92729, Q92913, Q92918, Q96B97, Q96CW1, Q96GW7, Q96JA1, Q99075, Q99527, Q99558, Q99650, Q9H5V8, Q9UBN7, Q9UJM3, Q9ULV8, Q9UQM7, Q9Y5X1, Q9Y6I3	ABL1, ABL2, ACP1, AKT1, AKT2, AMH, ANG, ANXA1, ANXA2, AP2M1, AR, AREG, ARF4, AURKA, AXL, BCAN, BLK, BTC, CALM1, CALM2, CALM3, CAMK2A, CAMK2G, CAMP, CASP3, CAV1, CBL, CBLB, CBLC, CCN2, CDC25A, CDCP1, CDH1, CDK1, CDK2, CEACAM1, CEACAM6, CHKA, CMTM8, CNTF, CSK, CSNK2A2, CTNNA1, CTNNB1, CTNND1, DCN, DUSP3, EFEMP1, EGF, EGR1, ELF3, EPGN, EPHA2, EPN1, EPS15, ERBB2, ERBB4, EREG, ERRFI1, FAS, FGF1, FGF13, FGL1, FGR, FLT1, FOS, FRK, GNAI2, GPER1, GRB2, GRK2, GRN, GSTP1, HBEGF, HCK, HDAC6, HSP90AA1, HSPB1, ICAM1, IGF1R, IGFBP3, ITGB1, ITGB4, JAK1, JAK2, JUNB, JUP, L1CAM, LRIG1, LRIG2, LYN, MAP2K1, MAP3K14, MAP4K1, MAPK1, MAPK11, MAPK14, MAPK3, MET, MIF, MMP2, MYO1D, NRG1, NRG3, NRG4, OSMR, PAK1, PDCD6IP, PKN1, PLA2G2A, PLCG1, PLCG2, PRKACA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCZ, PRKD1, PTGIR, PTK2B, PTK6, PTPN1, PTPN11, PTPN12, PTPN2, PTPN6, PTPN9, PTPRA, PTPRG, PTPRJ, PTPRK, PTPRS, PTPRU, RARA, RASA1, RIN1, RIPK1, S100A4, SCAMP3, SH3KBP1, SHC4, SNX9, SOCS6, SPINK1, SRC, ST6GAL1, STAMBP, STAT3, TGFA, TGFB1, TNC, TNK2, TP53, TPBG, TRIP13, UBA52, USP8, VAV2, VCAN, VEGFA, ZP3	TP53 [SPIKE:18431400], GRB2 [DIP:1322798;DOMINO:12577067;DOMINO:16273093;DOMINO:16729043;ELM:7518560;HPRD:11726515;HPRD:12577067;HPRD:1322798;HPRD:14679214;HPRD:16799092;HPRD:7518560;HPRD:7527043;HPRD:8662998;HPRD:8810325;HPRD:8887653;InnateDB:16799092;IntAct:10229072;IntAct:11896612;IntAct:14679214;IntAct:16273093;IntAct:16729043;IntAct:21278786;IntAct:23799367;IntAct:24658140;IntAct:27059931;IntAct:31980649;IntAct:7518560;IntAct:7527043;IntAct:8887653;IntAct:8940013;IntAct:9020117;LMPID:7518560;LMPID:8491186;Lit-BM-17:10026169;Lit-BM-17:10085134;Lit-BM-17:10229072;Lit-BM-17:10595738;Lit-BM-17:11370743;Lit-BM-17:11408594;Lit-BM-17:11896612;Lit-BM-17:11960376;Lit-BM-17:12577067;Lit-BM-17:1322798;Lit-BM-17:14679214;Lit-BM-17:15657067;Lit-BM-17:16273093;Lit-BM-17:16729043;Lit-BM-17:16799092;Lit-BM-17:17242169;Lit-BM-17:17971399;Lit-BM-17:18271526;Lit-BM-17:19289468;Lit-BM-17:19531499;Lit-BM-17:19836242;Lit-BM-17:20124286;Lit-BM-17:21596750;Lit-BM-17:21706016;Lit-BM-17:23178716;Lit-BM-17:23799367;Lit-BM-17:23956138;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:24797263;Lit-BM-17:25402006;Lit-BM-17:27059931;Lit-BM-17:7506413;Lit-BM-17:7510700;Lit-BM-17:7518560;Lit-BM-17:7527043;Lit-BM-17:7592693;Lit-BM-17:7650032;Lit-BM-17:8647858;Lit-BM-17:8662998;Lit-BM-17:8810340;Lit-BM-17:8887653;Lit-BM-17:8940013;Lit-BM-17:9020117;Lit-BM-17:9050991;Lit-BM-17:9416834;Lit-BM-17:9886492;NetPath:12577067;NetPath:17991782;NetPath:19509291;NetPath:19531499;NetPath:9544989;SIGNOR:11726515;SPIKE:11084343;SPIKE:12648464;SPIKE:16713569;SPIKE:7518560;SPIKE:8887653], EGF [AlzPathway:18270696;Baccin2019:10788520;Baccin2019:12093292;Baccin2019:12297050;Baccin2019:12620237;Baccin2019:15620700;Baccin2019:16274239;Baccin2019:6289330;BioGRID:12093292;BioGRID:26280537;CancerCellMap:3494473;CellTalkDB:12093292;DIP:10085134;DIP:10970856;DIP:11684674;DIP:17697999;DIP:18427122;DIP:21822280;DIP:26280537;DIP:8663535;HPMR:6289330;HPRD:10788520;HPRD:12093292;HPRD:12297050;HPRD:12620237;HPRD:15620700;HPRD:16274239;ICELLNET:8639530;IntAct:12297050;IntAct:12620237;IntAct:17697999;IntAct:21439278;IntAct:21822280;IntAct:25241761;IntAct:26280537;IntAct:2790960;IntAct:28988771;IntAct:30083275;IntAct:9135143;LRdb:10788520;LRdb:12093292;LRdb:12297050;LRdb:12620237;LRdb:15620700;LRdb:16274239;LRdb:6289330;Lit-BM-17:10085134;Lit-BM-17:10970856;Lit-BM-17:11684674;Lit-BM-17:12093292;Lit-BM-17:12297050;Lit-BM-17:12620237;Lit-BM-17:17697999;Lit-BM-17:18271526;Lit-BM-17:18427122;Lit-BM-17:19531499;Lit-BM-17:21439278;Lit-BM-17:23597562;Lit-BM-17:25080504;Lit-BM-17:25241761;Lit-BM-17:25453753;Lit-BM-17:26280537;Lit-BM-17:2790960;Lit-BM-17:8663535;NetPath:19531499;NetPath:3494473;ProtMapper:11116185;ProtMapper:12771140;ProtMapper:14568001;ProtMapper:15708576;ProtMapper:15958209;ProtMapper:16729043;ProtMapper:16843263;ProtMapper:17081983;ProtMapper:17563729;ProtMapper:17575160;ProtMapper:17971399;ProtMapper:18253097;ProtMapper:18320059;ProtMapper:18762250;ProtMapper:19129184;ProtMapper:19135477;ProtMapper:19531623;ProtMapper:19895983;ProtMapper:20813200;ProtMapper:20953304;ProtMapper:21107857;ProtMapper:21303971;ProtMapper:21311755;ProtMapper:21532939;ProtMapper:21649524;ProtMapper:21722395;ProtMapper:21858221;ProtMapper:22216880;ProtMapper:22260327;ProtMapper:23185569;ProtMapper:23613900;ProtMapper:23912460;ProtMapper:23950932;ProtMapper:24096486;ProtMapper:24709886;ProtMapper:25366117;ProtMapper:26821125;ProtMapper:26921391;ProtMapper:27387652;ProtMapper:27462018;ProtMapper:27564112;ProtMapper:29617357;ProtMapper:30197274;SIGNOR:12297050;SIGNOR:12648462;SPIKE:20458382;SignaLink3:10085134;SignaLink3:10209155;SignaLink3:19531499;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10788520;connectomeDB2020:12093292;connectomeDB2020:12297050;connectomeDB2020:12620237;connectomeDB2020:15620700;connectomeDB2020:16274239;connectomeDB2020:6289330], TGFA [Baccin2019:12297049;Baccin2019:3018723;CellTalkDB:3018723;HPRD:12297049;ICELLNET:27635238;IntAct:12297049;IntAct:24658140;IntAct:28988771;IntAct:31980649;LRdb:123;LRdb:3018723;Lit-BM-17:10775655;Lit-BM-17:12297049;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:8663070;ProtMapper:21722395;ProtMapper:23155381;SIGNOR:16585207;SPIKE:12648464;SPIKE:17145710;SignaLink3:10209155;SignaLink3:12297049;SignaLink3:23331499;connectomeDB2020:12297049;connectomeDB2020:3018723], SRC [BioGRID:10971656;BioGRID:8845374;CancerCellMap:10075741;HPRD-phos:11983694;HPRD-phos:15951569;HPRD-phos:16729043;HPRD-phos:16799092;HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:18669648;HPRD-phos:8845374;HPRD:10075741;HPRD:11983694;HPRD:8845374;InnateDB:14963038;IntAct:20935677;IntAct:21278788;IntAct:24658140;IntAct:28065597;IntAct:31980649;KEA:10075741;KEA:11983694;KEA:15302935;KEA:15618223;KEA:15657067;KEA:15951569;KEA:16729043;KEA:17081983;KEA:17570479;KEA:18083107;KEA:8845374;Lit-BM-17:10358079;Lit-BM-17:10777553;Lit-BM-17:10971656;Lit-BM-17:17158602;Lit-BM-17:17284441;Lit-BM-17:20333651;Lit-BM-17:21268077;Lit-BM-17:21573184;Lit-BM-17:23175185;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:25402006;NetPath:10075741;NetPath:19625610;PhosphoSite:10075741;PhosphoSite:11756413;PhosphoSite:11960379;PhosphoSite:11983694;PhosphoSite:12063263;PhosphoSite:12101233;PhosphoSite:12397069;PhosphoSite:12842895;PhosphoSite:14512423;PhosphoSite:14523024;PhosphoSite:14530278;PhosphoSite:14764607;PhosphoSite:15282306;PhosphoSite:15476828;PhosphoSite:15548697;PhosphoSite:15592458;PhosphoSite:15615697;PhosphoSite:15618223;PhosphoSite:15657067;PhosphoSite:15660394;PhosphoSite:15708852;PhosphoSite:15899872;PhosphoSite:16037379;PhosphoSite:16461772;PhosphoSite:16505275;PhosphoSite:16543144;PhosphoSite:16729043;PhosphoSite:16843263;PhosphoSite:16849545;PhosphoSite:16862179;PhosphoSite:16936701;PhosphoSite:16943190;PhosphoSite:17237269;PhosphoSite:17523611;PhosphoSite:17551925;PhosphoSite:17561374;PhosphoSite:17575160;PhosphoSite:17646646;PhosphoSite:17653080;PhosphoSite:18083107;PhosphoSite:18180459;PhosphoSite:18234969;PhosphoSite:18271526;PhosphoSite:18451158;PhosphoSite:18460189;PhosphoSite:18687633;PhosphoSite:18707149;PhosphoSite:19154417;PhosphoSite:19305428;PhosphoSite:19336574;PhosphoSite:19690143;PhosphoSite:19704002;PhosphoSite:19836242;PhosphoSite:19935697;PhosphoSite:20071362;PhosphoSite:20190765;PhosphoSite:20215522;PhosphoSite:20371672;PhosphoSite:20407013;PhosphoSite:20421302;PhosphoSite:20562096;PhosphoSite:20628053;PhosphoSite:20926745;PhosphoSite:21080693;PhosphoSite:21278788;PhosphoSite:21399647;PhosphoSite:21787862;PhosphoSite:23246962;PhosphoSite:23376850;PhosphoSite:23636329;PhosphoSite:24349301;PhosphoSite:24797263;PhosphoSite:24919575;PhosphoSite:25159151;PhosphoSite:25347738;PhosphoSite:2543678;PhosphoSite:25537504;PhosphoSite:25573954;PhosphoSite:25884760;PhosphoSite:25958313;PhosphoSite:26150526;PhosphoSite:26290602;PhosphoSite:26494466;PhosphoSite:26936397;PhosphoSite:27716204;PhosphoSite:2803273;PhosphoSite:28102297;PhosphoSite:28759036;PhosphoSite:31952541;PhosphoSite:31978707;PhosphoSite:33657368;PhosphoSite:33706413;PhosphoSite:33883672;PhosphoSite:34088769;PhosphoSite:34367939;PhosphoSite:7797556;PhosphoSite:9777370;ProtMapper:11160627;ProtMapper:11250711;ProtMapper:11311660;ProtMapper:11983694;ProtMapper:12878163;ProtMapper:14630916;ProtMapper:14750954;ProtMapper:15212693;ProtMapper:15282306;ProtMapper:16414009;ProtMapper:17043637;ProtMapper:17653080;ProtMapper:17897439;ProtMapper:17971399;ProtMapper:18295415;ProtMapper:18957516;ProtMapper:19151764;ProtMapper:19258037;ProtMapper:19275932;ProtMapper:19305428;ProtMapper:19840943;ProtMapper:20190765;ProtMapper:20802523;ProtMapper:20935677;ProtMapper:21822308;ProtMapper:22426783;ProtMapper:22430206;ProtMapper:22927910;ProtMapper:22957061;ProtMapper:23066441;ProtMapper:23119029;ProtMapper:23119185;ProtMapper:23349873;ProtMapper:23449029;ProtMapper:23702846;ProtMapper:23866081;ProtMapper:23873690;ProtMapper:23942551;ProtMapper:24335899;ProtMapper:25077442;ProtMapper:25301722;ProtMapper:25356505;ProtMapper:25366117;ProtMapper:25505586;ProtMapper:25573954;ProtMapper:25748412;ProtMapper:25841779;ProtMapper:25955608;ProtMapper:25958313;ProtMapper:26325669;ProtMapper:26571308;ProtMapper:26771606;ProtMapper:27495374;ProtMapper:27564112;ProtMapper:27716204;ProtMapper:28513565;ProtMapper:29036202;ProtMapper:29124875;ProtMapper:29285309;ProtMapper:29321659;ProtMapper:29641465;ProtMapper:7488034;ProtMapper:8845374;ProtMapper:9069259;ProtMapper:9990038;SIGNOR:11983694;SIGNOR:8845374;SPIKE:10075741;SPIKE:18789131;SPIKE:19377510;iPTMnet:10075741;iPTMnet:11983694;iPTMnet:15951569;iPTMnet:16729043;iPTMnet:16799092;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:18669648;iPTMnet:7797556;iPTMnet:8845374;phosphoELM:10075741;phosphoELM:11983694;phosphoELM:8845374], MAPK14 [ACSN:11274345;ACSN:12738796;ACSN:15187187;ACSN:18039929;Lit-BM-17:23397142;Lit-BM-17:7535770;ProtMapper:17139251;SIGNOR:16932740;SPIKE:19138820;iPTMnet:16785992], ABL1 [BioGRID:7678409;DOMINO:16273093;IntAct:16273093;IntAct:24658140;IntAct:31980649;KEA:15618223;KEA:15901825;Lit-BM-17:16273093;Lit-BM-17:24658140;Lit-BM-17:25402006;PhosphoSite:10069801;PhosphoSite:12631709;PhosphoSite:1314835;PhosphoSite:14760089;PhosphoSite:15192046;PhosphoSite:15329413;PhosphoSite:18668345;PhosphoSite:19915609;PhosphoSite:2022651;PhosphoSite:2022652;PhosphoSite:24430869;PhosphoSite:25073158;PhosphoSite:25173817;PhosphoSite:26079946;PhosphoSite:28724430;PhosphoSite:29880877;PhosphoSite:32019812;PhosphoSite:3263271;PhosphoSite:33574089;PhosphoSite:33707748;PhosphoSite:33889303;PhosphoSite:33947961;PhosphoSite:34107301;PhosphoSite:34155348;PhosphoSite:34290403;PhosphoSite:34385595;PhosphoSite:34469737;PhosphoSite:7506413;PhosphoSite:7741752;PhosphoSite:8408058;PhosphoSite:8490966;PhosphoSite:8910327;PhosphoSite:9733788;ProtMapper:16943190;ProtMapper:28338646;SIGNOR:16943190;SPIKE:16943190;SPIKE:20841568;iPTMnet:16943190], MMP2 [SPIKE:15313914], STAT3 [BioGRID:18258752;BioGRID:20145033;CancerCellMap:12070153;HPRD:12873986;InnateDB:12873986;InnateDB:14963038;InnateDB:15284024;InnateDB:15950906;IntAct:14966128;IntAct:24135280;IntAct:24658140;IntAct:25241761;IntAct:31980649;Lit-BM-17:10358079;Lit-BM-17:14966128;Lit-BM-17:15284024;Lit-BM-17:15485908;Lit-BM-17:15657067;Lit-BM-17:15950906;Lit-BM-17:18258752;Lit-BM-17:21573184;Lit-BM-17:23956138;Lit-BM-17:24135280;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:25241761;Lit-BM-17:25402006;Lit-BM-17:9756944;NetPath:20032199;ProtMapper:29560131], CAV1 [BioGRID:10781609;BioGRID:12388423;BioGRID:16407214;BioGRID:19446582;CancerCellMap:10781609;HPRD:16799092;HPRD:9374534;InnateDB:16799092;IntAct:22411794;IntAct:24658140;IntAct:31980649;Lit-BM-17:10781609;Lit-BM-17:12388423;Lit-BM-17:15657067;Lit-BM-17:16407214;Lit-BM-17:16799092;Lit-BM-17:19446582;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:9374534;NetPath:10781609;NetPath:19625610;SPIKE:10781609;SPIKE:17145710;SPIKE:18789131], MAP2K1 [CancerCellMap:12556561;HPRD:12556561;NetPath:12556561], JUNB [SPIKE:12791272], EGR1 [SPIKE:11830539], CBLC [ACSN:10514377;ACSN:17635922;CancerCellMap:10362357;HPRD:10362357;Lit-BM-17:10362357;Lit-BM-17:22888118;NetPath:10362357;SPIKE:10362357], PLCG1 [BioGRID:9207933;DOMINO:16273093;HPRD:12601080;HPRD:15144186;HPRD:1689310;HPRD:7682059;HPRD:8657103;HPRD:8885868;HPRD:9207933;IntAct:14568990;IntAct:16273093;IntAct:7693694;IntAct:7993895;IntAct:9020117;Lit-BM-17:11983899;Lit-BM-17:12061819;Lit-BM-17:12803489;Lit-BM-17:14568990;Lit-BM-17:16273093;Lit-BM-17:24797263;Lit-BM-17:7693694;Lit-BM-17:7993895;Lit-BM-17:9020117;Lit-BM-17:9207933;Lit-BM-17:9756944;NetPath:7805859;SPIKE:12648464;SPIKE:16273093;SPIKE:16713569;SPIKE:7805859], ERBB4 [HPRD:10572067;KEA:17570479;Lit-BM-17:10572067;Lit-BM-17:23153581;Lit-BM-17:25140053;SPIKE:10572067;SPIKE:12648464;SPIKE:17145710], ERBB2 [BioGRID:16207817;BioGRID:21044682;BioGRID:28369073;HPRD-phos:10635327;HPRD-phos:16799092;HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:18669648;HPRD-phos:18691976;HPRD-phos:9363897;HPRD:11500516;HPRD:11500850;HPRD:12354693;HPRD:16843263;HPRD:1706616;HPRD:17426253;IntAct:10572067;IntAct:16516204;IntAct:16843263;IntAct:17148612;IntAct:19650109;IntAct:21203579;IntAct:21278786;IntAct:23436906;IntAct:24557338;IntAct:25241761;KEA:16843263;Lit-BM-17:10572067;Lit-BM-17:11408594;Lit-BM-17:15657067;Lit-BM-17:16207817;Lit-BM-17:16516204;Lit-BM-17:16843263;Lit-BM-17:17307140;Lit-BM-17:17486068;Lit-BM-17:18803307;Lit-BM-17:19060928;Lit-BM-17:19650109;Lit-BM-17:20211985;Lit-BM-17:21044682;Lit-BM-17:23436906;Lit-BM-17:24189400;Lit-BM-17:24557338;Lit-BM-17:25241761;NetPath:10233167;ProtMapper:23027125;SIGNOR:8816440;SPIKE:10572067;SPIKE:12648464;SPIKE:16516204;SPIKE:16713569;iPTMnet:10635327;iPTMnet:16799092;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:18669648;iPTMnet:18691976;iPTMnet:9363897], AREG [Baccin2019:10085134;Baccin2019:2466334;CellTalkDB:2466334;HPRD:10085134;ICELLNET:2466334;LRdb:101;LRdb:2466334;ProtMapper:23762360;ProtMapper:29045902;SIGNOR:10085134;SIGNOR:10209155;SIGNOR:20513444;SignaLink3:10085134;SignaLink3:10209155;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10085134;connectomeDB2020:2466334], HBEGF [Baccin2019:12725245;BioGRID:12725245;CellTalkDB:12725245;HPRD:12725245;ICELLNET:12097488;ICELLNET:12621152;IntAct:28988771;IntAct:9135143;LRdb:12725245;ProtMapper:19531065;ProtMapper:22529914;ProtMapper:23888518;ProtMapper:28943431;ProtMapper:29274275;ProtMapper:30071291;SIGNOR:14967450;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:12725245], CBL [ACSN:10514377;ACSN:17635922;BioGRID:11239464;BioGRID:12604776;BioGRID:15383614;BioGRID:15465819;BioGRID:15735736;BioGRID:16105874;BioGRID:16923119;BioGRID:16969069;BioGRID:17545148;BioGRID:17995934;BioGRID:18255265;BioGRID:18316398;BioGRID:18319245;BioGRID:19531499;BioGRID:19578043;BioGRID:19947936;BioGRID:20562913;BioGRID:21772844;BioGRID:22394513;BioGRID:22591401;BioGRID:23158001;BioGRID:23457600;BioGRID:23897813;BioGRID:25521828;BioGRID:26177020;BioGRID:27903975;BioGRID:28198003;BioGRID:28541302;BioGRID:29629558;BioGRID:31182136;BioGRID:32714745;BioGRID:32904620;BioGRID:33323455;BioGRID:9121472;CancerCellMap:15465819;CancerCellMap:8662998;HPRD:10092522;HPRD:10799548;HPRD:11239464;HPRD:11994282;HPRD:16729043;HPRD:18273061;HPRD:7657591;HPRD:8662998;HPRD:8798643;HPRD:9890970;IntAct:15677445;IntAct:15962011;IntAct:16729043;IntAct:18273061;IntAct:20562913;IntAct:23799367;IntAct:27059931;IntAct:7657591;IntAct:8662998;LMPID:10635327;LMPID:15737992;Lit-BM-17:10086340;Lit-BM-17:10428778;Lit-BM-17:10635327;Lit-BM-17:11239464;Lit-BM-17:11370743;Lit-BM-17:11408594;Lit-BM-17:12061819;Lit-BM-17:12593795;Lit-BM-17:12604776;Lit-BM-17:12734385;Lit-BM-17:12803489;Lit-BM-17:14505571;Lit-BM-17:14627991;Lit-BM-17:15107835;Lit-BM-17:15117950;Lit-BM-17:15159412;Lit-BM-17:15210722;Lit-BM-17:15282549;Lit-BM-17:15383614;Lit-BM-17:15465819;Lit-BM-17:15657067;Lit-BM-17:15668240;Lit-BM-17:15677445;Lit-BM-17:15735736;Lit-BM-17:15962011;Lit-BM-17:16105874;Lit-BM-17:16246327;Lit-BM-17:16729043;Lit-BM-17:16849543;Lit-BM-17:16923119;Lit-BM-17:16969069;Lit-BM-17:17182860;Lit-BM-17:17242169;Lit-BM-17:17486068;Lit-BM-17:17545148;Lit-BM-17:17880946;Lit-BM-17:17971399;Lit-BM-17:17995934;Lit-BM-17:18271526;Lit-BM-17:18273061;Lit-BM-17:18316398;Lit-BM-17:18508924;Lit-BM-17:19155296;Lit-BM-17:19225046;Lit-BM-17:19531499;Lit-BM-17:19578043;Lit-BM-17:19713535;Lit-BM-17:19836242;Lit-BM-17:19947936;Lit-BM-17:20124286;Lit-BM-17:20562913;Lit-BM-17:20877636;Lit-BM-17:20940296;Lit-BM-17:21772844;Lit-BM-17:22203672;Lit-BM-17:22266821;Lit-BM-17:22394513;Lit-BM-17:22591401;Lit-BM-17:22833562;Lit-BM-17:22976291;Lit-BM-17:23153581;Lit-BM-17:23158001;Lit-BM-17:23175185;Lit-BM-17:23418353;Lit-BM-17:23457600;Lit-BM-17:23774213;Lit-BM-17:23799367;Lit-BM-17:23897813;Lit-BM-17:24714105;Lit-BM-17:24797263;Lit-BM-17:25140053;Lit-BM-17:25521828;Lit-BM-17:25872741;Lit-BM-17:26055326;Lit-BM-17:26177020;Lit-BM-17:27059931;Lit-BM-17:28198003;Lit-BM-17:7592693;Lit-BM-17:7657591;Lit-BM-17:7782294;Lit-BM-17:8662998;Lit-BM-17:9121472;Lit-BM-17:9130710;Lit-BM-17:9756944;NetPath:19531499;NetPath:8662998;ProtMapper:22239438;ProtMapper:23027125;SIGNOR:20332299;SignaLink3:10086340;SignaLink3:10428778;SignaLink3:10514377;SignaLink3:12061819;SignaLink3:12593795;SignaLink3:12604776;SignaLink3:12734385;SignaLink3:14505571;SignaLink3:14627991;SignaLink3:15107835;SignaLink3:15159412;SignaLink3:15210722;SignaLink3:15282549;SignaLink3:15668240;SignaLink3:15962011;SignaLink3:16105874;SignaLink3:16246327;SignaLink3:16969069;SignaLink3:17242169;SignaLink3:17486068;SignaLink3:17545148;SignaLink3:17971399;SignaLink3:17995934;SignaLink3:18273061;SignaLink3:18316398;SignaLink3:18508924;SignaLink3:19225046;SignaLink3:19531499;SignaLink3:19713535;SignaLink3:20940296;SignaLink3:21071413;SignaLink3:21772844;SignaLink3:23331499], LRIG1 [BioGRID:18542056;IntAct:15282549;IntAct:15345710;IntAct:18542056;SIGNOR:15282549], NRG3 [SignaLink3:23331499;SignaLink3:9772300], BTC [Baccin2019:8144591;Baccin2019:9528863;CellTalkDB:8144591;HPRD:9528863;LRdb:8144591;LRdb:953;ProtMapper:24440602;SIGNOR:10209155;SIGNOR:14967450;SIGNOR:23382875;SIGNOR:9528863;SignaLink3:10209155;SignaLink3:23331499;SignaLink3:9528863;connectomeDB2020:8144591;connectomeDB2020:9528863], TPBG [SignaLink3:15282549;SignaLink3:23331499], SNX9 [Lit-BM-17:24658140;Lit-BM-17:25402006;SignaLink3:16316319;SignaLink3:23331499], RARA [SignaLink3:11788593;SignaLink3:23331499], EPGN [CellChatDB:27298358;CellTalkDB:28988771;Cellinker:27298358;IntAct:28988771;SIGNOR:20513444;connectomeDB2020:28988771], EREG [Baccin2019:8626392;Baccin2019:9419975;CellTalkDB:8626392;HPRD:9419975;IntAct:28988771;LRdb:8626392;LRdb:942;SIGNOR:20513444;SIGNOR:9419975;connectomeDB2020:8626392;connectomeDB2020:9419975], PTK2B [CA1:11274221;HPRD:10777553;InnateDB:14963038], CBLB [ACSN:10514377;ACSN:17635922;CA1:11375397;CancerCellMap:10086340;CancerCellMap:10542134;HPRD:10086340;NetPath:10086340;NetPath:12577067;NetPath:19531499;SIGNOR:11375397], AP2M1 [IntAct:20029029;IntAct:31980649;Lit-BM-17:20029029;Lit-BM-17:23956138;Lit-BM-17:24189400;Lit-BM-17:24797263;SIGNOR:19351721], GPER1 [SIGNOR:11897506], ERRFI1 [BioGRID:18046415;CancerCellMap:11843178;DIP:18046415;DIP:18776048;DIP:23273428;HPRD:11843178;InnateDB:19815557;IntAct:18046415;IntAct:23273428;Lit-BM-17:18271526;Lit-BM-17:18776048;Lit-BM-17:19531499;Lit-BM-17:19815557;Lit-BM-17:20946980;Lit-BM-17:23956138;Lit-BM-17:24189400;Lit-BM-17:24797263;Lit-BM-17:26280531;NetPath:11843178;NetPath:19531499;SIGNOR:11003669;SIGNOR:18046415;SIGNOR:20421427], CAMK2A [HPRD-phos:10347170;HPRD-phos:16799092;HPRD-phos:17389395;HPRD-phos:18669648;HPRD-phos:18691976;HPRD-phos:20068231;HPRD-phos:20166139;HPRD:10347170;HPRD:1309762;KEA:10347170;KEA:1309762;KEA:15302935;KEA:15901825;KEA:16799092;KEA:17081983;KEA:1956339;KEA:3138233;KEA:7505275;KEA:7805884;KEA:92065884;ProtMapper:10347170;SIGNOR:10347170;iPTMnet:10347170;iPTMnet:1309762;iPTMnet:16799092;iPTMnet:17389395;iPTMnet:18669648;iPTMnet:18691976;iPTMnet:20068231;iPTMnet:20166139;phosphoELM:10347170], EPN1 [BioGRID:19054389;SIGNOR:19054389], DUSP3 [DEPOD:1281549;DEPOD:21262974;ProtMapper:21262974;SIGNOR:21262974], CTNND1 [HPRD:14996911;IntAct:24658140;IntAct:31980649;Lit-BM-17:15657067;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:24797263;Lit-BM-17:25402006;Lit-BM-17:27316454;Lit-BM-17:9535896;SIGNOR:14996911], JAK2 [DOMINO:16273093;HPRD-phos:10635327;HPRD-phos:16799092;HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:18669648;HPRD-phos:18691976;HPRD-phos:9363897;HPRD:10635327;HPRD:9363897;InnateDB:15284024;KEA:10635327;KEA:15302935;KEA:17081983;KEA:9363897;Lit-BM-17:10358079;Lit-BM-17:16273093;Lit-BM-17:23838182;ProtMapper:10459005;ProtMapper:23838182;ProtMapper:9363897;SIGNOR:9363897;iPTMnet:10635327;iPTMnet:16799092;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:18669648;iPTMnet:18691976;iPTMnet:9363897], PTPN2 [BioGRID:11514572;DEPOD:10488121;DEPOD:11479308;DEPOD:9488479;HPRD:15588985;HPRD:9488479;ProtMapper:10488121;ProtMapper:11479308;ProtMapper:9488479;SIGNOR:11514572;SIGNOR:15592458], PRKCD [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;HPRD-phos:2984676;HPRD-phos:2987962;HPRD:2984676;HPRD:2987962;KEA:15302935;KEA:1860884;KEA:2984676;KEA:2987962;KEA:3379075;KEA:6090944;KEA:85012702;NetPath:17956904;ProtMapper:1860884;SIGNOR:1860884;iPTMnet:2984676;iPTMnet:2987962], SCAMP3 [HPRD:15144186;HPRD:9658162;MPPI:9658162;SIGNOR:9658162], ANXA1 [CellTalkDB:15581623;Cellinker:15581623;HPRD:15581623;IntAct:15581623;IntAct:20029029;IntAct:31980649;LRdb:15581623;Lit-BM-17:15581623;Lit-BM-17:20029029;Lit-BM-17:24189400;connectomeDB2020:15581623], GSTP1 [CellTalkDB:26429914], CALM1 [BioGRID:12359306;BioGRID:14960328;HPRD:12153558;InnateDB:16799092;Lit-BM-17:14960328;Lit-BM-17:16799092;Lit-BM-17:20029029;Lit-BM-17:24658140;Lit-BM-17:25402006], CALM2 [CellTalkDB:21115073;HPRD:12153558;InnateDB:16799092;IntAct:14960328;IntAct:20029029;IntAct:24658140;Lit-BM-17:14960328;Lit-BM-17:16799092;Lit-BM-17:20029029;Lit-BM-17:24658140;Lit-BM-17:25402006], CALM3 [CellTalkDB:19527647;HPRD:12153558;InnateDB:16799092;Lit-BM-17:14960328;Lit-BM-17:16799092;Lit-BM-17:20029029;Lit-BM-17:24658140;Lit-BM-17:25402006], PTPN1 [BioGRID:10889023;BioGRID:8621392;BioGRID:9050838;DEPOD:10889023;DEPOD:12424235;DEPOD:21123182;DEPOD:7540771;DEPOD:8621392;DEPOD:9050838;DEPOD:9355745;DOMINO:9355745;HPRD:10889023;HPRD:11506178;HPRD:12573287;HPRD:7540771;HPRD:8621392;HPRD:9355745;InnateDB:15982634;IntAct:24658140;IntAct:25796184;IntAct:31980649;IntAct:9050838;IntAct:9355745;Lit-BM-17:10889023;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:7693694;Lit-BM-17:8621392;Lit-BM-17:9050838;Lit-BM-17:9355745;NetPath:9050838;ProtMapper:11900546;ProtMapper:12424235;ProtMapper:8621392;ProtMapper:9050838;SIGNOR:8621392], RASA1 [CancerCellMap:1633149;CancerCellMap:1850098;DOMINO:16273093;HPRD:1633149;HPRD:1850098;Lit-BM-17:1385407;Lit-BM-17:16273093;Lit-BM-17:8647858;NetPath:1850098;SIGNOR:1850098], EPS15 [HPRD:10953014;HPRD:9049247;NetPath:9049247;SIGNOR:15383614], VAV2 [HPRD:10618391;HPRD:10938113;HPRD:11516622;HPRD:12454019;NetPath:10618391;NetPath:12577067;NetPath:19531499;SIGNOR:10618391], TRIP13 [SIGNOR:32860853], HDAC6 [BioGRID:20133936;IntAct:20029029;IntAct:24658140;IntAct:31980649;Lit-BM-17:20029029;Lit-BM-17:20133936;Lit-BM-17:24658140;Lit-BM-17:25402006], CDK1 [IntAct:24658140;IntAct:31980649;KEA:15302935;KEA:15901825;KEA:8360196;Lit-BM-17:15657067;Lit-BM-17:18271526;Lit-BM-17:23956138;Lit-BM-17:24658140;Lit-BM-17:25402006;PhosphoSite:8360196;ProtMapper:28150246;ProtMapper:8360196;SIGNOR:8360196;iPTMnet:8360196;phosphoELM:8360196], PRKCA [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;CancerCellMap:12878187;HPRD:12878187;IntAct:24658140;IntAct:31980649;KEA:15302935;KEA:1860884;KEA:2984676;KEA:2987962;KEA:3379075;KEA:6090944;KEA:7805884;KEA:85012702;Lit-BM-17:12878187;Lit-BM-17:24658140;Lit-BM-17:25402006;NetPath:12878187;ProtMapper:10816576;ProtMapper:15212693;ProtMapper:20888375;SIGNOR:10816576;iPTMnet:10816576;phosphoELM:1860884;phosphoELM:6090944], PTPRG [ProtMapper:25624455;SIGNOR:25624455], MAPK3 [KEA:15302935;KEA:15901825;KEA:1651323;KEA:17081983;KEA:17192257;KEA:17570479;KEA:1939237;KEA:2115882;KEA:2543683;KEA:3138233;KEA:91332050;PhosphoSite:16785992;PhosphoSite:1939237;PhosphoSite:2115882;PhosphoSite:2543683;PhosphoSite:27531070;PhosphoSite:34086370;ProtMapper:1651322;SIGNOR:1651322;iPTMnet:1651322;iPTMnet:1939237;phosphoELM:1939237], MAPK1 [CancerCellMap:12556561;HPRD:12556561;KEA:15302935;KEA:15901825;KEA:1651323;KEA:17081983;KEA:17192257;KEA:1939237;KEA:2115882;KEA:2543683;KEA:3138233;KEA:91332050;NetPath:12556561;ProtMapper:1651322;SIGNOR:1651322;iPTMnet:1651322;iPTMnet:1939237;phosphoELM:1939237], PTPN6 [CancerCellMap:7518460;CancerCellMap:7673163;Cellinker:9733788;DEPOD:9038217;HPRD-phos:9733788;HPRD:9733788;NetPath:7673163;ProtMapper:9733788;SIGNOR:9733788], CHKA [SIGNOR:21822308], USP8 [BioGRID:16120644;BioGRID:25853104;SIGNOR:16120644;SIGNOR:16520378;SIGNOR:20736164], PTPN11 [BioGRID:7588774;CancerCellMap:7673163;CancerCellMap:8197172;DEPOD:12582165;DEPOD:14560030;DOMINO:16273093;DOMINO:16729043;HPRD:11223155;HPRD:14560030;HPRD:16729043;HPRD:7673163;InnateDB:12270932;IntAct:16273093;IntAct:16729043;IntAct:28065597;KEA:15618223;Lit-BM-17:16273093;Lit-BM-17:16729043;Lit-BM-17:7673163;Lit-BM-17:9756944;NetPath:12577067;NetPath:7673163;ProtMapper:10411909;ProtMapper:12582165;ProtMapper:14560030;ProtMapper:9642214;SIGNOR:12582165;SIGNOR:14560030], PTPRJ [DEPOD:19836242;HPRD:9115287;Lit-BM-17:19167335;Lit-BM-17:19836242;ProtMapper:19836242;SIGNOR:19836242], CAMK2G [HPRD:10347170;HPRD:1309762;KEA:10347170;KEA:1309762;KEA:15302935;KEA:16799092;KEA:3138233;KEA:7505275;KEA:7805884;KEA:92065884;ProtMapper:1309762;SIGNOR:1309762;iPTMnet:10347170;iPTMnet:1309762;iPTMnet:16799092], RIN1 [SIGNOR:12783862], PTPRK [DEPOD:16263724;ProtMapper:16263724;SIGNOR:16263724], MAPK11 [ACSN:11274345;ACSN:12738796;ACSN:15187187;ACSN:18039929;SIGNOR:16932740], PKN1 [ProtMapper:21749319;SIGNOR:21749319;iPTMnet:21749319], DCN [Baccin2019:12105206;Baccin2019:9988678;BioGRID:9988678;CellTalkDB:12105207;Cellinker:12105206;Cellinker:23350913;Cellinker:9988678;HPRD:12105206;HPRD:9988678;LRdb:12105207;Lit-BM-17:12105206;Lit-BM-17:9988678;connectomeDB2020:12105206;connectomeDB2020:9988678], GRN [CellTalkDB:32103204], CEACAM1 [CellTalkDB:15467833;HPRD:15467833], ST6GAL1 [CellTalkDB:29402301], CEACAM6 [CellTalkDB:28892050], MIF [CellTalkDB:26280537;Cellinker:26280537], AMH [Baccin2019:8596488;CellTalkDB:8596488;Cellinker:8596488;HPRD:8596488;LRdb:8596488;connectomeDB2020:8596488], TGFB1 [CellTalkDB:32103204;ProtMapper:19132220;ProtMapper:20953304;ProtMapper:28943431], CDH1 [Baccin2019:10969083;BioGRID:10969083;CellTalkDB:10969083;Cellinker:10969083;HPRD:10969083;InnateDB:17548604;IntAct:24658140;IntAct:25241761;IntAct:31980649;LRdb:10969083;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:25241761;Lit-BM-17:25402006;Lit-BM-17:25468996;connectomeDB2020:10969083], ICAM1 [CellTalkDB:16799092;Cellinker:16799092;HPRD:16799092;InnateDB:16799092;LRdb:16799092], VCAN [Baccin2019:23449934;CellTalkDB:16045811;Cellinker:16045811;LRdb:16045811;Ramilowski2015:16045811;connectomeDB2020:16045811;talklr:16045811], TNC [Baccin2019:11470832;CellTalkDB:11470832;Cellinker:11470832;HPRD:11470832;LRdb:11470832;connectomeDB2020:11470832], BCAN [CellTalkDB:32196115], S100A4 [CellTalkDB:30083275;Cellinker:30083275;IntAct:24658140;IntAct:30083275;IntAct:31980649;Lit-BM-17:24658140;Lit-BM-17:25402006], ZP3 [CellTalkDB:22577141;connectomeDB2020:22577141], NRG1 [BioGRID:7730382;CellTalkDB:32251632;Cellinker:30813222;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:7730382], FGF1 [CellTalkDB:32196115], NRG4 [CellTalkDB:32196115], L1CAM [CellTalkDB:14718570;Cellinker:14718570;LRdb:14718570;Ramilowski2015:14718570;connectomeDB2020:14718570;talklr:14718570], EFEMP1 [Baccin2019:19804359;CellTalkDB:19804359;Cellinker:19804359;LRdb:19804359;Ramilowski2015:19804359;connectomeDB2020:19804359;talklr:19804359], FGL1 [CellTalkDB:24768768;Cellinker:24768768;LRdb:24768768;Ramilowski2015:24768768;connectomeDB2020:24768768;talklr:24768768], ARF4 [CancerCellMap:12446727;HPRD:12446727;Lit-BM-17:12446727;NetPath:12446727], GNAI2 [HPRD:11286993;LRdb:11286993;connectomeDB2020:11286993], ANG [CellTalkDB:30449278;ProtMapper:19254952], FGF13 [CellTalkDB:32196115], HSP90AA1 [BioGRID:16024644;CellTalkDB:18199556;IntAct:20029029;IntAct:24658140;IntAct:31980649;LRdb:18199556;Lit-BM-17:12006493;Lit-BM-17:12471035;Lit-BM-17:16024644;Lit-BM-17:16849543;Lit-BM-17:20029029;Lit-BM-17:23956138;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:25402006;Ramilowski2015:18199556;connectomeDB2020:18199556;talklr:18199556], CAMP [CellTalkDB:26527065], CNTF [CellTalkDB:32103204], CCN2 [CellTalkDB:23929714], LRIG2 [CellTalkDB:25353163], VEGFA [CellTalkDB:32196115], SPINK1 [CellTalkDB:21368222;Cellinker:21368222;LRdb:21368222;Ramilowski2015:21368222;connectomeDB2020:21368222;talklr:21368222], MYO1D [Cellinker:31420606], ANXA2 [Cellinker:26438086], CDCP1 [Cellinker:23045285], EPHA2 [Cellinker:23045285;HPRD:15657067], PTGIR [Cellinker:16373414], MET [BioGRID:21918175;BioGRID:24362532;Cellinker:28004613;Cellinker:28536399;HPRD:10722725;IntAct:20624308;IntAct:23866081;IntAct:26551075], JAK1 [Cellinker:23045285;InnateDB:15284024], AXL [Cellinker:23045285;Lit-BM-17:25873175], PLA2G2A [Cellinker:28440478], OSMR [Cellinker:27110918], IGF1R [BioGRID:17047074;Cellinker:15253384], ITGB4 [Cellinker:23045285;InnateDB:19940114;NetPath:11684709], AR [CancerCellMap:12534934;Cellinker:15288768;HPRD:12534934;HPRD:15288768;NetPath:12534934;NetPath:18358509;ProtMapper:18951974;ProtMapper:22260327], FLT1 [Cellinker:31717527], UBA52 [NA], CTNNB1 [HPRD:9233779], PRKCE [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;Lit-BM-17:24658140;Lit-BM-17:25402006;PhosphoSite:10816576;PhosphoSite:11185568;PhosphoSite:12359306;PhosphoSite:1556153;PhosphoSite:16793002;PhosphoSite:17942932;PhosphoSite:18042729;PhosphoSite:1860884;PhosphoSite:20692258;PhosphoSite:21749319;PhosphoSite:23205726;PhosphoSite:2984676;PhosphoSite:2987962;PhosphoSite:3379075;PhosphoSite:6090944;ProtMapper:23830194;ProtMapper:27016036], AKT2 [PhosphoSite:21487020], CDC25A [DEPOD:11912208;HPRD:11912208], ACP1 [DEPOD:2787757;DEPOD:7532092;DEPOD:9784386], PTPN9 [DEPOD:20335174], PTPRU [DEPOD:8870675], PTPRS [DEPOD:10435588;DEPOD:15522239;HPRD:10435588], CSK [ACSN:18829532;ACSN:9819392;DOMINO:16729043;IntAct:16729043;IntAct:24658140;IntAct:31980649;Lit-BM-17:16729043;Lit-BM-17:24658140;Lit-BM-17:24797263;Lit-BM-17:25402006;NetPath:16729043;ProtMapper:12771140;ProtMapper:20667610;ProtMapper:22430206;ProtMapper:23830194;ProtMapper:28325761], PLCG2 [DOMINO:16273093;IntAct:16273093;IntAct:24658140;IntAct:25241761;IntAct:31980649;Lit-BM-17:16273093;Lit-BM-17:24658140;Lit-BM-17:25241761;Lit-BM-17:25402006], ABL2 [DOMINO:16273093;IntAct:16273093;IntAct:24658140;IntAct:31980649;Lit-BM-17:16273093;Lit-BM-17:24658140;Lit-BM-17:25402006], BLK [DOMINO:16273093;IntAct:16273093;IntAct:24658140;IntAct:31980649;Lit-BM-17:16273093;Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:11160627], PTK6 [BioGRID:8940083;CancerCellMap:11114724;CancerCellMap:8940083;DOMINO:16273093;HPRD:8940083;Lit-BM-17:16273093;Lit-BM-17:8940083;NetPath:8940083;ProtMapper:22231447;iPTMnet:22231447], PRKD1 [CancerCellMap:10523301;CancerCellMap:2984676;CancerCellMap:2987962;HPRD:10523301;HPRD:2984676;HPRD:2987962;ProtMapper:26465157;dbPTM:10523301;dbPTM:15302935;dbPTM:16083266;dbPTM:17081983;dbPTM:17192257;dbPTM:18220336;dbPTM:18669648;dbPTM:18691976;dbPTM:19369195;dbPTM:19413330;dbPTM:3138233;iPTMnet:10523301], CDK2 [KEA:17570479], CSNK2A2 [KEA:17570479], PRKCB [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:17570479;KEA:7805884], PTPRA [IntAct:28065597;IntAct:31980649;KEA:15618223], GRK2 [HPRD:15620700;NetPath:18463167], PRKACA [BioGRID:12589790;HPRD:9050991], TNK2 [BioGRID:20359967;HPRD:8497321;HPRD:8647288;NetPath:17182860], ITGB1 [BioGRID:31641961], FOS [ACSN:11274345;ACSN:12738796;ACSN:16393692;ACSN:17439715;ACSN:18039929;ACSN:8545107;BioGRID:31444232], MAP3K14 [CancerCellMap:11116146;HPRD:11116146;NetPath:11116146], RIPK1 [CancerCellMap:11116146;HPRD:11116146;NetPath:11116146], ELF3 [CancerCellMap:1651322;HPRD:1651322;ProtMapper:1651323], AKT1 [Lit-BM-17:24658140;Lit-BM-17:25402006;NetPath:18662999], STAMBP [NetPath:15314065], PAK1 [HPRD:12522133;Lit-BM-17:24658140;Lit-BM-17:25402006;NetPath:12522133], CASP3 [ACSN:16455648;ACSN:17613518;ACSN:19900451;ACSN:9390557;InnateDB:11226410], LYN [HPRD:16799092;InnateDB:16799092;IntAct:23764002;IntAct:23866081;IntAct:24658140;IntAct:31980649;Lit-BM-17:16799092;Lit-BM-17:23764002;Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:11160627;ProtMapper:22430206], SH3KBP1 [IntAct:11894095], PDCD6IP [HPRD:15557335;IntAct:15557335;IntAct:24658140;IntAct:31980649;Lit-BM-17:12771190;Lit-BM-17:15456872;Lit-BM-17:15557335;Lit-BM-17:24658140;Lit-BM-17:25402006], PTPN12 [IntAct:20029029;IntAct:21376233;IntAct:24658140;IntAct:28065597;IntAct:31980649;Lit-BM-17:20029029;Lit-BM-17:21376233;Lit-BM-17:24658140;Lit-BM-17:25402006], CTNNA1 [IntAct:25241761;Lit-BM-17:15657067;Lit-BM-17:24189400;Lit-BM-17:25241761], HCK [IntAct:23397142;IntAct:24658140;IntAct:31980649;Lit-BM-17:23397142;Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:11160627], HSPB1 [IntAct:23397142;Lit-BM-17:15657067;Lit-BM-17:23397142;Lit-BM-17:24189400;ProtMapper:28646091], SHC4 [IntAct:24658140;IntAct:31980649;Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:24430869], FGR [IntAct:24658140;IntAct:31980649;Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:11160627], MAP4K1 [HPRD:9346925;Lit-BM-17:24658140;Lit-BM-17:25402006], JUP [Lit-BM-17:24658140;Lit-BM-17:24797263;Lit-BM-17:25402006;Lit-BM-17:9535896], AURKA [Lit-BM-17:23520446;ProtMapper:23520446], FRK [Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:25594057;ProtMapper:29348886], PRKCZ [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;Lit-BM-17:24658140;Lit-BM-17:25402006], SOCS6 [Lit-BM-17:24658140;Lit-BM-17:25402006;ProtMapper:28751715], IGFBP3 [Lit-BM-17:23178489], FAS [HPRD:12586732], CMTM8 [HPRD:16263120]	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]	actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor binding [GO:0048408]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]	activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGFR&keywords=EGFR	13.69901175	132	3430.68	46	0.7174692483	309	0	0.5214570858	0.01548672566	0.1472422062	0.1077441077	0.001692047377	9.07E-04	0	3.70E-04	4.67E-04	4.25E-04	233	329	334	0.07234464174	0.1259336259	0.1271163721	0.1266015167	425	415	420	246
KDR	kinase insert domain receptor	Yes	Yes	aka VEGFR2. Receptor for VEGF	ENSG00000128052	P35968	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	23	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14786, O43915, O60565, P00533, P04004, P06241, P07585, P07947, P08069, P10145, P12931, P15692, P16333, P17706, P17948, P22681, P23467, P23470, P24666, P29350, P35625, P35916, P39060, P49765, P49767, P98077, Q00535, Q03135, Q06124, Q12913, Q13322, Q13535, Q8NFY4, Q9NQ36, Q9NRA1, Q9UKB1	ACP1, ATR, CAV1, CBL, CDK5, COL18A1, CXCL8, DCN, EGFR, FBXW11, FLT1, FLT4, FYN, GRB10, GREM1, IGF1R, NCK1, NRP1, PDGFC, PTPN11, PTPN2, PTPN6, PTPRB, PTPRG, PTPRJ, SCUBE2, SEMA6D, SHC2, SRC, TIMP3, VEGFA, VEGFB, VEGFC, VEGFD, VTN, YES1	PTPN2 [DEPOD:18840653;ProtMapper:18840653;SIGNOR:18840653;SPIKE:19737086], SHC2 [HPRD:10749680;HPRD:9790910;Lit-BM-17:10749680;Lit-BM-17:12214271;Lit-BM-17:9790910;SignaLink3:10749680;SignaLink3:1220983;SignaLink3:23331499], VEGFA [Baccin2019:15637071;Baccin2019:17318185;Baccin2019:8621427;BioGRID:16901919;CellChatDB:16633338;CellTalkDB:8621427;Cellinker:15637071;Cellinker:17318185;Cellinker:8621427;DIP:11333271;DIP:20145116;DIP:8621427;DIP:8631822;DIP:9556609;HPMR:8356051;HPRD:17318185;HPRD:8621427;ICELLNET:11181169;ICELLNET:1417831;IntAct:1417831;IntAct:16763549;IntAct:20145116;IntAct:20660291;IntAct:21596751;IntAct:22897854;IntAct:23374253;IntAct:23583373;IntAct:31932617;LRdb:15637071;LRdb:17318185;LRdb:8621427;Lit-BM-17:11333271;Lit-BM-17:12716911;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:18325345;Lit-BM-17:19818105;Lit-BM-17:20145116;Lit-BM-17:22897854;Lit-BM-17:23374253;Lit-BM-17:23583373;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9556609;ProtMapper:12189247;ProtMapper:22174934;ProtMapper:24023956;ProtMapper:24966171;ProtMapper:27005951;SIGNOR:17658244;connectomeDB2020:15637071;connectomeDB2020:17318185;connectomeDB2020:8621427;scConnect:31023826], VEGFC [Baccin2019:11332691;Baccin2019:8612600;CellChatDB:16633338;CellTalkDB:8612600;Cellinker:11332691;Cellinker:8612600;DIP:20145116;HPRD:11332691;ICELLNET:11181169;IntAct:20145116;LRdb:11332691;LRdb:8612600;Lit-BM-17:20145116;SIGNOR:9435229;connectomeDB2020:11332691;connectomeDB2020:8612600], PDGFC [NA], PTPRG [ProtMapper:25624455;SIGNOR:25624455], PTPN6 [DEPOD:18377662;HPRD:16453023;HPRD:9405464;ProtMapper:16337972;ProtMapper:18377662;ProtMapper:18840653;SIGNOR:18377662;SIGNOR:18840653], VEGFD [CellChatDB:16633338;CellTalkDB:9435229;Cellinker:9435229;HPRD:9435229;ICELLNET:16835467;SIGNOR:9435229;connectomeDB2020:9435229], PTPRB [DEPOD:19136612;ProtMapper:19136612;SIGNOR:19136612], PTPRJ [DEPOD:18936167;IntAct:18936167;ProtMapper:12771128;ProtMapper:18936167;SIGNOR:18936167], VTN [CellTalkDB:32196115;Cellinker:31677479], GREM1 [Baccin2019:27174917;CellTalkDB:20660291;IntAct:20660291;connectomeDB2020:20660291;connectomeDB2020:25810250;connectomeDB2020:27174917;connectomeDB2020:27894090], TIMP3 [Baccin2019:12652295;CellTalkDB:12652295;Cellinker:12652295;HPRD:12652295;LRdb:12652295;connectomeDB2020:12652295], SEMA6D [Baccin2019:14977921;CellTalkDB:14977921;LRdb:14977921;connectomeDB2020:14977921], CXCL8 [CellTalkDB:32196115], COL18A1 [Baccin2019:12029087;CellTalkDB:12682293;Cellinker:12029087;HPRD:12029087;LRdb:12029087;connectomeDB2020:12029087], DCN [Cellinker:23350913], VEGFB [Cellinker:27834687], SCUBE2 [Cellinker:27834687], SRC [BioGRID:18194650;HPRD:10455194;HPRD:16966330;IntAct:12509223;IntAct:18377662;IntAct:18662404;PhosphoSite:10749680;PhosphoSite:12214271;ProtMapper:19050761], CDK5 [PhosphoSite:27438154;ProtMapper:27438154;iPTMnet:27438154], ACP1 [DEPOD:10608891;HPRD:10608891], PTPN11 [DEPOD:19706677;HPRD:9405464], EGFR [KEA:17570479], IGF1R [KEA:17570479], FLT4 [HPRD:15474514;IntAct:16530705;IntAct:20224550;IntAct:21130043], FLT1 [BioGRID:12796773;BioGRID:25387128;HPRD:10865839;ProtMapper:18504303], CBL [BioGRID:20011623;HPRD:12649282], NRP1 [BioGRID:11948691;BioGRID:19857463;BioGRID:26037503;HPRD:11333271;HPRD:16763549;HPRD:17222790], FBXW11 [Lit-BM-17:21900206;Lit-BM-17:22711876], GRB10 [HPRD:11494124], ATR [HPRD:10749680], NCK1 [HPRD:16966330;HPRD:9405464;ProtMapper:26659946], CAV1 [HPRD:12529448;ProtMapper:19923922;ProtMapper:20462514], FYN [HPRD:7929439], YES1 [HPRD:7929439]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDR&keywords=KDR	27.60083415	80	NA	NA	1.66707087	147	0	0.002994011976	1.180309735	0.1038369305	0	0.001692047377	0.002719854941	0.00163132137	0.001109877913	7.01E-04	0.003206490245	231	324	260	0.1180182997	0.08678351406	0.08358983206	0.1031609565	436	429	428	245
CCR10	C-C motif chemokine receptor 10	Yes	Yes		ENSG00000184451	P46092	G-protein coupled receptor 1 family	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00585, O15444, O43927, P13500, P80075, P80098, Q99731, Q9NRJ3, Q9Y4X3	CCL19, CCL2, CCL21, CCL25, CCL27, CCL28, CCL7, CCL8, CXCL13	CCL27 [CellPhoneDB:24218476;CellTalkDB:11821900;Cellinker:10725697;Cellinker:11821900;Cellinker:12718728;DIP:10725697;DIP:10781587;Guide2Pharma:10725697;HPMR:11821900;HPMR:12718728;HPRD:10725697;HPRD:11821900;ICELLNET:22633458;LRdb:10725697;LRdb:11821900;LRdb:12718728;connectomeDB2020:10725697;connectomeDB2020:11821900;connectomeDB2020:12718728;scConnect:10725697], CCL28 [Baccin2019:10781587;Baccin2019:10975800;Cellinker:10781587;Cellinker:10975800;HPRD:10781587;HPRD:10975800;ICELLNET:22633458;LRdb:10781587;LRdb:11;connectomeDB2020:10781587;connectomeDB2020:10975800], CCL2 [Baccin2019:10706668;Baccin2019:9364936;CellTalkDB:9364936;Cellinker:10706668;Cellinker:9364936;HPRD:10706668;HPRD:9364936;LRdb:107;LRdb:9364936;connectomeDB2020:10706668;connectomeDB2020:9364936], CXCL13 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCL19 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;InnateDB:10706668;LRdb:10706668;connectomeDB2020:10706668], CCL25 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCL7 [Baccin2019:9364936;CellTalkDB:9364936;Cellinker:9364936;HPRD:9364936;LRdb:9364936;connectomeDB2020:10706668;connectomeDB2020:9364936], CCL21 [connectomeDB2020:10706668], CCL8 [Baccin2019:10706668;Baccin2019:9364936]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR10&keywords=CCR10	0.126699511	593	NA	NA	0.0439417504	751	0	0.003992015968	0.00110619469	0.01534772182	0.003367003367	0.0372250423	0.05439709882	0.01794453507	0.01368849427	0.03712111096	0.01371450647	194	146	185	0.01799124761	0.8462821877	1.683423033	0.8472114855	172	29	139	380
CCR4	C-C motif chemokine receptor 4	Yes	Yes		ENSG00000183813	P51679	G-protein coupled receptor 1 family	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00626, P10147, P13500, P13501, P16619, P25098, P35626, P48061, P80075, Q92583, Q9UBR5	CCL17, CCL2, CCL22, CCL3, CCL3L1, CCL5, CCL8, CKLF, CXCL12, GRK2, GRK3	CCL17 [CellPhoneDB:24218476;Cellinker:29637711;DIP:10488147;DIP:10498628;DIP:9169459;DIP:9169480;DIP:9430724;Guide2Pharma:9430724;HPMR:9169480;HPRD:9169480;HPRD:9430724;ICELLNET:10540332;ICELLNET:22633458;InnateDB:9169480;LRdb:10699158;connectomeDB2020:9169480;connectomeDB2020:9430724;scConnect:9430724], CCL22 [Baccin2019:9430724;Baccin2019:9743322;Baccin2019:9933589;CellPhoneDB:24218476;Cellinker:29637711;DIP:9430724;Guide2Pharma:9430724;HPRD:9430724;HPRD:9743322;HPRD:9933589;ICELLNET:22633458;InnateDB:9430724;LRdb:10699158;connectomeDB2020:9430724;connectomeDB2020:9743322;connectomeDB2020:9933589;scConnect:9430724], CCL2 [Baccin2019:16421945;CellTalkDB:16421945;LRdb:16421945;SIGNOR:17160712;connectomeDB2020:16421945], CKLF [CellTalkDB:10699158;LRdb:10699158], CXCL12 [CellTalkDB:32196115], CCL5 [Baccin2019:12270118;Baccin2019:8573157;CellPhoneDB:24218476;Cellinker:12270118;HPRD:12270118;HPRD:8573157;LRdb:12270118;LRdb:86;connectomeDB2020:12270118;connectomeDB2020:8573157], CCL3 [CellTalkDB:8573157;HPRD:8573157;LRdb:8573157;connectomeDB2020:8573157], CCL8 [Baccin2019:16421945], CCL3L1 [Baccin2019:8573157], GRK2 [HPRD:10754297], GRK3 [HPRD:10754297]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron migration [GO:0001764]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of positive chemotaxis [GO:0050927]; response to antibiotic [GO:0046677]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]; tolerance induction [GO:0002507]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR4&keywords=CCR4	0.07549434382	647	NA	NA	0.2401537535	490	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	569
CCR8	C-C motif chemokine receptor 8	Yes	Yes		ENSG00000179934	P51685	G-protein coupled receptor 1 family	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15467, P10451, P13236, P22362, P55774, Q92583	CCL1, CCL16, CCL17, CCL18, CCL4, SPP1	CCL1 [Baccin2019:10419462;Baccin2019:11154210;Baccin2019:12645948;Baccin2019:12967681;Baccin2019:16221874;Baccin2019:9211859;CellPhoneDB:24218476;Cellinker:10419462;Cellinker:11154210;Cellinker:12645948;Cellinker:12967681;Cellinker:16221874;Cellinker:9211859;DIP:10910894;DIP:11470772;DIP:9211859;DIP:9469461;Guide2Pharma:10419462;Guide2Pharma:11154210;Guide2Pharma:16221874;HPMR:12645948;HPRD:12967681;HPRD:9211859;ICELLNET:9207005;InnateDB:9211859;LRdb:10699158;SIGNOR:12645948;connectomeDB2020:10419462;connectomeDB2020:11154210;connectomeDB2020:12645948;connectomeDB2020:12967681;connectomeDB2020:16221874;connectomeDB2020:9211859;scConnect:10419462;scConnect:11154210;scConnect:16221874], CCL16 [CellTalkDB:10910894;Cellinker:10910894;DIP:10910894;HPRD:10910894;ICELLNET:22633458;LRdb:10910894;connectomeDB2020:10910894], CCL18 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:24218476;ICELLNET:23999500;InnateDB:23999500;LRdb:24218476;connectomeDB2020:24218476], CCL17 [CellTalkDB:10699158;Cellinker:12832759;Cellinker:9521068;DIP:10910894;HPRD:12832759;HPRD:9521068;LRdb:10699158;connectomeDB2020:12832759;connectomeDB2020:9521068], CCL4 [Baccin2019:9521068;CellTalkDB:10699158;Cellinker:9521068;HPRD:9521068;LRdb:10699158;connectomeDB2020:9521068], SPP1 [NA]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; coreceptor activity [GO:0015026]	calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR8&keywords=CCR8	0.02826315056	714	NA	NA	0.4993143657	371	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	543
CCR9	C-C motif chemokine receptor 9	Yes	Yes		ENSG00000173585	P51686	G-protein coupled receptor 1 family	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15444, Q99616	CCL13, CCL25	CCL25 [Baccin2019:10229797;Baccin2019:10498628;Baccin2019:11159507;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:11159507;DIP:10229797;DIP:10498628;HPMR:11159507;HPRD:10229797;HPRD:10498628;ICELLNET:22633458;LRdb:10699158;SIGNOR:11159507;connectomeDB2020:10229797;connectomeDB2020:10498628;connectomeDB2020:11159507], CCL13 [CellTalkDB:32196115]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]	calcium-mediated signaling [GO:0019722]; CD8-positive, gamma-delta intraepithelial T cell differentiation [GO:0002305]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR9&keywords=CCR9	0.1695154888	562	NA	NA	0.7925370157	290	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	426
CSF1R	colony stimulating factor 1 receptor	Yes	Yes		ENSG00000182578	P07333	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14543, P04141, P06213, P08069, P09603, P09919, P22681, P49715, Q01196, Q02548, Q15717, Q6ZMJ4	CBL, CEBPA, CSF1, CSF1_IL34, CSF2, CSF3, ELAVL1, IGF1R, IL34, INSR, PAX5, RUNX1, SOCS3	ELAVL1 [SPIKE:19151756], PAX5 [SPIKE:15676205], CSF1 [Baccin2019:2408759;Baccin2019:7883784;Baccin2019:8355686;CellTalkDB:8355686;Cellinker:2408759;Cellinker:7883784;Cellinker:8355686;DIP:22153499;DIP:22483114;DIP:22902366;DIP:26235028;HPMR:1702217;HPMR:7883784;HPRD:2408759;HPRD:8355686;ICELLNET:26095744;IntAct:22153499;IntAct:22483114;IntAct:22902366;IntAct:26235028;LRdb:2408759;LRdb:7883784;LRdb:8355686;SIGNOR:24890514;connectomeDB2020:2408759;connectomeDB2020:7883784;connectomeDB2020:8355686], RUNX1 [SPIKE:15676205], CEBPA [SPIKE:15676205], CSF3 [NA], CSF2 [NA], IL34 [Baccin2019:30205037;CellTalkDB:22729249;Cellinker:31616414;DIP:22483114;DIP:23478061;ICELLNET:26095744;IntAct:22483114;IntAct:23478061;LRdb:22729249;ProtMapper:29796177;Ramilowski2015:22729249;SIGNOR:24890514;connectomeDB2020:22729249;scConnect:18467591;talklr:22729249], CBL [HPRD:11847211;LMPID:11847211;LMPID:15737992;Lit-BM-17:10025673;Lit-BM-17:10648820;Lit-BM-17:11847211;Lit-BM-17:11850825;Lit-BM-17:7782294], IGF1R [KEA:17570479], INSR [KEA:17570479], SOCS3 [HPRD:12133942]	cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; cytokine binding [GO:0019955]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; cell-cell junction maintenance [GO:0045217]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cytokine-mediated signaling pathway [GO:0019221]; forebrain neuron differentiation [GO:0021879]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary gland duct morphogenesis [GO:0060603]; microglial cell proliferation [GO:0061518]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation by host of viral process [GO:0044794]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; response to ischemia [GO:0002931]; ruffle organization [GO:0031529]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF1R&keywords=CSF1R	2.365493187	295	NA	NA	0.1286324099	605	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	450
CSF3R	colony stimulating factor 3 receptor	Yes	No		ENSG00000119535	Q99062	Type I cytokine receptor family, Type 2 subfamily	22	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14543, O60674, P04141, P06239, P07948, P08246, P08631, P09603, P09919, P23458, P43405, P49715	CEBPA, CSF1, CSF2, CSF3, ELANE, HCK, JAK1, JAK2, LCK, LYN, SOCS3, SYK	SOCS3 [HPRD:12133942;InnateDB:12133942;SPIKE:17312100], CSF3 [Baccin2019:10364174;CellTalkDB:10364174;Cellinker:10364174;DIP:16492764;HPRD:10364174;ICELLNET:10537111;LRdb:10364174;SIGNOR:16492764;SPIKE:15676205;SignaLink3:10364174;SignaLink3:16492764;SignaLink3:23331499;connectomeDB2020:10364174], CEBPA [SPIKE:15676205], JAK1 [HPRD:7512720], JAK2 [HPRD:7775438], CSF1 [SIGNOR:16492764;SignaLink3:16492764;SignaLink3:23331499], CSF2 [Baccin2019:11091218;CellTalkDB:11091218;Cellinker:11091218;Cellinker:16720384;DIP:11468284;HPMR:11091218;HPMR:7691413;LRdb:11091218;Lit-BM-17:11468284;Lit-BM-17:9187659;SIGNOR:16492764;SIGNOR:7691413;SignaLink3:16492764;SignaLink3:23331499;connectomeDB2020:11091218], HCK [HPRD:9790917;KEA:8547634;KEA:9790917;ProtMapper:9790917;SIGNOR:9790917;iPTMnet:9790917], ELANE [HPRD:14587040], LCK [HPRD:9790917], LYN [HPRD:8197119], SYK [HPRD:8197119]	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023]	cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF3R&keywords=CSF3R	0.2009771496	544	NA	NA	0.003812463758	873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	709
CX3CR1	C-X3-C motif chemokine receptor 1	Yes	No		ENSG00000168329	P49238	G-protein coupled receptor 1 family	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P78423, Q9Y258	CCL26, CX3CL1	CX3CL1 [Baccin2019:11432858;Baccin2019:14607932;Baccin2019:9390561;Baccin2019:9931005;CellPhoneDB:24218476;Cellinker:11432858;Cellinker:14607932;Cellinker:28389721;Cellinker:9390561;Cellinker:9931005;DIP:10488147;Guide2Pharma:14607932;HPMR:11432858;HPRD:9390561;HPRD:9931005;ICELLNET:22633458;InnateDB:9390561;InnateDB:9931005;LRdb:10699158;Lit-BM-17:10488147;Lit-BM-17:9931005;SIGNOR:11432858;connectomeDB2020:11432858;connectomeDB2020:14607932;connectomeDB2020:9390561;connectomeDB2020:9931005;scConnect:14607932], CCL26 [Cellinker:29637711;ICELLNET:20974991;ICELLNET:22633458;InnateDB:20974991]	cell surface [GO:0009986]; dendritic tree [GO:0097447]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; C-X3-C chemokine binding [GO:0019960]; C-X3-C chemokine receptor activity [GO:0016495]; CX3C chemokine receptor binding [GO:0031737]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]	adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; autocrine signaling [GO:0035425]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system maturation [GO:0021626]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; leukocyte tethering or rolling [GO:0050901]; memory [GO:0007613]; microglial cell activation involved in immune response [GO:0002282]; modulation of chemical synaptic transmission [GO:0050804]; multiple spine synapse organization, single dendrite [GO:0150090]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of microglial cell mediated cytotoxicity [GO:1904150]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of microglial cell migration [GO:1904139]; regulation of neurogenesis [GO:0050767]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of synaptic plasticity [GO:0048167]; regulation of tumor necrosis factor production [GO:0032680]; response to ischemia [GO:0002931]; response to wounding [GO:0009611]; social behavior [GO:0035176]; synapse maturation [GO:0060074]; synapse pruning [GO:0098883]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CX3CR1&keywords=CX3CR1	0.2429348269	527	NA	NA	0.1551261337	569	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	548
CXCR3	C-X-C motif chemokine receptor 3	Yes	TBD		ENSG00000186810	P49682	G-protein coupled receptor 1 family	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00585, O14625, O43927, P02776, P02778, P04899, P10720, P13501, P48061, P51671, P78556, P80098, Q07325, Q99616, Q99731	CCL11, CCL13, CCL19, CCL20, CCL21, CCL5, CCL7, CXCL10, CXCL11, CXCL12, CXCL13, CXCL9, GNAI2, PF4, PF4V1	CXCL9 [Baccin2019:12782716;Baccin2019:12884299;Baccin2019:15761110;Baccin2019:9660793;BioGRID:12782716;BioGRID:9660793;CellPhoneDB:24218476;Cellinker:12782716;Cellinker:12884299;Cellinker:15761110;Cellinker:9660793;DIP:11259614;DIP:9625760;DIP:9660793;Guide2Pharma:15761110;Guide2Pharma:9660793;HPRD:12782716;HPRD:9660793;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:9660793;connectomeDB2020:12782716;connectomeDB2020:12884299;connectomeDB2020:15761110;connectomeDB2020:9660793;scConnect:15761110;scConnect:9660793], CXCL10 [Baccin2019:10233762;Baccin2019:12571234;Baccin2019:12884299;Baccin2019:15761110;Baccin2019:9064356;Baccin2019:9660793;CellPhoneDB:24218476;Cellinker:10233762;Cellinker:12571234;Cellinker:12884299;Cellinker:15761110;Cellinker:9064356;Cellinker:9660793;DIP:9625760;DIP:9660793;Guide2Pharma:15761110;Guide2Pharma:9660793;HPMR:9064356;HPRD:10233762;HPRD:12571234;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:10233762;SPIKE:12571234;connectomeDB2020:10233762;connectomeDB2020:12571234;connectomeDB2020:12884299;connectomeDB2020:15761110;connectomeDB2020:9064356;connectomeDB2020:9660793;scConnect:15761110;scConnect:9660793], CXCL11 [Baccin2019:12884299;Baccin2019:15273303;Baccin2019:15761110;Baccin2019:9625760;CellPhoneDB:24218476;Cellinker:12884299;Cellinker:15273303;Cellinker:15761110;Cellinker:9625760;DIP:11259614;DIP:9625760;Guide2Pharma:15761110;HPRD:15273303;HPRD:9625760;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:16189514;connectomeDB2020:12884299;connectomeDB2020:15273303;connectomeDB2020:15761110;connectomeDB2020:9625760;scConnect:15761110], CCL13 [CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCL19 [Baccin2019:9660793;CellTalkDB:9660793;Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCL20 [Baccin2019:9660793;Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCL5 [Baccin2019:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CXCL12 [Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCL11 [Baccin2019:96607939660793;CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;ICELLNET:22633458;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCL7 [Baccin2019:9660793;CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CXCL13 [Baccin2019:11554781;CellTalkDB:11554781;Cellinker:11554781;HPRD:11554781;ICELLNET:11554781;ICELLNET:22633458;LRdb:11554781;connectomeDB2020:11554781], PF4 [Baccin2019:12782716;CellPhoneDB:24218476;Cellinker:12782716;HPRD:12782716;ICELLNET:12782716;ICELLNET:21655676;LRdb:10699158;connectomeDB2020:12782716], PF4V1 [ICELLNET:22633458;connectomeDB2020:28859966], CCL21 [Baccin2019:26888559;CellTalkDB:11907075;Cellinker:26888559;Ramilowski2015:11907075;connectomeDB2020:11907075;talklr:11907075], GNAI2 [CellTalkDB:32196115]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine binding [GO:0019956]; chemokine receptor activity [GO:0004950]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; signaling receptor activity [GO:0038023]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of leukocyte migration [GO:0002685]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR3&keywords=CXCR3	0.03367716742	708	NA	NA	0.04264594765	756	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	732
CXCR4	C-X-C motif chemokine receptor 4	Yes	Yes		ENSG00000121966	P61073	G-protein coupled receptor 1 family	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O60674, O95715, P01137, P01730, P04233, P06748, P07550, P09429, P11309, P14174, P19835, P23458, P25106, P34947, P35348, P35368, P35626, P41597, P43250, P48061, P51681, P52333, P54578, P62937, P63096, Q03403, Q05397, Q05655, Q07654, Q96DA0, Q96J02, Q9Y5W3	ACKR3, ADRA1A, ADRA1B, ADRB2, CCR2, CCR5, CD4, CD74, CEL, CXCL12, CXCL14, GNAI1, GRK3, GRK5, GRK6, HMGB1, ITCH, JAK1, JAK2, JAK3, KLF2, MIF, NPM1, PIM1, PPIA, PRKCD, PTK2, TFF2, TFF3, TGFB1, USP14, ZG16B	KLF2 [SPIKE:19671192], JAK3 [HPRD:10506573;InnateDB:10506573], GNAI1 [HPRD:10506573], CXCL12 [Baccin2019:10233851;Baccin2019:12714578;Baccin2019:8752280;Baccin2019:8752281;Baccin2019:9551924;Baccin2019:9712844;BioGRID:21757744;BioGRID:25495026;CellPhoneDB:24218476;Cellinker:10233851;Cellinker:12714578;Cellinker:18448868;Cellinker:8752280;Cellinker:8752281;Cellinker:9551924;Cellinker:9712844;Guide2Pharma:16626895;Guide2Pharma:18648536;Guide2Pharma:30476826;Guide2Pharma:9551924;Guide2Pharma:9712844;HPMR:8752280;HPRD:10233851;HPRD:8752281;ICELLNET:22633458;InnateDB:16725153;InnateDB:19837984;LRdb:10699158;ProtMapper:24023874;ProtMapper:26582643;SIGNOR:11859124;connectomeDB2020:10233851;connectomeDB2020:12714578;connectomeDB2020:8752280;connectomeDB2020:8752281;connectomeDB2020:9551924;connectomeDB2020:9712844;scConnect:16626895;scConnect:18648536;scConnect:30476826;scConnect:9551924;scConnect:9712844], CD74 [Cellinker:29637711;SIGNOR:19665027], MIF [CellTalkDB:19665027;ICELLNET:17435771;SIGNOR:17435771;connectomeDB2020:17435771], USP14 [SIGNOR:26523394], PRKCD [ProtMapper:28449947;SIGNOR:10521508], TGFB1 [Baccin2019:27314628;CellTalkDB:32196115], CXCL14 [CellTalkDB:32239134;connectomeDB2020:28360196], HMGB1 [CellTalkDB:22370717;Cellinker:23519706], CEL [CellTalkDB:18037996;Cellinker:18037996;LRdb:18037996;Ramilowski2015:18037996;connectomeDB2020:18037996;talklr:18037996], ZG16B [CellTalkDB:20802527;LRdb:20802527;Ramilowski2015:20802527;connectomeDB2020:20802527;talklr:20802527], TFF2 [connectomeDB2020:19064997;connectomeDB2020:23183167], TFF3 [connectomeDB2020:26780310], ADRA1A [Cellinker:29637711;IntAct:25775528;IntAct:27331810;IntAct:28862946], ADRA1B [Cellinker:29637711;IntAct:25775528;IntAct:28862946;IntAct:29426850], CCR5 [DIP:18632580;HPRD:12429730;InnateDB:18923649;InnateDB:19758998;IntAct:15660419;IntAct:18632580;Lit-BM-17:12429730;Lit-BM-17:15660419;Lit-BM-17:18632580], ACKR3 [Cellinker:29637711;IntAct:19380869;IntAct:21730065;IntAct:25775528;IntAct:27331810;IntAct:28862946;IntAct:29386406], ADRB2 [Cellinker:29637711], CD4 [BioGRID:10816381;BioGRID:14592831;Cellinker:29637711;HPRD:15660419;InnateDB:19066282], CCR2 [Cellinker:29637711;InnateDB:19758998], GRK6 [PhosphoSite:19116316;PhosphoSite:20048153;PhosphoSite:24309376;PhosphoSite:24489825;PhosphoSite:25355818;PhosphoSite:30936203;ProtMapper:20048153;ProtMapper:28328745;dbPTM:19116316;dbPTM:20048153;iPTMnet:20048153], PIM1 [PhosphoSite:16357147;PhosphoSite:26212080;PhosphoSite:28694325;ProtMapper:18778182;ProtMapper:19687226;ProtMapper:23360755;ProtMapper:23817178;ProtMapper:26075720;ProtMapper:29665227;iPTMnet:19687226], GRK5 [ProtMapper:24632620;iPTMnet:24632620], ITCH [BioGRID:24489825;BioGRID:28264927;Lit-BM-17:19116316;Lit-BM-17:24489825], PTK2 [HPRD:11668182;NetPath:11668182], GRK3 [HPRD:11668182;NetPath:11668182], PPIA [InnateDB:17991743], NPM1 [InnateDB:17715399], JAK2 [HPRD:10506573;InnateDB:10506573], JAK1 [HPRD:12163560]	cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; coreceptor activity [GO:0015026]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]	apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR4&keywords=CXCR4	33.13135713	65	NA	NA	0.8257754044	278	0.4409448819	0.00748502994	1.853982301	0.160911271	0	0.006768189509	0.009972801451	0	0.00332963374	0.00257043664	0.007031099092	225	272	225	0.2266359676	0.05632970285	0.05312141162	0.07197172628	446	443	443	265
CXCR6	C-X-C motif chemokine receptor 6	Yes	No		ENSG00000172215	O00574	G-protein coupled receptor 1 family	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q9H2A7	CXCL16	CXCL16 [Baccin2019:11017100;Baccin2019:11290797;Baccin2019:14625285;CellTalkDB:14625285;Cellinker:11017100;Cellinker:11290797;Cellinker:14625285;Guide2Pharma:11290797;HPMR:14625285;HPRD:11017100;HPRD:11290797;ICELLNET:22633458;LRdb:11017100;LRdb:11290797;LRdb:14625285;SPIKE:14625285;connectomeDB2020:11017100;connectomeDB2020:11290797;connectomeDB2020:14625285;scConnect:11290797]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; coreceptor activity [GO:0015026]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; viral genome replication [GO:0019079]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR6&keywords=CXCR6	0.1690201912	563	NA	NA	0.1890833418	531	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	547
FLT1	fms related receptor tyrosine kinase 1	Yes	No		ENSG00000102755	P17948	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O15197, O43915, O75487, P00747, P05067, P06213, P15692, P22681, P35968, P49763, P49765, P49767, P51654, Q05397, Q06124, Q07326, Q12913, Q13535, Q9NRA1	APP, ATR, CBL, EPHB6, GPC3, GPC4, INSR, KDR, PDGFC, PGF, PIGF, PLG, PTK2, PTPN11, PTPRJ, VEGFA, VEGFB, VEGFC, VEGFD	VEGFB [Baccin2019:9751730;Baccin2019:97517301;BioGRID:10409677;CellChatDB:16633338;CellTalkDB:9751730;Cellinker:9751730;HPRD:9751730;ICELLNET:11181169;ICELLNET:26285753;LRdb:97517301;LRdb:98;ProtMapper:29397867;SignaLink3:10409677;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9751730;connectomeDB2020:9751730;connectomeDB2020:97517301], VEGFA [Baccin2019:15637071;Baccin2019:17051153;Baccin2019:8621427;Baccin2019:9393862;CellChatDB:16633338;CellTalkDB:17051153;Cellinker:15637071;Cellinker:17051153;Cellinker:8621427;Cellinker:9393862;DIP:8621427;DIP:8631822;HPMR:8356051;HPRD:17051153;HPRD:8621427;HPRD:9393862;ICELLNET:26285753;IntAct:10543948;IntAct:20660291;IntAct:9393862;LRdb:15637071;LRdb:17051153;LRdb:8621427;LRdb:9393862;Lit-BM-17:10543948;Lit-BM-17:21939755;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9393862;ProtMapper:21441409;ProtMapper:22348123;SIGNOR:14704231;connectomeDB2020:15637071;connectomeDB2020:17051153;connectomeDB2020:8621427;connectomeDB2020:9393862], PTPRJ [IntAct:12771128;IntAct:16893970;SIGNOR:12771128], PGF [Baccin2019:14684734;Baccin2019:9452434;CellChatDB:16633338;CellTalkDB:9452434;Cellinker:14684734;Cellinker:9452434;DIP:8700872;HPRD:14684734;HPRD:9452434;ICELLNET:19029957;IntAct:14684734;LRdb:147;LRdb:9452434;Lit-BM-17:14684734;Lit-BM-17:8700872;Lit-BM-17:9452434;ProtMapper:27009237;ProtMapper:29193887;connectomeDB2020:14684734;connectomeDB2020:9452434], PIGF [CellTalkDB:7929268;LRdb:7929268;ProtMapper:22177802;Ramilowski2015:7929268;talklr:7929268], PDGFC [CellTalkDB:32196115], VEGFC [CellTalkDB:32196115], PLG [CellTalkDB:32196115], VEGFD [CellTalkDB:32196115], GPC4 [Cellinker:32589946], EPHB6 [Cellinker:32589946], GPC3 [Cellinker:32589946], APP [Cellinker:32589946], PTPN11 [HPRD-phos:9600074;HPRD:9600074], INSR [KEA:17570479], KDR [BioGRID:12796773;BioGRID:25387128;HPRD:10865839], CBL [ACSN:10514377;ACSN:17635922;Lit-BM-17:18273061;Lit-BM-17:25387128], ATR [HPRD:10749680], PTK2 [HPRD:12023386]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLT1&keywords=FLT1	20.99667374	100	NA	NA	1.829381241	132	0	0.005988023952	1.213495575	0.1333333333	0.001683501684	0.001692047377	0.001813236627	0	0.001849796522	8.68E-04	0.004519992274	229	320	246	0.1241130406	0.08835678074	0.0810356666	0.1082668189	435	431	426	246
FLT4	fms related receptor tyrosine kinase 4	Yes	No		ENSG00000037280	P35916	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	22	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43915, P01375, P02452, P02751, P07948, P08123, P12931, P35968, P49767, Q02413, Q05397, Q9NRA1	COL1A1, COL1A2, DSG1, FN1, KDR, LYN, PDGFC, PTK2, SRC, TNF, VEGFC, VEGFD	VEGFC [Baccin2019:12881528;Baccin2019:16530705;Baccin2019:8700872;CellChatDB:16633338;CellTalkDB:12881528;Cellinker:12881528;Cellinker:16530705;Cellinker:8700872;DIP:8700872;HPMR:12881528;HPRD:16530705;HPRD:8700872;ICELLNET:11532940;ICELLNET:16336962;LRdb:12881528;LRdb:16530705;LRdb:8700872;ProtMapper:24798152;SIGNOR:9435229;connectomeDB2020:12881528;connectomeDB2020:16530705;connectomeDB2020:8700872], VEGFD [BioGRID:11279005;CellChatDB:16633338;CellTalkDB:9435229;Cellinker:9435229;HPRD:9435229;ICELLNET:11532940;ICELLNET:16336962;SIGNOR:9435229;connectomeDB2020:21148085;connectomeDB2020:9435229], PDGFC [NA], SRC [PhosphoSite:20431062;ProtMapper:20431062;SIGNOR:20431062;dbPTM:12881528;dbPTM:16076871;dbPTM:18083107;dbPTM:20431062;iPTMnet:20431062], COL1A1 [CellTalkDB:32196115], TNF [CellTalkDB:32103204], COL1A2 [CellTalkDB:32196115], FN1 [CellTalkDB:15389531], DSG1 [Cellinker:32589946], LYN [KEA:17570479], KDR [HPRD:15474514;IntAct:16530705;IntAct:20224550;IntAct:21130043;iPTMnet:12881528], PTK2 [HPRD:16452200]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLT4&keywords=FLT4	1.528139544	334	NA	NA	0.1476533047	576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	455
IL13RA1	interleukin 13 receptor subunit alpha 1	Yes	No		ENSG00000131724	P78552	Type I cytokine receptor family, Type 5 subfamily	22	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P05112, P24394, P29597, P35225	IL13, IL4, IL4R, TYK2	IL13 [Baccin2019:1270434311278620;CellTalkDB:12704343;DIP:20223216;DIP:8910586;HPMR:12704343;HPRD:11278629;InnateDB:9013879;IntAct:18243101;IntAct:20223216;LRdb:11;LRdb:12704343;Lit-BM-17:18243101;Lit-BM-17:8910586;SIGNOR:12704343;SignaLink3:10485906;SignaLink3:11867689;SignaLink3:12223527;SignaLink3:12401408;SignaLink3:14610620;SignaLink3:14657224;SignaLink3:15099563;SignaLink3:16243976;SignaLink3:16413922;SignaLink3:17404308;SignaLink3:17485448;SignaLink3:18250477;SignaLink3:18451175;SignaLink3:19833085;SignaLink3:20184663;SignaLink3:20406969;SignaLink3:20510870;SignaLink3:20856220;SignaLink3:21097505;SignaLink3:21115385;SignaLink3:21469115;SignaLink3:21840487;SignaLink3:23124025;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:23390297;SignaLink3:24030977;SignaLink3:24091328;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:27216177;SignaLink3:7512720;SignaLink3:7521688;SignaLink3:7543512;SignaLink3:8910586;SignaLink3:9013879;SignaLink3:9535722;connectomeDB2020:11278629;connectomeDB2020:12704343], TYK2 [HPRD:10409622;InnateDB:12223527;KEA:10409622], IL4R [HPRD:8910586;InnateDB:18243101;InnateDB:8910586;Lit-BM-17:18243101;NetPath:16682236], IL4 [CellTalkDB:18480254;IntAct:18243101;LRdb:10641437;LRdb:18480254;Lit-BM-17:18243101;Ramilowski2015:10641437;SIGNOR:12704343;connectomeDB2020:10641437;talklr:10641437]	external side of plasma membrane [GO:0009897]; interleukin-13 receptor complex [GO:0005898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]	cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL13RA1&keywords=IL13RA1	45.30396383	47	NA	NA	1.218336175	194	0.1732283465	0.2195608782	0.139380531	0.09712230216	0.2154882155	0.3553299492	0.3200362647	0.1092985318	0.1757306696	0.2289357725	0.09565385358	46	37	66	0.1936150286	0.9121658204	1.173468256	0.5188902524	141	86	267	91
IL1R1	interleukin 1 receptor type 1	Yes	Yes		ENSG00000115594	P14778	Interleukin-1 receptor family	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43187, P01583, P01584, P17252, P18510, Q5VT25, Q8WWZ1, Q99836, Q9NPH3	CDC42BPA, IL1A, IL1B, IL1F10, IL1RAP, IL1RN, IRAK2, MYD88, PRKCA	IL1A [Baccin2019:29469592946959;CellTalkDB:2946959;HPRD:2946959;InnateDB:8142597;LRdb:2946959;NetPath:17507369;NetPath:2946959;NetPath:7775431;SIGNOR:7964161;SIGNOR:9565970;SPIKE:19479203;SignaLink3:23331499;SignaLink3:2946959;SignaLink3:9565970;connectomeDB2020:2946959], IL1B [Baccin2019:62193;Baccin2019:9062193;Baccin2019:9820540;CellTalkDB:9062193;HPRD:9062193;InnateDB:8142597;LRdb:62193;LRdb:9062193;LRdb:9820540;Lit-BM-17:7878046;Lit-BM-17:9062193;Macrophage:9062193;NetPath:2946959;NetPath:7775431;SIGNOR:24166242;SIGNOR:9625767;SPIKE:17145710;SPIKE:9062193;SignaLink3:23331499;SignaLink3:9062193;connectomeDB2020:62193;connectomeDB2020:9062193;connectomeDB2020:9820540], IRAK2 [HPRD:12659850;HPRD:9374458;InnateDB:12659850;InnateDB:9374458;NetPath:9374458], IL1RAP [Cellinker:11756486;HPRD:9371760;InnateDB:15044087;InnateDB:15866876;InnateDB:9371760;InnateDB:9430229;NetPath:10854325;NetPath:17507369;NetPath:7775431;NetPath:9430229;SIGNOR:12530978;SignaLink3:12530978;SignaLink3:23331499;SignaLink3:9371760], IL1RN [Baccin2019:11641511;Baccin2019:9062194;BioGRID:9062194;CellTalkDB:11641511;Cellinker:11641511;Cellinker:9062194;HPRD:11641511;HPRD:9062194;ICELLNET:20959797;ICELLNET:24332029;InnateDB:8142597;LRdb:11641511;LRdb:91;NetPath:7589429;SIGNOR:2876877;connectomeDB2020:9062194], MYD88 [HPRD:12659850;InnateDB:12609980;InnateDB:12659850;InnateDB:15866876;InnateDB:15905496;InnateDB:16286016;InnateDB:16354686;InnateDB:19940113;InnateDB:9430229;Macrophage:17507369;NetPath:17507369;NetPath:9430229], IL1F10 [Baccin2019:11278614;CellTalkDB:11278614;Cellinker:11278614;HPRD:11278614;LRdb:11278614;connectomeDB2020:11278614], CDC42BPA [KEA:17570479], PRKCA [KEA:17570479]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	interleukin-1, type I, activating receptor activity [GO:0004909]; interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; platelet-derived growth factor receptor binding [GO:0005161]; protease binding [GO:0002020]; transmembrane signaling receptor activity [GO:0004888]	cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1-mediated signaling pathway [GO:2000661]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1R1&keywords=IL1R1	49.90035059	42	NA	NA	1.333977134	181	0.1653543307	0.5124750499	0.06305309735	0.8678657074	0.1565656566	0.1692047377	0.3200362647	0.1044045677	0.04402515723	0.08385632261	0.2412207842	133	95	38	0.2480056069	0.2093952836	0.3637762905	0.9737028091	397	337	87	164
IL4R	interleukin 4 receptor	Yes	Yes		ENSG00000077238	P24394	Type I cytokine receptor family, Type 4 subfamily	22	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, O75159, P05112, P07332, P23458, P29350, P35225, P42226, P52333, P78552, Q05513, Q9HBE4	FES, IL13, IL13RA1, IL21, IL4, JAK1, JAK2, JAK3, PRKCZ, PTPN6, SOCS5, STAT6	JAK1 [HPRD:12133952;InnateDB:12133952;InnateDB:12223527;NetPath:11127821], IL4 [Baccin2019:791837811786020;CellTalkDB:7918378;DIP:10219247;DIP:7721786;DIP:9874253;HPMR:11815609;HPMR:7918378;HPRD:11786020;InnateDB:21889455;InnateDB:2278997;InnateDB:2307934;InnateDB:8266078;InnateDB:8639787;IntAct:10219247;IntAct:18243101;IntAct:23597562;IntAct:8266078;LRdb:118;LRdb:7918378;Lit-BM-17:10219247;Lit-BM-17:11786020;Lit-BM-17:18243101;Lit-BM-17:23597562;Lit-BM-17:7721786;Lit-BM-17:8266078;Lit-BM-17:9874253;NetPath:10850446;NetPath:8266078;SIGNOR:10219247;SIGNOR:12704343;SIGNOR:18852293;SPIKE:11786020;SPIKE:17312100;SignaLink3:10219247;SignaLink3:23331499;connectomeDB2020:11786020;connectomeDB2020:7918378], JAK3 [HPRD:7538655;InnateDB:12207328;NetPath:12207328], IL13RA1 [HPRD:8910586;InnateDB:18243101;InnateDB:8910586;Lit-BM-17:18243101;NetPath:16682236;SignaLink3:23331499;SignaLink3:8910586], IL13 [Baccin2019:1270434311709750;CellTalkDB:8920992;DIP:7721786;HPMR:12704343;HPRD:11709756;InnateDB:18243101;InnateDB:8910586;LRdb:12;LRdb:12704343;NetPath:7721786;SIGNOR:12704343;SIGNOR:19880493;connectomeDB2020:11709756;connectomeDB2020:12704343], JAK2 [HPRD:8609418;InnateDB:12223527;InnateDB:8609418;NetPath:8609418], IL21 [Cellinker:21058223], STAT6 [BioGRID:9651359;HPRD:15661890;InnateDB:21268015;IntAct:8816495;IntAct:9392697;IntAct:9651359;LMPID:9712048;Lit-BM-17:8816495;Lit-BM-17:9392697;Lit-BM-17:9651359;NetPath:10358772], FES [HPRD:7518439;NetPath:7518439], PTPN6 [HPRD:11714803;InnateDB:9065461;NetPath:11714803], PRKCZ [HPRD:15526032;NetPath:15526032], SOCS5 [HPRD:12242343;NetPath:12242343]	centriolar satellite [GO:0034451]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	interleukin-4 receptor activity [GO:0004913]	defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL4R&keywords=IL4R	34.43175314	61	NA	NA	0.8364367237	277	0.1338582677	0.3103792415	0.3207964602	0.2086330935	0.1464646465	0.005076142132	0.002719854941	0.00163132137	0.001109877913	8.68E-04	0.002704268882	231	320	269	0.1031128286	0.09821943323	0.09608052227	0.1123150136	433	425	425	271
IL6R	interleukin 6 receptor	Yes	Yes		ENSG00000160712	P08887	Type I cytokine receptor family, Type 3 subfamily	22	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14543, O14672, O95998, P05231, P12931, P20809, P23458, P25189, P26441, P30530, P78536, Q8N475	ADAM10, ADAM17, AXL, CNTF, FSTL5, IL11, IL18BP, IL6, JAK1, MPZ, SOCS3, SRC	SOCS3 [SPIKE:17312100], IL6 [AlzPathway:18067990;Baccin2019:12829785;Baccin2019:14557255;Baccin2019:3136546;BioGRID:14557255;BioGRID:2788034;CellTalkDB:12829785;DIP:7744001;DIP:8702737;DIP:9028955;DIP:9694899;Guide2Pharma:1995637;HPMR:15895091;HPMR:3136546;HPRD:12829785;HPRD:14557255;InnateDB:14557255;InnateDB:14656210;InnateDB:15895091;InnateDB:7744875;InnateDB:8706672;InnateDB:9694899;IntAct:11238858;IntAct:28265003;LRdb:12829785;LRdb:14557255;LRdb:3136546;Lit-BM-17:12643274;Lit-BM-17:12829785;Lit-BM-17:14557255;Lit-BM-17:18775332;Lit-BM-17:2788034;Lit-BM-17:7744001;Lit-BM-17:8702737;Lit-BM-17:9028955;Lit-BM-17:9694899;NetPath:2788034;NetPath:7893704;SIGNOR:15895091;SIGNOR:18923185;SIGNOR:23663276;SIGNOR:8676083;SignaLink3:11238858;SignaLink3:12643274;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2788034;connectomeDB2020:12829785;connectomeDB2020:14557255;connectomeDB2020:3136546;scConnect:1995637], ADAM10 [CellTalkDB:21454673], ADAM17 [CellTalkDB:22575642;InnateDB:24790088], CNTF [Baccin2019:1281789;BioGRID:1281789;Cellinker:1281789;HPRD:1281789;LRdb:1281789;connectomeDB2020:1281789], MPZ [Cellinker:32822567], IL18BP [Cellinker:32822567], IL11 [Cellinker:26551279], FSTL5 [Cellinker:32822567], AXL [Cellinker:32822567], JAK1 [DOMINO:11557047], SRC [HPRD:10462375]	apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803]	acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL6R&keywords=IL6R	14.30919641	129	NA	NA	1.081158567	224	0.1653543307	0.08832335329	0.02765486726	0.1110311751	0.1060606061	0.3214890017	0.4650951949	0.2022838499	0.1305956345	0.1432434237	0.3310025111	59	63	25	0.1901939953	0.7022969609	0.7654746261	1.703360336	226	208	14	156
KIT	KIT proto-oncogene, receptor tyrosine kinase	Yes	Yes		ENSG00000157404	P10721	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	22	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14544, O60674, O96017, P00519, P05771, P06213, P06239, P06241, P07947, P07948, P08069, P08631, P08962, P12931, P17252, P21583, P21926, P22681, P22694, P23470, P29350, P41240, P42224, P42679, P60033, Q06124, Q06187, Q13191, Q13239, Q13976, Q9ULZ2, Q9Y240	ABL1, BTK, CBL, CBLB, CD63, CD81, CD9, CHEK2, CLEC11A, CSK, FYN, HCK, IGF1R, INSR, JAK2, KITLG, LCK, LYN, MATK, PRKACB, PRKCA, PRKCB, PRKG1, PTPN11, PTPN6, PTPRG, SLA, SOCS6, SRC, STAP1, STAT1, YES1	KITLG [Baccin2019:1375232;Baccin2019:1698556;Baccin2019:7680037;BioGRID:1375232;BioGRID:7680037;CancerCellMap:7680037;CellTalkDB:1698556;Cellinker:12036870;Cellinker:1375232;Cellinker:1698556;Cellinker:7680037;Guide2Pharma:7536489;HPRD:1375232;HPRD:7680037;ICELLNET:17662946;LRdb:1375232;LRdb:1698556;LRdb:7680037;Lit-BM-17:1375232;Lit-BM-17:17662946;Lit-BM-17:7680037;NetPath:7680037;ProtMapper:25717186;ProtMapper:26358753;SIGNOR:1698556;SIGNOR:17259966;SPIKE:1375232;SPIKE:7680037;connectomeDB2020:1375232;connectomeDB2020:1698556;connectomeDB2020:7680037;scConnect:7536489], CSK [SignaLink3:23707526], MATK [BioGRID:9038210;CancerCellMap:7536744;CancerCellMap:9038210;HPRD:7536744;HPRD:9038210;NetPath:9038210;SignaLink3:23331499;SignaLink3:7536744;SignaLink3:9038210], STAP1 [HPRD:10679268;NetPath:10679268;SIGNOR:10679268], SOCS6 [HPRD:14707129;Lit-BM-17:21030588;Lit-BM-17:24728074;NetPath:14707129;SIGNOR:21030588], SLA [SIGNOR:24284075], STAT1 [CancerCellMap:10358045;CancerCellMap:9355737;HPRD:9355737;InnateDB:10358045;LMPID:23416972;Lit-BM-17:25241761;Lit-BM-17:9355737;NetPath:9355737], SRC [CancerCellMap:10523831;CancerCellMap:12878163;HPRD:12878163;KEA:12878163;NetPath:7520444;ProtMapper:12878163;SIGNOR:12878163;iPTMnet:12878163;phosphoELM:12878163], PRKCA [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;CancerCellMap:7539802;CancerCellMap:7693453;HPRD-phos:7539802;HPRD:7539802;KEA:7539802;PhosphoSite:7539802;ProtMapper:7539802;SIGNOR:7539802;iPTMnet:7539802;phosphoELM:7539802], PTPN6 [DEPOD:7684496;HPRD:7684496;HPRD:9528781;LMPID:23416972;NetPath:9528781;ProtMapper:15526160;SIGNOR:9528781], PTPRG [ProtMapper:25624455;SIGNOR:25624455], CHEK2 [SIGNOR:22558186], JAK2 [CancerCellMap:7527392;CancerCellMap:8611693;HPRD:7527392;HPRD:8611693;HPRD:9355737;NetPath:8611693], PTPN11 [BioGRID:7523381;HPRD:7523381;HPRD:9528781;LMPID:23416972;Lit-BM-17:24728074;Lit-BM-17:7523381;Lit-BM-17:9528781;NetPath:9528781], CBL [ACSN:10514377;ACSN:17635922;BioGRID:15315962;BioGRID:25737303;CancerCellMap:8950973;HPRD:8950973;NetPath:15315962;NetPath:17904548;NetPath:8950973;NetPath:9092574;SIGNOR:15315962], CBLB [ACSN:10514377;ACSN:17635922;HPRD:15315962;NetPath:12177062;NetPath:15315962;SIGNOR:15315962], CLEC11A [NA], CD63 [Cellinker:12036870], CD9 [Cellinker:12036870;HPRD:12036870], CD81 [Cellinker:12036870;HPRD:12036870], FYN [CancerCellMap:9799234;HPRD:12374739;HPRD:9799234;KEA:12374739;NetPath:9038210], IGF1R [KEA:17570479], INSR [KEA:17570479], LCK [BioGRID:9788619;HPRD:9788619;KEA:17570479;Lit-BM-17:24728074;Lit-BM-17:9788619], LYN [CancerCellMap:11825908;CancerCellMap:9341198;HPRD:9341198;InnateDB:9341198;KEA:17570479;Lit-BM-17:11825908;Lit-BM-17:24728074;Lit-BM-17:9341198;NetPath:11825908;NetPath:9341198], PRKACB [KEA:17570479], PRKCB [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;CancerCellMap:7693453;HPRD:7693453;KEA:17570479], PRKG1 [KEA:17570479], HCK [CancerCellMap:11071635;HPRD:11071635;NetPath:11071635], YES1 [CancerCellMap:11071635;HPRD:11071635;NetPath:11071635], BTK [HPRD:15007095;NetPath:15007095], ABL1 [HPRD:12374739]	acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of programmed cell death [GO:0043069]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KIT&keywords=KIT	2.069614822	305	NA	NA	0.1845781564	536	0	4.99E-04	0.01991150442	0.001918465228	0.003367003367	0.001692047377	0	0	0.001479837218	1.67E-04	5.02E-04	230	341	329	0.002685181131	0.9049801575	0.8014794085	0.8279126057	144	194	148	344
MET	MET proto-oncogene, receptor tyrosine kinase	Yes	No		ENSG00000105976	P08581	Protein kinase superfamily, Tyr protein kinase family	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O00182, O14672, O43293, P00519, P00533, P04637, P06213, P07585, P07948, P08069, P10586, P12830, P12931, P14210, P17252, P17706, P18031, P19174, P22681, P23467, P23470, P35222, P35625, P40818, P42574, P51608, P51812, P62714, P78536, Q02156, Q04912, Q05513, Q05655, Q12913, Q13191, Q13480, Q13591, Q92854, Q96JA1	ABL1, ADAM10, ADAM17, CASP3, CBL, CBLB, CDH1, CTNNB1, DAPK3, DCN, EGFR, GAB1, HGF, IGF1R, INSR, LGALS9, LRIG1, LYN, MECP2, MST1R, PLCG1, PPP2CB, PRKCA, PRKCD, PRKCE, PRKCZ, PTPN1, PTPN2, PTPRB, PTPRF, PTPRG, PTPRJ, RPS6KA3, SEMA4D, SEMA5A, SRC, TIMP3, TP53, USP8	TP53 [SPIKE:18431400], HGF [Baccin2019:15167892;Baccin2019:1655405;Baccin2019:1846706;Baccin2019:18495663;BioGRID:1655405;CellChatDB:28475121;CellTalkDB:1846706;Cellinker:15167892;Cellinker:1655405;Cellinker:1846706;Cellinker:18495663;Cellinker:28475121;DIP:16537482;DIP:17804794;DIP:20624990;HPRD:15167892;HPRD:1655405;HPRD:18495663;ICELLNET:15218027;IntAct:15167892;IntAct:16537482;IntAct:17804794;IntAct:17981115;IntAct:1846706;IntAct:20624990;IntAct:22897854;LRdb:15167892;LRdb:1655405;LRdb:1846706;LRdb:18495663;Lit-BM-17:15167892;Lit-BM-17:17804794;Lit-BM-17:17981115;Lit-BM-17:1846706;Lit-BM-17:19433454;Lit-BM-17:22897854;Lit-BM-17:8380735;ProtMapper:16397249;ProtMapper:17667909;ProtMapper:20178463;ProtMapper:22001117;ProtMapper:24362531;ProtMapper:27147579;ProtMapper:28534512;SIGNOR:8380735;SPIKE:14685170;SPIKE:17145710;SPIKE:1846706;SignaLink3:23331499;SignaLink3:8380735;connectomeDB2020:15167892;connectomeDB2020:1655405;connectomeDB2020:1846706;connectomeDB2020:18495663], GAB1 [HPRD:10734310;HPRD:10995442;ProtMapper:20072648;SPIKE:10913131;SPIKE:14685170], CBL [ACSN:10514377;ACSN:17635922;BioGRID:17533376;BioGRID:19450681;DOMINO:11894096;HPRD:11894096;HPRD:18273061;IntAct:11894096;IntAct:18273061;IntAct:21163258;IntAct:25241761;LMPID:15123609;Lit-BM-17:11894096;Lit-BM-17:15123609;Lit-BM-17:16397241;Lit-BM-17:18273061;Lit-BM-17:19433454;Lit-BM-17:19450681;Lit-BM-17:21163258;Lit-BM-17:21222362;Lit-BM-17:25241761;ProtMapper:18672314;SIGNOR:19450681;SignaLink3:11894096;SignaLink3:15123609;SignaLink3:16397241;SignaLink3:18273061;SignaLink3:19450681;SignaLink3:23331499], PRKCA [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:15075332;KEA:17570479;KEA:8294430;KEA:94124523;ProtMapper:8294430;SIGNOR:8294430;iPTMnet:8294430], PTPRB [DEPOD:21454675;HPRD:16101282;ProtMapper:16101282;ProtMapper:21454675;SIGNOR:16101282;SIGNOR:21454675], PTPN1 [DEPOD:18819921;IntAct:16537444;IntAct:18579758;IntAct:22789536;Lit-BM-17:16537444;Lit-BM-17:18579758;Lit-BM-17:22789536;ProtMapper:16537444;ProtMapper:18819921;SIGNOR:16537444;SIGNOR:18819921], PTPN2 [DEPOD:18819921;ProtMapper:18819921;SIGNOR:18819921], PTPRG [ProtMapper:25624455;SIGNOR:25624455], USP8 [SIGNOR:16520378], MECP2 [SIGNOR:24150225], PTPRJ [DEPOD:12475979;HPRD-phos:12370829;HPRD:12370829;IntAct:12475979;IntAct:19167335;KEA:15475459;ProtMapper:12475979;SIGNOR:12475979], DCN [Baccin2019:26522384;CellTalkDB:10942781;LRdb:10942781;Ramilowski2015:10942781;connectomeDB2020:10942781;talklr:10942781], ADAM10 [CellTalkDB:22689693], TIMP3 [CellTalkDB:11228164], LRIG1 [BioGRID:17178829;CellTalkDB:17178829], ADAM17 [CellTalkDB:22689693], SEMA4D [CellTalkDB:12198496;LRdb:12198496;connectomeDB2020:12198496], SEMA5A [CellTalkDB:15218527;HPMR:15218527;LRdb:15218527;connectomeDB2020:15218527], IGF1R [KEA:17570479], CDH1 [InnateDB:16909210], EGFR [BioGRID:21918175;BioGRID:24362532;HPRD:10722725;IntAct:20624308;IntAct:23866081;IntAct:26551075], MST1R [PhosphoSite:12611639;PhosphoSite:12746450;PhosphoSite:14559966;PhosphoSite:15475459;PhosphoSite:1655790;PhosphoSite:16849525;PhosphoSite:16914575;PhosphoSite:17967179;PhosphoSite:19450681;PhosphoSite:21247903;PhosphoSite:21455220;PhosphoSite:21496277;PhosphoSite:23618918;PhosphoSite:26670562;PhosphoSite:33727228;PhosphoSite:33839159;PhosphoSite:8208547;PhosphoSite:8302603;ProtMapper:10871856;iPTMnet:10871856], LGALS9 [NA], ABL1 [KEA:10069803;KEA:12475979;KEA:15475459;KEA:7513258;KEA:7687741;KEA:7708691;KEA:7731718;KEA:7961992;KEA:8662889;KEA:9252406;KEA:9444958;KEA:9826708;PhosphoSite:10490849;PhosphoSite:10506185;PhosphoSite:11741535;PhosphoSite:12475979;PhosphoSite:12766170;PhosphoSite:21777671;PhosphoSite:7513258;PhosphoSite:7687741;PhosphoSite:7731718;PhosphoSite:7838524;PhosphoSite:7961992;PhosphoSite:8547236;PhosphoSite:8906793;PhosphoSite:9242692;PhosphoSite:9391119;PhosphoSite:9444958;PhosphoSite:9826708], PRKCE [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:15075332;KEA:7925482;KEA:8294430;KEA:94124523;PhosphoSite:15075332;PhosphoSite:8294430;ProtMapper:15212693;phosphoELM:15075332], PTPRF [DEPOD:16415345], CBLB [ACSN:10514377;ACSN:17635922;LMPID:15123609], PRKCD [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:15075332;KEA:7925482;KEA:8294430;KEA:94124523;phosphoELM:15075332], INSR [KEA:17570479], LYN [KEA:17570479], PPP2CB [ACSN:10995457;ACSN:16680151;ACSN:18039929;ACSN:18042541;ACSN:18588945;KEA:15075332], PRKCZ [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:15075332], RPS6KA3 [KEA:17570479], SRC [BioGRID:9837958;HPRD:9837958;IntAct:24034250;IntAct:24728074;KEA:17570479;Lit-BM-17:24034250;Lit-BM-17:24728074;Lit-BM-17:9837958], CTNNB1 [HPRD:11929826;InnateDB:16909210], DAPK3 [HPRD:15546961], PLCG1 [HPRD:7513258;HPRD:8662733], CASP3 [ACSN:16455648;ACSN:17613518;ACSN:19900451;ACSN:9390557;HPRD:15542841]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MET&keywords=MET	3.596513465	255	NA	NA	0.6124713981	334	0.2047244094	0.7894211577	0.02544247788	0.007194244604	0.4781144781	0.1065989848	0.05530371714	0.03425774878	0.1213466519	0.005207637869	0.07927371064	66	234	75	0.1733532017	0.716358649	0.08294176337	0.4868947464	222	430	276	313
PDGFRA	platelet derived growth factor receptor alpha	Yes	Yes		ENSG00000134853	P16234	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14786, P01127, P04085, P09619, P14410, P22681, P23458, P23470, Q03135, Q15238, Q9GZP0, Q9NRA1	CAV1, CBL, JAK1, NRP1, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRB, PSG5, PTPRG, SI	PDGFRB [BioGRID:2542288;HPRD:1847074;HPRD:2161888;HPRD:2542288;HPRD:7523122;Lit-BM-17:11331882;Lit-BM-17:2542288;Lit-BM-17:7523122;PhosphoSite:7523122;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2542288;SignaLink3:7523122;iPTMnet:10417313;iPTMnet:7523122], CBL [ACSN:10514377;ACSN:17635922;HPRD:9234717;SIGNOR:10347229;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9234717], CAV1 [HPRD:10066366;SignaLink3:10066366;SignaLink3:18988627;SignaLink3:23331499], PDGFC [Baccin2019:10806482;Baccin2019:11297552;Baccin2019:11342471;CellChatDB:15207812;CellTalkDB:10806482;Cellinker:15207812;Cellinker:28267575;DIP:11297552;DIP:20534510;HPMR:10806482;HPMR:15207811;HPRD:10806482;HPRD:11297552;HPRD:11342471;ICELLNET:15207811;ICELLNET:9739761;IntAct:11297552;IntAct:20534510;LRdb:10806482;LRdb:11297552;LRdb:11342471;SignaLink3:10806482;SignaLink3:11297552;SignaLink3:11342471;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10806482;connectomeDB2020:11297552;connectomeDB2020:11342471], PDGFA [Baccin2019:152078112544881;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:2544881;ICELLNET:15207811;ICELLNET:9739761;IntAct:25241761;IntAct:7679113;LRdb:15207811;LRdb:25;Lit-BM-17:11297552;Lit-BM-17:15767546;Lit-BM-17:25241761;Lit-BM-17:2544881;Lit-BM-17:7679113;SIGNOR:11803579;SignaLink3:11803579;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2544881;connectomeDB2020:15207811;connectomeDB2020:2544881], PDGFB [Baccin2019:152078112544881;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:2544881;ICELLNET:15207811;ICELLNET:9739761;IntAct:10806482;IntAct:7679113;LRdb:15207811;LRdb:25;Lit-BM-17:10806482;Lit-BM-17:11297552;Lit-BM-17:15767546;Lit-BM-17:2544881;Lit-BM-17:7679113;Lit-BM-17:9677323;SIGNOR:11331882;SignaLink3:11803579;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2544881;connectomeDB2020:15207811;connectomeDB2020:2544881], PTPRG [ProtMapper:25624455;SIGNOR:25624455], PDGFD [CellTalkDB:32196115], NRP1 [Cellinker:25744030], PSG5 [Cellinker:32822567], SI [Baccin2019:152078112544881], JAK1 [HPRD:11468294]	cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFRA&keywords=PDGFRA	8.775041181	170	NA	NA	0.2502354635	482	0	0.005988023952	0.0110619469	0.4599520384	0.0101010101	0.001692047377	9.07E-04	0.01468189233	0.001109877913	0.001402056349	0.001352134441	231	306	306	0.04620433146	0.1976694256	0.2028679295	0.2019797077	400	389	391	337
TGFBR1	transforming growth factor beta receptor 1	Yes	Yes		ENSG00000106799	P36897	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	22	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, tight_junction, transmembrane, transmembrane_predicted	O00444, O14920, O15105, O15111, O43541, O60383, O94921, O95405, O95747, O95972, P01137, P07900, P0CG47, P0CG48, P10600, P11802, P16520, P17252, P19784, P27539, P36873, P37023, P37173, P48729, P55107, P61812, P62942, P62979, P62987, P63151, P84022, P98082, Q00532, Q00534, Q00537, Q04771, Q08881, Q13107, Q13145, Q13153, Q15172, Q15796, Q16625, Q5SW24, Q6SA08, Q7Z4P5, Q7Z5Y6, Q86SG6, Q8NEV4, Q8TDR2, Q96GD4, Q9BXA7, Q9H093, Q9H0M0, Q9HAU4, Q9HC98, Q9HCE7, Q9NR23, Q9P2K8, Q9P2M7, Q9UI12, Q9UIK4, Q9Y5K5	ACVR1, ACVRL1, ATP6V1H, AURKB, BAMBI, BMP15, BMP8A, CDK14, CDK17, CDK4, CDK6, CDKL1, CGN, CHUK, CSNK1A1, CSNK2A2, DAB2, DACT2, DAPK2, EIF2AK4, FKBP1A, GDF1, GDF10, GDF3, GDF7, GDF9, GNB3, HSP90AA1, IKBKB, ITK, MYO3A, NEK6, NEK8, NUAK2, OCLN, OXSR1, PAK1, PLK4, PPP1CC, PPP2R2A, PPP2R5A, PRKCA, RPS27A, SMAD2, SMAD3, SMAD6, SMAD7, SMURF1, SMURF2, STK35, TGFB1, TGFB2, TGFB3, TGFBR2, TSSK1B, TSSK4, UBA52, UBB, UBC, UCHL5, USP4, WWP1, ZFYVE9	SMAD3 [HPRD:9311995;NetPath:11438668;NetPath:8774881], SMAD2 [HPRD:18511908;HPRD:9346908;HPRD:9525694;HPRD:9892009;InnateDB:8980228;InnateDB:9346908;NetPath:8980228;NetPath:9463378], TGFB1 [Baccin2019:12809600;Baccin2019:8235612;BioGRID:8235612;CellTalkDB:12809600;DIP:10187774;DIP:7706250;HPMR:12809600;HPRD:8235612;LRdb:12809600;LRdb:82;NetPath:11323414;NetPath:8047140;SIGNOR:22326956;SIGNOR:22703233;SIGNOR:26194464;SPIKE:7852346;connectomeDB2020:12809600;connectomeDB2020:8235612], SMAD7 [ACSN:11163210;ACSN:11278251;ACSN:12151385;ACSN:15761153;ACSN:21897371;ACSN:22286770;ACSN:22921829;ACSN:9215638;ACSN:9335505;ACSN:9335507;HPRD:15148321;HPRD:9215638;NetPath:11278251;NetPath:15221015;NetPath:18725536;NetPath:9215638;ProtMapper:16571110;SIGNOR:20663871;SIGNOR:30017632;SIGNOR:9892110;SignaLink3:14657019;SignaLink3:14722617;SignaLink3:15148321;SignaLink3:17314099;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:21791611;SignaLink3:23331499;SignaLink3:9215638], SMAD6 [ACSN:11163210;ACSN:11278251;ACSN:12151385;ACSN:15761153;ACSN:21897371;ACSN:22286770;ACSN:22921829;ACSN:9215638;ACSN:9335505;ACSN:9335507;HPRD:9335505;NetPath:9335505;SIGNOR:20663871;SIGNOR:9892110;SignaLink3:23331499;SignaLink3:9892110], BAMBI [SignaLink3:10519551;SignaLink3:23331499], ZFYVE9 [HPRD:9865696;NetPath:9865696;ProtMapper:12134149;ProtMapper:14718519;SignaLink3:12052882;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9865696], ACVRL1 [Cellinker:24319055;HPRD:14580334;InnateDB:18333754], TGFBR2 [BioGRID:25825445;DIP:10026191;DIP:23868260;DIP:7878020;HPRD-phos:8576253;HPRD:7890683;HPRD:8576253;InnateDB:18243111;KEA:8576253;Lit-BM-17:10026191;Lit-BM-17:11483955;Lit-BM-17:19556242;Lit-BM-17:19758997;Lit-BM-17:21791611;Lit-BM-17:25825445;Lit-BM-17:7878020;Lit-BM-17:7890683;NetPath:11124802;NetPath:11278251;NetPath:11323414;NetPath:11387212;NetPath:15221015;NetPath:7566156;NetPath:8047140;NetPath:9463378;PhosphoSite:7774578;ProtMapper:22802914;ProtMapper:7774578;ProtMapper:8576253;SIGNOR:26194464;SIGNOR:7774578;SIGNOR:8576253;SignaLink3:11102446;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:21791611;SignaLink3:23331499;SignaLink3:7890683;SignaLink3:8576253;dbPTM:7774578;iPTMnet:8576253;iPTMnet:8947046], DACT2 [SIGNOR:17197390;SignaLink3:19855013;SignaLink3:23331499], USP4 [SignaLink3:22706160], SMURF2 [ACSN:11163210;ACSN:11278251;ACSN:12151385;ACSN:15761153;ACSN:21897371;ACSN:22286770;ACSN:22921829;ACSN:9215638;ACSN:9335505;ACSN:9335507;HPRD:11163210;HPRD:14722617;NetPath:15221015;SIGNOR:11163210;SIGNOR:17317136;SignaLink3:22624557], DAB2 [HPRD:11387212;NetPath:11387212;SignaLink3:11387212;SignaLink3:23331499], SMURF1 [ACSN:11163210;ACSN:11278251;ACSN:12151385;ACSN:15761148;ACSN:15761153;ACSN:21572392;ACSN:21897371;ACSN:22286770;ACSN:22921829;ACSN:22949611;ACSN:9215638;ACSN:9335505;ACSN:9335507;NetPath:11278251;NetPath:15221015;SIGNOR:17317136;SignaLink3:12519765;SignaLink3:12857866;SignaLink3:14657019;SignaLink3:23331499], PPP1CC [SIGNOR:14718519;SignaLink3:14718519;SignaLink3:23331499], UCHL5 [SIGNOR:17052192;SignaLink3:17052192;SignaLink3:23331499], FKBP1A [DIP:10025408;HPRD:7518616;HPRD:9346894;Lit-BM-17:10025408;Lit-BM-17:24658140;Lit-BM-17:7518616;Lit-BM-17:7791754;NetPath:10025408;SIGNOR:8756725;SignaLink3:16720724;SignaLink3:23331499], GDF1 [NA], GDF10 [NA], GDF3 [NA], GDF7 [NA], GDF9 [Baccin2019:14684852;CellTalkDB:14514671;Cellinker:14684852;Cellinker:27252362;LRdb:14684852;connectomeDB2020:14684852], TGFB2 [Baccin2019:11157750;Baccin2019:12809600;CellTalkDB:12809600;DIP:10187774;HPMR:12809600;HPRD:11157754;LRdb:11;LRdb:12809600;NetPath:7608141;SIGNOR:22326956;connectomeDB2020:11157754;connectomeDB2020:12809600], TGFB3 [Baccin2019:11850637;Baccin2019:12060054;Baccin2019:12607775;CellTalkDB:11850637;DIP:10187774;HPRD:11850637;HPRD:12060054;HPRD:12607775;InnateDB:18243111;LRdb:11850637;LRdb:12060054;LRdb:12607775;Lit-BM-17:10187774;Lit-BM-17:21423151;connectomeDB2020:11850637], WWP1 [NetPath:15221015;SIGNOR:15221015], ATP6V1H [SIGNOR:29782852], HSP90AA1 [BioGRID:21465483;SIGNOR:18591668], PPP2R2A [HPRD:9774674;NetPath:9774674;SIGNOR:9774674], PPP2R5A [SIGNOR:9774674], GNB3 [Baccin2019:15761153;CellTalkDB:15761153;Cellinker:15761153;HPRD:15761153;LRdb:15761153], CGN [CellTalkDB:32196115], BMP8A [connectomeDB2020:28465413], BMP15 [Cellinker:27252362], OCLN [Cellinker:17916321;HPRD:15761153], RPS27A [HPRD:15761153], UBA52 [HPRD:15761153], UBB [HPRD:15761153], UBC [NA], PRKCA [PhosphoSite:23290522;iPTMnet:23290522], ACVR1 [HPRD:15761153], AURKB [HPRD:15761153], CDK4 [HPRD:15761153], CDK6 [HPRD:15761153], CDKL1 [HPRD:15761153], CHUK [HPRD:15761153], CSNK1A1 [HPRD:15761153], CSNK2A2 [HPRD:15761153], DAPK2 [HPRD:15761153], EIF2AK4 [HPRD:15761153], IKBKB [HPRD:15761153], ITK [HPRD:15761153], MYO3A [HPRD:15761153], NEK6 [HPRD:15761153], NEK8 [HPRD:15761153], NUAK2 [HPRD:15761153], OXSR1 [HPRD:15761153], PAK1 [HPRD:15761153], CDK17 [HPRD:15761153], CDK14 [HPRD:15761153], PLK4 [HPRD:15761153], STK35 [HPRD:15761153], TSSK1B [HPRD:15761153], TSSK4 [HPRD:15761153]	activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]	activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]	activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; germ cell migration [GO:0008354]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFBR1&keywords=TGFBR1	31.08114687	72	NA	NA	2.190222553	109	0.06299212598	0.2270459082	0.25	0.1494004796	0.1111111111	0.07275803723	0.08431550317	0.03262642741	0.05882352941	0.05738416344	0.02862661773	115	120	136	0.1031894458	0.6080383993	0.5953219666	0.3412563554	262	264	334	141
TNFRSF14	TNF receptor superfamily member 14	Yes	Yes		ENSG00000273936, ENSG00000157873	Q92956	Tumor necrosis factor receptor superfamily	22	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43557, O75888, O95971, P01374, P14174, P24071, Q7Z6A9	BTLA, CD160, FCAR, LTA, MIF, TNFSF13, TNFSF14	BTLA [Baccin2019:15568026;CellChatDB:21941365;CellTalkDB:22437870;Cellinker:15568026;Cellinker:21941365;HPRD:15568026;ICELLNET:12796776;ICELLNET:15568026;LRdb:22437870;Lit-BM-17:21982860;connectomeDB2020:15568026], TNFSF14 [Baccin2019:10894944;Baccin2019:11390428;Baccin2019:9462508;CellTalkDB:10894944;Cellinker:10894944;Cellinker:11390428;Cellinker:9462508;HPMR:10894944;HPRD:11390428;HPRD:9462508;ICELLNET:11239407;InnateDB:11164894;IntAct:10318773;IntAct:26977880;IntAct:9462508;LRdb:10894944;LRdb:11390428;LRdb:9462508;Lit-BM-17:10318773;Lit-BM-17:11390428;Lit-BM-17:26977880;Lit-BM-17:9462508;SIGNOR:10894944;connectomeDB2020:10894944;connectomeDB2020:11390428;connectomeDB2020:9462508], LTA [Baccin2019:9153189;Baccin2019:9462508;CellTalkDB:9153189;Cellinker:9153189;Cellinker:9462508;HPRD:9153189;HPRD:9462508;ICELLNET:7995952;InnateDB:11164894;LRdb:9153189;LRdb:946;connectomeDB2020:9153189;connectomeDB2020:9462508], CD160 [CellTalkDB:21959263;Cellinker:21959263;Cellinker:30885361;ICELLNET:18193050;LRdb:21959263;Lit-BM-17:21982860;connectomeDB2020:21959263], TNFSF13 [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], FCAR [Cellinker:32589946], MIF [NA]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine binding [GO:0019955]; tumor necrosis factor-activated receptor activity [GO:0005031]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of adaptive immune memory response [GO:1905675]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell migration [GO:2000406]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF14&keywords=TNFRSF14	2.96925059	270	NA	NA	0.04325476522	752	0.3543307087	0.07934131737	0.2455752212	0.08944844125	0.1060606061	0.1099830795	0.1260199456	0.1337683524	0.06844247133	0.09413806917	0.07316978945	107	89	77	0.1345707275	0.5425888955	0.7203261061	0.5752878948	292	225	246	334
ACVR1B	activin A receptor type 1B	Yes	Yes		ENSG00000135503	P36896	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	21	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00292, O60383, O75610, O95390, P05111, P08476, P09529, P0CG37, P12645, P13385, P18075, P27037, P27539, P55103, P55107, P58166, P61160, Q13705, Q7Z4P5, Q8N6C5, Q96S42, Q9NR23	ACTR2, ACVR2A, ACVR2B, BMP3, BMP7, CFC1, GDF1, GDF10, GDF11, GDF3, GDF7, GDF9, IGSF1, INHA, INHBA, INHBB, INHBC, INHBE, LEFTY1, LEFTY2, NODAL, TDGF1	ACVR2B [BioGRID:8622651;HPRD:8622651;InnateDB:12364468;ProtMapper:8622651;SIGNOR:8622651;SignaLink3:12364468;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:8622651;iPTMnet:8622651], ACTR2 [SignaLink3:16446785;SignaLink3:23331499], INHBA [Baccin2019:81675688397373;CellTalkDB:8167568;DIP:7890768;DIP:9605406;HPMR:8167568;HPRD:8397373;LRdb:8167568;LRdb:84;connectomeDB2020:8167568;connectomeDB2020:8397373], INHBB [Baccin2019:11266516;Baccin2019:12032389;Baccin2019:15196700;CellTalkDB:11266516;HPRD:11266516;HPRD:12032389;HPRD:15196700;LRdb:11266516;LRdb:12032389;LRdb:15196700;connectomeDB2020:11266516;connectomeDB2020:15196700], INHA [NA], GDF1 [CellTalkDB:32196115], GDF10 [CellTalkDB:22155034], GDF3 [NA], GDF7 [NA], GDF9 [NA], NODAL [Baccin2019:11952836;CellTalkDB:11952836;LRdb:11952836;SIGNOR:19874624;connectomeDB2020:11952836], TDGF1 [BioGRID:11909953;CellTalkDB:11909953;Cellinker:11909953;HPRD:11909953;LRdb:11909953;SIGNOR:19874624;connectomeDB2020:11909953], ACVR2A [DIP:8612709;InnateDB:9032295;SIGNOR:12682303], GDF11 [Baccin2019:12414726;CellTalkDB:12414726;LRdb:12414726;connectomeDB2020:12414726], CFC1 [CellTalkDB:32196115], LEFTY1 [CellTalkDB:32196115], INHBC [Baccin2019:12651901;HPRD:12651901;LRdb:12651901], LEFTY2 [CellTalkDB:32196115], INHBE [NA], BMP3 [Cellinker:27252362], IGSF1 [Cellinker:11266516;HPRD:11266516], BMP7 [Cellinker:31619522]	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]	activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVR1B&keywords=ACVR1B	28.22442068	78	NA	NA	1.50131268	161	0.0157480315	0.1561876248	0.0232300885	0.04748201439	0.05050505051	0.2250423012	0.1640979148	0.05057096248	0.115427303	0.1324609427	0.01255553409	70	68	190	0.09030070617	1.250512661	1.420338382	0.2248791156	63	50	383	89
ACVR2A	activin A receptor type 2A	Yes	Yes		ENSG00000121989	P27037	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00292, O60383, O75610, O95390, O95393, O95972, P05111, P08476, P09529, P0CG37, P12643, P12644, P12645, P13385, P18075, P22003, P22004, P27539, P34820, P37023, P43026, P55103, P55107, P58166, Q7Z4P5, Q7Z5Y6, Q96S42, Q9NR23, Q9UK05	ACVRL1, BMP10, BMP15, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, CFC1, GDF1, GDF10, GDF11, GDF2, GDF3, GDF5, GDF7, GDF9, INHA, INHA_INHBA, INHBA, INHBB, INHBC, INHBE, LEFTY1, LEFTY2, NODAL, TDGF1	INHBA [Baccin2019:11266510;Baccin2019:12466190;BioGRID:10746731;CellTalkDB:12466190;DIP:9605406;HPMR:12466190;HPRD:11266516;LRdb:11;LRdb:12466190;SIGNOR:1646080;connectomeDB2020:11266516;connectomeDB2020:12466190], INHBB [Baccin2019:1246619011266510;CellTalkDB:12466190;HPRD:11266516;LRdb:11;LRdb:12466190;connectomeDB2020:11266516;connectomeDB2020:12466190], INHA [Baccin2019:12493742;CellTalkDB:12493742;LRdb:12493742;connectomeDB2020:12493742], BMP10 [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], BMP2 [Baccin2019:20959140;CellTalkDB:21702718;DIP:10880444;DIP:25938661;InnateDB:17295905;InnateDB:17483092;Ramilowski2015:21702718;connectomeDB2020:21702718;talklr:21702718], BMP4 [Baccin2019:20959140], BMP5 [NA], BMP6 [Baccin2019:10504300;CellTalkDB:10504300;HPRD:10504300;LRdb:10504300;connectomeDB2020:10504300], BMP7 [Baccin2019:12667445;Baccin2019:7790373;Baccin2019:9748228;CellTalkDB:7790373;HPRD:12667445;HPRD:9748228;LRdb:12667445;LRdb:7790373;LRdb:9748228;SIGNOR:9748228;connectomeDB2020:12667445;connectomeDB2020:7790373;connectomeDB2020:9748228], BMP8A [connectomeDB2020:28465413], BMP8B [NA], GDF2 [CellTalkDB:22622516;LRdb:19996292;Ramilowski2015:19996292;connectomeDB2020:19996292;talklr:19996292], GDF1 [CellTalkDB:24798330], GDF10 [NA], GDF3 [NA], GDF7 [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], GDF9 [Baccin2019:12135884;CellTalkDB:12135884;Cellinker:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], TDGF1 [CellTalkDB:12682303;Cellinker:12682303;LRdb:12682303;SIGNOR:12682303;connectomeDB2020:12682303], INHBC [Baccin2019:12651901;CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;HPRD:12651901;LRdb:12651901;connectomeDB2020:12651901], CFC1 [CellTalkDB:32196115], NODAL [Baccin2019:11952836;CellTalkDB:11952836;LRdb:11952836;connectomeDB2020:11952836], BMP15 [CellTalkDB:26198319;Cellinker:27252362;Ramilowski2015:2419820;connectomeDB2020:2419820;talklr:2419820], LEFTY1 [CellTalkDB:32196115], INHBE [CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174], LEFTY2 [CellTalkDB:32196115;Cellinker:11952836], GDF11 [Baccin2019:12414726;LRdb:12414726;connectomeDB2020:12414726], GDF5 [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;connectomeDB2020:8702914], BMP3 [Baccin2019:20959140;Cellinker:27252362], ACVRL1 [Cellinker:30761306;DIP:10187774;DIP:8612709;HPRD:10187774]	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin binding [GO:0048185]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]	activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; odontogenesis of dentin-containing tooth [GO:0042475]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; sperm ejaculation [GO:0042713]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVR2A&keywords=ACVR2A	6.847262592	199	NA	NA	0.9532524987	247	0.03937007874	0.05339321357	0.02876106195	0.03357314149	0.01515151515	0.07783417936	0.04442429737	0.02936378467	0.0410654828	0.0358192015	0.01916167665	137	148	158	0.03799251211	1.064030211	0.9547156312	0.607629719	92	141	234	184
ACVR2B	activin A receptor type 2B	Yes	No		ENSG00000114739	Q13705	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00292, O14793, O60383, O75610, O95390, O95393, O95972, P05111, P08476, P09529, P12643, P12644, P12645, P13385, P16070, P18075, P22003, P22004, P27539, P34820, P43026, P55103, P55107, P58166, Q7Z4P5, Q7Z5Y6, Q96S42, Q9NR23, Q9UK05	BMP10, BMP15, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, CD44, GDF1, GDF10, GDF11, GDF2, GDF3, GDF5, GDF7, GDF9, INHA, INHA_INHBB, INHBA, INHBB, INHBC, INHBE, LEFTY1, LEFTY2, MSTN, NODAL, TDGF1	INHBA [Baccin2019:9202237;CellTalkDB:9202237;HPRD:9202237;LRdb:9202237;SIGNOR:8622651;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:9202237], BMP7 [Baccin2019:9748228;CellTalkDB:9748228;HPRD:9748228;LRdb:9748228;SIGNOR:9748228;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:9748228], BMP6 [SignaLink3:10504300;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499], BMP2 [Baccin2019:15064755;CellTalkDB:20385559;HPRD:15064755;InnateDB:17295905;LRdb:15064755;SignaLink3:15064755;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:28977600], GDF11 [Baccin2019:1241472616845370;CellTalkDB:12414726;HPRD:16845371;LRdb:12414726;LRdb:17;SIGNOR:12414726;SIGNOR:16845371;SignaLink3:16446785;SignaLink3:16845371;SignaLink3:23331499;connectomeDB2020:12414726;connectomeDB2020:16845371], NODAL [Baccin2019:11952836;CellTalkDB:11952836;HPMR:11952836;LRdb:11952836;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:11952836], GDF5 [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;SignaLink3:16446785;SignaLink3:23331499;SignaLink3:8702914;connectomeDB2020:8702914], INHBB [Baccin2019:9202237;CellTalkDB:9202237;HPRD:9202237;LRdb:9202237;connectomeDB2020:9202237], INHA [CellTalkDB:32196115;LRdb:29747587], BMP10 [Cellinker:27252362], BMP4 [NA], BMP5 [NA], BMP8A [connectomeDB2020:28465413], BMP8B [NA], GDF2 [Cellinker:26047946;Cellinker:27252362;LRdb:15851468;Ramilowski2015:15851468;connectomeDB2020:15851468;talklr:15851468], GDF1 [CellTalkDB:32196115], GDF10 [Cellinker:27252362], GDF3 [NA], GDF7 [NA], GDF9 [NA], MSTN [Baccin2019:11459935;CellTalkDB:11459935;HPRD:11459935;LRdb:11459935;Lit-BM-17:11459935;Lit-BM-17:23829672;SIGNOR:11459935;connectomeDB2020:11459935], INHBE [CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;LRdb:22710174], LEFTY1 [CellTalkDB:32196115], BMP3 [CellTalkDB:22074949;Cellinker:27252362;Ramilowski2015:22074949;connectomeDB2020:22074949;talklr:22074949], TDGF1 [CellTalkDB:19035567], INHBC [Baccin2019:12651901;CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;HPRD:12651901;LRdb:12651901;connectomeDB2020:12651901], LEFTY2 [Baccin2019:11952836;CellTalkDB:11952836;Cellinker:11952836;LRdb:11952836;connectomeDB2020:11952836], BMP15 [Cellinker:27252362], CD44 [Cellinker:30297743]	activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVR2B&keywords=ACVR2B	1.644403853	324	NA	NA	0.5718894672	348	0.0157480315	0.05489021956	0.03761061947	0.02997601918	0.07575757576	0.08291032149	0.07524932004	0.03425774878	0.02996670366	0.03822272667	0.02634730539	162	143	144	0.04553969014	0.7196061693	0.8682570347	0.6544383899	220	174	212	247
AXL	AXL receptor tyrosine kinase	Yes	Yes		ENSG00000167601	P30530	Protein kinase superfamily, Tyr protein kinase family, AXL/UFO subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14672, P00533, P01133, P06213, P07225, P08631, P12931, Q00887, Q13261, Q14393, Q9NR99	ADAM10, EGF, EGFR, GAS6, HCK, IL15RA, INSR, MXRA5, PROS1, PSG9, SRC	GAS6 [Baccin2019:16362042;Baccin2019:7854420;Baccin2019:8621659;Baccin2019:8939948;CellChatDB:27801848;CellTalkDB:7854420;Cellinker:16362042;Cellinker:27801848;Cellinker:7854420;Cellinker:8621659;Cellinker:8939948;DOMINO:16362042;Guide2Pharma:8939948;HPMR:7854420;HPMR:8939948;HPRD:16362042;HPRD:8621659;InnateDB:12218057;InnateDB:16362042;InnateDB:7854420;InnateDB:8939948;LRdb:16362042;LRdb:7854420;LRdb:8621659;LRdb:8939948;Lit-BM-17:16362042;Lit-BM-17:8939948;ProtMapper:27829217;SIGNOR:16362042;SIGNOR:7867073;SignaLink3:16362042;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8621659;connectomeDB2020:16362042;connectomeDB2020:7854420;connectomeDB2020:8621659;connectomeDB2020:8939948;scConnect:8939948], PROS1 [Baccin2019:78670737867073;CellChatDB:29531161;CellTalkDB:7867073;Cellinker:29531161;Guide2Pharma:7867073;LRdb:7867073;SIGNOR:7867073;connectomeDB2020:7867073;scConnect:7867073], ADAM10 [CellTalkDB:7822279;HPRD:16227584;HPRD:7822279;LRdb:7822279], EGF [CellTalkDB:27775700], MXRA5 [Cellinker:32822567], EGFR [Lit-BM-17:25873175;ProtMapper:27775700;iPTMnet:27775700], PSG9 [Cellinker:32822567], IL15RA [HPRD:16308569], HCK [KEA:17570479], INSR [KEA:17570479], SRC [HPRD:9178760;ProtMapper:28675785]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]	animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AXL&keywords=AXL	6.170910951	206	NA	NA	0.1579264648	565	0.07086614173	0.1761477046	0.00110619469	0.3340527578	0.01515151515	0	0.001813236627	0	0	7.01E-04	9.27E-04	234	324	317	0.05461506879	0.1547626612	0.1656119598	0.1691119132	419	403	408	375
BMPR1A	bone morphogenetic protein receptor type 1A	Yes	Yes		ENSG00000107779	P36894	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15105, O15169, O43541, O60383, O95390, O95393, O95476, O95972, P03971, P12643, P12644, P12645, P13497, P18075, P22003, P22004, P27539, P34820, P43026, P55107, Q13145, Q13253, Q13705, Q13873, Q6KF10, Q7Z4P5, Q7Z5Y6, Q9HAU4, Q9HCE7, Q9NR23, Q9UK05	ACVR2B, AMH, AXIN1, BAMBI, BMP1, BMP10, BMP15, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, BMPR2, CTDNEP1, GDF1, GDF10, GDF11, GDF2, GDF3, GDF5, GDF6, GDF7, GDF9, NOG, SMAD6, SMAD7, SMURF1, SMURF2	BAMBI [SignaLink3:10519551;SignaLink3:23331499], SMAD6 [SignaLink3:10564272;SignaLink3:23331499], SMAD7 [SignaLink3:10564272;SignaLink3:23331499], ACVR2B [InnateDB:17295905;SignaLink3:16446785;SignaLink3:23331499], BMP8B [SignaLink3:10504300;SignaLink3:23331499], CTDNEP1 [DEPOD:17141153;SIGNOR:17141153;SignaLink3:17141153;SignaLink3:23331499], AMH [NA], BMP10 [Baccin2019:16049014;Cellinker:16049014;LRdb:16049014;SIGNOR:16049014;connectomeDB2020:16049014], BMP2 [Baccin2019:10692589;Baccin2019:10881198;Baccin2019:11263668;Baccin2019:12700180;Baccin2019:15064755;BioGRID:10692589;BioGRID:11263668;CellTalkDB:15621726;DIP:10880444;DIP:10881198;DIP:11263668;DIP:16672363;DIP:25938661;HPMR:12700180;HPRD:10692589;HPRD:10881198;HPRD:11263668;HPRD:15064755;InnateDB:16672363;InnateDB:17483092;InnateDB:18937504;IntAct:10881198;IntAct:15064755;IntAct:16672363;IntAct:19804412;IntAct:20860622;IntAct:21054789;IntAct:25938661;LRdb:10692589;LRdb:10881198;LRdb:11263668;LRdb:12700180;LRdb:15064755;Lit-BM-17:10692589;Lit-BM-17:10712517;Lit-BM-17:10880444;Lit-BM-17:10881198;Lit-BM-17:11263668;Lit-BM-17:15064755;Lit-BM-17:19804412;Lit-BM-17:20860622;Lit-BM-17:21054789;SIGNOR:18937504;SIGNOR:26330344;connectomeDB2020:10692589;connectomeDB2020:10881198;connectomeDB2020:11263668;connectomeDB2020:12700180;connectomeDB2020:15064755], BMP4 [Baccin2019:11241215;Baccin2019:7644468;Baccin2019:8006002;Baccin2019:8702914;HPRD:11241215;HPRD:7644468;HPRD:8702914;IntAct:20860622;IntAct:21054789;LRdb:11241215;LRdb:7644468;LRdb:8006002;LRdb:8702914;Lit-BM-17:20860622;Lit-BM-17:21054789;Lit-BM-17:8006002;SIGNOR:26330344;connectomeDB2020:11241215;connectomeDB2020:7644468;connectomeDB2020:8006002;connectomeDB2020:8702914], BMP5 [Baccin2019:11580864;HPRD:11580864;LRdb:11580864], BMP6 [Baccin2019:10504300;Baccin2019:11401330;Baccin2019:12297674;HPRD:10504300;HPRD:11401330;LRdb:10504300;LRdb:11401330;LRdb:12297674;connectomeDB2020:10504300;connectomeDB2020:11401330;connectomeDB2020:12297674], BMP7 [Baccin2019:12297674;Baccin2019:7791754;Baccin2019:8605097;HPRD:7791754;HPRD:8605097;LRdb:12297674;LRdb:7791754;LRdb:8605097;connectomeDB2020:12297674;connectomeDB2020:7791754;connectomeDB2020:8605097], BMP8A [connectomeDB2020:28465413], GDF2 [NA], GDF1 [connectomeDB2020:28955827], GDF10 [NA], GDF3 [NA], GDF7 [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], GDF9 [Baccin2019:10712517;Baccin2019:12135884;CellTalkDB:12135884;Cellinker:10712517;Cellinker:12135884;HPRD:10712517;HPRD:12135884;LRdb:11;LRdb:12135884;connectomeDB2020:12135884], GDF6 [Baccin2019:160490149525338;CellTalkDB:16049014;HPRD:9525338;LRdb:16049014;LRdb:95;SIGNOR:16049014;connectomeDB2020:16049014;connectomeDB2020:9525338], SMURF2 [SIGNOR:22298955], SMURF1 [SIGNOR:17317136;SIGNOR:22298955], AXIN1 [SIGNOR:22298955], BMPR2 [DIP:10712517;HPRD:10712517;MPPI:10712517;SIGNOR:10712517;SIGNOR:18756288;SIGNOR:7791754], NOG [SIGNOR:12478285;SIGNOR:22298955], BMP15 [LRdb:2419820;Ramilowski2015:2419820;connectomeDB2020:2419820;talklr:2419820], GDF11 [CellTalkDB:32196115], BMP3 [Cellinker:26511181], BMP1 [CellTalkDB:15621726], GDF5 [Baccin2019:11282024;Baccin2019:9525338;CellTalkDB:11282024;HPRD:11282024;HPRD:9525338;IntAct:16127465;IntAct:19229295;IntAct:21543859;LRdb:11282024;LRdb:95;Lit-BM-17:19229295;Lit-BM-17:9525338;connectomeDB2020:9525338]	dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]	atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal aorta morphogenesis [GO:0035912]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMPR1A&keywords=BMPR1A	23.33202192	91	NA	NA	2.932667014	77	0	0.09580838323	0.002212389381	0.05323741007	0.04208754209	0.09475465313	0.1205802357	0.09951060359	0.05290418054	0.07153825611	0.05331272938	121	101	99	0.06235876211	0.8693374334	1.126860849	0.8749835891	159	95	126	91
BMPR2	bone morphogenetic protein receptor type 2	Yes	Yes		ENSG00000204217	Q13873	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	21	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00238, O60383, O95390, O95393, O95476, O95972, P00540, P04003, P05771, P12643, P12644, P12645, P13497, P18075, P19883, P22003, P22004, P27539, P34820, P36894, P36897, P41279, P43026, P48995, P55107, P62714, P67775, Q12792, Q12866, Q13253, Q6KF10, Q6NW40, Q7Z4P5, Q7Z5Y6, Q96B86, Q99873, Q9HAU4, Q9HCE7, Q9NR23, Q9UK05	BMP1, BMP10, BMP15, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, BMPR1A, BMPR1B, C4BPA, CTDNEP1, FST, GDF1, GDF10, GDF11, GDF2, GDF3, GDF5, GDF6, GDF7, GDF9, MAP3K8, MERTK, MOS, NOG, PPP2CA, PPP2CB, PRKCB, PRMT1, RGMA, RGMB, SMURF1, SMURF2, TGFBR1, TRPC1, TWF1	BMP2 [Baccin2019:10880440;Baccin2019:11263668;DIP:10880444;DIP:25938661;HPRD:10880444;InnateDB:17295905;InnateDB:18342887;LRdb:11;LRdb:11263668;Lit-BM-17:10712517;Lit-BM-17:10880444;Lit-BM-17:7791754;SIGNOR:7791754;SignaLink3:16446785;SignaLink3:17295905;SignaLink3:18342887;SignaLink3:23180781;SignaLink3:23331499;connectomeDB2020:10880444;connectomeDB2020:11263668], GDF5 [Baccin2019:87029149525338;CellTalkDB:8702914;HPRD:9525338;InnateDB:18342887;LRdb:8702914;LRdb:953;Lit-BM-17:19229295;Lit-BM-17:9525338;SignaLink3:16446785;SignaLink3:18342887;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:9525338;connectomeDB2020:8702914;connectomeDB2020:9525338], BMPR1B [HPRD:10712517], BMP7 [Baccin2019:7791754;DIP:7644468;HPRD:7791754;InnateDB:18342887;LRdb:7791754;SIGNOR:7644468;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:7791754], BMP6 [Baccin2019:11401330;HPRD:11401330;LRdb:11401330;SignaLink3:10504300;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10504300], GDF6 [Baccin2019:160490149525338;CellTalkDB:16049014;HPRD:9525338;LRdb:16049014;LRdb:95;SIGNOR:16049014;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9525338;connectomeDB2020:16049014;connectomeDB2020:9525338], BMP4 [Baccin2019:7644468;Baccin2019:7673243;Baccin2019:8702914;BioGRID:12045205;DIP:7644468;DIP:7673243;HPRD:7644468;HPRD:8702914;LRdb:7644468;LRdb:7673243;LRdb:8702914;SIGNOR:7673243;SIGNOR:8006002;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:7644468;connectomeDB2020:7644468;connectomeDB2020:7673243;connectomeDB2020:8702914], PRMT1 [SignaLink3:23747011], BMP15 [Baccin2019:12419820;CellTalkDB:15621726;HPMR:12419820;LRdb:12419820;SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:12419820], BMP10 [Baccin2019:16049014;CellTalkDB:15621726;LRdb:16049014;connectomeDB2020:16049014], BMP5 [NA], BMP8A [connectomeDB2020:28465413], BMP8B [NA], GDF2 [CellTalkDB:28646109;LRdb:15851468;Ramilowski2015:15851468;connectomeDB2020:15851468;talklr:15851468], GDF1 [connectomeDB2020:28955827], GDF10 [Cellinker:27252362], GDF3 [NA], GDF7 [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], GDF9 [Baccin2019:1213588412135880;CellTalkDB:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], SMURF2 [SIGNOR:22298955], SMURF1 [SIGNOR:17317136;SIGNOR:22298955], CTDNEP1 [SIGNOR:17141153], NOG [SIGNOR:12478285;SIGNOR:22298955], BMPR1A [DIP:10712517;HPRD:10712517;MPPI:10712517;SIGNOR:10712517], FST [CellTalkDB:32196115], GDF11 [CellTalkDB:32196115], BMP3 [Cellinker:27252362], BMP1 [CellTalkDB:15621726], RGMB [CellTalkDB:32196115], C4BPA [CellTalkDB:15188402;Cellinker:15188402;HPRD:15188402;LRdb:15188402;connectomeDB2020:15188402], RGMA [CellTalkDB:32196115], PPP2CA [DEPOD:19339557], PPP2CB [DEPOD:19339557], TGFBR1 [Lit-BM-17:7791754;Lit-BM-17:7890683], PRKCB [HPRD:15188402], MOS [HPRD:15188402], MAP3K8 [HPRD:15188402], MERTK [HPRD:15188402], TWF1 [HPRD:15188402], TRPC1 [HPRD:15188402]	adherens junction [GO:0005912]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]	activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activator activity [GO:0030546]; transforming growth factor beta-activated receptor activity [GO:0005024]	anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMPR2&keywords=BMPR2	12.25852893	142	NA	NA	0.7424946904	302	0.04724409449	0.2599800399	0.5077433628	0.2741007194	0.09595959596	0.421319797	0.4242973708	0.176182708	0.1720310766	0.2816464147	0.1165926212	47	30	58	0.2524634364	0.6935483245	1.111188738	0.4823247875	229	97	278	143
CCR1	C-C motif chemokine receptor 1	Yes	No		ENSG00000163823	P32246	G-protein coupled receptor 1 family	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15467, P10147, P13236, P13500, P13501, P16619, P22362, P23458, P55773, P55774, P80075, P80098, Q16627, Q16663, Q8NHW4, Q99616, Q9Y258	CCL1, CCL13, CCL14, CCL15, CCL16, CCL18, CCL2, CCL23, CCL26, CCL3, CCL3L1, CCL4, CCL4L1, CCL5, CCL7, CCL8, JAK1	CCL13 [CellTalkDB:10699158;Cellinker:23846739;LRdb:10699158], CCL8 [Baccin2019:76793288631787;CellPhoneDB:24218476;Cellinker:9115216;DIP:9115216;HPRD:9115216;ICELLNET:22633458;InnateDB:9115216;LRdb:10699158;connectomeDB2020:9115216], CCL14 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11085751;Cellinker:12381680;Cellinker:20483925;Cellinker:9687537;DIP:9687537;Guide2Pharma:12381680;HPRD:11085751;ICELLNET:22633458;InnateDB:12381680;InnateDB:15905581;InnateDB:9346309;InnateDB:9548457;LRdb:9405404;connectomeDB2020:11085751;connectomeDB2020:12381680;connectomeDB2020:9687537;scConnect:12381680], CCL15 [CellTalkDB:10699158;Cellinker:9346309;DIP:9346309;Guide2Pharma:9346309;HPRD:9346309;ICELLNET:9346309;LRdb:10699158;connectomeDB2020:9346309;scConnect:9346309], CCL23 [CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10660125;Cellinker:12381680;Cellinker:9558365;Cellinker:9886417;Guide2Pharma:12381680;HPRD:10660125;HPRD:9558365;HPRD:9886417;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10660125;connectomeDB2020:12381680;connectomeDB2020:9558365;connectomeDB2020:9886417;scConnect:12381680], CCL3 [CellPhoneDB:24218476;Cellinker:10202040;Cellinker:10660125;Cellinker:11170631;Cellinker:12381680;Cellinker:7545673;Cellinker:8530354;Cellinker:9115216;Cellinker:9624164;DIP:10488147;DIP:10498628;DIP:10910894;DIP:7545673;DIP:7622448;DIP:8530354;DIP:9115216;DIP:9169459;DIP:9207005;DIP:9336350;DIP:9687537;Guide2Pharma:11170631;Guide2Pharma:12381680;Guide2Pharma:8530354;Guide2Pharma:9624164;HPRD:10202040;HPRD:10660125;HPRD:7545673;ICELLNET:22633458;InnateDB:12381680;InnateDB:23765404;InnateDB:7545673;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;SIGNOR:10734056;SIGNOR:20219869;connectomeDB2020:10202040;connectomeDB2020:10660125;connectomeDB2020:11170631;connectomeDB2020:12381680;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9115216;connectomeDB2020:9624164;scConnect:11170631;scConnect:12381680;scConnect:8530354;scConnect:9624164], CCL5 [Baccin2019:11116158;Baccin2019:12270118;Baccin2019:14637022;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9289016;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11116158;Cellinker:12270118;Cellinker:14637022;Cellinker:7545673;Cellinker:8530354;Cellinker:9289016;Cellinker:9624164;DIP:10910894;DIP:7545673;DIP:7622448;DIP:8530354;DIP:9115216;DIP:9336350;Guide2Pharma:8530354;Guide2Pharma:9624164;HPRD:11116158;HPRD:12270118;HPRD:14637022;HPRD:7545673;HPRD:9289016;ICELLNET:22633458;InnateDB:7545673;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;SIGNOR:10734056;connectomeDB2020:11116158;connectomeDB2020:12270118;connectomeDB2020:14637022;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9289016;connectomeDB2020:9624164;scConnect:8530354;scConnect:9624164], CCL7 [Baccin2019:11994538;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;CellPhoneDB:24218476;Cellinker:11994538;Cellinker:12381680;Cellinker:7545673;Cellinker:8530354;Cellinker:9115216;DIP:7545673;DIP:8530354;DIP:9336350;Guide2Pharma:11994538;Guide2Pharma:12381680;HPRD:7545673;HPRD:8530354;ICELLNET:22633458;InnateDB:12381680;InnateDB:7545673;InnateDB:8530354;LRdb:10699158;SIGNOR:14991608;connectomeDB2020:11994538;connectomeDB2020:12381680;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9115216;scConnect:11994538;scConnect:12381680], CCL4 [Baccin2019:12381680;Baccin2019:7594543;Baccin2019:8530354;CellTalkDB:10699158;Cellinker:12381680;Cellinker:7594543;Cellinker:8530354;DIP:10910894;DIP:7545673;Guide2Pharma:12381680;Guide2Pharma:8530354;HPRD:7594543;InnateDB:12381680;LRdb:10699158;connectomeDB2020:12381680;connectomeDB2020:7594543;connectomeDB2020:8530354;scConnect:12381680;scConnect:8530354], CCL16 [CellPhoneDB:24218476;CellTalkDB:11470772;Cellinker:10910894;Cellinker:11470772;DIP:10910894;DIP:11470772;HPRD:10910894;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11;LRdb:11470772;connectomeDB2020:10910894;connectomeDB2020:11470772], CCL26 [CellPhoneDB:24218476;Cellinker:15039444;HPRD:15039444;ICELLNET:15039444;ICELLNET:22633458;InnateDB:15039444;LRdb:15039444;connectomeDB2020:15039444], CCL3L1 [Baccin2019:10202040;Baccin2019:10660125;Baccin2019:11170631;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCL2 [Baccin2019:76793288631787;CellTalkDB:10699158;Cellinker:7679328;Cellinker:8631787;DIP:9115216;HPMR:7679328;HPRD:8631787;InnateDB:9115216;LRdb:10699158;connectomeDB2020:7679328;connectomeDB2020:8631787], CCL18 [CellTalkDB:32103204;scConnect:23951310], CCL4L1 [connectomeDB2020:15240137], CCL1 [DIP:10910894;DIP:11470772], JAK1 [HPRD:14674010]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine (C-C motif) ligand 7 binding [GO:0035717]; chemokine receptor activity [GO:0004950]; phosphatidylinositol phospholipase C activity [GO:0004435]	calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of osteoclast differentiation [GO:0045672]; response to wounding [GO:0009611]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR1&keywords=CCR1	1.538805562	332	NA	NA	0.3800811128	412	0.09448818898	0	0	0.009592326139	0	0	0	0	0	0	0	234	346	347	0.00946186501	0.5138253705	0.5138253705	0.5138253705	303	290	272	345
CCR3	C-C motif chemokine receptor 3	Yes	No		ENSG00000183625	P51677	G-protein coupled receptor 1 family	21	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00175, O14625, P02778, P08631, P09769, P10147, P13236, P13500, P13501, P16619, P51671, P55774, P80075, P80098, Q07325, Q16627, Q16663, Q8NHW4, Q99616, Q9NRJ3, Q9Y258, Q9Y4X3	CCL11, CCL13, CCL14, CCL15, CCL18, CCL2, CCL24, CCL26, CCL27, CCL28, CCL3, CCL3L1, CCL4, CCL4L1, CCL5, CCL7, CCL8, CXCL10, CXCL11, CXCL9, FGR, HCK	CCL11 [Baccin2019:10488147;Baccin2019:10854442;Baccin2019:12149192;Baccin2019:12761559;Baccin2019:16339911;Baccin2019:8609214;Baccin2019:8642344;Baccin2019:8676064;Baccin2019:9005985;Baccin2019:9276730;Baccin2019:9712872;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10488147;Cellinker:10854442;Cellinker:12761559;Cellinker:16339911;Cellinker:8609214;Cellinker:8642344;Cellinker:8676064;Cellinker:9276730;Cellinker:9712872;DIP:10733106;DIP:25450766;DIP:9169459;DIP:9207005;Guide2Pharma:10488147;Guide2Pharma:10854442;Guide2Pharma:12761559;Guide2Pharma:16339911;Guide2Pharma:8642344;Guide2Pharma:9276730;HPRD:8609214;HPRD:8642344;HPRD:8676064;HPRD:9712872;ICELLNET:22633458;InnateDB:12218106;InnateDB:16102831;InnateDB:8642344;LRdb:10699158;Lit-BM-17:10733106;Lit-BM-17:23597562;Lit-BM-17:8642344;Lit-BM-17:9169459;Lit-BM-17:9207005;SIGNOR:10706854;SIGNOR:24702154;connectomeDB2020:10488147;connectomeDB2020:10854442;connectomeDB2020:12761559;connectomeDB2020:16339911;connectomeDB2020:8609214;connectomeDB2020:8642344;connectomeDB2020:8676064;connectomeDB2020:9276730;connectomeDB2020:9712872;scConnect:10488147;scConnect:10854442;scConnect:12761559;scConnect:16339911;scConnect:8642344;scConnect:9276730], CCL13 [CellPhoneDB:24218476;Cellinker:12149192;Cellinker:16339911;Cellinker:9005985;Cellinker:9276730;DIP:10733106;Guide2Pharma:16339911;Guide2Pharma:9276730;HPRD:12149192;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:16339911;connectomeDB2020:9005985;connectomeDB2020:9276730;scConnect:16339911;scConnect:9276730], CCL15 [CellTalkDB:10699158;Cellinker:9346309;DIP:9346309;Guide2Pharma:9346309;HPRD:9346309;ICELLNET:9346309;LRdb:10699158;connectomeDB2020:9346309;scConnect:9346309], CCL2 [Baccin2019:8642344;CellTalkDB:8642344;Cellinker:8642344;Guide2Pharma:8642344;InnateDB:8642344;LRdb:8642344;connectomeDB2020:8642344;scConnect:8642344], CCL24 [Baccin2019:10488147;Baccin2019:12218106;Baccin2019:15207250;Baccin2019:16339911;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10488147;Cellinker:12218106;Cellinker:15207250;Cellinker:16339911;DIP:10733106;Guide2Pharma:15207250;Guide2Pharma:16339911;HPRD:12218106;ICELLNET:22633458;InnateDB:12218106;InnateDB:16102831;LRdb:10699158;connectomeDB2020:10488147;connectomeDB2020:12218106;connectomeDB2020:15207250;connectomeDB2020:16339911;scConnect:15207250;scConnect:16339911], CCL26 [CellPhoneDB:24218476;Cellinker:10488147;Cellinker:15207250;Cellinker:16339911;DIP:10488147;Guide2Pharma:10488147;Guide2Pharma:15207250;Guide2Pharma:16339911;HPRD:10488147;ICELLNET:22633458;InnateDB:10488147;InnateDB:16102831;LRdb:10699158;connectomeDB2020:10488147;connectomeDB2020:15207250;connectomeDB2020:16339911;scConnect:10488147;scConnect:15207250;scConnect:16339911], CCL28 [Baccin2019:10975800;Baccin2019:12964882;CellTalkDB:12964882;Cellinker:10975800;Cellinker:12964882;HPRD:10975800;ICELLNET:22633458;LRdb:11;LRdb:12964882;connectomeDB2020:10975800;connectomeDB2020:12964882], CCL5 [Baccin2019:8642344;Baccin2019:9289016;BioGRID:8642344;CellPhoneDB:24218476;Cellinker:8642344;Cellinker:9289016;DIP:10733106;DIP:7622448;Guide2Pharma:8642344;HPMR:8642344;HPRD:8642344;HPRD:9289016;ICELLNET:22633458;InnateDB:8642344;LRdb:10699158;SIGNOR:10734056;connectomeDB2020:8642344;connectomeDB2020:9289016;scConnect:8642344], CCL7 [CellPhoneDB:24218476;Cellinker:8642344;DIP:10733106;Guide2Pharma:8642344;HPRD:8642344;ICELLNET:22633458;InnateDB:8642344;LRdb:10699158;connectomeDB2020:8642344;scConnect:8642344], CCL8 [Baccin2019:8642344;CellPhoneDB:24218476;Cellinker:9005985;HPRD:9005985;LRdb:10699158;connectomeDB2020:9005985], CXCL10 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], CXCL11 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:15178708;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], CXCL9 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], CCL18 [CellTalkDB:23951310;Cellinker:23951310;Cellinker:29637711;ICELLNET:22633458;ICELLNET:23999500;InnateDB:10640766;connectomeDB2020:24218476;scConnect:23951310], CCL3L1 [Baccin2019:7594543;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCL14 [CellPhoneDB:24218476;CellTalkDB:11085751;Cellinker:11085751;HPRD:11085751;InnateDB:9346309;InnateDB:9548457;LRdb:11085751;connectomeDB2020:11085751], CCL3 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:7594543;DIP:7622448;HPRD:7594543;LRdb:7594543;connectomeDB2020:7594543], CCL4 [Baccin2019:7622448;CellTalkDB:7622448;Cellinker:7622448;DIP:7622448;HPRD:7622448;LRdb:7622448;connectomeDB2020:7622448], CCL27 [NA], CCL4L1 [connectomeDB2020:15240137], FGR [HPRD:10527858], HCK [HPRD:10527858]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell proliferation [GO:0001938]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR3&keywords=CCR3	0.01238593146	766	NA	NA	0.1999466141	524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	645
CCR6	C-C motif chemokine receptor 6	Yes	No		ENSG00000112486	P51684	G-protein coupled receptor 1 family	21	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15263, P50591, P60022, P78556, P81534	CCL20, DEFB1, DEFB103A, DEFB4B, TNFSF10	DEFB4B [CellTalkDB:20068036;CellTalkDB:26198319;Guide2Pharma:10521347;HPRD:11714836;InnateDB:10521347;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:10521347;connectomeDB2020:11714836;scConnect:10521347], CCL20 [Baccin2019:12081481;Baccin2019:12964882;Baccin2019:9169459;Baccin2019:9223454;Baccin2019:9294137;CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:12081481;Cellinker:12964882;Cellinker:9169459;Cellinker:9223454;Cellinker:9294137;DIP:10488147;DIP:10498628;DIP:9169459;Guide2Pharma:12081481;Guide2Pharma:9169459;Guide2Pharma:9294137;HPMR:12964882;HPRD:9169459;HPRD:9223454;HPRD:9294137;ICELLNET:22633458;InnateDB:9169459;LRdb:10699158;connectomeDB2020:12081481;connectomeDB2020:12964882;connectomeDB2020:9169459;connectomeDB2020:9223454;connectomeDB2020:9294137;scConnect:12081481;scConnect:9169459;scConnect:9294137], DEFB1 [CellTalkDB:20068036;HPRD:12149255;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:12149255], DEFB103A [CellTalkDB:23390582;HPRD:11714836;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:11714836;connectomeDB2020:23390582;talklr:23390582], TNFSF10 [Cellinker:16230375]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524]; sperm principal piece [GO:0097228]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; signaling receptor activity [GO:0038023]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; DN2 thymocyte differentiation [GO:1904155]; DN3 thymocyte differentiation [GO:1904156]; humoral immune response [GO:0006959]; immune response [GO:0006955]; isotype switching to IgA isotypes [GO:0048290]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration [GO:0072676]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; regulation of T cell migration [GO:2000404]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR6&keywords=CCR6	0.3302107833	493	NA	NA	0.2776892314	471	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	482
CCR7	C-C motif chemokine receptor 7	Yes	No		ENSG00000126353	P32248	G-protein coupled receptor 1 family	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00585, O00626, P07550, P12931, P61073, Q99731	ADRB2, CCL19, CCL21, CCL22, CXCR4, SRC	CCL19 [Baccin2019:11342595;Baccin2019:9153236;Baccin2019:9507024;CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11342595;Cellinker:9153236;Cellinker:9507024;DIP:9153236;DIP:9507024;Guide2Pharma:10512740;Guide2Pharma:16904643;Guide2Pharma:9153236;Guide2Pharma:9507024;HPMR:11342595;HPRD:9153236;ICELLNET:22633458;InnateDB:15546958;InnateDB:9153236;LRdb:10699158;connectomeDB2020:11342595;connectomeDB2020:9153236;connectomeDB2020:9507024;scConnect:10512740;scConnect:16904643;scConnect:9153236;scConnect:9507024], CCL21 [Baccin2019:11970971;Baccin2019:9507024;Baccin2019:9585422;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:11970971;Cellinker:9507024;Cellinker:9585422;DIP:10488147;DIP:9507024;Guide2Pharma:9507024;HPRD:9507024;HPRD:9585422;ICELLNET:22633458;InnateDB:22221265;InnateDB:9507024;LRdb:10699158;SIGNOR:11970971;connectomeDB2020:11970971;connectomeDB2020:9507024;connectomeDB2020:9585422;scConnect:9507024], ADRB2 [Cellinker:29637711], CXCR4 [Cellinker:29637711], SRC [PhosphoSite:26789922;PhosphoSite:31644919], CCL22 [InnateDB:15546958]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930]	activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell motility [GO:2000147]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR7&keywords=CCR7	1.181442806	366	NA	NA	0.200579699	523	1.086614173	9.98E-04	0.003318584071	0.006714628297	0.001683501684	0.005076142132	0.005439709882	0.003262642741	0.001479837218	0.004072639872	1.93E-04	230	246	342	0.1017139114	0.1027610355	0.1259703442	0.09124344441	429	417	433	388
CXCR2	C-X-C motif chemokine receptor 2	Yes	Yes		ENSG00000180871	P25025	G-protein coupled receptor 1 family	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P02775, P04233, P04899, P09341, P10145, P14174, P19875, P19876, P22694, P25098, P30153, P42830, P50552, P67775, P80162	CD74, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8, GNAI2, GRK2, MIF, PPBP, PPP2CA, PPP2R1A, PRKACB, VASP	CXCL1 [CellPhoneDB:24218476;Cellinker:10188995;Cellinker:1379593;Cellinker:28389721;Cellinker:8550564;Cellinker:8702798;Cellinker:8940121;DIP:10216072;DIP:8550564;DIP:9195914;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:8940121;HPRD:1379593;HPRD:8550564;HPRD:8702798;HPRD:8940121;ICELLNET:22633458;ICELLNET:24218476;ICELLNET:8702798;InnateDB:12549928;InnateDB:12628493;InnateDB:7592830;InnateDB:8662882;InnateDB:8702798;InnateDB:9126332;LRdb:10699158;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:8550564;connectomeDB2020:8702798;connectomeDB2020:8940121;scConnect:10188995;scConnect:1379593;scConnect:8940121], CXCL2 [Baccin2019:10188995;Baccin2019:1379593;Baccin2019:8550564;Baccin2019:8702798;Baccin2019:8940121;Baccin2019:9260277;CellPhoneDB:24218476;Cellinker:8702798;Cellinker:9260277;DIP:8702798;Guide2Pharma:8702798;HPMR:12964882;HPRD:8702798;HPRD:9260277;ICELLNET:22633458;ICELLNET:8702798;LRdb:10699158;connectomeDB2020:8702798;connectomeDB2020:9260277;scConnect:8702798], CXCL3 [Baccin2019:8702798;CellPhoneDB:24218476;Cellinker:8702798;DIP:8702798;Guide2Pharma:8702798;HPRD:8702798;ICELLNET:22633458;ICELLNET:8702798;LRdb:10699158;connectomeDB2020:8702798;scConnect:8702798], CXCL5 [CellPhoneDB:24218476;Cellinker:8702798;Cellinker:9692902;DIP:8702798;Guide2Pharma:8702798;HPRD:8702798;HPRD:9692902;ICELLNET:22633458;InnateDB:8702798;InnateDB:9485196;LRdb:10699158;connectomeDB2020:8702798;connectomeDB2020:9692902;scConnect:8702798], CXCL6 [Baccin2019:10593335;Baccin2019:12964882;Baccin2019:8702798;Baccin2019:9692902;CellPhoneDB:24218476;CellTalkDB:9692902;Cellinker:10593335;Cellinker:12964882;Cellinker:9692902;Guide2Pharma:9692902;HPRD:10593335;HPRD:9692902;ICELLNET:22633458;InnateDB:9485196;LRdb:10593335;LRdb:12964882;LRdb:9692902;connectomeDB2020:10593335;connectomeDB2020:12964882;connectomeDB2020:9692902;scConnect:9692902], PPBP [CellPhoneDB:24218476;CellTalkDB:1427896;Cellinker:8195702;Cellinker:8702798;DIP:8550564;DIP:8702798;Guide2Pharma:8702798;HPRD:8195702;HPRD:8702798;ICELLNET:22633458;ICELLNET:24335961;InnateDB:8702798;InnateDB:9126332;LRdb:10699158;connectomeDB2020:8195702;connectomeDB2020:8702798;scConnect:8702798], CXCL8 [CellPhoneDB:24218476;CellTalkDB:1379593;Cellinker:10188995;Cellinker:11511101;Cellinker:1379593;Cellinker:15282370;Cellinker:15946947;Cellinker:8626516;Cellinker:8702798;Cellinker:8940121;Cellinker:9464567;DIP:10206993;DIP:10216072;DIP:22904195;DIP:7559482;DIP:8550564;DIP:9195914;DIP:9553055;DIP:9725262;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:15282370;Guide2Pharma:15946947;Guide2Pharma:8940121;HPRD:8626516;HPRD:8702798;HPRD:9464567;ICELLNET:1891716;InnateDB:12628493;InnateDB:19190236;InnateDB:7592830;InnateDB:8245475;InnateDB:8662882;InnateDB:8702798;InnateDB:9126332;InnateDB:9464567;InnateDB:9485196;IntAct:22904195;IntAct:23597562;LRdb:10188995;LRdb:10699158;LRdb:1379593;LRdb:15282370;LRdb:15946947;LRdb:8626516;LRdb:8702798;LRdb:8940121;LRdb:9464567;Lit-BM-17:10206993;Lit-BM-17:10216072;Lit-BM-17:23597562;Lit-BM-17:7559482;Lit-BM-17:8550564;Lit-BM-17:9195914;Lit-BM-17:9464567;Lit-BM-17:9553055;Lit-BM-17:9725262;SIGNOR:11350788;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:15282370;connectomeDB2020:15946947;connectomeDB2020:8626516;connectomeDB2020:8702798;connectomeDB2020:8940121;connectomeDB2020:9464567;scConnect:10188995;scConnect:1379593;scConnect:15282370;scConnect:15946947;scConnect:8940121], MIF [CellTalkDB:18852457;ICELLNET:17435771;SIGNOR:17435771;connectomeDB2020:17435771], GRK2 [SIGNOR:22634615], VASP [CellTalkDB:19435808;Cellinker:19435808;InnateDB:21876773;LRdb:19435808;Ramilowski2015:19435808;connectomeDB2020:19435808;talklr:19435808], GNAI2 [CellTalkDB:8662698;Cellinker:8662698;HPRD:8662698;LRdb:8662698;connectomeDB2020:8662698], CD74 [Cellinker:29637711], PRKACB [KEA:17570479], PPP2CA [HPRD:11278485;InnateDB:11278485], PPP2R1A [InnateDB:11278485]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR2&keywords=CXCR2	0.06806659112	655	NA	NA	0.01015104011	849	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	752
CXCR5	C-X-C motif chemokine receptor 5	Yes	No		ENSG00000160683	P32302	G-protein coupled receptor 1 family	21	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15467, O43927, P10147, P13236, P13501	CCL16, CCL3, CCL4, CCL5, CXCL13	CXCL13 [Baccin2019:9463416;Baccin2019:9486651;CellPhoneDB:24218476;Cellinker:28389721;Cellinker:9463416;Cellinker:9486651;DIP:9463416;Guide2Pharma:22913878;HPMR:9463416;HPRD:9463416;HPRD:9486651;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:9463416;connectomeDB2020:9486651;scConnect:22913878], CCL16 [DIP:11470772], CCL3 [DIP:11470772;DIP:9312096], CCL5 [DIP:9312096], CCL4 [DIP:9312096]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]	B cell activation [GO:0042113]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; lymph node development [GO:0048535]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR5&keywords=CXCR5	0.5834274589	443	NA	NA	1.210814223	196	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	320
EDNRA	endothelin receptor type A	Yes	Yes		ENSG00000151617	P25101	G-protein coupled receptor 1 family, Endothelin receptor subfamily, EDNRA sub-subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01374, P04899, P05305, P14138, P20800, P25098, P43250	EDN1, EDN2, EDN3, GNAI2, GRK2, GRK6, LTA	EDN1 [Baccin2019:6479761;Baccin2019:90829707;CellTalkDB:7647976;Cellinker:10770212;Cellinker:7647976;Cellinker:9082970;Guide2Pharma:7647976;HPMR:9082970;HPRD:10770212;ICELLNET:8440682;LRdb:10770212;LRdb:7647976;LRdb:9082970;Lit-BM-17:23597562;Lit-BM-17:7509919;SIGNOR:16597412;connectomeDB2020:10770212;connectomeDB2020:7647976;connectomeDB2020:9082970;scConnect:7647976], EDN2 [Baccin2019:2175397;Baccin2019:7647976;Baccin2019:9082970;CellTalkDB:2175397;Cellinker:2175397;Cellinker:7647976;Cellinker:9082970;Guide2Pharma:7647976;ICELLNET:8440682;LRdb:2175397;LRdb:7647976;LRdb:9082970;connectomeDB2020:2175397;connectomeDB2020:7647976;connectomeDB2020:9082970;scConnect:7647976], GNAI2 [HPRD:7882989;LRdb:7882989;connectomeDB2020:7882989], EDN3 [Baccin2019:11982704;CellTalkDB:11982704;Cellinker:11982704;HPRD:11982704;LRdb:11982704;connectomeDB2020:11982704], LTA [NA], GRK2 [PhosphoSite:14636059;PhosphoSite:24064210], GRK6 [HPRD:9211925]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435]	activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; glomerular visceral epithelial cell differentiation [GO:0072112]; G protein-coupled receptor signaling pathway [GO:0007186]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDNRA&keywords=EDNRA	15.27649209	124	NA	NA	1.085069101	222	0	9.98E-04	0.00110619469	0.521822542	0.005050505051	0	0.001813236627	0	7.40E-04	6.34E-04	3.86E-04	232	325	336	0.04841372624	0.1838595019	0.1820507656	0.1778062246	409	399	404	268
EPOR	erythropoietin receptor	Yes	Yes		ENSG00000187266	P19235	Type I cytokine receptor family, Type 1 subfamily	21	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14508, O14543, O60674, P01241, P01588, P04626, P06213, P07288, P07948, P10721, P10912, P18031, P21583, P22681, P27361, P27986, P28482, P29350, P35968, P38484, P40189, P42229, P43405, P46109, Q04912, Q06187, Q9NSE2, Q9Y639	BTK, CBL, CISH, CRKL, EPO, ERBB2, GH1, GHR, IFNGR2, IL6ST, INSR, JAK2, KDR, KIT, KITLG, KLK3, LYN, MAPK1, MAPK3, MST1R, NPTN, PIK3R1, PTPN1, PTPN6, SOCS2, SOCS3, STAT5A, SYK	JAK2 [BioGRID:8343951;Cellinker:9030561;HPRD-phos:12441334;HPRD:11779507;HPRD:12441334;HPRD:8343951;KEA:10579919;KEA:10660611;KEA:11443118;KEA:12027890;KEA:12441334;KEA:7559499;KEA:9573010;ProtMapper:12441334;ProtMapper:15212693;SIGNOR:12441334;SPIKE:12524467;SPIKE:18672044;iPTMnet:10579919;iPTMnet:12441334;phosphoELM:10579919], EPO [Baccin2019:10318834;Baccin2019:16982323;Baccin2019:9442088;Baccin2019:9808045;BioGRID:10318834;BioGRID:15358619;BioGRID:17327410;BioGRID:9808045;Cellinker:10318834;Cellinker:16982323;Cellinker:9442088;Cellinker:9808045;DIP:10318834;DIP:8662939;DIP:9030560;DIP:9774108;Guide2Pharma:16982323;HPMR:9442088;HPRD:10318834;HPRD:9808045;ICELLNET:2163696;ICELLNET:9974393;InnateDB:21889455;InnateDB:9774108;IntAct:29997244;IntAct:9774108;LRdb:10318834;LRdb:16982323;LRdb:9442088;LRdb:9808045;Lit-BM-17:10318834;Lit-BM-17:15358619;Lit-BM-17:17327410;Lit-BM-17:8662939;Lit-BM-17:9030560;Lit-BM-17:9774108;Lit-BM-17:9808045;SIGNOR:9442088;SIGNOR:9774108;SPIKE:18586265;SignaLink3:23331499;SignaLink3:9774108;connectomeDB2020:10318834;connectomeDB2020:16982323;connectomeDB2020:9442088;connectomeDB2020:9808045;scConnect:16982323], PIK3R1 [Cellinker:24113870;HPRD:7559499;Lit-BM-17:15644415;Lit-BM-17:24113870;Lit-BM-17:7559499;Lit-BM-17:9162069], KLK3 [CellTalkDB:10374881;HPRD:10374881;LRdb:10374881], KITLG [CellTalkDB:11124255;Cellinker:11124255;HPRD:11124255;LRdb:11124255], IFNGR2 [Cellinker:9030561], GHR [Cellinker:11751584], CISH [BioGRID:7796808;Cellinker:28038963;HPRD:15644415;HPRD:7796808;HPRD:9774439;InnateDB:9774439;Lit-BM-17:11781573;Lit-BM-17:15644415;Lit-BM-17:16961462;Lit-BM-17:7796808], BTK [Cellinker:15007095], ERBB2 [Cellinker:27321103], SOCS2 [Cellinker:31182716;HPRD:11781573;HPRD:15644415;Lit-BM-17:11781573;Lit-BM-17:15644415;Lit-BM-17:16961462], GH1 [Cellinker:11751584], NPTN [Cellinker:1451111;Cellinker:8507186], KDR [Cellinker:24630601], SYK [Cellinker:9852052;HPRD:9852052], LYN [Cellinker:9573010;HPRD:9573010;KEA:10579919;KEA:12441334;iPTMnet:10579919;phosphoELM:10579919], CRKL [Cellinker:11443118;HPRD:11443118], KIT [CancerCellMap:7545788;Cellinker:17554063;HPRD:11124255;NetPath:7545788], IL6ST [Cellinker:19002875], PTPN1 [DEPOD:14527337;IntAct:14527337], PTPN6 [DOMINO:7228577;DOMINO:7528577;HPRD:7528577;HPRD:7889566;IntAct:7228577;IntAct:7528537;IntAct:7528577], INSR [KEA:17570479], SOCS3 [BioGRID:12027890;HPRD:10882725;HPRD:12027890], STAT5A [HPRD:15644415;HPRD:8977232;Lit-BM-17:10374881;Lit-BM-17:15644415;Lit-BM-17:8977232], CBL [HPRD:11443118], MST1R [HPRD:14982882], MAPK1 [HPRD:12538595], MAPK3 [HPRD:12538595]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	erythropoietin receptor activity [GO:0004900]; identical protein binding [GO:0042802]	brain development [GO:0007420]; decidualization [GO:0046697]; heart development [GO:0007507]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPOR&keywords=EPOR	2.883126284	276	NA	NA	0.1786038038	543	0.0157480315	0.0129740519	0.05199115044	0.06978417266	0.02693602694	0.08291032149	0.09156844968	0.0603588907	0.05401405845	0.06219121378	0.04075719529	120	116	115	0.05174850571	1.036690001	1.169116774	0.8219987626	99	87	149	256
ERBB4	erb-b2 receptor tyrosine kinase 4	Yes	No		ENSG00000178568	Q15303	Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily	21	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14511, O14944, P00519, P00533, P01133, P01135, P04626, P07585, P09237, P21860, P29279, P35070, P42684, P56975, P78352, P78536, Q02297, Q13425, Q6UW88, Q8WWG1, Q96J02, Q96JA1, Q99075, Q9BZG2, Q9H4P4	ABL1, ABL2, ACP4, ADAM17, BTC, CCN2, DCN, DLG4, EGF, EGFR, EPGN, ERBB2, ERBB3, EREG, HBEGF, ITCH, LRIG1, MMP7, NRG1, NRG2, NRG3, NRG4, RNF41, SNTB2, TGFA	EGFR [HPRD:10572067;Lit-BM-17:10572067;Lit-BM-17:23153581;Lit-BM-17:25140053;SPIKE:10572067;SPIKE:12648464;SPIKE:17145710], NRG3 [Baccin2019:9275162;CellTalkDB:9275162;HPMR:9275162;HPRD:9275162;LRdb:9275162;SIGNOR:14967450;SIGNOR:7477375;SIGNOR:9275162;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:9275162], NRG1 [CellTalkDB:10537356;HPRD:10537356;HPRD:7721889;HPRD:8062828;HPRD:9565587;LRdb:10537356;LRdb:7721889;LRdb:8062828;LRdb:9565587;Lit-BM-17:10970856;Lit-BM-17:9168115;ProtMapper:25052836;SIGNOR:14967450;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:10537356;connectomeDB2020:7721889;connectomeDB2020:8062828;connectomeDB2020:9565587], NRG4 [Baccin2019:10348342;CellTalkDB:10348342;HPRD:10348342;LRdb:10348342;SIGNOR:14967450;SIGNOR:7477375;SignaLink3:10348342;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:10348342], LRIG1 [SIGNOR:16123311;SignaLink3:16123311;SignaLink3:23331499], NRG2 [Baccin2019:9168114;Baccin2019:9168115;CellTalkDB:9168115;HPRD:9168114;HPRD:9168115;LRdb:9168115;LRdb:917;SIGNOR:14967450;SIGNOR:7477375;SignaLink3:23331499;SignaLink3:9168114;SignaLink3:9168115;connectomeDB2020:9168114;connectomeDB2020:9168115], BTC [Baccin2019:10214951;Baccin2019:11254912;CellTalkDB:10214951;HPRD:11254912;LRdb:10214951;LRdb:11;SIGNOR:10209155;SIGNOR:16829981;SIGNOR:22232668;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:10214951;connectomeDB2020:11254912], HBEGF [Baccin2019:1840698;Baccin2019:9135143;CellTalkDB:1840698;HPRD:9135143;ICELLNET:12621152;LRdb:1840698;LRdb:914;SIGNOR:10209155;SIGNOR:9135143;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:1840698;connectomeDB2020:9135143], EREG [Baccin2019:9419975;CellTalkDB:9419975;HPRD:9419975;LRdb:9419975;SIGNOR:16829981;SIGNOR:22891299;connectomeDB2020:9419975], SNTB2 [HPRD:10725395;MPPI:10725395], EPGN [SIGNOR:16469638;SIGNOR:16829981], ERBB2 [HPRD:16767099;IntAct:10572067;IntAct:16767099;IntAct:21203579;IntAct:24557338;Lit-BM-17:10572067;Lit-BM-17:10839362;Lit-BM-17:16767099;Lit-BM-17:24557338;SIGNOR:8816440], DCN [CellTalkDB:10942781;Cellinker:10942781;LRdb:10942781;Ramilowski2015:10942781;connectomeDB2020:10942781;talklr:10942781], MMP7 [CellTalkDB:17638887;Cellinker:17638887;LRdb:17638887;Ramilowski2015:17638887;connectomeDB2020:17638887;talklr:17638887], EGF [CellTalkDB:9305636;LRdb:9305636;Ramilowski2015:9305636;connectomeDB2020:9305636;talklr:9305636], TGFA [Baccin2019:10918572;CellTalkDB:10918572;HPRD:10918572;LRdb:10918572;connectomeDB2020:10918572], ADAM17 [Baccin2019:15534001;CellTalkDB:26554003;HPRD:15534001;LRdb:15534001;ProtMapper:10744726;ProtMapper:15746097;ProtMapper:17486069;ProtMapper:9685416], CCN2 [Baccin2019:12297288;Cellinker:12297288;HPRD:12297288;LRdb:12297288], ACP4 [DEPOD:15219672], ITCH [InnateDB:17463226;LMPID:18334649;LMPID:20855944;Lit-BM-17:17463226;Lit-BM-17:18334649], ABL1 [DOMINO:16273093], ABL2 [DOMINO:16273093], DLG4 [BioGRID:12716924;BioGRID:16767099;HPRD:10725395;HPRD:16767099;IntAct:10725395;IntAct:16767099;Lit-BM-17:10725395;Lit-BM-17:10839362;Lit-BM-17:16767099;Lit-BM-17:17018285;MPPI:10725395], ERBB3 [HPRD:7689552], RNF41 [HPRD:11867753]	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERBB4&keywords=ERBB4	0.5368817878	451	NA	NA	0.239995907	492	0	0.00748502994	0	4.80E-04	0	0.08121827411	9.07E-04	0.00163132137	0.08065112838	3.67E-04	0.002472474406	98	333	275	0.01592833346	3.496218857	0.3998407862	0.4810364856	3	324	279	400
FZD1	frizzled class receptor 1	Yes	Yes		ENSG00000157240	Q9UP38	G-protein coupled receptor Fz/Smo family	21	adhesion, receptor	adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, receptor, transmembrane	O00744, O00755, O96014, P04628, P09544, P41221, P49407, P56703, P56704, P56705, P56706, Q07954, Q99972, Q9BQ69, Q9GZT5, Q9H1J7, Q9Y6F9	ARRB1, LRP1, MACROD1, MYOC, WNT1, WNT10A, WNT10B, WNT11, WNT2, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B	ARRB1 [CA1:11742073], WNT6 [CA1:12857724;CA1:8717036], MACROD1 [CA1:12857724], WNT10B [SIGNOR:12055200;SIGNOR:19008118], WNT1 [CancerCellMap:10557084;CellPhoneDB:24032637;CellTalkDB:24032637;NetPath:10557084;SIGNOR:15578921;SIGNOR:16936075;SIGNOR:22944199;connectomeDB2020:24032637], WNT3A [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;MPPI:10557084;NetPath:10557084;SIGNOR:10601008;SIGNOR:21078818;connectomeDB2020:10557084], WNT7B [Baccin2019:15923619;CellPhoneDB:24032637;CellTalkDB:15923619;LRdb:15923619;NetPath:15923619;SIGNOR:15923619;connectomeDB2020:15923619], WNT3 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;NetPath:10557084;connectomeDB2020:10557084], WNT5A [Baccin2019:10557084;CellPhoneDB:24032637;CellTalkDB:10557084;Cellinker:10557084;HPRD:10557084;LRdb:10557084;MPPI:10557084;connectomeDB2020:10557084], WNT2 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;NetPath:10557084;connectomeDB2020:10557084], WNT4 [CellTalkDB:32103204], WNT5B [NA], WNT11 [NA], MYOC [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], WNT10A [connectomeDB2020:28733458], WNT7A [connectomeDB2020:28733458], LRP1 [CancerCellMap:14739301;NetPath:14739301]	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]	frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	astrocyte-dopaminergic neuron signaling [GO:0036520]; autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; hard palate development [GO:0060022]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; presynapse assembly [GO:0099054]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD1&keywords=FZD1	2.518221236	288	NA	NA	0.2170796542	507	0.0157480315	0.01746506986	0.009955752212	0.02877697842	0.01683501684	0.03045685279	0.03626473255	0.01957585644	0.004439511654	0.02086393377	0.01877535252	222	171	161	0.01992337169	0.4825496206	1.031432356	0.9616346989	309	118	92	271
FZD3	frizzled class receptor 3	Yes	Yes		ENSG00000104290	Q9NPG1	G-protein coupled receptor Fz/Smo family	21	adhesion, receptor	adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00744, O00755, O14904, O14905, O96014, P04628, P09544, P41221, P56703, P56704, P56705, P56706, Q5S007, Q93097, Q93098, Q96CG8, Q99972, Q9GZT5, Q9H1J5, Q9H1J7, Q9UBV4, Q9Y6F9	CTHRC1, LRRK2, MYOC, WNT1, WNT10A, WNT10B, WNT11, WNT16, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B	WNT4 [SignaLink3:14671310;SignaLink3:23331499], WNT2B [SIGNOR:15578921], WNT8B [SIGNOR:15578921], WNT10A [SIGNOR:15578921], WNT8A [SIGNOR:15578921], WNT5B [SIGNOR:15578921;SIGNOR:16273260], WNT16 [SIGNOR:15578921], WNT6 [SIGNOR:15578921], WNT1 [Baccin2019:14642436;CellTalkDB:14642436;HPMR:14642436;LRdb:14642436;SIGNOR:15578921;connectomeDB2020:14642436], WNT10B [SIGNOR:15578921], WNT7A [SIGNOR:15578921], WNT9A [SIGNOR:15578921], WNT9B [SIGNOR:15578921], WNT11 [SIGNOR:15578921;SIGNOR:16273260], WNT5A [CellPhoneDB:24032637;CellTalkDB:24032637;Cellinker:24032637;LRdb:24032637;NetPath:17804197;SIGNOR:15578921;SIGNOR:16273260;SIGNOR:21903638;connectomeDB2020:24032637], WNT3 [SIGNOR:15578921], WNT3A [CellTalkDB:18212053;SIGNOR:10601008;SIGNOR:21078818], WNT7B [SIGNOR:15578921], WNT2 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;NetPath:19038973;connectomeDB2020:24032637], CTHRC1 [Cellinker:18606138;LRdb:18606138;Ramilowski2015:18606138;connectomeDB2020:18606138;talklr:18606138], MYOC [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], LRRK2 [PhosphoSite:32641508]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]	G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; commissural neuron axon guidance [GO:0071679]; dopaminergic neuron axon guidance [GO:0036514]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of neuroblast proliferation [GO:0002052]; post-anal tail morphogenesis [GO:0036342]; response to electrical stimulus [GO:0051602]; response to xenobiotic stimulus [GO:0009410]; serotonergic neuron axon guidance [GO:0036515]; sympathetic ganglion development [GO:0061549]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD3&keywords=FZD3	7.271592404	193	NA	NA	2.324498182	102	0	0.1012974052	0.04092920354	0.06163069544	0.09259259259	0.1945854484	0.2076155938	0.1076672104	0.1243063263	0.1012818801	0.1001738459	63	85	64	0.102916382	1.189431719	0.9855246701	0.975711796	74	131	86	128
FZD5	frizzled class receptor 5	Yes	Yes		ENSG00000163251	Q13467	G-protein coupled receptor Fz/Smo family	21	adhesion, receptor	adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, tight_junction, transmembrane	O00744, O00755, O14905, O96014, P04628, P09544, P41221, P56703, P56704, P56706, Q01974, Q13145, Q96CG8, Q96HF1, Q9GZT5, Q9H1J5, Q9H1J7, Q9ULT6	BAMBI, CTHRC1, ROR2, SFRP2, WNT1, WNT10A, WNT10B, WNT11, WNT2, WNT3, WNT3A, WNT5A, WNT5B, WNT7A, WNT7B, WNT8A, WNT9B, ZNRF3	WNT5A [Baccin2019:9054360;CellPhoneDB:24032637;CellTalkDB:9054360;Cellinker:9054360;HPRD:9054360;ICELLNET:11029007;LRdb:9054360;SIGNOR:9054360;SPIKE:9054360;SignaLink3:23331499;SignaLink3:9054360;connectomeDB2020:9054360], WNT10B [SIGNOR:12055200;SignaLink3:11092808;SignaLink3:23331499], WNT7A [Baccin2019:1285772412857720;CancerCellMap:12857724;CellPhoneDB:24032637;CellTalkDB:12857724;HPMR:12857724;HPRD:12857724;LRdb:12857724;NetPath:18567805;SignaLink3:12857724;SignaLink3:23331499;connectomeDB2020:12857724], ZNRF3 [SIGNOR:22575959], BAMBI [SIGNOR:2662247], WNT3 [CellTalkDB:32196115], WNT2 [Baccin2019:24032637;LRdb:18302287;Ramilowski2015:18302287;connectomeDB2020:18302287;talklr:18302287], SFRP2 [CellTalkDB:28840375;connectomeDB2020:28840375], WNT3A [Baccin2019:24032637;CellTalkDB:22753465;LRdb:22753465;NetPath:17117926;Ramilowski2015:22753465;connectomeDB2020:22753465;talklr:22753465], WNT1 [CellTalkDB:32196115], CTHRC1 [Cellinker:18606138;LRdb:18606138;Ramilowski2015:18606138;connectomeDB2020:18606138;talklr:18606138], WNT5B [NA], WNT11 [NA], WNT10A [connectomeDB2020:28733458], WNT7B [connectomeDB2020:28733458], WNT8A [connectomeDB2020:28733458], WNT9B [connectomeDB2020:25892522;connectomeDB2020:28733458;connectomeDB2020:30978219], ROR2 [HPRD:12839624;NetPath:12839624]	axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cell maturation [GO:0048469]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic camera-type eye development [GO:0031077]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD5&keywords=FZD5	7.924147865	182	NA	NA	1.647978771	149	0	0.1586826347	0.004424778761	0.003357314149	0.1094276094	0.09983079526	0.07162284678	0.03752039152	0.07695153533	0.03144612098	0.02047517867	100	152	154	0.05579447324	1.321562907	0.6299331682	0.4631875168	54	256	290	185
IGF1R	insulin like growth factor 1 receptor	Yes	No		ENSG00000140443	P08069	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	21	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14508, O14654, O60674, P00533, P01308, P01344, P03372, P04899, P05019, P06213, P06241, P07585, P08581, P12830, P12931, P18031, P22681, P25098, P29353, P41240, P46934, P49913, P51654, P63244, Q00987, Q05655, Q06124, Q13322, Q15139, Q99683, Q9NZN5, Q9UEF7	ARHGEF12, CAMP, CBL, CDH1, CSK, DCN, EGFR, ESR1, FYN, GNAI2, GPC3, GRB10, GRK2, IGF1, IGF2, INS, INSR, IRS4, JAK2, KL, MAP3K5, MDM2, MET, NEDD4, PRKCD, PRKD1, PTPN1, PTPN11, RACK1, SHC1, SOCS2, SRC	IGF1 [Baccin2019:1852007;Baccin2019:2877871;CA1:8408032;CellChatDB:14604834;CellTalkDB:2877871;Cellinker:14604834;Cellinker:1852007;Cellinker:2877871;DIP:11287679;DIP:21645859;HPMR:2877871;HPRD:1852007;IntAct:21645859;IntAct:8452530;LRdb:185;LRdb:2877871;ProtMapper:19258508;ProtMapper:23675206;SIGNOR:19029956;SIGNOR:21798082;SPIKE:1852007;SignaLink3:12067807;SignaLink3:1852007;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:1852007;connectomeDB2020:2877871], IGF2 [Baccin2019:9972281;CellChatDB:14604834;CellPhoneDB:27102148;CellTalkDB:9972281;Cellinker:14604834;Cellinker:9972281;HPRD:9972281;LRdb:9972281;SIGNOR:22810696;SPIKE:20980691;SignaLink3:11867533;SignaLink3:23331499;connectomeDB2020:9972281], KL [HPRD:18762812;SPIKE:17684529], INS [Baccin2019:1851182;CellTalkDB:1851182;Cellinker:1851182;HPRD:1851182;LRdb:1851182;SIGNOR:1851182;SignaLink3:1851182;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:1851182], IRS4 [HPRD:11316748;HPRD:9553137], NEDD4 [HPRD:12697834;SignaLink3:12697834;SignaLink3:18988627;SignaLink3:19165858;SignaLink3:21071413;SignaLink3:23331499], PTPN11 [HPRD:7642582;IntAct:28065597;IntAct:7642582;IntAct:8895367;Lit-BM-17:10082579;Lit-BM-17:7642582;Lit-BM-17:8895367;SignaLink3:10082579;SignaLink3:11779860;SignaLink3:23331499;SignaLink3:7642582], PTPN1 [DEPOD:8702689;DOMINO:15976035;DOMINO:16926280;HPRD:8999839;IntAct:15976035;IntAct:16926280;IntAct:8999839;Lit-BM-17:15976035;Lit-BM-17:16926280;Lit-BM-17:8999839;SIGNOR:11884589;SignaLink3:11884589;SignaLink3:23331499;SignaLink3:8999839], RACK1 [BioGRID:11884618;HPRD:11884618;HPRD:16382134;InnateDB:16382134;SignaLink3:11884618;SignaLink3:11964397;SignaLink3:16382134;SignaLink3:23331499], SOCS2 [HPRD:9727029;Lit-BM-17:9727029;SignaLink3:16574995;SignaLink3:23331499;SignaLink3:9727029], MDM2 [BioGRID:28092675;HPRD:12821780;HPRD:18632619;Lit-BM-17:12821780;Lit-BM-17:18632619;Lit-BM-17:19165858;Lit-BM-17:20195357;Lit-BM-17:25241761;Lit-BM-17:28092675;SignaLink3:12821780;SignaLink3:17303558;SignaLink3:18632619;SignaLink3:19165858;SignaLink3:23331499], CSK [HPRD:10026153;Lit-BM-17:10026153], ARHGEF12 [CA1:11724822;DOMINO:11724822;HPRD:11724822;IntAct:11724822;Lit-BM-17:11724822], SHC1 [DIP:7559507;InnateDB:14764897;LMPID:7537849;LMPID:7541045;Lit-BM-17:14764897;Lit-BM-17:15629149;Lit-BM-17:16113100;Lit-BM-17:24051437;Lit-BM-17:7541045;Lit-BM-17:7559507;Lit-BM-17:8776723], GRB10 [DOMINO:9506989;HPRD:8621530;HPRD:8764099;HPRD:9506989;Lit-BM-17:12697834;Lit-BM-17:19165858;Lit-BM-17:8764099;Lit-BM-17:8776723;Lit-BM-17:9506989;SIGNOR:21659604], SRC [HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:18691976;HPRD-phos:20068231;HPRD-phos:8940173;HPRD:8940173;KEA:7537849;KEA:7559478;KEA:8550552;KEA:8940173;KEA:9480911;ProtMapper:15212693;ProtMapper:23472139;ProtMapper:7493944;ProtMapper:8940173;SIGNOR:7493944;SIGNOR:8940173;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:18691976;iPTMnet:20068231;iPTMnet:8940173;phosphoELM:8940173], CDH1 [CellTalkDB:22479204;LRdb:22479204;Ramilowski2015:22479204;connectomeDB2020:22479204;talklr:22479204], GPC3 [Baccin2019:18413366;CellTalkDB:18413366;Cellinker:18413366;LRdb:18413366;Ramilowski2015:18413366;connectomeDB2020:18413366;talklr:18413366], GNAI2 [CellTalkDB:11120746;HPRD:11120746;LRdb:11120746;connectomeDB2020:11120746], CAMP [CellTalkDB:32196115;InnateDB:21685939], MET [Cellinker:28536399], DCN [Cellinker:23350913], EGFR [BioGRID:17047074], GRK2 [PhosphoSite:22509025], FYN [KEA:17570479], INSR [HPRD:7895674;KEA:17570479], JAK2 [HPRD:10747872;HPRD:9492017;InnateDB:25211187], ESR1 [HPRD:10749889;HPRD:16113100;InnateDB:14764897], PRKCD [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;HPRD:11884618], PRKD1 [HPRD:11884618], MAP3K5 [HPRD:12556535], CBL [ACSN:10514377;ACSN:17635922;HPRD:18632619]	alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315]	ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-activated receptor activity [GO:0005009]; insulin binding [GO:0043559]; insulin-like growth factor-activated receptor activity [GO:0005010]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF1R&keywords=IGF1R	20.8166709	101	2213.28	60	1.398288164	170	0.03937007874	0.2225548902	0.08628318584	0.1213429257	0.1734006734	0.4365482234	0.6001813237	0.1517128874	0.1261561228	0.351949526	0.1599768206	62	23	48	0.224497878	0.5806283793	1.543508748	0.7248544082	270	40	188	79
IL12RB1	interleukin 12 receptor subunit beta 1	Yes	No		ENSG00000096996	P42701	Type I cytokine receptor family, Type 2 subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14543, P29459, P29460, Q5VWK5, Q9NPF7	IL12A, IL12B, IL23A, IL23R, SOCS3	IL12A [Baccin2019:11086056;CellTalkDB:11086056;Cellinker:11086056;DIP:8943050;HPMR:11086056;InnateDB:7911493;InnateDB:8943050;LRdb:11086056;Lit-BM-17:11114383;Lit-BM-17:8943050;SIGNOR:12023369;SignaLink3:23331499;SignaLink3:7527811;connectomeDB2020:11086056], IL23A [Baccin2019:11114383;Baccin2019:12023369;Baccin2019:12671732;CellTalkDB:12023369;HPMR:12023369;HPRD:11114383;HPRD:12023369;HPRD:12671732;LRdb:11114383;LRdb:12023369;LRdb:12671732;SIGNOR:12023369;SIGNOR:12671732;SignaLink3:11114383;SignaLink3:12023369;SignaLink3:12671732;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:11114383;connectomeDB2020:12023369;connectomeDB2020:12671732], SOCS3 [SignaLink3:18708154;SignaLink3:23331499], IL12B [Baccin2019:7527811;Baccin2019:7843232;CellTalkDB:7843232;HPMR:11086056;HPRD:7527811;HPRD:7843232;InnateDB:7911493;InnateDB:8943050;LRdb:753;LRdb:7843232;SIGNOR:7527811;connectomeDB2020:7527811;connectomeDB2020:7843232], IL23R [Cellinker:12023369;HPRD:12023369;InnateDB:12023369]	external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12RB1&keywords=IL12RB1	0.1791962124	557	NA	NA	0.1234846133	614	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	586
IL15RA	interleukin 15 receptor subunit alpha	Yes	TBD		ENSG00000134470	Q13261	NA	21	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P30530, P40933, P43405	AXL, IL15, SYK	IL15 [Baccin2019:15265897;Baccin2019:16284400;Baccin2019:7641685;CellTalkDB:15265897;Guide2Pharma:19710453;HPMR:15265897;HPRD:16284400;HPRD:7641685;InnateDB:16284400;IntAct:16284400;LRdb:15265897;LRdb:16284400;LRdb:7641685;Lit-BM-17:10903799;Lit-BM-17:16284400;SIGNOR:17709786;SignaLink3:23331499;SignaLink3:8530383;connectomeDB2020:15265897;connectomeDB2020:16284400;connectomeDB2020:7641685], SYK [HPRD:11714793;KEA:11714793;ProtMapper:11714793;SIGNOR:11714793;iPTMnet:11714793], AXL [HPRD:16308569]	cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; protein kinase binding [GO:0019901]	interleukin-15-mediated signaling pathway [GO:0035723]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phagocytosis [GO:0050766]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL15RA&keywords=IL15RA	11.55168764	150	NA	NA	1.158686947	203	0.05511811024	0.1057884232	0.1183628319	0.1402877698	0.1228956229	0.01015228426	0.009972801451	0.0277324633	0.009618941916	0.004973961811	0.02549739231	202	237	146	0.05730914573	0.2914751288	0.2224654859	0.5273784406	379	384	263	244
IL2RG	interleukin 2 receptor subunit gamma	Yes	No		ENSG00000147168	P31785	Type I cytokine receptor family, Type 5 subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P01589, P05112, P05362, P13232, P14784, P15248, P18510, P23458, P24394, P30530, P35225, P40933, P52333, P60568, Q9HBE4	AXL, ICAM1, IL13, IL15, IL1RN, IL2, IL21, IL2RA, IL2RB, IL4, IL4R, IL7, IL9, JAK1, JAK3	IL2 [Baccin2019:10662798;Baccin2019:15265897;Baccin2019:8049354;CellTalkDB:15265897;DIP:8006584;HPMR:15265897;HPMR:15933202;HPRD:10662798;HPRD:8049354;InnateDB:11418623;InnateDB:7681595;InnateDB:8568232;LRdb:10662798;LRdb:15265897;LRdb:8049354;NetPath:8049354;NetPath:8260650;SIGNOR:16477002;SignaLink3:10807786;SignaLink3:10820393;SignaLink3:10849428;SignaLink3:11418623;SignaLink3:12095053;SignaLink3:15289500;SignaLink3:15563472;SignaLink3:16212621;SignaLink3:16799562;SignaLink3:17371980;SignaLink3:1825141;SignaLink3:18758473;SignaLink3:19528259;SignaLink3:19833085;SignaLink3:20856220;SignaLink3:21840487;SignaLink3:22224781;SignaLink3:23124025;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:23650441;SignaLink3:24829413;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:2965306;SignaLink3:6164929;SignaLink3:7512720;SignaLink3:7521688;SignaLink3:7681595;SignaLink3:7829965;SignaLink3:8683106;SignaLink3:9625766;connectomeDB2020:10662798;connectomeDB2020:15265897;connectomeDB2020:8049354], JAK1 [HPRD:7973658;NetPath:7973658], JAK3 [DIP:7973658;HPRD:7973658;InnateDB:10629052;InnateDB:7973657;NetPath:10856136;NetPath:15621723;NetPath:7973658;NetPath:7973659], IL4R [HPRD:8266076;InnateDB:8266078;Lit-BM-17:18243101;Lit-BM-17:8266078;NetPath:8266078;SIGNOR:12704343;SIGNOR:8266078;SignaLink3:23331499;SignaLink3:8266078], IL15 [Baccin2019:1526589;Baccin2019:78568232;CellTalkDB:15265897;Cellinker:15265897;Cellinker:8568232;DIP:10903799;DIP:8178155;DIP:9371812;Guide2Pharma:19710453;HPMR:15265897;HPRD:8568232;LRdb:15265897;LRdb:86;Lit-BM-17:10903799;Lit-BM-17:8178155;Lit-BM-17:9371812;NetPath:8026467;SIGNOR:11418623;connectomeDB2020:15265897;connectomeDB2020:8568232;scConnect:19710453], IL21 [Baccin2019:11418623;CellTalkDB:11418623;HPMR:11418623;InnateDB:11418623;LRdb:11418623;SIGNOR:11418623;connectomeDB2020:11418623], IL1RN [NA], IL4 [Baccin2019:79183788266078;CellTalkDB:7918378;HPMR:11815609;HPMR:7918378;HPRD:8266078;InnateDB:8266078;LRdb:7918378;LRdb:827;Lit-BM-17:18243101;Lit-BM-17:8266078;NetPath:8266078;SIGNOR:11418623;connectomeDB2020:7918378;connectomeDB2020:8266078], IL7 [Baccin2019:11858939;Baccin2019:7522165;Baccin2019:9010926;CellTalkDB:11858939;DIP:8128231;DIP:9371812;HPMR:7522165;HPMR:8128231;HPRD:11858939;HPRD:9010926;InnateDB:8266077;LRdb:11858939;LRdb:7522165;LRdb:9010926;Lit-BM-17:8128231;Lit-BM-17:9371812;SIGNOR:11418623;SIGNOR:20089933;connectomeDB2020:11858939;connectomeDB2020:7522165;connectomeDB2020:9010926], IL9 [Baccin2019:9535918;CellTalkDB:9535918;HPMR:9535918;LRdb:9535918;NetPath:7718508;SIGNOR:11418623;connectomeDB2020:9535918], ICAM1 [CellTalkDB:1976256;Cellinker:1976256;HPRD:1976256;LRdb:1976256], IL13 [CellTalkDB:8920992;Ramilowski2015:8920992;connectomeDB2020:8920992;talklr:8920992], IL2RB [DIP:10903799;DIP:8006584;HPRD:11886175;InnateDB:15178252;InnateDB:1545122;InnateDB:7681595;InnateDB:8026467;InnateDB:8568232;Lit-BM-17:10903799;Lit-BM-17:8006584;NetPath:7514277;NetPath:8026467;NetPath:8260650], IL2RA [InnateDB:8568232;NetPath:8260650], AXL [HPRD:16308569]	cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976]	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; positive regulation of phagocytosis [GO:0050766]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2RG&keywords=IL2RG	1.362626788	350	NA	NA	0.05865068716	715	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	533
IL3RA	interleukin 3 receptor subunit alpha	Yes	Yes		ENSG00000185291	P26951	Type I cytokine receptor family, Type 5 subfamily	21	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60674, P04141, P08700, P23458, Q05516	CSF2, IL3, JAK1, JAK2, ZBTB16	JAK2 [HPRD:15988755;NetPath:15988755], ZBTB16 [SPIKE:19723763], IL3 [BioGRID:8649415;CellTalkDB:11700046;DIP:8649415;HPMR:11700046;HPRD:8649415;HPRD:9278420;InnateDB:7957082;LRdb:11700046;LRdb:8649415;LRdb:9278420;NetPath:9278420;SIGNOR:11700046;SIGNOR:1465408;SignaLink3:1465408;SignaLink3:23331499;connectomeDB2020:11700046;connectomeDB2020:8649415;connectomeDB2020:9278420], CSF2 [Baccin2019:7957082;CellTalkDB:7957082;Cellinker:7957082;HPRD:7957082;LRdb:7957082;connectomeDB2020:7957082], JAK1 [HPRD:15988755;NetPath:15988755]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-3 receptor activity [GO:0004912]	cytokine-mediated signaling pathway [GO:0019221]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL3RA&keywords=IL3RA	2.538809301	287	NA	NA	0.1720703059	548	0.8031496063	0.005489021956	0.6659292035	0.04580335731	0	0.001692047377	0.00725294651	0	0.001849796522	0.001368674055	0.003090593008	229	307	261	0.1396022951	0.07920865459	0.07599264466	0.0875026215	438	435	435	394
IL6ST	interleukin 6 cytokine family signal transducer	Yes	Yes		ENSG00000134352	P40189	Type I cytokine receptor family, Type 2 subfamily	21	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14543, O60674, O75462, P04626, P05231, P08631, P08887, P13725, P15018, P20809, P21860, P23458, P26441, P29016, P29350, P29597, P42702, P50750, P62714, P67775, Q05655, Q14213, Q16619, Q8NEV9, Q99650, Q9UBD9, Q9UQM7	CAMK2A, CD1B, CDK9, CLCF1, CNTF, CRLF1, CTF1, EBI3, ERBB2, ERBB3, HCK, IL11, IL27, IL6, IL6R, JAK1, JAK2, LIF, LIFR, OSM, OSMR, PPP2CA, PPP2CB, PRKCD, PTPN6, SOCS3, TYK2	IL6 [Baccin2019:14557255;Baccin2019:3136546;Baccin2019:8293462;CellTalkDB:14557255;DIP:11251120;DIP:7744001;Guide2Pharma:1995637;HPMR:15895091;HPMR:3136546;HPRD:14557255;InnateDB:15895091;LRdb:14557255;LRdb:3136546;LRdb:8293462;Lit-BM-17:11251120;Lit-BM-17:12829785;Lit-BM-17:18775332;Lit-BM-17:7744001;NetPath:2788034;SIGNOR:15895091;SPIKE:15895091;SPIKE:19715447;connectomeDB2020:14557255;connectomeDB2020:3136546;connectomeDB2020:8293462;scConnect:1995637], JAK2 [KEA:10661409;NetPath:7896787], OSMR [HPRD:9188471;SignaLink3:10692570;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8999038;SignaLink3:9188471], IL6R [HPRD:2788034;InnateDB:14656210;InnateDB:2788034;InnateDB:7744875;InnateDB:8706672;InnateDB:9694899;NetPath:2788034;SIGNOR:11238858;SIGNOR:23663276;SignaLink3:11238858;SignaLink3:23331499], LIFR [BioGRID:12047380;BioGRID:8999038;HPRD:12047380;SIGNOR:24710148;SignaLink3:16254248;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8999038], CTF1 [Baccin2019:11834704;CellTalkDB:11834704;HPRD:11834704;LRdb:11834704;SIGNOR:9030543;SignaLink3:23331499;SignaLink3:9030543;connectomeDB2020:11834704], TYK2 [DIP:9388212;HPRD:9388212], JAK1 [BioGRID:11742534;DIP:21220115;DIP:9388212;HPRD:11468294;HPRD:11742534;KEA:10661409;NetPath:7896787], CNTF [Baccin2019:12643274;Baccin2019:16051226;Cellinker:12643274;Cellinker:16051226;DOMINO:16051226;HPMR:10966616;HPRD:12643274;HPRD:16051226;IntAct:16051226;LRdb:12643274;LRdb:16;Lit-BM-17:16051226;Lit-BM-17:18775332;SIGNOR:9143707;connectomeDB2020:12643274;connectomeDB2020:16051226], CLCF1 [Baccin2019:10966616;CellTalkDB:10966616;HPMR:10966616;LRdb:10966616;SIGNOR:9143707;connectomeDB2020:10966616], CRLF1 [NA], IL11 [Baccin2019:10948192;CellTalkDB:10948192;DIP:8360477;HPMR:10948192;InnateDB:9560294;LRdb:10948192;SIGNOR:9143707;connectomeDB2020:10948192], IL27 [NA], EBI3 [Baccin2019:28280243;CellTalkDB:22306691;connectomeDB2020:28280243], LIF [Baccin2019:971648712707269;CellTalkDB:9716487;DOMINO:16051226;HPMR:9716487;HPRD:12707269;IntAct:14527405;IntAct:16051226;LRdb:127;LRdb:9716487;Lit-BM-17:14527405;Lit-BM-17:16051226;ProtMapper:10811661;SIGNOR:9143707;connectomeDB2020:12707269;connectomeDB2020:9716487], OSM [Baccin2019:10854424;Baccin2019:16051226;Baccin2019:8999038;CellTalkDB:16051226;DIP:8999038;DOMINO:16051226;HPMR:10854424;HPMR:8999038;HPRD:16051226;HPRD:8999038;LRdb:10854424;LRdb:16051226;LRdb:8999038;SIGNOR:9143707;connectomeDB2020:10854424;connectomeDB2020:16051226;connectomeDB2020:8999038], SOCS3 [HPRD:10946280;HPRD:12403768;NetPath:10777583;ProtMapper:24710148;ProtMapper:30591653;SIGNOR:19620279;SIGNOR:23454976], PRKCD [HPRD-phos:12361954;HPRD:12361954;KEA:12361954;NetPath:12361954;PhosphoSite:12361954;ProtMapper:12361954;SIGNOR:12361954;iPTMnet:12361954;phosphoELM:12361954], CD1B [Cellinker:32589946], ERBB3 [HPRD:11821958], ERBB2 [HPRD:11821958;NetPath:9590694], CAMK2A [KEA:16036214;PhosphoSite:10811661], PPP2CA [DEPOD:15786731], PPP2CB [DEPOD:15786731], CDK9 [HPRD:12386808;NetPath:12386808], HCK [HPRD:11689697;NetPath:9406996], PTPN6 [HPRD:10800945]	ciliary neurotrophic factor receptor complex [GO:0070110]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor activity [GO:0004897]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-27 receptor activity [GO:0045509]; scaffold protein binding [GO:0097110]	ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; glycogen metabolic process [GO:0005977]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; leukemia inhibitory factor signaling pathway [GO:0048861]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of neuron apoptotic process [GO:0043524]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; response to cytokine [GO:0034097]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL6ST&keywords=IL6ST	106.9773295	17	NA	NA	1.801572361	137	0.125984252	1.271956088	1.137168142	0.8383693046	0.4124579125	0.7969543147	0.8549410698	0.6345840131	0.3862375139	0.5284083322	0.4273131157	19	14	15	0.6740340053	0.5792658126	0.7871075533	0.6393148767	273	201	221	92
IL7R	interleukin 7 receptor	Yes	Yes		ENSG00000168685	P16871	Type I cytokine receptor family, Type 4 subfamily	21	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P06241, P07948, P10721, P13232, P23458, P52333, Q14289, Q969D9	FYN, IL7, JAK1, JAK3, KIT, LYN, PTK2B, TSLP	JAK3 [HPRD:15996891;HPRD:7481769;InnateDB:20167604;NetPath:7481769;ProtMapper:22551764;ProtMapper:27423467], IL7 [Baccin2019:10390077;Baccin2019:11858939;Baccin2019:7522165;CellTalkDB:11858939;DIP:1558969;DIP:19141282;DIP:8409434;HPMR:7522165;HPMR:8128231;HPRD:10390077;HPRD:11858939;InnateDB:8266077;IntAct:19141282;IntAct:8266077;LRdb:10390077;LRdb:11858939;LRdb:7522165;Lit-BM-17:1558969;Lit-BM-17:19141282;Lit-BM-17:8409434;NetPath:2317865;SIGNOR:20089933;SIGNOR:8204885;SignaLink3:23331499;SignaLink3:8204885;connectomeDB2020:10390077;connectomeDB2020:11858939;connectomeDB2020:7522165], TSLP [Baccin2019:11418668;CellTalkDB:11418668;HPRD:11418668;InnateDB:11418668;LRdb:11418668;NetPath:10881176;NetPath:10974032;connectomeDB2020:11418668], JAK1 [HPRD:15996891;HPRD:8647212;InnateDB:20167604;NetPath:20974963;NetPath:8647212;ProtMapper:27729062], KIT [Cellinker:17554063;NetPath:17554063], FYN [HPRD:7515933;InnateDB:7515933;NetPath:7515933], PTK2B [HPRD:10702271;NetPath:10702271], LYN [HPRD:7515933]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	antigen binding [GO:0003823]; cytokine receptor activity [GO:0004896]; interleukin-7 receptor activity [GO:0004917]	B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-positive bacterium [GO:0050830]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; lymph node development [GO:0048535]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of T cell differentiation in thymus [GO:0033089]; regulation of cell size [GO:0008361]; regulation of DNA recombination [GO:0000018]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL7R&keywords=IL7R	2.395739271	293	NA	NA	0.3539207147	426	2.614173228	0.00748502994	0.005530973451	0.05443645084	0.001683501684	0.006768189509	0.00725294651	0.003262642741	0.002959674436	0.003238082521	0.01433262507	226	258	181	0.2473748495	0.05035330553	0.05143502772	0.09454158056	448	444	432	355
LEPR	leptin receptor	Yes	No		ENSG00000116678	P48357	Type I cytokine receptor family, Type 2 subfamily	21	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14508, O14543, O60674, P05090, P41159, Q9NSE2	APOD, CISH, JAK2, LEP, SOCS2, SOCS3	JAK2 [HPRD:8608603;NetPath:9092791;ProtMapper:11970889;SIGNOR:11018044], LEP [Baccin2019:8608603;Baccin2019:9463481;CellTalkDB:9463481;Cellinker:8608603;Cellinker:9463481;DIP:22405007;DIP:9786864;HPMR:9463481;HPRD:8608603;ICELLNET:9463481;LRdb:861;LRdb:9463481;NetPath:12226096;NetPath:9218470;SIGNOR:9463481;SignaLink3:23331499;SignaLink3:9207021;connectomeDB2020:8608603;connectomeDB2020:9463481], CISH [NetPath:16684815;SignaLink3:18708154;SignaLink3:23331499], SOCS2 [NetPath:16684815;SignaLink3:18708154;SignaLink3:23331499], SOCS3 [BioGRID:11018044;BioGRID:21239736;HPRD:11018044;SignaLink3:11018044;SignaLink3:18708154;SignaLink3:21239736;SignaLink3:23331499], APOD [Baccin2019:11344130;CellTalkDB:11344130;Cellinker:11344130;HPRD:11344130;LRdb:11344130;connectomeDB2020:11344130]	basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; leptin receptor activity [GO:0038021]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]	angiogenesis [GO:0001525]; bone growth [GO:0098868]; cell surface receptor signaling pathway [GO:0007166]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; energy homeostasis [GO:0097009]; energy reserve metabolic process [GO:0006112]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; glycogen metabolic process [GO:0005977]; leptin-mediated signaling pathway [GO:0033210]; multicellular organism development [GO:0007275]; negative regulation of autophagy [GO:0010507]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of hydrolase activity [GO:0051346]; phagocytosis [GO:0006909]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein phosphorylation [GO:0001934]; regulation of bone remodeling [GO:0046850]; regulation of feeding behavior [GO:0060259]; regulation of transport [GO:0051049]; response to leptin [GO:0044321]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; transport across blood-brain barrier [GO:0150104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEPR&keywords=LEPR	11.96000649	146	NA	NA	2.358126998	99	0.02362204724	0.02644710579	0.0232300885	0.01894484412	0.01515151515	0.5042301184	0.02447869447	0.006525285481	0.3984461709	0.01091601015	0.01116476724	16	201	201	0.09665060432	3.829759555	0.1961171273	0.1984495763	1	391	393	209
LIFR	LIF receptor subunit alpha	Yes	Yes		ENSG00000113594	P42702	Type I cytokine receptor family, Type 2 subfamily	21	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14543, O75462, P13725, P15018, P26441, P27361, P28482, P29350, P48029, P49841, P53779, Q16619, Q92520, Q9UBD9	CLCF1, CNTF, CRLF1, CTF1, FAM3C, GSK3B, LIF, MAPK1, MAPK10, MAPK3, OSM, PTPN6, SLC6A8, SOCS3	SOCS3 [SPIKE:17312100], LIF [Baccin2019:12601009;Baccin2019:16051226;Baccin2019:9716487;CellTalkDB:12601009;DIP:8662595;DIP:8999038;DIP:9852103;DOMINO:16051226;HPMR:9716487;HPRD:12601009;HPRD:16051226;LRdb:12601009;LRdb:16051226;LRdb:9716487;SIGNOR:16051226;SIGNOR:24710148;SIGNOR:9143707;SignaLink3:10428964;SignaLink3:11306493;SignaLink3:12601009;SignaLink3:16051226;SignaLink3:19833085;SignaLink3:21840487;SignaLink3:22595692;SignaLink3:23331499;SignaLink3:24857661;SignaLink3:26192618;SignaLink3:7512720;SignaLink3:7521688;connectomeDB2020:12601009;connectomeDB2020:16051226;connectomeDB2020:9716487], CTF1 [Baccin2019:11834704;CellTalkDB:11834704;HPRD:11834704;LRdb:11834704;SIGNOR:11834704;SignaLink3:11834704;SignaLink3:23331499;SignaLink3:9030543;connectomeDB2020:11834704], CNTF [Baccin2019:12643274;Baccin2019:16051226;DIP:10207005;DOMINO:16051226;HPMR:10966616;HPRD:12643274;HPRD:16051226;IntAct:16051226;IntAct:18775332;LRdb:12643274;LRdb:16;Lit-BM-17:10207005;Lit-BM-17:16051226;Lit-BM-17:18775332;SIGNOR:10966616;connectomeDB2020:12643274;connectomeDB2020:16051226], CLCF1 [Baccin2019:10966616;CellTalkDB:10966616;HPMR:10966616;LRdb:10966616;connectomeDB2020:10966616], CRLF1 [NA], OSM [Baccin2019:10854424;Baccin2019:1536831;Baccin2019:1542794;Baccin2019:16051226;CellTalkDB:10854424;DIP:8999038;DOMINO:16051226;HPRD:1536831;HPRD:1542794;HPRD:16051226;LRdb:10854424;LRdb:1536831;LRdb:1542794;LRdb:16051226;SIGNOR:1536831;connectomeDB2020:10854424;connectomeDB2020:1536831;connectomeDB2020:1542794;connectomeDB2020:16051226], MAPK3 [KEA:7777512;PhosphoSite:18624908;PhosphoSite:22306348;PhosphoSite:28122243;PhosphoSite:30851421;PhosphoSite:7777512;ProtMapper:7777512;SIGNOR:7777512;iPTMnet:7777512;phosphoELM:7777512], MAPK1 [HPRD-phos:7777512;HPRD:7777512;KEA:7777512;ProtMapper:30851421;ProtMapper:7777512;SIGNOR:7777512;iPTMnet:7777512;phosphoELM:7777512], FAM3C [connectomeDB2020:30692635], SLC6A8 [Cellinker:26187859], GSK3B [KEA:17570479], MAPK10 [KEA:17570479], PTPN6 [HPRD:10800945]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]	cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LIFR&keywords=LIFR	5.709988171	216	NA	NA	0.2805028535	469	0	0.04640718563	0.0685840708	0.03645083933	0.1094276094	0.01692047377	0.01269265639	0.006525285481	0.008879023307	0.007477633863	0.007494688043	204	214	221	0.02916904237	0.4819883808	0.4462103949	0.4466457944	310	307	296	302
MPL	MPL proto-oncogene, thrombopoietin receptor	Yes	No		ENSG00000117400	P40238	Type I cytokine receptor family, Type 1 subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15524, O60674, P01579, P07202, P27797, P40225, Q8WWM7	ATXN2L, CALR, IFNG, JAK2, SOCS1, THPO, TPO	JAK2 [HPRD:10224114;HPRD:10918061;HPRD:10979953;HPRD:7534285;Lit-BM-17:24931576], THPO [Baccin2019:10495959;Baccin2019:9766811;CellTalkDB:10495959;Cellinker:10495959;Cellinker:8521814;Cellinker:9766811;DIP:9252374;HPRD:9766811;ICELLNET:11784712;LRdb:10495959;LRdb:98;SIGNOR:11784712;SignaLink3:23331499;SignaLink3:7543416;SignaLink3:9766811;connectomeDB2020:10495959;connectomeDB2020:9766811], ATXN2L [HPRD:11784712;Lit-BM-17:11784712;SIGNOR:11784712], CALR [CellTalkDB:32462673;Cellinker:29288169], TPO [Cellinker:30803992], IFNG [Cellinker:30803992], SOCS1 [BioGRID:10517496;HPRD:10517496]	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	thrombopoietin receptor activity [GO:0038164]	basophil homeostasis [GO:1990960]; cellular response to hypoxia [GO:0071456]; eosinophil homeostasis [GO:1990959]; monocyte homeostasis [GO:0035702]; neutrophil homeostasis [GO:0001780]; platelet aggregation [GO:0070527]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of platelet formation [GO:1905221]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MPL&keywords=MPL	0.6477871602	432	NA	NA	2.277159404	107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	270
NGFR	nerve growth factor receptor	Yes	No		ENSG00000064300	P08138	NA	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane, transmembrane_predicted	O43353, P01138, P02766, P04629, P05067, P05129, P07288, P20783, P22694, P23515, P23560, P27361, P28482, P30990, P33681, P34130, P60568, Q12923, Q16288, Q16620, Q9NQC3	APP, BDNF, CD80, IL2, KLK3, MAPK1, MAPK3, NGF, NTF3, NTF4, NTRK1, NTRK2, NTRK3, NTS, OMG, PRKACB, PRKCG, PTPN13, RIPK2, RTN4, TTR	BDNF [AlzPathway:9775403;Cellinker:19908279;connectomeDB2020:25354496], NTF3 [AlzPathway:9775403;CellTalkDB:20036257;connectomeDB2020:27434667], NTF4 [AlzPathway:9775403;Baccin2019:7541633;CellTalkDB:7541633;Cellinker:7541633;HPRD:7541633;LRdb:7541633;connectomeDB2020:7541633], NGF [AlzPathway:16893414;AlzPathway:9775403;Baccin2019:11114882;Baccin2019:14985763;CellTalkDB:11114882;Cellinker:11114882;Cellinker:14985763;Cellinker:24224055;DIP:1372492;DIP:1714587;DIP:2172988;DIP:3037029;Guide2Pharma:22227462;HPMR:11114882;HPRD:14985763;LRdb:11114882;LRdb:15;Lit-BM-17:11729324;Lit-BM-17:1372492;Lit-BM-17:14985763;Lit-BM-17:1714587;Lit-BM-17:2172988;Lit-BM-17:3037029;SIGNOR:10764727;SIGNOR:14699954;connectomeDB2020:11114882;connectomeDB2020:14985763;scConnect:22227462], PTPN13 [HPRD:10544233], PRKACB [HPRD-phos:12682012;HPRD:12682012;KEA:12682012;Lit-BM-17:12682012;PhosphoSite:12682012;PhosphoSite:26119933;ProtMapper:12682012;SIGNOR:12682012;iPTMnet:12682012], IL2 [Baccin2019:1316918;CellTalkDB:1316918;Cellinker:1316918;HPRD:1316918;LRdb:1316918], RTN4 [CellTalkDB:32196115], OMG [CellTalkDB:32196115], APP [BioGRID:19710315;CellTalkDB:11756426;Cellinker:24224055;DIP:19225519;Lit-BM-17:11756426;Lit-BM-17:19225519], NTS [CellTalkDB:32196115], KLK3 [NA], CD80 [Cellinker:32822567;Lit-BM-17:21982860], TTR [NA], PRKCG [PhosphoSite:19710323], NTRK1 [DIP:7616616;DIP:7836442;HPRD:9927421;Lit-BM-17:25708205;Lit-BM-17:7616616;Lit-BM-17:7836442], MAPK1 [HPRD:8407983], MAPK3 [HPRD:8407983], NTRK3 [HPRD:9927421], NTRK2 [HPRD:9927421], RIPK2 [HPRD:11487608;HPRD:16498402]	cell-cell junction [GO:0005911]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NGFR&keywords=NGFR	0.8640935483	399	NA	NA	0.03552256399	776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	588
NOTCH1	notch receptor 1	Yes	No		ENSG00000148400	P46531	NOTCH family	21	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	A0PJZ3, O00303, O00505, O00548, O00587, O00629, O14672, O60684, O75056, O75553, P01375, P04628, P05067, P06239, P09958, P10745, P24863, P25490, P35222, P41240, P48745, P49336, P49757, P49768, P49810, P49840, P49841, P53350, P55001, P56705, P62987, P67809, P68400, P78504, P78536, P80370, P84022, Q00987, Q12860, Q13361, Q13526, Q13573, Q13627, Q13761, Q13950, Q16873, Q4G148, Q6UY11, Q86Y01, Q8IUQ4, Q8IZL2, Q8NBI6, Q8NBL1, Q8NES3, Q8NFP9, Q8NFT8, Q92585, Q92630, Q92831, Q92993, Q969H0, Q96EB6, Q96J02, Q96JK9, Q9H488, Q9NR61, Q9NWT6, Q9NYJ7, Q9P2R6, Q9UBE8, Q9UBP5, Q9UIW2, Q9ULJ6, Q9UQ52, Q9UQF2, Q9Y219, Q9Y644, Q9Y6R0	_APH1A_NCSTN_PSEN1_PSENEN, ADAM10, ADAM17, APP, CCN3, CCNC, CDK8, CNTN1, CNTN6, CSK, CSNK2A1, CTNNB1, DAB1, DLK1, DLK2, DLL1, DLL3, DLL4, DNER, DTX1, DYRK1A, DYRK2, EIF3F, FBXW7, FURIN, GSK3A, GSK3B, GXYLT1, GXYLT2, HEY2, HIF1AN, ITCH, JAG1, JAG2, KAT2B, KAT5, KPNA3, KPNA4, KPNA6, LCK, LFNG, LTC4S, MAML1, MAML2, MAML3, MAPK8IP1, MDM2, MFAP2, MFAP5, MFNG, NBEA, NLK, NUMB, NUMBL, PIN1, PLK1, PLXNA1, POFUT1, POGLUT1, PSEN1, PSEN2, RBP3, RERE, RFNG, RUNX2, RUNX3, SDC3, SIAH1, SIRT1, SMAD3, SNW1, TNF, UBA52, WNT1, WNT4, XXYLT1, YBX1, YY1, ZMIZ1	NUMB [BioGRID:8755477;HPRD:12682059;HPRD:8755477;NetPath:8755477;SIGNOR:12682059;SPIKE:15358736], JAG2 [Baccin2019:1100613311006130;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:11006133;Cellinker:22353464;HPRD:11006133;ICELLNET:16921404;ICELLNET:21352254;ICELLNET:22503540;LRdb:11006133;NetPath:11006133;SIGNOR:9315665;SignaLink3:10958687;SignaLink3:11006133;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11006133], DLL1 [Baccin2019:1006133;Baccin2019:98194281;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:11006133;Cellinker:22353464;Cellinker:9819428;HPRD:11006133;ICELLNET:21685328;LRdb:11;LRdb:9819428;NetPath:11006133;SIGNOR:16140393;SPIKE:11006133;SPIKE:17537801;connectomeDB2020:11006133;connectomeDB2020:9819428], WNT1 [SPIKE:18495817], JAG1 [ACSN:22330899;ACSN:22363130;Baccin2019:769772111006133;BioGRID:11006133;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:11006133;Cellinker:22353464;Cellinker:7697721;DIP:18660822;HPMR:7697721;HPRD:11006133;ICELLNET:15137944;ICELLNET:16921404;ICELLNET:18292500;IntAct:18660822;IntAct:23086448;LRdb:11;LRdb:7697721;Lit-BM-17:11006133;Lit-BM-17:18660822;Lit-BM-17:21820430;NetPath:11006133;SIGNOR:18660822;SPIKE:11006133;SPIKE:16713569;SPIKE:17537801;SPIKE:18495817;SignaLink3:10958687;SignaLink3:11006133;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11006133;connectomeDB2020:7697721], FBXW7 [BioGRID:11425854;BioGRID:26108681;BioGRID:27229929;BioGRID:32792479;DIP:17909182;DIP:20823234;DIP:25344755;HPRD:11425854;HPRD:11585921;IntAct:17909182;IntAct:20823234;IntAct:25344755;IntAct:27229929;LMPID:11461910;LMPID:11585921;NetPath:11425854;SIGNOR:15546612;SPIKE:11461910;SPIKE:20571051;SignaLink3:11425854;SignaLink3:11585921;SignaLink3:17646408;SignaLink3:23331499], SMAD3 [HPRD:14638857;NetPath:14638857;SIGNOR:14638857;SignaLink3:14638857;SignaLink3:18988627;SignaLink3:23331499], DLL3 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;Cellinker:29910816;ICELLNET:16921404;LRdb:22353464;NetPath:18676613;SIGNOR:16140393;SignaLink3:10958687;SignaLink3:23331499;connectomeDB2020:22353464], DTX1 [BioGRID:20208568;HPRD:11226752;NetPath:11564735;SIGNOR:11153911;SIGNOR:11226752;SIGNOR:22162134;SignaLink3:11153911;SignaLink3:11226752;SignaLink3:11564735;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499], DLL4 [Baccin2019:10837024;Baccin2019:11739188;Baccin2019:16219802;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:10837024;Cellinker:11739188;Cellinker:16219802;Cellinker:22353464;HPRD:10837024;HPRD:11739188;ICELLNET:15137944;ICELLNET:19494260;LRdb:10837024;LRdb:11739188;LRdb:16219802;SIGNOR:10837024;SIGNOR:11739188;SIGNOR:16140393;SignaLink3:10837024;SignaLink3:11739188;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:10837024;connectomeDB2020:11739188;connectomeDB2020:16219802], MFAP5 [CellTalkDB:16492672;Cellinker:16492672;LRdb:16492672;Ramilowski2015:16492672;SignaLink3:16492672;SignaLink3:23331499;talklr:16492672], DAB1 [SIGNOR:22394407;SignaLink3:18593473;SignaLink3:23331499], LTC4S [SignaLink3:11390662;SignaLink3:23331499], MAML2 [HPRD:12370315;NetPath:12370315;SignaLink3:12370315;SignaLink3:23331499], MAML3 [HPRD:12370315;Lit-BM-17:12370315;Lit-BM-17:23022380;NetPath:12370315;SignaLink3:12370315;SignaLink3:23331499], ITCH [HPRD:12682059;NetPath:10940313;SIGNOR:10940313;SignaLink3:10940313;SignaLink3:12682059;SignaLink3:23331499], CNTN1 [HPRD:14567914;NetPath:14567914;SignaLink3:14567914;SignaLink3:23331499;connectomeDB2020:14567914], CCN3 [Baccin2019:1590625312050160;CellTalkDB:15906253;Cellinker:12050162;Cellinker:15906253;HPRD:12050162;LRdb:12;LRdb:15906253;NetPath:12050162;SignaLink3:12050162;SignaLink3:23331499;connectomeDB2020:12050162;connectomeDB2020:15906253], MFAP2 [Baccin2019:18417156;CellTalkDB:16492672;Cellinker:16492672;LRdb:16492672;Ramilowski2015:16492672;SignaLink3:16492672;SignaLink3:23331499;talklr:16492672], CDK8 [SIGNOR:15546612;SignaLink3:15546612;SignaLink3:23331499], SNW1 [HPRD:10713164;Lit-BM-17:10713164;Lit-BM-17:11404076;Lit-BM-17:15546612;NetPath:10713164;SIGNOR:10713164;SIGNOR:11404076], LCK [HPRD:14583609;NetPath:14583609;SIGNOR:14583609;SignaLink3:14583609;SignaLink3:23331499], GXYLT1 [SIGNOR:22117070], DLK2 [CellTalkDB:21419176;Cellinker:21419176;LRdb:21419176;Ramilowski2015:21419176;SIGNOR:21419176;connectomeDB2020:21419176;talklr:21419176], SIAH1 [SIGNOR:20940030], XXYLT1 [SIGNOR:22117070], POGLUT1 [SIGNOR:22872643], LFNG [HPRD:10935626;HPRD:12486116;SIGNOR:12486116], NBEA [SIGNOR:26999814], DNER [SIGNOR:15965470], MAML1 [HPRD:11101851;HPRD:12644465;HPRD:16530044;IntAct:12370315;IntAct:18427106;IntAct:19907488;Lit-BM-17:11101851;Lit-BM-17:11390662;Lit-BM-17:11997524;Lit-BM-17:12370315;Lit-BM-17:16530044;Lit-BM-17:18427106;Lit-BM-17:21820430;Lit-BM-17:22100894;Lit-BM-17:23022380;NetPath:11101851;NetPath:12644465;SIGNOR:11101851;SIGNOR:11390662], KAT2B [HPRD:10747963;NetPath:10747963;NetPath:14500836;SIGNOR:22120716;SIGNOR:23029358], KAT5 [SIGNOR:17636029], SIRT1 [SIGNOR:22223095], POFUT1 [HPRD:12697902;SIGNOR:12909620], HIF1AN [SIGNOR:18299578], RERE [SIGNOR:28144959], NLK [SIGNOR:20118921], HEY2 [SIGNOR:16682003], ZMIZ1 [Lit-BM-17:26522984;SIGNOR:26522984], CNTN6 [SIGNOR:15082708;connectomeDB2020:15082708], RFNG [SIGNOR:12486116], GXYLT2 [SIGNOR:22117070], ADAM10 [ACSN:19601831;ACSN:19704010;ACSN:19726682;CellTalkDB:22399336;Cellinker:22399336;LRdb:22399336;SIGNOR:28624438], MAPK8IP1 [SIGNOR:20508646], KPNA3 [SIGNOR:20454918], KPNA4 [SIGNOR:20454918], ADAM17 [ACSN:19601831;ACSN:19704010;ACSN:19726682;CellTalkDB:10882063;Cellinker:10882063;Cellinker:9620803;HPRD-phos:10882063;HPRD-phos:9620803;HPRD:10882063;HPRD:9620803;LRdb:10882063;LRdb:96;SIGNOR:10882063;connectomeDB2020:10882063;connectomeDB2020:9620803], PIN1 [ELM:19151708;LMPID:19151708;Lit-BM-17:19151708;SIGNOR:19151708], EIF3F [SIGNOR:21124883], MFNG [CellTalkDB:10935626;HPRD:10935626;HPRD:12486116;LRdb:10935626;LRdb:12;SIGNOR:10935626;connectomeDB2020:10935626;connectomeDB2020:12486116], KPNA6 [SIGNOR:20454918], SDC3 [SIGNOR:20696709], FURIN [HPRD:9653148;SIGNOR:22479394], CCNC [SIGNOR:15546612], YY1 [HPRD:12913000;NetPath:12913000;SIGNOR:12913000], CTNNB1 [SIGNOR:19000719], CSK [SIGNOR:22479394], PSEN1 [BioGRID:10077672;CellTalkDB:10077672;Cellinker:10077672;Cellinker:10206645;Cellinker:12374741;HPRD:10077672;HPRD:10206645;HPRD:12374741;LRdb:10077672;LRdb:10206645;LRdb:12374741;NetPath:10077672;SIGNOR:10593990;connectomeDB2020:10077672;connectomeDB2020:10206645;connectomeDB2020:12374741], GSK3A [SIGNOR:19214430], GSK3B [ACSN:11967263;ACSN:14663202;ACSN:15020233;ACSN:15465828;ACSN:16944320;ACSN:21828089;ACSN:8524413;ACSN:9832503;HPRD:12123574;SIGNOR:12123574], DLK1 [Baccin2019:26791579;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:21419176;Cellinker:22353464;LRdb:22353464;Ramilowski2015:21419176;SIGNOR:21419176;connectomeDB2020:21419176;talklr:21419176], MDM2 [SIGNOR:23252402], DYRK1A [SIGNOR:19383720], RUNX3 [SIGNOR:19800882], RUNX2 [SIGNOR:20740684], TNF [CellTalkDB:32103204], WNT4 [CellTalkDB:32103204], RBP3 [Baccin2019:11511084;HPRD:11511084;LRdb:11511084;connectomeDB2020:11511084], YBX1 [connectomeDB2020:30321499], PLXNA1 [HPRD:12050162;LRdb:12;LRdb:15906253], UBA52 [NA], DYRK2 [PhosphoSite:25344755;PhosphoSite:27335110;PhosphoSite:27806347;PhosphoSite:31605148], PLK1 [PhosphoSite:31597699], CSNK2A1 [PhosphoSite:21685388;PhosphoSite:24220241], APP [BioGRID:16175584], NUMBL [HPRD:9169836;NetPath:9169836], PSEN2 [HPRD:11518718;NetPath:11518718]	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOTCH1&keywords=NOTCH1	1.170901104	368	NA	NA	0.05861356334	716	0.06299212598	0.04590818363	0.1637168142	0.07122302158	0.02356902357	0	0.003626473255	0	0.001849796522	3.67E-04	0.001892988217	229	333	286	0.03410414838	0.2686775952	0.2350619072	0.2696569065	385	380	365	449
NOTCH4	notch receptor 4	Yes	No, Yes		ENSG00000238196, ENSG00000232339, ENSG00000223355, ENSG00000235396, ENSG00000234876, ENSG00000206312, ENSG00000204301	Q99466	NOTCH family	21	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00548, P10321, P35442, P49768, P49810, P78504, P80370, Q00987, Q15369, Q16873, Q8IZL2, Q92585, Q969H0, Q96JK9, Q9NR61, Q9NYJ7, Q9Y219	_APH1A_NCSTN_PSEN1_PSENEN, DLK1, DLL1, DLL3, DLL4, ELOC, FBXW7, HLA-C, JAG1, JAG2, LTC4S, MAML1, MAML2, MAML3, MDM2, PSEN1, PSEN2, THBS2	DLL4 [Baccin2019:1621980212814940;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:16219802;Cellinker:12814948;Cellinker:16219802;Cellinker:22353464;HPMR:16219802;HPRD:12814948;LRdb:13;LRdb:16219802;NetPath:12814948;SignaLink3:10837027;SignaLink3:12814948;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:12814948;connectomeDB2020:16219802], LTC4S [SignaLink3:11101851;SignaLink3:23331499], MAML2 [HPRD:12370315;NetPath:12370315;SignaLink3:12370315;SignaLink3:23331499], MAML3 [CancerCellMap:12370315;HPRD:12370315;NetPath:12370315;SIGNOR:12370315;SignaLink3:12370315;SignaLink3:23331499], MAML1 [CancerCellMap:11101851;HPRD:11101851;HPRD:11585921;NetPath:11101851;SIGNOR:11101851], FBXW7 [HPRD:11585921;NetPath:11585921;SIGNOR:11585921], MDM2 [SIGNOR:21402876], ELOC [Lit-BM-17:22001063;SIGNOR:22001063], DLL3 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;Cellinker:29910816;ICELLNET:16921404;LRdb:22353464;connectomeDB2020:22353464], JAG1 [ACSN:22330899;ACSN:22363130;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:24563863;Cellinker:22353464;Cellinker:29910816;LRdb:24563863;Ramilowski2015:24563863;connectomeDB2020:24563863;talklr:24563863], PSEN1 [Cellinker:11518718;HPRD:11518718;LRdb:11518718;NetPath:11518718;connectomeDB2020:11518718], JAG2 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;Cellinker:29910816;connectomeDB2020:22353464], DLL1 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;Cellinker:29910816;connectomeDB2020:22353464], THBS2 [CellTalkDB:32196115], HLA-C [CellTalkDB:32196115], DLK1 [CellChatDB:22353464;CellPhoneDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], PSEN2 [HPRD:11518718;NetPath:11518718]	cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023]	branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; endothelial cell morphogenesis [GO:0001886]; epithelial to mesenchymal transition [GO:0001837]; hemopoiesis [GO:0030097]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell differentiation [GO:0045596]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription of Notch receptor target [GO:0007221]; vasculature development [GO:0001944]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOTCH4&keywords=NOTCH4	0.7919277726	410	NA	NA	0.04875202415	739	0	0.006986027944	0.4258849558	0.07314148681	0.001683501684	0.01184433164	0.01269265639	0.01305057096	0.01442841287	0.009814394445	0.007571952868	193	204	220	0.05246348103	0.3910831172	0.3172156613	0.2813156196	338	354	360	427
NTRK1	neurotrophic receptor tyrosine kinase 1	Yes	No		ENSG00000198400	P04629	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15240, P00519, P01138, P04626, P05067, P06213, P06744, P07288, P08069, P08138, P12931, P20783, P22681, P23471, P27361, P28799, P29279, P29350, P34130, P43490, P51149, P53621, Q12904, Q13332, Q13501, Q8WU20, Q96PU5, Q9NRF2	ABL1, AIMP1, APP, CBL, CCN2, COPA, ERBB2, FRS2, GPI, GRN, IGF1R, INSR, KLK3, MAPK3, NAMPT, NEDD4L, NGF, NGFR, NTF3, NTF4, PTPN6, PTPRS, PTPRZ1, RAB7A, SH2B1, SQSTM1, SRC, VGF	NGF [AlzPathway:17404842;AlzPathway:9775403;Baccin2019:10490030;Baccin2019:14985763;BioGRID:10490030;CA1:1706478;CA1:9290260;CA1:9547236;CellChatDB:27908981;CellTalkDB:10490030;Cellinker:10490030;Cellinker:14985763;Cellinker:24224055;Cellinker:27908981;DIP:10490030;DIP:10713102;DIP:1849459;DIP:9083066;DIP:9857023;HPMR:10490030;HPRD:10490030;HPRD:14985763;IntAct:10490030;IntAct:14985763;LRdb:10490030;LRdb:15;Lit-BM-17:10490030;Lit-BM-17:10713102;Lit-BM-17:11729324;Lit-BM-17:11738045;Lit-BM-17:14985763;Lit-BM-17:1849459;Lit-BM-17:9083066;Lit-BM-17:9857023;ProtMapper:12067229;ProtMapper:17409494;ProtMapper:22666365;ProtMapper:23772401;ProtMapper:25611061;ProtMapper:27229480;ProtMapper:28090201;SIGNOR:11114882;SPIKE:14985763;SPIKE:17145710;SPIKE:8155326;connectomeDB2020:10490030;connectomeDB2020:14985763], FRS2 [HPRD:10092678;Lit-BM-17:10092678], ABL1 [BioGRID:10679771;HPRD:10679771;HPRD:10708759;Lit-BM-17:10679771;Lit-BM-17:10708759], SQSTM1 [BioGRID:11244088;HPRD:10747026;HPRD:11244088;InnateDB:12471037;SignaLink3:12471037;SignaLink3:18174161;SignaLink3:18457658;SignaLink3:23331499], SH2B1 [HPRD:10708759;HPRD:9856458;Lit-BM-17:10708759;Lit-BM-17:9856458], PTPN6 [DEPOD:14662744;ProtMapper:14662744;SIGNOR:14662744], NTF4 [Baccin2019:11114882;CellTalkDB:11114882;Cellinker:11114882;LRdb:11114882;SIGNOR:11114882;connectomeDB2020:11114882], RAB7A [SIGNOR:16306406], CCN2 [CellTalkDB:15601748;Cellinker:15601748;LRdb:15601748;Ramilowski2015:15601748;connectomeDB2020:15601748;talklr:15601748], NTF3 [CellChatDB:27908981;CellTalkDB:17439940;Cellinker:27908981;LRdb:17439940;Ramilowski2015:17439940;connectomeDB2020:17439940;talklr:17439940], KLK3 [CellChatDB:27908981;Cellinker:27908981], APP [Cellinker:24224055], NAMPT [NA], VGF [NA], GRN [NA], AIMP1 [NA], GPI [NA], COPA [NA], PTPRZ1 [DEPOD:18477627], PTPRS [DEPOD:17967490], ERBB2 [KEA:17570479], IGF1R [KEA:17570479], INSR [KEA:17570479], SRC [KEA:17570479;ProtMapper:23319303], CBL [BioGRID:21570973], NGFR [DIP:7616616;DIP:7836442;HPRD:9927421;Lit-BM-17:25708205;Lit-BM-17:7616616;Lit-BM-17:7836442;ProtMapper:10235685;ProtMapper:10490030;ProtMapper:10985348;ProtMapper:11238898;ProtMapper:11425862;ProtMapper:1280261;ProtMapper:1849459;ProtMapper:1850549;ProtMapper:1850821;ProtMapper:7510697;ProtMapper:8155326;ProtMapper:8356095;ProtMapper:8382740;ProtMapper:9099755], MAPK3 [HPRD:1463607], NEDD4L [HPRD:16701206]	axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]	ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTRK1&keywords=NTRK1	0.230614503	533	NA	NA	0.1874451153	535	0	0	0	0.02757793765	0	0	0	0	0	4.34E-04	1.16E-04	234	330	344	0.002557073155	0.7963639199	0.8309237107	0.8055935577	191	188	158	397
PDGFRB	platelet derived growth factor receptor beta	Yes			ENSG00000113721	P09619	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14786, O43639, O60674, P00519, P00533, P01127, P04085, P06213, P06241, P07947, P07948, P10721, P12318, P12931, P14410, P16234, P16333, P17706, P18031, P19525, P22681, P23458, P23470, P24666, P25098, P51452, P52798, P60484, Q03135, Q05209, Q05397, Q06124, Q08431, Q12913, Q13237, Q13442, Q9BQ66, Q9GZP0, Q9NRA1, Q9UQQ2	ABL1, ACP1, CAV1, CBL, DUSP3, EFNA4, EGFR, EIF2AK2, FCGR2A, FYN, GRK2, INSR, JAK1, JAK2, KIT, KRTAP4-12, LYN, MFGE8, NCK1, NCK2, NRP1, PDAP1, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PRKG2, PTEN, PTK2, PTPN1, PTPN11, PTPN12, PTPN2, PTPRG, PTPRJ, SH2B3, SI, SRC, YES1	ABL1 [PhosphoSite:19275932;ProtMapper:19275932;SIGNOR:19275932;SPIKE:14993293;SPIKE:20841568;iPTMnet:19275932], PDGFRA [BioGRID:2542288;HPRD:1847074;HPRD:2161888;HPRD:2542288;HPRD:7523122;KEA:10821867;KEA:17570479;KEA:2550144;KEA:8195171;Lit-BM-17:11331882;Lit-BM-17:2542288;Lit-BM-17:7523122], PDGFC [Baccin2019:19795151;CellTalkDB:32196115;SignaLink3:11297552;SignaLink3:23331499;connectomeDB2020:19795151], PTPN11 [BioGRID:7691811;DEPOD:7545675;HPRD:12681492;HPRD:7691811;HPRD:8041791;IntAct:12614164;IntAct:23397142;IntAct:7530043;IntAct:7688466;IntAct:8119896;IntAct:8183548;IntAct:8538796;KEA:14966296;KEA:7876130;KEA:8290276;Lit-BM-17:11266449;Lit-BM-17:12614164;Lit-BM-17:23397142;Lit-BM-17:7530043;Lit-BM-17:7688466;Lit-BM-17:7691811;Lit-BM-17:8119896;Lit-BM-17:8183548;Lit-BM-17:8538796;ProtMapper:30150707;ProtMapper:7545675;SIGNOR:7545675], NCK1 [ELM:16636066;HPRD:9362449;ProtMapper:30150707], CAV1 [Cellinker:11168929;SignaLink3:10066366;SignaLink3:23331499], PDGFD [Baccin2019:1520781114514730;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:14514732;LRdb:15;LRdb:15207811;SignaLink3:14514732;SignaLink3:21098708;SignaLink3:23331499;connectomeDB2020:14514732;connectomeDB2020:15207811], NCK2 [BioGRID:11027258;ELM:16636066;HPRD:11027258;Lit-BM-17:10026169;Lit-BM-17:11027258;Lit-BM-17:9737977;ProtMapper:30150707], PDGFB [Baccin2019:285049611903042;CellChatDB:15207812;CellTalkDB:2850496;Cellinker:15207812;Cellinker:28267575;DIP:11297552;DIP:20534510;HPMR:2850496;HPRD:11903042;ICELLNET:15207811;ICELLNET:9739761;IntAct:10806482;IntAct:11297552;IntAct:17981115;IntAct:20534510;IntAct:7679113;LRdb:119;LRdb:2850496;Lit-BM-17:10806482;Lit-BM-17:11297552;Lit-BM-17:17981115;Lit-BM-17:20577048;Lit-BM-17:7679113;ProtMapper:30150707;SIGNOR:11331882;connectomeDB2020:11903042;connectomeDB2020:2850496], PTPN1 [DEPOD:7545675;DEPOD:7693671;DEPOD:9355745;DOMINO:9355745;HPRD-phos:7545675;HPRD:7545675;IntAct:12614164;IntAct:19167335;IntAct:9355745;KEA:14966296;KEA:7876130;KEA:8290276;ProtMapper:12424235;ProtMapper:18567737;ProtMapper:7545675;SIGNOR:18567737;SIGNOR:7545675], PTPRG [ProtMapper:25624455;SIGNOR:25624455], FYN [HPRD:1696179;HPRD:9425276;IntAct:1661130;IntAct:7685273;IntAct:7687537;KEA:17570479], SRC [BioGRID:18315570;HPRD:2173144;ProtMapper:19275932], PTK2 [HPRD:10806474], PTPN2 [DEPOD:14966296;HPRD-phos:14966296;HPRD-phos:15588985;HPRD:14966296;HPRD:15588985;ProtMapper:14966296;ProtMapper:16971512;SIGNOR:14966296], ACP1 [DEPOD:12149261;KEA:1691440;KEA:7876130;ProtMapper:12149261;SIGNOR:12149261], PTPRJ [DEPOD:10821867;DEPOD:12062403;HPRD-phos:12062403;HPRD:12062403;IntAct:10821867;IntAct:19167335;KEA:10391677;KEA:10821867;KEA:14966296;KEA:1691440;KEA:7876130;KEA:8940081;ProtMapper:10821867;ProtMapper:12062403;SIGNOR:12062403], PDAP1 [Cellinker:11331882;HPRD:11331882;LRdb:11331882], MFGE8 [CellTalkDB:21868707;Cellinker:21868707;LRdb:21868707;Ramilowski2015:21868707;connectomeDB2020:21868707;talklr:21868707], PDGFA [CellChatDB:15207812;CellTalkDB:25737405;Cellinker:15207812;Lit-BM-17:7679113], KRTAP4-12 [Cellinker:16189514;HPRD:16189514;LRdb:16189514], SH2B3 [Cellinker:21310211], EFNA4 [Cellinker:32116646], NRP1 [Cellinker:25744030], FCGR2A [Cellinker:32822567], SI [Baccin2019:285049611903042], PRKG2 [PhosphoSite:29935031], PTEN [ACSN:10648629;ACSN:12040186;ACSN:15584861;ACSN:16288286;ACSN:17218262;DEPOD:14718524;DOMINO:16456542;IntAct:16456542;IntAct:25241761;Lit-BM-17:16456542;Lit-BM-17:24012959;Lit-BM-17:25241761], DUSP3 [DEPOD:1281549], GRK2 [KEA:15271984;phosphoELM:15271984], INSR [KEA:17570479], KIT [KEA:17570479], LYN [KEA:17570479], CBL [ACSN:10514377;ACSN:17635922;HPRD:10514377], EGFR [BioGRID:9506992;HPRD:9506992], PTPN12 [IntAct:12614164;IntAct:19167335;IntAct:21376233;Lit-BM-17:12614164;Lit-BM-17:19167335;Lit-BM-17:21376233], EIF2AK2 [HPRD:11350938], JAK1 [HPRD:8657151;HPRD:9484840], JAK2 [HPRD:8657151;HPRD:9484840], YES1 [HPRD:7685273]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor-activated receptor activity [GO:0005017]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]	aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFRB&keywords=PDGFRB	116.6831761	13	105932	3	1.183997457	200	0	0.006487025948	0	2.249640288	0.005050505051	0	0.003626473255	0.008156606852	0.002219755827	0.002002937642	0.003824608847	228	284	252	0.2073643819	0.056217839	0.05522035181	0.06360107725	447	442	445	188
TEK	TEK receptor tyrosine kinase	Yes	No		ENSG00000120156	Q02763	Protein kinase superfamily, Tyr protein kinase family, Tie subfamily	21	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15123, O95841, P00533, P04070, P07333, P23467, P35590, P42680, Q15389, Q9Y264	ANGPT1, ANGPT2, ANGPT4, ANGPTL1, CSF1R, EGFR, PROC, PTPRB, TEC, TIE1	ANGPT2 [Baccin2019:9204896;Baccin2019:9723709;CellChatDB:20651738;CellTalkDB:9204896;Cellinker:20651738;Cellinker:28396397;Cellinker:9204896;Cellinker:9723709;DIP:15893672;DIP:16732286;HPRD:9723709;IntAct:15893672;IntAct:16732286;IntAct:20708158;LRdb:9204896;LRdb:972;Lit-BM-17:12427764;Lit-BM-17:15893672;Lit-BM-17:16732286;Lit-BM-17:20708158;Lit-BM-17:25237190;Lit-BM-17:9204896;Lit-BM-17:9723709;SIGNOR:9723709;SignaLink3:12427764;SignaLink3:15893672;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9204896;SignaLink3:9723709;connectomeDB2020:9204896;connectomeDB2020:9723709], ANGPT1 [Baccin2019:12427764;Baccin2019:8980223;Baccin2019:8980224;Baccin2019:9723709;BioGRID:8980223;CellChatDB:20651738;CellTalkDB:8980223;Cellinker:12427764;Cellinker:20651738;Cellinker:28396397;Cellinker:8980223;Cellinker:8980224;Cellinker:9723709;HPMR:8980223;HPRD:12427764;HPRD:8980223;HPRD:8980224;HPRD:9723709;IntAct:20708158;IntAct:29106382;LRdb:12427764;LRdb:8980223;LRdb:8980224;LRdb:9723709;Lit-BM-17:12427764;Lit-BM-17:20708158;Lit-BM-17:8980223;Lit-BM-17:9204896;Lit-BM-17:9723709;ProtMapper:21858121;SIGNOR:9204896;SignaLink3:12427764;SignaLink3:18988627;SignaLink3:20937382;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8980223;SignaLink3:8980224;SignaLink3:9204896;SignaLink3:9723709;connectomeDB2020:12427764;connectomeDB2020:8980223;connectomeDB2020:8980224;connectomeDB2020:9723709], ANGPT4 [Baccin2019:10051567;CellTalkDB:10051567;Cellinker:10051567;HPRD:10051567;LRdb:10051567;SIGNOR:15284220;SignaLink3:10051567;SignaLink3:15284220;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10051567;connectomeDB2020:15284220], ANGPTL1 [CellTalkDB:10051567;Cellinker:10051567;HPRD:10051567;LRdb:10051567;SIGNOR:10051567;SIGNOR:15284220;SignaLink3:10051567;SignaLink3:15284220;SignaLink3:23331499;connectomeDB2020:10051567], PROC [connectomeDB2020:28005151], TIE1 [Cellinker:28396439;HPRD:10995770], CSF1R [Cellinker:32589946], PTPRB [DEPOD:10557082;DEPOD:19116766;DEPOD:19451274;HPRD:10557082;InnateDB:12237455], EGFR [KEA:17570479], TEC [KEA:10521483;KEA:11080633;KEA:11513602;KEA:12082108;KEA:9632797]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TEK&keywords=TEK	0.7845818712	414	NA	NA	0.08341483444	669	0	4.99E-04	0.1902654867	0.02470023981	0	0	0	0	0	6.68E-05	3.86E-04	234	344	336	0.01962889248	0.3375083968	0.3397617577	0.3505471605	362	347	329	444
TGFBR2	transforming growth factor beta receptor 2	Yes	No		ENSG00000163513	P37173	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	21	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15105, O95405, P01137, P06493, P07900, P0CG47, P0CG48, P10600, P12931, P36897, P37023, P48730, P61812, P62979, P62987, P84022, P98082, Q00005, Q13153, Q13347, Q15796, Q16625, Q7Z5Y6, Q99988, Q9BXA7, Q9HAU4, Q9HCE7, Q9P2M7, Q9UER7	ACVRL1, BMP8A, CDK1, CGN, CSNK1D, DAB2, DAXX, EIF3I, GDF15, HSP90AA1, OCLN, PAK1, PPP2R2B, RPS27A, SMAD2, SMAD3, SMAD7, SMURF1, SMURF2, SRC, TGFB1, TGFB2, TGFB3, TGFBR1, TSSK1B, UBA52, UBB, UBC, ZFYVE9	SMAD2 [InnateDB:8980228;NetPath:9463378], SMAD3 [HPRD:8774881], TGFB1 [Baccin2019:10716993;Baccin2019:12809600;Baccin2019:7935686;CancerCellMap:11382746;CancerCellMap:12729750;CancerCellMap:8106553;CellTalkDB:10716993;DIP:10026191;DIP:7706250;DIP:7878020;DIP:9261125;HPMR:10716993;HPMR:12809600;HPRD:7935686;InnateDB:15034927;InnateDB:18382895;IntAct:20856203;IntAct:20860622;IntAct:21054789;IntAct:21441952;LRdb:10716993;LRdb:12809600;LRdb:7935686;Lit-BM-17:10026191;Lit-BM-17:11157754;Lit-BM-17:20860622;Lit-BM-17:21054789;Lit-BM-17:7706250;Lit-BM-17:7878020;Lit-BM-17:8242742;Lit-BM-17:9261125;NetPath:11323414;NetPath:1333888;NetPath:8047140;SIGNOR:1310899;SIGNOR:26194464;SPIKE:11382746;SPIKE:7852346;SignaLink3:10678166;SignaLink3:11013220;SignaLink3:11133108;SignaLink3:11157754;SignaLink3:11274345;SignaLink3:11278410;SignaLink3:11279127;SignaLink3:11792802;SignaLink3:12154066;SignaLink3:12717440;SignaLink3:12724770;SignaLink3:12738796;SignaLink3:12767520;SignaLink3:12809600;SignaLink3:14557817;SignaLink3:15003992;SignaLink3:15099563;SignaLink3:15265520;SignaLink3:15282297;SignaLink3:15548370;SignaLink3:15653932;SignaLink3:15761148;SignaLink3:15761153;SignaLink3:16127449;SignaLink3:16200688;SignaLink3:16424049;SignaLink3:16446785;SignaLink3:16474430;SignaLink3:16572188;SignaLink3:17070508;SignaLink3:17404308;SignaLink3:17673906;SignaLink3:17768418;SignaLink3:17934056;SignaLink3:17979848;SignaLink3:18423981;SignaLink3:18490733;SignaLink3:18758450;SignaLink3:18855897;SignaLink3:18922473;SignaLink3:19010789;SignaLink3:19038247;SignaLink3:19050695;SignaLink3:19109155;SignaLink3:19732719;SignaLink3:19747910;SignaLink3:19920116;SignaLink3:20060931;SignaLink3:20519943;SignaLink3:20538542;SignaLink3:20616810;SignaLink3:20644162;SignaLink3:21041659;SignaLink3:21071413;SignaLink3:21098712;SignaLink3:21278795;SignaLink3:21372296;SignaLink3:21614932;SignaLink3:21900405;SignaLink3:22315516;SignaLink3:22703233;SignaLink3:22710166;SignaLink3:22874531;SignaLink3:22943793;SignaLink3:22949611;SignaLink3:23034983;SignaLink3:23070005;SignaLink3:23331499;SignaLink3:23784029;SignaLink3:24132110;SignaLink3:24336330;SignaLink3:24403530;SignaLink3:26192618;SignaLink3:26201938;SignaLink3:26966341;SignaLink3:2871107;SignaLink3:7594497;SignaLink3:8515656;SignaLink3:9311995;SignaLink3:9865696;connectomeDB2020:10716993;connectomeDB2020:12809600;connectomeDB2020:7935686], TGFB3 [Baccin2019:11382746;Baccin2019:11850637;Baccin2019:12729750;Baccin2019:8106553;BioGRID:11850637;BioGRID:12729750;CancerCellMap:11382746;CancerCellMap:11850637;CancerCellMap:12729750;CellTalkDB:11850637;DIP:7878020;Guide2Pharma:29170498;HPRD:11382746;HPRD:11850637;HPRD:12729750;HPRD:8106553;InnateDB:15017149;InnateDB:18243111;IntAct:11850637;IntAct:21423151;LRdb:11382746;LRdb:11850637;LRdb:12729750;LRdb:8106553;Lit-BM-17:11157754;Lit-BM-17:11850637;Lit-BM-17:12729750;Lit-BM-17:21423151;Lit-BM-17:7878020;Lit-BM-17:9872992;NetPath:11382746;SIGNOR:11157754;SignaLink3:11157754;SignaLink3:11382746;SignaLink3:11850637;SignaLink3:12729750;SignaLink3:15017149;SignaLink3:16446785;SignaLink3:18243111;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:8106553;SignaLink3:9872992;connectomeDB2020:11382746;connectomeDB2020:11850637;connectomeDB2020:12729750;connectomeDB2020:8106553;scConnect:29170498], TGFBR1 [BioGRID:25825445;Cellinker:24319055;DIP:10026191;DIP:23868260;DIP:7878020;HPRD:7890683;HPRD:8576253;InnateDB:18243111;Lit-BM-17:10026191;Lit-BM-17:11483955;Lit-BM-17:19556242;Lit-BM-17:19758997;Lit-BM-17:21791611;Lit-BM-17:25825445;Lit-BM-17:7878020;Lit-BM-17:7890683;NetPath:11124802;NetPath:11278251;NetPath:11323414;NetPath:11387212;NetPath:15221015;NetPath:7566156;NetPath:8047140;NetPath:9463378], TGFB2 [Baccin2019:11157754;Baccin2019:12809600;Baccin2019:8106553;CellTalkDB:11157754;HPMR:12809600;HPRD:11157754;HPRD:8106553;LRdb:11157754;LRdb:12809600;LRdb:8106553;NetPath:12729750;SIGNOR:11157754;SIGNOR:1310899;SignaLink3:11157754;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11157754;connectomeDB2020:12809600;connectomeDB2020:8106553], SRC [ProtMapper:16859511;ProtMapper:17440088;ProtMapper:19114990;ProtMapper:21532881;ProtMapper:26357075;SIGNOR:19114990;SignaLink3:19114990;SignaLink3:23331499;iPTMnet:17440088;iPTMnet:19114990], DAB2 [CancerCellMap:11387212;HPRD:11387212;NetPath:11387212;SignaLink3:11387212;SignaLink3:23331499], DAXX [CancerCellMap:11483955;HPRD:11483955;Lit-BM-17:11483955;NetPath:11483955;SIGNOR:11483955;SignaLink3:11483955;SignaLink3:23331499], SMURF2 [NetPath:15221015;SIGNOR:22298955], SMURF1 [ACSN:15761148;ACSN:21572392;ACSN:22949611;BioGRID:27048878;CancerCellMap:11278251;NetPath:11278251;NetPath:15221015;SIGNOR:22298955], HSP90AA1 [SIGNOR:18591668], ZFYVE9 [CancerCellMap:9865696;HPRD:9865696;NetPath:9865696], EIF3I [CancerCellMap:7566156;HPRD:11781097;HPRD:7566156;NetPath:7566156;SIGNOR:9774674], CGN [CellTalkDB:32196115], GDF15 [NA], BMP8A [connectomeDB2020:28465413], OCLN [Cellinker:17916321], PPP2R2B [Cellinker:24319055], RPS27A [NA], UBA52 [NA], UBB [NA], UBC [NA], CSNK1D [KEA:17570479], CDK1 [CancerCellMap:9926943;HPRD:9926943;NetPath:9926943], SMAD7 [CancerCellMap:11278251;HPRD:11163210;NetPath:11278251;NetPath:15221015], ACVRL1 [DIP:10187774;DIP:23868260;HPRD:10716993;InnateDB:18333754;NetPath:10716993], TSSK1B [HPRD:15761153], PAK1 [HPRD:15761153]	caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]	activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type III transforming growth factor beta receptor binding [GO:0034714]; type I transforming growth factor beta receptor binding [GO:0034713]	activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; inferior endocardial cushion morphogenesis [GO:1905317]; in utero embryonic development [GO:0001701]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFBR2&keywords=TGFBR2	21.52853609	96	NA	NA	0.206497275	519	0.05511811024	0.2694610778	0.3196902655	0.1863309353	0.03872053872	0.01015228426	0.01541251133	0.05383360522	0.004069552349	0.001335291761	0.01734595325	223	308	163	0.08831546597	0.1431061961	0.1152951028	0.2781449794	423	420	361	336
TNFRSF10A	TNF receptor superfamily member 10a	Yes	Yes		ENSG00000104689	O00220	NA	21	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P02458, P04637, P22455, P50591, Q06187, Q13546	BTK, COL2A1, FGFR4, RIPK1, TNFSF10, TP53	RIPK1 [HPRD:9430227], TP53 [SPIKE:11382926], TNFSF10 [Baccin2019:10549288;Baccin2019:15766588;Baccin2019:9082980;Baccin2019:9242610;Baccin2019:9311998;Baccin2019:9314565;Baccin2019:9325248;Baccin2019:9430226;Baccin2019:9613612;CellTalkDB:15766588;Cellinker:10549288;Cellinker:15766588;Cellinker:9082980;Cellinker:9325248;HPMR:15766588;HPRD:10549288;HPRD:9082980;HPRD:9325248;ICELLNET:11239407;InnateDB:10894161;IntAct:20103630;LRdb:10549288;LRdb:15766588;LRdb:9082980;LRdb:9325248;Lit-BM-17:10894160;Lit-BM-17:19427028;Lit-BM-17:20103630;Lit-BM-17:9082980;Macrophage:10549288;Macrophage:12628743;Macrophage:9082980;SIGNOR:14585074;SPIKE:15538968;connectomeDB2020:10549288;connectomeDB2020:15766588;connectomeDB2020:9082980;connectomeDB2020:9325248], COL2A1 [CellTalkDB:9811967;Cellinker:9811967;HPRD:9811967;LRdb:9811967;connectomeDB2020:9811967], BTK [Cellinker:15007095;HPRD:15007095;NetPath:15007095], FGFR4 [NA]	cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF10A&keywords=TNFRSF10A	9.161981419	167	NA	NA	2.047963449	118	0.007874015748	0.1457085828	0.02433628319	0.007913669065	0.07575757576	0.005076142132	0.002719854941	0	0	9.35E-04	0.001313502028	234	319	307	0.02469402999	0.2882340276	0.3151753842	0.3260936256	381	355	344	240
XCR1	X-C motif chemokine receptor 1	Yes	No		ENSG00000173578	P46094	G-protein coupled receptor 1 family	21	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P19875, P47992, Q9UBD3	CXCL2, XCL1, XCL2	XCL1 [Baccin2019:11446740;Baccin2019:9632725;CellPhoneDB:24218476;Cellinker:11446740;Cellinker:19556286;Cellinker:9632725;Guide2Pharma:25497737;HPMR:9632725;HPRD:11446740;HPRD:9632725;ICELLNET:22633458;InnateDB:9632725;LRdb:10699158;SIGNOR:10518929;connectomeDB2020:11446740;connectomeDB2020:9632725;scConnect:25497737], XCL2 [CellTalkDB:10699158;Cellinker:19556286;Cellinker:9632725;Guide2Pharma:25497737;HPRD:9632725;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:9632725;scConnect:25497737], CXCL2 [Baccin2019:10518929;CellTalkDB:10679309;Cellinker:10518929;LRdb:10518929;connectomeDB2020:10518929]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=XCR1&keywords=XCR1	0.09315791011	625	NA	NA	0.4403456463	385	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	505
ACKR3	atypical chemokine receptor 3	Yes	Yes		ENSG00000144476	P25106	G-protein coupled receptor 1 family, Atypical chemokine receptor subfamily	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14625, P01258, P04233, P06881, P14174, P35318, P48061, Q07654	ADM, CALCA, CD74, CXCL11, CXCL12, MIF, TFF3	CXCL12 [Baccin2019:16107333;CellTalkDB:16107333;Cellinker:16107333;Cellinker:20956518;Cellinker:23396314;Guide2Pharma:20956518;Guide2Pharma:23396314;HPMR:16107333;ICELLNET:20161793;ICELLNET:22633458;ICELLNET:24218476;LRdb:16107333;LRdb:20956518;LRdb:23396314;SIGNOR:16107333;connectomeDB2020:16107333;connectomeDB2020:20956518;connectomeDB2020:23396314;scConnect:20956518;scConnect:23396314], CXCL11 [CellTalkDB:27875312;ICELLNET:20161793;ICELLNET:22633458;ICELLNET:24218476;connectomeDB2020:27875312;connectomeDB2020:29180449;connectomeDB2020:29386406], MIF [CellChatDB:26175090;Cellinker:26175090;Cellinker:29637711], TFF3 [connectomeDB2020:26780310], CD74 [Cellinker:29637711], ADM [Cellinker:29637711], CALCA [Cellinker:15193773], CALCA [Cellinker:15193773]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; coreceptor activity [GO:0015026]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; scavenger receptor activity [GO:0005044]	angiogenesis [GO:0001525]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; chemokine-mediated signaling pathway [GO:0070098]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; oculomotor nerve development [GO:0021557]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mesenchymal stem cell migration [GO:1905322]; receptor internalization [GO:0031623]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR3&keywords=ACKR3	12.53520115	140	NA	NA	0.307474764	460	0	9.98E-04	0.003318584071	0.007434052758	0	0	0	0	0	3.34E-05	0	234	345	347	0.001071274829	0.9032383492	0.906253566	0.9032383492	145	162	114	277
ACKR4	atypical chemokine receptor 4	Yes	Yes		ENSG00000129048	Q9NPB9	G-protein coupled receptor 1 family, Atypical chemokine receptor subfamily	20	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00585, O15444, O43927, P13500, P13501, P22362, P51671, P78556, P80075, P80098, Q99616, Q99731, Q9NRJ3	CCL1, CCL11, CCL13, CCL19, CCL2, CCL20, CCL21, CCL25, CCL28, CCL5, CCL7, CCL8, CXCL13	CCL19 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCL21 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCL25 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CXCL13 [Baccin2019:10706668;CellPhoneDB:24218476;Cellinker:10706668;HPRD:10706668;ICELLNET:22633458;ICELLNET:706668;LRdb:10706668;connectomeDB2020:10706668], CCL2 [Baccin2019:10734104;CellTalkDB:10734104;Cellinker:10734104;DIP:10734104;HPRD:10734104;HPRD:9364936;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCL13 [CellChatDB:26740381;CellTalkDB:10734104;Cellinker:10734104;Cellinker:26740381;DIP:10734104;HPRD:10734104;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCL5 [Cellinker:9469451;HPRD:9405404;HPRD:9469451;LRdb:9469451], CCL11 [CellTalkDB:10734104;Cellinker:10734104;HPRD:10734104;HPRD:9405404;LRdb:10734104;connectomeDB2020:10734104], CCL7 [CellTalkDB:10734104;Cellinker:10734104;DIP:10734104;HPRD:10734104;HPRD:9364936;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCL8 [Baccin2019:10734104;CellChatDB:26740381;CellTalkDB:10734104;Cellinker:10734104;Cellinker:26740381;DIP:10734104;HPRD:10734104;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCL1 [NA], CCL20 [Cellinker:32480426;connectomeDB2020:32533638], CCL28 [HPRD:10781587]	early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR4&keywords=ACKR4	1.935653933	311	NA	NA	1.154496496	204	0	0.003493013972	0	0.2431654676	0.03872053872	0.006768189509	0.003626473255	0	0.00332963374	0.003171317933	0.002008885455	225	259	285	0.0276621382	0.3539266323	0.3497230524	0.3188583025	357	342	346	279
ACVR1	activin A receptor type 1	Yes	Yes		ENSG00000115170	Q04771	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	20	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14920, O15105, O43541, O94921, O95393, O95972, P03971, P05111, P08476, P09529, P12643, P12644, P12645, P18075, P22003, P22004, P27037, P27539, P34820, P43026, P55103, P58166, P61812, P62987, Q13153, Q13705, Q13873, Q16671, Q7Z5Y6, Q86SG6, Q9H093, Q9UK05	ACVR2A, ACVR2B, AMH, AMHR2, BMP10, BMP15, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, BMPR2, CDK14, GDF1, GDF2, GDF5, IKBKB, INHA, INHBA, INHBB, INHBC, INHBE, NEK8, NUAK2, PAK1, SMAD6, SMAD7, TGFB2, UBA52	SMAD6 [BioGRID:23455153;SignaLink3:10564272;SignaLink3:23331499], SMAD7 [SignaLink3:10564272;SignaLink3:23331499], ACVR2B [SignaLink3:16446785;SignaLink3:23331499], BMPR2 [Lit-BM-17:7791754;Lit-BM-17:7890683;SIGNOR:7791754;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:7791754], BMP8B [SignaLink3:10504300;SignaLink3:23331499], AMHR2 [SIGNOR:14746809;SignaLink3:16446785;SignaLink3:23331499], AMH [CellTalkDB:14656470;LRdb:14656470;Ramilowski2015:14656470;connectomeDB2020:14656470;talklr:14656470], BMP10 [Cellinker:27252362;Cellinker:30246251;Cellinker:30246252;Cellinker:31127068], BMP2 [Baccin2019:8006002;CellTalkDB:28977600;HPRD:8006002;LRdb:8006002], BMP4 [Baccin2019:20959140], BMP5 [NA], BMP6 [Baccin2019:12297674;CellTalkDB:12297674;LRdb:12297674;connectomeDB2020:12297674], BMP7 [Baccin2019:122976748006002;CellTalkDB:31619522;HPRD:8006002;LRdb:12297674;LRdb:8;SIGNOR:11282024;connectomeDB2020:12297674;connectomeDB2020:8006002], BMP8A [NA], GDF2 [CellTalkDB:19996292;Cellinker:27252362;LRdb:19996292;Ramilowski2015:19996292;connectomeDB2020:19996292;talklr:19996292], ACVR2A [DIP:8612709;SIGNOR:9748228], INHBA [CellTalkDB:11266516;HPRD:11266516;LRdb:11266516;connectomeDB2020:11266516], INHA [CellTalkDB:32196115;LRdb:29747587], INHBC [Baccin2019:12651901;HPRD:12651901;LRdb:12651901], INHBB [Baccin2019:11266516;CellTalkDB:11266516;HPRD:11266516;LRdb:11266516;connectomeDB2020:11266516], GDF5 [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;connectomeDB2020:8702914], TGFB2 [Baccin2019:21102460;CellTalkDB:32196115;connectomeDB2020:21102460], GDF1 [connectomeDB2020:28955827], BMP15 [NA], BMP3 [NA], INHBE [NA], UBA52 [HPRD:15761153], IKBKB [HPRD:15761153], NEK8 [HPRD:15761153], NUAK2 [HPRD:15761153], PAK1 [HPRD:15761153], CDK14 [HPRD:15761153]	activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]	activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; regulation of skeletal muscle tissue development [GO:0048641]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVR1&keywords=ACVR1	42.61167494	51	NA	NA	2.625806393	88	0.05511811024	0.1042914172	0.05088495575	0.2043165468	0.1195286195	0.2267343486	0.2864913871	0.1125611746	0.1328153903	0.1220790493	0.1695190265	57	74	47	0.1440309114	0.9271865561	0.8574840468	1.165474026	134	180	49	98
ACVR1C	activin A receptor type 1C	Yes	Yes		ENSG00000123612	Q8NER5	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	20	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60383, O95390, P05111, P08476, P09529, P13385, P27539, P55107, Q13705, Q7Z4P5, Q96S42, Q9NR23	ACVR2B, GDF1, GDF10, GDF11, GDF3, GDF7, GDF9, INHA, INHBA, INHBB, NODAL, TDGF1	ACVR2B [SignaLink3:16446785;SignaLink3:23331499], INHBA [connectomeDB2020:15196700], INHBB [Baccin2019:15196700;CellTalkDB:15196700;HPRD:15196700;LRdb:15196700;connectomeDB2020:15196700], INHA [NA], GDF1 [NA], GDF10 [NA], GDF3 [NA], GDF7 [NA], GDF9 [NA], NODAL [Baccin2019:12606401;CellTalkDB:12606401;HPMR:12606401;LRdb:12606401;SIGNOR:15531507;connectomeDB2020:12606401], TDGF1 [CellTalkDB:11485994;Cellinker:11485994;HPRD:11485994;LRdb:11485994], GDF11 [Cellinker:16845371]	activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; nodal binding [GO:0038100]; protein serine/threonine kinase activity [GO:0004674]	activin receptor signaling pathway [GO:0032924]; apoptotic nuclear changes [GO:0030262]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; lipid storage [GO:0019915]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of insulin secretion [GO:0046676]; negative regulation of trophoblast cell migration [GO:1901164]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein phosphorylation [GO:0006468]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; trophectodermal cell proliferation [GO:0001834]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVR1C&keywords=ACVR1C	6.853567637	198	NA	NA	5.266513576	45	0.007874015748	0.02594810379	0.002212389381	0.02374100719	0.0202020202	0.2098138748	0.2946509519	0.1468189233	0.03440621532	0.2018961143	0.09082480201	152	45	70	0.09621712891	0.4180701905	1.994933552	0.9492329819	327	18	96	77
CD27	CD27 molecule	Yes	Yes	its ligand is cd70, which has evidence to be soluble in addition to being a cell surface ligand	ENSG00000139193	P26842	NA	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P22301, P32970	CD70, IL10	CD70 [Baccin2019:15723067;Baccin2019:7479974;Baccin2019:8120384;Baccin2019:8186199;Baccin2019:8580829;Baccin2019:9767422;Baccin2019:9862673;BioGRID:21917027;CellPhoneDB:26697006;CellTalkDB:8120384;Cellinker:15723067;Cellinker:7479974;Cellinker:8120384;Cellinker:8186199;Cellinker:8580829;Cellinker:9767422;Cellinker:9862673;HPMR:8120384;HPRD:15723067;HPRD:7479974;HPRD:8120384;HPRD:8186199;HPRD:8580829;HPRD:9767422;HPRD:9862673;ICELLNET:26697006;ICELLNET:8120384;LRdb:15723067;LRdb:7479974;LRdb:8120384;LRdb:8186199;LRdb:8580829;LRdb:9767422;LRdb:9862673;SIGNOR:12324477;SIGNOR:8120384;SPIKE:9862673;connectomeDB2020:15723067;connectomeDB2020:7479974;connectomeDB2020:8120384;connectomeDB2020:8186199;connectomeDB2020:8580829;connectomeDB2020:9767422;connectomeDB2020:9862673], IL10 [Cellinker:9767422]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; transmembrane signaling receptor activity [GO:0004888]	cell surface receptor signaling pathway [GO:0007166]; extrinsic apoptotic signaling pathway [GO:0097191]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of apoptotic process [GO:0043066]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell differentiation [GO:0045582]; response to ethanol [GO:0045471]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD27&keywords=CD27	5.296177371	224	NA	NA	0.6634385362	319	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	272
CXCR1	C-X-C motif chemokine receptor 1	Yes	TBD		ENSG00000163464	P25024	G-protein coupled receptor 1 family	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P02775, P04899, P09341, P10145, P19875, P19876, P42830, P54577, P80162, Q00765	CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8, GNAI2, PPBP, REEP5, YARS1	YARS1 [NA], CXCL6 [Baccin2019:10593335;Baccin2019:12964882;Baccin2019:8702798;Baccin2019:9692902;CellPhoneDB:24218476;Cellinker:10593335;Cellinker:12964882;Cellinker:9692902;Guide2Pharma:9692902;HPMR:12964882;HPRD:10593335;HPRD:9692902;ICELLNET:22633458;InnateDB:9485196;LRdb:10699158;connectomeDB2020:10593335;connectomeDB2020:12964882;connectomeDB2020:9692902;scConnect:9692902], CXCL8 [CellPhoneDB:24218476;CellTalkDB:1379593;Cellinker:10188995;Cellinker:1379593;Cellinker:15282370;Cellinker:15946947;Cellinker:1840701;Cellinker:8137938;Cellinker:8940121;DIP:10206993;DIP:10368283;DIP:8550564;DIP:9195914;DIP:9553055;DIP:9725262;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:15282370;Guide2Pharma:15946947;Guide2Pharma:8940121;HPRD:1840701;ICELLNET:1840701;InnateDB:10368283;InnateDB:12628493;InnateDB:1840701;InnateDB:8245475;InnateDB:8662882;InnateDB:8702798;InnateDB:9485196;LRdb:10188995;LRdb:10699158;LRdb:1379593;LRdb:15282370;LRdb:15946947;LRdb:1840701;LRdb:8137938;LRdb:8940121;Lit-BM-17:10206993;Lit-BM-17:10368283;Lit-BM-17:8550564;Lit-BM-17:9195914;Lit-BM-17:9553055;Lit-BM-17:9725262;SIGNOR:11350788;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:15282370;connectomeDB2020:15946947;connectomeDB2020:1840701;connectomeDB2020:8137938;connectomeDB2020:8940121;scConnect:10188995;scConnect:1379593;scConnect:15282370;scConnect:15946947;scConnect:22262769;scConnect:8940121], REEP5 [SIGNOR:27966653], PPBP [CellPhoneDB:24218476;CellTalkDB:1427896;Cellinker:1427896;Cellinker:8137938;Cellinker:8195702;DIP:8702798;HPRD:1427896;HPRD:8195702;ICELLNET:22633458;ICELLNET:24335961;LRdb:1427896;LRdb:8137938;LRdb:8195702;connectomeDB2020:1427896;connectomeDB2020:8137938;connectomeDB2020:8195702], GNAI2 [BioGRID:8662698;BioGRID:8903513;CellTalkDB:8662698;Cellinker:8662698;Cellinker:8903513;HPRD:8662698;HPRD:8903513;LRdb:8662698;LRdb:89;MPPI:8903513;connectomeDB2020:8662698;connectomeDB2020:8903513], CXCL3 [Baccin2019:129648828702798;CellTalkDB:12964882;Cellinker:12964882;Cellinker:8702798;HPRD:8702798;LRdb:12964882;LRdb:87;connectomeDB2020:12964882;connectomeDB2020:8702798], CXCL2 [Baccin2019:12964882;Baccin2019:1379593;Baccin2019:8702798;Baccin2019:9260277;CellTalkDB:12964882;Cellinker:12964882;Cellinker:9260277;HPRD:9260277;LRdb:12964882;LRdb:93;connectomeDB2020:12964882;connectomeDB2020:9260277], CXCL5 [CellPhoneDB:24218476;Cellinker:12964882;Cellinker:8702798;Cellinker:9692902;DIP:8702798;HPRD:8702798;HPRD:9692902;InnateDB:9485196;LRdb:10699158;connectomeDB2020:12964882;connectomeDB2020:8702798;connectomeDB2020:9692902], CXCL1 [CellPhoneDB:24218476;Cellinker:12964882;Cellinker:1379593;Cellinker:8702798;DIP:9195914;HPRD:1379593;HPRD:8702798;LRdb:10699158;connectomeDB2020:12964882;connectomeDB2020:1379593;connectomeDB2020:8702798;scConnect:1379593]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; dendritic cell chemotaxis [GO:0002407]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; neutrophil chemotaxis [GO:0030593]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCR1&keywords=CXCR1	0.002020822472	823	NA	NA	7.29E-04	882	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	853
EDNRB	endothelin receptor type B	Yes	Yes		ENSG00000136160	P24530	G-protein coupled receptor 1 family, Endothelin receptor subfamily, EDNRB sub-subfamily	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04899, P05305, P14138, P20800, P39905, P43250	EDN1, EDN2, EDN3, GDNF, GNAI2, GRK6	EDN3 [Baccin2019:11982704;Baccin2019:7524189;Baccin2019:8001160;Baccin2019:8086489;Baccin2019:8460684;Baccin2019:8904635;CellTalkDB:11982704;Cellinker:11982704;Cellinker:7524189;Cellinker:8001160;Cellinker:8086489;Cellinker:8460684;Cellinker:8904635;Guide2Pharma:7524189;Guide2Pharma:8460684;Guide2Pharma:8904635;HPMR:8001160;HPRD:11982704;HPRD:8001160;ICELLNET:8440682;LRdb:11982704;LRdb:7524189;LRdb:8001160;LRdb:8086489;LRdb:8460684;LRdb:8904635;SIGNOR:8086489;connectomeDB2020:11982704;connectomeDB2020:7524189;connectomeDB2020:8001160;connectomeDB2020:8086489;connectomeDB2020:8460684;connectomeDB2020:8904635;scConnect:7524189;scConnect:8460684;scConnect:8904635], EDN1 [Baccin2019:12972292;CellTalkDB:12972292;Cellinker:12972292;HPRD:12972292;ICELLNET:8440682;LRdb:12972292;SIGNOR:16597412;connectomeDB2020:12972292], GNAI2 [CellTalkDB:32196115], EDN2 [Cellinker:18199583;LRdb:14659083;Ramilowski2015:14659083;connectomeDB2020:14659083;talklr:14659083], GDNF [CellTalkDB:32196115], GRK6 [HPRD:9211925]	integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	endothelin receptor activity [GO:0004962]; peptide hormone binding [GO:0017046]; type 1 angiotensin receptor binding [GO:0031702]	aging [GO:0007568]; aldosterone metabolic process [GO:0032341]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; cGMP-mediated signaling [GO:0019934]; endothelin receptor signaling pathway [GO:0086100]; enteric nervous system development [GO:0048484]; enteric smooth muscle cell differentiation [GO:0035645]; epithelial fluid transport [GO:0042045]; establishment of endothelial barrier [GO:0061028]; gene expression [GO:0010467]; glomerular visceral epithelial cell differentiation [GO:0072112]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of neuron maturation [GO:0014043]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; peripheral nervous system development [GO:0007422]; pharynx development [GO:0060465]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; posterior midgut development [GO:0007497]; protein transmembrane transport [GO:0071806]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fever generation [GO:0031620]; regulation of heart rate [GO:0002027]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; renal albumin absorption [GO:0097018]; renal sodium excretion [GO:0035812]; renal sodium ion absorption [GO:0070294]; renin secretion into blood stream [GO:0002001]; response to endothelin [GO:1990839]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to sodium phosphate [GO:1904383]; sensory perception of pain [GO:0019233]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDNRB&keywords=EDNRB	33.19116101	64	NA	NA	1.667577657	146	0.02362204724	0.0124750499	0.06747787611	1.767146283	0.005050505051	0.001692047377	0.009972801451	0.009787928222	0.006659267481	0.0022366137	0.001429399266	212	278	301	0.1734136199	0.09082895529	0.06671594894	0.06231488846	434	436	448	231
EPHA4	EPH receptor A4	Yes	Yes		ENSG00000116106	P54764	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43921, P06241, P16234, P20827, P21802, P22455, P22607, P52797, P52798, P52799, P52803, P98172, Q13233, Q15768, Q16827	EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, EFNB1, EFNB2, EFNB3, FGFR2, FGFR3, FGFR4, FYN, MAP3K1, PDGFRA, PTPRO	EFNA1 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;HPRD:8755474;LRdb:11114742;Lit-BM-17:10366629;Lit-BM-17:19836338;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EFNA5 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;DIP:23812375;HPMR:9330863;HPRD:8755474;IntAct:19836338;IntAct:23812375;LRdb:11114742;SIGNOR:9330863;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EFNA4 [Baccin2019:10366629;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;HPRD:10366629;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9267020;connectomeDB2020:10366629], FYN [HPRD:12084815], MAP3K1 [CA1:7997270], EFNA3 [Baccin2019:933086312496762;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;HPRD:12496762;LRdb:11114742;SIGNOR:9330863;connectomeDB2020:12496762;connectomeDB2020:9330863], EFNA2 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;IntAct:19836338;LRdb:11114742;Lit-BM-17:19836338;SIGNOR:9330863;connectomeDB2020:9330863], EFNB3 [Baccin2019:12383247;Baccin2019:12649481;Baccin2019:9484836;BioGRID:9484836;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:12383247;Cellinker:12649481;Cellinker:15114347;Cellinker:9484836;DIP:23812375;HPRD:12383247;HPRD:9484836;LRdb:12094214;SIGNOR:9330863;connectomeDB2020:12383247;connectomeDB2020:9484836], EFNB1 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:15114347;Cellinker:28589441;connectomeDB2020:15114347], EFNB2 [Baccin2019:12761826;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:12761826;Cellinker:15114347;Cellinker:9330863;DIP:19836338;HPRD:12761826;IntAct:19836338;LRdb:128;LRdb:9330863;Lit-BM-17:19836338;connectomeDB2020:12761826;connectomeDB2020:9330863], PDGFRA [Cellinker:32116646], FGFR3 [HPRD:16365308], FGFR2 [HPRD:16365308], FGFR4 [HPRD:16365308], PTPRO [DEPOD:16680165;KEA:11136979]	adherens junction [GO:0005912]; axon [GO:0030424]; axonal growth cone [GO:0044295]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase binding [GO:1990782]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA4&keywords=EPHA4	1.980110341	308	NA	NA	0.2302309391	498	0	0.005489021956	0.007743362832	0.001199040767	0	0.001692047377	0.01178603808	0	7.40E-04	2.34E-04	0.002549739231	232	339	273	0.002857531355	0.835301763	0.7959285321	0.9760613359	179	196	85	335
EPHB2	EPH receptor B2	Yes	Yes		ENSG00000133216	P29323	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60229, P00519, P01100, P04626, P06213, P06241, P12931, P14780, P15692, P20290, P32004, P42684, P52799, P52803, P55196, P98172, Q15768, Q16827	ABL1, ABL2, AFDN, BTF3, EFNA5, EFNB1, EFNB2, EFNB3, ERBB2, FOS, FYN, INSR, KALRN, L1CAM, MMP9, PTPRO, SRC, VEGFA	BTF3 [SPIKE:17312387], EFNB2 [Baccin2019:933086311780069;BioGRID:11780069;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:15114347;HPRD:11780069;LRdb:11114742;ProtMapper:28719605;SignaLink3:11780069;SignaLink3:23331499;SignaLink3:9267020;connectomeDB2020:11780069;connectomeDB2020:9330863], EFNB1 [Baccin2019:93308638878483;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;HPMR:9330863;HPRD:8878483;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8878483;connectomeDB2020:9330863], SRC [HPRD:18713744;HPRD:9632142;KEA:17570479;Lit-BM-17:10644995;Lit-BM-17:9632142], ABL1 [HPRD:11494128;Lit-BM-17:11494128;SIGNOR:11494128;SignaLink3:11494128;SignaLink3:23331499], AFDN [CellTalkDB:9707552;Cellinker:9707552;DOMINO:9707552;HPRD:9707552;LRdb:9707552;connectomeDB2020:9707552], EFNB3 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;LRdb:11114742;connectomeDB2020:9330863], EFNA5 [Baccin2019:1510785715107850;CellChatDB:15107857;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15107857;Cellinker:15107857;Cellinker:15114347;HPRD:15107857;LRdb:15107857;connectomeDB2020:15107857], L1CAM [CellTalkDB:32196115;connectomeDB2020:22579729], MMP9 [Baccin2019:18713744;Cellinker:18713744;HPRD:18713744;LRdb:18713744;connectomeDB2020:18713744], VEGFA [Baccin2019:17318185;HPRD:17318185;LRdb:17318185], PTPRO [DEPOD:16680165], ERBB2 [KEA:17570479], FYN [KEA:17570479], INSR [KEA:17570479], KALRN [HPRD:12546821], ABL2 [HPRD:11494128], FOS [ACSN:11274345;ACSN:12738796;ACSN:16393692;ACSN:17439715;ACSN:18039929;ACSN:8545107;HPRD:12972619;HPRD:7816602]	axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHB2&keywords=EPHB2	9.515042438	164	NA	NA	5.591541543	41	0.03149606299	0.8552894212	0.002212389381	0.01798561151	0.08417508418	0.02199661591	0.003626473255	0.01794453507	0.02996670366	0.006676458806	0.01274869616	162	220	189	0.09855618655	0.3681660616	0.153620529	0.2095568837	347	410	387	209
ERBB3	erb-b2 receptor tyrosine kinase 3	Yes	TBD		ENSG00000065361	P21860	Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14511, O14944, O43374, P00519, P00533, P01133, P01135, P04196, P04626, P06213, P06239, P06241, P08581, P08631, P10275, P11362, P12830, P14555, P15514, P16144, P16591, P17181, P23229, P26447, P32004, P35070, P40189, P41240, P42684, P46934, P48551, P56975, Q00535, Q01973, Q02297, Q05397, Q13882, Q14451, Q8NFZ8, Q96JA1, Q9BY67, Q9H4P4, Q9UQ80, Q9Y6I3	ABL1, ABL2, AR, AREG, BTC, CADM1, CADM4, CDH1, CDK5, CSK, EGF, EGFR, EPN1, ERBB2, EREG, FER, FGFR1, FYN, GRB7, HCK, HRG, IFNAR1, IFNAR2, IL6ST, INSR, ITGA6, ITGB4, L1CAM, LCK, LRIG1, MET, NEDD4, NRG1, NRG2, NRG3, PA2G4, PLA2G2A, PTK2, PTK6, RASA4, RNF41, ROR1, S100A4, TGFA	GRB7 [BioGRID:9516479;Cellinker:11809769;DOMINO:16273093;HPRD:9516479;IntAct:16273093;IntAct:9516479;Lit-BM-17:16273093;Lit-BM-17:24189400;Lit-BM-17:9516479;SPIKE:16189514;SPIKE:16273093;SPIKE:9516479], EGFR [BioGRID:10527633;BioGRID:27756321;HPRD:10527633;IntAct:10572067;IntAct:17148612;IntAct:21278786;IntAct:23436906;IntAct:23866081;Lit-BM-17:10527633;Lit-BM-17:10572067;Lit-BM-17:18803307;Lit-BM-17:22439932;Lit-BM-17:23436906;Lit-BM-17:24189400;ProtMapper:7929151;SIGNOR:7929151;SPIKE:10572067;SPIKE:12648464;SPIKE:17145710;iPTMnet:7929151], ERBB2 [BioGRID:15504738;Cellinker:30898150;HPRD:10799311;HPRD:11173924;HPRD:7538656;IntAct:10572067;IntAct:17148612;IntAct:17426253;IntAct:19411071;IntAct:20227043;IntAct:21203579;IntAct:21278786;IntAct:22733765;IntAct:22806884;IntAct:23436906;IntAct:23680147;IntAct:23688700;IntAct:24557338;IntAct:25241761;KEA:17570479;Lit-BM-17:10572067;Lit-BM-17:15504738;Lit-BM-17:16843263;Lit-BM-17:17426253;Lit-BM-17:19060928;Lit-BM-17:19411071;Lit-BM-17:20227043;Lit-BM-17:21075308;Lit-BM-17:22806884;Lit-BM-17:23436906;Lit-BM-17:23680147;Lit-BM-17:23688700;Lit-BM-17:24557338;Lit-BM-17:25241761;Lit-BM-17:7592681;Lit-BM-17:9130710;ProtMapper:27531070;ProtMapper:29066975;SIGNOR:12648465;SIGNOR:8816440;SignaLink3:12648465;SignaLink3:23331499], LRIG1 [SIGNOR:16123311;SignaLink3:16123311;SignaLink3:23331499], NRG2 [Baccin2019:9168114;Baccin2019:9168115;CellTalkDB:9168115;HPMR:9168115;HPRD:9168114;HPRD:9168115;LRdb:9168115;LRdb:917;SIGNOR:7514177;SignaLink3:23331499;SignaLink3:9168114;SignaLink3:9168115;connectomeDB2020:9168114;connectomeDB2020:9168115], NRG1 [BioGRID:7592681;CellTalkDB:7514177;DIP:17697999;HPRD:11555649;HPRD:7592681;HPRD:8702572;HPRD:9565587;IntAct:7592681;LRdb:11555649;LRdb:7514177;LRdb:7592681;LRdb:8702572;LRdb:9565587;Lit-BM-17:10970856;Lit-BM-17:11555649;Lit-BM-17:17697999;Lit-BM-17:7592681;Lit-BM-17:9168115;ProtMapper:16843264;ProtMapper:26148232;SIGNOR:7477375;SIGNOR:7514177;SignaLink3:11555649;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:11555649;connectomeDB2020:7514177;connectomeDB2020:7592681;connectomeDB2020:8702572;connectomeDB2020:9565587], AR [SignaLink3:15542423;SignaLink3:23331499], EREG [CellTalkDB:32196115;SIGNOR:16829981;SIGNOR:22891299], CDK5 [HPRD:12824184;KEA:12824184;ProtMapper:12824184;SIGNOR:12824184;iPTMnet:12824184], HRG [CellTalkDB:10995872;ProtMapper:24036211;ProtMapper:26148232], CDH1 [CellTalkDB:32196115], EGF [Baccin2019:12093292;CellTalkDB:12093292;Cellinker:12093292;HPRD:12093292;LRdb:12093292;connectomeDB2020:12093292], NRG3 [CellTalkDB:9772300], AREG [CellTalkDB:8702723;LRdb:8702723;Ramilowski2015:8702723;connectomeDB2020:8702723;talklr:8702723], L1CAM [CellTalkDB:22815787;LRdb:22815787;Ramilowski2015:22815787;connectomeDB2020:22815787;talklr:22815787], TGFA [CellTalkDB:32196115], BTC [CellTalkDB:9312020;Cellinker:9312020;LRdb:9312020;Ramilowski2015:9312020;connectomeDB2020:9312020;talklr:9312020], S100A4 [Cellinker:30083275], CADM4 [Cellinker:23611113], PLA2G2A [Cellinker:28440478], MET [Cellinker:28536399], IL6ST [Cellinker:11821958;HPRD:11821958], CADM1 [Cellinker:19561085], IFNAR2 [Cellinker:14647452], IFNAR1 [Cellinker:14647451], PA2G4 [BioGRID:11325528;BioGRID:11708806;Cellinker:31362984;HPRD:10682683;HPRD:11325528;HPRD:15583694;Lit-BM-17:10682683;Lit-BM-17:11325528;Lit-BM-17:11708806;Lit-BM-17:19037095], EPN1 [Cellinker:26975582], ITGA6 [Cellinker:20695903], ITGB4 [Cellinker:20695903], ABL1 [DOMINO:16273093], HCK [DOMINO:16273093], FGFR1 [DOMINO:16273093], FER [DOMINO:16273093], CSK [ACSN:18829532;ACSN:9819392;DOMINO:16729043], ABL2 [DOMINO:16273093], PTK6 [BioGRID:11114724;DOMINO:16273093;HPRD:11114724;Lit-BM-17:11114724;Lit-BM-17:16273093], FYN [KEA:17570479], INSR [KEA:17570479], LCK [KEA:17570479], ROR1 [ProtMapper:28114269;iPTMnet:28114269], RNF41 [BioGRID:17384230;BioGRID:27353365;HPRD:12411582], NEDD4 [BioGRID:27793840], PTK2 [HPRD:11807823], RASA4 [ACSN:16488589;HPRD:16169070]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]	cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERBB3&keywords=ERBB3	30.86410869	73	NA	NA	1.671039447	145	0	0.1931137725	0.00110619469	0.003836930456	0.2676767677	0.02368866328	0.0199456029	0.01141924959	0.008139104698	0.004740285752	0.02136372416	207	240	153	0.05045729961	0.3000316722	0.2438131681	0.5187748108	376	374	268	208
FAS	Fas cell surface death receptor	Yes	Yes		ENSG00000026103	P25445	NA	20	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15350, O60936, O75888, P00533, P01375, P04637, P06239, P06241, P08581, P0DP23, P11274, P17252, P17612, P25490, P31749, P42224, P42575, P45983, P48023, P48729, P49137, Q05655, Q06187, Q12923, Q13158, Q13546, Q14790, Q9H422, Q9UER7	AKT1, BCR, BTK, CALM1, CASP2, CASP8, CSNK1A1, DAXX, EGFR, FADD, FASLG, FYN, HIPK3, LCK, MAPK8, MAPKAPK2, MET, NOL3, PRKACA, PRKCA, PRKCD, PTPN13, RIPK1, STAT1, TNF, TNFSF13, TP53, TP73, YY1	STAT1 [SPIKE:17992189], DAXX [BioGRID:11773067;BioGRID:14637155;HPRD:11193028;HPRD:11483955;HPRD:9215629;IntAct:11003656;IntAct:11495919;IntAct:25241761;Lit-BM-17:11003656;Lit-BM-17:11495919;Lit-BM-17:11773067;Lit-BM-17:14637155;Lit-BM-17:25241761;Lit-BM-17:9215629;Macrophage:15725726;Macrophage:9215629;Macrophage:9743501;SIGNOR:9215629], TP73 [SPIKE:19788416], NOL3 [SPIKE:15383280], YY1 [SPIKE:18495079], TP53 [SPIKE:9841917], FADD [CellTalkDB:19118384;Cellinker:19118384;DIP:19118384;DIP:20935634;DIP:21713032;DIP:26942442;DIP:7538907;DOMINO:7538907;HPRD:17159907;HPRD:19118384;HPRD:7536190;HPRD:7538907;HPRD:9325248;InnateDB:11464215;InnateDB:12721308;InnateDB:15993755;InnateDB:16410793;InnateDB:16762833;InnateDB:9880544;IntAct:16498403;IntAct:17159907;IntAct:18328427;IntAct:19118384;IntAct:20935634;IntAct:21382479;IntAct:25241761;IntAct:7536190;IntAct:7538907;LRdb:19118384;Lit-BM-17:11035039;Lit-BM-17:11717445;Lit-BM-17:12107169;Lit-BM-17:15659383;Lit-BM-17:16498403;Lit-BM-17:17159907;Lit-BM-17:18328427;Lit-BM-17:20935634;Lit-BM-17:21382479;Lit-BM-17:21625644;Lit-BM-17:21803845;Lit-BM-17:22864571;Lit-BM-17:25241761;Lit-BM-17:26186194;Lit-BM-17:27321185;Lit-BM-17:7536190;Lit-BM-17:7538907;Lit-BM-17:8967952;Lit-BM-17:9082980;Lit-BM-17:9325248;MPPI:10196099;Macrophage:15725726;Macrophage:7538907;Macrophage:8967952], FASLG [Baccin2019:9126929;Baccin2019:9228058;BioGRID:9126929;BioGRID:9228058;CA1:1375228;CA1:1713127;CA1:7505205;CellTalkDB:9126929;Cellinker:9126929;Cellinker:9228058;HPMR:9126929;HPRD:9126929;HPRD:9228058;ICELLNET:11239407;IntAct:21803845;IntAct:25241761;LRdb:9126929;LRdb:9228058;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:15659383;Lit-BM-17:21803845;Lit-BM-17:25241761;Lit-BM-17:9126929;Lit-BM-17:9228058;Macrophage:15725726;Macrophage:8521815;Macrophage:9039262;Macrophage:9126929;Macrophage:9228058;SIGNOR:14965271;SIGNOR:9228058;SPIKE:9126929;SPIKE:9228058;connectomeDB2020:9126929;connectomeDB2020:9228058], PTPN13 [HPRD:12724420;HPRD:7536343;HPRD:9079683;HPRD:9835052;InnateDB:18195016], RIPK1 [DIP:7538908;HPRD:7538908;HPRD:9740801;SIGNOR:18545270], TNFSF13 [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], TNF [CellTalkDB:32103204], CALM1 [CellTalkDB:23760276;HPRD:14594800], CASP8 [BioGRID:11978827;Cellinker:19118384;HPRD:11101867;HPRD:17159907;InnateDB:12721308;InnateDB:15993755;InnateDB:17047155;InnateDB:17898872;InnateDB:22421964;InnateDB:9208847;IntAct:16498403;IntAct:17159907;IntAct:18328427;IntAct:20956295;MPPI:10196099], MET [Cellinker:28536399;HPRD:15911745], AKT1 [KEA:12861023], BCR [KEA:9360956], CSNK1A1 [KEA:9360956], MAPK8 [KEA:7890696;Lit-BM-17:15659383;Lit-BM-17:25241761], MAPKAPK2 [KEA:12861023], PRKACA [KEA:12861023], PRKCD [KEA:12861023], BTK [HPRD:9751072;InnateDB:9880544], CASP2 [AlzPathway:14555243], EGFR [HPRD:12586732], PRKCA [HPRD:12586732], FYN [HPRD:8626376], LCK [HPRD:8864141], HIPK3 [HPRD:11034606]	CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; Fas signaling pathway [GO:0036337]; immune response [GO:0006955]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of protein phosphorylation [GO:0001934]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FAS&keywords=FAS	10.55746036	156	768.245	78	0.7725650905	296	0.02362204724	0.122754491	0	0.248441247	0.03535353535	0.0152284264	0.01178603808	0.02936378467	0.02182759896	0.01101615703	0.01124203206	178	200	199	0.04823957798	0.5464943268	0.3608569594	0.3647353364	290	339	325	214
FLT3	fms related receptor tyrosine kinase 3	Yes	No		ENSG00000122025	P36888	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	20	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P06239, P07333, P10721, P11309, P22681, P41240, P43405, P49771, Q13191, Q9H6Q3	CBL, CBLB, CSF1R, CSK, FLT3LG, KIT, LCK, PIM1, SLA2, SYK	FLT3LG [Baccin2019:15147956;Baccin2019:7505204;Baccin2019:9651358;CellChatDB:25992210;CellTalkDB:9651358;Cellinker:15147956;Cellinker:15618475;Cellinker:19830725;Cellinker:25992210;Cellinker:7505204;Cellinker:9651358;HPMR:12681969;HPMR:15147956;HPRD:7505204;HPRD:9651358;ICELLNET:21389326;LRdb:15147956;LRdb:7505204;LRdb:9651358;SIGNOR:10080542;SIGNOR:12681969;SPIKE:7505204;SPIKE:9651358;connectomeDB2020:15147956;connectomeDB2020:7505204;connectomeDB2020:9651358], CSK [SignaLink3:23707526], SLA2 [SIGNOR:27458164], PIM1 [ProtMapper:24040307;SIGNOR:24040307;iPTMnet:24040307], CBL [ACSN:10514377;ACSN:17635922;SIGNOR:19276253], CBLB [ACSN:10514377;ACSN:17635922;HPRD:9614102;SIGNOR:19276253], CSF1R [KEA:17570479], KIT [KEA:17570479], LCK [KEA:17570479], SYK [IntAct:24525236;IntAct:28086240;ProtMapper:24525236]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; glucocorticoid receptor binding [GO:0035259]; growth factor binding [GO:0019838]; protein-containing complex binding [GO:0044877]; protein self-association [GO:0043621]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLT3&keywords=FLT3	0.8927042518	396	NA	NA	0.6161648203	333	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	365
FZD6	frizzled class receptor 6	Yes	No		ENSG00000164930	O60353	G-protein coupled receptor Fz/Smo family	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O96014, P04628, P25098, P41221, P56704, P56705, Q8N474, Q96CG8, Q9H1J7, Q9UBV4, Q9ULT6	CTHRC1, GRK2, SFRP1, WNT1, WNT11, WNT16, WNT3A, WNT4, WNT5A, WNT5B, ZNRF3	WNT3A [Baccin2019:21128903;Baccin2019:21665003;CellTalkDB:21665003;Guide2Pharma:21128903;Guide2Pharma:21665003;LRdb:21;LRdb:21665003;connectomeDB2020:21128903;connectomeDB2020:21665003;scConnect:21128903;scConnect:21665003], WNT4 [Baccin2019:15265686;Baccin2019:21541287;CellPhoneDB:24032637;Guide2Pharma:15265686;Guide2Pharma:21541287;HPMR:15265686;HPRD:15265686;LRdb:15265686;LRdb:21541287;NetPath:15265686;connectomeDB2020:15265686;connectomeDB2020:21541287;scConnect:15265686;scConnect:21541287], WNT5A [Baccin2019:21665003;CellPhoneDB:24032637;Cellinker:21665003;Guide2Pharma:21665003;LRdb:21665003;SIGNOR:16273260;connectomeDB2020:21665003;scConnect:21665003], WNT5B [SIGNOR:16273260], ZNRF3 [SIGNOR:22575959], WNT11 [SIGNOR:16273260], WNT1 [SIGNOR:22944199], SFRP1 [Baccin2019:10347172;CellTalkDB:10347172;Cellinker:10347172;HPRD:10347172;LRdb:10347172;NetPath:10347172;connectomeDB2020:10347172], WNT16 [CellTalkDB:32196115], CTHRC1 [Cellinker:18606138;LRdb:18606138;Ramilowski2015:18606138;connectomeDB2020:18606138;talklr:18606138], GRK2 [PhosphoSite:30309985]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; embryonic nail plate morphogenesis [GO:0035880]; establishment of body hair planar orientation [GO:0048105]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; platelet activation [GO:0030168]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD6&keywords=FZD6	19.67718682	110	NA	NA	1.429215726	165	0	0.122754491	0.0685840708	0.02398081535	0.05387205387	0.09644670051	0.07706255666	0.05057096248	0.03699593045	0.05661637068	0.02808576396	146	122	138	0.0559063378	0.7130714893	1.010773363	0.5778771091	223	123	244	130
FZD7	frizzled class receptor 7	Yes	Yes		ENSG00000155760	O75084	G-protein coupled receptor Fz/Smo family	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00744, O00755, O96014, P04628, P09544, P41221, P56703, P56704, Q16512, Q93097, Q99972, Q9H1J5, Q9H1J7, Q9Y6F9	MYOC, PKN1, WNT1, WNT10B, WNT11, WNT2, WNT2B, WNT3, WNT3A, WNT5A, WNT5B, WNT6, WNT7A, WNT8A	WNT8A [SignaLink3:10097073;SignaLink3:23331499], PKN1 [SignaLink3:24114839], WNT7A [NetPath:19497282;SIGNOR:22944199;SIGNOR:23290138], WNT11 [Baccin2019:10862746;CellTalkDB:10862746;Cellinker:10862746;LRdb:10862746;SIGNOR:10862746;connectomeDB2020:10862746], WNT3 [Baccin2019:24032637;CellPhoneDB:24032637;CellTalkDB:18313787;LRdb:18313787;NetPath:18313787;Ramilowski2015:18313787;connectomeDB2020:18313787;connectomeDB2020:25892522;talklr:18313787], WNT5A [Baccin2019:10990458;Cellinker:10990458;HPMR:10990458;LRdb:10990458;connectomeDB2020:10990458], WNT2 [LRdb:23815780;Ramilowski2015:23815780;connectomeDB2020:23815780;talklr:23815780], WNT3A [CellTalkDB:18215320;LRdb:18215320;Ramilowski2015:18215320;connectomeDB2020:18215320;talklr:18215320], WNT1 [CellTalkDB:32196115], WNT5B [NA], MYOC [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], WNT10B [connectomeDB2020:29979633], WNT2B [connectomeDB2020:18567805], WNT6 [connectomeDB2020:27122540]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; mesenchymal to epithelial transition [GO:0060231]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of ectodermal cell fate specification [GO:0042666]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; stem cell population maintenance [GO:0019827]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation in thymus [GO:0033077]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD7&keywords=FZD7	NA	NA	NA	NA	NA	NA	0	0.003992015968	0	0.01103117506	0	0	0	0.00163132137	7.40E-04	3.00E-04	3.86E-05	232	337	346	0.001612136733	0.9248873705	0.8870409368	0.8644948508	135	170	130	254
FZD8	frizzled class receptor 8	Yes	Yes		ENSG00000177283	Q9H461	G-protein coupled receptor Fz/Smo family	20	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O14905, O96014, P04628, P09544, P22692, P34925, P41221, P56703, P56704, P56705, P56706, Q2MKA7, Q9BXY4, Q9GZT5, Q9H1J5, Q9H1J7, Q9ULT6	IGFBP4, RSPO1, RSPO3, RYK, WNT1, WNT10A, WNT11, WNT2, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT7B, WNT8A, WNT9B, ZNRF3	WNT8A [SignaLink3:10097073;SignaLink3:23331499;connectomeDB2020:28733458], ZNRF3 [SIGNOR:22575959], WNT1 [Baccin2019:1545408415454080;CellTalkDB:15454084;HPMR:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:11448771;connectomeDB2020:15454084], WNT3A [CellTalkDB:22303445;LRdb:22303445;NetPath:20093360;Ramilowski2015:22303445;SIGNOR:22653731;connectomeDB2020:22303445;talklr:22303445], RYK [HPRD:15454084;NetPath:15454084;SIGNOR:17035295], WNT3 [Baccin2019:15454084;Baccin2019:18528331;CellTalkDB:18528331;LRdb:15;LRdb:18528331;connectomeDB2020:15454084;connectomeDB2020:18528331], WNT5A [CellTalkDB:21518267;LRdb:21518267;NetPath:20093360;Ramilowski2015:21518267;connectomeDB2020:21518267;talklr:21518267], WNT2 [CellTalkDB:23815780;LRdb:23815780;Ramilowski2015:23815780;connectomeDB2020:23815780;talklr:23815780], IGFBP4 [CellTalkDB:18528331;Cellinker:18528331;LRdb:18528331;Ramilowski2015:18528331;connectomeDB2020:18528331;talklr:18528331], WNT4 [CellTalkDB:32103204], RSPO1 [CellTalkDB:32196115;NetPath:17976036], RSPO3 [Cellinker:16543246;LRdb:16543246;NetPath:17976036;Ramilowski2015:16543246;connectomeDB2020:16543246;talklr:16543246], WNT5B [NetPath:20093360;connectomeDB2020:26849959], WNT11 [connectomeDB2020:29717114], WNT10A [connectomeDB2020:28733458], WNT7B [connectomeDB2020:28733458], WNT9B [connectomeDB2020:28733458]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; neuron differentiation [GO:0030182]; positive regulation of JUN kinase activity [GO:0043507]; T cell differentiation in thymus [GO:0033077]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD8&keywords=FZD8	NA	NA	NA	NA	NA	NA	0	0.03842315369	0.0232300885	0.01318944844	0.0101010101	0	9.07E-04	0	0.001109877913	0.002002937642	5.79E-04	231	286	327	0.008140238253	0.6124438807	0.6616747517	0.5832054707	261	243	242	265
FZD9	frizzled class receptor 9	Yes	TBD		ENSG00000188763	O00144	G-protein coupled receptor Fz/Smo family	20	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00755, O96014, P04628, P09544, P41221, Q9H1J7	WNT1, WNT11, WNT2, WNT5A, WNT5B, WNT7A	WNT2 [Baccin2019:12138115;CellPhoneDB:24032637;CellTalkDB:12138115;HPRD:12138115;LRdb:12138115;NetPath:19038973;SignaLink3:12138115;SignaLink3:23331499;connectomeDB2020:12138115], WNT5A [CellTalkDB:27402827], WNT7A [Baccin2019:15705594;CellTalkDB:15705594;HPRD:15705594;LRdb:15705594;NetPath:15705594;connectomeDB2020:15705594], WNT1 [Baccin2019:91476519147651;CellTalkDB:9147651;HPMR:9147651;HPRD:9147651;LRdb:9147651;connectomeDB2020:9147651], WNT5B [NA], WNT11 [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	B cell differentiation [GO:0030183]; bone regeneration [GO:1990523]; canonical Wnt signaling pathway [GO:0060070]; learning or memory [GO:0007611]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904394]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; postsynapse organization [GO:0099173]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; release of cytochrome c from mitochondria [GO:0001836]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD9&keywords=FZD9	0.03724034157	697	NA	NA	0.02865463126	796	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	747
GHSR	growth hormone secretagogue receptor	Yes	Yes	https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(22)00089-1#%20	ENSG00000121853	Q92847	G-protein coupled receptor 1 family	20	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P01286, Q969E1, Q9UBU3	CORT, GHRH, GHRL, LEAP2	GHRL [Baccin2019:10604470;Baccin2019:10628755;Baccin2019:11227737;Baccin2019:11314756;Baccin2019:12907757;Baccin2019:15905359;Baccin2019:21402696;CellChatDB:29233536;CellTalkDB:10604470;Cellinker:10604470;Cellinker:10628755;Cellinker:11227737;Cellinker:11314756;Cellinker:12907757;Cellinker:15905359;Cellinker:21402696;Guide2Pharma:10628755;Guide2Pharma:11314756;Guide2Pharma:12907757;Guide2Pharma:15905359;Guide2Pharma:21402696;HPMR:10604470;HPRD:10604470;HPRD:11227737;LRdb:10604470;LRdb:10628755;LRdb:11227737;LRdb:11314756;LRdb:12907757;LRdb:15905359;LRdb:21402696;SIGNOR:15070777;connectomeDB2020:10604470;connectomeDB2020:10628755;connectomeDB2020:11227737;connectomeDB2020:11314756;connectomeDB2020:12907757;connectomeDB2020:15905359;connectomeDB2020:21402696;scConnect:10628755;scConnect:11314756;scConnect:12907757;scConnect:15905359;scConnect:21402696;scConnect:29233536], CORT [Baccin2019:1122773711227730;CellTalkDB:11227737;Cellinker:11227737;HPRD:11227737;LRdb:11227737;SIGNOR:12161511;connectomeDB2020:11227737], GHRH [CellChatDB:19088192;Cellinker:19088192], LEAP2 [Cellinker:29233536;connectomeDB2020:29233536;scConnect:29233536]	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]	G protein-coupled receptor activity [GO:0004930]; growth hormone-releasing hormone receptor activity [GO:0016520]; growth hormone secretagogue receptor activity [GO:0001616]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]	actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; ghrelin secretion [GO:0036321]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHSR&keywords=GHSR	1.597471336	328	NA	NA	13.93735225	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	171
IFNAR1	interferon alpha and beta receptor subunit 1	Yes	Yes		ENSG00000142166	P17181	Type II cytokine receptor family	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P01562, P01563, P01566, P01567, P01568, P01569, P01570, P01571, P01574, P05000, P05013, P05014, P05015, P06239, P08069, P08631, P14780, P17612, P19784, P23458, P28482, P29350, P29597, P32881, P42336, P43403, P48729, Q08334, Q16539, Q86WN2, Q9BZL6, Q9NZH8, Q9P0W0	CSNK1A1, CSNK2A2, HCK, IFNA1, IFNA10, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNB1, IFNE, IFNK, IFNW1, IGF1R, IL10RB, IL36G, JAK1, LCK, MAPK1, MAPK14, MMP9, PIK3CA, PRKACA, PRKD2, PTPN6, TYK2, ZAP70	CSNK1A1 [ProtMapper:29793495;SPIKE:19805514;iPTMnet:19805514], JAK1 [Cellinker:16551269;DIP:9334213;InnateDB:8524272;Lit-BM-17:9334213;ProtMapper:25386349], TYK2 [BioGRID:9733772;Cellinker:16551269;DIP:24704786;DIP:7526154;HPRD:95059042;HPRD:9677371;HPRD:9733772;InnateDB:14647450;InnateDB:15337770;InnateDB:7559568;InnateDB:8524272;InnateDB:8605876;InnateDB:8702790;InnateDB:9461596;InnateDB:9733772;KEA:7526154;KEA:8605876;KEA:8700538;KEA:95059042;KEA:9677371;LMPID:24704786;MPPI:8628273;Macrophage:7526154;Macrophage:8628273;PhosphoSite:12220192;PhosphoSite:8605876;PhosphoSite:9121453;ProtMapper:18166147;ProtMapper:20937132;ProtMapper:21949722;ProtMapper:21994561;ProtMapper:23223197;ProtMapper:7526154;ProtMapper:8605876;SIGNOR:7526154;SIGNOR:8605876;iPTMnet:7526154;iPTMnet:8605876;iPTMnet:8700538;iPTMnet:95059042;iPTMnet:9677371;phosphoELM:7526154;phosphoELM:8605876;phosphoELM:8700538], IFNA1 [CellTalkDB:11698684;CellTalkDB:21856167;HPMR:11698684;HPRD:7932753;LRdb:11698684;LRdb:79;Ramilowski2015:21856167;SIGNOR:8181059;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;connectomeDB2020:7932753;talklr:21856167], IFNB1 [Baccin2019:112785381834641;CellTalkDB:11278538;DIP:10049744;DIP:7592797;Guide2Pharma:29311663;HPRD:1834641;LRdb:11278538;LRdb:18;Macrophage:7623815;SIGNOR:11278538;SignaLink3:1834641;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11278538;connectomeDB2020:1834641;scConnect:29311663], IFNK [SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:22410872], IL36G [SignaLink3:17208301;SignaLink3:23331499], IFNA10 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA14 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA16 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA17 [CellTalkDB:21856167;LRdb:21856167;Macrophage:7623815;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA2 [CellTalkDB:1834641;DIP:7592797;DIP:9334213;HPRD:1834641;LRdb:1834641;connectomeDB2020:1834641], IFNA21 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA4 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA5 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA6 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA7 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA8 [CellTalkDB:21856167;DIP:7592797;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNW1 [CellTalkDB:11278538;HPRD:1834641;LRdb:11278538;LRdb:18;SIGNOR:11278538;connectomeDB2020:11278538;connectomeDB2020:1834641], IFNE [CellTalkDB:32196115;connectomeDB2020:22410872], MMP9 [CellTalkDB:28122987], IL10RB [Cellinker:23769803], PIK3CA [Cellinker:10542297], PRKD2 [PhosphoSite:15337770;PhosphoSite:16551269;PhosphoSite:19948722;PhosphoSite:21666722;PhosphoSite:21695243;PhosphoSite:21865166;PhosphoSite:23129613;PhosphoSite:26676772;iPTMnet:21865166], MAPK14 [InnateDB:21695243;PhosphoSite:28122987;ProtMapper:21695243], CSNK2A2 [KEA:17570479], HCK [KEA:17570479], IGF1R [KEA:17570479], PTPN6 [HPRD:8524272;HPRD:9029147;InnateDB:8524272], MAPK1 [HPRD:9029147], PRKACA [HPRD:9029147], LCK [HPRD:9403695], ZAP70 [HPRD:9403695]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]	cellular response to interferon-alpha [GO:0035457]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNAR1&keywords=IFNAR1	47.21143316	45	NA	NA	2.586777058	91	0.2913385827	0.4441117764	0.5575221239	0.4127098321	0.5168350168	0.3519458545	0.3490480508	0.1924959217	0.1823899371	0.2583455735	0.1949005215	43	33	44	0.3410584719	0.5480281848	0.7643899663	0.5836649388	287	211	241	95
IL10RA	interleukin 10 receptor subunit alpha	Yes	No		ENSG00000110324	Q13651	Type II cytokine receptor family	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P22301, P23458, P29597, Q08334, Q9GZX6	IL10, IL10RB, IL22, JAK1, TYK2	IL10 [Baccin2019:10231374;Baccin2019:11485736;Baccin2019:11717514;Baccin2019:12974481;Baccin2019:7759550;Baccin2019:8248239;Baccin2019:8897595;BioGRID:10231374;BioGRID:11485736;BioGRID:11717514;BioGRID:7759550;BioGRID:8248239;CellTalkDB:12974481;DIP:15837194;DIP:20462497;DIP:8120391;HPRD:10231374;HPRD:11485736;HPRD:11717514;HPRD:7759550;HPRD:8248239;HPRD:8897595;InnateDB:10788470;InnateDB:11717514;InnateDB:9568901;IntAct:11485736;IntAct:12513909;IntAct:15837194;IntAct:20462497;LRdb:10231374;LRdb:11485736;LRdb:11717514;LRdb:12974481;LRdb:7759550;LRdb:8248239;LRdb:8897595;Lit-BM-17:10231374;Lit-BM-17:11485736;Lit-BM-17:11717514;Lit-BM-17:12513909;Lit-BM-17:15837194;Lit-BM-17:8120391;SIGNOR:10347215;SIGNOR:26260587;SPIKE:11591769;SignaLink3:17208301;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8248239;connectomeDB2020:10231374;connectomeDB2020:11485736;connectomeDB2020:11717514;connectomeDB2020:12974481;connectomeDB2020:7759550;connectomeDB2020:8248239;connectomeDB2020:8897595;scConnect:19161426], JAK1 [BioGRID:12374810;HPRD-phos:10433356;HPRD:10433356;HPRD:12133952;HPRD:12374810;InnateDB:12133952;KEA:10433356;ProtMapper:10433356;SIGNOR:10433356;iPTMnet:10433356], TYK2 [KEA:10433356;iPTMnet:10433356;phosphoELM:10433356], IL22 [Baccin2019:58985;CellTalkDB:10875937;LRdb:58985;connectomeDB2020:58985], IL10RB [Cellinker:23769803;HPMR:15985167;HPRD:9312047]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-10 binding [GO:0019969]; interleukin-10 receptor activity [GO:0004920]; signaling receptor activity [GO:0038023]	cytokine-mediated signaling pathway [GO:0019221]; negative regulation of autophagy [GO:0010507]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of synapse organization [GO:0050807]; response to lipopolysaccharide [GO:0032496]; ubiquitin-dependent endocytosis [GO:0070086]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL10RA&keywords=IL10RA	4.174825731	242	NA	NA	0.3167351442	451	0.3228346457	0.001497005988	0	0.003836930456	0	0.003384094755	0.008159564823	0.006525285481	0.005179430263	0.00173587929	0.01464168437	217	294	178	0.03343586555	0.3494676592	0.2701886826	0.567311922	359	368	247	339
IL11RA	interleukin 11 receptor subunit alpha	Yes	Yes		ENSG00000137070	Q14626	Type I cytokine receptor family, Type 3 subfamily	20	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P20809	IL11	IL11 [Baccin2019:10504396;Baccin2019:10948192;Baccin2019:7670098;CellTalkDB:10948192;DIP:8940087;HPMR:10948192;HPRD:10504396;HPRD:7670098;InnateDB:8940087;LRdb:10504396;LRdb:10948192;LRdb:7670098;Lit-BM-17:26551460;Lit-BM-17:8940087;SIGNOR:10948192;SignaLink3:12740032;SignaLink3:23331499;connectomeDB2020:10504396;connectomeDB2020:10948192;connectomeDB2020:7670098]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888]	cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL11RA&keywords=IL11RA	1.269687508	358	NA	NA	0.0419395016	757	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	558
IL17RB	interleukin 17 receptor B	Yes	Yes		ENSG00000056736	Q9NRM6	NA	20	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q5TCX8, Q9H293, Q9UHF5	IL17B, IL25, MAP3K21	IL17B [Baccin2019:1074988710749880;CellTalkDB:10749887;Cellinker:10749887;HPRD:10749887;ICELLNET:24011563;InnateDB:10749887;InnateDB:11058597;LRdb:10749887;SIGNOR:10749887;connectomeDB2020:10749887], IL25 [CellTalkDB:11058597;HPMR:11058597;HPRD:11058597;ICELLNET:24011563;InnateDB:11058597;InnateDB:19838198;LRdb:11058597;connectomeDB2020:11058597], MAP3K21 [PhosphoSite:33658352]	centriolar satellite [GO:0034451]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-17 receptor activity [GO:0030368]	defense response [GO:0006952]; regulation of cell growth [GO:0001558]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RB&keywords=IL17RB	12.80035319	139	NA	NA	0.9877120541	241	0	0.02095808383	0.00110619469	0.002158273381	0.0303030303	0.08798646362	0.09791477788	0.1566068515	0.04402515723	0.09817732675	0.02549739231	132	86	147	0.05133941378	0.8807576386	1.763585924	0.5787044598	150	26	243	123
MERTK	MER proto-oncogene, tyrosine kinase	Yes	Yes		ENSG00000153208	Q12866	Protein kinase superfamily, Tyr protein kinase family, AXL/UFO subfamily	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P07225, P08069, P20382, P21754, Q07912, Q14393	GAS6, IGF1R, PMCH, PROS1, TNK2, ZP3	GAS6 [CellChatDB:27801848;CellTalkDB:9160883;Cellinker:27801848;Cellinker:8939948;Cellinker:9160883;Guide2Pharma:8939948;HPMR:9160883;HPRD:8939948;ICELLNET:9160883;InnateDB:9160883;LRdb:894;LRdb:9160883;SIGNOR:8939948;SignaLink3:23331499;SignaLink3:8939948;connectomeDB2020:8939948;connectomeDB2020:9160883;scConnect:8939948], PROS1 [CellTalkDB:25624460;connectomeDB2020:25074926], PMCH [CellChatDB:30501104;Cellinker:30501104], ZP3 [Baccin2019:7541556;Cellinker:7541556;LRdb:7541556;connectomeDB2020:7541556], IGF1R [KEA:17570479], TNK2 [HPRD:16288044]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rhabdomere [GO:0016028]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; natural killer cell differentiation [GO:0001779]; negative regulation of cytokine production [GO:0001818]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of lymphocyte activation [GO:0051250]; nervous system development [GO:0007399]; neutrophil clearance [GO:0097350]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of kinase activity [GO:0033674]; positive regulation of phagocytosis [GO:0050766]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; retina development in camera-type eye [GO:0060041]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MERTK&keywords=MERTK	3.767243265	252	NA	NA	0.2530291074	480	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	366
NOTCH2	notch receptor 2	Yes			ENSG00000134250	Q04721	NOTCH family	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	A0PJZ3, O00548, O00587, O14672, P05067, P06493, P17252, P21741, P24941, P49768, P49810, P49841, P78504, P80370, Q12860, Q13007, Q16539, Q16873, Q4G148, Q8IZL2, Q8NBL1, Q8NES3, Q92585, Q96JK9, Q9NR61, Q9NYJ7, Q9Y219	_APH1A_NCSTN_PSEN1_PSENEN, ADAM10, APP, CDK1, CDK2, CNTN1, DLK1, DLL1, DLL3, DLL4, GSK3B, GXYLT1, GXYLT2, IL24, JAG1, JAG2, LFNG, LTC4S, MAML1, MAML2, MAML3, MAPK14, MDK, MFNG, POGLUT1, PRKCA, PSEN1, PSEN2	ADAM10 [ACSN:19601831;ACSN:19704010;ACSN:19726682;CellTalkDB:24842903;SignaLink3:10423016;SignaLink3:23331499], JAG1 [ACSN:22330899;ACSN:22363130;Baccin2019:10551863;Baccin2019:10958687;CellChatDB:22353464;CellPhoneDB:22353464;Cellinker:10551863;Cellinker:10958687;Cellinker:22353464;HPMR:10551863;HPRD:10551863;HPRD:10958687;ICELLNET:16921404;LRdb:10551863;LRdb:11;NetPath:10958687;SIGNOR:10551863;SIGNOR:10958687;SIGNOR:18660822;SignaLink3:10551863;SignaLink3:10958687;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10551863;connectomeDB2020:10958687], JAG2 [Baccin2019:10958687;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:10958687;Cellinker:22353464;HPRD:10958687;ICELLNET:16921404;LRdb:10958687;NetPath:10958687;SIGNOR:10958687;SignaLink3:10958687;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10958687], DLL1 [Baccin2019:10958687;BioGRID:9244302;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:10958687;Cellinker:10958687;Cellinker:22353464;HPRD:10958687;ICELLNET:21685328;LRdb:10958687;NetPath:10958687;SIGNOR:23111325;connectomeDB2020:10958687], LTC4S [SignaLink3:11101851;SignaLink3:23331499], DLL3 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;Cellinker:29910816;ICELLNET:16921404;LRdb:22353464;SignaLink3:11823422;SignaLink3:23331499;connectomeDB2020:22353464], MAML2 [HPRD:12370315;NetPath:12370315;SignaLink3:12370315;SignaLink3:23331499], MAML3 [CancerCellMap:12370315;HPRD:12370315;NetPath:12370315;SIGNOR:12370315;SignaLink3:12370315;SignaLink3:23331499], MDK [SIGNOR:18469519;SignaLink3:18469519;SignaLink3:23331499;connectomeDB2020:18469519], GXYLT1 [SIGNOR:22117070], POGLUT1 [SIGNOR:22872643], LFNG [HPRD:11346656;SIGNOR:11346656], MAML1 [CancerCellMap:11101851;HPRD:11101851;NetPath:11101851;SIGNOR:11101851], GXYLT2 [SIGNOR:22117070], MFNG [CancerCellMap:11346656;HPRD:11346656;LRdb:11346656;SIGNOR:11346656;connectomeDB2020:11346656], GSK3B [ACSN:11967263;ACSN:14663202;ACSN:15020233;ACSN:15465828;ACSN:16944320;ACSN:21828089;ACSN:8524413;ACSN:9832503;CancerCellMap:12794074;HPRD-phos:12794074;HPRD-phos:15302935;HPRD-phos:18669648;HPRD-phos:20068231;HPRD:12794074;KEA:12794074;KEA:15302935;KEA:17570479;NetPath:12794074;ProtMapper:12794074;SIGNOR:12794074;iPTMnet:12794074;iPTMnet:15302935;iPTMnet:18669648;iPTMnet:20068231], DLL4 [Baccin2019:30181175;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22842086;Cellinker:22353464;Cellinker:30289388;ICELLNET:15137944;ICELLNET:19494260;LRdb:22353464;Ramilowski2015:22842086;connectomeDB2020:22842086;talklr:22842086], DLK1 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], PSEN1 [Cellinker:11518718;HPRD:11518718;LRdb:11518718;NetPath:11518718;connectomeDB2020:11518718], APP [CellTalkDB:16118793], CNTN1 [HPRD:14567914;NetPath:14567914;connectomeDB2020:14567914], IL24 [NA], CDK1 [KEA:17570479], CDK2 [KEA:17570479], MAPK14 [KEA:17570479], PRKCA [KEA:17570479], PSEN2 [HPRD:11518718;NetPath:11518718]	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOTCH2&keywords=NOTCH2	26.79306994	84	NA	NA	1.325747434	183	0.125984252	0.3902195609	0.003318584071	0.6820143885	0.08080808081	0	9.07E-04	0.003262642741	0.002959674436	0.001869408466	0.001429399266	226	289	302	0.1175247827	0.1016247522	0.09307530832	0.08962492644	430	426	434	246
NOTCH3	notch receptor 3	Yes	No		ENSG00000074181	Q9UM47	NOTCH family	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00548, O14672, O60469, P35442, P49768, P49810, P78504, P80370, Q16873, Q8IZL2, Q92585, Q96JK9, Q96QR1, Q9NR61, Q9NYJ7, Q9Y219, Q9Y2E6	_APH1A_NCSTN_PSEN1_PSENEN, ADAM10, DLK1, DLL1, DLL3, DLL4, DSCAM, DTX4, JAG1, JAG2, LTC4S, MAML1, MAML2, MAML3, PSEN1, PSEN2, SCGB3A1, THBS2	JAG2 [Baccin2019:1100613311006130;CancerCellMap:11006133;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:11006133;Cellinker:22353464;HPRD:11006133;ICELLNET:16921404;LRdb:11006133;NetPath:11006133;SIGNOR:11006133;SignaLink3:10958687;SignaLink3:11006133;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11006133], ADAM10 [ACSN:19601831;ACSN:19704010;ACSN:19726682;SignaLink3:12651094;SignaLink3:23331499], DTX4 [SignaLink3:10531053;SignaLink3:23331499], LTC4S [SignaLink3:11101851;SignaLink3:23331499], MAML2 [HPRD:12370315;NetPath:12370315;SignaLink3:12370315;SignaLink3:23331499], MAML3 [HPRD:12370315;NetPath:12370315;SIGNOR:12370315;SignaLink3:12370315;SignaLink3:23331499], MAML1 [HPRD:11101851;NetPath:11101851;SIGNOR:11101851], DLL1 [Baccin2019:11006133;Baccin2019:12482954;CancerCellMap:11006133;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:12482954;Cellinker:11006133;Cellinker:12482954;Cellinker:22353464;HPRD:11006133;HPRD:12482954;ICELLNET:21685328;LRdb:11;LRdb:12482954;NetPath:11006133;SIGNOR:11006133;connectomeDB2020:11006133;connectomeDB2020:12482954], JAG1 [ACSN:22330899;ACSN:22363130;Baccin2019:11006133;Baccin2019:12482954;Baccin2019:14714274;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:11006133;Cellinker:12482954;Cellinker:14714274;Cellinker:22353464;HPMR:11006133;HPRD:12482954;HPRD:14714274;ICELLNET:16921404;LRdb:11006133;LRdb:12482954;LRdb:14714274;NetPath:11006133;SIGNOR:18660822;connectomeDB2020:11006133;connectomeDB2020:12482954;connectomeDB2020:14714274], DLL3 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;Cellinker:29910816;ICELLNET:16921404;LRdb:22353464;connectomeDB2020:22353464], DLL4 [Baccin2019:29230914;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:18182388;Cellinker:22353464;Cellinker:29910816;ICELLNET:15137944;ICELLNET:19494260;LRdb:22353464;Ramilowski2015:18182388;connectomeDB2020:18182388;talklr:18182388], DLK1 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], PSEN1 [HPRD:11518718;LRdb:11518718;NetPath:11518718;connectomeDB2020:11518718], THBS2 [Baccin2019:19147503;CellTalkDB:19147503;Cellinker:19147503;LRdb:19147503;Ramilowski2015:19147503;connectomeDB2020:19147503;talklr:19147503], SCGB3A1 [CellTalkDB:32103204], DSCAM [Cellinker:32822567], PSEN2 [HPRD:11518718;NetPath:11518718]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]	artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOTCH3&keywords=NOTCH3	16.87116069	120	NA	NA	0.3182945343	450	0	0.03393213573	0.002212389381	0.1172661871	0.006734006734	0.003384094755	0.003626473255	0	0.002219755827	0.001635732408	0.002202047518	228	299	282	0.01574662024	0.474615919	0.4519324206	0.4739281274	312	305	284	294
NTRK3	neurotrophic receptor tyrosine kinase 3	Yes	TBD		ENSG00000140538	Q16288	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P06213, P08069, P20783, P27361, P28482, P34130, Q13332, Q16827	IGF1R, INSR, MAPK1, MAPK3, NTF3, NTF4, PTPRO, PTPRS	NTF3 [AlzPathway:9775403;Baccin2019:7679912;Baccin2019:9488719;Baccin2019:9973222;CellChatDB:27908981;CellTalkDB:7679912;Cellinker:27908981;Cellinker:7679912;Cellinker:9488719;Cellinker:9973222;DIP:10713102;HPMR:1653651;HPMR:7679912;HPRD:9488719;HPRD:9973222;LRdb:7679912;LRdb:9488719;LRdb:9973222;SIGNOR:1653651;SignaLink3:1653651;SignaLink3:23331499;connectomeDB2020:7679912;connectomeDB2020:9488719;connectomeDB2020:9973222], PTPRS [Cellinker:32822567;DEPOD:17967490], NTF4 [NA], PTPRO [DEPOD:19573017], IGF1R [KEA:17570479], INSR [KEA:17570479], MAPK1 [HPRD:11205744;HPRD:9973222], MAPK3 [HPRD:11205744]	axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; heart development [GO:0007507]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTRK3&keywords=NTRK3	0.1448617148	580	NA	NA	0.03572386397	774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	677
OSMR	oncostatin M receptor	Yes	No		ENSG00000145623	Q99650	Type I cytokine receptor family, Type 2 subfamily	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60674, P13725, P23458, Q6EBC2	IL31, JAK1, JAK2, OSM	IL31 [CellTalkDB:15184896;HPMR:15184896;HPMR:15194700;LRdb:15184896;SIGNOR:15184896;SignaLink3:16286453;SignaLink3:23331499;connectomeDB2020:15184896], OSM [Baccin2019:10997905;Baccin2019:8999038;CellTalkDB:8999038;HPMR:10854424;HPMR:8999038;HPRD:10997905;HPRD:8999038;LRdb:10997905;LRdb:8999038;SIGNOR:16286453;SignaLink3:16286453;SignaLink3:23331499;connectomeDB2020:10997905;connectomeDB2020:8999038], JAK2 [HPRD:10586060], JAK1 [HPRD:10586060]	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]	cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OSMR&keywords=OSMR	39.75582106	55	NA	NA	1.69215484	143	0	0.3423153693	0.05088495575	0.2033573141	0.2828282828	0.003384094755	0.001813236627	0.003262642741	0.003699593045	0.001635732408	0.006876569442	224	299	230	0.08182343555	0.1491949518	0.1267185478	0.1837937052	421	416	399	228
TNFRSF11A	TNF receptor superfamily member 11a	Yes	Yes		ENSG00000141655	Q9Y6Q6	NA	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14788, O43318, P12931, Q9Y4K3	MAP3K7, SRC, TNFSF11, TRAF6	TNFSF11 [Baccin2019:11581298;Baccin2019:9367155;CellTalkDB:11581298;Cellinker:11581298;Cellinker:9367155;HPMR:11581298;HPMR:15110169;HPRD:9367155;ICELLNET:11239407;IntAct:23333834;LRdb:11581298;LRdb:94;NetPath:14741739;NetPath:20483727;NetPath:9520411;SIGNOR:12897775;connectomeDB2020:11581298;connectomeDB2020:9367155], TRAF6 [BioGRID:11809792;HPRD:10025951;HPRD:10075662;HPRD:10635328;HPRD:9685412;InnateDB:10025951;InnateDB:11406619;InnateDB:11809792;InnateDB:9685412;MPPI:9685412;NetPath:10075662;NetPath:10635328;NetPath:11406619;NetPath:11809792;NetPath:17544369;SIGNOR:10075662], MAP3K7 [HPRD:11809792;InnateDB:11809792;NetPath:11809792], SRC [HPRD:10635328;NetPath:10635328]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; tumor necrosis factor-activated receptor activity [GO:0005031]	adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; circadian temperature homeostasis [GO:0060086]; lymph node development [GO:0048535]; mammary gland alveolus development [GO:0060749]; monocyte chemotaxis [GO:0002548]; multinuclear osteoclast differentiation [GO:0072674]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; TNFSF11-mediated signaling pathway [GO:0071847]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF11A&keywords=TNFRSF11A	8.94447635	169	NA	NA	5.548025643	42	0	0.0998003992	0	0.002637889688	0.02693602694	0.1353637902	0.1586582049	0.1076672104	0.01590825009	0.1359660836	0.01622561329	188	66	170	0.0635603153	0.352204174	1.984304757	0.3565185003	358	20	327	74
TNFRSF18	TNF receptor superfamily member 18	Yes	No		ENSG00000186891	Q9Y5U5	NA	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q9UNG2	TNFSF18	TNFSF18 [Baccin2019:10037686;Baccin2019:10074428;CellTalkDB:10037686;Cellinker:10037686;Cellinker:10074428;DIP:18040044;DIP:18378892;HPMR:10037686;HPRD:10037686;HPRD:10074428;ICELLNET:11239407;IntAct:18040044;IntAct:18378892;LRdb:1;LRdb:10037686;Lit-BM-17:10037686;Lit-BM-17:18040044;Lit-BM-17:18378892;connectomeDB2020:10037686;connectomeDB2020:10074428]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	tumor necrosis factor-activated receptor activity [GO:0005031]	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF18&keywords=TNFRSF18	0.1072042416	607	NA	NA	0.03352393925	782	0	0.001996007984	0	0.004076738609	0	0.01692047377	0.01087941976	0.03425774878	0.02737698853	0.005574843103	0.03770523469	168	231	122	0.01261704138	1.652602915	0.6886330903	2.109260618	29	236	8	464
TNFRSF1A	TNF receptor superfamily member 1A	Yes			ENSG00000067182	P19438	NA	20	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O14920, O15111, O43353, O60674, O75888, O95429, P01374, P01375, P02533, P17612, P20333, P21580, P23458, P28482, P28799, P48023, P53355, P55210, Q05397, Q06643, Q13546, Q15628, Q9Y572	BAG4, CASP7, CHUK, DAPK1, FASLG, GRN, IKBKB, JAK1, JAK2, KRT14, LTA, LTB, MAPK1, PRKACA, PTK2, RIPK1, RIPK2, RIPK3, TNF, TNFAIP3, TNFRSF1B, TNFSF13, TRADD	CASP7 [CancerCellMap:11755217;HPRD:11755217;SPIKE:11755217], RIPK3 [HPRD:10339433], LTA [Baccin2019:8387891;BioGRID:8387891;CellTalkDB:8387891;Cellinker:8387891;DIP:2170974;DIP:8387891;HPRD:8387891;ICELLNET:7995952;InnateDB:8171323;LRdb:8387891;Lit-BM-17:1310388;Lit-BM-17:2170974;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8387891;SPIKE:12387745;connectomeDB2020:8387891], BAG4 [CancerCellMap:10634209;CancerCellMap:12748303;CancerCellMap:9915703;HPRD:11909948;HPRD:9915703;Macrophage:10339421;Macrophage:9915703;NetPath:9915703;SIGNOR:12748303;SPIKE:18161752], RIPK1 [BioGRID:11002422;BioGRID:18621737;BioGRID:18724939;BioGRID:25388546;BioGRID:28817177;CancerCellMap:12887920;DIP:7538908;HPRD:8612133;InnateDB:10356400;InnateDB:10795740;InnateDB:12721308;InnateDB:15115707;InnateDB:15357952;InnateDB:23815148;IntAct:16611992;IntAct:19524513;IntAct:22817896;Lit-BM-17:11002422;Lit-BM-17:15258597;Lit-BM-17:16115877;Lit-BM-17:16611992;Lit-BM-17:16968706;Lit-BM-17:18022363;Lit-BM-17:18450452;Lit-BM-17:18621737;Lit-BM-17:18724939;Lit-BM-17:18939944;Lit-BM-17:18949366;Lit-BM-17:19524513;Lit-BM-17:19773432;Lit-BM-17:19815541;Lit-BM-17:20448643;Lit-BM-17:20825417;Lit-BM-17:21113135;Lit-BM-17:21331078;Lit-BM-17:21737329;Lit-BM-17:22179575;Lit-BM-17:22733818;Lit-BM-17:22817896;Lit-BM-17:22848449;Lit-BM-17:24098568;Lit-BM-17:24130170;Lit-BM-17:24758719;Lit-BM-17:25388546;Lit-BM-17:25681446;Lit-BM-17:26802121;Lit-BM-17:27321185;Lit-BM-17:27552911;Lit-BM-17:7538908;Lit-BM-17:8612133;Lit-BM-17:8985253;NetPath:10744744;NetPath:10755617;NetPath:12887920;NetPath:20448643;NetPath:20547836;NetPath:21119000;NetPath:21741934;SPIKE:18329793], TRADD [CancerCellMap:10634209;CancerCellMap:12887920;CancerCellMap:7758105;CancerCellMap:8791485;CancerCellMap:8943045;DIP:19641494;DIP:23955153;DIP:9129204;DOMINO:8565075;DOMINO:8621670;HPRD:11934887;HPRD:7758105;HPRD:8565075;HPRD:8612133;HPRD:8621670;InnateDB:10795740;InnateDB:12721308;InnateDB:15115707;InnateDB:15173123;InnateDB:15310755;InnateDB:15357952;InnateDB:15465831;IntAct:11684708;IntAct:23955153;IntAct:7758105;IntAct:8565075;IntAct:8621670;Lit-BM-17:10187805;Lit-BM-17:11035039;Lit-BM-17:11684708;Lit-BM-17:11821416;Lit-BM-17:15310755;Lit-BM-17:16611992;Lit-BM-17:18776134;Lit-BM-17:18939944;Lit-BM-17:19524513;Lit-BM-17:21724995;Lit-BM-17:22297296;Lit-BM-17:24130170;Lit-BM-17:24758719;Lit-BM-17:27552911;Lit-BM-17:7758105;Lit-BM-17:8565075;Lit-BM-17:8612133;Lit-BM-17:8621670;Lit-BM-17:8943045;Lit-BM-17:9082980;Lit-BM-17:9129204;Lit-BM-17:9915703;MPPI:9916731;Macrophage:15725726;Macrophage:7758105;Macrophage:9430227;NetPath:12887920;NetPath:15485837;NetPath:21119000;NetPath:21741934;NetPath:21760970;NetPath:7758105], TNF [AlzPathway:18067990;Baccin2019:10634209;Baccin2019:14743216;Baccin2019:19084540;Baccin2019:7852363;BioGRID:2170559;CancerCellMap:10634209;CancerCellMap:14743216;CellTalkDB:19084540;Cellinker:10634209;Cellinker:14743216;Cellinker:19084540;Cellinker:7852363;DIP:14743216;DIP:20080539;DIP:2158863;DIP:2170974;DIP:22801493;DIP:23955153;HPMR:7852363;HPRD:10634209;HPRD:14743216;HPRD:19084540;ICELLNET:11239407;InnateDB:11448951;InnateDB:12887920;InnateDB:14743216;InnateDB:19287455;InnateDB:2158863;InnateDB:2848815;InnateDB:7852363;IntAct:14743216;IntAct:20103630;IntAct:24070898;IntAct:25241761;IntAct:2848815;LRdb:10634209;LRdb:14743216;LRdb:19084540;LRdb:7852363;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:1310388;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:20103630;Lit-BM-17:2158863;Lit-BM-17:2170559;Lit-BM-17:2170974;Lit-BM-17:22028622;Lit-BM-17:22099304;Lit-BM-17:22675546;Lit-BM-17:23032187;Lit-BM-17:23746843;Lit-BM-17:24070898;Lit-BM-17:24726327;Lit-BM-17:24980434;Lit-BM-17:25241761;Lit-BM-17:25911380;Lit-BM-17:26186194;Lit-BM-17:26670046;Lit-BM-17:27560715;Lit-BM-17:2848815;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:1331108;Macrophage:2158863;NetPath:10634209;NetPath:15485837;NetPath:3034874;ProtMapper:21724995;SIGNOR:10634209;SIGNOR:11502070;SIGNOR:14732063;SIGNOR:17151142;SIGNOR:21133840;SIGNOR:23070005;SPIKE:10634209;SPIKE:19442713;SPIKE:2158863;connectomeDB2020:10634209;connectomeDB2020:14743216;connectomeDB2020:19084540;connectomeDB2020:7852363], KRT14 [SIGNOR:11684708], MAPK1 [BioGRID:11606045;HPRD:11606045;KEA:10702263;KEA:11606045;ProtMapper:11606045;SIGNOR:11606045;iPTMnet:11606045], GRN [CellTalkDB:24070898;IntAct:24070898;Lit-BM-17:24070898;SIGNOR:21393509;connectomeDB2020:21393509], FASLG [NA], TNFSF13 [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], LTB [Baccin2019:7995952;CellTalkDB:7995952;Cellinker:7995952;HPRD:7995952;LRdb:7995952;connectomeDB2020:7995952], IKBKB [HPRD:10755617;InnateDB:10755617;InnateDB:23815148;Lit-BM-17:10755617;Lit-BM-17:11002417;Lit-BM-17:11821416;Lit-BM-17:18949366;Lit-BM-17:21331078;Lit-BM-17:21724995;Lit-BM-17:25241761;NetPath:10755617;NetPath:21119000;NetPath:21724995;PhosphoSite:21724995;ProtMapper:21724995], PRKACA [PhosphoSite:32159413], JAK1 [BioGRID:11801527;HPRD:11801527;InnateDB:15173123], PTK2 [HPRD:12748169;NetPath:12748169], CHUK [HPRD:10755617;InnateDB:10755617;InnateDB:10795740;InnateDB:23815148;InnateDB:24323043;NetPath:10755617;NetPath:21724995], TNFRSF1B [NetPath:15485837], TNFAIP3 [NetPath:20448643], JAK2 [HPRD:9510175;InnateDB:18606683], DAPK1 [HPRD:12911633], RIPK2 [HPRD:9642260]	cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]	tumor necrosis factor-activated receptor activity [GO:0005031]; tumor necrosis factor binding [GO:0043120]	aortic valve development [GO:0003176]; cellular response to mechanical stimulus [GO:0071260]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin metabolic process [GO:0006693]; protein localization to plasma membrane [GO:0072659]; pulmonary valve development [GO:0003177]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF1A&keywords=TNFRSF1A	107.2761816	16	NA	NA	1.33732783	180	0.2519685039	0.4660678643	0.2123893805	0.5395683453	0.3821548822	0.3976311337	0.4904805077	0.3654159869	0.2815390307	0.2961343304	0.3417809542	28	28	21	0.3659209927	0.7755327219	0.8143581664	0.9357842766	197	192	102	104
TNFRSF1B	TNF receptor superfamily member 1B	Yes	Yes		ENSG00000028137	P20333	NA	20	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01374, P01375, P06493, P19438, P23515, P28799, P45983, P48729, P51813, Q12933, Q13077	BMX, CDK1, CSNK1A1, GRN, LTA, MAPK8, OMG, TNF, TNFRSF1A, TRAF1, TRAF2	TNF [Baccin2019:19084540;Baccin2019:2158863;Baccin2019:7664431;BioGRID:7930591;BioGRID:7966397;CancerCellMap:2158863;CancerCellMap:7664431;CellTalkDB:19084540;Cellinker:19084540;Cellinker:2158863;Cellinker:7664431;DIP:1328224;DIP:14743216;DIP:2172983;HPMR:2158863;HPRD:19084540;HPRD:2158863;HPRD:7664431;ICELLNET:11239407;InnateDB:11448951;InnateDB:14743216;InnateDB:19287455;IntAct:14743216;IntAct:24070898;LRdb:19084540;LRdb:2158863;LRdb:7664431;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:2172983;Lit-BM-17:24070898;Lit-BM-17:7930591;Lit-BM-17:7966397;Lit-BM-17:8182064;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:7852363;Macrophage:8590321;NetPath:15485837;NetPath:1655744;NetPath:7664431;SIGNOR:12040173;SIGNOR:14732063;SIGNOR:17151142;SPIKE:15450251;connectomeDB2020:19084540;connectomeDB2020:2158863;connectomeDB2020:7664431], TRAF2 [BioGRID:11907088;BioGRID:18671942;CancerCellMap:11112773;CancerCellMap:14743216;CancerCellMap:7544915;CancerCellMap:8548810;HPRD:7639698;HPRD:8069916;HPRD:8702708;HPRD:9461607;InnateDB:15572357;InnateDB:8855313;InnateDB:9168896;LMPID:10206649;Lit-BM-17:10206649;Lit-BM-17:11907088;Lit-BM-17:14743216;Lit-BM-17:18671942;Lit-BM-17:7639698;Lit-BM-17:8069916;Lit-BM-17:8548810;Lit-BM-17:8702708;Lit-BM-17:8710854;Lit-BM-17:9162022;Lit-BM-17:9168896;Macrophage:8069916;Macrophage:8702708;NetPath:11112773;NetPath:15485837;NetPath:7544915], LTA [Baccin2019:2160731;Baccin2019:8123048;Baccin2019:9552007;CellTalkDB:9552007;Cellinker:2160731;Cellinker:8123048;Cellinker:9552007;DIP:1328224;HPRD:2160731;HPRD:8123048;HPRD:9552007;ICELLNET:7995952;LRdb:2160731;LRdb:8123048;LRdb:9552007;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:8182064;connectomeDB2020:2160731;connectomeDB2020:8123048;connectomeDB2020:9552007], TRAF1 [CancerCellMap:8548810;HPRD:8069916;InnateDB:18429822;InnateDB:9168896;Lit-BM-17:18429822;Lit-BM-17:7859281;Lit-BM-17:8069916;Lit-BM-17:9162022;Lit-BM-17:9168896], GRN [CellTalkDB:29740434;IntAct:24070898;Lit-BM-17:24070898;connectomeDB2020:21393509], OMG [Cellinker:14966521;HPMR:14966521;LRdb:14966521;connectomeDB2020:14966521], CDK1 [KEA:17570479], MAPK8 [KEA:17570479], CSNK1A1 [BioGRID:7559483;BioGRID:9109395;HPRD:7559483], TNFRSF1A [NetPath:15485837], BMX [HPRD:12370298;InnateDB:12370298]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tumor necrosis factor receptor superfamily complex [GO:0002947]; varicosity [GO:0043196]	tumor necrosis factor-activated receptor activity [GO:0005031]; tumor necrosis factor binding [GO:0043120]; ubiquitin protein ligase binding [GO:0031625]	aging [GO:0007568]; aortic valve development [GO:0003176]; cellular response to growth factor stimulus [GO:0071363]; cellular response to lipopolysaccharide [GO:0071222]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell-neuron signaling [GO:0150098]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell death [GO:0060548]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; pulmonary valve development [GO:0003177]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of myelination [GO:0031641]; regulation of neuroinflammatory response [GO:0150077]; regulation of RNA biosynthetic process [GO:2001141]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell proliferation [GO:0042129]; RNA destabilization [GO:0050779]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF1B&keywords=TNFRSF1B	2.009896297	306	NA	NA	0.05182996569	732	0.2283464567	0.003992015968	0.02433628319	0.01558752998	0.001683501684	0.005076142132	0.008159564823	0	0.001479837218	0.002670583522	0.003013328182	230	270	263	0.02675865849	0.3123029428	0.3446965706	0.3540207591	369	345	328	413
TNFRSF4	TNF receptor superfamily member 4	Yes	No		ENSG00000186827	P43489	NA	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P23510	TNFSF4	TNFSF4 [Baccin2019:12134113;CellTalkDB:12134113;Cellinker:12134113;DIP:16905106;DIP:8076595;HPMR:12134113;HPRD:12134113;ICELLNET:11239407;InnateDB:16905106;LRdb:12134113;Lit-BM-17:16905106;Lit-BM-17:8076595;SIGNOR:9488716;connectomeDB2020:12134113]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	tumor necrosis factor-activated receptor activity [GO:0005031]; virus receptor activity [GO:0001618]	immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immunoglobulin production [GO:0002639]; T cell proliferation [GO:0042098]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF4&keywords=TNFRSF4	0.2110811326	541	NA	NA	0.06123588223	710	0.02362204724	9.98E-04	0.5685840708	0.08057553957	0	0	0	0	7.40E-04	6.34E-04	8.11E-04	232	325	321	0.06145137495	0.1503108739	0.1488321756	0.1513096238	420	411	416	497
TSHR	thyroid stimulating hormone receptor	Yes	TBD	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000165409	P16473	G-protein coupled receptor 1 family, FSH/LSH/TSH subfamily	20	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O60674, O95467, P01185, P01189, P01215, P01222, P01225, P01229, P01258, P01270, P01275, P01282, P01286, P02751, P04090, P04899, P06850, P06881, P09681, P09683, P0C0P6, P10092, P10997, P12272, P18509, P23458, P27797, P35318, P51460, P63092, P84996, Q5JWF2, Q7Z4H4, Q86YW7, Q8WXF3, Q96A98, Q96T91	ADCYAP1, ADM, ADM2, AVP, CALCA, CALCB, CALR, CGA, CGA_TSHB, CRH, FN1, FSHB, GCG, GHRH, GIP, GNAI2, GNAS, GPHA2, GPHB5, IAPP, INSL3, JAK1, JAK2, LHB, NPS, POMC, PTH, PTH2, PTHLH, RLN2, RLN3, SCT, TSHB, VIP	CGA [HPMR:15571461;NetPath:20181794;SIGNOR:12045258], TSHB [Baccin2019:15571461;Baccin2019:2558651;CellTalkDB:15571461;Cellinker:15571461;Cellinker:2558651;HPMR:15571461;HPRD:2558651;LRdb:15571461;LRdb:26;NetPath:20181794;SIGNOR:12045258;connectomeDB2020:15571461;connectomeDB2020:2558651], GPHA2 [Baccin2019:12045258;CellTalkDB:12045258;Cellinker:12045258;LRdb:12045258;SIGNOR:12045258;connectomeDB2020:12045258], GNAS [Baccin2019:9525885;CellTalkDB:9525885;Cellinker:9525885;HPRD:9525885;LRdb:9525885;NetPath:17891229;connectomeDB2020:9525885], SCT [CellTalkDB:32196115], LHB [CellTalkDB:32196115], IAPP [CellTalkDB:32196115], PTH2 [CellTalkDB:32196115], CRH [CellTalkDB:32196115], PTH [CellTalkDB:32196115], GNAI2 [Baccin2019:8552586;CellTalkDB:8552586;Cellinker:8552586;HPRD:8552586;LRdb:8552586;NetPath:17891229;connectomeDB2020:8552586], CALR [Baccin2019:12383251;CellTalkDB:12383251;HPRD:12383251;LRdb:12383251;NetPath:12383251;connectomeDB2020:12383251], CALCA [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], FN1 [Baccin2019:11981027;CellTalkDB:11981027;Cellinker:11981027;HPRD:11981027;LRdb:11981027;connectomeDB2020:11981027], GIP [CellTalkDB:32196115], VIP [CellTalkDB:32196115], GNAS [Baccin2019:9525885;CellTalkDB:9525885;Cellinker:9525885;HPRD:9525885;LRdb:9525885;NetPath:17891229;connectomeDB2020:9525885], GNAS [Baccin2019:9525885;CellTalkDB:9525885;Cellinker:9525885;HPRD:9525885;LRdb:9525885;NetPath:17891229;connectomeDB2020:9525885], GNAS [Baccin2019:9525885;CellTalkDB:9525885;Cellinker:9525885;HPRD:9525885;LRdb:9525885;NetPath:17891229;connectomeDB2020:9525885], GHRH [CellTalkDB:32196115], INSL3 [CellTalkDB:32196115], AVP [CellTalkDB:32196115], RLN2 [CellTalkDB:32196115], ADM2 [CellTalkDB:32196115], NPS [CellTalkDB:32196115], POMC [CellTalkDB:32196115], GCG [CellTalkDB:32196115], RLN3 [CellTalkDB:32196115], FSHB [CellTalkDB:32196115], CALCB [CellTalkDB:32196115], ADM [CellTalkDB:32196115], PTHLH [CellTalkDB:32196115], ADCYAP1 [CellTalkDB:32196115], GPHB5 [connectomeDB2020:16210345], JAK1 [HPRD:10809230;NetPath:10809230], JAK2 [HPRD:10809230;NetPath:10809230]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	G protein-coupled peptide receptor activity [GO:0008528]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; thyroid-stimulating hormone receptor activity [GO:0004996]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; thyroid-stimulating hormone signaling pathway [GO:0038194]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TSHR&keywords=TSHR	0.4363592519	473	NA	NA	0.1159328212	623	0.0157480315	0.003992015968	0.006637168142	0.01007194245	0.01178451178	0.01184433164	0.009066183137	0.009787928222	0.01553829079	0.008178662038	0.01000579486	189	213	206	0.01024135096	1.261689046	0.898095294	0.9883626298	61	167	79	369
MST1R	macrophage stimulating 1 receptor	Yes	No	MST1 receptor	ENSG00000164078	Q04912	Protein kinase superfamily, Tyr protein kinase family	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60674, P06241, P08069, P08581, P26927, P31749, P62136, Q12891	AKT1, FYN, HYAL2, IGF1R, JAK2, MET, MST1, PPP1CA	MST1 [Baccin2019:8062829;Baccin2019:9045873;CellPhoneDB:23792360;CellTalkDB:8062829;Cellinker:8062829;Cellinker:9045873;DIP:9374547;HPMR:8062829;HPRD:9045873;IntAct:22087277;IntAct:25193665;LRdb:8062829;LRdb:905;Lit-BM-17:22087277;Lit-BM-17:25193665;Lit-BM-17:9374547;SIGNOR:8062829;SignaLink3:12764615;SignaLink3:23331499;connectomeDB2020:8062829;connectomeDB2020:9045873], AKT1 [CancerCellMap:12919677;HPRD:12919677;KEA:12919677;PhosphoSite:12919677;PhosphoSite:14505491;ProtMapper:12919677;ProtMapper:14505491;SIGNOR:14505491;SignaLink3:12919677;SignaLink3:23331499;iPTMnet:14505491], MET [Cellinker:28536399;PhosphoSite:10871856;PhosphoSite:11064459;PhosphoSite:18836480;PhosphoSite:20016000;PhosphoSite:20726546;PhosphoSite:24305878;PhosphoSite:24739671;ProtMapper:10871856], FYN [KEA:17570479], IGF1R [KEA:17570479], PPP1CA [InnateDB:14505491;KEA:12919677], HYAL2 [HPRD:12676986], JAK2 [HPRD:14982882]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MST1R&keywords=MST1R	3.499329054	259	NA	NA	0.7310914605	306	0	0.05638722555	0.00110619469	0	0.003367003367	0	0	0	7.40E-04	2.34E-04	2.70E-04	232	339	340	0.005645858651	0.6864384275	0.6540820984	0.6564310159	232	244	209	287
TYRO3	TYRO3 protein tyrosine kinase	Yes	Yes		ENSG00000092445	Q06418	Protein kinase superfamily, Tyr protein kinase family, AXL/UFO subfamily	20	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P06241, P07225, P12931, P15692, P43250, P49765, Q14393, Q8TDQ1	CD300LF, FYN, GAS6, GRK6, PROS1, SRC, VEGFA, VEGFB	GRK6 [SignaLink3:23331499;SignaLink3:8939948], GAS6 [Baccin2019:7867073;Baccin2019:8621659;Baccin2019:8939948;BioGRID:8621659;BioGRID:8939948;CellChatDB:27801848;CellTalkDB:7867073;Cellinker:27801848;Cellinker:7867073;Cellinker:8621659;Cellinker:8939948;Guide2Pharma:8939948;HPMR:7867073;HPRD:8621659;HPRD:8939948;InnateDB:8939948;LRdb:7867073;LRdb:8621659;LRdb:8939948;SIGNOR:7867073;connectomeDB2020:7867073;connectomeDB2020:8621659;connectomeDB2020:8939948;scConnect:8939948], PROS1 [CellChatDB:30501104;CellTalkDB:7867073;Cellinker:30501104;Cellinker:7867073;Cellinker:8641360;Guide2Pharma:7867073;HPRD:8641360;LRdb:7867073;LRdb:864;connectomeDB2020:7867073;connectomeDB2020:8641360;scConnect:7867073], VEGFA [CellTalkDB:32196115], VEGFB [NA], CD300LF [Cellinker:32822567], SRC [HPRD:7537495], FYN [HPRD:7537495]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]	apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron cellular homeostasis [GO:0070050]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TYRO3&keywords=TYRO3	3.902188199	247	NA	NA	0.3202146214	449	0	0.04091816367	0.005530973451	0.009352517986	0.03703703704	0.003384094755	0.009066183137	0	0.004069552349	0.004373080518	0.002627004056	223	243	272	0.01057805518	0.6837163292	0.6984664194	0.6136150354	235	233	230	293
ACVRL1	activin A receptor like type 1	Yes	Yes		ENSG00000139567	P37023	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15105, O95393, P01137, P10600, P12643, P12644, P18075, P22003, P22004, P27037, P34820, P36897, P62136, Q13145, Q13705, Q7Z5Y6, Q9UK05	ACVR2A, ACVR2B, BAMBI, BMP10, BMP2, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, GDF2, PPP1CA, SMAD7, TGFB1, TGFB3, TGFBR1	SMAD7 [SignaLink3:12023024;SignaLink3:23331499], TGFBR1 [HPRD:14580334;InnateDB:18333754;SignaLink3:14580334;SignaLink3:23331499], ACVR2B [SignaLink3:16446785;SignaLink3:23331499], BAMBI [SignaLink3:10519551;SignaLink3:23331499], PPP1CA [SignaLink3:16571110;SignaLink3:23331499], BMP10 [Baccin2019:17068149;CellTalkDB:17068149;LRdb:17068149;SIGNOR:17068149;connectomeDB2020:17068149], BMP2 [NA], BMP4 [NA], BMP5 [NA], BMP6 [NA], BMP7 [NA], BMP8A [NA], BMP8B [NA], GDF2 [Baccin2019:17068149;BioGRID:25237187;CellTalkDB:17068149;LRdb:17068149;SIGNOR:17068149;connectomeDB2020:17068149], TGFB1 [Baccin2019:1071699310716990;CellTalkDB:10716993;Cellinker:10716993;DIP:10187774;HPMR:10716993;HPRD:10716993;InnateDB:18333754;LRdb:10716993;NetPath:10716993;connectomeDB2020:10716993], TGFB3 [Baccin2019:1185063710187770;CellTalkDB:11850637;Cellinker:10187774;Cellinker:11850637;DIP:10187774;HPRD:10187774;LRdb:1;LRdb:11850637;connectomeDB2020:10187774;connectomeDB2020:11850637], ACVR2A [DIP:10187774;DIP:8612709;HPRD:10187774]	BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]	angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVRL1&keywords=ACVRL1	6.016341458	211	NA	NA	0.2827847556	468	0.0157480315	0.005489021956	0.4026548673	0.06474820144	0	0	0.003626473255	0.00163132137	7.40E-04	4.34E-04	0.001506664091	232	331	298	0.04514349721	0.1947631027	0.189214873	0.2086676521	403	395	388	351
BMPR1B	bone morphogenetic protein receptor type 1B	Yes	Yes		ENSG00000138696	O00238	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15105, O43541, O60383, O94921, O95390, O95393, O95747, O95972, P03971, P11802, P12643, P12644, P12645, P13497, P18075, P19883, P22003, P22004, P27539, P34820, P36894, P36897, P43026, P55107, P62987, Q01974, Q13145, Q13153, Q13253, Q13705, Q13873, Q16671, Q6KF10, Q6NW40, Q7Z4P5, Q7Z5Y6, Q8TDR2, Q96B86, Q9NR23, Q9UK05	ACVR2B, AMH, AMHR2, BAMBI, BMP1, BMP10, BMP15, BMP2, BMP3, BMP4, BMP5, BMP6, BMP7, BMP8A, BMP8B, BMPR1A, BMPR2, CDK14, CDK4, FST, GDF1, GDF10, GDF11, GDF2, GDF3, GDF5, GDF6, GDF7, GDF9, NOG, OXSR1, PAK1, RGMA, RGMB, ROR2, SMAD6, SMAD7, STK35, TGFBR1, UBA52	ROR2 [SignaLink3:15569154;SignaLink3:23331499], ACVR2B [SignaLink3:16446785;SignaLink3:23331499], BMPR2 [HPRD:10712517;SIGNOR:10712517;SIGNOR:18756288;SignaLink3:10712517;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:7791754], BAMBI [SignaLink3:10519551;SignaLink3:23331499], SMAD6 [HPRD:15761153;SignaLink3:10564272;SignaLink3:23331499], SMAD7 [HPRD:15761153;SignaLink3:10564272;SignaLink3:23331499], AMHR2 [HPRD:11420127;SIGNOR:14746809;SignaLink3:16446785;SignaLink3:23331499], AMH [Cellinker:11420127], BMP10 [CellTalkDB:15621726;Cellinker:31127068;LRdb:16049014;Ramilowski2015:16049014;connectomeDB2020:16049014;talklr:16049014], BMP2 [Baccin2019:12700180;Baccin2019:15064755;Baccin2019:7811286;Baccin2019:9872992;HPMR:12700180;HPRD:15064755;HPRD:7811286;HPRD:9872992;LRdb:12700180;LRdb:15064755;LRdb:7811286;LRdb:9872992;Lit-BM-17:10712517;Lit-BM-17:19229295;connectomeDB2020:12700180;connectomeDB2020:15064755;connectomeDB2020:7811286;connectomeDB2020:9872992], BMP4 [Baccin2019:11282024;Baccin2019:7811286;Baccin2019:8006002;Baccin2019:8702914;HPRD:11282024;HPRD:7811286;HPRD:8702914;LRdb:11282024;LRdb:7811286;LRdb:8006002;LRdb:8702914;connectomeDB2020:11282024;connectomeDB2020:7811286;connectomeDB2020:8006002;connectomeDB2020:8702914], BMP5 [NA], BMP6 [Baccin2019:10504300;Baccin2019:11401330;HPRD:10504300;HPRD:11401330;LRdb:10504300;LRdb:11;connectomeDB2020:10504300;connectomeDB2020:11401330], BMP7 [Baccin2019:106311828605097;CellTalkDB:15621726;HPRD:8605097;LRdb:10631182;LRdb:86;connectomeDB2020:10631182;connectomeDB2020:8605097], BMP8A [CellTalkDB:15621726], BMP8B [NA], GDF2 [NA], GDF1 [NA], GDF10 [NA], GDF3 [NA], GDF7 [NA], GDF9 [Baccin2019:12135884;CellTalkDB:12135884;Cellinker:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], BMPR1A [HPRD:10712517;SIGNOR:10712517], GDF5 [Baccin2019:11282024;Baccin2019:15569154;Baccin2019:8702914;CellTalkDB:11282024;HPMR:15569154;HPRD:11282024;IntAct:16127465;IntAct:19229295;LRdb:11282024;LRdb:15569154;LRdb:8702914;Lit-BM-17:19229295;Lit-BM-17:9525338;SIGNOR:15890363;connectomeDB2020:11282024;connectomeDB2020:15569154;connectomeDB2020:8702914], NOG [SIGNOR:22298955], BMP15 [Baccin2019:1204491412419820;CellTalkDB:15621726;HPRD:12419820;LRdb:12;LRdb:12044914;connectomeDB2020:12044914;connectomeDB2020:12419820], FST [CellTalkDB:32196115], GDF11 [CellTalkDB:32196115], BMP3 [Cellinker:13678778], GDF6 [Baccin2019:9525338;CellTalkDB:9525338;HPRD:9525338;LRdb:9525338;connectomeDB2020:9525338], BMP1 [CellTalkDB:15621726], RGMB [CellTalkDB:32196115], RGMA [CellTalkDB:32196115], UBA52 [HPRD:15761153], TGFBR1 [HPRD:11420127], CDK4 [HPRD:15761153], OXSR1 [HPRD:15761153], PAK1 [HPRD:15761153], CDK14 [HPRD:15761153], STK35 [HPRD:15761153]	HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]	BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; eye development [GO:0001654]; inflammatory response [GO:0006954]; negative regulation of chondrocyte proliferation [GO:1902731]; osteoblast differentiation [GO:0001649]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMPR1B&keywords=BMPR1B	1.947808198	310	NA	NA	0.5594969529	354	0	0.08682634731	0.00110619469	0.04340527578	0	0	0.002719854941	0.00163132137	7.40E-04	8.35E-04	0.001390766853	232	321	303	0.01260493063	0.4751139823	0.4793006238	0.5039062955	311	300	274	321
C3AR1	complement C3a receptor 1	Yes	No		ENSG00000171860	Q16581	G-protein coupled receptor 1 family	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01024, P0C0L4	C3, C4A	C3 [CellTalkDB:11342658;Cellinker:11342658;Cellinker:20527893;Guide2Pharma:20527893;Guide2Pharma:9476119;HPMR:11342658;HPRD:11342658;ICELLNET:8702752;LRdb:11342658;LRdb:21;SIGNOR:8765043;connectomeDB2020:11342658;connectomeDB2020:20527893;scConnect:20527893;scConnect:9476119], C4A [Baccin2019:9725198;CellChatDB:16234578;CellTalkDB:9725198;Cellinker:16234578;HPRD:9725198;LRdb:9725198;connectomeDB2020:9725198]	azurophil granule membrane [GO:0035577]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	complement component C3a receptor activity [GO:0004876]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]	blood circulation [GO:0008015]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular endothelial growth factor production [GO:0010575]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C3AR1&keywords=C3AR1	0.5781040272	444	NA	NA	0.07074579458	691	0.2440944882	0	0	0	0	0	0	0	0	0	0	234	346	347	0.02219040802	0.3106515455	0.3106515455	0.3106515455	370	357	348	460
CCR2	C-C motif chemokine receptor 2	Yes	TBD		ENSG00000121807	P41597	G-protein coupled receptor 1 family	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00175, O15467, O60674, P08253, P10147, P13500, P51671, P80075, P80098, P81534, Q1L6U9, Q8N104, Q99616, Q9NRR1, Q9Y258, Q9Y4X3	CCL11, CCL13, CCL16, CCL2, CCL24, CCL26, CCL27, CCL3, CCL7, CCL8, CYTL1, DEFB103A, DEFB106B, JAK2, MMP2, MSMP	CCL13 [Baccin2019:24890717;CellPhoneDB:24218476;Cellinker:12149192;Cellinker:12554737;Cellinker:9195948;Cellinker:9276730;DIP:9195948;Guide2Pharma:12554737;Guide2Pharma:9276730;HPRD:12149192;HPRD:9195948;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:12554737;connectomeDB2020:9195948;connectomeDB2020:9276730;scConnect:12554737;scConnect:9276730], CCL16 [CellPhoneDB:24218476;CellTalkDB:11470772;Cellinker:11470772;DIP:11470772;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11470772;connectomeDB2020:11470772], CCL2 [Baccin2019:10529171;Baccin2019:10770925;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9276730;Baccin2019:9287323;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:10529171;Cellinker:10770925;Cellinker:12554737;Cellinker:15207250;Cellinker:28389721;Cellinker:9276730;Cellinker:9287323;Cellinker:9346309;DIP:10488147;DIP:10770925;DIP:11470772;DIP:8530354;DIP:9115216;DIP:9169459;DIP:9312096;DIP:9336350;Guide2Pharma:10770925;Guide2Pharma:12554737;Guide2Pharma:15207250;Guide2Pharma:9276730;Guide2Pharma:9346309;HPMR:9287323;HPRD:10529171;HPRD:9287323;ICELLNET:22633458;InnateDB:10529171;InnateDB:11310855;InnateDB:15629146;InnateDB:7759884;InnateDB:8530354;InnateDB:9115216;InnateDB:9287323;InnateDB:9837883;LRdb:10699158;SIGNOR:20219869;connectomeDB2020:10529171;connectomeDB2020:10770925;connectomeDB2020:12554737;connectomeDB2020:15207250;connectomeDB2020:9276730;connectomeDB2020:9287323;connectomeDB2020:9346309;scConnect:10770925;scConnect:12554737;scConnect:15207250;scConnect:9276730;scConnect:9346309], CCL7 [Baccin2019:12554737;Baccin2019:8530354;Baccin2019:9276730;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:12554737;Cellinker:8530354;Cellinker:9276730;Cellinker:9346309;DIP:8530354;DIP:9195948;DIP:9312096;DIP:9336350;Guide2Pharma:12554737;Guide2Pharma:9276730;Guide2Pharma:9346309;HPRD:8530354;ICELLNET:22633458;InnateDB:7759884;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;connectomeDB2020:12554737;connectomeDB2020:8530354;connectomeDB2020:9276730;connectomeDB2020:9346309;scConnect:12554737;scConnect:9276730;scConnect:9346309], CCL8 [Baccin2019:10529171;Baccin2019:10770925;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9276730;Baccin2019:9287323;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:12149192;Cellinker:12554737;Cellinker:9115216;DIP:9115216;DIP:9195948;Guide2Pharma:12554737;HPRD:12149192;HPRD:9115216;ICELLNET:22633458;InnateDB:9115216;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:12554737;connectomeDB2020:9115216;scConnect:12554737], CCL11 [Baccin2019:11264152;Baccin2019:12149192;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9115216;Baccin2019:9195948;Baccin2019:9276730;CellTalkDB:12554737;Cellinker:11264152;Cellinker:12554737;Cellinker:15207250;Guide2Pharma:12554737;Guide2Pharma:15207250;HPRD:11264152;ICELLNET:22633458;InnateDB:11264152;LRdb:11264152;LRdb:12554737;LRdb:15207250;connectomeDB2020:11264152;connectomeDB2020:12554737;connectomeDB2020:15207250;scConnect:12554737;scConnect:15207250], CCL24 [Baccin2019:15207250;CellTalkDB:15207250;Cellinker:15207250;Guide2Pharma:15207250;LRdb:15207250;connectomeDB2020:15207250;scConnect:15207250], CCL26 [CellPhoneDB:24218476;Cellinker:15207250;Guide2Pharma:15207250;ICELLNET:22633458;InnateDB:12689946;LRdb:15207250;connectomeDB2020:15207250;scConnect:15207250], JAK2 [HPRD:9670957;KEA:9670957;PhosphoSite:9670957;ProtMapper:9670957;SIGNOR:9670957;iPTMnet:9670957;phosphoELM:9670957], CCL3 [SIGNOR:15075201], MMP2 [CellTalkDB:30132565], DEFB103A [CellTalkDB:23390582;InnateDB:20483750;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:23390582;talklr:23390582], DEFB106B [CellTalkDB:23938203;Cellinker:23938203;InnateDB:23938203;LRdb:23938203;connectomeDB2020:23938203], CCL27 [NA], CYTL1 [connectomeDB2020:27084102], MSMP [connectomeDB2020:28698550]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR2 chemokine receptor binding [GO:0031727]; chemokine (C-C motif) ligand 12 binding [GO:0035716]; chemokine (C-C motif) ligand 2 binding [GO:0035715]; chemokine (C-C motif) ligand 7 binding [GO:0035717]; chemokine receptor activity [GO:0004950]; identical protein binding [GO:0042802]	blood vessel remodeling [GO:0001974]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular homeostasis [GO:0019725]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to wounding [GO:0090594]; leukocyte adhesion to vascular endothelial cell [GO:0061756]; macrophage migration [GO:1905517]; monocyte chemotaxis [GO:0002548]; monocyte extravasation [GO:0035696]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of angiogenesis [GO:0016525]; negative regulation of eosinophil degranulation [GO:0043310]; negative regulation of type 2 immune response [GO:0002829]; neutrophil clearance [GO:0097350]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of astrocyte chemotaxis [GO:2000464]; positive regulation of CD8-positive, alpha-beta T cell extravasation [GO:2000451]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of immune complex clearance by monocytes and macrophages [GO:0090265]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of thymocyte migration [GO:2000412]; positive regulation of tumor necrosis factor production [GO:0032760]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of inflammatory response [GO:0050727]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell differentiation [GO:0045580]; regulation of vascular endothelial growth factor production [GO:0010574]; response to wounding [GO:0009611]; sensory perception of pain [GO:0019233]; T-helper 17 cell chemotaxis [GO:0035705]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR2&keywords=CCR2	0.02784752584	715	NA	NA	0.02904402994	794	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	755
CCR5	C-C motif chemokine receptor 5	Yes	No		ENSG00000160791	P51681	G-protein coupled receptor 1 family	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14625, O15467, O60674, P01730, P02763, P04899, P06239, P10147, P13236, P13500, P13501, P16619, P23458, P25098, P26447, P35626, P42681, P51671, P61073, P80075, P80098, Q05397, Q14005, Q14289, Q16570, Q16627, Q8NHW4, Q99616, Q9Y258	ACKR1, CCL11, CCL13, CCL14, CCL16, CCL2, CCL26, CCL3, CCL3L1, CCL4, CCL4L1, CCL5, CCL7, CCL8, CD4, CXCL11, CXCR4, GNAI2, GRK2, GRK3, IL16, JAK1, JAK2, LCK, ORM1, PTK2, PTK2B, S100A4, TXK	CCL3L1 [Baccin2019:10364178;Baccin2019:10477718;Baccin2019:11170631;Baccin2019:11700073;Baccin2019:11734558;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:9790730;BioGRID:11734558;CellTalkDB:10364178;Cellinker:10364178;Cellinker:11449371;Cellinker:11734558;HPRD:10364178;HPRD:11449371;HPRD:11734558;ICELLNET:22633458;LRdb:11;LRdb:11734558;SPIKE:11734558;connectomeDB2020:10364178;connectomeDB2020:11449371;connectomeDB2020:11734558], CCL5 [Baccin2019:10318947;Baccin2019:10477718;Baccin2019:11116158;Baccin2019:12964882;Baccin2019:14637022;Baccin2019:16298345;Baccin2019:8663314;Baccin2019:9289016;Baccin2019:9790730;BioGRID:14637022;CellPhoneDB:24218476;Cellinker:10318947;Cellinker:10477718;Cellinker:11116158;Cellinker:12964882;Cellinker:14637022;Cellinker:16298345;Cellinker:8663314;Cellinker:9289016;Cellinker:9790730;DIP:10477718;DIP:10488147;DIP:9207005;DIP:9334377;Guide2Pharma:10318947;Guide2Pharma:16298345;Guide2Pharma:9790730;HPRD:10477718;HPRD:11116158;HPRD:14637022;HPRD:8663314;HPRD:9289016;ICELLNET:22633458;InnateDB:10477718;InnateDB:12213786;IntAct:23480650;IntAct:28381538;LRdb:10699158;Lit-BM-17:10477718;Lit-BM-17:10488147;Lit-BM-17:11116158;Lit-BM-17:11449371;Lit-BM-17:14637022;Lit-BM-17:23480650;Lit-BM-17:9207005;Lit-BM-17:9334377;ProtMapper:25923671;SPIKE:10477718;connectomeDB2020:10318947;connectomeDB2020:10477718;connectomeDB2020:11116158;connectomeDB2020:12964882;connectomeDB2020:14637022;connectomeDB2020:16298345;connectomeDB2020:8663314;connectomeDB2020:9289016;connectomeDB2020:9790730;scConnect:10318947;scConnect:16298345;scConnect:9790730], CCL8 [Baccin2019:1629834510477710;CellPhoneDB:24218476;Cellinker:10477718;Cellinker:12964882;Cellinker:9468473;Cellinker:9790730;DIP:10477718;DIP:9468473;Guide2Pharma:9790730;HPRD:10477718;HPRD:9468473;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;SPIKE:10477718;connectomeDB2020:10477718;connectomeDB2020:12964882;connectomeDB2020:9468473;connectomeDB2020:9790730;scConnect:9790730], CCL4 [Baccin2019:12427015;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:8663314;Baccin2019:9790730;CellTalkDB:10699158;Cellinker:12427015;Cellinker:12964882;Cellinker:16298345;Cellinker:8663314;Cellinker:9790730;DIP:10477718;DIP:10498628;DIP:9334377;DIP:9468473;Guide2Pharma:16298345;Guide2Pharma:9790730;HPRD:12427015;HPRD:8663314;ICELLNET:22633458;InnateDB:10477718;InnateDB:12427015;InnateDB:16467191;LRdb:10699158;Lit-BM-17:10477718;Lit-BM-17:10498628;Lit-BM-17:23597562;Lit-BM-17:9334377;Lit-BM-17:9468473;SIGNOR:20219869;SPIKE:12427015;SPIKE:8663314;connectomeDB2020:12427015;connectomeDB2020:12964882;connectomeDB2020:16298345;connectomeDB2020:8663314;connectomeDB2020:9790730;scConnect:16298345;scConnect:9790730], GNAI2 [CellTalkDB:15251452;Cellinker:15251452;HPRD:15251452;LRdb:15251452;connectomeDB2020:15251452], CCL11 [Baccin2019:10477718;Baccin2019:11264152;Baccin2019:12964882;Baccin2019:9468473;Baccin2019:9790730;CellTalkDB:10699158;Cellinker:10477718;Cellinker:11264152;DIP:10477718;Guide2Pharma:10477718;HPRD:10477718;HPRD:11264152;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;connectomeDB2020:10477718;connectomeDB2020:11264152;scConnect:10477718], CCL13 [CellTalkDB:9790730;Cellinker:10477718;Cellinker:9790730;DIP:10477718;Guide2Pharma:9790730;HPRD:10477718;InnateDB:10477718;LRdb:105;LRdb:9790730;connectomeDB2020:10477718;connectomeDB2020:9790730;scConnect:9790730], CCL14 [CellTalkDB:11085751;Cellinker:11085751;Cellinker:12964882;Cellinker:16298345;Cellinker:20483925;Guide2Pharma:16298345;HPRD:11085751;ICELLNET:22633458;LRdb:11085751;LRdb:12964882;LRdb:16298345;connectomeDB2020:11085751;connectomeDB2020:12964882;connectomeDB2020:16298345;scConnect:16298345], CCL16 [CellTalkDB:11470772;Cellinker:11470772;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11470772;connectomeDB2020:11470772], CCL2 [Baccin2019:1629834510477710;CellTalkDB:16298345;Cellinker:10477718;Cellinker:16298345;DIP:10477718;Guide2Pharma:16298345;HPRD:10477718;InnateDB:10477718;LRdb:1;LRdb:16298345;connectomeDB2020:10477718;connectomeDB2020:16298345;scConnect:16298345], CCL3 [CellPhoneDB:15251452;Cellinker:10477718;Cellinker:11170631;Cellinker:11700073;Cellinker:12964882;Cellinker:16298345;Cellinker:9790730;DIP:10477718;DIP:9169459;DIP:9334377;DIP:9468473;Guide2Pharma:11170631;Guide2Pharma:16298345;Guide2Pharma:9790730;HPMR:12964882;HPRD:10477718;HPRD:11700073;ICELLNET:22633458;InnateDB:10477718;InnateDB:23765404;LRdb:10699158;SIGNOR:15075201;SIGNOR:20219869;connectomeDB2020:10477718;connectomeDB2020:11170631;connectomeDB2020:11700073;connectomeDB2020:12964882;connectomeDB2020:16298345;connectomeDB2020:9790730;scConnect:11170631;scConnect:16298345;scConnect:9790730], CCL7 [Baccin2019:10477710;Baccin2019:16298345;CellPhoneDB:24218476;Cellinker:10477718;Cellinker:16298345;DIP:10477718;Guide2Pharma:16298345;HPRD:10477718;ICELLNET:10477718;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;connectomeDB2020:10477718;connectomeDB2020:16298345;scConnect:16298345], GRK3 [HPRD:10085131;KEA:10085131;KEA:12403770;PhosphoSite:10085131;PhosphoSite:11782464;PhosphoSite:12065593;PhosphoSite:12403770;PhosphoSite:18753410;PhosphoSite:21148810;PhosphoSite:25923671;ProtMapper:10085131;SIGNOR:10085131;iPTMnet:10085131;phosphoELM:10085131;phosphoELM:12403770], CCL26 [Cellinker:29637711;ICELLNET:15039444;ICELLNET:22633458;InnateDB:15039444], CXCL11 [ICELLNET:15178708;ICELLNET:22633458], ORM1 [CellTalkDB:11336643;Cellinker:11336643;HPRD:11336643;LRdb:11336643;connectomeDB2020:11336643], S100A4 [CellTalkDB:30713770], IL16 [CellTalkDB:32196115], CCL4L1 [connectomeDB2020:15240137], CXCR4 [Cellinker:29637711;DIP:18632580;HPRD:12429730;InnateDB:18923649;InnateDB:19758998;IntAct:15660419;IntAct:18632580;Lit-BM-17:12429730;Lit-BM-17:15660419;Lit-BM-17:18632580], CD4 [Cellinker:29637711;HPRD:10816381;IntAct:10816381], ACKR1 [Cellinker:29637711], GRK2 [HPRD:10085131;dbPTM:10085131], TXK [HPRD:11859127], PTK2 [HPRD:10384144], PTK2B [HPRD:9446638], JAK1 [HPRD:10037796], JAK2 [HPRD:11591716], LCK [HPRD:11591716]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine receptor activity [GO:0004950]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; phosphatidylinositol phospholipase C activity [GO:0004435]; virus receptor activity [GO:0001618]	calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of macrophage apoptotic process [GO:2000110]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723]; signaling [GO:0023052]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR5&keywords=CCR5	0.02531399056	724	NA	NA	0.03605942856	772	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	748
CCRL2	C-C motif chemokine receptor like 2	Yes	Yes		ENSG00000121797	O00421	G-protein coupled receptor 1 family	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P13501, Q99731, Q99969	CCL19, CCL5, RARRES2	CCL19 [Baccin2019:20002784;CellTalkDB:20002784;Cellinker:20002784;Guide2Pharma:20002784;ICELLNET:22633458;InnateDB:20002784;LRdb:20002784;connectomeDB2020:20002784;scConnect:20002784], RARRES2 [Baccin2019:24671882;CellTalkDB:18794339;Cellinker:18794339;LRdb:18794339;Ramilowski2015:18794339;connectomeDB2020:18794339;talklr:18794339], CCL5 [NA]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCRL2&keywords=CCRL2	1.934325242	312	NA	NA	1.132994057	211	0.07086614173	4.99E-04	0.01659292035	0.005035971223	0.01515151515	0.001692047377	0.001813236627	0	0	0	0.001004442727	234	346	313	0.01024138884	0.4940372462	0.4940372462	0.5436604581	308	297	253	292
CNTFR	ciliary neurotrophic factor receptor	Yes	TBD		ENSG00000122756	P26992	Type I cytokine receptor family, Type 3 subfamily	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14931, O75462, P26441, Q92673, Q9BQ66, Q9UBD9	CLCF1, CLCF1_CRLF1, CNTF, CRLF1, KRTAP4-12, NCR3, SORL1	CNTF [Baccin2019:10812968;Baccin2019:7810882;Baccin2019:8627290;CellTalkDB:8627290;DIP:7539796;HPMR:10966616;HPRD:10812968;HPRD:7810882;HPRD:8627290;IntAct:18775332;IntAct:20584990;LRdb:10812968;LRdb:7810882;LRdb:8627290;Lit-BM-17:18775332;Lit-BM-17:7539796;Lit-BM-17:7810882;SIGNOR:10812968;SIGNOR:10966616;SignaLink3:10812968;SignaLink3:23331499;SignaLink3:7810882;SignaLink3:8081242;SignaLink3:8627290;connectomeDB2020:10812968;connectomeDB2020:7810882;connectomeDB2020:8627290], CLCF1 [CellTalkDB:10966616;HPMR:10966616;HPRD:10966616;HPRD:11285233;HPRD:11294841;LRdb:10966616;LRdb:11285233;LRdb:11294841;SIGNOR:10966616;connectomeDB2020:10966616;connectomeDB2020:11285233;connectomeDB2020:11294841], CRLF1 [HPRD:10966616;connectomeDB2020:23355913], KRTAP4-12 [Cellinker:16189514;HPRD:16189514;LRdb:16189514], SORL1 [Cellinker:26858303;IntAct:26858303], NCR3 [Cellinker:32822567]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102]	brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CNTFR&keywords=CNTFR	0.1652607594	566	NA	NA	0.005650804503	864	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	715
CRHR2	corticotropin releasing hormone receptor 2	Yes	No		ENSG00000106113	Q13324	G-protein coupled receptor 2 family	19	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P06850, P55089, Q969E3, Q96RP3	CRH, UCN, UCN2, UCN3	CRH [CellTalkDB:11123370;Cellinker:11123370;Cellinker:8243338;Cellinker:8536644;Guide2Pharma:11123370;HPMR:8536644;HPRD:8243338;LRdb:11123370;LRdb:8243338;LRdb:8536644;connectomeDB2020:11123370;connectomeDB2020:8243338;connectomeDB2020:8536644;scConnect:11123370], UCN [Baccin2019:10816663;Baccin2019:11123370;Baccin2019:11416224;Baccin2019:15450949;Baccin2019:8612563;Baccin2019:9423932;CellTalkDB:15450949;Cellinker:10816663;Cellinker:11123370;Cellinker:11416224;Cellinker:15450949;Cellinker:8612563;Cellinker:9423932;Guide2Pharma:11123370;Guide2Pharma:15450949;HPRD:11416224;HPRD:8612563;HPRD:9423932;LRdb:10816663;LRdb:11123370;LRdb:11416224;LRdb:15450949;LRdb:8612563;LRdb:9423932;connectomeDB2020:10816663;connectomeDB2020:11123370;connectomeDB2020:11416224;connectomeDB2020:15450949;connectomeDB2020:8612563;connectomeDB2020:9423932;scConnect:11123370;scConnect:15450949], UCN2 [Baccin2019:11226328;Baccin2019:11329063;Baccin2019:11416224;Baccin2019:15450949;CellTalkDB:11329063;Cellinker:11226328;Cellinker:11329063;Cellinker:11416224;Cellinker:15450949;Guide2Pharma:15450949;HPRD:11226328;HPRD:11416224;LRdb:11226328;LRdb:11329063;LRdb:11416224;LRdb:15450949;connectomeDB2020:11226328;connectomeDB2020:11329063;connectomeDB2020:11416224;connectomeDB2020:15450949;scConnect:15450949], UCN3 [Baccin2019:11329063;Baccin2019:11416224;Baccin2019:15450949;CellTalkDB:11329063;Cellinker:11329063;Cellinker:11416224;Cellinker:15450949;Guide2Pharma:15450949;HPRD:11329063;HPRD:11416224;LRdb:11329063;LRdb:11416224;LRdb:15450949;connectomeDB2020:11329063;connectomeDB2020:11416224;connectomeDB2020:15450949;scConnect:15450949]	axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRHR2&keywords=CRHR2	0.3510459613	490	NA	NA	0.4793482431	377	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	434
CSF2RA	colony stimulating factor 2 receptor subunit alpha	Yes	No		ENSG00000198223	P15509	Type I cytokine receptor family, Type 5 subfamily	19	ligand, receptor	cell_surface, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O14920, O15111, O60674, P04141, P05113, P07948, P08700, P09603, P09919, P10721, P49715, Q01196	CEBPA, CHUK, CSF1, CSF2, CSF3, IKBKB, IL3, IL5, JAK2, KIT, LYN, RUNX1	CEBPA [SPIKE:15676205], RUNX1 [SPIKE:15676205], CSF2 [Baccin2019:10572088;Baccin2019:1702217;Baccin2019:2828352;Baccin2019:8910448;Baccin2019:9211889;CellTalkDB:2828352;DIP:2555171;DIP:27396825;DIP:7957082;HPMR:10753826;HPMR:2828352;HPRD:10572088;HPRD:1702217;HPRD:8910448;HPRD:9211889;InnateDB:10572088;LRdb:10572088;LRdb:1702217;LRdb:2828352;LRdb:8910448;LRdb:9211889;Lit-BM-17:18692472;Lit-BM-17:2555171;Lit-BM-17:7957082;SIGNOR:10572088;SIGNOR:18551128;SIGNOR:9187659;SPIKE:10572088;SPIKE:2645577;SignaLink3:10572088;SignaLink3:11015446;SignaLink3:11306493;SignaLink3:11777960;SignaLink3:11867689;SignaLink3:12393492;SignaLink3:12811837;SignaLink3:14610620;SignaLink3:19833085;SignaLink3:20406969;SignaLink3:20805416;SignaLink3:21765015;SignaLink3:22323450;SignaLink3:22869907;SignaLink3:23046136;SignaLink3:23331499;SignaLink3:24030977;SignaLink3:24091328;SignaLink3:26192618;SignaLink3:27216177;connectomeDB2020:10572088;connectomeDB2020:1702217;connectomeDB2020:2828352;connectomeDB2020:8910448;connectomeDB2020:9211889], JAK2 [SIGNOR:8977526], CSF1 [SIGNOR:10572088;SignaLink3:10572088;SignaLink3:23331499], CSF3 [SIGNOR:10572088;SignaLink3:10572088;SignaLink3:23331499], IL5 [Cellinker:23046136], IL3 [Cellinker:23046136], IKBKB [HPRD:12637324;InnateDB:12637324;InnateDB:17952117;Lit-BM-17:12637324;Lit-BM-17:25241761], CHUK [HPRD:12637324;InnateDB:12637324], LYN [HPRD:8943427], KIT [HPRD:16760463]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023]	cytokine-mediated signaling pathway [GO:0019221]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF2RA&keywords=CSF2RA	1.653526149	321	NA	NA	0.5460510333	356	0.6692913386	0.002994011976	0.003318584071	0.002637889688	0	0.006768189509	0.004533091568	0.00163132137	0.004439511654	0.003905728402	0.004674521924	221	250	245	0.06401765352	0.1950819969	0.1878704301	0.1982570539	402	396	394	331
EPHA2	EPH receptor A2	Yes	Yes		ENSG00000142627	P29317	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	19	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, tight_junction, transmembrane	O43921, P00533, P04637, P12931, P17252, P20827, P22681, P24666, P31749, P52797, P52798, P52803, Q03135, Q05397, Q13239	ACP1, AKT1, CAV1, CBL, EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, EGFR, PRKCA, PTK2, SLA, SRC, TP53	TP53 [SPIKE:18431400], EFNA2 [Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;HPRD:8755474;LRdb:11114742;SIGNOR:10072375;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9267020;connectomeDB2020:8755474], EFNA1 [Baccin2019:11248553;Baccin2019:14692877;Baccin2019:7973638;Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11248553;Cellinker:14692877;Cellinker:15114347;Cellinker:7973638;Cellinker:8755474;DIP:20505120;DIP:22244754;DIP:8139691;DOMINO:19525919;HPMR:11248553;HPRD:14692877;HPRD:7973638;HPRD:8755474;IntAct:19525919;IntAct:19573808;IntAct:20505120;LRdb:11114742;Lit-BM-17:19525919;Lit-BM-17:19573808;Lit-BM-17:8139691;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:14692877;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:7973638;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:11248553;connectomeDB2020:14692877;connectomeDB2020:7973638;connectomeDB2020:8755474], ACP1 [HPRD:12167657;ProtMapper:21538645;SIGNOR:21538645;SignaLink3:12167657;SignaLink3:23331499], EFNA4 [Baccin2019:10607706;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10607706;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:10607706;HPRD:8755474;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:8755474;connectomeDB2020:9330863], SRC [ProtMapper:24457997;ProtMapper:26788993;ProtMapper:28957431;SIGNOR:24457997;iPTMnet:24457997], EFNA5 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9245480;Cellinker:9330863;DIP:20228801;DIP:20505120;HPRD:9245480;ICELLNET:9530499;IntAct:20228801;IntAct:20505120;LRdb:11114742;ProtMapper:22570727;SIGNOR:9330863;connectomeDB2020:9245480;connectomeDB2020:9330863], EFNA3 [Baccin2019:933086312907451;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:12907451;Cellinker:15114347;Cellinker:9330863;HPRD:12907451;LRdb:11114742;SIGNOR:9330863;connectomeDB2020:12907451;connectomeDB2020:9330863], SLA [HPRD:7543898;Lit-BM-17:24457997;Lit-BM-17:7543898;SIGNOR:24457997], CAV1 [Cellinker:23951165], PTK2 [Cellinker:19948216;HPRD:10655584], EGFR [HPRD:15657067], PRKCA [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;PhosphoSite:32413552], AKT1 [PhosphoSite:25908849;PhosphoSite:26158630;PhosphoSite:33907562;PhosphoSite:34006609;PhosphoSite:34018641;PhosphoSite:34445353;ProtMapper:29048432;dbPTM:17192257;dbPTM:18691976;dbPTM:19369195;dbPTM:19573808], CBL [ACSN:10514377;ACSN:17635922;BioGRID:12147253;BioGRID:22509030;BioGRID:23874206;HPRD:12496371]	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]	activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA2&keywords=EPHA2	7.324790648	190	709.408	80	0.3568789025	422	0	0.3143712575	0.05752212389	0.01247002398	0.05723905724	0.01184433164	0.003626473255	0	0.01997780244	0.00206970223	0.003708711609	181	280	253	0.04389358943	0.5562405985	0.223954321	0.2543662753	283	383	372	271
EPHA3	EPH receptor A3	Yes	No		ENSG00000044524	P29320	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	19	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14672, O43921, P06239, P18031, P20827, P52797, P52798, P52799, P52803, P98172, Q15768	ADAM10, EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, EFNB1, EFNB2, EFNB3, LCK, PTPN1	EFNA1 [Baccin2019:93308638070404;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8070404;Cellinker:9330863;HPRD:8070404;LRdb:11114742;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8070404;SignaLink3:9195962;SignaLink3:9576626;connectomeDB2020:8070404;connectomeDB2020:9330863], EFNA5 [Baccin2019:9195962;Baccin2019:9245480;Baccin2019:9330863;Baccin2019:9751130;BioGRID:9245480;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9195962;Cellinker:9245480;Cellinker:9330863;Cellinker:9751130;HPMR:9330863;HPRD:9195962;HPRD:9245480;HPRD:9751130;ICELLNET:9530499;LRdb:11114742;SIGNOR:9330863;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9195962;SignaLink3:9245480;SignaLink3:9576626;SignaLink3:9751130;connectomeDB2020:9195962;connectomeDB2020:9245480;connectomeDB2020:9330863;connectomeDB2020:9751130], EFNA3 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9195962;SignaLink3:9267020;connectomeDB2020:9330863], EFNA4 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;ICELLNET:9530499;LRdb:11114742;Ramilowski2015:8755474;SignaLink3:23331499;SignaLink3:9195962;SignaLink3:9576626;connectomeDB2020:8755474;talklr:8755474], EFNB2 [Baccin2019:8559144;BioGRID:8559144;CellTalkDB:8559144;Cellinker:32589946;HPRD:8559144;LRdb:8559144;SignaLink3:23331499;SignaLink3:8559144;SignaLink3:9195962;connectomeDB2020:8559144], PTPN1 [DEPOD:21135139;ProtMapper:21135139;SIGNOR:21135139], EFNA2 [Baccin2019:93308639751130;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;Cellinker:9751130;HPRD:9751130;LRdb:11114742;connectomeDB2020:9330863;connectomeDB2020:9751130], ADAM10 [Baccin2019:16239146;CellTalkDB:16239146;HPRD:16239146;LRdb:16239146;connectomeDB2020:16239146], EFNB3 [Cellinker:32589946], EFNB1 [Cellinker:32589946], LCK [KEA:17570479]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; negative regulation of endocytosis [GO:0045806]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA3&keywords=EPHA3	1.44030938	342	NA	NA	0.3888946585	408	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	375
EPHA5	EPH receptor A5	Yes	TBD		ENSG00000145242	P54756	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	19	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43921, P20827, P52797, P52798, P52803	EFNA1, EFNA2, EFNA3, EFNA4, EFNA5	EFNA5 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10531456;Cellinker:15114347;Cellinker:9330863;HPMR:9330863;HPRD:10531456;LRdb:11114742;SIGNOR:9330863;SignaLink3:10531456;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9267020;connectomeDB2020:10531456;connectomeDB2020:9330863], EFNA1 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EFNA2 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10531456;Cellinker:15114347;Cellinker:9330863;HPRD:10531456;LRdb:11114742;SIGNOR:10072375;SignaLink3:10531456;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10531456;connectomeDB2020:9330863], EFNA3 [Baccin2019:933086310516308;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10516308;Cellinker:15114347;Cellinker:9330863;HPRD:10516308;LRdb:11114742;SIGNOR:9330863;SignaLink3:10516308;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10516308;connectomeDB2020:9330863], EFNA4 [Baccin2019:10607706;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10607706;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:10607706;HPRD:8755474;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:8755474;connectomeDB2020:9330863]	axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA5&keywords=EPHA5	0.1500304068	574	NA	NA	0.2635840508	474	0	4.99E-04	0	0.001438848921	0	0.001692047377	0.003626473255	0.01468189233	3.70E-04	0.003271464815	0.002395209581	233	257	277	0.002543172507	0.8267413446	1.058062847	0.9882037079	182	109	80	354
EPHA7	EPH receptor A7	Yes	No		ENSG00000135333	Q15375	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	19	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43921, P20827, P41221, P52797, P52798, P52803, P55196	AFDN, EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, WNT5A	EFNA5 [Baccin2019:10366629;BioGRID:10366629;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10366629;Cellinker:15114347;HPRD:10366629;ICELLNET:9530499;LRdb:11114742;SignaLink3:10366629;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10366629], EFNA1 [Baccin2019:93308638755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPMR:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EFNA2 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNA3 [Baccin2019:933086310366629;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10366629;Cellinker:15114347;Cellinker:9330863;HPRD:10366629;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10366629;connectomeDB2020:9330863], EFNA4 [Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;HPRD:8755474;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474], AFDN [CellTalkDB:9707552;Cellinker:11544254;Cellinker:9707552;DOMINO:9707552;HPRD:9707552;LRdb:9707552;connectomeDB2020:9707552], WNT5A [CellTalkDB:32103204]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA7&keywords=EPHA7	0.0839754117	633	NA	NA	0.02059501218	821	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	727
EPHB1	EPH receptor B1	Yes	No		ENSG00000154928	P54762	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	19	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P20827, P52797, P52799, P52803, P98172, Q15768	EFNA1, EFNA3, EFNA5, EFNB1, EFNB2, EFNB3	EFNB1 [Baccin2019:10669731;Baccin2019:11713248;Baccin2019:12223469;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10669731;Cellinker:11713248;Cellinker:12223469;Cellinker:15114347;Cellinker:9330863;HPMR:11713248;HPRD:10669731;HPRD:12223469;ICELLNET:9530499;LRdb:11114742;SIGNOR:11713248;SignaLink3:23331499;SignaLink3:9267020;connectomeDB2020:10669731;connectomeDB2020:11713248;connectomeDB2020:12223469;connectomeDB2020:9330863], EFNB2 [Baccin2019:10066262;Baccin2019:8559144;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:10066262;Cellinker:15114347;Cellinker:8559144;Cellinker:9330863;HPMR:9330863;HPRD:10066262;HPRD:8559144;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10066262;connectomeDB2020:8559144;connectomeDB2020:9330863], EFNB3 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347], EFNA5 [CellTalkDB:9245480;HPRD:9245480;LRdb:9245480;connectomeDB2020:9245480], EFNA1 [CellTalkDB:8755474;HPRD:7973638;HPRD:8070404;HPRD:8755474;LRdb:7973638;LRdb:8070404;LRdb:8755474], EFNA3 [Baccin2019:9330863;CellTalkDB:9330863;LRdb:9330863;connectomeDB2020:9330863]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHB1&keywords=EPHB1	0.4662368746	463	NA	NA	0.1438052225	581	0	0.01946107784	0.004424778761	0.02350119904	0	0	0	0	0	7.01E-04	4.25E-04	234	324	334	0.004410276396	0.6939492155	0.7425970107	0.7234390411	228	216	189	396
FGFR2	fibroblast growth factor receptor 2	Yes	Yes		ENSG00000066468	P21802	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	19	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15520, O43320, O60258, O76093, O95750, O96013, P01033, P02776, P05230, P08620, P09038, P0CG47, P0CG48, P10767, P11362, P11487, P12034, P12931, P13591, P21781, P27361, P28482, P29279, P31371, P32004, P51452, P54764, P55075, P60484, P61328, P62979, P62987, Q02156, Q13443, Q92913, Q92914, Q92915, Q9GZV9, Q9HCT0, Q9NP95, Q9NSA1	ADAM9, CCN2, DUSP3, EPHA4, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, L1CAM, MAPK1, MAPK3, NCAM1, PAK4, PF4, PRKCE, PTEN, RPS27A, SRC, TIMP1, UBA52, UBB, UBC	FGF1 [Baccin2019:10618369;Baccin2019:11069186;Baccin2019:14732692;BioGRID:10618369;CellTalkDB:16597617;Cellinker:10618369;Cellinker:11069186;Cellinker:14732692;Cellinker:25772309;DIP:10339576;DIP:10618369;DIP:11069186;DIP:8663044;HPRD:10618369;HPRD:11069186;HPRD:14732692;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:10618369;Lit-BM-17:11069186;Lit-BM-17:11714710;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:8576175;Lit-BM-17:8663044;SIGNOR:10618369;SignaLink3:10618369;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8576175;connectomeDB2020:10618369;connectomeDB2020:11069186;connectomeDB2020:14732692], FGF2 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8663044;HPMR:8663044;IntAct:10830168;IntAct:11390973;LRdb:16597617;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11390973;Lit-BM-17:17981115;Lit-BM-17:26267536;ProtMapper:18332103;SIGNOR:11390973;SIGNOR:7687739;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:8663044], FGF3 [Baccin2019:75926248663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:7592624;Cellinker:8663044;DIP:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:7592624;connectomeDB2020:8663044], FGF4 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:11486033;connectomeDB2020:8663044], FGF7 [Baccin2019:125919597687739;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;Cellinker:27192911;Cellinker:7687739;DIP:10339576;DIP:10950949;DIP:11121055;DIP:8663044;HPRD:7687739;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11714710;Lit-BM-17:1309608;Lit-BM-17:8663044;Lit-BM-17:9582367;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8663044;SignaLink3:9582367;connectomeDB2020:12591959;connectomeDB2020:7687739], FGF8 [Baccin2019:10751172;Baccin2019:8663044;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;Cellinker:8663044;HPRD:10751172;HPRD:8663044;LRdb:16597617;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172;connectomeDB2020:8663044], FGF10 [Baccin2019:12591959;Baccin2019:9582367;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;Cellinker:9582367;HPRD:9582367;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:12591959;Lit-BM-17:25241761;Lit-BM-17:9582367;SIGNOR:8663044;SIGNOR:9582367;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8663044;SignaLink3:9582367;connectomeDB2020:12591959;connectomeDB2020:9582367], FGF6 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:8663044], FGF17 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172], FGF18 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172], FGF22 [Baccin2019:12591959;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:12591959], PTEN [ACSN:10648629;ACSN:12040186;ACSN:15584861;ACSN:16288286;ACSN:17218262;SIGNOR:22891331], FGF5 [Baccin2019:838682811876253;CellTalkDB:16597617;Cellinker:11876253;Cellinker:16597617;Cellinker:25772309;Cellinker:8386828;HPRD:11876253;LRdb:16597617;SIGNOR:8386828;connectomeDB2020:11876253;connectomeDB2020:8386828], PRKCE [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;ProtMapper:23564461;SIGNOR:23564461;iPTMnet:23564461], ADAM9 [SIGNOR:22632802], FGF20 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16597617], TIMP1 [CellTalkDB:32103204], FGF23 [Baccin2019:1608163512032140;CellTalkDB:16597617;Cellinker:12032146;Cellinker:16081635;HPRD:12032146;LRdb:16597617;connectomeDB2020:12032146;connectomeDB2020:16081635], FGF11 [CellTalkDB:16597617;LRdb:16597617], FGF19 [CellTalkDB:16597617;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], PF4 [Baccin2019:9558385;CellTalkDB:9558385;Cellinker:9558385;LRdb:9558385;connectomeDB2020:9558385], FGF13 [CellTalkDB:16597617;LRdb:16597617], L1CAM [CellTalkDB:32196115], FGF14 [CellTalkDB:16597617;LRdb:16597617], FGF9 [Baccin2019:86630448576175;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8576175;Cellinker:8663044;HPRD:8576175;LRdb:16597617;connectomeDB2020:8576175;connectomeDB2020:8663044], FGF16 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGF21 [CellTalkDB:16597617;LRdb:16597617], NCAM1 [Baccin2019:21710437;CellTalkDB:12121226], FGF12 [CellTalkDB:16597617;LRdb:16597617], CCN2 [Baccin2019:23142580;connectomeDB2020:23142580], FGFR1 [KEA:17570479], EPHA4 [HPRD:16365308], MAPK1 [NA], RPS27A [NA], UBA52 [NA], UBB [NA], UBC [NA], MAPK3 [PhosphoSite:31146385], DUSP3 [DEPOD:1281549], SRC [InnateDB:18840094], PAK4 [HPRD:12529371]	cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smooth muscle cell differentiation [GO:0051150]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR2&keywords=FGFR2	6.892304517	196	NA	NA	0.4050221586	401	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	299
FGFR3	fibroblast growth factor receptor 3	Yes	No		ENSG00000068078	P22607	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	19	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15520, O43320, O60258, O76093, O95750, P05230, P07900, P08069, P08620, P09038, P10767, P11487, P12034, P21709, P21781, P21810, P29317, P29320, P31371, P54756, P54764, P55075, P60484, P61328, Q15375, Q92913, Q92914, Q92915, Q9GZV9, Q9NP60, Q9NP95, Q9NSA1	BGN, EPHA1, EPHA2, EPHA3, EPHA4, EPHA5, EPHA7, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, HSP90AA1, IGF1R, IL1RAPL2, PTEN	FGF9 [Baccin2019:10574949;Baccin2019:15231666;Baccin2019:8576175;CellTalkDB:16597617;Cellinker:10574949;Cellinker:15231666;Cellinker:16597617;Cellinker:25772309;Cellinker:8576175;HPRD:10574949;HPRD:8576175;LRdb:16597617;SignaLink3:10574949;SignaLink3:23331499;SignaLink3:8576175;SignaLink3:8663044;connectomeDB2020:10574949;connectomeDB2020:15231666;connectomeDB2020:8576175], FGF1 [Baccin2019:10574949;Baccin2019:14732692;CellTalkDB:16597617;Cellinker:10574949;Cellinker:14732692;Cellinker:25772309;DIP:22244757;DIP:9045692;HPRD:10574949;HPRD:14732692;LRdb:16597617;Lit-BM-17:10574949;Lit-BM-17:14732692;Lit-BM-17:8576175;Lit-BM-17:9045692;SIGNOR:22298955;connectomeDB2020:10574949;connectomeDB2020:14732692], FGF2 [Baccin2019:866304410574949;CellTalkDB:16597617;Cellinker:10574949;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPMR:8663044;HPRD:10574949;LRdb:16597617;SIGNOR:15780951;SIGNOR:22298955;connectomeDB2020:10574949;connectomeDB2020:8663044], PTEN [ACSN:10648629;ACSN:12040186;ACSN:15584861;ACSN:16288286;ACSN:17218262;SIGNOR:22891331], FGF4 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:16597617;connectomeDB2020:11486033;connectomeDB2020:8663044], FGF20 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16597617], FGF6 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGF23 [Baccin2019:12032146;CellTalkDB:16597617;Cellinker:12032146;Cellinker:25772309;HPRD:12032146;LRdb:16597617;connectomeDB2020:12032146], FGF7 [CellTalkDB:8663044;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], FGF18 [Baccin2019:1578147310751170;CellTalkDB:16597617;Cellinker:10751172;Cellinker:15781473;Cellinker:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172;connectomeDB2020:15781473], FGF11 [CellTalkDB:16597617;LRdb:16597617], FGF19 [CellTalkDB:16597617;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGF5 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGF8 [Baccin2019:10574949;Baccin2019:11486033;Baccin2019:8663044;CellTalkDB:16597617;Cellinker:10574949;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:22244757;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949;connectomeDB2020:11486033;connectomeDB2020:8663044], FGF13 [CellTalkDB:16597617;LRdb:16597617], FGF3 [Baccin2019:8663044;CellTalkDB:8663044;Cellinker:8663044;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], HSP90AA1 [CellTalkDB:21487019;Cellinker:21487019;LRdb:21487019;Ramilowski2015:21487019;connectomeDB2020:21487019;talklr:21487019], FGF21 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617], FGF14 [CellTalkDB:16597617;LRdb:16597617], FGF17 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGF16 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGF12 [CellTalkDB:16597617;LRdb:16597617], BGN [connectomeDB2020:25260943], FGF10 [NA], EPHA5 [Cellinker:26024354], EPHA7 [Cellinker:26024354], EPHA4 [Cellinker:16365308;HPRD:16365308], EPHA3 [Cellinker:26024354], EPHA2 [Cellinker:26024354], IL1RAPL2 [Cellinker:32822567], EPHA1 [Cellinker:26024354], IGF1R [KEA:17570479]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR3&keywords=FGFR3	0.5149291003	456	NA	NA	0.01161122756	845	0	0.03193612774	0	0	0.001683501684	0.001692047377	9.07E-04	0.00163132137	0	3.00E-04	3.86E-05	234	336	346	0.00347169905	0.7422968672	0.7645984822	0.745164539	211	209	177	462
FZD10	frizzled class receptor 10	Yes	No		ENSG00000111432	Q9ULW2	G-protein coupled receptor Fz/Smo family	19	adhesion, receptor	adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00755, O14904, O14905, O96014, P04628, P41221, P56704, P56706, Q99972, Q9H1J7	MYOC, WNT1, WNT11, WNT3A, WNT5A, WNT5B, WNT7A, WNT7B, WNT9A, WNT9B	WNT7B [Baccin2019:15923619;CellPhoneDB:24032637;HPMR:15923619;LRdb:15923619;NetPath:15923619;SIGNOR:15923619;connectomeDB2020:15923619], WNT7A [LRdb:18567805;NetPath:18567805;Ramilowski2015:18567805;connectomeDB2020:12857724;connectomeDB2020:18567805;talklr:18567805], WNT5A [NA], WNT5B [NA], WNT11 [NA], MYOC [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], WNT1 [connectomeDB2020:24599775], WNT3A [connectomeDB2020:24599775], WNT9A [connectomeDB2020:28733458], WNT9B [connectomeDB2020:28733458]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD10&keywords=FZD10	0.2639891764	517	NA	NA	0.1403230547	585	0	0.00748502994	0	0.07793764988	0	0	0	0	0	1.67E-04	3.86E-05	234	341	346	0.007784383973	0.5622910535	0.5716763361	0.5644633195	280	273	248	429
FZD2	frizzled class receptor 2	Yes	TBD		ENSG00000180340	Q14332	G-protein coupled receptor Fz/Smo family	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00744, O96014, P04628, P09544, P41221, P56704, P56705, Q01974, Q68DV7, Q8N474, Q9H1J7, Q9UBV4, Q9ULT6	RNF43, ROR2, SFRP1, WNT1, WNT10B, WNT11, WNT16, WNT2, WNT3A, WNT4, WNT5A, WNT5B, ZNRF3	WNT5A [Baccin2019:9389482;CellPhoneDB:24032637;CellTalkDB:24032637;Cellinker:9389482;LRdb:9389482;NetPath:19910923;SIGNOR:19008118;SIGNOR:19910923;SIGNOR:2808370;SPIKE:19910923;connectomeDB2020:19910923;connectomeDB2020:9389482], RNF43 [SIGNOR:23151663], ZNRF3 [SIGNOR:22575959;SIGNOR:23151663], WNT10B [SIGNOR:12055200], WNT3A [CellTalkDB:18215320;LRdb:18215320;NetPath:19910923;Ramilowski2015:18215320;SIGNOR:19910923;connectomeDB2020:18215320;connectomeDB2020:19910923;talklr:18215320], SFRP1 [LRdb:6172602;Ramilowski2015:6172602;connectomeDB2020:6172602;talklr:6172602], WNT2 [CellPhoneDB:24032637;CellTalkDB:24032637;connectomeDB2020:24032637], WNT4 [Baccin2019:12325120;CellTalkDB:12325120;HPMR:12325120;LRdb:12325120;connectomeDB2020:12325120], WNT5B [connectomeDB2020:27036869], WNT11 [NA], WNT1 [connectomeDB2020:28733458], WNT16 [connectomeDB2020:26861315], ROR2 [HPRD:12839624;NetPath:12839624]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; epithelial cell differentiation [GO:0030855]; hard palate development [GO:0060022]; inner ear receptor cell development [GO:0060119]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neuron differentiation [GO:0030182]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory perception of smell [GO:0007608]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD2&keywords=FZD2	0.175227991	560	NA	NA	0.04180925594	758	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	659
FZD4	frizzled class receptor 4	Yes	Yes		ENSG00000174804	Q9ULV1	G-protein coupled receptor Fz/Smo family	19	adhesion, receptor	adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14904, O14905, O96014, P04628, P09544, P41221, P56704, P56706, Q00604, Q6UXX9, Q93097, Q99972, Q9H1J5, Q9H1J7, Q9ULT6, Q9Y6F9	MYOC, NDP, RSPO2, WNT1, WNT11, WNT2, WNT2B, WNT3A, WNT5A, WNT5B, WNT6, WNT7B, WNT8A, WNT9A, WNT9B, ZNRF3	NDP [Baccin2019:15035989;BioGRID:17955262;CellTalkDB:15035989;Cellinker:15035989;InnateDB:21856951;LRdb:15035989;SignaLink3:21856951;SignaLink3:23180781;SignaLink3:24186977;connectomeDB2020:15035989], WNT5A [Baccin2019:10990458;Cellinker:10990458;HPMR:10990458;LRdb:10990458;SIGNOR:16602827;SignaLink3:10990458;SignaLink3:23331499;connectomeDB2020:10990458], RSPO2 [SIGNOR:22575959], ZNRF3 [SIGNOR:22575959], WNT6 [CellTalkDB:31618077], WNT2 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;connectomeDB2020:24032637], WNT7B [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;NetPath:15923619;connectomeDB2020:24032637], WNT2B [CellPhoneDB:24032637;CellTalkDB:24032637;InnateDB:21856951;LRdb:24032637;connectomeDB2020:24032637], WNT5B [NA], WNT11 [NA], MYOC [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], WNT1 [connectomeDB2020:28733458], WNT8A [connectomeDB2020:28733458], WNT9A [connectomeDB2020:28733458], WNT9B [connectomeDB2020:28733458], WNT3A [NetPath:19020754]	cell-cell junction [GO:0005911]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; cerebellum vasculature morphogenesis [GO:0061301]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; retinal blood vessel morphogenesis [GO:0061304]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD4&keywords=FZD4	2.874662697	278	NA	NA	0.1125467299	628	0.007874015748	0.0119760479	0.09402654867	0.02182254197	0.001683501684	0.003384094755	0.002719854941	0	0.002589715131	0.003905728402	4.25E-04	227	250	334	0.01367336416	0.5318092962	0.587399759	0.4403665009	299	268	297	356
GALR2	galanin receptor 2	Yes	Yes		ENSG00000182687	O43603	G-protein coupled receptor 1 family	19	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P22466, Q9BT56, Q9UBC7	GAL, GALP, SPX	SPX [CellTalkDB:31730796;Guide2Pharma:24517231;connectomeDB2020:24517231;connectomeDB2020:30305242], GAL [Baccin2019:11600206;Baccin2019:9480833;Baccin2019:9685625;Baccin2019:9832121;Baccin2019:9880084;CellTalkDB:9880084;Cellinker:11600206;Cellinker:9480833;Cellinker:9685625;Cellinker:9832121;Cellinker:9880084;Guide2Pharma:11600206;Guide2Pharma:9480833;Guide2Pharma:9685625;Guide2Pharma:9880084;HPMR:9832121;HPRD:9685625;ICELLNET:9685625;ICELLNET:9880084;LRdb:11600206;LRdb:9480833;LRdb:9685625;LRdb:9832121;LRdb:9880084;SIGNOR:10601261;connectomeDB2020:11600206;connectomeDB2020:9480833;connectomeDB2020:9685625;connectomeDB2020:9832121;connectomeDB2020:9880084;scConnect:11600206;scConnect:9480833;scConnect:9685625;scConnect:9880084], GALP [Baccin2019:15944009;Baccin2019:20880399;Baccin2019:9832121;CellChatDB:23233848;CellTalkDB:15944009;Cellinker:15944009;Cellinker:20880399;Cellinker:23233848;Cellinker:9832121;LRdb:15944009;LRdb:20880399;LRdb:9832121;SIGNOR:10601261;connectomeDB2020:15944009;connectomeDB2020:20880399;connectomeDB2020:9832121;scConnect:15944009;scConnect:20880399]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	galanin receptor activity [GO:0004966]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GALR2&keywords=GALR2	0.009248861798	778	NA	NA	0.04421444726	748	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	763
GHRHR	growth hormone releasing hormone receptor	Yes	No		ENSG00000106128	Q02643	G-protein coupled receptor 2 family	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01286, Q9UBU3	GHRH, GHRL	GHRH [Baccin2019:76804131333056;CellChatDB:26917260;CellTalkDB:7680413;Cellinker:1333056;Cellinker:26917260;Cellinker:7680413;HPMR:7680413;HPRD:1333056;LRdb:133;LRdb:7680413;connectomeDB2020:1333056;connectomeDB2020:7680413], GHRL [Baccin2019:10461027;CellTalkDB:10461027;Cellinker:10461027;HPRD:10461027;LRdb:10461027]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHRHR&keywords=GHRHR	0.0161445573	751	NA	NA	0.004720284375	869	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	810
IFNAR2	interferon alpha and beta receptor subunit 2	Yes	Yes		ENSG00000159110	P48551	Type II cytokine receptor family	19	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P00533, P01562, P01563, P01566, P01567, P01568, P01569, P01570, P01571, P01574, P05000, P05013, P05014, P05015, P05771, P06493, P08069, P23458, P29597, P32881, P42336, P51812, Q00978, Q16539, Q86WN2, Q92793, Q9NZH8, Q9P0W0	CDK1, CREBBP, EGFR, IFNA1, IFNA10, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNB1, IFNE, IFNK, IFNW1, IGF1R, IL36G, IRF9, JAK1, MAPK14, PIK3CA, PRKCB, RPS6KA3, TYK2	JAK1 [Cellinker:16551269;HPRD:12133952;InnateDB:12133952;Macrophage:9334213], IFNA1 [CellTalkDB:11698684;CellTalkDB:21856167;DIP:10395669;HPMR:11698684;LRdb:11698684;Ramilowski2015:21856167;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;talklr:21856167], IFNB1 [Baccin2019:1127853810395660;CellTalkDB:11278538;DIP:10395669;HPRD:10395669;LRdb:1;LRdb:11278538;Macrophage:7623815;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:10395669;connectomeDB2020:11278538], TYK2 [Cellinker:16551269;HPRD:12960323], IFNK [SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:22410872], IL36G [SignaLink3:17208301;SignaLink3:23331499], IFNA10 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA14 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA16 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA17 [CellTalkDB:21856167;LRdb:21856167;Macrophage:7623815;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA2 [CellTalkDB:10339405;DIP:10395669;DIP:10984492;HPRD:10339405;HPRD:11888273;InnateDB:10339405;InnateDB:17001036;InnateDB:18027911;InnateDB:21854986;LRdb:10339405;LRdb:12;Lit-BM-17:10339405;Lit-BM-17:10395669;Lit-BM-17:10984492;Lit-BM-17:21854986;connectomeDB2020:10339405;connectomeDB2020:11888273], IFNA21 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA4 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA5 [CellTalkDB:10395669;DIP:10395669;HPRD:10395669;LRdb:10395669;connectomeDB2020:10395669], IFNA6 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA7 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNA8 [CellTalkDB:8969169;DIP:10395669;HPRD:8969169;LRdb:8969169;connectomeDB2020:8969169], IFNW1 [CellTalkDB:11278538;InnateDB:21854986;LRdb:11278538;SIGNOR:11278538;connectomeDB2020:11278538], CREBBP [InnateDB:17923090;SIGNOR:17923090;iPTMnet:17923090], IRF9 [InnateDB:17923090;InnateDB:18456457;IntAct:17923090;Lit-BM-17:17923090;SIGNOR:17923090], IFNE [CellTalkDB:32196115;connectomeDB2020:22410872], PIK3CA [Cellinker:10542297], CDK1 [KEA:17570479], EGFR [KEA:17570479], IGF1R [KEA:17570479], MAPK14 [KEA:17570479], RPS6KA3 [KEA:17570479], PRKCB [HPRD:16000408]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]	cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNAR2&keywords=IFNAR2	34.34540924	62	NA	NA	2.59556605	89	0.1417322835	0.2240518962	0.1272123894	0.07002398082	0.1245791246	0.09813874788	0.1051677244	0.06688417618	0.03477617462	0.07567766057	0.0625845084	151	97	84	0.102802606	0.396942732	0.7595361807	0.6434648183	336	213	220	115
IFNLR1	interferon lambda receptor 1	Yes	No		ENSG00000185436	Q8IU57	Type II cytokine receptor family	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	K9M1U5, P22301, Q08334, Q8IU54, Q8IZI9, Q8IZJ0	IFNL1, IFNL2, IFNL3, IFNL4, IL10, IL10RB	IL10RB [HPMR:12974481;SignaLink3:12483210;SignaLink3:23331499], IFNL1 [CellTalkDB:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNL2 [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNL3 [CellTalkDB:12974481;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IFNL4 [connectomeDB2020:26134097], IL10 [Cellinker:27133025]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; interleukin-28 receptor complex [GO:0032002]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]	cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; mucosal immune response [GO:0002385]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cellular respiration [GO:1901857]; regulation of defense response to virus by host [GO:0050691]; response to type III interferon [GO:0034342]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNLR1&keywords=IFNLR1	3.164890816	268	NA	NA	1.179985713	201	0	0.003992015968	0	0	0.001683501684	0.003384094755	0	0	0.00332963374	0.001802643878	0.001583928916	225	293	294	0.001434165358	1.165772343	1.032226097	1.0130979	76	117	74	220
IL13RA2	interleukin 13 receptor subunit alpha 2	Yes	Yes		ENSG00000123496	Q14627	Type I cytokine receptor family, Type 5 subfamily	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P05112, P35225, P41273, P43490	IL13, IL4, NAMPT, TNFSF9	IL13 [Baccin2019:1270434311003390;CellPhoneDB:26471366;CellTalkDB:26471366;DIP:20223216;DIP:8663118;HPMR:12704343;HPRD:11003391;ICELLNET:8663118;InnateDB:8663118;IntAct:20223216;IntAct:23972995;IntAct:27629921;LRdb:11;LRdb:12704343;SignaLink3:12223527;SignaLink3:12401408;SignaLink3:14610620;SignaLink3:14657224;SignaLink3:14985454;SignaLink3:15099563;SignaLink3:18250477;SignaLink3:18451175;SignaLink3:20184663;SignaLink3:21097505;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:8663118;SignaLink3:9535722;connectomeDB2020:11003391;connectomeDB2020:12704343], IL4 [Baccin2019:9130652;CellTalkDB:9130652;HPRD:9130652;LRdb:9130652;connectomeDB2020:9130652], TNFSF9 [NA], NAMPT [NA]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of mast cell degranulation [GO:0043305]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL13RA2&keywords=IL13RA2	10.25936841	160	NA	NA	3.04737538	74	0.007874015748	0.0374251497	0.1150442478	1.49616307	0.01683501684	0.089678511	0.092475068	0.2691680261	0.1846096929	0.0117171852	0.3438671045	41	195	20	0.2422597352	0.7714655403	0.08609057322	1.402788694	202	427	25	214
IL20RA	interleukin 20 receptor subunit alpha	Yes	Yes		ENSG00000016402	Q9UHF4	Type II cytokine receptor family	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60462, Q13007, Q16653, Q9GZX6, Q9NPH9, Q9NYY1, Q9UHD0	IL19, IL20, IL22, IL24, IL26, MOG, NRP2	IL26 [CellTalkDB:14764663;InnateDB:15178681;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23106140;SignaLink3:23331499;connectomeDB2020:14764663], IL22 [SignaLink3:17208301;SignaLink3:23331499], IL19 [Baccin2019:1297448111564760;CellTalkDB:12974481;HPRD:11564763;LRdb:12;LRdb:12974481;SIGNOR:11564763;SignaLink3:11564763;SignaLink3:17208301;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:11564763;connectomeDB2020:12974481], IL20 [Baccin2019:11163236;Baccin2019:12351624;Baccin2019:12974481;Baccin2019:14580208;CellTalkDB:12974481;HPRD:11163236;HPRD:12351624;HPRD:14580208;IntAct:22802649;LRdb:11163236;LRdb:12351624;LRdb:12974481;LRdb:14580208;Lit-BM-17:22802649;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11163236;connectomeDB2020:12351624;connectomeDB2020:12974481;connectomeDB2020:14580208], IL24 [Baccin2019:1297448111706020;CellTalkDB:12974481;HPRD:11706020;LRdb:12;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11706020;connectomeDB2020:12974481], MOG [Cellinker:32589946], NRP2 [Cellinker:32589946]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-20 binding [GO:0042015]	cytokine-mediated signaling pathway [GO:0019221]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of bone resorption [GO:0045124]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL20RA&keywords=IL20RA	7.289734519	192	NA	NA	1.821017622	134	0	0.0623752495	0.002212389381	0.002637889688	0.03535353535	0.1708967851	0.184950136	0.1386623165	0.08583055864	0.159967953	0.01035348658	91	55	204	0.07756729997	1.094364662	1.940997987	0.2324325014	88	22	379	101
IL23R	interleukin 23 receptor	Yes	No		ENSG00000162594	Q5VWK5	Type I cytokine receptor family, Type 2 subfamily	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60674, P29460, P29597, P42701, Q12860, Q9NPF7	CNTN1, IL12B, IL12RB1, IL23A, JAK2, TYK2	JAK2 [HPRD:12023369], IL23A [Baccin2019:1202336912023360;CellTalkDB:12023369;HPMR:12023369;HPRD:12023369;InnateDB:12023369;LRdb:12023369;Lit-BM-17:12023369;SIGNOR:12023369;SignaLink3:12023369;SignaLink3:23331499;connectomeDB2020:12023369], TYK2 [Cellinker:12023369], IL12B [CellTalkDB:17587057;InnateDB:12023369;LRdb:17587057;Ramilowski2015:17587057;connectomeDB2020:17587057;talklr:17587057], IL12RB1 [HPRD:12023369;InnateDB:12023369], CNTN1 [Cellinker:32589946]	external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL23R&keywords=IL23R	0.2705866068	513	NA	NA	2.801808603	84	0	0	0.00110619469	0	0	0.001692047377	0.003626473255	0.004893964111	0.002219755827	5.34E-04	0.003051960595	228	327	262	0.001556773869	1.05736739	0.9115101519	1.129377519	93	160	53	271
IL2RA	interleukin 2 receptor subunit alpha	Yes	TBD		ENSG00000134460	P01589	NA	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P05362, P05771, P14784, P17252, P18510, P40933, P51692, P60568	ICAM1, IL15, IL1RN, IL2, IL2RB, PRKCA, PRKCB, STAT5B	IL2 [Baccin2019:15265897;Baccin2019:1993646;CellTalkDB:15265897;DIP:17032757;HPMR:15265897;HPMR:15933202;HPRD:1993646;InnateDB:12649439;InnateDB:15178252;InnateDB:1940342;InnateDB:3095922;InnateDB:6815536;InnateDB:8580082;InnateDB:8894436;InnateDB:8960125;IntAct:17032757;LRdb:15265897;LRdb:2;NetPath:3116143;NetPath:8260650;SIGNOR:16477002;connectomeDB2020:15265897;connectomeDB2020:1993646], IL1RN [NA], PRKCA [PhosphoSite:2941417;ProtMapper:2303462;SIGNOR:2303462;iPTMnet:2303462;iPTMnet:2941417], ICAM1 [CellTalkDB:1976256;Cellinker:1976256;HPRD:1976256;LRdb:1976256;connectomeDB2020:1976256], IL15 [CellTalkDB:8734356;LRdb:8734356;Ramilowski2015:8734356;connectomeDB2020:8734356;talklr:8734356], PRKCB [KEA:17570479], IL2RB [DIP:8006584;HPRD:11886175;InnateDB:15178252;InnateDB:1545122;InnateDB:8568232;NetPath:3116143;NetPath:8260650], STAT5B [HPRD:10602027]	external side of plasma membrane [GO:0009897]; interleukin-2 receptor complex [GO:0005893]; plasma membrane [GO:0005886]	interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911]	activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell proliferation [GO:0042130]; Notch signaling pathway [GO:0007219]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of T cell differentiation [GO:0045582]; regulation of T cell homeostatic proliferation [GO:0046013]; regulation of T cell tolerance induction [GO:0002664]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2RA&keywords=IL2RA	0.1231988001	596	NA	NA	0.1407475772	584	0.5748031496	0	0.00110619469	0.001199040767	0.001683501684	0	0	0	7.40E-04	3.34E-05	1.16E-04	232	345	344	0.05269828044	0.1712952657	0.1600264349	0.1613424988	413	407	412	483
IL5RA	interleukin 5 receptor subunit alpha	Yes	No		ENSG00000091181	Q01344	Type I cytokine receptor family, Type 5 subfamily	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60674, P05113, P07948, P23458	IL5, JAK1, JAK2, LYN	JAK2 [HPRD:9516124;NetPath:11823534], IL5 [Baccin2019:10880230;Baccin2019:11748263;Baccin2019:1732409;Baccin2019:7721873;BioGRID:10823900;BioGRID:1732409;CellTalkDB:11748263;DIP:1495999;DIP:22153509;HPRD:10880230;HPRD:1732409;HPRD:7721873;InnateDB:1732409;InnateDB:7721873;IntAct:22153509;LRdb:10880230;LRdb:11748263;LRdb:1732409;LRdb:7721873;Lit-BM-17:1495999;Lit-BM-17:1732409;Lit-BM-17:7721873;Lit-BM-17:7957082;NetPath:1732409;NetPath:1833065;SIGNOR:8567620;SignaLink3:22528658;SignaLink3:23331499;SignaLink3:8567620;connectomeDB2020:10880230;connectomeDB2020:11748263;connectomeDB2020:1732409;connectomeDB2020:7721873], JAK1 [HPRD:9516124;NetPath:9516124], LYN [NetPath:11823534]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914]	cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL5RA&keywords=IL5RA	0.4107352956	480	NA	NA	2.343553742	100	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	290
IL9R	interleukin 9 receptor	Yes	No		ENSG00000124334	Q01113	Type I cytokine receptor family, Type 4 subfamily	19	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01589, P15248, P23458	IL2RA, IL9, JAK1	JAK1 [HPRD:8756628;InnateDB:8756628;KEA:8756628;NetPath:8756628], IL9 [Baccin2019:953591811588013;CellTalkDB:9535918;DIP:9261146;HPMR:9535918;HPRD:11588013;LRdb:116;LRdb:9535918;NetPath:1376929;SIGNOR:10642536;SignaLink3:10642536;SignaLink3:23331499;connectomeDB2020:11588013;connectomeDB2020:9535918], IL2RA [Cellinker:18829468]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	interleukin-9 receptor activity [GO:0004919]	regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL9R&keywords=IL9R	0.2353366404	530	NA	NA	1.7759721	139	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	335
LHCGR	luteinizing hormone/choriogonadotropin receptor	Yes	Yes		ENSG00000138039	P22888	G-protein coupled receptor 1 family, FSH/LSH/TSH subfamily	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	A0A1B0GTJ6, O95467, P01215, P01229, P04899, P08047, P0DN86, P0DN87, P63092, P84996, Q5JWF2	CGA, CGB7, CGB8, GNAI2, GNAS, LHB, LOC101059948, SP1	SP1 [SPIKE:12972613], CGA [Baccin2019:10342833;Baccin2019:12727981;Baccin2019:1922095;CellTalkDB:1922095;Cellinker:10342833;Cellinker:12727981;Cellinker:1922095;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:10342833;LRdb:10342833;LRdb:12727981;LRdb:1922095;connectomeDB2020:10342833;connectomeDB2020:12727981;connectomeDB2020:1922095;scConnect:12727981;scConnect:1922095], CGB8 [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], LHB [CellTalkDB:1922095;Cellinker:12727981;Cellinker:1922095;Cellinker:3470775;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:3470775;LRdb:12727981;LRdb:1922095;LRdb:3470775;SIGNOR:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:3470775;scConnect:12727981;scConnect:1922095], CGB7 [SIGNOR:10446903], GNAI2 [CellTalkDB:10493819;Cellinker:10493819;HPRD:10493819;LRdb:10493819;connectomeDB2020:10493819], GNAS [CellTalkDB:10493819;Cellinker:10493819;HPRD:10493819;LRdb:10493819;connectomeDB2020:10493819], GNAS [CellTalkDB:10493819;Cellinker:10493819;HPRD:10493819;LRdb:10493819;connectomeDB2020:10493819], GNAS [CellTalkDB:10493819;Cellinker:10493819;HPRD:10493819;LRdb:10493819;connectomeDB2020:10493819], GNAS [CellTalkDB:10493819;Cellinker:10493819;HPRD:10493819;LRdb:10493819;connectomeDB2020:10493819], LOC101059948 [Baccin2019:12727981;Baccin2019:1922095;Baccin2019:3470775]	endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LHCGR&keywords=LHCGR	0.0014323	834	NA	NA	0.03092292225	786	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	810
NTSR1	neurotensin receptor 1	Yes	No		ENSG00000101188	P30989	G-protein coupled receptor 1 family, Neurotensin receptor subfamily, NTSR1 sub-subfamily	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P30990	NTS	NTS [Baccin2019:10930533;Baccin2019:11559354;Baccin2019:11723247;Baccin2019:11811984;Baccin2019:1331689;Baccin2019:16087676;Baccin2019:1694443;CellTalkDB:11811984;Cellinker:10930533;Cellinker:11559354;Cellinker:11723247;Cellinker:11811984;Cellinker:1331689;Cellinker:16087676;Cellinker:1694443;DIP:17620610;Guide2Pharma:10930533;Guide2Pharma:11723247;Guide2Pharma:11811984;HPMR:1694443;HPRD:11559354;HPRD:16087676;LRdb:10930533;LRdb:11559354;LRdb:11723247;LRdb:11811984;LRdb:1331689;LRdb:16087676;LRdb:1694443;Lit-BM-17:11559354;Lit-BM-17:23597562;SIGNOR:1331689;connectomeDB2020:10930533;connectomeDB2020:11559354;connectomeDB2020:11723247;connectomeDB2020:11811984;connectomeDB2020:1331689;connectomeDB2020:16087676;connectomeDB2020:1694443;scConnect:10930533;scConnect:11723247;scConnect:11811984]	cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; terminal bouton [GO:0043195]	G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]	adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate catabolic process [GO:0071545]; learning [GO:0007612]; L-glutamate import across plasma membrane [GO:0098712]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of action potential [GO:0098900]; regulation of membrane depolarization [GO:0003254]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of sensory perception of pain [GO:0051930]; response to lipid [GO:0033993]; temperature homeostasis [GO:0001659]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTSR1&keywords=NTSR1	0.009852868539	774	NA	NA	0.01606653103	832	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	803
OXTR	oxytocin receptor	Yes	No		ENSG00000180914	P30559	G-protein coupled receptor 1 family, Vasopressin/oxytocin receptor subfamily	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01178, P01185	AVP, OXT	OXT [Baccin2019:10519430;Baccin2019:10698266;Baccin2019:12660315;Baccin2019:1313946;Baccin2019:16158071;Baccin2019:7475979;Baccin2019:7774575;Baccin2019:8955347;CellTalkDB:10519430;Cellinker:10519430;Cellinker:10698266;Cellinker:12660315;Cellinker:1313946;Cellinker:16158071;Cellinker:7475979;Cellinker:7774575;Cellinker:8955347;Guide2Pharma:10519430;Guide2Pharma:12660315;Guide2Pharma:16158071;Guide2Pharma:7475979;Guide2Pharma:7774575;Guide2Pharma:8955347;HPMR:1313946;HPRD:10698266;LRdb:10519430;LRdb:10698266;LRdb:12660315;LRdb:1313946;LRdb:16158071;LRdb:7475979;LRdb:7774575;LRdb:8955347;SIGNOR:1313946;connectomeDB2020:10519430;connectomeDB2020:10698266;connectomeDB2020:12660315;connectomeDB2020:1313946;connectomeDB2020:16158071;connectomeDB2020:7475979;connectomeDB2020:7774575;connectomeDB2020:8955347;scConnect:10519430;scConnect:12660315;scConnect:16158071;scConnect:7475979;scConnect:7774575;scConnect:8955347], AVP [Baccin2019:10519430;Baccin2019:11337500;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:16158071;Baccin2019:7475979;Baccin2019:7774575;Baccin2019:7921229;Baccin2019:8955347;CellTalkDB:12446593;Guide2Pharma:10519430;Guide2Pharma:11337500;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:16158071;Guide2Pharma:7475979;Guide2Pharma:7774575;Guide2Pharma:8955347;HPRD:7921229;LRdb:10519430;LRdb:11337500;LRdb:12446593;LRdb:15084136;LRdb:16158071;LRdb:7475979;LRdb:7774575;LRdb:7921229;LRdb:8955347;connectomeDB2020:10519430;connectomeDB2020:11337500;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:16158071;connectomeDB2020:7475979;connectomeDB2020:7774575;connectomeDB2020:7921229;connectomeDB2020:8955347;scConnect:10519430;scConnect:11337500;scConnect:12446593;scConnect:15084136;scConnect:16158071;scConnect:7475979;scConnect:7774575;scConnect:8955347]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000]	cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OXTR&keywords=OXTR	0.2070354337	543	NA	NA	0.1367763566	591	0	0.1511976048	0	0.002158273381	0.008417508418	0.003384094755	0.002719854941	0	0.002219755827	0.002870877287	4.25E-04	228	265	334	0.01576299327	0.4743142887	0.4995878062	0.4046484984	313	296	309	424
PRLR	prolactin receptor	Yes	No		ENSG00000113494	P16471	Type I cytokine receptor family, Type 1 subfamily	19	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14508, O14543, O60674, P01236, P01241, P07333, P0DML2, P0DML3, P42680, P43403, P49841, P51956, Q14406, Q99075, Q9BZV3, Q9NSE2	CISH, CSF1R, CSH1, CSH2, CSHL1, GH1, GSK3B, HBEGF, IMPG2, JAK2, NEK3, PRL, SOCS2, SOCS3, TEC, ZAP70	JAK2 [BioGRID:9202403;HPRD:10772872;PhosphoSite:15082796;PhosphoSite:16278670;PhosphoSite:18252943;PhosphoSite:19276348], PRL [CellChatDB:23192981;CellTalkDB:2558309;Cellinker:10966654;Cellinker:11356126;Cellinker:18253483;Cellinker:2558309;Cellinker:7984244;Cellinker:9175708;Cellinker:9626554;DIP:22325776;HPMR:11356126;HPMR:2558309;HPRD:10966654;HPRD:7984244;HPRD:9626554;ICELLNET:18467331;InnateDB:21889455;IntAct:23048206;LRdb:10966654;LRdb:11356126;LRdb:2558309;LRdb:7984244;LRdb:9626554;Lit-BM-17:23048206;SIGNOR:10585417;SignaLink3:10585417;SignaLink3:10966654;SignaLink3:15082796;SignaLink3:16546209;SignaLink3:18988627;SignaLink3:20053995;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7984244;SignaLink3:9626554;connectomeDB2020:10966654;connectomeDB2020:11356126;connectomeDB2020:2558309;connectomeDB2020:7984244;connectomeDB2020:9626554], GH1 [CellChatDB:23192981;CellTalkDB:27003442;Cellinker:23192981;Cellinker:31100495;Cellinker:9556914;HPRD:9556914;LRdb:9556914;SIGNOR:7984244;SignaLink3:15082796;SignaLink3:16546209;SignaLink3:20053995;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7984244;connectomeDB2020:9556914], SOCS3 [HPRD:11713228;SignaLink3:11713228;SignaLink3:18988627;SignaLink3:23331499], CISH [HPRD:11713228;SignaLink3:11713228;SignaLink3:18988627;SignaLink3:23331499], CSH1 [CellTalkDB:10966654;Cellinker:10966654;HPRD:10966654;LRdb:10966654;connectomeDB2020:10966654], CSH2 [Cellinker:10966654], CSHL1 [NA], HBEGF [CellTalkDB:32196115], IMPG2 [Cellinker:32589946], CSF1R [Cellinker:10692427], GSK3B [ProtMapper:18316598;ProtMapper:19276348;ProtMapper:22606260;iPTMnet:18316598], TEC [HPRD:11328862], NEK3 [HPRD:15618286], SOCS2 [HPRD:10455112;HPRD:9202403], ZAP70 [HPRD:10221598]	cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901]	activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRLR&keywords=PRLR	3.138280482	269	NA	NA	0.9711552859	246	0.007874015748	0.05988023952	0.004424778761	0.0103117506	0.05723905724	0.1336717428	0.1296464189	0.07830342577	0.119126896	0.01265188944	0.1136565579	68	193	60	0.06607152479	1.697440618	0.2977709399	1.62553016	28	361	17	267
RXFP3	relaxin family peptide receptor 3	Yes	No		ENSG00000277069, ENSG00000182631	Q9NSD7	G-protein coupled receptor 1 family	19	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04090, P04808, P51460, Q8WXF3, Q9Y5Q6	INSL3, INSL5, RLN1, RLN2, RLN3	RLN3 [Baccin2019:14522968;Baccin2019:15367576;CellTalkDB:27245781;Cellinker:14522968;Cellinker:15367576;Cellinker:25761609;Guide2Pharma:14522968;Guide2Pharma:15367576;Guide2Pharma:17351017;Guide2Pharma:18434306;Guide2Pharma:22257012;HPMR:14522968;LMPID:24615237;connectomeDB2020:14522968;connectomeDB2020:15367576;scConnect:14522968;scConnect:15367576;scConnect:17351017;scConnect:18434306;scConnect:20159943;scConnect:22257012;scConnect:24641548], INSL5 [Baccin2019:15525639;CellTalkDB:15525639;Cellinker:15525639;Cellinker:25761609;Guide2Pharma:18582868;LRdb:15525639;connectomeDB2020:15525639;scConnect:18582868], RLN2 [CellTalkDB:32103204;connectomeDB2020:24641548;scConnect:20159943;scConnect:24641548], INSL3 [NA], RLN1 [NA]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RXFP3&keywords=RXFP3	0.459176173	465	NA	NA	20.858908	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	236
SSTR1	somatostatin receptor 1	Yes	Yes		ENSG00000139874	P30872	G-protein coupled receptor 1 family	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P61278	CORT, SST	CORT [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:9650799;Cellinker:10598788;Cellinker:11011067;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPMR:11011067;HPMR:9125122;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SST [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1346068;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:1346068;Cellinker:15333679;Cellinker:7988476;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPRD:1346068;LRdb:10598788;LRdb:11520208;LRdb:1346068;LRdb:15333679;LRdb:7988476;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1346068;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]	cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; glutamate receptor signaling pathway [GO:0007215]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSTR1&keywords=SSTR1	6.526674719	202	NA	NA	2.521810548	93	0	0.01097804391	0.006637168142	0.002877697842	0.003367003367	0.1878172589	0.08340888486	0.1419249592	0.1317055124	0.04646815329	0.05451033417	58	132	97	0.0608813651	1.999192767	0.7966572485	0.9101169832	17	195	112	156
TNFRSF13C	TNF receptor superfamily member 13C	Yes	No		ENSG00000159958	Q96RJ3	NA	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	Q13114, Q9Y275	TNFSF13B, TRAF3	TNFSF13B [Baccin2019:11509692;Baccin2019:12721620;Baccin2019:15851487;CellTalkDB:15851487;Cellinker:11509692;Cellinker:12721620;Cellinker:15851487;HPMR:15851487;HPRD:11509692;HPRD:12721620;ICELLNET:11239407;InnateDB:12571250;LRdb:11509692;LRdb:12721620;LRdb:15851487;SIGNOR:15644327;SIGNOR:15851487;connectomeDB2020:11509692;connectomeDB2020:12721620;connectomeDB2020:15851487], TRAF3 [BioGRID:12471121;BioGRID:21041452;HPRD:12471121;InnateDB:12471121;InnateDB:15585864;Lit-BM-17:12471121;Lit-BM-17:15585864;Lit-BM-17:21041452]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]	adaptive immune response [GO:0002250]; B cell costimulation [GO:0031296]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF13C&keywords=TNFRSF13C	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
TNFRSF17	TNF receptor superfamily member 17	Yes	Yes		ENSG00000048462	Q02223	NA	19	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O75888, P32970, Q9Y275	CD70, TNFSF13, TNFSF13B	TNFSF13 [Baccin2019:10973284;Baccin2019:14764606;CellTalkDB:14764606;Cellinker:10973284;Cellinker:14764606;HPMR:14764606;HPRD:10973284;ICELLNET:11239407;LRdb:11;LRdb:14764606;SIGNOR:10973284;connectomeDB2020:10973284;connectomeDB2020:14764606], TNFSF13B [Baccin2019:10801128;Baccin2019:10908663;Baccin2019:10973284;BioGRID:10908663;CellTalkDB:10973284;Cellinker:10801128;Cellinker:10908663;Cellinker:10973284;HPRD:10801128;HPRD:10908663;HPRD:10973284;ICELLNET:11239407;InnateDB:12571250;LRdb:10801128;LRdb:10908663;LRdb:10973284;Lit-BM-17:10801128;Lit-BM-17:10908663;Lit-BM-17:12721620;connectomeDB2020:10801128;connectomeDB2020:10908663;connectomeDB2020:10973284], CD70 [CellTalkDB:32103204]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]	adaptive immune response [GO:0002250]; lymphocyte homeostasis [GO:0002260]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF17&keywords=TNFRSF17	0.06732022022	659	NA	NA	0.02390711588	807	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	733
TNFRSF8	TNF receptor superfamily member 8	Yes	No		ENSG00000120949	P28908	TNFR8 family	19	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43508, P32971, Q9UM73	ALK, TNFSF12, TNFSF8	TNFSF8 [Baccin2019:11754357;Baccin2019:8391931;CellTalkDB:8391931;Cellinker:11754357;Cellinker:8391931;DIP:10768840;HPMR:8391931;HPRD:11754357;ICELLNET:11239407;LRdb:118;LRdb:8391931;connectomeDB2020:11754357;connectomeDB2020:8391931], TNFSF12 [CellTalkDB:32196115], ALK [HPRD:10641597]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	transmembrane signaling receptor activity [GO:0004888]	cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&keywords=TNFRSF8	0.01141201236	769	NA	NA	0.007908009573	856	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	813
TNFRSF9	TNF receptor superfamily member 9	Yes	No		ENSG00000049249	Q07011	NA	19	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P41273	TNFSF9	TNFSF9 [CellTalkDB:13130507;Cellinker:13130507;Cellinker:8088337;Cellinker:9045669;DIP:8088337;HPMR:8088337;HPRD:13130507;HPRD:8088337;HPRD:9045669;ICELLNET:11239407;LRdb:13130507;LRdb:8088337;LRdb:9045669;SPIKE:16596186;connectomeDB2020:13130507;connectomeDB2020:8088337;connectomeDB2020:9045669]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine binding [GO:0019955]; signaling receptor activity [GO:0038023]	apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF9&keywords=TNFRSF9	0.5344984397	454	NA	NA	3.918667003	59	0.1338582677	0.02744510978	0.03207964602	0.07026378897	0.01178451178	0.01692047377	0.009972801451	0.004893964111	0.00739918609	0.002837494993	0.01355997682	209	267	186	0.03009229286	0.4339783247	0.3201985737	0.5876435379	323	352	239	283
EDA2R	ectodysplasin A2 receptor	Yes	Yes		ENSG00000131080	Q9HAV5	NA	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O75015, Q92838	EDA, FCGR3B	EDA [Baccin2019:11039935;Baccin2019:12084975;Baccin2019:12270937;CellTalkDB:11039935;Cellinker:11039935;Cellinker:12084975;Cellinker:12270937;Guide2Pharma:11039935;HPMR:12084975;HPRD:11039935;HPRD:12270937;ICELLNET:10484778;LRdb:11039935;LRdb:12084975;LRdb:12270937;SIGNOR:12084975;connectomeDB2020:11039935;connectomeDB2020:12084975;connectomeDB2020:12270937;scConnect:11039935], FCGR3B [Cellinker:32589946]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDA2R&keywords=EDA2R	2.858373306	281	NA	NA	0.6071461833	336	0	0.0124750499	0	0.01606714628	0.02188552189	0.02199661591	0.04533091568	0.01141924959	0.02071772105	0.02103084524	0.01174425343	179	170	195	0.01660611991	1.154535917	1.166304796	0.8172651069	79	89	152	219
EDAR	ectodysplasin A receptor	Yes	No		ENSG00000135960	Q9UNE0	NA	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P05771, Q8NHL6, Q92838, Q99558	EDA, LILRB1, MAP3K14, PRKCB	EDA [CellTalkDB:11039935;Cellinker:11039935;Cellinker:11309369;Cellinker:12084975;Guide2Pharma:11039935;HPMR:12084975;HPRD:11309369;ICELLNET:10484778;LRdb:11039935;LRdb:11309369;LRdb:12084975;SIGNOR:18304980;connectomeDB2020:11039935;connectomeDB2020:11309369;connectomeDB2020:12084975;scConnect:11039935], LILRB1 [Cellinker:32822567], PRKCB [KEA:17570479], MAP3K14 [HPRD:11035039]	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; salivary gland cavitation [GO:0060662]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDAR&keywords=EDAR	0.2784946226	510	NA	NA	0.8425995798	275	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	393
ACKR2	atypical chemokine receptor 2	Yes	No		ENSG00000144648	O00590	G-protein coupled receptor 1 family, Atypical chemokine receptor subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, receptor, transmembrane	O00175, O00585, O00626, O15444, P10147, P13236, P13500, P13501, P16619, P51671, P55773, P80075, P80098, Q16627, Q8NHW4, Q92583, Q99616, Q99731, Q9NRJ3, Q9Y258, Q9Y4X3	CCL11, CCL13, CCL14, CCL17, CCL19, CCL2, CCL21, CCL22, CCL23, CCL24, CCL25, CCL26, CCL27, CCL28, CCL3, CCL3L1, CCL4, CCL4L1, CCL5, CCL7, CCL8	CCL11 [CellChatDB:26740381;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCL13 [Baccin2019:24890717;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCL14 [CellChatDB:26740381;CellPhoneDB:24218476;CellTalkDB:9660793;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:9660793;connectomeDB2020:9405404], CCL17 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:25297873], CCL2 [Baccin2019:9364936;Baccin2019:9405404;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9364936;Cellinker:9405404;HPRD:9364936;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9364936;connectomeDB2020:9405404], CCL22 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:25297873], CCL23 [CellTalkDB:10699158;ICELLNET:22633458;LRdb:10699158], CCL24 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;ICELLNET:22633458;LRdb:10699158], CCL3 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCL3L1 [CellChatDB:26740381;CellTalkDB:10364178;Cellinker:26740381;Cellinker:29637711;HPRD:10364178;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10364178;connectomeDB2020:25297873], CCL4 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:29637711;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCL4L1 [Cellinker:29637711;ICELLNET:22633458], CCL5 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCL7 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9364936;Cellinker:9405404;HPRD:9364936;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9364936;connectomeDB2020:9405404], CCL8 [Baccin2019:9364936;Baccin2019:9405404;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCL21 [CellTalkDB:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCL27 [CellTalkDB:10725697;Cellinker:10725696;Cellinker:10725697;Cellinker:11821900;HPRD:10725696;HPRD:10725697;HPRD:11821900;LRdb:10725696;LRdb:10725697;LRdb:11821900;connectomeDB2020:10725696;connectomeDB2020:10725697;connectomeDB2020:11821900], CCL19 [CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCL28 [Baccin2019:10781587;Cellinker:10781587;HPRD:10781587;LRdb:28843907;connectomeDB2020:10781587], CCL25 [CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCL26 [CellChatDB:26740381;Cellinker:26740381]	actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR2&keywords=ACKR2	0.7794921644	417	NA	NA	0.6199510463	332	0.007874015748	0	0	7.19E-04	0	0	0.001813236627	0.004893964111	0	1.00E-04	0.007417423218	234	343	222	0.002074382822	0.8281996808	0.8364938424	1.442510435	181	186	23	320
ADCYAP1R1	ADCYAP receptor type I	Yes	No		ENSG00000078549	P41586	G-protein coupled receptor 2 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, tight_junction, transmembrane	P01185, P01189, P01215, P01222, P01225, P01229, P01258, P01270, P01275, P01282, P01286, P04090, P06850, P06881, P09681, P09683, P0C0P6, P0DP23, P10092, P10997, P12272, P18509, P35318, P51460, Q7Z4H4, Q8WXF3, Q96A98	ADCYAP1, ADM, ADM2, AVP, CALCA, CALCB, CALM1, CGA, CRH, FSHB, GCG, GHRH, GIP, IAPP, INSL3, LHB, NPS, POMC, PTH, PTH2, PTHLH, RLN2, RLN3, SCT, TSHB, VIP	ADCYAP1 [Baccin2019:10100920;Baccin2019:10583729;Baccin2019:11931347;Baccin2019:16930633;Baccin2019:8253796;Baccin2019:8703026;CellChatDB:21350482;CellTalkDB:10100920;Cellinker:10100920;Cellinker:10583729;Cellinker:11931347;Cellinker:12488235;Cellinker:16930633;Cellinker:21350482;Cellinker:8253796;Cellinker:8703026;DIP:17470806;Guide2Pharma:10583729;Guide2Pharma:11931347;Guide2Pharma:16930633;HPMR:10100920;HPRD:10583729;HPRD:8253796;LRdb:10100920;LRdb:10583729;LRdb:11931347;LRdb:16930633;LRdb:8253796;LRdb:8703026;SIGNOR:8703026;connectomeDB2020:10100920;connectomeDB2020:10583729;connectomeDB2020:11931347;connectomeDB2020:16930633;connectomeDB2020:8253796;connectomeDB2020:8703026;scConnect:10583729;scConnect:11931347;scConnect:16930633], VIP [Baccin2019:10583729;Baccin2019:11931347;Baccin2019:16930633;CellTalkDB:10583729;Cellinker:10583729;Cellinker:11931347;Cellinker:12488235;Cellinker:16930633;Guide2Pharma:10583729;Guide2Pharma:11931347;Guide2Pharma:16930633;LRdb:10583729;LRdb:11931347;LRdb:16930633;connectomeDB2020:10583729;connectomeDB2020:11931347;connectomeDB2020:16930633;scConnect:10583729;scConnect:11931347;scConnect:16930633], SCT [CellTalkDB:32196115], LHB [CellTalkDB:32196115], IAPP [CellTalkDB:32196115], TSHB [CellTalkDB:32196115], PTH2 [CellTalkDB:32196115], CRH [CellTalkDB:32196115], PTH [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], CALM1 [CellTalkDB:20172594;HPRD:15670850], GIP [CellTalkDB:32196115], GHRH [CellTalkDB:32196115], INSL3 [CellTalkDB:32196115], AVP [CellTalkDB:32196115], RLN2 [CellTalkDB:32196115], ADM2 [CellTalkDB:32196115], NPS [CellTalkDB:32196115], POMC [CellTalkDB:32196115], GCG [CellTalkDB:32196115], RLN3 [CellTalkDB:32196115], FSHB [CellTalkDB:32196115], CALCB [CellTalkDB:32196115], ADM [CellTalkDB:32196115], PTHLH [CellTalkDB:32196115], CGA [CellTalkDB:32196115]	bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]	adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADCYAP1R1&keywords=ADCYAP1R1	0.6151352084	437	NA	NA	0.04559792624	744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	591
AMHR2	anti-Mullerian hormone receptor type 2	Yes	No		ENSG00000135409	Q16671	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00238, P03971, P22004, P36897	AMH, BMP6, BMPR1B, TGFBR1	AMH [Baccin2019:79972308889695;CellTalkDB:7997230;HPMR:7997230;HPRD:8889695;LRdb:7997230;LRdb:889;SIGNOR:8119126;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8889695;connectomeDB2020:7997230;connectomeDB2020:8889695], BMP6 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [HPRD:11420127], TGFBR1 [HPRD:11420127]	activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	activin-activated receptor activity [GO:0017002]; activin binding [GO:0048185]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]	activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMHR2&keywords=AMHR2	0.4500588959	469	NA	NA	0.1719565017	549	0	4.99E-04	0	0	0.005050505051	0	0	0.00163132137	0.001109877913	3.34E-04	0.001892988217	231	334	286	9.56E-04	1.014032313	0.9431994179	1.08550917	105	149	59	375
AVPR2	arginine vasopressin receptor 2	Yes	Yes		ENSG00000126895	P30518	G-protein coupled receptor 1 family, Vasopressin/oxytocin receptor subfamily	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O95467, P01178, P01185, P17612, P22694, P34947, P63092, P84996, Q5JWF2, Q9BXJ1	AVP, C1QTNF1, GNAS, GRK5, OXT, PRKACA, PRKACB	OXT [Baccin2019:12660315;Baccin2019:7774575;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:9884074;Guide2Pharma:12660315;Guide2Pharma:7774575;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:12660315;LRdb:7774575;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9884074;connectomeDB2020:12660315;connectomeDB2020:7774575;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:12660315;scConnect:7774575;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9884074], AVP [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:11012895;Baccin2019:11857925;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:7774575;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:9884074;Cellinker:10519430;Cellinker:10780976;Cellinker:11012895;Cellinker:11857925;Cellinker:12446593;Cellinker:15084136;Cellinker:7774575;Cellinker:9264324;Cellinker:9322919;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:11012895;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:7774575;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPRD:11857925;LRdb:10519430;LRdb:10780976;LRdb:11012895;LRdb:11857925;LRdb:12446593;LRdb:15084136;LRdb:7774575;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9864265;LRdb:9884074;SIGNOR:1560825;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:11012895;connectomeDB2020:11857925;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:7774575;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:11012895;scConnect:12446593;scConnect:15084136;scConnect:7774575;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9864265;scConnect:9884074], GNAS [Baccin2019:8621513;CellTalkDB:8621513;HPRD:8621513;LRdb:8621513;connectomeDB2020:8621513], C1QTNF1 [Baccin2019:12409230;CellTalkDB:12409230;Cellinker:12409230;HPRD:12409230;LRdb:12409230;Lit-BM-17:12409230;connectomeDB2020:12409230], GNAS [Baccin2019:8621513;CellTalkDB:8621513;HPRD:8621513;LRdb:8621513;connectomeDB2020:8621513], GNAS [Baccin2019:8621513;CellTalkDB:8621513;HPRD:8621513;LRdb:8621513;connectomeDB2020:8621513], GNAS [Baccin2019:8621513;CellTalkDB:8621513;HPRD:8621513;LRdb:8621513;connectomeDB2020:8621513], PRKACA [PhosphoSite:18578504], PRKACB [iPTMnet:18578504], GRK5 [HPRD:10858434]	clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; excretion [GO:0007588]; G protein-coupled receptor signaling pathway [GO:0007186]; hemostasis [GO:0007599]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of urine volume [GO:0035811]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to cytokine [GO:0034097]; telencephalon development [GO:0021537]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AVPR2&keywords=AVPR2	0.004322880899	804	NA	NA	0.00542319365	866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	835
BDKRB2	bradykinin receptor B2	Yes	No		ENSG00000168398	P30411	G-protein coupled receptor 1 family, Bradykinin receptor subfamily, BDKRB2 sub-subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01042, P04637, P05771, P08069, P12821, P12931, P17252, P25098, P32298, P34947, P35626, P43250, Q05655, Q15835	ACE, GRK1, GRK2, GRK3, GRK4, GRK5, GRK6, IGF1R, KNG1, PRKCA, PRKCB, PRKCD, SRC, TP53	TP53 [SPIKE:18431400], KNG1 [CellTalkDB:8063797;Cellinker:8063797;Cellinker:8302267;Cellinker:9203620;Guide2Pharma:8302267;Guide2Pharma:9203620;HPMR:8063797;LRdb:8063797;LRdb:8302267;LRdb:9203620;SIGNOR:28966616;connectomeDB2020:8063797;connectomeDB2020:8302267;connectomeDB2020:9203620;scConnect:8302267;scConnect:9203620], SRC [KEA:10085087;KEA:16226010;PhosphoSite:16226010;ProtMapper:16226010;SIGNOR:16226010;iPTMnet:16226010;phosphoELM:16226010], GRK2 [HPRD-phos:11517230;HPRD:11517230;KEA:11517230;ProtMapper:11517230;SIGNOR:11517230;iPTMnet:11517230], GRK4 [HPRD-phos:11517230;HPRD:11517230;KEA:11517230;PhosphoSite:11517230;ProtMapper:11517230;SIGNOR:11517230;iPTMnet:11517230;phosphoELM:11517230], GRK5 [HPRD-phos:11517230;HPRD:11517230;KEA:11517230;ProtMapper:11517230;SIGNOR:11517230;iPTMnet:11517230], GRK3 [HPRD-phos:11517230;HPRD:11517230;KEA:11517230;ProtMapper:11517230;SIGNOR:11517230;iPTMnet:11517230], GRK6 [HPRD-phos:11517230;HPRD:11517230;KEA:11517230;ProtMapper:11517230;SIGNOR:11517230;dbPTM:11517230;iPTMnet:11517230], PRKCD [HPRD-phos:11517230;HPRD:11517230;KEA:11517230;ProtMapper:11517230;SIGNOR:11517230;iPTMnet:11517230], ACE [Baccin2019:10748135;CellTalkDB:10748135;HPRD:10748135;LRdb:10748135;Lit-BM-17:17077303;connectomeDB2020:10748135], PRKCA [KEA:11517230;phosphoELM:11517230], GRK1 [KEA:11517230], IGF1R [KEA:17570479], PRKCB [KEA:17570479]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	bradykinin receptor activity [GO:0004947]; G protein-coupled receptor activity [GO:0004930]; phosphatidylinositol phospholipase C activity [GO:0004435]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; type 1 angiotensin receptor binding [GO:0031702]	arachidonic acid secretion [GO:0050482]; blood circulation [GO:0008015]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1902239]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of vascular permeability [GO:0043114]; regulation of vasoconstriction [GO:0019229]; response to salt stress [GO:0009651]; smooth muscle contraction [GO:0006939]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BDKRB2&keywords=BDKRB2	1.038292755	379	NA	NA	0.2220501592	504	0	0.06037924152	0.3252212389	0.05635491607	0.01851851852	0.0152284264	0.01903898459	0.008156606852	0.01146873844	0.01375350514	0.005369905351	199	187	241	0.04849909835	0.3669926383	0.4060490813	0.2627374743	348	320	367	348
C5AR1	complement C5a receptor 1	Yes	Yes		ENSG00000197405	P21730	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01031, P02751, P04899, P05771, P17252, P22694, P39019, Q05655	C5, FN1, GNAI2, PRKACB, PRKCA, PRKCB, PRKCD, RPS19	C5 [Baccin2019:10602324;Baccin2019:11773063;Baccin2019:15661745;Baccin2019:1847994;Baccin2019:9553099;Baccin2019:9881961;CellTalkDB:1847994;Cellinker:10602324;Cellinker:11773063;Cellinker:15661745;Cellinker:1847994;Cellinker:9553099;Cellinker:9881961;Guide2Pharma:10602324;Guide2Pharma:11773063;Guide2Pharma:15661745;HPMR:1847994;HPRD:9553099;LRdb:10602324;LRdb:11773063;LRdb:15661745;LRdb:1847994;LRdb:9553099;LRdb:9881961;SIGNOR:1847994;connectomeDB2020:10602324;connectomeDB2020:11773063;connectomeDB2020:15661745;connectomeDB2020:1847994;connectomeDB2020:9553099;connectomeDB2020:9881961;scConnect:10602324;scConnect:11773063;scConnect:15661745;scConnect:9881961], RPS19 [Guide2Pharma:11107061;HPRD:11733378;LRdb:11107061;LRdb:12;connectomeDB2020:11107061;connectomeDB2020:11733378;scConnect:11107061], PRKCB [ProtMapper:17145764;SIGNOR:17145764;iPTMnet:17145764], PRKCD [ProtMapper:10636859;ProtMapper:12464600;ProtMapper:17145764;SIGNOR:10636859;SIGNOR:12464600;SIGNOR:17145764;iPTMnet:10636859;iPTMnet:12464600;iPTMnet:17145764], GNAI2 [BioGRID:7962171;CellTalkDB:7962171;HPRD:7962171;LRdb:7962171;Lit-BM-17:25241761;Lit-BM-17:7962171;connectomeDB2020:7962171], FN1 [CellTalkDB:32196115], PRKCA [KEA:12464600;KEA:17570479;KEA:7642584;PhosphoSite:10636859;PhosphoSite:12464600;PhosphoSite:17145764;PhosphoSite:7642584;ProtMapper:15212693;phosphoELM:7642584], PRKACB [KEA:17570479]	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	complement component C5a receptor activity [GO:0004878]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]	activation of phospholipase C activity [GO:0007202]; amyloid-beta clearance [GO:0097242]; astrocyte activation [GO:0048143]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; cognition [GO:0050890]; complement component C5a signaling pathway [GO:0038178]; complement receptor mediated signaling pathway [GO:0002430]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; mRNA transcription by RNA polymerase II [GO:0042789]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynapse organization [GO:0099172]; regulation of tau-protein kinase activity [GO:1902947]; response to peptidoglycan [GO:0032494]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C5AR1&keywords=C5AR1	3.906684727	246	NA	NA	0.2081867261	517	0.6929133858	0.004491017964	0.002212389381	0.002398081535	0.001683501684	0.01184433164	0.005439709882	0.00163132137	0.005179430263	0.01124983309	0.001892988217	218	198	286	0.06735781735	0.196223611	0.2746953549	0.1537399661	401	366	415	332
CALCRL	calcitonin receptor like receptor	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000064989	Q16602	G-protein coupled receptor 2 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01258, P06881, P10092, P10997, P35318, Q7Z4H4	ADM, ADM2, CALCA, CALCB, IAPP	ADM [CellTalkDB:9620797;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:9620797;LRdb:9620797;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], ADM2 [Baccin2019:14615490;CellTalkDB:14615490;Cellinker:14615490;Guide2Pharma:21658025;LRdb:14615490;connectomeDB2020:14615490;scConnect:21658025], CALCA [CellTalkDB:9620797;Cellinker:12234182;Cellinker:14668209;Cellinker:3001670;Cellinker:8626685;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:12234182;HPRD:14668209;HPRD:3001670;HPRD:8626685;HPRD:9620797;IntAct:23597562;LRdb:12234182;LRdb:14668209;LRdb:3001670;LRdb:8626685;LRdb:9620797;Lit-BM-17:16293613;Lit-BM-17:23597562;Lit-BM-17:9620797;connectomeDB2020:12234182;connectomeDB2020:14668209;connectomeDB2020:3001670;connectomeDB2020:8626685;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], CALCA [Baccin2019:12234182;Baccin2019:14668209;Baccin2019:3001670;Baccin2019:8626685;Baccin2019:9620797;CellTalkDB:9620797;Cellinker:12234182;Cellinker:14668209;Cellinker:3001670;Cellinker:8626685;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:12234182;HPRD:14668209;HPRD:3001670;HPRD:8626685;HPRD:9620797;LRdb:12234182;LRdb:14668209;LRdb:3001670;LRdb:8626685;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:14668209;connectomeDB2020:3001670;connectomeDB2020:8626685;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], CALCB [Baccin2019:12196113;Baccin2019:12234182;Baccin2019:14668209;Baccin2019:3001670;Baccin2019:8626685;Baccin2019:9620797;CellTalkDB:12196113;Cellinker:12196113;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;LRdb:12196113;connectomeDB2020:12196113;scConnect:10347248;scConnect:11693189;scConnect:9620797], IAPP [NA]	adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; negative regulation of inflammatory response [GO:0050728]; negative regulation of smooth muscle contraction [GO:0045986]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein transport [GO:0015031]; receptor internalization [GO:0031623]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCRL&keywords=CALCRL	11.09451546	153	NA	NA	1.277720068	188	0.03937007874	0.004491017964	0.7511061947	0.07314148681	0.003367003367	0.003384094755	0.008159564823	0.004893964111	0.005549389567	0.002436907464	0.00417230056	216	274	249	0.08182472753	0.1693377153	0.1354418118	0.1543407853	415	412	414	257
CCKAR	cholecystokinin A receptor	Yes	No		ENSG00000163394	P32238	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P06307	CCK	CCK [Baccin2019:10368033;Baccin2019:10400673;Baccin2019:10595537;Baccin2019:11300760;Baccin2019:9006937;Baccin2019:9603948;CellTalkDB:10368033;Cellinker:10368033;Cellinker:10400673;Cellinker:10595537;Cellinker:11300760;Cellinker:9006937;Cellinker:9603948;HPRD:10400673;HPRD:10595537;HPRD:11300760;HPRD:9006937;HPRD:9603948;LRdb:10368033;LRdb:10400673;LRdb:10595537;LRdb:11300760;LRdb:9006937;LRdb:9603948;SIGNOR:10368033;connectomeDB2020:10368033;connectomeDB2020:10400673;connectomeDB2020:10595537;connectomeDB2020:11300760;connectomeDB2020:9006937;connectomeDB2020:9603948]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]	axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCKAR&keywords=CCKAR	0.427711818	474	NA	NA	1.431024596	164	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	319
CCKBR	cholecystokinin B receptor	Yes	No		ENSG00000110148	P32239	G-protein coupled receptor 1 family	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01350, P06307, P07550, P14416, P51679	ADRB2, CCK, CCR4, DRD2, GAST	GAST [Baccin2019:7681836;CellTalkDB:7681836;Cellinker:7681836;DIP:8824290;ICELLNET:8349705;LRdb:7681836;SIGNOR:10368033;connectomeDB2020:7681836], CCK [Baccin2019:10368033;Baccin2019:10438490;Baccin2019:12695525;Baccin2019:15001692;Baccin2019:15068617;Baccin2019:15520004;Baccin2019:7681836;Baccin2019:8349705;BioGRID:12695525;BioGRID:15001692;BioGRID:15520004;CellTalkDB:10368033;Cellinker:10368033;Cellinker:10438490;Cellinker:12695525;Cellinker:15001692;Cellinker:15068617;Cellinker:15520004;Cellinker:7681836;Cellinker:8349705;Guide2Pharma:7681836;Guide2Pharma:8349705;HPRD:10438490;HPRD:12695525;HPRD:15001692;HPRD:15068617;HPRD:15520004;LRdb:10368033;LRdb:10438490;LRdb:12695525;LRdb:15001692;LRdb:15068617;LRdb:15520004;LRdb:7681836;LRdb:8349705;Lit-BM-17:12695525;Lit-BM-17:15001692;Lit-BM-17:15520004;Lit-BM-17:23597562;SIGNOR:10368033;connectomeDB2020:10368033;connectomeDB2020:10438490;connectomeDB2020:12695525;connectomeDB2020:15001692;connectomeDB2020:15068617;connectomeDB2020:15520004;connectomeDB2020:7681836;connectomeDB2020:8349705;scConnect:7681836;scConnect:8349705], CCR4 [Cellinker:23023127], ADRB2 [Cellinker:23023127;Cellinker:24561123], DRD2 [Cellinker:23023127]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; cholecystokinin receptor activity [GO:0004951]; gastrin receptor activity [GO:0015054]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; type B gastrin/cholecystokinin receptor binding [GO:0031741]	cell surface receptor signaling pathway [GO:0007166]; cholecystokinin signaling pathway [GO:0038188]; digestive tract development [GO:0048565]; gastric acid secretion [GO:0001696]; gland development [GO:0048732]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pH reduction [GO:0045851]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCKBR&keywords=CCKBR	0.9803500967	383	NA	NA	0.3107070542	455	0	9.98E-04	0	4.80E-04	0.01346801347	0.03553299492	0.02175883953	0.02120717781	0.09322974473	0.01412071038	0.009001352134	82	186	214	0.01907240484	3.550781068	0.8296771631	0.6535872157	2	189	213	303
EPHA1	EPH receptor A1	Yes	Yes, No		ENSG00000284816, ENSG00000146904	P21709	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43921, P20827, P52797, P52798, P52803	EFNA1, EFNA2, EFNA3, EFNA4, EFNA5	EFNA1 [Baccin2019:11519828;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11519828;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPMR:9330863;HPRD:11519828;HPRD:8755474;LRdb:11114742;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:11519828;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9267020;connectomeDB2020:11519828;connectomeDB2020:8755474;connectomeDB2020:9330863], EFNA2 [CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347], EFNA3 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;Ramilowski2015:16466970;connectomeDB2020:16466970;talklr:16466970], EFNA5 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347], EFNA4 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA1&keywords=EPHA1	3.775428999	251	NA	NA	0.4912963149	375	0	0.008483033932	0.00110619469	2.40E-04	0.001683501684	0.006768189509	0.002719854941	0	0.002589715131	0.001702496996	7.34E-04	227	295	323	0.002366073716	1.018085079	0.9463389322	0.8680213369	102	147	128	267
EPHA8	EPH receptor A8	Yes	No		ENSG00000070886	P29322	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43921, P20827, P52797, P52798, P52799, P52803	EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, EFNB2	EFNA1 [Baccin2019:10515610;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10515610;Cellinker:15114347;HPRD:10515610;LRdb:11114742;SIGNOR:17420126;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10515610], EFNA2 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNA3 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNA4 [Baccin2019:10515610;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10515610;Cellinker:15114347;HPRD:10515610;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10515610], EFNA5 [Baccin2019:933086311416136;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11416136;Cellinker:15114347;Cellinker:9330863;HPMR:9330863;HPRD:11416136;LRdb:11114742;SIGNOR:9330863;SignaLink3:11416136;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:11416136;connectomeDB2020:9330863], EFNB2 [Cellinker:32589946]	early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA8&keywords=EPHA8	0.2338762989	531	NA	NA	0.5694898117	350	0	0	0	0	0.001683501684	0.005076142132	0.001813236627	0	0.005549389567	0.003939110696	7.73E-05	216	249	345	0.001648967776	1.334829821	1.19659621	0.865077921	52	80	129	303
EPHB3	EPH receptor B3	Yes	No		ENSG00000182580	P54753	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P08631, P52799, P55196, P98172, Q15768	AFDN, EFNB1, EFNB2, EFNB3, HCK	EFNB3 [Baccin2019:93308639484836;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;Cellinker:9484836;HPRD:9484836;LRdb:11114742;SIGNOR:9330863;SIGNOR:9484836;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9267020;SignaLink3:9484836;connectomeDB2020:9330863;connectomeDB2020:9484836], EFNB1 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:9330863;HPMR:9330863;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNB2 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:15114347;Cellinker:9330863;LRdb:11114742;SIGNOR:8559144;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], AFDN [CellTalkDB:9707552;Cellinker:9707552;DOMINO:9707552;HPRD:9707552;LRdb:9707552;Lit-BM-17:9707552;connectomeDB2020:9707552], HCK [KEA:17570479]	cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHB3&keywords=EPHB3	1.628350417	327	NA	NA	0.1271923218	608	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	468
EPHB4	EPH receptor B4	Yes	Yes		ENSG00000196411	P54760	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P01588, P52799, P98172, Q15768	EFNB1, EFNB2, EFNB3, EPO	EFNB2 [Baccin2019:12051776;Baccin2019:7534404;Baccin2019:9718367;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:15114347;Cellinker:12051776;Cellinker:15114347;Cellinker:7534404;Cellinker:9718367;HPMR:7534404;HPRD:12051776;HPRD:9718367;LRdb:11114742;SignaLink3:12051776;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9576626;SignaLink3:9718367;connectomeDB2020:12051776;connectomeDB2020:7534404;connectomeDB2020:9718367], EFNB1 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;LRdb:11114742;SIGNOR:9330863;connectomeDB2020:9330863], EFNB3 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;CellTalkDB:8755474;Cellinker:15114347;LRdb:11114742;Ramilowski2015:8755474;connectomeDB2020:8755474;talklr:8755474], EPO [CellTalkDB:26481148;connectomeDB2020:25586589;connectomeDB2020:26481148]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHB4&keywords=EPHB4	10.77649432	155	NA	NA	0.3332781464	439	0	0.1067864271	0.0342920354	0.01270983213	0.01683501684	0.001692047377	0.001813236627	0	3.70E-04	9.68E-04	6.18E-04	233	318	326	0.01600770545	0.3987264207	0.4217244981	0.4082681812	335	315	308	307
FGFR1	fibroblast growth factor receptor 1	Yes	No	small molecule receptor	ENSG00000077782	P11362	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15520, O43320, O43559, O60258, O76093, O95750, P00533, P05230, P06213, P08069, P08253, P08620, P09038, P09486, P10767, P11487, P12034, P13591, P16234, P21709, P21781, P21802, P23352, P27361, P28482, P29317, P29320, P31371, P32004, P35222, P51812, P54756, P54764, P55075, P61328, P98160, Q01094, Q02156, Q13308, Q15223, Q15375, Q15418, Q15464, Q16539, Q8N441, Q92913, Q92914, Q92915, Q9GZV9, Q9HCT0, Q9NP84, Q9NP95, Q9NSA1, Q9UEF7	ANOS1, CTNNB1, E2F1, EGFR, EPHA1, EPHA2, EPHA3, EPHA4, EPHA5, EPHA7, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR2, FGFRL1, FRS3, HSPG2, IGF1R, INSR, KL, L1CAM, MAPK1, MAPK14, MAPK3, MMP2, NCAM1, NECTIN1, PDGFRA, PRKCE, PTK7, RPS6KA1, RPS6KA3, SHB, SPARC, TNFRSF12A	E2F1 [SPIKE:19303924], FGF1 [Baccin2019:10336501;Baccin2019:11032250;Baccin2019:8663044;Baccin2019:8756477;BioGRID:1309595;BioGRID:1383494;BioGRID:8756477;BioGRID:9624181;CellTalkDB:16597617;Cellinker:10336501;Cellinker:11032250;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;Cellinker:8756477;DIP:10830168;DIP:1722683;DIP:22244757;DIP:7730326;HPMR:8663044;HPRD:10336501;HPRD:11032250;IntAct:10830168;IntAct:14613973;IntAct:18441324;IntAct:25241761;LRdb:16597617;Lit-BM-17:10830168;Lit-BM-17:11030354;Lit-BM-17:11714710;Lit-BM-17:1722683;Lit-BM-17:18441324;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:7730326;Lit-BM-17:8576175;MatrixDB:18441324;SIGNOR:11030354;SIGNOR:18940940;SignaLink3:11030354;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8576175;connectomeDB2020:10336501;connectomeDB2020:11032250;connectomeDB2020:8663044;connectomeDB2020:8756477], SHB [HPRD-phos:12181353;HPRD-phos:7516330;HPRD-phos:8622701;KEA:12181353;KEA:7516330;KEA:8622701;KEA:9880324;iPTMnet:12181353;iPTMnet:7516330;iPTMnet:8622701], MAPK14 [ACSN:11274345;ACSN:12738796;ACSN:15187187;ACSN:18039929;KEA:18411303;ProtMapper:18411303;ProtMapper:20626350;SIGNOR:20626350;iPTMnet:18411303;iPTMnet:20626350], MAPK3 [PhosphoSite:18411303;ProtMapper:23405013;ProtMapper:27342992;SIGNOR:23405013;iPTMnet:23405013], MAPK1 [ProtMapper:23405013;ProtMapper:27342992;SIGNOR:23405013;iPTMnet:23405013], FGF5 [Baccin2019:83868288386828;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;DIP:8386828;HPRD:8386828;LRdb:16597617;SIGNOR:8386828;connectomeDB2020:8386828], PRKCE [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;ProtMapper:23564461;SIGNOR:23564461;iPTMnet:23564461], FGF4 [Baccin2019:1148603311486030;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;HPRD:11486033;LRdb:16597617;connectomeDB2020:11486033], FGF20 [CellTalkDB:16597617;Cellinker:25772309;Cellinker:31276493;LRdb:16597617;connectomeDB2020:16597617], FGF22 [CellTalkDB:16597617;LRdb:16597617;connectomeDB2020:16597617], MMP2 [CellTalkDB:8692946;HPRD-phos:8692946;HPRD:8692946], FGF6 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGF23 [Baccin2019:16081635;BioGRID:27879395;CellTalkDB:16597617;Cellinker:25772309;DIP:19966287;LRdb:16597617;Lit-BM-17:19966287;Lit-BM-17:22393163;connectomeDB2020:16081635], ANOS1 [BioGRID:20874775;BioGRID:23189990;CellTalkDB:19696444;Cellinker:19696444;IntAct:19696444;LRdb:19696444;Lit-BM-17:19696444;Ramilowski2015:19696444;connectomeDB2020:19696444;talklr:19696444], FGF2 [Baccin2019:10950949;Baccin2019:11030354;BioGRID:10950949;BioGRID:11786412;BioGRID:14505356;BioGRID:15096041;BioGRID:16829530;BioGRID:8868466;BioGRID:9174056;CellTalkDB:16597617;Cellinker:10950949;Cellinker:11030354;Cellinker:16597617;Cellinker:25772309;DIP:10574979;DIP:10950949;DIP:17086194;DIP:1722683;DIP:7730326;HPRD:10950949;HPRD:11030354;IntAct:10490103;IntAct:11030354;IntAct:14613973;IntAct:23597563;IntAct:26267536;LRdb:16597617;Lit-BM-17:10490103;Lit-BM-17:10574979;Lit-BM-17:10950949;Lit-BM-17:11030354;Lit-BM-17:1722683;Lit-BM-17:23597562;Lit-BM-17:23597563;Lit-BM-17:26267536;Lit-BM-17:7730326;Lit-BM-17:9174056;connectomeDB2020:10950949;connectomeDB2020:11030354], FGF10 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:30809251;LRdb:16597617;connectomeDB2020:16597617], FGF7 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGF18 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGF11 [CellTalkDB:16597617;LRdb:16597617], FGF19 [CellTalkDB:16597617;Cellinker:22442730;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGF8 [Baccin2019:829025710574949;CellTalkDB:16597617;Cellinker:25772309;DIP:22244757;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949;connectomeDB2020:8290257], FGF13 [CellTalkDB:16597617;LRdb:16597617], FGF3 [Baccin2019:75926248663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:7592624;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:7592624;connectomeDB2020:8663044], FGF17 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], HSPG2 [CellTalkDB:19591432;Cellinker:15096041;MatrixDB:24509440], FGF14 [CellTalkDB:16597617;LRdb:16597617], FGF9 [Baccin2019:10574949;CellTalkDB:16597617;Cellinker:25772309;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949], FGF21 [CellTalkDB:16597617;Cellinker:22442730;Cellinker:25772309;LRdb:16597617], NCAM1 [Baccin2019:12121226;BioGRID:12121226;BioGRID:12791257;CellChatDB:12791257;CellTalkDB:12121226;Cellinker:12121226;Cellinker:12791257;HPRD:12121226;LRdb:12121226;connectomeDB2020:12121226], FGF16 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617], FGF12 [CellTalkDB:16597617;LRdb:16597617], NECTIN1 [Cellinker:22955284], TNFRSF12A [Cellinker:24571920], SPARC [Cellinker:14505356], EPHA5 [Cellinker:26024354], EPHA3 [Cellinker:26024354], FGFRL1 [Cellinker:24026051;Cellinker:30217817], FRS3 [Cellinker:9660748;HPRD:10629055;HPRD:9660748], EPHA1 [Cellinker:26024354], L1CAM [BioGRID:18222703;BioGRID:23212305;Cellinker:23212305], KL [NA], EGFR [Cellinker:21868365;KEA:17570479], PDGFRA [Cellinker:16322476], EPHA7 [Cellinker:26024354], PTK7 [Cellinker:31490704], EPHA2 [Cellinker:26024354], FGFR2 [NA], RPS6KA3 [Lit-BM-17:24141780;PhosphoSite:24141780;ProtMapper:24141780], IGF1R [KEA:17570479], INSR [KEA:17570479], CTNNB1 [Lit-BM-17:11401320;Lit-BM-17:25241761], EPHA4 [HPRD:16365308], RPS6KA1 [HPRD:15117958]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR1&keywords=FGFR1	82.23597091	24	1866.19	67	1.43526438	163	0.08661417323	0.5828343313	0.1725663717	0.7340527578	0.2794612795	0.4957698816	0.4125113327	0.5644371941	0.3348131706	0.2053344906	0.2726675681	20	44	31	0.3764602319	0.8922345485	0.5571970226	0.7314273106	148	277	184	115
FGFR4	fibroblast growth factor receptor 4	Yes	Yes		ENSG00000160867	P22455	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	18	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15520, O43300, O43320, O60258, O75487, O76093, O95750, P05230, P08620, P09038, P10767, P11487, P12034, P21781, P31371, P51654, P54764, P55075, P61328, Q00887, Q13046, Q6ISS4, Q92913, Q92914, Q92915, Q9GZV9, Q9NP95, Q9NSA1	EPHA4, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, GPC3, GPC4, LAIR2, LRRTM2, PSG7, PSG9	FGF19 [Baccin2019:1473096710525310;CellTalkDB:16597617;Cellinker:10525310;Cellinker:14730967;Cellinker:22442730;Cellinker:31529503;DIP:10525310;DIP:19706524;Guide2Pharma:10525310;HPRD:10525310;LRdb:16597617;connectomeDB2020:10525310;connectomeDB2020:14730967], FGF6 [Baccin2019:13851111385111;CellTalkDB:16597617;Cellinker:1385111;Cellinker:25772309;HPRD:1385111;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:1385111], FGF1 [Baccin2019:10336501;Baccin2019:10736564;Baccin2019:8663044;BioGRID:10336501;BioGRID:10736564;CellTalkDB:16597617;Cellinker:10336501;Cellinker:10736564;Cellinker:25772309;Cellinker:8663044;DIP:7680645;HPRD:10336501;HPRD:10736564;LRdb:16597617;Lit-BM-17:10336501;Lit-BM-17:10736564;Lit-BM-17:11714710;Lit-BM-17:25241761;Lit-BM-17:7680645;SIGNOR:1385111;connectomeDB2020:10336501;connectomeDB2020:10736564;connectomeDB2020:8663044], FGF4 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:25772309;Cellinker:8663044;HPMR:11486033;HPRD:8663044;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:11486033;connectomeDB2020:8663044], FGF2 [Baccin2019:86630448530375;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8530375;Cellinker:8663044;DIP:7680645;HPRD:8530375;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:8530375;connectomeDB2020:8663044], FGF20 [Cellinker:25772309;LRdb:15621532;LRdb:17;Ramilowski2015:15621532;connectomeDB2020:15621532;talklr:15621532], FGF23 [Baccin2019:16081635;CellTalkDB:16597617;Cellinker:16081635;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16081635], FGF7 [CellTalkDB:7680645;Cellinker:7680645;HPRD:7680645;LRdb:7680645], FGF18 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGF21 [CellTalkDB:22442730;Cellinker:22442730;LRdb:16597617;LRdb:22;Ramilowski2015:22442730;connectomeDB2020:22442730;talklr:22442730], FGF3 [Baccin2019:8663044;CellTalkDB:8663044;Cellinker:8663044;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], FGF5 [Baccin2019:13851118663044;CellTalkDB:16597617;Cellinker:1385111;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:1385111;connectomeDB2020:8663044], FGF14 [CellTalkDB:16597617;LRdb:16597617], FGF11 [CellTalkDB:16597617;LRdb:16597617], FGF17 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGF16 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGF13 [CellTalkDB:16597617;LRdb:16597617], FGF12 [CellTalkDB:16597617;LRdb:16597617], FGF9 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGF8 [Baccin2019:1148603310736560;CellTalkDB:16597617;Cellinker:10736564;Cellinker:11486033;Cellinker:25772309;HPRD:10736564;LRdb:16597617;connectomeDB2020:10736564;connectomeDB2020:11486033], FGF10 [NA], PSG9 [Cellinker:32822567], LRRTM2 [Cellinker:32822567], PSG7 [Cellinker:32822567], GPC4 [Cellinker:32589946], LAIR2 [Cellinker:32822567], GPC3 [Cellinker:32589946], EPHA4 [HPRD:16365308]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR4&keywords=FGFR4	5.473013001	223	NA	NA	0.59967037	338	0	0.07784431138	0.00110619469	0.003836930456	0.003367003367	0.006768189509	0.005439709882	0.003262642741	0.009988901221	7.68E-04	0.009155881785	201	322	211	0.01104886889	0.9496425354	0.5115615865	0.910067039	124	291	113	294
FPR2	formyl peptide receptor 2	Yes	Yes		ENSG00000171049	P25090	G-protein coupled receptor 1 family	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04083, P05067, P0DJI8, P49913, P55773, Q8IVG9, Q96BQ1	ANXA1, APP, APP_BACE1_PSEN1, CAMP, CCL23, FAM3D, MT-RNR2, SAA1	ANXA1 [Baccin2019:10882119;Baccin2019:12368905;Baccin2019:12560218;Baccin2019:16278303;CellChatDB:23230437;CellPhoneDB:22610094;CellTalkDB:22610094;Cellinker:10882119;Cellinker:12368905;Cellinker:12560218;Cellinker:16278303;Cellinker:22610094;Cellinker:23230437;Guide2Pharma:12368905;LRdb:10882119;LRdb:12368905;LRdb:12560218;LRdb:16278303;SIGNOR:15187149;connectomeDB2020:10882119;connectomeDB2020:12368905;connectomeDB2020:12560218;connectomeDB2020:16278303;scConnect:10882119;scConnect:12368905;scConnect:12560218;scConnect:16278303], MT-RNR2 [Guide2Pharma:15465011;scConnect:15465011], CAMP [CellTalkDB:11015447;Cellinker:11015447;Guide2Pharma:11015447;HPMR:11015447;HPRD:11015447;LRdb:11015447;SIGNOR:11015447;connectomeDB2020:11015447;scConnect:11015447], SAA1 [Baccin2019:9892621;CellChatDB:22610094;CellTalkDB:9892621;Cellinker:22610094;Cellinker:9892621;Guide2Pharma:9892621;ICELLNET:26130702;LRdb:9892621;connectomeDB2020:9892621;scConnect:9892621], CCL23 [Cellinker:29637711;ICELLNET:22633458], APP [CellTalkDB:11316806;Cellinker:11160457;Cellinker:11316806;LRdb:11;LRdb:11316806;connectomeDB2020:11160457;connectomeDB2020:11316806;scConnect:11160457;scConnect:11316806], FAM3D [connectomeDB2020:29853563]	cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FPR2&keywords=FPR2	0.1684705146	564	NA	NA	0.08320631041	670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	617
FSHR	follicle stimulating hormone receptor	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000170820	P23945	G-protein coupled receptor 1 family, FSH/LSH/TSH subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01133, P01215, P01225, P25098, P31751, P32298, P43250, P62987	AKT2, CGA, EGF, FSHB, GRK2, GRK4, GRK6, UBA52	CGA [CellTalkDB:30910395;HPMR:2126341;NetPath:12374801;NetPath:15662415], FSHB [Baccin2019:10395410;Baccin2019:2126341;CellTalkDB:2126341;Cellinker:10395410;Cellinker:2126341;HPMR:2126341;HPRD:10395410;LRdb:104;LRdb:2126341;NetPath:15662415;connectomeDB2020:10395410;connectomeDB2020:2126341], EGF [CellTalkDB:32196115], UBA52 [HPRD:12960054], AKT2 [HPRD:15070827;InnateDB:15070827;NetPath:15070827], GRK2 [HPRD:10379886], GRK4 [HPRD:10379886], GRK6 [HPRD:10379886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; gonad development [GO:0008406]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FSHR&keywords=FSHR	0.006016625843	793	NA	NA	0.1685749729	551	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	672
GALR1	galanin receptor 1	Yes	TBD		ENSG00000166573	P47211	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P22466, Q9UBC7	GAL, GALP	GAL [Baccin2019:10689365;Baccin2019:11481429;Baccin2019:11600206;Baccin2019:7524088;Baccin2019:8617199;Baccin2019:9168941;Baccin2019:9685625;Baccin2019:9808667;Baccin2019:9880084;CellTalkDB:11481429;Cellinker:10689365;Cellinker:11481429;Cellinker:11600206;Cellinker:7524088;Cellinker:8617199;Cellinker:9168941;Cellinker:9685625;Cellinker:9808667;Cellinker:9880084;Guide2Pharma:11481429;Guide2Pharma:11600206;Guide2Pharma:7524088;Guide2Pharma:9168941;Guide2Pharma:9685625;Guide2Pharma:9808667;Guide2Pharma:9880084;HPMR:10689365;HPRD:7524088;HPRD:8617199;HPRD:9808667;LRdb:10689365;LRdb:11481429;LRdb:11600206;LRdb:7524088;LRdb:8617199;LRdb:9168941;LRdb:9685625;LRdb:9808667;LRdb:9880084;connectomeDB2020:10689365;connectomeDB2020:11481429;connectomeDB2020:11600206;connectomeDB2020:7524088;connectomeDB2020:8617199;connectomeDB2020:9168941;connectomeDB2020:9685625;connectomeDB2020:9808667;connectomeDB2020:9880084;scConnect:11481429;scConnect:11600206;scConnect:7524088;scConnect:9168941;scConnect:9685625;scConnect:9808667;scConnect:9880084], GALP [Baccin2019:1068936515944000;CellChatDB:23233848;CellTalkDB:10689365;Cellinker:10689365;Cellinker:15944009;Cellinker:23233848;LRdb:10689365;LRdb:16;connectomeDB2020:10689365;connectomeDB2020:15944009;scConnect:15944009]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	galanin receptor activity [GO:0004966]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GALR1&keywords=GALR1	0.1264598979	594	NA	NA	0.637635195	326	0	4.99E-04	0.01991150442	0.004316546763	0	0.005076142132	0.005439709882	0	7.40E-04	0.002336760582	0.001390766853	232	277	304	0.003610031931	0.7891178113	0.906446116	0.8369390249	193	161	143	340
GHR	growth hormone receptor	Yes	No		ENSG00000112964	P10912	Type I cytokine receptor family, Type 1 subfamily	18	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14508, O14543, O15524, O60674, P01241, P01242, P08069, P17706, P18031, P23458, P23467, P26045, P29350, P29597, P40763, P42229, P43378, Q06124, Q14406, Q16829, Q9HD43, Q9NSE2	CISH, CSHL1, DUSP7, GH1, GH2, IGF1R, JAK1, JAK2, PTPN1, PTPN11, PTPN2, PTPN3, PTPN6, PTPN9, PTPRB, PTPRH, SOCS1, SOCS2, SOCS3, STAT3, STAT5A, TYK2	JAK2 [BioGRID:10502458;BioGRID:21347402;BioGRID:7540178;BioGRID:8063815;HPRD:10502458;HPRD:7540178;HPRD:8063815;KEA:8647880;KEA:9121492;iPTMnet:9121492;phosphoELM:9121492], GH1 [BioGRID:7862673;CellChatDB:10551877;CellTalkDB:7862673;Cellinker:10551877;Cellinker:31100495;Cellinker:7862673;DIP:9571026;ICELLNET:2387255;InnateDB:21889455;IntAct:31279174;IntAct:8943276;IntAct:9353194;LRdb:7862673;Lit-BM-17:17500058;Lit-BM-17:24280222;Lit-BM-17:7862673;Lit-BM-17:8943276;Lit-BM-17:9353194;Lit-BM-17:9571026;SIGNOR:7862673;SignaLink3:1549776;SignaLink3:1935820;SignaLink3:19927328;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:2825030;SignaLink3:29145629;SignaLink3:3349036;SignaLink3:7691587;SignaLink3:9030599;connectomeDB2020:7862673], TYK2 [HPRD:10502458], JAK1 [HPRD:10502458], GH2 [CellTalkDB:1955498;Cellinker:1955498;HPRD:1955498;ICELLNET:2387255;LRdb:1955498;connectomeDB2020:1955498], DUSP7 [DOMINO:12907755;Lit-BM-17:12907755;SIGNOR:12907755], PTPRH [IntAct:12907755;Lit-BM-17:12907755;SIGNOR:12907755], PTPN1 [DEPOD:12907755;DOMINO:12907755;IntAct:12907755;Lit-BM-17:12907755;ProtMapper:12907755;SIGNOR:12907755], PTPRB [DOMINO:12907755;IntAct:12907755;IntAct:19167335;Lit-BM-17:12907755;Lit-BM-17:19167335;SIGNOR:12907755], PTPN3 [DEPOD:12907755;DOMINO:12907755;IntAct:12907755;Lit-BM-17:12907755;ProtMapper:12907755;SIGNOR:12907755], PTPN2 [DOMINO:12907755;HPRD:12907755;IntAct:12907755;Lit-BM-17:12907755;ProtMapper:12907755;SIGNOR:12907755], PTPN9 [DOMINO:12907755;Lit-BM-17:12907755;SIGNOR:12907755], CSHL1 [CellTalkDB:32196115], IGF1R [Cellinker:31100495;InnateDB:25211187;KEA:17570479], PTPN11 [BioGRID:10976913;BioGRID:9632636;HPRD:10976913], SOCS2 [BioGRID:12135564;BioGRID:28967904;HPRD:10585430;InnateDB:12135564;Lit-BM-17:10585430;Lit-BM-17:12135564;Lit-BM-17:16675548;Lit-BM-17:21980433], CISH [HPRD:12586763;InnateDB:10585430], PTPN6 [HPRD:9632636], STAT5A [HPRD:8702683], SOCS1 [HPRD:10585430], SOCS3 [HPRD:10585430], STAT3 [HPRD:8923468]	cell surface [GO:0009986]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth hormone receptor complex [GO:0070195]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; growth hormone receptor activity [GO:0004903]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; proline-rich region binding [GO:0070064]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH2 domain binding [GO:0042169]	activation of Janus kinase activity [GO:0042976]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; growth hormone receptor signaling pathway [GO:0060396]; hormone-mediated signaling pathway [GO:0009755]; hormone metabolic process [GO:0042445]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of neuron death [GO:1901215]; positive regulation of cell differentiation [GO:0045597]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor internalization [GO:0031623]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of multicellular organism growth [GO:0040014]; response to cycloheximide [GO:0046898]; response to estradiol [GO:0032355]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to interleukin-1 [GO:0070555]; response to morphine [GO:0043278]; taurine metabolic process [GO:0019530]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHR&keywords=GHR	1.679194346	320	NA	NA	0.2445083047	486	0	4.99E-04	0.002212389381	0.05275779376	0	0.02707275804	0.002719854941	0	0.03070662227	0.004005875284	0.001352134441	159	248	305	0.01102967547	1.935675248	0.6660052984	0.5398150085	22	241	256	324
GIPR	gastric inhibitory polypeptide receptor	Yes	No		ENSG00000010310	P48546	G-protein coupled receptor 2 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01275, P09681	GCG, GIP	GIP [Baccin2019:12627975;Baccin2019:15655707;Baccin2019:7589426;Baccin2019:8795084;CellTalkDB:15655705;Cellinker:12627975;Cellinker:15655707;Cellinker:7589426;Cellinker:8795084;DIP:17715056;Guide2Pharma:7589426;HPRD:12627975;HPRD:15655707;HPRD:7589426;HPRD:8795084;IntAct:17715056;LRdb:12627975;LRdb:15655707;LRdb:7589426;LRdb:8795084;Lit-BM-17:17715056;connectomeDB2020:12627975;connectomeDB2020:15655707;connectomeDB2020:7589426;connectomeDB2020:8795084;scConnect:26572091;scConnect:7589426], GCG [DIP:17715056;Lit-BM-17:17715056]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GIPR&keywords=GIPR	8.141974235	177	NA	NA	2.635191208	87	0	0.02694610778	0.00110619469	0.007673860911	0.02693602694	0.20642978	0.1740707162	0.1044045677	0.1143174251	0.152590466	0.0309831949	72	59	131	0.07685984912	1.43124155	1.871871384	0.4718312928	42	24	286	87
GLP2R	glucagon like peptide 2 receptor	Yes	No		ENSG00000065325	O95838	G-protein coupled receptor 2 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01275, P0DP23	CALM1, GCG	GCG [CellTalkDB:9990065;Cellinker:11738243;Cellinker:24990862;Cellinker:9990065;Guide2Pharma:11738243;HPMR:9990065;HPRD:11738243;LRdb:117;LRdb:9990065;connectomeDB2020:11738243;connectomeDB2020:9990065;scConnect:11738243], CALM1 [CellTalkDB:32196115;HPRD:15670850]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	glucagon receptor activity [GO:0004967]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GLP2R&keywords=GLP2R	0.5879125556	442	NA	NA	0.3100766834	456	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	449
GPR37	G protein-coupled receptor 37	Yes	No		ENSG00000170775	O15354	G-protein coupled receptor 1 family	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, intracellular, plasma_membrane, receptor, transmembrane	O60260, P07550, P07602, P29274, Q13639, Q86TM6	ADORA2A, ADRB2, HTR4, PRKN, PSAP, SYVN1	PRKN [HPRD:11439185;HPRD:12150907;Lit-BM-17:11439185;Lit-BM-17:12150907;Lit-BM-17:14579121;SIGNOR:12666095;SPIKE:15194120], PSAP [Baccin2019:2369059423690590;CellChatDB:23690594;CellTalkDB:23690594;Cellinker:23690594;Guide2Pharma:23690594;LRdb:23690594;connectomeDB2020:23690594;scConnect:23690594], ADRB2 [Cellinker:24561123;Lit-BM-17:24561123], HTR4 [Cellinker:28298427], ADORA2A [Cellinker:28298427], SYVN1 [BioGRID:18344614]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR37&keywords=GPR37	1.443245067	341	NA	NA	0.1666625569	554	0	0.04091816367	0.00110619469	9.59E-04	0.008417508418	0.02368866328	0.02357207616	0.02283849918	0.01479837218	0.005007344105	0.02244543172	191	236	149	0.01488649873	0.9964588611	0.6030315581	1.303736298	113	263	36	349
GPR37L1	G protein-coupled receptor 37 like 1	Yes	No		ENSG00000170075	O60883	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P07602	PSAP	PSAP [Baccin2019:2369059423690590;CellChatDB:23690594;CellTalkDB:23690594;Cellinker:23690594;Guide2Pharma:23690594;LRdb:23690594;connectomeDB2020:23690594;scConnect:23690594]	ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR37L1&keywords=GPR37L1	0.06756601798	658	NA	NA	0.00700526136	860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	759
HCRTR1	hypocretin receptor 1	Yes	No		ENSG00000121764	O43613	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43612, P12931, P21554	CNR1, HCRT, SRC	HCRT [Baccin2019:10498827;Baccin2019:11162621;Baccin2019:11250867;Baccin2019:11266181;Baccin2019:11403934;Baccin2019:12208495;Baccin2019:12606634;Baccin2019:12702704;Baccin2019:14691055;Baccin2019:18599270;Baccin2019:21362456;Baccin2019:9491897;CellTalkDB:9491897;Cellinker:10498827;Cellinker:11162621;Cellinker:11250867;Cellinker:11266181;Cellinker:11403934;Cellinker:12208495;Cellinker:12606634;Cellinker:12702704;Cellinker:14691055;Cellinker:18599270;Cellinker:21362456;Cellinker:9491897;Guide2Pharma:10498827;Guide2Pharma:11162621;Guide2Pharma:11266181;Guide2Pharma:12208495;Guide2Pharma:12606634;Guide2Pharma:12702704;Guide2Pharma:14691055;Guide2Pharma:17115071;Guide2Pharma:18488139;Guide2Pharma:20002100;Guide2Pharma:21362456;Guide2Pharma:21718304;Guide2Pharma:22550093;Guide2Pharma:26582739;Guide2Pharma:9491897;HPMR:9491897;HPRD:9491897;LRdb:10498827;LRdb:11162621;LRdb:11250867;LRdb:11266181;LRdb:11403934;LRdb:12208495;LRdb:12606634;LRdb:12702704;LRdb:14691055;LRdb:18599270;LRdb:21362456;LRdb:9491897;SIGNOR:9491897;connectomeDB2020:10498827;connectomeDB2020:11162621;connectomeDB2020:11250867;connectomeDB2020:11266181;connectomeDB2020:11403934;connectomeDB2020:12208495;connectomeDB2020:12606634;connectomeDB2020:12702704;connectomeDB2020:14691055;connectomeDB2020:18599270;connectomeDB2020:21362456;connectomeDB2020:9491897;scConnect:10498827;scConnect:11162621;scConnect:11205421;scConnect:11266181;scConnect:11403934;scConnect:12208495;scConnect:12606634;scConnect:12702704;scConnect:14691055;scConnect:15271651;scConnect:17115071;scConnect:18488139;scConnect:20002100;scConnect:21362456;scConnect:21718304;scConnect:22550093;scConnect:26582739;scConnect:9491897], CNR1 [HPRD:12690115;SIGNOR:29751001], SRC [PhosphoSite:18198212]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]	chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HCRTR1&keywords=HCRTR1	0.06567258809	661	NA	NA	0.324827924	444	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	553
HCRTR2	hypocretin receptor 2	Yes	Yes		ENSG00000137252	O43614	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43612	HCRT	HCRT [Baccin2019:11162621;Baccin2019:12208495;Baccin2019:12702704;Baccin2019:18599270;Baccin2019:9491897;CellTalkDB:9491897;Cellinker:11162621;Cellinker:12208495;Cellinker:12702704;Cellinker:18599270;Cellinker:9491897;Guide2Pharma:10498827;Guide2Pharma:11162621;Guide2Pharma:12208495;Guide2Pharma:12606634;Guide2Pharma:12702704;Guide2Pharma:18599270;Guide2Pharma:26582739;Guide2Pharma:27237973;Guide2Pharma:9491897;HPMR:9491897;HPRD:9491897;LRdb:11162621;LRdb:12208495;LRdb:12702704;LRdb:18599270;LRdb:9491897;SIGNOR:9491897;connectomeDB2020:11162621;connectomeDB2020:12208495;connectomeDB2020:12702704;connectomeDB2020:18599270;connectomeDB2020:9491897;scConnect:10498827;scConnect:11162621;scConnect:12208495;scConnect:12606634;scConnect:12702704;scConnect:12890892;scConnect:18599270;scConnect:26582739;scConnect:27237973;scConnect:9491897]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]	chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HCRTR2&keywords=HCRTR2	0.002460120225	815	NA	NA	0.156054867	568	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	692
IFNGR1	interferon gamma receptor 1	Yes	No		ENSG00000027697	P15260	Type II cytokine receptor family	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14543, O15389, O15524, O60674, O75019, P01579, P17181, P20138, P23458, Q06124, Q08ET2, Q8N423, Q9Y336	CD33, IFNAR1, IFNG, JAK1, JAK2, LILRA1, LILRB2, PTPN11, SIGLEC14, SIGLEC5, SIGLEC9, SOCS1, SOCS3	IFNG [Baccin2019:10811850;Baccin2019:10986460;Baccin2019:11250200;Baccin2019:12165521;BioGRID:10986460;CellTalkDB:10811850;DIP:10860730;DIP:7617032;HPMR:10811850;HPMR:12438563;HPRD:10986460;HPRD:11250200;HPRD:12165521;InnateDB:10986460;InnateDB:7673114;IntAct:11250200;IntAct:7617032;LRdb:10811850;LRdb:10986460;LRdb:11250200;LRdb:12165521;Lit-BM-17:10860730;Lit-BM-17:10986460;Lit-BM-17:11250200;Lit-BM-17:7617032;Lit-BM-17:7673114;Macrophage:7617032;SIGNOR:10986460;SIGNOR:12438563;SIGNOR:23898330;SPIKE:16110316;SignaLink3:10986460;SignaLink3:11250200;SignaLink3:12165521;SignaLink3:12438563;SignaLink3:12915721;SignaLink3:1396683;SignaLink3:15143187;SignaLink3:15530433;SignaLink3:16237089;SignaLink3:16467876;SignaLink3:18591661;SignaLink3:18988627;SignaLink3:20304997;SignaLink3:23331499;SignaLink3:29145629;SignaLink3:7510216;SignaLink3:7514165;SignaLink3:7615558;SignaLink3:7617032;SignaLink3:7673114;SignaLink3:8550631;SignaLink3:8631301;SignaLink3:9111318;connectomeDB2020:10811850;connectomeDB2020:10986460;connectomeDB2020:11250200;connectomeDB2020:12165521], JAK1 [HPRD:12133952;InnateDB:12133952;KEA:8156998;Macrophage:7615558;Macrophage:7796299;Macrophage:8232552;Macrophage:8550631;Macrophage:8649432;ProtMapper:7615558;SIGNOR:19041276;SIGNOR:7615558;iPTMnet:7615558;iPTMnet:8156998;phosphoELM:8156998], JAK2 [HPRD:11438544;HPRD:7499845;KEA:8156998;SIGNOR:23898330], SOCS1 [HPRD:15522878;SIGNOR:18708154;SignaLink3:15522878;SignaLink3:18708154;SignaLink3:18988627;SignaLink3:23331499], IFNAR1 [SignaLink3:18929502;SignaLink3:23331499], SOCS3 [Macrophage:14525967], SIGLEC14 [Cellinker:32822567], SIGLEC5 [Cellinker:32822567], SIGLEC9 [Cellinker:32822567], CD33 [Cellinker:32822567], LILRB2 [Cellinker:32822567], LILRA1 [Cellinker:32822567], PTPN11 [HPRD:10022928]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interferon-gamma receptor activity [GO:0004906]	astrocyte activation [GO:0048143]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; microglial cell activation [GO:0001774]; negative regulation of amyloid-beta clearance [GO:1900222]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of gene expression [GO:0010628]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNGR1&keywords=IFNGR1	69.6604079	32	137.905	85	0.8926825474	261	0.4881889764	0.2644710579	0.2876106195	0.4136690647	0.2373737374	0.179357022	0.2466001813	0.1158238173	0.08694043655	0.1621378021	0.1263279892	89	52	55	0.2371364277	0.3922547456	0.6965294584	0.551630492	337	234	251	133
IL12RB2	interleukin 12 receptor subunit beta 2	Yes	No		ENSG00000081985	Q99665	Type I cytokine receptor family, Type 2 subfamily	18	receptor	cell_surface, extracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60674, P29459, P29460, Q9NPF7	IL12A, IL12B, IL23A, JAK2	IL12A [CellTalkDB:943050;DIP:8943050;HPMR:11086056;LRdb:943050;Ramilowski2015:943050;SIGNOR:11086056;connectomeDB2020:943050;talklr:943050], IL12B [Baccin2019:1108605611940480;CellTalkDB:11086056;HPMR:11086056;HPRD:11940489;InnateDB:8943050;LRdb:11086056;LRdb:12;connectomeDB2020:11086056;connectomeDB2020:11940489], IL23A [CellTalkDB:32196115], JAK2 [HPRD:10198225]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]	cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; response to lipopolysaccharide [GO:0032496]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12RB2&keywords=IL12RB2	0.2903571165	508	NA	NA	0.4899508931	376	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	442
IL17RA	interleukin 17 receptor A	Yes	Yes		ENSG00000177663	Q96F46	NA	18	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43734, P49841, Q16552, Q96PD4, Q9H293, Q9P0M4, Q9UHF5	GSK3B, IL17A, IL17B, IL17C, IL17F, IL25, TRAF3IP2	IL17C [connectomeDB2020:21993848], IL17A [Baccin2019:93675399367539;CellTalkDB:9367539;HPMR:9367539;HPRD:9367539;InnateDB:11058597;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;InnateDB:9367539;LRdb:9367539;SIGNOR:9367539;connectomeDB2020:9367539], IL17F [CellTalkDB:18684971;InnateDB:18684971;InnateDB:19838198;LRdb:18684971;Ramilowski2015:18684971;connectomeDB2020:18684971;talklr:18684971], IL17B [NA], IL25 [InnateDB:19838198], GSK3B [iPTMnet:26871944], TRAF3IP2 [InnateDB:17035243;InnateDB:17277779]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102]	cell surface receptor signaling pathway [GO:0007166]; defense response to fungus [GO:0050832]; fibroblast activation [GO:0072537]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; protein catabolic process [GO:0030163]; response to virus [GO:0009615]; T-helper 17 type immune response [GO:0072538]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RA&keywords=IL17RA	6.151030432	208	NA	NA	0.5856575488	346	0.09448818898	0.06437125749	0.03650442478	0.05347721823	0.07070707071	0.07275803723	0.08794197643	0.03752039152	0.04365519793	0.05391240486	0.03480780375	134	126	124	0.05910399744	0.7764413046	0.9248727603	0.6484111687	196	155	218	209
IL17RC	interleukin 17 receptor C	Yes	No		ENSG00000163702	Q8NAC3	NA	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P02751, Q16552, Q96PD4	FN1, IL17A, IL17F	IL17A [CellTalkDB:18684971;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;LRdb:18684971;Ramilowski2015:18684971;connectomeDB2020:18684971;talklr:18684971], IL17F [CellTalkDB:28827714;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198], FN1 [CellTalkDB:32196115]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	interleukin-17 receptor activity [GO:0030368]	inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RC&keywords=IL17RC	17.05591141	118	NA	NA	0.4340171453	388	0.03937007874	0.05089820359	0.006637168142	0.04748201439	0.0404040404	0.08629441624	0.06527651859	0.07830342577	0.05993340733	0.06422753372	0.05713733823	114	112	91	0.05417855865	1.089669335	1.156578385	1.046102306	90	92	66	178
IL18R1	interleukin 18 receptor 1	Yes	No		ENSG00000115604	Q13478	Interleukin-1 receptor family	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	Q14116, Q9NZH6	IL18, IL37	IL18 [Baccin2019:9325300;CellTalkDB:9325300;HPMR:11046021;HPMR:9325300;HPRD:9325300;InnateDB:12096920;InnateDB:9325300;LRdb:9325300;Lit-BM-17:25261253;Lit-BM-17:9325300;SIGNOR:9792649;connectomeDB2020:9325300], IL37 [HPRD:12096920;InnateDB:12096920;InnateDB:25654981]	interleukin-18 receptor complex [GO:0045092]; plasma membrane [GO:0005886]	interleukin-18 binding [GO:0042007]; interleukin-18 receptor activity [GO:0042008]; interleukin-1 receptor activity [GO:0004908]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]	immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; natural killer cell activation [GO:0030101]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; signal transduction [GO:0007165]; T-helper 1 cell differentiation [GO:0045063]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL18R1&keywords=IL18R1	0.4407629078	471	NA	NA	0.07746654706	682	0.04724409449	0.04091816367	0.01438053097	0.05419664269	0	0.003384094755	0.01631912965	0.006525285481	0.002959674436	0.002336760582	0.01081707553	226	277	203	0.01809831384	0.4612260547	0.4390569716	0.7408656493	316	310	180	435
IL1R2	interleukin 1 receptor type 2	Yes	Yes		ENSG00000115590	P27930	Interleukin-1 receptor family	18	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01583, P01584, P18510	IL1A, IL1B, IL1RN	IL1B [Baccin2019:7878046;Baccin2019:8332913;CellTalkDB:8332913;Cellinker:7878046;Cellinker:8332913;HPMR:8332913;HPRD:7878046;InnateDB:1833184;InnateDB:20802483;InnateDB:7878046;LRdb:788;LRdb:8332913;NetPath:7878046;SIGNOR:8332913;SPIKE:7878046;connectomeDB2020:7878046;connectomeDB2020:8332913], IL1RN [Baccin2019:1834644;CellTalkDB:1834644;Cellinker:1834644;HPRD:1834644;ICELLNET:20959797;ICELLNET:24332029;InnateDB:1833184;LRdb:1834644;NetPath:7878046;connectomeDB2020:1834644], IL1A [Baccin2019:78780467878046;CellTalkDB:7878046;Cellinker:7878046;HPRD:7878046;InnateDB:1833184;InnateDB:23395675;IntAct:16971486;IntAct:25241761;LRdb:7878046;NetPath:7878046;NetPath:9862719;connectomeDB2020:7878046]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	interleukin-1, type II, blocking receptor activity [GO:0004910]; interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]	immune response [GO:0006955]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of protein processing [GO:0010955]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1R2&keywords=IL1R2	2.867764689	280	NA	NA	0.2150260047	509	0.0157480315	0.1636726547	0	0.01247002398	0.02693602694	0.03553299492	0.06980961015	0.01305057096	0.02219755827	0.006175724396	0.1016418775	176	223	63	0.04247591576	0.6135682971	0.3082504452	2.127487933	260	358	7	343
IL21R	interleukin 21 receptor	Yes	No		ENSG00000103522	Q9HBE5	Type I cytokine receptor family, Type 4 subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P05112, P23458, Q9GZX6, Q9HBE4	IL21, IL22, IL4, JAK1	JAK1 [HPRD:11016959;HPRD:11418623;InnateDB:11016959], IL21 [Baccin2019:1141862311418620;CellTalkDB:11418623;HPMR:11418623;HPRD:11418623;LRdb:11418623;SIGNOR:16424177;SignaLink3:11418623;SignaLink3:16424177;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11418623], IL22 [CellTalkDB:15546387], IL4 [Cellinker:21058223]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-21 receptor activity [GO:0001532]; transmembrane signaling receptor activity [GO:0004888]	natural killer cell activation [GO:0030101]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL21R&keywords=IL21R	0.2239941261	537	NA	NA	0.1353478033	594	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	566
IL22RA1	interleukin 22 receptor subunit alpha 1	Yes	Yes		ENSG00000142677	Q8N6P7	Type II cytokine receptor family	18	receptor	cell_surface, extracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	Q13007, Q9GZX6, Q9NYY1	IL20, IL22, IL24	IL20 [Baccin2019:12974481;CellTalkDB:12974481;LRdb:12974481;SIGNOR:11163236;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL24 [Baccin2019:12974481;CellTalkDB:12974481;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL22 [Baccin2019:5898511035029;BioGRID:10875937;BioGRID:11035029;CellTalkDB:18675809;DIP:18599299;DIP:20462497;DOMINO:18675809;HPRD:11035029;InnateDB:18599299;IntAct:12513909;IntAct:18599299;IntAct:18675809;IntAct:20462497;LRdb:11035;LRdb:58985;Lit-BM-17:10875937;Lit-BM-17:11035029;Lit-BM-17:12513909;Lit-BM-17:15120653;Lit-BM-17:18599299;Lit-BM-17:18675809;SIGNOR:12941475;connectomeDB2020:11035029;connectomeDB2020:58985]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015]	cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL22RA1&keywords=IL22RA1	8.370009337	175	NA	NA	1.296626518	185	0	0.001497005988	0.00110619469	0	0.1666666667	0	0	0	3.70E-04	0	3.86E-05	233	346	346	0.01542531446	0.4078596283	0.3933088031	0.3948282499	331	325	316	258
INSR	insulin receptor	Yes	No		ENSG00000171105	P06213	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14492, O14508, O14512, O14543, O15524, P01112, P01308, P01344, P02765, P05019, P07948, P08069, P09681, P09958, P0DP23, P0DP24, P0DP25, P10586, P15498, P17252, P17706, P18031, P18433, P20936, P22413, P22681, P23467, P23469, P23470, P24666, P27361, P29122, P29350, P29353, P35568, P41240, P43378, P43490, P51452, P54646, P84077, Q05209, Q05397, Q05655, Q06124, Q12913, Q12923, Q13322, Q13480, Q14449, Q9BX66, Q9HD43, Q9UEF7, Q9UHD2	ACP1, AHSG, ARF1, CALM1, CALM2, CALM3, CBL, CSK, DUSP3, ENPP1, FURIN, GAB1, GIP, GRB10, GRB14, HRAS, IGF1, IGF1R, IGF2, INS, IRS1, KL, LYN, MAPK3, NAMPT, PCSK6, PRKAA1_PRKAA2_PRKAB1_PRKAB2_PRKAG1_PRKAG2_PRKAG3, PRKAA2, PRKCA, PRKCD, PTK2, PTPN1, PTPN11, PTPN12, PTPN13, PTPN2, PTPN6, PTPN9, PTPRA, PTPRB, PTPRE, PTPRF, PTPRG, PTPRH, PTPRJ, RASA1, SH2B2, SHC1, SOCS1, SOCS2, SOCS3, SOCS7, SORBS1, TBK1, VAV1	KL [SPIKE:17684529], INS [Baccin2019:2550426;CellChatDB:24633815;CellTalkDB:2550426;Cellinker:2550426;DIP:11278498;DIP:23302862;HPRD:2550426;IntAct:23302862;IntAct:29512653;LRdb:2550426;ProtMapper:17227660;ProtMapper:19752148;ProtMapper:19902173;ProtMapper:20332342;ProtMapper:21317886;ProtMapper:21743783;ProtMapper:22521887;ProtMapper:22832498;ProtMapper:23223021;ProtMapper:23304064;ProtMapper:23363978;ProtMapper:24296476;ProtMapper:26245346;ProtMapper:26374090;ProtMapper:29069585;ProtMapper:30197476;ProtMapper:8393875;SIGNOR:16956584;SIGNOR:2550426;SPIKE:15870194;SignaLink3:16956584;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:2550426;connectomeDB2020:2550426], IRS1 [Adhesome:10592173;Adhesome:11606564;Adhesome:12446583;Adhesome:1385403;Adhesome:16582879;Adhesome:2159922;Adhesome:7499194;Adhesome:7935368;Adhesome:8626379;Adhesome:8662806;BioGRID:10455177;BioGRID:8626379;DIP:17167487;DIP:7935368;ELM:7537849;ELM:8626723;HPRD:11606564;HPRD:15629149;HPRD:16582879;HPRD:7935368;HPRD:8662806;IntAct:16582879;IntAct:7935368;IntAct:8662806;LMPID:7537849;LMPID:7935368;LMPID:8626723;Lit-BM-17:11606564;Lit-BM-17:11781100;Lit-BM-17:16582879;Lit-BM-17:7499194;Lit-BM-17:7935368;Lit-BM-17:8626379;Lit-BM-17:8662806;ProtMapper:15718410;ProtMapper:25365322], PTPN1 [Adhesome:10592173;Adhesome:10751417;Adhesome:10807907;Adhesome:11163213;Adhesome:11506178;Adhesome:11579209;Adhesome:11726652;Adhesome:12237455;Adhesome:12612081;Adhesome:12634852;Adhesome:14722096;Adhesome:15588987;Adhesome:16271887;Adhesome:16582879;Adhesome:16926280;Adhesome:17092689;Adhesome:17159996;Adhesome:17481567;Adhesome:19029027;Adhesome:21806020;Adhesome:8702689;Adhesome:8999839;CA1:14722096;DEPOD:11163213;DEPOD:11579209;DEPOD:12237455;DEPOD:12634852;DEPOD:14722096;DEPOD:15588987;DEPOD:16271887;DEPOD:16582879;DEPOD:17159996;DEPOD:17481567;DEPOD:8826975;DEPOD:8999839;DIP:16271887;DOMINO:11163213;DOMINO:11579209;DOMINO:12237455;DOMINO:12634852;DOMINO:15588987;DOMINO:16926280;DOMINO:17481567;HPRD-phos:16582879;HPRD:11506178;HPRD:12237455;HPRD:16582879;HPRD:8826975;HPRD:9355745;InnateDB:11579209;InnateDB:12237455;InnateDB:12612081;InnateDB:14722096;InnateDB:17481567;IntAct:11163213;IntAct:11506178;IntAct:11579209;IntAct:12237455;IntAct:12634852;IntAct:14722096;IntAct:15588987;IntAct:16582879;IntAct:16926280;IntAct:17092689;IntAct:17159996;IntAct:17481567;IntAct:19029027;IntAct:21806020;IntAct:8702689;IntAct:8999839;KEA:10852715;KEA:11850117;Lit-BM-17:11163213;Lit-BM-17:11506178;Lit-BM-17:11579209;Lit-BM-17:11726652;Lit-BM-17:12237455;Lit-BM-17:12634852;Lit-BM-17:14722096;Lit-BM-17:15588987;Lit-BM-17:16271887;Lit-BM-17:16582879;Lit-BM-17:16926280;Lit-BM-17:17092689;Lit-BM-17:17159996;Lit-BM-17:17481567;Lit-BM-17:19029027;Lit-BM-17:21806020;Lit-BM-17:8999839;ProtMapper:10066179;ProtMapper:11579209;ProtMapper:12612081;ProtMapper:1321126;ProtMapper:15192089;ProtMapper:15632081;ProtMapper:1599438;ProtMapper:16582879;ProtMapper:8244979;SIGNOR:11579209;SIGNOR:16582879;SignaLink3:11506178;SignaLink3:12237455;SignaLink3:15632081;SignaLink3:16582879;SignaLink3:23331499;SignaLink3:8826975;SignaLink3:9355745], PTPN2 [Adhesome:12612081;Adhesome:15192089;DEPOD:10734133;DEPOD:12612081;HPRD-phos:12612081;HPRD-phos:15192089;HPRD-phos:15588985;HPRD-phos:15632081;HPRD:12612081;HPRD:15192089;HPRD:15588985;ProtMapper:10734133;ProtMapper:12612081;ProtMapper:1373652;ProtMapper:15192089;ProtMapper:15632081;SIGNOR:10734133;SIGNOR:12612081;SIGNOR:1373652;SignaLink3:15632081;SignaLink3:23331499], PTPRF [Adhesome:10592173;Adhesome:11158333;Adhesome:1321126;DEPOD:11158333;DEPOD:1321126;DEPOD:7852302;DEPOD:8732688;DEPOD:8995282;HPRD:11158333;HPRD:1321126;HPRD:15588985;ProtMapper:10734133;ProtMapper:1303753;SIGNOR:10734133;SIGNOR:1303753;SignaLink3:11158333;SignaLink3:1321126;SignaLink3:15588985;SignaLink3:19910497;SignaLink3:23331499], GRB10 [BioGRID:15664450;BioGRID:9006901;DOMINO:9506989;HPRD:12493740;HPRD:7479769;HPRD:8621530;HPRD:9506989;InnateDB:12493740;Lit-BM-17:10871840;Lit-BM-17:15664450;Lit-BM-17:19648926;Lit-BM-17:7479769;Lit-BM-17:8621530;Lit-BM-17:9006901;Lit-BM-17:9506989;SIGNOR:21659604], PTPRH [ProtMapper:10734133;SIGNOR:10734133], SH2B2 [HPRD:10196204;Lit-BM-17:15031295;Lit-BM-17:17620296;SIGNOR:11498022], IGF2 [Baccin2019:9281335;Baccin2019:9722981;CellTalkDB:9281335;Cellinker:9281335;Cellinker:9722981;HPRD:9722981;LRdb:9281335;LRdb:972;SIGNOR:9281335;connectomeDB2020:9281335;connectomeDB2020:9722981], SHC1 [Adhesome:10592173;Adhesome:10803466;Adhesome:11075717;Adhesome:15629149;Adhesome:7559507;Adhesome:7685165;Adhesome:9593725;DIP:7559507;ELM:7537849;ELM:8626723;HPRD:10482988;HPRD:10764799;HPRD:10816433;HPRD:10896916;HPRD:10921922;HPRD:11075717;HPRD:12237775;HPRD:8702728;HPRD:9083103;HPRD:9121430;HPRD:9446569;HPRD:9710204;HPRD:9741627;LMPID:7537849;LMPID:8626723;Lit-BM-17:10803466;Lit-BM-17:15629149;Lit-BM-17:7499194;Lit-BM-17:7559507;Lit-BM-17:9593725], PTK2 [Adhesome:7529876;Adhesome:9507031;HPRD:7529876;HPRD:9507031], GAB1 [Adhesome:10734310;Adhesome:10753869;Adhesome:10978177;Adhesome:9658397;Adhesome:9890893;HPRD:10978177;HPRD:9658397], CBL [Adhesome:10592173;Adhesome:10635327;Adhesome:11997497;HPRD:10635327;HPRD:11997497;SIGNOR:11498022], PTPN6 [Adhesome:12468540;Adhesome:7512963;Adhesome:8114715;Adhesome:8692915;HPRD:12468540;HPRD:7512963;HPRD:8114715;HPRD:8692915;ProtMapper:10734133;SIGNOR:10734133], ENPP1 [HPRD:10615944;SIGNOR:10615944], PTPRB [ProtMapper:10734133;SIGNOR:10734133], PTPRE [DEPOD:15738637;ProtMapper:15738637;SIGNOR:15738637], PTPRG [ProtMapper:25624455;SIGNOR:25624455], PTPN9 [ProtMapper:16679294;SIGNOR:16679294], PTPRJ [ProtMapper:10734133;ProtMapper:1715686;SIGNOR:10734133;SIGNOR:1715686], PTPN13 [ProtMapper:15611135;SIGNOR:15611135], CALM1 [CellTalkDB:32196115;HPRD:12153558;HPRD:8639568], CALM2 [CellTalkDB:32196115;HPRD:12153558], CALM3 [CellTalkDB:32196115;HPRD:12153558], FURIN [SIGNOR:25527501], PRKCA [Adhesome:2110001;Adhesome:7926007;Adhesome:8454604;Adhesome:8463287;Adhesome:92065884;HPRD:7926007;HPRD:8463287;KEA:17570479;KEA:1956339;KEA:2110001;KEA:7926007;KEA:8454604;KEA:8463287;KEA:92065884;PhosphoSite:10819237;PhosphoSite:12472845;PhosphoSite:7926007;ProtMapper:15212693;ProtMapper:7926007;ProtMapper:8463287;SIGNOR:7926007;SIGNOR:8463287;iPTMnet:7926007;iPTMnet:8463287;phosphoELM:2110001;phosphoELM:7926007], PCSK6 [SIGNOR:25527501], PRKAA2 [SIGNOR:22207502], PTPN12 [Adhesome:19167335;Adhesome:8454633;HPRD:8454633;ProtMapper:10734133;ProtMapper:8454633;SIGNOR:10734133;SIGNOR:8454633], GRB14 [HPRD:16582879;Lit-BM-17:11726652;Lit-BM-17:16582879;Lit-BM-17:19648926;Lit-BM-17:24535599;SIGNOR:24535599], PTPN11 [Adhesome:7493946;Adhesome:8135823;Adhesome:9593725;Adhesome:9832615;BioGRID:8135823;HPRD:7493946;HPRD:8135823], RASA1 [Adhesome:1331107;Adhesome:9593725;HPRD:1331107], VAV1 [Adhesome:11094073;Adhesome:7535775;HPRD:7535775], SORBS1 [Adhesome:11374898;Adhesome:9447983;CellTalkDB:11374898;Cellinker:11374898;HPRD:11374898;LRdb:11374898], HRAS [Adhesome:3109943;CellTalkDB:3109943;HPRD:3109943;LRdb:3109943;connectomeDB2020:3109943], CSK [Adhesome:10026153;HPRD:10026153], ARF1 [Adhesome:9197239;CellTalkDB:9197239;HPRD:9197239;LRdb:9197239;MPPI:9197239;connectomeDB2020:9197239], IGF1 [Baccin2019:23518924;CellTalkDB:32196115], AHSG [Baccin2019:7906861;CellTalkDB:7906861;Cellinker:7906861;HPRD:7906861;LRdb:7906861;connectomeDB2020:7906861], GIP [CellTalkDB:32196115], NAMPT [CellChatDB:28490838;Cellinker:28490838;LRdb:15604363;connectomeDB2020:15604363], ACP1 [DEPOD:17353188;DEPOD:9299573;HPRD:1304913], DUSP3 [DEPOD:1281549], IGF1R [HPRD:7895674;KEA:17570479], LYN [KEA:17570479], PTPRA [KEA:10852715;KEA:10940390;KEA:11850117;ProtMapper:1321126;ProtMapper:1599438;ProtMapper:8244979], TBK1 [ProtMapper:30223576;iPTMnet:19251743], SOCS3 [BioGRID:12560330;HPRD:11071852;HPRD:12560330;ProtMapper:11325969;ProtMapper:21873554;ProtMapper:25138272;ProtMapper:25352752;ProtMapper:25888955], PRKCD [BioGRID:11266508;HPRD:11266508], SOCS1 [BioGRID:11342531;HPRD:15169905], MAPK3 [HPRD:11409918;InnateDB:11409918], SOCS7 [InnateDB:16127460], SOCS2 [HPRD:10453981]	axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin-activated receptor activity [GO:0005009]; insulin binding [GO:0043559]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSR&keywords=INSR	17.07125569	117	1919.81	65	0.7587952224	299	0.03149606299	0.1946107784	0.5807522124	0.1539568345	0.4393939394	0.09644670051	0.1115140526	0.1353996737	0.0580836108	0.05598210709	0.1091365656	117	123	61	0.1787975035	0.3606171139	0.3494861207	0.631028289	354	343	223	189
KISS1R	KISS1 receptor	Yes	No		ENSG00000116014	Q969F8	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q15726	KISS1	KISS1 [Baccin2019:11385580;Baccin2019:11457843;Baccin2019:12944565;Baccin2019:15665093;CellTalkDB:12944565;Cellinker:11385580;Cellinker:11457843;Cellinker:12944565;Cellinker:15665093;Guide2Pharma:11385580;Guide2Pharma:11457843;HPMR:12944565;HPRD:11457843;LRdb:11385580;LRdb:11457843;LRdb:12944565;LRdb:15665093;SIGNOR:11385580;connectomeDB2020:11385580;connectomeDB2020:11457843;connectomeDB2020:12944565;connectomeDB2020:15665093;scConnect:11385580;scConnect:11457843]	cell surface [GO:0009986]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188]	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KISS1R&keywords=KISS1R	0.4899486888	457	NA	NA	1.418243023	167	0.007874015748	4.99E-04	0	2.40E-04	0.008417508418	0.04399323181	0.05077062557	0.02120717781	0.006659267481	0.04403124583	0.001313502028	211	135	308	0.01681867135	0.6211816858	2.014687645	0.4218516973	255	16	301	194
MC4R	melanocortin 4 receptor	Yes	Yes		ENSG00000166603	P32245	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00253, P01189, P01303, P17252, P17612, P25098, P42127, Q8TCY5, Q96G30	AGRP, ASIP, GRK2, MRAP, MRAP2, NPY, POMC, PRKACA, PRKCA	POMC [Baccin2019:10493100;Baccin2019:11101306;Baccin2019:12165561;Baccin2019:8884876;BioGRID:11101306;BioGRID:9058374;CellChatDB:11024027;Cellinker:10493100;Cellinker:11101306;Cellinker:12165561;Cellinker:8884876;Guide2Pharma:10493100;Guide2Pharma:11101306;HPRD:11101306;HPRD:12165561;LRdb:10493100;LRdb:11101306;LRdb:12165561;LRdb:8884876;SIGNOR:20694162;connectomeDB2020:10493100;connectomeDB2020:11101306;connectomeDB2020:12165561;connectomeDB2020:8884876;scConnect:10493100;scConnect:11101306;scConnect:8884876], AGRP [Baccin2019:10318826;Baccin2019:11747427;Baccin2019:12815165;Baccin2019:9299416;Baccin2019:9311920;BioGRID:10318826;BioGRID:12815165;CellTalkDB:9311920;Cellinker:10318826;Cellinker:11747427;Cellinker:12815165;Cellinker:9299416;Cellinker:9311920;Guide2Pharma:9299416;HPMR:9311920;HPRD:10318826;HPRD:11747427;HPRD:12815165;LRdb:10318826;LRdb:11747427;LRdb:12815165;LRdb:9299416;LRdb:9311920;SIGNOR:10318826;SIGNOR:9311920;connectomeDB2020:10318826;connectomeDB2020:11747427;connectomeDB2020:12815165;connectomeDB2020:9299416;connectomeDB2020:9311920;scConnect:9299416], MRAP [SIGNOR:19329486], MRAP2 [SIGNOR:19329486], PRKACA [HPRD:12639913;KEA:12639913;ProtMapper:12639913;SIGNOR:12639913;iPTMnet:12639913], GRK2 [HPRD:12639913;KEA:12639913;ProtMapper:12639913;SIGNOR:12639913;iPTMnet:12639913;phosphoELM:12639913], NPY [Baccin2019:12015205;Cellinker:12015205;HPRD:12015205;LRdb:12015205], ASIP [Baccin2019:9058374;CellTalkDB:9058374;Cellinker:9058374;HPRD:9058374;LRdb:9058374;connectomeDB2020:9058374], PRKCA [KEA:17570479]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; ubiquitin protein ligase binding [GO:0031625]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; diet induced thermogenesis [GO:0002024]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; insulin secretion [GO:0030073]; negative regulation of feeding behavior [GO:2000252]; positive regulation of bone resorption [GO:0045780]; regulation of eating behavior [GO:1903998]; regulation of grooming behavior [GO:2000821]; regulation of metabolic process [GO:0019222]; response to insulin [GO:0032868]; response to melanocyte-stimulating hormone [GO:1990680]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MC4R&keywords=MC4R	0.004873325843	800	NA	NA	0.04914014225	737	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	769
MC5R	melanocortin 5 receptor	Yes	TBD		ENSG00000176136	P33032	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00253, P01189, P42127, Q8TCY5, Q96G30	AGRP, ASIP, MRAP, MRAP2, POMC	POMC [Baccin2019:11606131;Baccin2019:11785979;Baccin2019:12007532;Baccin2019:7774675;Baccin2019:8185570;Cellinker:11606131;Cellinker:11785979;Cellinker:12007532;Cellinker:7774675;Cellinker:8185570;Guide2Pharma:12007532;HPMR:11785979;HPRD:11606131;HPRD:8185570;LRdb:11606131;LRdb:11785979;LRdb:12007532;LRdb:7774675;LRdb:8185570;SIGNOR:11785979;connectomeDB2020:11606131;connectomeDB2020:11785979;connectomeDB2020:12007532;connectomeDB2020:7774675;connectomeDB2020:8185570;scConnect:12007532;scConnect:7774675], AGRP [Baccin2019:98920209892020;CellTalkDB:9892020;Cellinker:9892020;Guide2Pharma:9892020;HPRD:9892020;LRdb:9892020;connectomeDB2020:9892020;scConnect:9892020], MRAP [SIGNOR:19329486], MRAP2 [SIGNOR:19329486], ASIP [Baccin2019:9058374;CellTalkDB:9058374;Cellinker:9058374;HPRD:9058374;LRdb:9058374;connectomeDB2020:9058374]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of metabolic process [GO:0019222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MC5R&keywords=MC5R	0.01254678427	764	NA	NA	0.4575649714	382	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	573
MCHR1	melanin concentrating hormone receptor 1	Yes	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000128285	Q99705	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P20382	PMCH	PMCH [Baccin2019:10421367;Baccin2019:10421368;Baccin2019:11375253;Baccin2019:11478907;Baccin2019:11839762;CellTalkDB:10421368;Cellinker:10421367;Cellinker:10421368;Cellinker:11375253;Cellinker:11478907;Cellinker:11839762;Guide2Pharma:10421367;Guide2Pharma:11375253;HPMR:10421367;HPMR:10421368;HPRD:11478907;HPRD:11839762;LRdb:10421367;LRdb:10421368;LRdb:11375253;LRdb:11478907;LRdb:11839762;SIGNOR:10421367;connectomeDB2020:10421367;connectomeDB2020:10421368;connectomeDB2020:11375253;connectomeDB2020:11478907;connectomeDB2020:11839762;scConnect:10421367;scConnect:11375253]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; generation of precursor metabolites and energy [GO:0006091]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MCHR1&keywords=MCHR1	0.421867862	476	NA	NA	0.4094485524	399	0	0.001996007984	0.002212389381	0.002158273381	0	0.0524534687	0.04170444243	0.0163132137	0.07103218646	0.02777406863	0.02225226965	105	157	150	0.02162693821	2.56212555	1.194363754	1.019772114	7	81	71	278
NPR1	natriuretic peptide receptor 1	Yes	No		ENSG00000169418	P16066	Adenylyl cyclase class-4/guanylyl cyclase family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P01160, P05771, P16860, P17612, P22694, P23582, Q13976	NPPA, NPPB, NPPC, PRKACA, PRKACB, PRKCB, PRKG1	NPPA [CellChatDB:29934640;Cellinker:12488235;Cellinker:12547834;Cellinker:15911069;Cellinker:8700153;Guide2Pharma:8700153;HPMR:15911069;HPRD:12547834;LRdb:12547834;LRdb:15911069;LRdb:8700153;SIGNOR:15911069;connectomeDB2020:12547834;connectomeDB2020:15911069;connectomeDB2020:8700153;scConnect:8700153], NPPB [BioGRID:15709752;CellChatDB:29934641;Cellinker:1309330;Cellinker:7901875;Cellinker:8700153;Guide2Pharma:8700153;HPRD:1309330;HPRD:7901875;LRdb:1309330;LRdb:7901875;LRdb:8700153;connectomeDB2020:1309330;connectomeDB2020:7901875;connectomeDB2020:8700153;scConnect:8700153], NPPC [CellTalkDB:32103204], PRKACA [KEA:9528788;PhosphoSite:20977274;PhosphoSite:28416574;PhosphoSite:9528788;iPTMnet:9528788], PRKACB [KEA:17570479], PRKCB [KEA:17570479], PRKG1 [HPRD:12855709]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]	blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPR1&keywords=NPR1	0.6643112959	429	NA	NA	0.025168038	801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	615
NPR2	natriuretic peptide receptor 2	Yes	Yes		ENSG00000159899	P20594	Adenylyl cyclase class-4/guanylyl cyclase family	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P01160, P05771, P16860, P23582, P49674, Q12884	CSNK1E, FAP, NPPA, NPPB, NPPC, PRKCB	NPPC [CellChatDB:29934642;CellTalkDB:11952095;Cellinker:11952095;Cellinker:12709393;Cellinker:1309330;Guide2Pharma:1309330;HPRD:12709393;LRdb:11952095;LRdb:12709393;LRdb:1309330;connectomeDB2020:11952095;connectomeDB2020:12709393;connectomeDB2020:1309330;scConnect:1309330], NPPB [Cellinker:2570358;HPMR:2570358;LRdb:2570358;connectomeDB2020:2570358], NPPA [CellTalkDB:32103204;connectomeDB2020:1309330;connectomeDB2020:1660465;connectomeDB2020:1672777], FAP [Cellinker:21314817], CSNK1E [KEA:17570479], PRKCB [KEA:17570479]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]	bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; reproductive process [GO:0022414]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPR2&keywords=NPR2	1.73867713	316	NA	NA	0.07637545327	683	0.0157480315	0.008982035928	0.008849557522	0.03261390887	0.003367003367	0.05922165821	0.05621033545	0.01305057096	0.03477617462	0.03788890373	0.01460305196	151	144	179	0.02593738474	1.245949725	1.332565073	0.684608859	65	59	202	301
NPR3	natriuretic peptide receptor 3	Yes	No		ENSG00000113389	P17342	ANF receptor family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P01160, P01282, P16860, P23582, P61366	NPPA, NPPB, NPPC, OSTN, VIP	OSTN [Baccin2019:17951249;CellChatDB:29326144;CellTalkDB:17951249;Cellinker:17951249;Cellinker:29326144;Guide2Pharma:17951249;ICELLNET:17951249;ICELLNET:19244276;LRdb:17951249;connectomeDB2020:17951249;scConnect:17951249], NPPC [Baccin2019:11533490;Baccin2019:1309330;CellTalkDB:11533490;Cellinker:11533490;Cellinker:1309330;HPRD:11533490;HPRD:1309330;LRdb:11533490;LRdb:13;connectomeDB2020:11533490;connectomeDB2020:1309330], NPPB [CellTalkDB:1309330;Cellinker:1309330;Cellinker:7901875;HPRD:1309330;HPRD:7901875;LRdb:1309330;LRdb:79;Lit-BM-17:1309330;Lit-BM-17:1660465;Lit-BM-17:1672777;Lit-BM-17:16870210;connectomeDB2020:1309330;connectomeDB2020:7901875], VIP [CellTalkDB:16723209], NPPA [Baccin2019:21697332169733;CellTalkDB:2169733;Cellinker:12488235;Cellinker:2169733;HPMR:2169733;HPRD:2169733;LRdb:2169733;Lit-BM-17:1309330;Lit-BM-17:1660465;Lit-BM-17:1672777;Lit-BM-17:16870210;connectomeDB2020:2169733]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]	chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPR3&keywords=NPR3	1.067541818	374	NA	NA	0.3241639845	446	0	0.003493013972	0.00110619469	0.02829736211	0.006734006734	0.003384094755	0.001813236627	0	3.70E-04	9.35E-04	5.79E-04	233	319	327	0.004246550783	0.7278926291	0.7675334472	0.7425998299	216	206	179	336
NPY1R	neuropeptide Y receptor Y1	Yes	Yes		ENSG00000164128	P25929	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01298, P01303, P10082	NPY, PPY, PYY	NPY [Baccin2019:12007534;Baccin2019:7559383;Baccin2019:9001438;Baccin2019:9549761;CellTalkDB:9001438;Cellinker:12007534;Cellinker:7559383;Cellinker:9001438;Cellinker:9549761;HPMR:9549761;HPRD:12007534;HPRD:7559383;HPRD:9001438;LRdb:12007534;LRdb:7559383;LRdb:9001438;LRdb:9549761;Lit-BM-17:23597562;Lit-BM-17:7559383;SIGNOR:9549761;connectomeDB2020:12007534;connectomeDB2020:7559383;connectomeDB2020:9001438;connectomeDB2020:9549761], PYY [Baccin2019:954976112665544;CellTalkDB:9549761;Cellinker:12665544;Cellinker:9549761;HPRD:12665544;LRdb:127;LRdb:9549761;connectomeDB2020:12665544;connectomeDB2020:9549761], PPY [CellTalkDB:15966750]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; feeding behavior [GO:0007631]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; sensory perception of pain [GO:0019233]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPY1R&keywords=NPY1R	2.147947131	303	NA	NA	0.2055289699	520	0	0.02844311377	0	0.001918465228	0.003367003367	0.001692047377	0	0.00163132137	0	1.67E-04	1.55E-04	234	341	343	0.003397581112	0.746403393	0.7588617217	0.7579375385	207	214	173	345
NTRK2	neurotrophic receptor tyrosine kinase 2	Yes	TBD		ENSG00000148053	Q16620	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P06213, P06241, P07948, P08138, P18031, P20783, P23560, P34130, Q00535, Q13332, Q13501, Q13562	BDNF, CDK5, FYN, INSR, LYN, NEUROD1, NGFR, NTF3, NTF4, PTPN1, PTPRS, SQSTM1	NEUROD1 [SPIKE:16251211], BDNF [AlzPathway:9775403;Baccin2019:76445409312147;BioGRID:21651720;BioGRID:9312147;CA1:1645620;CA1:9648856;CellChatDB:27908981;CellTalkDB:7644540;Cellinker:27908981;Cellinker:7644540;Cellinker:9312147;DIP:9312147;HPMR:7644540;HPRD:9312147;LRdb:7644540;LRdb:931;Lit-BM-17:11855816;Lit-BM-17:21651720;Lit-BM-17:9312147;ProtMapper:21849472;ProtMapper:26740873;ProtMapper:26899129;ProtMapper:28679669;SIGNOR:7679912;SignaLink3:23331499;SignaLink3:9312147;connectomeDB2020:7644540;connectomeDB2020:9312147], FYN [HPRD:9648856], SQSTM1 [HPRD:12471037;SignaLink3:12471037;SignaLink3:18457658;SignaLink3:23331499], PTPN1 [BioGRID:12237455;BioGRID:25288805;HPRD:12237455;InnateDB:12237455;SIGNOR:26214522], NTF4 [AlzPathway:9775403;Baccin2019:767991211855816;CellChatDB:27908981;CellTalkDB:7679912;Cellinker:11855816;Cellinker:27908981;Cellinker:7679912;HPRD:11855816;LRdb:119;LRdb:7679912;Lit-BM-17:11738045;Lit-BM-17:11855816;Lit-BM-17:25241761;SIGNOR:7679912;connectomeDB2020:11855816;connectomeDB2020:7679912], NTF3 [Baccin2019:8621424;CellChatDB:27908981;CellTalkDB:8621424;Cellinker:27908981;HPRD:8621424;LRdb:8621424;connectomeDB2020:8621424], PTPRS [DEPOD:17967490], CDK5 [KEA:17341134], INSR [KEA:17570479], LYN [KEA:17570479], NGFR [HPRD:9927421]	axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195]	ATP binding [GO:0005524]; brain-derived neurotrophic factor-activated receptor activity [GO:0060175]; brain-derived neurotrophic factor binding [GO:0048403]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuronal action potential propagation [GO:0019227]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTRK2&keywords=NTRK2	NA	NA	NA	NA	NA	NA	0.007874015748	0.2270459082	0.002212389381	0.01079136691	0.006734006734	0.0524534687	0.02538531278	0.1549755302	0.08435072142	0.006976899453	0.03272165347	94	217	127	0.055592843	1.438430126	0.2588224367	0.6513157765	39	371	214	294
PLXNB2	plexin B2	Yes	Yes		ENSG00000196576	O15031	Plexin family	18	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43157, P03950, P21246, Q92854, Q9C0C4, Q9H3S1, Q9NPR2, Q9NTN9, Q9NZN5	ANG, ARHGEF12, PLXNB1, PTN, SEMA4A, SEMA4B, SEMA4C, SEMA4D, SEMA4G	ARHGEF12 [HPRD:12183458], SEMA4A [CellChatDB:27533782;CellTalkDB:29981480;Cellinker:22442441;Cellinker:26633812;Cellinker:27533782;Cellinker:29981480;ICELLNET:29981480;connectomeDB2020:29981480], SEMA4C [CellChatDB:27533782;Cellinker:21122816;Cellinker:24043639;Cellinker:26633812;Cellinker:27533782;ICELLNET:11245885;LRdb:21122816;Ramilowski2015:21122816;connectomeDB2020:21122816;talklr:21122816], SEMA4D [Baccin2019:15330859;CellChatDB:27533782;CellPhoneDB:22325954;CellTalkDB:15330859;Cellinker:26633812;Cellinker:27533782;HPMR:15330859;ICELLNET:11245885;LRdb:15330859;connectomeDB2020:15330859], SEMA4G [CellChatDB:27533782;Cellinker:21122816;Cellinker:26633812;Cellinker:27533782;LRdb:21122816;Ramilowski2015:21122816;connectomeDB2020:21122816;talklr:21122816], ANG [connectomeDB2020:29100074], PTN [Cellinker:16169070;HPRD:16169070;LRdb:16169070;connectomeDB2020:16169070], SEMA4B [Cellinker:32589946], PLXNB1 [Cellinker:24043639]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNB2&keywords=PLXNB2	42.68076745	50	8069.11	24	0.42018924	396	0.02362204724	0.6142714571	0.05862831858	0.09016786571	0.1885521886	0.4585448393	0.3599274705	0.4225122349	0.2360340363	0.2669582054	0.1362565192	32	32	51	0.259588653	0.9126275663	1.027336286	0.5425173412	140	120	254	124
PROKR1	prokineticin receptor 1	Yes	No		ENSG00000169618	Q8TCW9	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P42574, P55210, P58294, Q14790, Q9HC23	CASP3, CASP7, CASP8, PROK1, PROK2	PROK1 [Baccin2019:11886876;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:11886876;Cellinker:11886876;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;HPMR:11886876;HPMR:12054613;LRdb:11886876;LRdb:12054613;LRdb:15772293;SIGNOR:12054613;connectomeDB2020:11886876;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], PROK2 [Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:12054613;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;LRdb:12054613;LRdb:16;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], CASP8 [CA1:11555640], CASP3 [CA1:11555640], CASP7 [CA1:11555640]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROKR1&keywords=PROKR1	0.01353324303	759	NA	NA	0.1438264369	579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	669
PROKR2	prokineticin receptor 2	Yes	Yes		ENSG00000101292	Q8NFJ6	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P58294, Q15848, Q9HC23	ADIPOQ, PROK1, PROK2	PROK1 [Baccin2019:11886876;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:12054613;Cellinker:11886876;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;HPMR:11886876;HPMR:12054613;LRdb:11886876;LRdb:12054613;LRdb:15772293;connectomeDB2020:11886876;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], PROK2 [Baccin2019:12024206;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:15772293;Cellinker:12024206;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;LRdb:12024206;LRdb:12054613;LRdb:15772293;SIGNOR:12024206;connectomeDB2020:12024206;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], ADIPOQ [NA]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]	circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROKR2&keywords=PROKR2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
PTH1R	parathyroid hormone 1 receptor	Yes	TBD		ENSG00000160801	Q03431	G-protein coupled receptor 2 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14745, P01185, P01189, P01215, P01222, P01225, P01229, P01258, P01270, P01275, P01282, P01286, P04090, P06850, P06881, P08069, P09681, P09683, P0C0P6, P10092, P10997, P12272, P18509, P35318, P51460, Q7Z4H4, Q8WXF3, Q96A98	ADCYAP1, ADM, ADM2, AVP, CALCA, CALCB, CGA, CRH, FSHB, GCG, GHRH, GIP, IAPP, IGF1R, INSL3, LHB, NPS, POMC, PTH, PTH2, PTHLH, RLN2, RLN3, SCT, SLC9A3R1, TSHB, VIP	PTHLH [CellChatDB:29577935;CellTalkDB:9108031;Cellinker:2558877;Cellinker:29577935;Cellinker:8702701;Cellinker:9108031;Guide2Pharma:8702701;HPMR:2558877;HPRD:9108031;IntAct:19674967;LRdb:2558877;LRdb:8702701;LRdb:9108031;connectomeDB2020:2558877;connectomeDB2020:8702701;connectomeDB2020:9108031;scConnect:8702701], PTH2 [Baccin2019:10854439;Baccin2019:11159842;CellTalkDB:11159842;Cellinker:10854439;Cellinker:11159842;Guide2Pharma:10854439;Guide2Pharma:11159842;LRdb:11;LRdb:11159842;connectomeDB2020:10854439;connectomeDB2020:11159842;scConnect:10854439;scConnect:11159842], PTH [CellTalkDB:12947048;Cellinker:12947048;Cellinker:9108031;HPRD:9108031;IntAct:19674967;LRdb:12947048;LRdb:91;ProtMapper:29444827;SIGNOR:18981475;connectomeDB2020:12947048;connectomeDB2020:9108031], SCT [CellTalkDB:32196115], LHB [CellTalkDB:32196115], IAPP [CellTalkDB:32196115], TSHB [CellTalkDB:32196115], CRH [CellTalkDB:32196115], GHRH [CellTalkDB:32196115], AVP [CellTalkDB:32196115], POMC [CellTalkDB:32196115], RLN2 [CellTalkDB:32196115], ADCYAP1 [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], ADM [CellTalkDB:32196115], CGA [CellTalkDB:32196115], GCG [CellTalkDB:32196115], VIP [CellTalkDB:32196115], ADM2 [CellTalkDB:32196115], NPS [CellTalkDB:32196115], FSHB [CellTalkDB:32196115], CALCB [CellTalkDB:32196115], RLN3 [CellTalkDB:32196115], GIP [CellTalkDB:32196115], INSL3 [CellTalkDB:32196115], IGF1R [PhosphoSite:29507819;ProtMapper:29507819], SLC9A3R1 [HPRD:12075354;Lit-BM-17:12075354]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; chondrocyte differentiation [GO:0002062]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; in utero embryonic development [GO:0001701]; negative regulation of cell population proliferation [GO:0008285]; osteoblast development [GO:0002076]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTH1R&keywords=PTH1R	0.1476136119	575	NA	NA	0.007679067924	858	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	717
ROR1	receptor tyrosine kinase like orphan receptor 1	Yes	No		ENSG00000185483	Q01973	Protein kinase superfamily, Tyr protein kinase family, ROR subfamily	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane, transmembrane_predicted	P41221, P56704	WNT3A, WNT5A	WNT5A [CellTalkDB:18287027;Cellinker:18287027;LRdb:18287027;NetPath:18287027;Ramilowski2015:18287027;SIGNOR:22343533;SIGNOR:23151663;SIGNOR:26690702;SignaLink3:21481194;SignaLink3:23331499;connectomeDB2020:18287027;talklr:18287027], WNT3A [CellTalkDB:27709494]	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROR1&keywords=ROR1	1.388745159	348	NA	NA	0.4601365224	381	0	0.1501996008	0.002212389381	0.01822541966	0.04545454545	0.2013536379	0.2257479601	0.1272430669	0.06289308176	0.1676458806	0.07019509368	110	50	80	0.09737915239	0.6788383046	1.654379614	0.7468404425	236	34	176	203
ROR2	receptor tyrosine kinase like orphan receptor 2	Yes	No		ENSG00000169071	Q01974	Protein kinase superfamily, Tyr protein kinase family, ROR subfamily	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane, transmembrane_predicted	P04628, P41221, P43026, P49674, P49841, P56703, Q15750, Q96CG8, Q9Y287	APC_AXIN1_GSK3B, CSNK1E, CTHRC1, GDF5, GSK3B, ITM2B, TAB1, WNT1, WNT3, WNT5A	WNT5A [Baccin2019:12839624;CellTalkDB:12839624;Cellinker:18606138;HPRD:12839624;LRdb:12839624;NetPath:12839624;SIGNOR:26690702;SPIKE:12839624;SPIKE:20215527;SPIKE:21069266;SignaLink3:17203201;SignaLink3:23331499;connectomeDB2020:12839624], CSNK1E [SIGNOR:15375164;SignaLink3:18848778;SignaLink3:23331499], GSK3B [ProtMapper:21078818;SIGNOR:21078818;iPTMnet:21078818], TAB1 [SIGNOR:18762249], WNT3 [CellTalkDB:15388793;NetPath:15388793], WNT1 [CellTalkDB:15388793;NetPath:18762249;connectomeDB2020:15388793], GDF5 [Baccin2019:15569154;Cellinker:15569154;HPMR:15569154;LRdb:15569154;connectomeDB2020:15569154], CTHRC1 [Cellinker:18606138;connectomeDB2020:18606138], ITM2B [Cellinker:15569154]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]	astrocyte development [GO:0014002]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; embryonic digit morphogenesis [GO:0042733]; embryonic genitalia morphogenesis [GO:0030538]; inner ear morphogenesis [GO:0042472]; JNK cascade [GO:0007254]; macrophage migration [GO:1905517]; male genitalia development [GO:0030539]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROR2&keywords=ROR2	1.197313827	364	478.11	84	0.1420312585	582	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	343
RXFP2	relaxin family peptide receptor 2	Yes	TBD		ENSG00000133105	Q8WXD0	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04090, P04808, P51460, Q13129, Q8WXF3, Q9Y5Q6	INSL3, INSL5, RLF, RLN1, RLN2, RLN3	INSL3 [Baccin2019:12114498;Baccin2019:15649866;Baccin2019:20560146;CellTalkDB:12114498;Cellinker:12114498;Cellinker:15649866;Cellinker:20560146;Cellinker:22973049;Cellinker:25761609;Guide2Pharma:15649866;Guide2Pharma:18434306;HPMR:12114498;HPRD:12114498;HPRD:15649866;LRdb:12114498;LRdb:15649866;LRdb:20560146;connectomeDB2020:12114498;connectomeDB2020:15649866;connectomeDB2020:20560146;scConnect:15649866;scConnect:18434306], RLN2 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:12506116;Cellinker:15649866;Cellinker:22973049;Guide2Pharma:15649866;Guide2Pharma:18434306;HPRD:12506116;HPRD:15649866;LRdb:11809971;LRdb:12506116;LRdb:15649866;SIGNOR:11809971;connectomeDB2020:11809971;connectomeDB2020:12506116;connectomeDB2020:15649866;scConnect:15649866;scConnect:18434306], RLN1 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:16411781;Guide2Pharma:16411781;LRdb:11809971;LRdb:16;connectomeDB2020:11809971;connectomeDB2020:16411781;scConnect:16411781], RLN3 [Baccin2019:16411781;CellTalkDB:16411781;Cellinker:16411781;Guide2Pharma:16411781;LRdb:16411781;connectomeDB2020:16411781;scConnect:16411781], INSL5 [NA], RLF [Baccin2019:12114498;Baccin2019:15649866;Baccin2019:20560146]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RXFP2&keywords=RXFP2	0.001610392135	830	NA	NA	0.2086865706	516	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	673
RXFP4	relaxin family peptide/INSL5 receptor 4	Yes	No		ENSG00000173080	Q8TDU9	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01042, P04808, P51460, Q8WXF3, Q9Y5Q6	INSL3, INSL5, KNG1, RLN1, RLN3	INSL5 [Baccin2019:1546592515525630;CellTalkDB:15465925;Cellinker:15465925;Cellinker:15525639;Cellinker:25761609;Cellinker:27888281;Guide2Pharma:15525639;Guide2Pharma:18582868;Guide2Pharma:18682868;Guide2Pharma:22257012;Guide2Pharma:24188028;Guide2Pharma:26824523;LRdb:15465925;LRdb:16;connectomeDB2020:15465925;connectomeDB2020:15525639;scConnect:15525639;scConnect:18582868;scConnect:18682868;scConnect:22257012;scConnect:24188028;scConnect:26824523;scConnect:27243554], RLN3 [CellTalkDB:14522967;Cellinker:14522967;Cellinker:25761609;Cellinker:27888281;Guide2Pharma:14522967;Guide2Pharma:17606621;Guide2Pharma:18582868;HPMR:14522967;HPMR:15367576;HPRD:14522967;LMPID:24802387;LRdb:14522967;connectomeDB2020:14522967;scConnect:14522967;scConnect:15525639;scConnect:17606621;scConnect:18582868], KNG1 [CellTalkDB:14530218;Cellinker:14530218;HPRD:14530218;LRdb:14530218;connectomeDB2020:14530218], INSL3 [NA], RLN1 [NA]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]	neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RXFP4&keywords=RXFP4	0.01655459438	748	NA	NA	0.1881494017	534	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	641
SCTR	secretin receptor	Yes	No		ENSG00000080293	P47872	G-protein coupled receptor 2 family	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01282, P09683, P0DP23, P17252, P18509, Q8IZJ3	ADCYAP1, CALM1, CPAMD8, PRKCA, SCT, VIP	SCT [Baccin2019:7612008;Baccin2019:7782300;Baccin2019:8579602;Baccin2019:9440501;CellTalkDB:7782300;Cellinker:7612008;Cellinker:7782300;Cellinker:8579602;Cellinker:9440501;Guide2Pharma:7612008;HPMR:7782300;HPRD:7782300;HPRD:8579602;HPRD:9440501;LRdb:7612008;LRdb:7782300;LRdb:8579602;LRdb:9440501;connectomeDB2020:7612008;connectomeDB2020:7782300;connectomeDB2020:8579602;connectomeDB2020:9440501;scConnect:7612008], VIP [Baccin2019:1646711;CellTalkDB:8390245;Cellinker:1646711;Guide2Pharma:1646711;LRdb:1646711;connectomeDB2020:1646711;scConnect:1646711], CPAMD8 [CellTalkDB:1335692;Cellinker:1335692;HPRD:1335692;LRdb:1335692;connectomeDB2020:1335692], ADCYAP1 [Baccin2019:1335692;CellTalkDB:1335692;HPRD:1335692;LRdb:1335692;connectomeDB2020:1335692], CALM1 [CellTalkDB:32196115;HPRD:15670850], PRKCA [HPRD:9506976]	cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; secretin receptor activity [GO:0015055]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCTR&keywords=SCTR	21.512733	98	NA	NA	11.94617246	18	0.007874015748	0.1611776447	0.004424778761	0.001199040767	0.02356902357	0.1759729272	0.08794197643	0.02446982055	0.09544950055	0.07814795033	0.004442727448	79	96	247	0.06042449146	1.497341314	1.251666125	0.2050810329	35	71	389	71
SSTR2	somatostatin receptor 2	Yes	Yes		ENSG00000180616	P30874	G-protein coupled receptor 1 family	18	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P35626, P61278, Q9Y566	CORT, GRK3, SHANK1, SST	CORT [Baccin2019:10598788;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:15333679;Cellinker:9125122;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPRD:9125122;LRdb:10598788;LRdb:15333679;LRdb:9125122;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SST [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1346068;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8702767;Baccin2019:8769372;Baccin2019:9650799;Baccin2019:9652348;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:10598788;Cellinker:10598788;Cellinker:11520208;Cellinker:1346068;Cellinker:15333679;Cellinker:7988476;Cellinker:8702767;Cellinker:8769372;Cellinker:9650799;Cellinker:9652348;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9650799;Guide2Pharma:9652348;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8702767;HPRD:1346068;LRdb:10598788;LRdb:11520208;LRdb:1346068;LRdb:15333679;LRdb:7988476;LRdb:8702767;LRdb:8769372;LRdb:9650799;LRdb:9652348;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1346068;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8702767;connectomeDB2020:8769372;connectomeDB2020:9650799;connectomeDB2020:9652348;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9650799;scConnect:9652348;scConnect:9724791;scConnect:9784130], SHANK1 [Baccin2019:10551867;Baccin2019:11087996;CellTalkDB:10551867;HPRD:10551867;HPRD:11087996;LRdb:10551867;LRdb:11;connectomeDB2020:10551867;connectomeDB2020:11087996], GRK3 [PhosphoSite:21343287;PhosphoSite:22538189;PhosphoSite:23418396;PhosphoSite:24565897;PhosphoSite:24637622;PhosphoSite:25012983]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432]; regulation of muscle contraction [GO:0006937]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSTR2&keywords=SSTR2	11.71530652	149	2767.75	55	3.24976556	70	0.0157480315	0.03842315369	0.0110619469	0.1342925659	0.05892255892	0.4467005076	0.459655485	0.3360522023	0.3011468738	0.2888569903	0.3088661387	24	29	27	0.2181569504	1.363740501	1.309874583	1.397573636	48	63	26	73
SSTR3	somatostatin receptor 3	Yes	Yes		ENSG00000278195	P32745	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P17252, P51812, P61278, P78527, Q13315	ATM, CORT, PRKCA, PRKDC, RPS6KA3, SST	CORT [Baccin2019:10598788;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPMR:9125122;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SST [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1337145;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8097479;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:1337145;Cellinker:15333679;Cellinker:7988476;Cellinker:8097479;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8097479;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPRD:1337145;LRdb:10598788;LRdb:11520208;LRdb:1337145;LRdb:15333679;LRdb:7988476;LRdb:8097479;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1337145;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8097479;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8097479;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], ATM [KEA:17570479], PRKCA [KEA:17570479], PRKDC [KEA:17570479], RPS6KA3 [KEA:17570479]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; signaling receptor binding [GO:0005102]; somatostatin receptor activity [GO:0004994]	cell-cell signaling [GO:0007267]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated apoptotic signaling pathway [GO:0008628]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSTR3&keywords=SSTR3	9.607332458	163	NA	NA	6.29706389	35	0	0.008982035928	0	0.001199040767	0.005050505051	0.1065989848	0.1205802357	0.04893964111	0.04180540141	0.07093737482	0.05597836585	136	103	95	0.04182468958	0.9996278188	1.5617532	1.273106822	110	39	37	85
SSTR4	somatostatin receptor 4	Yes	Yes		ENSG00000132671	P31391	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P61278	CORT, SST	CORT [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:11011067;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:9650799;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:9125122;LRdb:9205124;LRdb:9650799;SIGNOR:11011067;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:9650799], SST [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8100352;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:15333679;Cellinker:7988476;Cellinker:8100352;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8769372;HPRD:8100352;LRdb:10598788;LRdb:11520208;LRdb:15333679;LRdb:7988476;LRdb:8100352;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;SIGNOR:10433861;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8100352;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]	cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSTR4&keywords=SSTR4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
TNFRSF13B	TNF receptor superfamily member 13B	Yes	TBD		ENSG00000240505	O14836	NA	18	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O75888, P32970, Q9Y275	CD70, TNFSF13, TNFSF13B	TNFSF13B [Baccin2019:10801128;Baccin2019:10956646;CellTalkDB:10956646;Cellinker:10801128;Cellinker:10956646;DIP:10956646;HPRD:10801128;ICELLNET:11239407;IntAct:10801128;IntAct:10880535;IntAct:10956646;LRdb:10956646;LRdb:11;Lit-BM-17:10801128;Lit-BM-17:10880535;Lit-BM-17:10956646;SIGNOR:10956646;connectomeDB2020:10801128;connectomeDB2020:10956646], TNFSF13 [Baccin2019:1095664610956640;CellTalkDB:10956646;Cellinker:10956646;HPMR:10956646;HPRD:10956646;ICELLNET:11239407;LRdb:10956646;SIGNOR:10956646;connectomeDB2020:10956646], CD70 [CellTalkDB:32103204]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]	adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; cell surface receptor signaling pathway [GO:0007166]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of B cell proliferation [GO:0030889]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF13B&keywords=TNFRSF13B	0.1629360257	570	NA	NA	0.03596790572	773	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	672
VIPR2	vasoactive intestinal peptide receptor 2	Yes	No		ENSG00000106018	P41587	G-protein coupled receptor 2 family	18	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01282, P01286, P09683, P18509, P49767	ADCYAP1, GHRH, SCT, VEGFC, VIP	ADCYAP1 [Baccin2019:11931347;Baccin2019:11978642;Baccin2019:16930633;Baccin2019:8146174;Baccin2019:9928018;CellTalkDB:9928018;Cellinker:11931347;Cellinker:11978642;Cellinker:12488235;Cellinker:16930633;Cellinker:8146174;Cellinker:9928018;Guide2Pharma:11931347;Guide2Pharma:11978642;Guide2Pharma:16930633;Guide2Pharma:9928018;HPRD:8146174;LRdb:11931347;LRdb:11978642;LRdb:16930633;LRdb:8146174;LRdb:9928018;connectomeDB2020:11931347;connectomeDB2020:11978642;connectomeDB2020:16930633;connectomeDB2020:8146174;connectomeDB2020:9928018;scConnect:11931347;scConnect:11978642;scConnect:16930633;scConnect:9928018], VIP [Baccin2019:10570056;Baccin2019:10801840;Baccin2019:11931347;Baccin2019:12220741;Baccin2019:16930633;Baccin2019:8146174;Baccin2019:9152366;Baccin2019:9437714;Baccin2019:9454823;Baccin2019:9726637;Baccin2019:9928018;CellTalkDB:16930633;Cellinker:10570056;Cellinker:10801840;Cellinker:11931347;Cellinker:12220741;Cellinker:12488235;Cellinker:16930633;Cellinker:8146174;Cellinker:9152366;Cellinker:9437714;Cellinker:9454823;Cellinker:9726637;Cellinker:9928018;Guide2Pharma:10570056;Guide2Pharma:10801840;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:9152366;Guide2Pharma:9437714;Guide2Pharma:9454823;Guide2Pharma:9726637;Guide2Pharma:9928018;HPMR:12220741;HPRD:10801840;HPRD:8146174;HPRD:9454823;LRdb:10570056;LRdb:10801840;LRdb:11931347;LRdb:12220741;LRdb:16930633;LRdb:8146174;LRdb:9152366;LRdb:9437714;LRdb:9454823;LRdb:9726637;LRdb:9928018;connectomeDB2020:10570056;connectomeDB2020:10801840;connectomeDB2020:11931347;connectomeDB2020:12220741;connectomeDB2020:16930633;connectomeDB2020:8146174;connectomeDB2020:9152366;connectomeDB2020:9437714;connectomeDB2020:9454823;connectomeDB2020:9726637;connectomeDB2020:9928018;scConnect:10570056;scConnect:10801840;scConnect:11931347;scConnect:16930633;scConnect:9152366;scConnect:9437714;scConnect:9454823;scConnect:9726637;scConnect:9928018], SCT [CellTalkDB:9437714;LRdb:9437714;Ramilowski2015:9437714;connectomeDB2020:9437714;talklr:9437714], GHRH [CellChatDB:10655511;Cellinker:10655511], VEGFC [Cellinker:12881528;HPMR:12881528;LRdb:12881528;connectomeDB2020:12881528]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VIPR2&keywords=VIPR2	0.2626552898	519	NA	NA	0.06270375675	705	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	612
LGR4	leucine rich repeat containing G protein-coupled receptor 4	Yes	TBD		ENSG00000205213	Q9BXB1	G-protein coupled receptor 1 family	18	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14788, Q00604, Q02297, Q2I0M5, Q2MKA7, Q6UXX9, Q9BXY4	NDP, NRG1, RSPO1, RSPO2, RSPO3, RSPO4, TNFSF11	RSPO1 [Baccin2019:2169364621693640;BioGRID:24225776;CellTalkDB:21693646;Cellinker:21693646;Cellinker:24349440;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:24165923;Lit-BM-17:24225776;Lit-BM-17:25504990;connectomeDB2020:21693646;scConnect:21693646], RSPO2 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:25504990;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], RSPO3 [Baccin2019:21693646;Baccin2019:21909076;CellTalkDB:21693646;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;LRdb:21909076;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:21693646;connectomeDB2020:21909076;scConnect:21693646;scConnect:21909076], RSPO4 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:21693646;scConnect:21693646], NDP [Baccin2019:23444378;CellTalkDB:23444378;Cellinker:23444378;LRdb:23444378;connectomeDB2020:23444378], NRG1 [CellTalkDB:32103204], TNFSF11 [CellTalkDB:27064449]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGR4&keywords=LGR4	30.85077979	74	NA	NA	2.012634785	121	0.007874015748	0.3557884232	0.004424778761	0.03573141487	0.2811447811	0.06260575296	0.02810516772	0.009787928222	0.04032556419	0.03498464414	0.01290322581	142	150	188	0.07942506334	0.5627680016	0.5030429106	0.2561164058	279	294	370	160
ACKR1	atypical chemokine receptor 1 (Duffy blood group)	Yes	No		ENSG00000213088	Q16570	G-protein coupled receptor 1 family, Atypical chemokine receptor subfamily	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00626, O14625, O15467, O43927, P02775, P02776, P02778, P09341, P10145, P13500, P13501, P19875, P19876, P22362, P42830, P51671, P55774, P80075, P80098, P80162, Q07325, Q10586, Q16627, Q92583, Q99616	CCL1, CCL11, CCL13, CCL14, CCL16, CCL17, CCL18, CCL2, CCL22, CCL5, CCL7, CCL8, CXCL1, CXCL10, CXCL11, CXCL13, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8, CXCL9, DBP, PF4, PPBP	CCL11 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158], CCL13 [Baccin2019:24890717;CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158], CCL14 [CellChatDB:26740381;CellTalkDB:9405404;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:9405404], CCL17 [CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;ICELLNET:22633458;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], CCL2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:13679391;Cellinker:17416748;Cellinker:26740381;HPRD:13679391;HPRD:17416748;ICELLNET:22633458;InnateDB:8132497;LRdb:10699158;LRdb:13679391;LRdb:17;connectomeDB2020:13679391;connectomeDB2020:17416748], CCL5 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:12081195;Cellinker:17416748;Cellinker:26740381;HPRD:12081195;HPRD:17416748;ICELLNET:22633458;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:12081195;LRdb:17;connectomeDB2020:12081195;connectomeDB2020:17416748], CXCL1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:12734373;Cellinker:26740381;Cellinker:7592830;DIP:7592830;HPMR:12734373;HPRD:7592830;ICELLNET:22633458;ICELLNET:24625696;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:12734373;LRdb:76;connectomeDB2020:12734373;connectomeDB2020:7592830], CXCL2 [Baccin2019:28553950;CellChatDB:26740381;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;ICELLNET:30446388], CXCL8 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:17416748;Cellinker:26740381;Cellinker:9921412;DIP:10206993;DIP:7592830;DIP:8558064;DIP:9195930;HPRD:17416748;HPRD:9921412;ICELLNET:22633458;InnateDB:15720550;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:174;LRdb:9921412;connectomeDB2020:17416748;connectomeDB2020:9921412], PPBP [CellTalkDB:10699158;ICELLNET:22633458;LRdb:10699158], CXCL6 [Baccin2019:20643340;CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;LRdb:10699158], CXCL5 [CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], PF4 [CellTalkDB:32103204;InnateDB:8132497], CXCL11 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;LRdb:10699158], CCL7 [Baccin2019:13679391;CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], CCL8 [CellChatDB:26740381;CellTalkDB:13679391;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:13679391;connectomeDB2020:13679391], CCL1 [CellChatDB:26740381;Cellinker:26740381], CCL16 [CellChatDB:26740381;Cellinker:26740381], CCL18 [CellChatDB:26740381;Cellinker:26740381], CXCL3 [CellChatDB:26740381;Cellinker:26740381;Cellinker:29637711], CXCL9 [CellChatDB:26740381;Cellinker:26740381], CXCL10 [CellChatDB:26740381;Cellinker:26740381], CXCL13 [CellChatDB:26740381;Cellinker:26740381], DBP [Cellinker:29637711], CCL22 [Baccin2019:24013383]	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	C-C chemokine binding [GO:0019957]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	chemokine-mediated signaling pathway [GO:0070098]; defense response [GO:0006952]; inflammatory response [GO:0006954]; regulation of chemokine production [GO:0032642]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR1&keywords=ACKR1	0.05227774652	675	NA	NA	9.12E-04	881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	778
ADIPOR1	adiponectin receptor 1	Yes	Yes		ENSG00000159346	Q96A54	ADIPOR family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q15848	ADIPOQ	ADIPOQ [Baccin2019:12802337;CellChatDB:21284979;CellTalkDB:12802337;Cellinker:12802337;Cellinker:21284979;HPMR:12802337;LRdb:12802337;SIGNOR:16622416;connectomeDB2020:12802337]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADIPOR1&keywords=ADIPOR1	105.6447339	18	NA	NA	1.190020029	199	0.5039370079	0.4301397206	0.2942477876	0.5175059952	0.3956228956	0.4331641286	0.5131459655	0.3262642741	0.2974472808	0.3771197757	0.304964265	26	21	28	0.3994144633	0.7509438682	0.9455449437	0.7693041972	205	148	168	97
ADIPOR2	adiponectin receptor 2	Yes	Yes, No		ENSG00000285070, ENSG00000006831	Q86V24	ADIPOR family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q15848	ADIPOQ	ADIPOQ [Baccin2019:12802330;Baccin2019:12802337;CellChatDB:21284979;CellTalkDB:12802337;Cellinker:12802337;Cellinker:21284979;HPRD:12802337;LRdb:12802337;SIGNOR:12802337;SIGNOR:16622416;connectomeDB2020:12802337]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]	adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cold-induced thermogenesis [GO:0120162]; vascular wound healing [GO:0061042]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADIPOR2&keywords=ADIPOR2	17.3981618	115	NA	NA	0.469069073	379	0.07874015748	0.2574850299	0.1006637168	0.2220623501	0.2171717172	0.1353637902	0.1504986401	0.07177814029	0.1002589715	0.107057017	0.08197797952	78	79	74	0.1384597736	0.7426858388	0.7884763265	0.6195481595	210	199	225	193
APLNR	apelin receptor	Yes	Yes		ENSG00000134817	P35414	G-protein coupled receptor 1 family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P0DMC3, P14136, Q9ULZ1	APELA, APLN, GFAP	APLN [Baccin2019:10617103;Baccin2019:10777510;Baccin2019:11336787;Baccin2019:12603839;Baccin2019:12939143;Baccin2019:15341513;Baccin2019:9792798;CellTalkDB:10617103;Guide2Pharma:10777510;Guide2Pharma:11336787;Guide2Pharma:12603839;Guide2Pharma:12939143;Guide2Pharma:15341513;HPMR:10802050;HPMR:9792798;HPRD:12603839;LRdb:10617103;LRdb:10777510;LRdb:11336787;LRdb:12603839;LRdb:12939143;LRdb:15341513;LRdb:9792798;connectomeDB2020:10617103;connectomeDB2020:10777510;connectomeDB2020:11336787;connectomeDB2020:12603839;connectomeDB2020:12939143;connectomeDB2020:15341513;connectomeDB2020:9792798;scConnect:10777510;scConnect:11336787;scConnect:12603839;scConnect:12939143;scConnect:15341513], APELA [CellChatDB:25995451;CellTalkDB:28663440;Cellinker:25995451;Cellinker:29079036;Cellinker:29357134;Guide2Pharma:25995451;connectomeDB2020:25639753;connectomeDB2020:26611206;connectomeDB2020:28137936;scConnect:25995451], GFAP [Cellinker:12603839]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apelin receptor activity [GO:0060182]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]	adult heart development [GO:0007512]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; apelin receptor signaling pathway [GO:0060183]; atrioventricular valve development [GO:0003171]; blood vessel development [GO:0001568]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; gastrulation [GO:0007369]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart looping [GO:0001947]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of body fluid levels [GO:0050878]; regulation of gap junction assembly [GO:1903596]; regulation of gene expression [GO:0010468]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APLNR&keywords=APLNR	0.08037988989	640	NA	NA	0.009096068435	853	0	0	0.1559734513	0.007673860911	0	0	0	0	0	0	2.70E-04	234	346	339	0.01490161265	0.4015804174	0.4015804174	0.4124402316	333	322	306	540
AVPR1A	arginine vasopressin receptor 1A	Yes	No		ENSG00000166148	P37288	G-protein coupled receptor 1 family, Vasopressin/oxytocin receptor subfamily	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01178, P01185, P01282, P17252, P34947, P48061	AVP, CXCL12, GRK5, OXT, PRKCA, VIP	OXT [Baccin2019:10519430;Baccin2019:12660315;Baccin2019:8106369;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9334232;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:8106369;Cellinker:10519430;Cellinker:12660315;Cellinker:8106369;Cellinker:9264324;Cellinker:9322919;Cellinker:9334232;Cellinker:9459574;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:12660315;Guide2Pharma:8106369;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9334232;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:10519430;LRdb:12660315;LRdb:8106369;LRdb:9264324;LRdb:9322919;LRdb:9334232;LRdb:9459574;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:12660315;connectomeDB2020:8106369;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9334232;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:10519430;scConnect:12660315;scConnect:8106369;scConnect:9264324;scConnect:9322919;scConnect:9334232;scConnect:9459574;scConnect:9884074], AVP [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:10866830;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:1560825;Baccin2019:8106369;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9334232;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:1560825;Cellinker:10519430;Cellinker:10780976;Cellinker:10866830;Cellinker:12446593;Cellinker:15084136;Cellinker:1560825;Cellinker:8106369;Cellinker:9264324;Cellinker:9322919;Cellinker:9334232;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:10866830;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:8106369;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9334232;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPMR:1560825;HPRD:8106369;LRdb:10519430;LRdb:10780976;LRdb:10866830;LRdb:12446593;LRdb:15084136;LRdb:1560825;LRdb:8106369;LRdb:9264324;LRdb:9322919;LRdb:9334232;LRdb:9459574;LRdb:9864265;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:10866830;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:1560825;connectomeDB2020:8106369;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9334232;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:10866830;scConnect:12446593;scConnect:15084136;scConnect:8106369;scConnect:9264324;scConnect:9322919;scConnect:9334232;scConnect:9459574;scConnect:9864265;scConnect:9884074], CXCL12 [CellTalkDB:29386406], VIP [CellTalkDB:32103204], PRKCA [HPRD:10858434], GRK5 [HPRD:10858434]	endocytic vesicle [GO:0030139]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000]	activation of phospholipase C activity [GO:0007202]; blood circulation [GO:0008015]; calcium-mediated signaling [GO:0019722]; cellular response to water deprivation [GO:0042631]; generation of precursor metabolites and energy [GO:0006091]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organism aging [GO:0010259]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537]; transport across blood-brain barrier [GO:0150104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AVPR1A&keywords=AVPR1A	0.4518174372	468	NA	NA	0.09248149218	655	0	0	0	0.01007194245	0	0	0	0	0	6.68E-05	0	234	344	347	9.22E-04	0.9156083224	0.9217213436	0.9156083224	139	156	110	406
AVPR1B	arginine vasopressin receptor 1B	Yes	No		ENSG00000198049	P47901	G-protein coupled receptor 1 family, Vasopressin/oxytocin receptor subfamily	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01178, P01185, P34947	AVP, GRK5, OXT	OXT [Baccin2019:16158071;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:16158071;Guide2Pharma:16158071;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:16158071;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9884074;connectomeDB2020:16158071;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:16158071;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9884074], AVP [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:16158071;Baccin2019:7929452;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:7929452;Cellinker:10519430;Cellinker:10780976;Cellinker:12446593;Cellinker:15084136;Cellinker:16158071;Cellinker:7929452;Cellinker:9264324;Cellinker:9322919;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:16158071;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPRD:7929452;LRdb:10519430;LRdb:10780976;LRdb:12446593;LRdb:15084136;LRdb:16158071;LRdb:7929452;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9864265;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:16158071;connectomeDB2020:7929452;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:12446593;scConnect:15084136;scConnect:16158071;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9864265;scConnect:9884074], GRK5 [HPRD:10858434]	axon terminus [GO:0043679]; dendrite [GO:0030425]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; vasopressin receptor activity [GO:0005000]	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; hyperosmotic salinity response [GO:0042538]; multicellular organism aging [GO:0010259]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AVPR1B&keywords=AVPR1B	0.8822449831	397	NA	NA	4.222699258	51	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	224
BDKRB1	bradykinin receptor B1	Yes	No		ENSG00000100739	P46663	G-protein coupled receptor 1 family, Bradykinin receptor subfamily, BDKRB1 sub-subfamily	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01042	KNG1	KNG1 [CellTalkDB:8856107;Cellinker:10422787;Cellinker:8063797;Cellinker:9111052;Cellinker:9313952;Guide2Pharma:10422787;Guide2Pharma:8735629;Guide2Pharma:9111052;Guide2Pharma:9313952;HPMR:8063797;LRdb:10422787;LRdb:8063797;LRdb:9111052;LRdb:9313952;connectomeDB2020:10422787;connectomeDB2020:8063797;connectomeDB2020:9111052;connectomeDB2020:9313952;scConnect:10422787;scConnect:8735629;scConnect:9111052;scConnect:9313952]	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	bradykinin receptor activity [GO:0004947]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]	cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell growth [GO:0030308]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BDKRB1&keywords=BDKRB1	3.543027337	257	NA	NA	2.454392957	96	0	0.006487025948	0.03207964602	0.03501199041	0.005050505051	0	0.001813236627	0.006525285481	3.70E-04	0.001836026172	8.11E-04	233	292	321	0.008180450516	0.5703906675	0.651030411	0.5946651682	274	247	238	223
CALCR	calcitonin receptor	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000004948	P30988	G-protein coupled receptor 2 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, receptor, transmembrane	P01258, P04114, P06881, P0DP23, P10092, P10997, P11226, P35318, Q7Z4H4	ADM, ADM2, APOB, CALCA, CALCB, CALM1, IAPP, MBL2	ADM [Baccin2019:12565884;Baccin2019:15692146;CellTalkDB:10781016;Cellinker:12565884;Cellinker:15692146;Guide2Pharma:12565884;Guide2Pharma:15692146;LRdb:13;LRdb:15692146;connectomeDB2020:12565884;connectomeDB2020:15692146;scConnect:12565884;scConnect:15692146], ADM2 [Baccin2019:15692146;CellTalkDB:15692146;Guide2Pharma:15692146;Guide2Pharma:21658025;LRdb:15692146;connectomeDB2020:15692146;scConnect:15692146;scConnect:21658025], CALCA [CellTalkDB:2158663;Cellinker:10342886;Cellinker:11023820;Cellinker:11033437;Cellinker:12565884;Cellinker:14722252;Cellinker:15692146;Cellinker:2158663;Cellinker:7588285;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:7588285;Guide2Pharma:9487987;ICELLNET:1331173;ICELLNET:6148938;LRdb:10342886;LRdb:11023820;LRdb:11033437;LRdb:12565884;LRdb:14722252;LRdb:15692146;LRdb:2158663;LRdb:7588285;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:11023820;connectomeDB2020:11033437;connectomeDB2020:12565884;connectomeDB2020:14722252;connectomeDB2020:15692146;connectomeDB2020:2158663;connectomeDB2020:7588285;connectomeDB2020:9487987;scConnect:10342886;scConnect:11023820;scConnect:11033437;scConnect:12565884;scConnect:14722252;scConnect:15692146;scConnect:26125036;scConnect:7588285;scConnect:9487987], CALCA [Baccin2019:10342886;Baccin2019:11023820;Baccin2019:11033437;Baccin2019:12565884;Baccin2019:14722252;Baccin2019:15692146;Baccin2019:2158663;Baccin2019:7588285;Baccin2019:9487987;CellTalkDB:2158663;Cellinker:10342886;Cellinker:11023820;Cellinker:11033437;Cellinker:12565884;Cellinker:14722252;Cellinker:15692146;Cellinker:2158663;Cellinker:7588285;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:7588285;Guide2Pharma:9487987;LRdb:10342886;LRdb:11023820;LRdb:11033437;LRdb:12565884;LRdb:14722252;LRdb:15692146;LRdb:2158663;LRdb:7588285;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:11023820;connectomeDB2020:11033437;connectomeDB2020:12565884;connectomeDB2020:14722252;connectomeDB2020:15692146;connectomeDB2020:2158663;connectomeDB2020:7588285;connectomeDB2020:9487987;scConnect:10342886;scConnect:11023820;scConnect:11033437;scConnect:12565884;scConnect:14722252;scConnect:15692146;scConnect:26125036;scConnect:7588285;scConnect:9487987], IAPP [Baccin2019:10342886;Baccin2019:12529937;Baccin2019:9487987;CellTalkDB:10342886;Cellinker:10342886;Cellinker:12529937;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:24169554;Guide2Pharma:9487987;LRdb:10342886;LRdb:12529937;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:12529937;connectomeDB2020:9487987;scConnect:10342886;scConnect:24169554;scConnect:9487987], CALCB [Baccin2019:10342886;Baccin2019:11023820;Baccin2019:11033437;Baccin2019:12565884;Baccin2019:14722252;Baccin2019:15692146;Baccin2019:2158663;Baccin2019:7588285;Baccin2019:9487987;CellTalkDB:15692146;Cellinker:15692146;Guide2Pharma:15692146;LRdb:15692146;connectomeDB2020:15692146;scConnect:15692146], APOB [CellTalkDB:32196115], CALM1 [CellTalkDB:32196115;HPRD:15670850], MBL2 [Baccin2019:11560994;CellTalkDB:11560994;HPRD:11560994;LRdb:11560994]	amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCR&keywords=CALCR	0.0207115467	736	NA	NA	0.1971713191	525	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	631
CRHR1	corticotropin releasing hormone receptor 1	Yes	No		ENSG00000276191, ENSG00000120088	P34998	G-protein coupled receptor 2 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O95467, P06850, P0DP23, P17612, P55089, P63092, P84996, Q5JWF2, Q969E3, Q96RP3	CALM1, CRH, GNAS, PRKACA, UCN, UCN2, UCN3	CRH [Baccin2019:11123370;Baccin2019:7477349;Baccin2019:7692441;Baccin2019:8536644;Baccin2019:8612563;Baccin2019:9178757;Baccin2019:9326293;Baccin2019:9851694;BioGRID:10598591;BioGRID:19124613;CellTalkDB:11123370;Cellinker:11123370;Cellinker:7477349;Cellinker:7692441;Cellinker:8536644;Cellinker:8612563;Cellinker:9178757;Cellinker:9326293;Cellinker:9851694;Guide2Pharma:11123370;Guide2Pharma:7477349;Guide2Pharma:7692441;Guide2Pharma:8612563;Guide2Pharma:9326293;Guide2Pharma:9851694;HPMR:8536644;HPRD:9178757;IntAct:18801728;IntAct:20966082;LRdb:11123370;LRdb:7477349;LRdb:7692441;LRdb:8536644;LRdb:8612563;LRdb:9178757;LRdb:9326293;LRdb:9851694;SIGNOR:11416224;connectomeDB2020:11123370;connectomeDB2020:7477349;connectomeDB2020:7692441;connectomeDB2020:8536644;connectomeDB2020:8612563;connectomeDB2020:9178757;connectomeDB2020:9326293;connectomeDB2020:9851694;scConnect:11123370;scConnect:7477349;scConnect:7692441;scConnect:8612563;scConnect:9326293;scConnect:9851694], UCN [Baccin2019:11123370;Baccin2019:11416224;Baccin2019:15450949;Baccin2019:8612563;Baccin2019:9423932;BioGRID:8612563;CellTalkDB:11416224;Cellinker:11123370;Cellinker:11416224;Cellinker:15450949;Cellinker:8612563;Cellinker:9423932;Guide2Pharma:11123370;Guide2Pharma:15450949;Guide2Pharma:8612563;HPRD:8612563;HPRD:9423932;LRdb:11123370;LRdb:11416224;LRdb:15450949;LRdb:8612563;LRdb:9423932;connectomeDB2020:11123370;connectomeDB2020:11416224;connectomeDB2020:15450949;connectomeDB2020:8612563;connectomeDB2020:9423932;scConnect:11123370;scConnect:15450949;scConnect:8612563], UCN2 [Baccin2019:15450949;CellTalkDB:15450949;Cellinker:15450949;Guide2Pharma:15450949;LRdb:15450949;connectomeDB2020:15450949;scConnect:15450949], CALM1 [CellTalkDB:32196115;HPRD:15670850], GNAS [Baccin2019:10598591;CellTalkDB:10598591;HPRD:10598591;LRdb:10598591;connectomeDB2020:10598591], GNAS [Baccin2019:10598591;CellTalkDB:10598591;HPRD:10598591;LRdb:10598591;connectomeDB2020:10598591], GNAS [Baccin2019:10598591;CellTalkDB:10598591;HPRD:10598591;LRdb:10598591;connectomeDB2020:10598591], GNAS [Baccin2019:10598591;CellTalkDB:10598591;HPRD:10598591;LRdb:10598591;connectomeDB2020:10598591], UCN3 [Baccin2019:11416224;CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224], PRKACA [PhosphoSite:14657255;iPTMnet:14657255]	endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; female pregnancy [GO:0007565]; immune response [GO:0006955]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; parturition [GO:0007567]; regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO:0010578]; regulation of corticosterone secretion [GO:2000852]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRHR1&keywords=CRHR1	0.08235683812	635	NA	NA	0.02348864557	810	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	723
DDR1	discoidin domain receptor tyrosine kinase 1	Yes	Yes,		ENSG00000223680, ENSG00000229767, ENSG00000234078, ENSG00000215522, ENSG00000230456, ENSG00000137332, ENSG00000204580	Q08345	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	17	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14672, P02452, P02458, P02461, P02462, P04637, P05997, P08123, P08253, P08572, P10321, P12107, P14780, P20908, P23560, P25067, P25940, P27658, P29400, P35625, P50281, P51511, P51512, P53420, Q01955, Q14031, Q16832, Q6UXA7, Q9HC98	ADAM10, BDNF, C6orf15, COL11A1, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL5A3, COL8A1, COL8A2, DDR2, HLA-C, MMP14, MMP15, MMP16, MMP2, MMP9, NEK6, TIMP3, TP53	TP53 [SPIKE:18431400], COL1A1 [Baccin2019:9659900;CellTalkDB:9659900;Cellinker:9659900;HPMR:9659900;InnateDB:21815193;LRdb:9659900;MatrixDB:21044884;SIGNOR:9659900;connectomeDB2020:9659900], COL3A1 [Baccin2019:9659900;CellTalkDB:9659900;Cellinker:9659900;DIP:22483115;HPRD:9659900;LRdb:9659900;MatrixDB:21044884;connectomeDB2020:9659900], COL11A1 [Baccin2019:9659900;CellTalkDB:9659900;HPRD:9659900;LRdb:9659900;connectomeDB2020:9659900], COL5A2 [Baccin2019:9659900;CellTalkDB:9659900;Cellinker:9659900;HPRD:9659900;LRdb:9659900;connectomeDB2020:9659900], COL2A1 [Baccin2019:9659900;CellTalkDB:9659900;Cellinker:9659900;HPRD:9659900;LRdb:9659900;connectomeDB2020:9659900], BDNF [NA], C6orf15 [NA], HLA-C [NA], COL5A3 [Cellinker:9659900], COL5A1 [Cellinker:9659900], MMP2 [Cellinker:19262089], COL4A5 [Cellinker:9659900], TIMP3 [Cellinker:16440311], COL4A2 [Cellinker:9659900], MMP16 [Cellinker:23519472], COL4A3 [Cellinker:9659900], DDR2 [Cellinker:29616590], COL4A1 [Cellinker:9659900], COL8A1 [Cellinker:11254672], COL8A2 [Cellinker:11254672], MMP15 [Cellinker:23519472], COL4A6 [Cellinker:9659900], COL1A2 [Cellinker:16440311;MatrixDB:21044884], ADAM10 [Cellinker:25540428], COL4A4 [Cellinker:9659900], MMP9 [Cellinker:19262089], MMP14 [Cellinker:23519472], NEK6 [iPTMnet:12023960]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell-matrix adhesion [GO:0061302]; smooth muscle cell migration [GO:0014909]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DDR1&keywords=DDR1	78.55541241	29	2422.04	58	2.080045943	115	0.03149606299	0.4356287425	0.01438053097	0.03141486811	0.3333333333	0.7411167513	0.7280145059	0.5089722675	0.4195338513	0.5211309921	0.2322580645	14	15	39	0.3633890882	1.150365302	1.422459865	0.6488086346	80	49	216	53
ERBB2	erb-b2 receptor tyrosine kinase 2	Yes	No		ENSG00000141736	P04626	Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily	17	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14511, O14672, O14944, O43157, O75131, P00519, P00533, P01133, P01135, P01138, P01236, P04196, P04439, P05771, P06241, P07900, P07948, P08238, P08581, P09769, P0CG47, P0CG48, P12931, P12955, P14625, P15309, P15514, P16591, P17252, P17612, P22681, P23470, P23560, P26447, P27361, P27986, P32004, P35070, P40189, P41161, P42684, P43378, P51451, P51452, P56975, P62979, P62987, P98172, Q00535, Q02297, Q05209, Q05397, Q06124, Q13153, Q13237, Q14451, Q15717, Q16543, Q16827, Q7RTS9, Q8WWG1, Q92854, Q96EY1, Q96JA1, Q99075, Q99102, Q99952, Q99988, Q9NRD5, Q9UJM3, Q9UNE7, Q9UQM7	ABL1, ABL2, ACP3, ADAM10, AREG, BDNF, BLK, BTC, CAMK2A, CBL, CDC37, CDK5, CPNE3, DNAJA3, DUSP3, DYM, EFNB1, EGF, EGFR, ELAVL1, EREG, ERRFI1, ETV5, FER, FGR, FYN, GDF15, GRB7, HBEGF, HLA-A, HRG, HSP90AA1, HSP90AB1, HSP90B1, IL6ST, L1CAM, LRIG1, LYN, MAPK3, MET, MUC4, NGF, NRG1, NRG2, NRG3, NRG4, PAK1, PEPD, PICK1, PIK3R1, PLXNB1, PRKACA, PRKCA, PRKCB, PRKG2, PRL, PTK2, PTPN11, PTPN12, PTPN18, PTPN9, PTPRG, PTPRO, RPS27A, S100A4, SEMA4D, SRC, STUB1, TGFA, UBA52, UBB, UBC	NRG1 [CellTalkDB:1350381;HPMR:1350381;LRdb:1350381;LRdb:751;ProtMapper:19293191;SIGNOR:7514177;SPIKE:14737100;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:1350381;connectomeDB2020:7514177], ELAVL1 [SPIKE:18644987], PAK1 [HPRD:9774445], GRB7 [BioGRID:9079677;Cellinker:11809769;Cellinker:9079677;DOMINO:16273093;ELM:11500516;ELM:12975581;ELM:15930003;HPRD:9079677;IntAct:12061724;IntAct:12975581;IntAct:16273093;IntAct:9079677;LMPID:11500516;LMPID:12975581;Lit-BM-17:12061724;Lit-BM-17:16273093;Lit-BM-17:17875712;Lit-BM-17:9079677;SPIKE:12853971;SPIKE:16273093], EGFR [BioGRID:16207817;BioGRID:21044682;BioGRID:28369073;Cellinker:20471394;HPRD-phos:11500516;HPRD-phos:12354693;HPRD-phos:1706616;HPRD-phos:17389395;HPRD-phos:17426253;HPRD:11500516;HPRD:11500850;HPRD:12354693;HPRD:16843263;HPRD:1706616;HPRD:17426253;IntAct:10572067;IntAct:16516204;IntAct:16843263;IntAct:17148612;IntAct:19650109;IntAct:21203579;IntAct:21278786;IntAct:23436906;IntAct:24557338;IntAct:25241761;KEA:11500516;KEA:12354693;KEA:1706616;KEA:17081983;KEA:17426253;Lit-BM-17:10572067;Lit-BM-17:11408594;Lit-BM-17:15657067;Lit-BM-17:16207817;Lit-BM-17:16516204;Lit-BM-17:16843263;Lit-BM-17:17307140;Lit-BM-17:17486068;Lit-BM-17:18803307;Lit-BM-17:19060928;Lit-BM-17:19650109;Lit-BM-17:20211985;Lit-BM-17:21044682;Lit-BM-17:23436906;Lit-BM-17:24189400;Lit-BM-17:24557338;Lit-BM-17:25241761;NetPath:10233167;ProtMapper:12354693;ProtMapper:15951569;ProtMapper:24355130;SIGNOR:11279155;SIGNOR:12354693;SPIKE:10572067;SPIKE:12648464;SPIKE:16516204;SPIKE:16713569;iPTMnet:11500516;iPTMnet:12354693;iPTMnet:1706616;iPTMnet:17389395;iPTMnet:17426253], LRIG1 [IntAct:15282549;IntAct:15345710;IntAct:23723069;SIGNOR:16123311;SignaLink3:16123311;SignaLink3:23331499], PIK3R1 [Cellinker:15632176;DOMINO:16273093;HPRD:1351056;HPRD:16843263;IntAct:16273093;Lit-BM-17:16273093;Lit-BM-17:16843263;Lit-BM-17:21075308;Lit-BM-17:9756944;NetPath:11331299], AREG [SIGNOR:7679104;SignaLink3:23331499;SignaLink3:7679104], EGF [Baccin2019:12093292;CellTalkDB:12093292;HPRD:12093292;LRdb:12093292;ProtMapper:15748904;SIGNOR:11279155;SignaLink3:11279155;SignaLink3:23331499;connectomeDB2020:12093292], GDF15 [CA1:6328316], PICK1 [HPRD:11278603], PTPN18 [HPRD:14660651;Lit-BM-17:25081058;SIGNOR:25081058], ERRFI1 [HPRD:11003669;Lit-BM-17:24189400;Lit-BM-17:25640309;SIGNOR:18046415], CBL [ACSN:10514377;ACSN:17635922;ProtMapper:25102001;SIGNOR:20332299], ADAM10 [SIGNOR:26284334], PRKACA [KEA:9855018;ProtMapper:18799465;SIGNOR:18799465;iPTMnet:18799465], PTPRG [ProtMapper:25624455;SIGNOR:25624455], DUSP3 [DEPOD:21262974;ProtMapper:21262974;SIGNOR:21262974], PTPN11 [DOMINO:16273093;HPRD:16729043;Lit-BM-17:16273093;Lit-BM-17:16729043;Lit-BM-17:9756944;SIGNOR:32024694], EFNB1 [CellTalkDB:22279592;Cellinker:22279592;LRdb:22279592;Ramilowski2015:22279592;connectomeDB2020:22279592;talklr:22279592], HBEGF [CellTalkDB:12958167;LRdb:12958167;Ramilowski2015:12958167;connectomeDB2020:12958167;talklr:12958167], HRG [CellTalkDB:10559227], EREG [CellTalkDB:32196115], S100A4 [CellTalkDB:30083275], NRG3 [CellTalkDB:9772300], SEMA4D [CellTalkDB:15210733;LRdb:15210733;ProtMapper:15210733;Ramilowski2015:15210733;connectomeDB2020:15210733;talklr:15210733], HLA-A [Baccin2019:10593938;CellTalkDB:10593938;HPRD:10593938;LRdb:10593938;connectomeDB2020:10593938], NRG4 [CellTalkDB:32196115], HSP90B1 [BioGRID:8617772;CellTalkDB:32196115;HPRD:8617772], L1CAM [CellTalkDB:22815787;LRdb:22815787;Ramilowski2015:22815787;connectomeDB2020:22815787;talklr:22815787], TGFA [Baccin2019:10918572;CellTalkDB:10918572;HPRD:10918572;LRdb:10918572;connectomeDB2020:10918572], NRG2 [CellTalkDB:32196115], HSP90AA1 [BioGRID:11071886;BioGRID:16144943;BioGRID:18655187;CellTalkDB:32196115;Cellinker:15632176;HPRD:11071886;IntAct:20558745;IntAct:23995768;IntAct:24658140;IntAct:25036637;Lit-BM-17:11071886;Lit-BM-17:12006493;Lit-BM-17:16144943;Lit-BM-17:17239458;Lit-BM-17:18655187;Lit-BM-17:20159553;Lit-BM-17:20558745;Lit-BM-17:21503962;Lit-BM-17:22315411;Lit-BM-17:22939624;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:25036637;Lit-BM-17:26804907], BTC [Baccin2019:9662041;CellTalkDB:9662041;HPRD:9662041;LRdb:9662041;ProtMapper:15163624;connectomeDB2020:9662041], PRL [Cellinker:22270933], BDNF [Cellinker:28446206], STUB1 [Cellinker:21710689;HPRD:12574167], CDC37 [Cellinker:15632176;Lit-BM-17:24189400;Lit-BM-17:25036637], NGF [Cellinker:12181354], DNAJA3 [Cellinker:21710689], PTPRO [Cellinker:27345410], PEPD [Cellinker:24810047], IL6ST [Cellinker:11821958;HPRD:11821958;NetPath:9590694], CPNE3 [Cellinker:20010870], MET [Cellinker:28536399], ETV5 [Cellinker:27029001], DYM [Cellinker:10702370], PLXNB1 [Cellinker:15210733], HSP90AB1 [Cellinker:15632176;IntAct:20650008;IntAct:22939624;Lit-BM-17:22939624;Lit-BM-17:24189400], SRC [Cellinker:22279592;HPRD:7542762;IntAct:11940572;IntAct:21075308;ProtMapper:11250711], RPS27A [NA], UBA52 [NA], UBB [HPRD:12239347], UBC [NA], PRKG2 [PhosphoSite:26676300;PhosphoSite:8702975;PhosphoSite:9855018], MAPK3 [PhosphoSite:28632938;PhosphoSite:30115691], FYN [Lit-BM-17:24815698;PhosphoSite:16785428;ProtMapper:21499296], ACP3 [DEPOD:11067847;DEPOD:9705354;HPRD-phos:10851066;HPRD-phos:11067847;HPRD-phos:9705354;HPRD:10851066;HPRD:11067847;HPRD:9705354], PTPN9 [DEPOD:20335174], CAMK2A [KEA:8700533;iPTMnet:8700533;phosphoELM:8700533], ABL1 [DOMINO:16273093], FGR [DOMINO:16273093], FER [DOMINO:16273093], ABL2 [DOMINO:16273093], BLK [DOMINO:16273093], LYN [KEA:17570479], PRKCA [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:9855018;iPTMnet:18799465], PRKCB [ACSN:11313945;ACSN:11447289;ACSN:11940581;ACSN:12040186;ACSN:12845332;ACSN:14585353;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:21386996;ACSN:6321473;ACSN:8321321;KEA:17570479], CDK5 [ProtMapper:12824184;iPTMnet:12824184;iPTMnet:17145757], PTK2 [HPRD:11807823;Lit-BM-17:12600989;Lit-BM-17:25241761], PTPN12 [Lit-BM-17:19167335;Lit-BM-17:21376233], MUC4 [HPRD:11598901;HPRD:11687512;HPRD:12434309;ProtMapper:20348949]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; ERBB3:ERBB2 complex [GO:0038143]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase I core binding [GO:0001042]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]	cell surface receptor signaling pathway [GO:0007166]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; enzyme linked receptor protein signaling pathway [GO:0007167]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine phosphorylation [GO:0018108]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of microtubule-based process [GO:0032886]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERBB2&keywords=ERBB2	22.33955034	94	NA	NA	0.5902061889	342	0.007874015748	0.2160678643	0.01216814159	0.01606714628	0.06734006734	0.0152284264	0.01178603808	0.003262642741	0.007029226785	0.01305247697	0.007031099092	210	192	224	0.03426428594	0.3847170789	0.5207917959	0.3847593773	341	288	318	229
F2R	coagulation factor II thrombin receptor	Yes	No		ENSG00000181104	P25116	G-protein coupled receptor 1 family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14640, P00734, P00747, P04899, P05106, P05771, P07384, P07477, P07478, P08246, P08253, P08311, P08514, P10275, P12544, P24158, P35030, P55085, Q13596, Q8TEW0, Q96G01, Q9UNN8	AR, BICD1, CAPN1, CTSG, DVL1, ELANE, F2, F2RL1, GNAI2, GZMA, ITGA2B, ITGB3, MMP2, PARD3, PLG, PRKCB, PROCR, PRSS1, PRSS2, PRSS3, PRTN3, SNX1	AR [SPIKE:15629896], DVL1 [CA1:11433294], CAPN1 [HPRD:10978167;SIGNOR:10978167], CTSG [HPRD:10978167;SIGNOR:10978167], PRTN3 [HPRD:10978167;SIGNOR:10978167], F2 [ACSN:14652070;ACSN:15707890;Baccin2019:10644723;Baccin2019:10978167;Baccin2019:11356985;Baccin2019:12563219;Baccin2019:9058715;CellTalkDB:10978167;Cellinker:11356985;DIP:18250335;HPMR:11356985;HPRD:10644723;HPRD:10978167;HPRD:12563219;HPRD:9058715;LRdb:10644723;LRdb:10978167;LRdb:11356985;LRdb:12563219;LRdb:9058715;SIGNOR:10978167;SIGNOR:22972936;SIGNOR:23450633;connectomeDB2020:10644723;connectomeDB2020:10978167;connectomeDB2020:11356985;connectomeDB2020:12563219;connectomeDB2020:9058715], PLG [Baccin2019:10978167;CellTalkDB:10978167;HPRD:10978167;LRdb:10978167;SIGNOR:10978167;connectomeDB2020:10978167], ELANE [HPRD:10978167;SIGNOR:10978167], GNAI2 [CellTalkDB:10644723;Cellinker:10644723;Cellinker:8982657;HPRD:10644723;HPRD:8982657;LRdb:10644723;LRdb:9;connectomeDB2020:10644723;connectomeDB2020:8982657], PRSS3 [NA], GZMA [NA], PRSS2 [NA], PRSS1 [NA], PARD3 [Cellinker:27127302], PROCR [Cellinker:17299037;IntAct:17299037;IntAct:20826780], ITGB3 [Cellinker:28034890], MMP2 [Cellinker:28034890], F2RL1 [Cellinker:27127302], ITGA2B [Cellinker:28034890], BICD1 [Cellinker:20164183], PRKCB [KEA:17570479], SNX1 [HPRD:12058063]	caveola [GO:0005901]; cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; platelet dense tubular network [GO:0031094]; postsynaptic membrane [GO:0045211]	G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor activity [GO:0004930]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cell-cell junction maintenance [GO:0045217]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of renin secretion into blood stream [GO:1900134]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of blood coagulation [GO:0030194]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of blood coagulation [GO:0030193]; regulation of interleukin-1 beta production [GO:0032651]; regulation of sensory perception of pain [GO:0051930]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=F2R&keywords=F2R	19.77141921	109	NA	NA	1.403155494	169	0	0.02195608782	0.2422566372	0.7611510791	0.005050505051	0.006768189509	0.005439709882	0	0.002219755827	0.002837494993	0.003476917133	228	266	257	0.09555967059	0.1157615949	0.1216136326	0.1276710799	428	419	419	241
FPR1	formyl peptide receptor 1	Yes	No		ENSG00000171051	P21462	G-protein coupled receptor 1 family	17	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04083, P04899, P0DJI8, P25098, P49674, P78527, Q16539, Q96BQ1, Q96LR4	ANXA1, CSNK1E, FAM3D, GNAI2, GRK2, MAPK14, PRKDC, SAA1, TAFA4	GRK2 [HPRD:7836371;KEA:7836371;ProtMapper:7836371;SIGNOR:7836371;iPTMnet:7836371;phosphoELM:7836371], ANXA1 [Baccin2019:10882119;Baccin2019:12560218;CellChatDB:23230437;CellTalkDB:10882119;Cellinker:10882119;Cellinker:12560218;Cellinker:23230437;HPMR:10882119;HPRD:10882119;LRdb:10882119;LRdb:13;SIGNOR:15187149;connectomeDB2020:10882119;connectomeDB2020:12560218;scConnect:10882119;scConnect:12560218], GNAI2 [CellTalkDB:8663057;Cellinker:8663057;HPRD:8663057;LRdb:8663057;connectomeDB2020:8663057], SAA1 [Baccin2019:10753626;CellTalkDB:10753626;Cellinker:10753626;HPRD:10753626;LRdb:10753626], FAM3D [connectomeDB2020:29853563], TAFA4 [connectomeDB2020:25109685], MAPK14 [PhosphoSite:22447027;iPTMnet:22447027], CSNK1E [KEA:17570479], PRKDC [KEA:17570479]	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FPR1&keywords=FPR1	0.1792342876	556	NA	NA	0.005893337122	863	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	710
GALR3	galanin receptor 3	Yes	TBD		ENSG00000128310	O60755	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P22466, Q9BT56, Q9UBC7	GAL, GALP, SPX	SPX [Guide2Pharma:24517231;connectomeDB2020:24517231;connectomeDB2020:30305242], GAL [Baccin2019:9722565;Baccin2019:9832121;Baccin2019:9880084;CellTalkDB:9722565;Cellinker:9722565;Cellinker:9832121;Cellinker:9880084;Guide2Pharma:9722565;Guide2Pharma:9832121;Guide2Pharma:9880084;HPMR:9832121;LRdb:9722565;LRdb:9832121;LRdb:9880084;connectomeDB2020:9722565;connectomeDB2020:9832121;connectomeDB2020:9880084;scConnect:9722565;scConnect:9832121;scConnect:9880084], GALP [Baccin2019:983212115944009;CellTalkDB:9832121;Cellinker:15944009;Cellinker:9832121;LRdb:159;LRdb:9832121;connectomeDB2020:15944009;connectomeDB2020:9832121;scConnect:15944009]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; synapse [GO:0045202]	galanin receptor activity [GO:0004966]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; galanin-activated signaling pathway [GO:0090663]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning or memory [GO:0007611]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GALR3&keywords=GALR3	0.001601569663	831	NA	NA	0.08030906626	675	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	753
GLP1R	glucagon like peptide 1 receptor	Yes	No		ENSG00000112164	P43220	G-protein coupled receptor 2 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O95467, P01275, P0DP23, P63092, P84996, Q5JWF2	CALM1, GCG, GNAS	GCG [Baccin2019:11116211;Baccin2019:15528268;Baccin2019:7937318;Baccin2019:8404634;BioGRID:11116211;BioGRID:18248821;CellTalkDB:11116211;Cellinker:11116211;Cellinker:15528268;Cellinker:7937318;Cellinker:8404634;Guide2Pharma:15528268;Guide2Pharma:8404634;HPMR:8404634;HPRD:11116211;LRdb:11116211;LRdb:15528268;LRdb:7937318;LRdb:8404634;SIGNOR:7937318;connectomeDB2020:11116211;connectomeDB2020:15528268;connectomeDB2020:7937318;connectomeDB2020:8404634;scConnect:15528268;scConnect:8404634], CALM1 [CellTalkDB:32196115;HPRD:15670850], GNAS [CellTalkDB:32196115], GNAS [CellTalkDB:32196115], GNAS [CellTalkDB:32196115], GNAS [CellTalkDB:32196115]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	glucagon-like peptide 1 receptor activity [GO:0044508]; glucagon receptor activity [GO:0004967]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; learning or memory [GO:0007611]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GLP1R&keywords=GLP1R	20.46189921	102	NA	NA	79.86749009	3	0	0.005489021956	0.00110619469	2.40E-04	0.006734006734	0.08121827411	0.05802357208	0.004893964111	0.02404735479	0.0654292963	6.18E-04	174	111	326	0.02252723741	1.046733676	2.318957966	0.3264377625	98	9	343	56
GNRHR	gonadotropin releasing hormone receptor	Yes	No		ENSG00000109163	P30968	G-protein coupled receptor 1 family	17	receptor	cell_surface, plasma_membrane, receptor, transmembrane	O43555, P01148, P84022, Q13285, Q13485, Q15796	GNRH1, GNRH2, NR5A1, SMAD2, SMAD3, SMAD4	SMAD2 [SPIKE:15561800], SMAD3 [SPIKE:15561800], SMAD4 [SPIKE:15561800], NR5A1 [SPIKE:15561800], GNRH1 [Baccin2019:11726197;Baccin2019:17095587;Baccin2019:17452338;Baccin2019:414473;Baccin2019:9414473;CellChatDB:19640273;CellTalkDB:17452338;Cellinker:11726197;Cellinker:17095587;Cellinker:17452338;Cellinker:19640273;Cellinker:414473;Cellinker:9414473;Guide2Pharma:11726197;Guide2Pharma:17095587;Guide2Pharma:17452338;Guide2Pharma:26398856;Guide2Pharma:26774084;HPRD:9414473;LRdb:11726197;LRdb:17095587;LRdb:17452338;LRdb:414473;LRdb:9414473;SPIKE:4930860;connectomeDB2020:11726197;connectomeDB2020:17095587;connectomeDB2020:17452338;connectomeDB2020:414473;connectomeDB2020:9414473;scConnect:11726197;scConnect:17095587;scConnect:17452338;scConnect:26398856;scConnect:26774084], GNRH2 [CellTalkDB:17942747;Cellinker:17452338;Cellinker:17942747;Cellinker:19638591;Guide2Pharma:17452338;Guide2Pharma:17942747;Guide2Pharma:19638591;LRdb:17452338;LRdb:17942747;LRdb:19638591;connectomeDB2020:17452338;connectomeDB2020:17942747;connectomeDB2020:19638591;scConnect:17452338;scConnect:17942747;scConnect:19638591]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	gonadotropin-releasing hormone receptor activity [GO:0004968]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]	G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism development [GO:0007275]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GNRHR&keywords=GNRHR	0.07934738697	642	NA	NA	0.3023285554	462	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	552
GPR75	G protein-coupled receptor 75	Yes	Yes		ENSG00000119737	O95800	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P13501	CCL5	CCL5 [Baccin2019:17001303;CellTalkDB:17001303;Cellinker:17001303;Guide2Pharma:17001303;LRdb:17001303;connectomeDB2020:17001303;scConnect:17001303]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]	chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR75&keywords=GPR75	3.423130135	260	NA	NA	1.549521525	156	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	208
GRPR	gastrin releasing peptide receptor	Yes	No		ENSG00000126010	P30550	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P07492, P08949	GRP, NMB	GRP [Baccin2019:10454496;Baccin2019:1720612;Baccin2019:19463875;Baccin2019:7838118;CellTalkDB:19463875;Cellinker:10454496;Cellinker:1720612;Cellinker:19463875;Cellinker:7838118;Guide2Pharma:10454496;Guide2Pharma:21729729;Guide2Pharma:7838118;HPRD:7838118;LRdb:10454496;LRdb:1720612;LRdb:19463875;LRdb:7838118;SIGNOR:17251915;connectomeDB2020:10454496;connectomeDB2020:1720612;connectomeDB2020:19463875;connectomeDB2020:7838118;scConnect:10454496;scConnect:19463875;scConnect:21729729;scConnect:7838118], NMB [Baccin2019:10454496;Baccin2019:1720612;Baccin2019:19463875;Baccin2019:21729729;Baccin2019:7838118;CellTalkDB:10454496;Cellinker:10454496;Cellinker:1720612;Cellinker:19463875;Cellinker:21729729;Cellinker:7838118;Guide2Pharma:10454496;Guide2Pharma:7838118;LRdb:10454496;LRdb:1720612;LRdb:19463875;LRdb:21729729;LRdb:7838118;connectomeDB2020:10454496;connectomeDB2020:1720612;connectomeDB2020:19463875;connectomeDB2020:21729729;connectomeDB2020:7838118;scConnect:10454496;scConnect:19463875;scConnect:21729729;scConnect:7838118]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]	G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRPR&keywords=GRPR	0.2948042247	503	NA	NA	0.8381505393	276	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	390
IL10RB	interleukin 10 receptor subunit beta	Yes	No		ENSG00000243646	Q08334	Type II cytokine receptor family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	K9M1U5, P22301, Q13007, Q8IU54, Q8IZI9, Q8IZJ0, Q969E3, Q96RP3, Q9GZX6, Q9NPH9	IFNL1, IFNL2, IFNL3, IFNL4, IL10, IL22, IL24, IL26, UCN2, UCN3	IL22 [CellTalkDB:10875937;HPRD:10875937;LRdb:10875937;Lit-BM-17:10875937;Lit-BM-17:12513909;Lit-BM-17:15120653;SIGNOR:17208301;SPIKE:18509351;SignaLink3:10875937;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:10875937], IL26 [CellTalkDB:14764663;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23106140;SignaLink3:23331499], IFNL1 [CellTalkDB:12974481;Cellinker:12974481;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IFNL2 [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNL3 [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IL10 [CellTalkDB:12974481;DIP:20462497;DIP:9312047;HPRD:11485736;HPRD:9312047;LRdb:11485736;LRdb:12974481;LRdb:9312047;Lit-BM-17:12513909;Lit-BM-17:9312047;SIGNOR:10347215;SIGNOR:11035029;SignaLink3:11485736;SignaLink3:17208301;SignaLink3:23331499;SignaLink3:9312047;connectomeDB2020:11485736;connectomeDB2020:12974481;connectomeDB2020:9312047], UCN2 [CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224], IL24 [CellTalkDB:20061404], UCN3 [CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224], IFNL4 [connectomeDB2020:26134097]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; interleukin-28 receptor complex [GO:0032002]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-10 receptor activity [GO:0004920]; signaling receptor activity [GO:0038023]	cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cellular respiration [GO:1901857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL10RB&keywords=IL10RB	28.59927686	77	NA	NA	1.874916723	129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	103
IL20RB	interleukin 20 receptor subunit beta	Yes	No		ENSG00000174564	Q6UXL0	Type II cytokine receptor family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	Q13007, Q9NPH9, Q9NYY1, Q9UHD0	IL19, IL20, IL24, IL26	IL19 [CellTalkDB:12974481;InnateDB:14580208;IntAct:22802649;LRdb:12974481;Lit-BM-17:22802649;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL20 [CellTalkDB:12974481;InnateDB:11163236;InnateDB:14580208;InnateDB:22232181;IntAct:22802649;LRdb:11163236;LRdb:12351624;LRdb:12974481;LRdb:14580208;Lit-BM-17:22802649;SIGNOR:11163236;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11163236;connectomeDB2020:12351624;connectomeDB2020:12974481;connectomeDB2020:14580208], IL24 [CellTalkDB:12974481;InnateDB:11706020;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL26 [connectomeDB2020:14764663]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-20 binding [GO:0042015]	cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; immune response-inhibiting signal transduction [GO:0002765]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of type IV hypersensitivity [GO:0001808]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-4 production [GO:0032753]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL20RB&keywords=IL20RB	1.052091639	376	NA	NA	0.06574146578	700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	538
IL27RA	interleukin 27 receptor subunit alpha	Yes	No		ENSG00000288185, ENSG00000104998	Q6UWB1	Type I cytokine receptor family, Type 2 subfamily	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P45983, Q14213, Q8NEV9	EBI3, IL27, MAPK8	IL27 [Baccin2019:12121660;CellTalkDB:12121660;Cellinker:12121660;HPRD:12121660;LRdb:12121660;SIGNOR:14764690;SignaLink3:12121660;SignaLink3:17318299;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:12121660], EBI3 [Baccin2019:12121660;CellTalkDB:12121660;HPRD:12121660;LRdb:12121660;connectomeDB2020:12121660], MAPK8 [HPRD:12734330]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor activity [GO:0045509]; transmembrane signaling receptor activity [GO:0004888]	cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell extravasation [GO:2000408]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T-helper 1 type immune response [GO:0002827]; regulation of isotype switching to IgG isotypes [GO:0048302]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL27RA&keywords=IL27RA	0.9682977978	385	NA	NA	0.164292609	559	0	0.06536926148	0.05973451327	0.01798561151	0.02693602694	0.008460236887	0.01178603808	0.0163132137	0.01220865705	0.01365335826	0.01131929689	198	188	198	0.02216056491	0.6905555641	0.7354770764	0.6629018161	230	218	208	338
IL2RB	interleukin 2 receptor subunit beta	Yes	No		ENSG00000100385	P14784	Type I cytokine receptor family, Type 4 subfamily	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14543, O15524, P04049, P06213, P06239, P06241, P07948, P08069, P18510, P23458, P27361, P29350, P31785, P40933, P43405, P52333, P60568, Q13261	FYN, IGF1R, IL15, IL15RA, IL1RN, IL2, IL2RG, INSR, JAK1, JAK3, LCK, LYN, MAPK3, PTPN6, RAF1, SOCS1, SOCS3, SYK	IL15 [Baccin2019:15265897;Baccin2019:8026467;Baccin2019:9176231;CellTalkDB:15265897;DIP:10903799;Guide2Pharma:19710453;HPMR:15265897;HPRD:8026467;HPRD:9176231;InnateDB:8026467;InnateDB:8178155;IntAct:23104097;IntAct:25416956;LRdb:15265897;LRdb:8026467;LRdb:9176231;Lit-BM-17:10903799;NetPath:8026467;connectomeDB2020:15265897;connectomeDB2020:8026467;connectomeDB2020:9176231], IL2 [Baccin2019:11035066;Baccin2019:15265897;Baccin2019:8049354;CellTalkDB:15265897;DIP:22446627;DIP:8006584;HPMR:15265897;HPMR:15933202;HPRD:11035066;HPRD:8049354;InnateDB:15178252;InnateDB:1940342;InnateDB:3095922;InnateDB:3098894;InnateDB:8568232;IntAct:22446627;LRdb:11035066;LRdb:15265897;LRdb:8049354;NetPath:3116143;NetPath:8260650;SIGNOR:16477002;connectomeDB2020:11035066;connectomeDB2020:15265897;connectomeDB2020:8049354], IL1RN [NA], JAK1 [BioGRID:9553136;BioGRID:9774657;DIP:7973658;HPRD-phos:8700888;HPRD:12133952;HPRD:7973659;HPRD:8700888;InnateDB:10373548;InnateDB:12133952;InnateDB:7973657;InnateDB:8041779;KEA:7499411;KEA:8643566;KEA:8700888;NetPath:7973659;ProtMapper:8700888;SIGNOR:8700888;iPTMnet:8700888], LCK [HPRD:10214954;HPRD:2047859;KEA:10214954;KEA:2047859;NetPath:2047859;PhosphoSite:10214954;PhosphoSite:10602027;PhosphoSite:12200137;PhosphoSite:18348982;ProtMapper:10214954;SIGNOR:10214954;iPTMnet:10214954;iPTMnet:2047859;phosphoELM:10214954;phosphoELM:2047859], PTPN6 [HPRD:9520455;InnateDB:9520455;NetPath:9520455;SIGNOR:9520455], IL15RA [HPRD:7641685;SIGNOR:17709786], MAPK3 [PhosphoSite:26152718], IGF1R [KEA:17570479], INSR [KEA:17570479], SOCS1 [BioGRID:11133764;HPRD:11133764;NetPath:11133764], IL2RG [DIP:10903799;DIP:8006584;HPRD:11886175;InnateDB:15178252;InnateDB:1545122;InnateDB:7681595;InnateDB:8026467;InnateDB:8568232;Lit-BM-17:10903799;Lit-BM-17:8006584;NetPath:7514277;NetPath:8026467;NetPath:8260650], JAK3 [HPRD:10825200;HPRD:7973659;HPRD:9553136;InnateDB:7973657;NetPath:7693677], LYN [HPRD:1557373;NetPath:1557373], RAF1 [HPRD:1639773;InnateDB:1639773;NetPath:1639773], SYK [HPRD:7600304;NetPath:7600304], SOCS3 [HPRD:10373548;InnateDB:10373548;NetPath:10373548], FYN [HPRD:8483935;NetPath:8483935]	cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-2 receptor complex [GO:0005893]; membrane [GO:0016020]; plasma membrane [GO:0005886]	interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911]	cytokine-mediated signaling pathway [GO:0019221]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; negative regulation of apoptotic process [GO:0043066]; positive regulation of phagocytosis [GO:0050766]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2RB&keywords=IL2RB	0.3028828384	500	NA	NA	0.06070937734	711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	606
IL31RA	interleukin 31 receptor A	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000164509	Q8NI17	Type I cytokine receptor family, Type 2 subfamily	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	Q6EBC2	IL31	IL31 [CellTalkDB:15184896;HPMR:15184896;HPMR:15194700;LRdb:15184896;SIGNOR:15184896;SignaLink3:15184896;SignaLink3:23331499;connectomeDB2020:15184896]	axon [GO:0030424]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]	acute inflammatory response to antigenic stimulus [GO:0002438]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to other organism [GO:0098542]; glandular epithelial cell differentiation [GO:0002067]; homeostatic process [GO:0042592]; macrophage differentiation [GO:0030225]; MAPK cascade [GO:0000165]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of macrophage activation [GO:0043031]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL31RA&keywords=IL31RA	0.2639869413	518	NA	NA	1.960228148	127	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	323
MC1R	melanocortin 1 receptor	Yes	No		ENSG00000258839	Q01726	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00253, P01189, P19784, P42127, P43250, P48730, Q8TCY5, Q96G30	AGRP, ASIP, CSNK1D, CSNK2A2, GRK6, MRAP, MRAP2, POMC	POMC [Baccin2019:10942578;Baccin2019:11041375;Baccin2019:12007532;Baccin2019:1516719;Baccin2019:7774675;CellTalkDB:10942578;Cellinker:10942578;Cellinker:11041375;Cellinker:12007532;Cellinker:1516719;Cellinker:7774675;Guide2Pharma:12007532;HPRD:10942578;HPRD:11041375;LRdb:10942578;LRdb:11041375;LRdb:12007532;LRdb:1516719;LRdb:7774675;SIGNOR:19656324;connectomeDB2020:10942578;connectomeDB2020:11041375;connectomeDB2020:12007532;connectomeDB2020:1516719;connectomeDB2020:7774675;scConnect:12007532;scConnect:7774675], MRAP [SIGNOR:19329486], MRAP2 [SIGNOR:19329486], GRK6 [SIGNOR:15650023], ASIP [Baccin2019:128513289058374;CellTalkDB:12851328;Cellinker:12851328;Cellinker:9058374;HPRD:9058374;LRdb:12851328;LRdb:91;SIGNOR:14500544;connectomeDB2020:12851328;connectomeDB2020:9058374], AGRP [Cellinker:14535656], CSNK1D [KEA:17570479], CSNK2A2 [KEA:17570479]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV-damage excision repair [GO:0070914]; UV protection [GO:0009650]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MC1R&keywords=MC1R	0.9430188469	390	NA	NA	0.1201597882	620	0	0.005489021956	0.004424778761	0.003117505995	0.001683501684	0.006768189509	0.01722574796	0.004893964111	0.00332963374	0.008846307918	0.003090593008	225	210	261	0.005351749513	0.8682810861	1.227632584	0.8527101746	161	74	136	324
MC2R	melanocortin 2 receptor	Yes	No		ENSG00000185231	Q01718	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01189, P06850, P42127, Q8TCY5, Q96G30	ASIP, CRH, MRAP, MRAP2, POMC	MRAP [IntAct:18840636;IntAct:19151134;SIGNOR:19329486], MRAP2 [SIGNOR:19329486], CRH [NA], POMC [Baccin2019:905837412213892;CellTalkDB:9058374;Cellinker:12213892;Cellinker:9058374;HPMR:9058374;HPRD:12213892;LRdb:122;LRdb:9058374;connectomeDB2020:12213892;connectomeDB2020:9058374], ASIP [Baccin2019:9058374;CellTalkDB:9058374;Cellinker:9058374;HPRD:9058374;LRdb:9058374;connectomeDB2020:9058374]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	corticotropin receptor activity [GO:0004978]; G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of metabolic process [GO:0019222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MC2R&keywords=MC2R	0.01497899888	757	NA	NA	0.02880117158	795	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	776
MC3R	melanocortin 3 receptor	Yes	Yes		ENSG00000124089	P41968	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00253, P01189, P42127, Q8TCY5, Q96G30	AGRP, ASIP, MRAP, MRAP2, POMC	POMC [Baccin2019:10358030;Baccin2019:10493100;Baccin2019:7774675;CellChatDB:11024027;CellTalkDB:10358030;Cellinker:10358030;Cellinker:10493100;Cellinker:7774675;Guide2Pharma:10358030;Guide2Pharma:10493100;LRdb:10358030;LRdb:10493100;LRdb:7774675;SIGNOR:17702843;connectomeDB2020:10358030;connectomeDB2020:10493100;connectomeDB2020:7774675;scConnect:10358030;scConnect:10493100;scConnect:7774675], AGRP [Baccin2019:11747427;Baccin2019:9311920;Baccin2019:9819197;Baccin2019:9893984;CellTalkDB:9311920;Cellinker:11747427;Cellinker:9311920;Cellinker:9819197;Cellinker:9893984;Guide2Pharma:9819197;HPRD:11747427;HPRD:9893984;LRdb:11747427;LRdb:9311920;LRdb:9819197;LRdb:9893984;SIGNOR:10318826;SIGNOR:9311920;connectomeDB2020:11747427;connectomeDB2020:9311920;connectomeDB2020:9819197;connectomeDB2020:9893984;scConnect:9819197], MRAP [SIGNOR:19329486], MRAP2 [SIGNOR:19329486], ASIP [Baccin2019:9058374;CellTalkDB:9058374;Cellinker:9058374;HPRD:9058374;LRdb:9058374;connectomeDB2020:9058374]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; circadian regulation of gene expression [GO:0032922]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; homoiothermy [GO:0042309]; locomotor rhythm [GO:0045475]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of blood pressure [GO:0008217]; regulation of feeding behavior [GO:0060259]; regulation of heart rate [GO:0002027]; regulation of metabolic process [GO:0019222]; sodium ion homeostasis [GO:0055078]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MC3R&keywords=MC3R	0.004875158427	799	NA	NA	0.6603546953	320	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	560
NMBR	neuromedin B receptor	Yes	TBD		ENSG00000135577	P28336	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P07492, P08949	GRP, NMB	NMB [Baccin2019:10454496;Baccin2019:10544247;Baccin2019:15169928;Baccin2019:7838118;Baccin2019:8253343;Baccin2019:8392057;CellTalkDB:10544247;Cellinker:10454496;Cellinker:10544247;Cellinker:15169928;Cellinker:7838118;Cellinker:8253343;Cellinker:8392057;Guide2Pharma:18055507;Guide2Pharma:21729729;Guide2Pharma:25976083;HPMR:15169928;HPRD:10544247;HPRD:8253343;HPRD:8392057;LRdb:10454496;LRdb:10544247;LRdb:15169928;LRdb:7838118;LRdb:8253343;LRdb:8392057;SIGNOR:11313903;connectomeDB2020:10454496;connectomeDB2020:10544247;connectomeDB2020:15169928;connectomeDB2020:7838118;connectomeDB2020:8253343;connectomeDB2020:8392057;scConnect:18055507;scConnect:21729729;scConnect:25976083], GRP [CellTalkDB:10545285;LRdb:10545285;Ramilowski2015:10545285;connectomeDB2020:10545285;talklr:10545285]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]	G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMBR&keywords=NMBR	0.02523827191	725	NA	NA	0.2646221465	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	599
NMUR1	neuromedin U receptor 1	Yes	TBD		ENSG00000171596	Q9HB89	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P48645, Q5H8A3	NMS, NMU	NMS [CellChatDB:29288685;CellTalkDB:15635449;Cellinker:15635449;Cellinker:29288685;Guide2Pharma:15635449;HPRD:15635449;LRdb:15635449;SIGNOR:15635449;connectomeDB2020:15635449;scConnect:15635449], NMU [Baccin2019:10811630;Baccin2019:10894543;Baccin2019:10899166;Baccin2019:15292653;Baccin2019:15331768;CellTalkDB:10894543;Cellinker:10811630;Cellinker:10894543;Cellinker:10899166;Cellinker:15292653;Cellinker:15331768;Guide2Pharma:10894543;Guide2Pharma:10899166;Guide2Pharma:15292653;Guide2Pharma:15331768;HPMR:10894543;HPRD:10811630;LRdb:10811630;LRdb:10894543;LRdb:10899166;LRdb:15292653;LRdb:15331768;connectomeDB2020:10811630;connectomeDB2020:10894543;connectomeDB2020:10899166;connectomeDB2020:15292653;connectomeDB2020:15331768;scConnect:10894543;scConnect:10899166;scConnect:15292653;scConnect:15331768]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]	activation of phospholipase C activity [GO:0007202]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chloride transport [GO:0006821]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; smooth muscle contraction [GO:0006939]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMUR1&keywords=NMUR1	0.09176144157	626	NA	NA	0.0709315413	689	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	658
NMUR2	neuromedin U receptor 2	Yes	No		ENSG00000132911	Q9GZQ4	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P48645, Q5H8A3	NMS, NMU	NMS [Baccin2019:1563544915635440;CellChatDB:29288685;CellTalkDB:15635449;Cellinker:15635449;Cellinker:29288685;Guide2Pharma:15635449;LRdb:15635449;SIGNOR:15635449;connectomeDB2020:15635449;scConnect:15635449], NMU [Baccin2019:10887190;Baccin2019:10894543;Baccin2019:10899166;Baccin2019:15292653;Baccin2019:15331768;BioGRID:10887190;CellTalkDB:10894543;Cellinker:10887190;Cellinker:10894543;Cellinker:10899166;Cellinker:15292653;Cellinker:15331768;Guide2Pharma:10894543;Guide2Pharma:10899166;Guide2Pharma:15292653;Guide2Pharma:15331768;HPMR:10894543;HPRD:10887190;HPRD:10894543;HPRD:10899166;LRdb:10887190;LRdb:10894543;LRdb:10899166;LRdb:15292653;LRdb:15331768;connectomeDB2020:10887190;connectomeDB2020:10894543;connectomeDB2020:10899166;connectomeDB2020:15292653;connectomeDB2020:15331768;scConnect:10894543;scConnect:10899166;scConnect:15292653;scConnect:15331768]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]	activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMUR2&keywords=NMUR2	0.06062105056	663	NA	NA	0.4194421861	397	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	530
NPY2R	neuropeptide Y receptor Y2	Yes	No		ENSG00000185149	P49146	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01298, P01303, P10082	NPY, PPY, PYY	NPY [Baccin2019:12007534;Baccin2019:7559383;Baccin2019:7592910;Baccin2019:8632753;Baccin2019:9001438;Baccin2019:9549761;CellTalkDB:9001438;Cellinker:12007534;Cellinker:7559383;Cellinker:7592910;Cellinker:8632753;Cellinker:9001438;Cellinker:9549761;Guide2Pharma:7592910;Guide2Pharma:8632753;HPMR:9549761;HPRD:12007534;HPRD:7559383;HPRD:9001438;LRdb:12007534;LRdb:7559383;LRdb:7592910;LRdb:8632753;LRdb:9001438;LRdb:9549761;SIGNOR:9549761;connectomeDB2020:12007534;connectomeDB2020:7559383;connectomeDB2020:7592910;connectomeDB2020:8632753;connectomeDB2020:9001438;connectomeDB2020:9549761;scConnect:7592910;scConnect:8632753], PYY [Baccin2019:11408607;Baccin2019:7592910;Baccin2019:8632753;CellTalkDB:8632753;Cellinker:11408607;Cellinker:7592910;Cellinker:8632753;Guide2Pharma:7592910;Guide2Pharma:8632753;HPRD:11408607;LRdb:11408607;LRdb:7592910;LRdb:8632753;connectomeDB2020:11408607;connectomeDB2020:7592910;connectomeDB2020:8632753;scConnect:7592910;scConnect:8632753], PPY [CellTalkDB:15966750]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	calcium channel regulator activity [GO:0005246]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; signaling receptor activity [GO:0038023]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPY2R&keywords=NPY2R	0.01045344382	772	NA	NA	0.08429560042	665	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	719
NTSR2	neurotensin receptor 2	Yes	Yes		ENSG00000169006	O95665	G-protein coupled receptor 1 family, Neurotensin receptor subfamily, NTSR2 sub-subfamily	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P30990	NTS	NTS [Baccin2019:11723247;Baccin2019:11801734;Baccin2019:16087676;Baccin2019:9851594;CellTalkDB:11723247;Cellinker:11723247;Cellinker:11801734;Cellinker:16087676;Cellinker:9851594;Guide2Pharma:11723247;HPMR:9851594;HPRD:11801734;HPRD:16087676;LRdb:11723247;LRdb:11801734;LRdb:16087676;LRdb:9851594;SIGNOR:9851594;connectomeDB2020:11723247;connectomeDB2020:11801734;connectomeDB2020:16087676;connectomeDB2020:9851594;scConnect:11723247]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTSR2&keywords=NTSR2	0.00474744382	801	NA	NA	0.001213491216	880	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	841
OPRK1	opioid receptor kappa 1	Yes	Yes		ENSG00000082556	P41145	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14745, P01189, P01210, P01213, P35626, P51608, Q15835, Q9H0R8	GABARAPL1, GRK1, GRK3, MECP2, PDYN, PENK, POMC, SLC9A3R1	PDYN [Baccin2019:1967312;Baccin2019:7624359;Baccin2019:7869844;Baccin2019:8170987;Baccin2019:9262330;Baccin2019:9686407;CellTalkDB:7869844;Cellinker:17503481;Cellinker:1967312;Cellinker:7624359;Cellinker:7869844;Cellinker:8170987;Cellinker:9262330;Cellinker:9686407;Guide2Pharma:1967312;Guide2Pharma:7624359;Guide2Pharma:7869844;Guide2Pharma:9262330;Guide2Pharma:9686407;LRdb:1967312;LRdb:7624359;LRdb:7869844;LRdb:8170987;LRdb:9262330;LRdb:9686407;SIGNOR:9262330;SIGNOR:9686407;connectomeDB2020:1967312;connectomeDB2020:7624359;connectomeDB2020:7869844;connectomeDB2020:8170987;connectomeDB2020:9262330;connectomeDB2020:9686407;scConnect:1967312;scConnect:7624359;scConnect:7869844;scConnect:9262330;scConnect:9686407], POMC [Baccin2019:7624359;Baccin2019:8624732;Baccin2019:9686407;CellTalkDB:8624732;Cellinker:7624359;Cellinker:8624732;Cellinker:9686407;Guide2Pharma:7624359;Guide2Pharma:9686407;HPMR:8624732;LRdb:7624359;LRdb:8624732;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:7624359;connectomeDB2020:8624732;connectomeDB2020:9686407;scConnect:7624359;scConnect:9686407], PENK [CA1:15082510;CellTalkDB:32196115], SLC9A3R1 [BioGRID:12004055;DOMINO:12004055;HPRD:12004055;HPRD:15070904], MECP2 [SIGNOR:18511691], GRK1 [PhosphoSite:18212250;PhosphoSite:23086943], GRK3 [KEA:14597630;KEA:15140929], GABARAPL1 [HPRD:16431922;InnateDB:16431922;IntAct:16431922;Lit-BM-17:16431922;Lit-BM-17:19001416]	axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to acrylamide [GO:1903937]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OPRK1&keywords=OPRK1	0.03796567484	695	NA	NA	0.1283038109	607	0	0	0	2.40E-04	0	0.001692047377	0	0	0.001479837218	1.34E-04	3.86E-04	230	342	335	3.57E-04	1.108369137	0.9783841684	1.002791319	86	135	76	445
OPRL1	opioid related nociceptin receptor 1	Yes	No, Yes		ENSG00000277044, ENSG00000125510	P41146	G-protein coupled receptor 1 family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01189, P01210, P01213, P25098, P35626, Q13519	GRK2, GRK3, PDYN, PENK, PNOC, POMC	PNOC [Baccin2019:10369464;Baccin2019:10692489;Baccin2019:11097863;Baccin2019:12070757;Baccin2019:12967935;Baccin2019:22827708;Baccin2019:7481766;Baccin2019:8849681;BioGRID:10692489;BioGRID:11097863;CellTalkDB:12967935;Cellinker:10369464;Cellinker:10692489;Cellinker:11097863;Cellinker:12070757;Cellinker:12967935;Cellinker:22827708;Cellinker:7481766;Cellinker:8849681;Guide2Pharma:10369464;Guide2Pharma:12070757;Guide2Pharma:9413015;HPMR:7481766;HPRD:10692489;HPRD:11097863;LRdb:10369464;LRdb:10692489;LRdb:11097863;LRdb:12070757;LRdb:12967935;LRdb:22827708;LRdb:7481766;LRdb:8849681;Lit-BM-17:10692489;Lit-BM-17:11097863;Lit-BM-17:23597562;connectomeDB2020:10369464;connectomeDB2020:10692489;connectomeDB2020:11097863;connectomeDB2020:12070757;connectomeDB2020:12967935;connectomeDB2020:22827708;connectomeDB2020:7481766;connectomeDB2020:8849681;scConnect:10369464;scConnect:12070757;scConnect:9353393;scConnect:9413015], PENK [CA1:15082510], PDYN [NA], POMC [NA], GRK2 [PhosphoSite:30914485], GRK3 [PhosphoSite:23086955]	cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; nociceptin receptor activity [GO:0001626]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; conditioned place preference [GO:1990708]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of blood pressure [GO:0045776]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of urine volume [GO:0035810]; regulation of locomotor rhythm [GO:1904059]; response to estradiol [GO:0032355]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OPRL1&keywords=OPRL1	0.05448013941	673	NA	NA	0.0200611105	822	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	748
OPRM1	opioid receptor mu 1	Yes	No		ENSG00000112038	P35372	G-protein coupled receptor 1 family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14939, P01189, P01210, P01213, P02775, P04843, P04899, P0DP23, P17252, P19784, P21333, P25098, P31749, P35626, P49407, P51812, Q9UQM7	AKT1, ARRB1, CALM1, CAMK2A, CSNK2A2, FLNA, GNAI2, GRK2, GRK3, PDYN, PENK, PLD2, POMC, PPBP, PRKCA, RPN1, RPS6KA3	PDYN [Baccin2019:9686407;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:9686407;scConnect:9686407], PENK [Baccin2019:9686407;CA1:15082510;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;connectomeDB2020:9686407;scConnect:9686407], GRK2 [CA1:10488100;CA1:11861651;KEA:12123746;PhosphoSite:18463167;PhosphoSite:21292762;PhosphoSite:22375000;ProtMapper:12123746;SIGNOR:12123746;iPTMnet:12123746], ARRB1 [CA1:11861651], CAMK2A [ProtMapper:10908300;SIGNOR:10908300;iPTMnet:10908300], RPN1 [SIGNOR:19289571], PPBP [SIGNOR:9686407], GRK3 [HPRD:11060299;KEA:11060299;ProtMapper:11060299;SIGNOR:11060299;iPTMnet:11060299], GNAI2 [CellTalkDB:12068084;Cellinker:12068084;HPRD:12068084;LRdb:12068084;connectomeDB2020:12068084], CALM1 [CellTalkDB:11457825;HPRD:11457836], POMC [Baccin2019:15464143;CellTalkDB:15464143;Cellinker:15464143;HPMR:15464143;LRdb:15464143;connectomeDB2020:15464143], FLNA [Cellinker:17215244;HPRD:14573758;IntAct:14573758], AKT1 [KEA:17570479], CSNK2A2 [KEA:17570479], PRKCA [KEA:17570479], RPS6KA3 [KEA:17570479], PLD2 [HPRD:12519790]	axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444]	beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor activity [GO:0004930]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245]	acute inflammatory response to antigenic stimulus [GO:0002438]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to cocaine [GO:0042220]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OPRM1&keywords=OPRM1	0.4260654509	475	NA	NA	3.974599516	56	0	0	0	0.001199040767	0.001683501684	0	0.008159564823	0.03752039152	3.70E-04	5.34E-04	0.0217886807	233	327	152	0.0064777505	0.6293310063	0.6392933735	1.929188132	253	251	10	277
PLXNB3	plexin B3	Yes	Yes		ENSG00000198753	Q9ULL4	Plexin family	17	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P08581, Q13591, Q92854, Q9H3S1	MET, SEMA4A, SEMA4D, SEMA5A	SEMA4A [CellChatDB:27533782;CellTalkDB:32196115;Cellinker:26633812;Cellinker:27533782;ICELLNET:11245885], SEMA5A [Baccin2019:15218527;CellChatDB:27533782;CellTalkDB:15218527;Cellinker:15218527;Cellinker:26633812;Cellinker:27533782;HPMR:15218527;LRdb:15218527;connectomeDB2020:15218527], SEMA4D [CellChatDB:27533782;Cellinker:26633812;Cellinker:27533782], MET [Cellinker:28536399]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154]	cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNB3&keywords=PLXNB3	1.789590818	313	NA	NA	0.1022406339	640	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	477
PLXND1	plexin D1	Yes	TBD		ENSG00000004399	Q9Y4D7	Plexin family	17	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15041, O95025, P08571, Q99985, Q9H3S1	CD14, SEMA3C, SEMA3D, SEMA3E, SEMA4A	SEMA4A [Baccin2019:17318185;CellPhoneDB:22325954;CellTalkDB:22325954;Cellinker:17318185;Cellinker:26633812;HPRD:17318185;ICELLNET:11245885;LRdb:17318185;Lit-BM-17:17318185;connectomeDB2020:17318185], SEMA3C [Baccin2019:27439112;CellChatDB:27533782;CellTalkDB:15239958;Cellinker:27533782;LRdb:15239958;Ramilowski2015:15239958;connectomeDB2020:15239958;talklr:15239958], SEMA3D [CellTalkDB:31163177], SEMA3E [Baccin2019:15550623;CellChatDB:22325954;CellPhoneDB:22325954;CellTalkDB:22325954;Cellinker:15550623;Cellinker:19887479;Cellinker:22325954;Cellinker:26633812;HPMR:15550623;LRdb:15550623;Lit-BM-17:17318185;connectomeDB2020:15550623], CD14 [Cellinker:32589946]	integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154]	angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXND1&keywords=PLXND1	31.5759025	69	NA	NA	0.8691635132	269	0.04724409449	0.003992015968	0.1261061947	0.06474820144	0.005050505051	0.03384094755	0.04170444243	0.03588907015	0.004809470958	0.0391240486	0.005833494302	219	142	238	0.03712204415	0.3142790434	1.042485518	0.3360103448	368	113	337	148
PRLHR	prolactin releasing hormone receptor	Yes	No		ENSG00000119973	P49683	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01303, P12272, P81277	NPY, PRLH, PTHLH	PRLH [CellTalkDB:11030716;Cellinker:10475064;Cellinker:11030716;Cellinker:12606605;Cellinker:9607765;Guide2Pharma:11030716;Guide2Pharma:12606605;HPMR:11030716;HPRD:10475064;HPRD:11030716;HPRD:9607765;LRdb:10475064;LRdb:11030716;LRdb:12606605;LRdb:9607765;connectomeDB2020:10475064;connectomeDB2020:11030716;connectomeDB2020:12606605;connectomeDB2020:9607765;scConnect:11030716;scConnect:12606605], PTHLH [NA], NPY [Baccin2019:15885496;CellTalkDB:15885496;Cellinker:15885496;Guide2Pharma:15885496;LRdb:15885496;connectomeDB2020:15885496;scConnect:15885496]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]	feeding behavior [GO:0007631]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone metabolic process [GO:0042445]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRLHR&keywords=PRLHR	0.781638218	416	NA	NA	1.651585146	148	0	0.00249500998	0	0.001199040767	0.001683501684	0.01015228426	0.009972801451	0.01305057096	0.02811690714	0.003939110696	0.01456441955	166	249	180	0.007743058772	2.148271481	0.7856092275	1.384452358	10	203	29	254
PTCH1	patched 1	Yes	Yes		ENSG00000185920	Q13635	Patched family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43323, P06493, P42574, P98164, Q14623, Q15465, Q9H2X6, Q9Y625	CASP3, CDK1, DHH, GPC6, HIPK2, IHH, LRP2, SHH	SHH [Baccin2019:16867986;Baccin2019:9811851;BioGRID:16282375;CellTalkDB:9811851;Cellinker:16867986;Cellinker:21339334;Cellinker:30613383;Cellinker:9811851;HPMR:16867986;HPRD:9811851;ICELLNET:27647915;IntAct:29954986;IntAct:30139912;LRdb:169;LRdb:9811851;NetPath:8906787;NetPath:9811851;SIGNOR:14556242;SIGNOR:15618519;SIGNOR:9811851;SPIKE:20083481;SPIKE:9811851;SignaLink3:14556242;SignaLink3:23331499;connectomeDB2020:16867986;connectomeDB2020:9811851], IHH [Baccin2019:115627869811851;CancerCellMap:9811851;CellTalkDB:11562786;Cellinker:11562786;Cellinker:9811851;HPRD:9811851;ICELLNET:29274272;LRdb:11562786;LRdb:98;NetPath:9811851;SIGNOR:9811851;SignaLink3:19399989;SignaLink3:23331499;connectomeDB2020:11562786;connectomeDB2020:9811851], DHH [Baccin2019:9811851;CancerCellMap:8906787;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SignaLink3:19399989;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], GPC6 [SIGNOR:31756413], CASP3 [SIGNOR:12907805;SIGNOR:23074268], CASP3 [SIGNOR:12907805;SIGNOR:23074268], LRP2 [SIGNOR:26872844], CDK1 [CancerCellMap:11331587;HPRD:11331587], HIPK2 [HPRD:12874272]	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]	animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTCH1&keywords=PTCH1	7.963540944	181	NA	NA	1.280367806	187	0	0.03093812375	0.01880530973	0.02038369305	0.02188552189	0.1302876481	0.06255666364	0.02610114192	0.02885682575	0.06135665643	0.009542205911	164	117	210	0.03733761728	0.8208445625	1.507398566	0.4128261419	184	44	305	132
PTH2R	parathyroid hormone 2 receptor	Yes	Yes		ENSG00000144407	P49190	G-protein coupled receptor 2 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01270, P05771, P0DP23, P12272, P22694, P51812, Q96A98	CALM1, PRKACB, PRKCB, PTH, PTH2, PTHLH, RPS6KA3	PTHLH [Baccin2019:8702701;CellTalkDB:8702701;Cellinker:8702701;Guide2Pharma:8702701;LRdb:8702701;connectomeDB2020:8702701;scConnect:8702701], PTH2 [Baccin2019:10854439;Baccin2019:11602681;Baccin2019:11861531;CellTalkDB:11861531;Cellinker:10854439;Cellinker:11602681;Cellinker:11861531;HPRD:10854439;LRdb:10854439;LRdb:11602681;LRdb:11861531;SIGNOR:11861531;connectomeDB2020:10854439;connectomeDB2020:11602681;connectomeDB2020:11861531;scConnect:10854439;scConnect:11602681], PTH [CellTalkDB:7797535;Cellinker:7797535;Cellinker:9482662;HPMR:7797535;HPRD:9482662;LRdb:7797535;LRdb:948;SIGNOR:11861531;connectomeDB2020:7797535;connectomeDB2020:9482662], CALM1 [CellTalkDB:32196115;HPRD:15670850], PRKACB [KEA:17570479], PRKCB [KEA:17570479], RPS6KA3 [KEA:17570479]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cold-induced thermogenesis [GO:0120162]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTH2R&keywords=PTH2R	5.923071985	214	NA	NA	10.75033503	21	0	0.00249500998	0	7.19E-04	0.003367003367	0.02538071066	0.002719854941	0	0.05105438402	0.005908666044	3.86E-05	122	226	346	0.008334880535	3.329958104	0.8676721953	0.5475155616	5	175	252	159
RET	ret proto-oncogene	Yes	No		ENSG00000165731	P07949	Protein kinase superfamily, Tyr protein kinase family	17	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60542, P06239, P07948, P08069, P08581, P10586, P12931, P15692, P17252, P17612, P22681, P27361, P28482, P39905, P45983, P49765, Q05397, Q12913, Q13191, Q16539, Q5T4W7, Q99748, Q99988	ARTN, CBL, CBLB, GDF15, GDNF, IGF1R, LCK, LYN, MAPK1, MAPK14, MAPK3, MAPK8, MET, NRTN, PRKACA, PRKCA, PSPN, PTK2, PTPRF, PTPRJ, SRC, VEGFA, VEGFB	GDNF [Baccin2019:14514671;Baccin2019:8674117;Baccin2019:9182803;Baccin2019:9482105;CellTalkDB:9182803;Cellinker:14514671;Cellinker:8674117;Cellinker:9182803;Cellinker:9482105;HPMR:11106404;HPMR:14514671;HPRD:8674117;LRdb:14514671;LRdb:8674117;LRdb:9182803;LRdb:9482105;ProtMapper:22751117;ProtMapper:23429478;ProtMapper:25684228;SIGNOR:9182803;SignaLink3:23331499;SignaLink3:8674117;connectomeDB2020:14514671;connectomeDB2020:8674117;connectomeDB2020:9182803;connectomeDB2020:9482105], NRTN [Baccin2019:91828039192898;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9192898;HPMR:9182803;HPMR:9192898;HPRD:9192898;LRdb:9182803;LRdb:919;SIGNOR:9182803;connectomeDB2020:9182803;connectomeDB2020:9192898], PTPRF [ProtMapper:11121408;SIGNOR:11121408], MAPK3 [HPRD:16153436], PTK2 [HPRD:16153436;ProtMapper:21454698;ProtMapper:25409876;SIGNOR:21454698;iPTMnet:21454698], MAPK14 [HPRD:16153436], MAPK1 [HPRD:16153436], PRKACA [KEA:11886862;ProtMapper:11886862;ProtMapper:15966897;ProtMapper:17050626;ProtMapper:20682772;SIGNOR:20682772;iPTMnet:20682772], PTPRJ [DEPOD:16778204;KEA:11713247;KEA:11886862;ProtMapper:16778204;SIGNOR:16778204], PSPN [Baccin2019:11116144;CellTalkDB:11116144;Cellinker:11116144;HPMR:11116144;LRdb:11116144;connectomeDB2020:11116144], GDF15 [CellTalkDB:28846099], VEGFB [CellTalkDB:32196115], ARTN [Baccin2019:9883723;CellTalkDB:9883723;Cellinker:9883723;HPMR:9883723;LRdb:9883723;connectomeDB2020:9883723], VEGFA [CellTalkDB:32196115], MET [Cellinker:28536399], PRKCA [PhosphoSite:22128160], MAPK8 [HPRD:16153436], IGF1R [KEA:17570479], LCK [KEA:17570479], LYN [KEA:17570479], SRC [BioGRID:10070972;HPRD:10070972;KEA:11713247;KEA:17570479], CBL [HPRD:12727845;IntAct:12727845;IntAct:15677445], CBLB [HPRD:16525057]	axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ureter maturation [GO:0035799]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RET&keywords=RET	0.4852112289	459	NA	NA	0.3725515381	415	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	437
RXFP1	relaxin family peptide receptor 1	Yes	TBD		ENSG00000171509	Q9HBX9	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04090, P04808, P51460, Q8WXF3, Q9Y5Q6	INSL3, INSL5, RLN1, RLN2, RLN3	RLN2 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:12506116;Cellinker:15649866;Cellinker:22973049;Guide2Pharma:12506116;Guide2Pharma:15649866;Guide2Pharma:18434306;HPMR:11809971;HPRD:12506116;HPRD:15649866;LRdb:11809971;LRdb:12506116;LRdb:15649866;SIGNOR:11809971;connectomeDB2020:11809971;connectomeDB2020:12506116;connectomeDB2020:15649866;scConnect:12506116;scConnect:15649866;scConnect:18434306], RLN1 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:16411781;Cellinker:25761609;Guide2Pharma:16411781;HPRD:11809971;LRdb:11809971;LRdb:16;connectomeDB2020:11809971;connectomeDB2020:16411781;scConnect:16411781], RLN3 [Baccin2019:12506116;Baccin2019:14522968;Baccin2019:15649866;CellTalkDB:12506116;Cellinker:12506116;Cellinker:14522968;Cellinker:15649866;Cellinker:16365033;Cellinker:25761609;Guide2Pharma:12506116;Guide2Pharma:15649866;HPRD:12506116;HPRD:14522968;HPRD:15649866;LRdb:12506116;LRdb:14522968;LRdb:15649866;connectomeDB2020:12506116;connectomeDB2020:14522968;connectomeDB2020:15649866;scConnect:12506116;scConnect:15649866], INSL3 [CellTalkDB:32103204;Cellinker:25761609;scConnect:23303914], INSL5 [NA]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; hormone-mediated signaling pathway [GO:0009755]; lung connective tissue development [GO:0060427]; nipple morphogenesis [GO:0060658]; parturition [GO:0007567]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RXFP1&keywords=RXFP1	0.02844315348	713	NA	NA	0.04494036579	747	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	730
SSTR5	somatostatin receptor 5	Yes	No		ENSG00000162009	P35346	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P61278, Q765I0	CORT, SST, UTS2B	CORT [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:9125122;Cellinker:10598788;Cellinker:11011067;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SST [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:15333679;Baccin2019:7908405;Baccin2019:7988476;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9652348;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:7908405;Cellinker:10598788;Cellinker:11520208;Cellinker:15333679;Cellinker:7908405;Cellinker:7988476;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9652348;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9652348;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8769372;HPRD:7908405;LRdb:10598788;LRdb:11520208;LRdb:15333679;LRdb:7908405;LRdb:7988476;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9652348;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:15333679;connectomeDB2020:7908405;connectomeDB2020:7988476;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9652348;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9652348;scConnect:9724791;scConnect:9784130], UTS2B [CellChatDB:31556942;Cellinker:31556942]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]	cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SSTR5&keywords=SSTR5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
TACR1	tachykinin receptor 1	Yes	TBD		ENSG00000115353	P25103	G-protein coupled receptor 1 family	17	receptor	cell_surface, intracellular, plasma_membrane, receptor, transmembrane	P20366, P34947, Q86UU9, Q9UHF0	GRK5, TAC1, TAC3, TAC4	TAC1 [Baccin2019:11786503;Baccin2019:12548712;Baccin2019:1311270;Baccin2019:15265501;Baccin2019:7557266;Baccin2019:8702757;Baccin2019:8985159;Baccin2019:9190866;BioGRID:8702757;CellTalkDB:7557266;Cellinker:11786503;Cellinker:12548712;Cellinker:1311270;Cellinker:15265501;Cellinker:7557266;Cellinker:8702757;Cellinker:8985159;Cellinker:9190866;Guide2Pharma:11786503;Guide2Pharma:1311270;Guide2Pharma:15265501;Guide2Pharma:8702757;Guide2Pharma:8985159;Guide2Pharma:9190866;HPRD:12548712;LRdb:11786503;LRdb:12548712;LRdb:1311270;LRdb:15265501;LRdb:7557266;LRdb:8702757;LRdb:8985159;LRdb:9190866;Lit-BM-17:11786503;Lit-BM-17:23597562;Lit-BM-17:8702757;connectomeDB2020:11786503;connectomeDB2020:12548712;connectomeDB2020:1311270;connectomeDB2020:15265501;connectomeDB2020:7557266;connectomeDB2020:8702757;connectomeDB2020:8985159;connectomeDB2020:9190866;scConnect:11786503;scConnect:1311270;scConnect:15265501;scConnect:8702757;scConnect:8985159;scConnect:9190866], TAC3 [CellTalkDB:8925404;Cellinker:12727971;Cellinker:8925404;Cellinker:9190866;Guide2Pharma:9190866;HPRD:12727971;LRdb:12727971;LRdb:8925404;LRdb:9190866;connectomeDB2020:12727971;connectomeDB2020:8925404;connectomeDB2020:9190866], TAC4 [CellTalkDB:11786503;Cellinker:11062498;Cellinker:11786503;Cellinker:15224188;HPRD:11786503;LRdb:11062498;LRdb:11786503;LRdb:15224188;connectomeDB2020:11062498;connectomeDB2020:11786503;connectomeDB2020:15224188], GRK5 [HPRD:12067742]	cell body [GO:0044297]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]	substance P receptor activity [GO:0016496]; tachykinin receptor activity [GO:0004995]	acute inflammatory response [GO:0002526]; aggressive behavior [GO:0002118]; angiotensin-mediated drinking behavior [GO:0003051]; associative learning [GO:0008306]; behavioral response to pain [GO:0048266]; detection of abiotic stimulus [GO:0009582]; eating behavior [GO:0042755]; inflammatory response [GO:0006954]; long-term memory [GO:0007616]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of action potential [GO:0045760]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of ossification [GO:0045778]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of saliva secretion [GO:0046878]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; positive regulation of vasoconstriction [GO:0045907]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell proliferation [GO:0048660]; response to auditory stimulus [GO:0010996]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to progesterone [GO:0032570]; sensory perception of pain [GO:0019233]; smooth muscle contraction involved in micturition [GO:0060083]; sperm ejaculation [GO:0042713]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TACR1&keywords=TACR1	0.1278958991	592	NA	NA	0.06446628219	703	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	648
TNFRSF10B	TNF receptor superfamily member 10b	Yes			ENSG00000120889	O14763	NA	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O00220, P01833, P04637, P08581, P48023, P50591, Q13546, Q8N6C8	FASLG, LILRA3, MET, PIGR, RIPK1, TNFRSF10A, TNFSF10, TP53	TNFRSF10A [HPRD:16319225;HPRD:9430228;SPIKE:9430228], RIPK1 [HPRD:9430227], TP53 [SPIKE:11498783], TNFSF10 [BioGRID:11094155;BioGRID:9311998;CellTalkDB:10549288;Cellinker:10549288;Cellinker:15766588;Cellinker:9311998;Cellinker:9325248;HPMR:15766588;HPRD:10549288;HPRD:9311998;HPRD:9325248;ICELLNET:11239407;InnateDB:10894161;InnateDB:16227629;IntAct:10542098;IntAct:10549288;IntAct:20103630;LRdb:10549288;LRdb:15766588;LRdb:9311998;LRdb:9325248;Lit-BM-17:10542098;Lit-BM-17:10549288;Lit-BM-17:10894160;Lit-BM-17:11094155;Lit-BM-17:19427028;Lit-BM-17:20097879;Lit-BM-17:20103630;Lit-BM-17:21459798;Lit-BM-17:21525171;Lit-BM-17:21822306;Lit-BM-17:22266862;Lit-BM-17:22585859;Lit-BM-17:23678861;Lit-BM-17:9311998;Lit-BM-17:9325248;Macrophage:10549288;Macrophage:12628743;Macrophage:9242610;Macrophage:9311998;SIGNOR:14585074;SIGNOR:15766588;SPIKE:15538968;connectomeDB2020:10549288;connectomeDB2020:15766588;connectomeDB2020:9311998;connectomeDB2020:9325248], FASLG [CellTalkDB:32103204], PIGR [Cellinker:32822567], MET [Cellinker:28536399], LILRA3 [Cellinker:32822567]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463]	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF10B&keywords=TNFRSF10B	27.03267707	82	NA	NA	0.9094222343	258	0.03149606299	0.2609780439	0.08075221239	0.1100719424	0.1868686869	0.01184433164	0.0262919311	0.0163132137	0.01220865705	0.01528909067	0.01193741549	198	184	194	0.0694592353	0.2794974928	0.3182649641	0.276083899	384	353	362	219
TNFRSF12A	TNF receptor superfamily member 12A	Yes	Yes		ENSG00000006327	Q9NP84	NA	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43508, Q15238, Q9NZC2	PSG5, TNFSF12, TREM2	TNFSF12 [Baccin2019:11728344;Baccin2019:12529173;Baccin2019:12787562;CellTalkDB:11728344;Cellinker:11728344;Cellinker:12529173;Cellinker:12787562;HPMR:12787562;HPRD:11728344;HPRD:12529173;ICELLNET:11239407;InnateDB:23750247;LRdb:11728344;LRdb:12529173;LRdb:12787562;Lit-BM-17:23438059;NetPath:16526941;connectomeDB2020:11728344;connectomeDB2020:12529173;connectomeDB2020:12787562], TREM2 [Cellinker:32822567], PSG5 [Cellinker:32822567]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NA	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; regulation of wound healing [GO:0061041]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF12A&keywords=TNFRSF12A	80.07733931	26	NA	NA	2.838649408	82	0.3070866142	4.968562874	0.4513274336	4.998081535	3.634680135	2.333333333	2.22574796	1.231647635	2.937846837	1.345473361	2.062352714	3	3	4	2.408740039	1.218753065	0.560404731	0.8567901802	69	276	134	97
TRHR	thyrotropin releasing hormone receptor	Yes	Yes		ENSG00000174417	P34981	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P20396	TRH	TRH [Baccin2019:15117874;Baccin2019:2175902;Baccin2019:9794253;CellTalkDB:9794253;Cellinker:15117874;Cellinker:2175902;Cellinker:9794253;HPMR:2175902;HPRD:15117874;HPRD:9794253;LRdb:15117874;LRdb:2175902;LRdb:9794253;SIGNOR:27515033;connectomeDB2020:15117874;connectomeDB2020:2175902;connectomeDB2020:9794253]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	thyrotropin-releasing hormone receptor activity [GO:0004997]	G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRHR&keywords=TRHR	0.009035097303	780	NA	NA	0.4951661485	373	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	577
UTS2R	urotensin 2 receptor	Yes	No		ENSG00000181408	Q9UKP6	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O95399, Q765I0	UTS2, UTS2B	UTS2 [Baccin2019:10499587;Baccin2019:10581185;Baccin2019:11976263;Baccin2019:12238917;Baccin2019:15109617;Baccin2019:15852036;Cellinker:10499587;Cellinker:10581185;Cellinker:11976263;Cellinker:12238917;Cellinker:15109617;Cellinker:15852036;Guide2Pharma:10499587;Guide2Pharma:10548501;Guide2Pharma:10559967;Guide2Pharma:10581185;HPMR:15109617;HPRD:10581185;LRdb:10499587;LRdb:10581185;LRdb:11976263;LRdb:12238917;LRdb:15109617;LRdb:15852036;connectomeDB2020:10499587;connectomeDB2020:10581185;connectomeDB2020:11976263;connectomeDB2020:12238917;connectomeDB2020:15109617;connectomeDB2020:15852036;scConnect:11976263;scConnect:12238917;scConnect:15852036], UTS2B [Baccin2019:11015293;Baccin2019:14550283;CellChatDB:31556942;CellTalkDB:14550283;Cellinker:11015293;Cellinker:14550283;Cellinker:31556942;Guide2Pharma:14550283;Guide2Pharma:17628210;Guide2Pharma:18710417;HPRD:14550283;LRdb:11;LRdb:14550283;connectomeDB2020:11015293;connectomeDB2020:14550283;scConnect:11015293;scConnect:14550283;scConnect:18710417]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; urotensin II receptor activity [GO:0001604]	blood circulation [GO:0008015]; blood vessel diameter maintenance [GO:0097746]; neuropeptide signaling pathway [GO:0007218]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UTS2R&keywords=UTS2R	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
VIPR1	vasoactive intestinal peptide receptor 1	Yes	Yes		ENSG00000114812	P32241	G-protein coupled receptor 2 family	17	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O95467, P01185, P01189, P01215, P01222, P01225, P01229, P01258, P01270, P01275, P01282, P01286, P04090, P06454, P06850, P06881, P09681, P09683, P0C0P6, P0DP23, P10092, P10997, P12272, P18509, P35318, P51460, P63092, P84996, Q5JWF2, Q7Z4H4, Q8WXF3, Q96A98	ADCYAP1, ADM, ADM2, AVP, CALCA, CALCB, CALM1, CGA, CRH, FSHB, GCG, GHRH, GIP, GNAS, IAPP, INSL3, LHB, NPS, POMC, PTH, PTH2, PTHLH, PTMA, RLN2, RLN3, SCT, TSHB, VIP	GHRH [Baccin2019:8791009;CellChatDB:10655511;CellTalkDB:8791009;Cellinker:10655511;Cellinker:8791009;Guide2Pharma:8791009;LRdb:8791009;connectomeDB2020:8791009;scConnect:8791009], ADCYAP1 [Baccin2019:11897681;Baccin2019:11931347;Baccin2019:12429744;Baccin2019:16930633;Baccin2019:8791009;Baccin2019:9928018;CellTalkDB:11897681;Cellinker:11897681;Cellinker:11931347;Cellinker:12429744;Cellinker:12488235;Cellinker:16930633;Cellinker:8791009;Cellinker:9928018;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:8791009;Guide2Pharma:9928018;HPRD:12429744;LRdb:11897681;LRdb:11931347;LRdb:12429744;LRdb:16930633;LRdb:8791009;LRdb:9928018;SIGNOR:11897681;connectomeDB2020:11897681;connectomeDB2020:11931347;connectomeDB2020:12429744;connectomeDB2020:16930633;connectomeDB2020:8791009;connectomeDB2020:9928018;scConnect:11931347;scConnect:16930633;scConnect:8791009;scConnect:9928018], VIP [Baccin2019:10570056;Baccin2019:10801840;Baccin2019:11027527;Baccin2019:11931347;Baccin2019:15247290;Baccin2019:16930633;Baccin2019:8074647;Baccin2019:807467;Baccin2019:8390245;Baccin2019:8791009;Baccin2019:9152366;Baccin2019:9437714;Baccin2019:9454823;Baccin2019:9726637;Baccin2019:9928018;CellChatDB:10655512;CellTalkDB:11027527;Cellinker:10570056;Cellinker:10655511;Cellinker:10801840;Cellinker:11027527;Cellinker:11931347;Cellinker:12488235;Cellinker:15247290;Cellinker:16930633;Cellinker:8074647;Cellinker:8390245;Cellinker:8791009;Cellinker:9152366;Cellinker:9437714;Cellinker:9454823;Cellinker:9726637;Cellinker:9928018;Guide2Pharma:10570056;Guide2Pharma:10801840;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:8074647;Guide2Pharma:8390245;Guide2Pharma:8791009;Guide2Pharma:9152366;Guide2Pharma:9437714;Guide2Pharma:9454823;Guide2Pharma:9726637;Guide2Pharma:9928018;HPMR:11027527;HPRD:11027527;HPRD:15247290;HPRD:807467;LRdb:10570056;LRdb:10801840;LRdb:11027527;LRdb:11931347;LRdb:15247290;LRdb:16930633;LRdb:8074647;LRdb:807467;LRdb:8390245;LRdb:8791009;LRdb:9152366;LRdb:9437714;LRdb:9454823;LRdb:9726637;LRdb:9928018;SIGNOR:11897681;connectomeDB2020:10570056;connectomeDB2020:10801840;connectomeDB2020:11027527;connectomeDB2020:11931347;connectomeDB2020:15247290;connectomeDB2020:16930633;connectomeDB2020:8074647;connectomeDB2020:807467;connectomeDB2020:8390245;connectomeDB2020:8791009;connectomeDB2020:9152366;connectomeDB2020:9437714;connectomeDB2020:9454823;connectomeDB2020:9726637;connectomeDB2020:9928018;scConnect:10570056;scConnect:10801840;scConnect:11931347;scConnect:16930633;scConnect:8074647;scConnect:8390245;scConnect:8791009;scConnect:9152366;scConnect:9437714;scConnect:9454823;scConnect:9726637;scConnect:9928018], SCT [Baccin2019:12133828;CellTalkDB:12133828;HPRD:12133828;LRdb:12133828;connectomeDB2020:12133828], LHB [CellTalkDB:32196115], IAPP [CellTalkDB:32196115], TSHB [CellTalkDB:32196115], PTH2 [CellTalkDB:32196115], CRH [CellTalkDB:32196115], PTH [CellTalkDB:32196115], AVP [CellTalkDB:32196115], PTHLH [CellTalkDB:32196115], POMC [CellTalkDB:32196115], RLN2 [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], CALCA [CellTalkDB:32196115], ADM [CellTalkDB:32196115], CGA [CellTalkDB:32196115], GCG [CellTalkDB:32196115], ADM2 [CellTalkDB:32196115], GNAS [Baccin2019:11812005;CellTalkDB:11812005;Cellinker:11812005;HPRD:11812005;LRdb:11812005;connectomeDB2020:11812005], GNAS [Baccin2019:11812005;CellTalkDB:11812005;Cellinker:11812005;HPRD:11812005;LRdb:11812005;connectomeDB2020:11812005], GNAS [Baccin2019:11812005;CellTalkDB:11812005;Cellinker:11812005;HPRD:11812005;LRdb:11812005;connectomeDB2020:11812005], GNAS [Baccin2019:11812005;CellTalkDB:11812005;Cellinker:11812005;HPRD:11812005;LRdb:11812005;connectomeDB2020:11812005], NPS [CellTalkDB:32196115], FSHB [CellTalkDB:32196115], PTMA [Cellinker:8886855;HPRD:8886855;LRdb:8886855;connectomeDB2020:8886855], CALM1 [CellTalkDB:32196115;HPRD:15670850], CALCB [CellTalkDB:32196115], RLN3 [CellTalkDB:32196115], GIP [CellTalkDB:32196115], INSL3 [CellTalkDB:32196115]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VIPR1&keywords=VIPR1	1.724177209	318	NA	NA	0.1314311072	601	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	460
LGR5	leucine rich repeat containing G protein-coupled receptor 5	Yes	TBD		ENSG00000139292	O75473	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P56704, Q2I0M5, Q2MKA7, Q6UXX9, Q9BXY4	RSPO1, RSPO2, RSPO3, RSPO4, WNT3A	RSPO1 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:24349440;Guide2Pharma:21693646;LRdb:21693646;connectomeDB2020:21693646;scConnect:21693646], RSPO2 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], RSPO3 [Baccin2019:21693640;Baccin2019:21693646;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], RSPO4 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Guide2Pharma:21693646;LRdb:21693646;connectomeDB2020:21693646;scConnect:21693646], WNT3A [CellTalkDB:22473993]	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; oocyte differentiation [GO:0009994]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGR5&keywords=LGR5	0.1702037182	561	NA	NA	0.09969226508	642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	602
LGR6	leucine rich repeat containing G protein-coupled receptor 6	Yes	TBD		ENSG00000133067	Q9HBX8	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q2I0M5, Q2MKA7, Q6UXX9, Q9BXY4	RSPO1, RSPO2, RSPO3, RSPO4	RSPO3 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], RSPO1 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:24349440;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], RSPO2 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:29769720;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], RSPO4 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]	heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888]	axon guidance [GO:0007411]; bone regeneration [GO:1990523]; G protein-coupled receptor signaling pathway [GO:0007186]; negative chemotaxis [GO:0050919]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGR6&keywords=LGR6	0.034049692	706	NA	NA	0.005624514609	865	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	786
MAS1	MAS1 proto-oncogene, G protein-coupled receptor	Yes	TBD		ENSG00000130368	P04201	G-protein coupled receptor 1 family	17	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01019	AGT	AGT [Baccin2019:1282979212829790;Cellinker:12829792;HPMR:12829792;HPRD:12829792;LRdb:12829792;connectomeDB2020:12829792]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	angiotensin receptor activity [GO:0001595]; angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]	activation of NF-kappaB-inducing kinase activity [GO:0007250]; G protein-coupled receptor signaling pathway [GO:0007186]; hippocampus development [GO:0021766]; male gonad development [GO:0008584]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; protein kinase C signaling [GO:0070528]; regulation of inflammatory response [GO:0050727]; response to activity [GO:0014823]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MAS1&keywords=MAS1	0.0261262744	720	NA	NA	0.2070601172	518	0.0157480315	0.00499001996	0.003318584071	0.003836930456	0.005050505051	0.01184433164	0.01178603808	0.006525285481	0.008139104698	0.007377486981	0.01139656172	207	215	197	0.008182989057	0.9975865157	0.9557002386	1.176735115	112	140	47	398
AGTR1	angiotensin II receptor type 1	Yes	No		ENSG00000144891	P30556	G-protein coupled receptor 1 family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O60674, P00533, P01019, P01112, P04049, P04201, P12931, P25098, P28482, P34947, P35626, P49407, P62987	AGT, ARRB1, EGFR, GRK2, GRK3, GRK5, HRAS, JAK2, MAPK1, MAS1, RAF1, SRC, UBA52	AGT [CellTalkDB:10993080;Guide2Pharma:10193788;Guide2Pharma:12006574;Guide2Pharma:21464395;HPRD:15930094;LRdb:10193788;LRdb:10993080;LRdb:12006574;LRdb:15930094;LRdb:21464395;SIGNOR:16597412;SIGNOR:17346243;connectomeDB2020:10193788;connectomeDB2020:10993080;connectomeDB2020:12006574;connectomeDB2020:15930094;connectomeDB2020:21464395;scConnect:10193788;scConnect:12006574;scConnect:21464395], MAS1 [SIGNOR:15809376], HRAS [HPRD:8753867;LRdb:8753867;connectomeDB2020:8753867], UBA52 [NA], SRC [PhosphoSite:9516477], RAF1 [HPRD:8753867;InnateDB:11226259], MAPK1 [InnateDB:11226259], GRK2 [HPRD:8662816], GRK3 [HPRD:8662816], GRK5 [HPRD:8662816], ARRB1 [HPRD:11579203], EGFR [HPRD:12522132], JAK2 [HPRD:7746328]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	angiotensin type II receptor activity [GO:0004945]; angiotensin type I receptor activity [GO:0001596]; bradykinin receptor binding [GO:0031711]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]	angiotensin-activated signaling pathway [GO:0038166]; blood vessel diameter maintenance [GO:0097746]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; renin-angiotensin regulation of aldosterone production [GO:0002018]; Rho protein signal transduction [GO:0007266]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGTR1&keywords=AGTR1	0.3287457556	494	NA	NA	0.04026737541	762	0	0	0	0.03381294964	0.001683501684	0.04060913706	0	0.03915171289	0.04069552349	2.67E-04	3.86E-04	140	338	336	0.01423692793	2.091664572	0.4236121996	0.4285330284	13	314	300	477
AGTR2	angiotensin II receptor type 2	Yes	Yes		ENSG00000180772	P50052	G-protein coupled receptor 1 family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01019, P04899, P08754, P12821, P21860, P35625	ACE, AGT, ERBB3, GNAI2, GNAI3, TIMP3	AGT [Baccin2019:17138938;Baccin2019:21464395;Baccin2019:2775266;Baccin2019:7850406;Baccin2019:8185599;Baccin2019:8242249;Baccin2019:8315512;CellTalkDB:17138938;Guide2Pharma:21542804;Guide2Pharma:2775266;Guide2Pharma:7850406;Guide2Pharma:8242249;HPRD:8185599;LRdb:17138938;LRdb:21464395;LRdb:2775266;LRdb:7850406;LRdb:8185599;LRdb:8242249;LRdb:8315512;connectomeDB2020:17138938;connectomeDB2020:21464395;connectomeDB2020:2775266;connectomeDB2020:7850406;connectomeDB2020:8185599;connectomeDB2020:8242249;connectomeDB2020:8315512;scConnect:17138938;scConnect:21464395;scConnect:21542804;scConnect:2775266;scConnect:7850406;scConnect:8242249], TIMP3 [CellTalkDB:18344519;Cellinker:18344519;LRdb:18344519;Lit-BM-17:18344519;Ramilowski2015:18344519;connectomeDB2020:18344519;talklr:18344519], ACE [Baccin2019:11459796;HPRD:11459796;LRdb:11459796], GNAI2 [Baccin2019:11055978;Baccin2019:8663053;Cellinker:11055978;Cellinker:8663053;HPRD:11055978;HPRD:8663053;LRdb:111;LRdb:8663053;connectomeDB2020:11055978;connectomeDB2020:8663053], GNAI3 [Cellinker:8663053;HPRD:11055978;HPRD:8663053], ERBB3 [HPRD:10710290]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; receptor antagonist activity [GO:0048019]	angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; brain renin-angiotensin system [GO:0002035]; cell surface receptor signaling pathway [GO:0007166]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of heart rate [GO:0010459]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of metanephros size [GO:0035566]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGTR2&keywords=AGTR2	0.007699924719	786	NA	NA	0.1653268158	558	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	672
ALK	ALK receptor tyrosine kinase	Yes	No		ENSG00000171094	Q9UM73	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P08069, P08631, P18206, P21246, P21741, P23467, P23471, P35568, Q6UX46, Q6UXT8	ALKAL1, ALKAL2, HCK, IGF1R, IRS1, MDK, PTN, PTPRB, PTPRZ1, VCL	PTN [Baccin2019:11278720;CellChatDB:25620911;CellChatDB:28356350;CellTalkDB:11278720;Cellinker:11278720;Cellinker:25620911;Cellinker:28356350;DIP:1848244;HPRD:11278720;LRdb:11278720;SIGNOR:11278720;SignaLink3:11278720;SignaLink3:23331499;connectomeDB2020:11278720], MDK [Baccin2019:1212200912122000;CellChatDB:19459784;CellTalkDB:12122009;Cellinker:19459784;HPMR:12122009;HPRD:12122009;LRdb:12122009;SignaLink3:12122009;SignaLink3:23331499;connectomeDB2020:12122009], PTPRZ1 [HPRD:17681947;SIGNOR:17681947;SignaLink3:17681947;SignaLink3:23331499], PTPRB [SIGNOR:17681947;SignaLink3:17681947;SignaLink3:23331499], VCL [CellTalkDB:21213368], ALKAL1 [CellTalkDB:26418745;IntAct:26418745;connectomeDB2020:26630010], ALKAL2 [CellTalkDB:26418745;connectomeDB2020:26630010], HCK [KEA:17570479], IGF1R [KEA:17570479], IRS1 [HPRD:9174053]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ALK&keywords=ALK	0.5390659617	450	NA	NA	1.215342766	195	0	4.99E-04	0	4.80E-04	0	0.02876480541	0.01359927471	0.004893964111	0.0251572327	0.006776605688	0.006915201854	172	219	227	0.007916882071	1.96224056	0.9363574322	0.9440929391	18	153	98	254
C5AR2	complement C5a receptor 2	Yes	TBD		ENSG00000134830	Q9P296	G-protein coupled receptor 1 family	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01024, P01031, P0C0L4	C3, C4A, C5	C5 [Baccin2019:11773063;Baccin2019:12899627;CellTalkDB:11773063;Guide2Pharma:11773063;Guide2Pharma:12899627;HPMR:11773063;LRdb:11773063;LRdb:13;SIGNOR:11773063;connectomeDB2020:11773063;connectomeDB2020:12899627;scConnect:11773063;scConnect:12899627], C3 [Baccin2019:11773063;CellTalkDB:11773063;HPRD:11773063;LRdb:11773063;connectomeDB2020:11773063], C4A [Baccin2019:11773063;CellTalkDB:11773063;HPRD:11773063;LRdb:11773063;connectomeDB2020:11773063]	apical part of cell [GO:0045177]; basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	complement component C5a receptor activity [GO:0004878]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]	chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of tumor necrosis factor production [GO:0032720]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of interleukin-8 production [GO:0032677]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C5AR2&keywords=C5AR2	0.1562557146	572	NA	NA	0.09500272684	649	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	611
CMKLR2	chemerin chemokine-like receptor 2	Yes	No		ENSG00000283448, ENSG00000183671	P46091	Chemokine-like receptor (CMKLR) family	16	receptor	cell_surface, intracellular, plasma_membrane, receptor, transmembrane	Q99969	RARRES2	RARRES2 [Baccin2019:18165312;Baccin2019:23396314;CellChatDB:24671882;CellTalkDB:18165312;Cellinker:18165312;Cellinker:23396314;Cellinker:24671882;Guide2Pharma:18165312;Guide2Pharma:23396314;LRdb:18165312;LRdb:23;connectomeDB2020:18165312;connectomeDB2020:23396314;scConnect:18165312;scConnect:23396314]	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]	glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CMKLR2&keywords=CMKLR2	0.05023272851	678	NA	NA	0.06152145895	709	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	694
CSF2RB	colony stimulating factor 2 receptor subunit beta	Yes	No		ENSG00000100368	P32927	Type I cytokine receptor family, Type 4 subfamily	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15524, O60674, P04141, P05113, P05771, P06239, P06241, P07332, P07948, P08631, P08700, P09919, P10721, P12931, P17612, P23458, P29350, P35968, P42336, P43405, Q06124	CSF2, CSF3, FES, FYN, HCK, IL3, IL5, JAK1, JAK2, KDR, KIT, LCK, LYN, PIK3CA, PRKACA, PRKCB, PTPN11, PTPN6, SOCS1, SRC, SYK	CSF3 [NA], CSF2 [Baccin2019:2645577;Baccin2019:2828352;Baccin2019:8278375;CellTalkDB:2828352;DIP:1702217;DIP:7957082;HPMR:10753826;HPMR:2828352;HPRD:2645577;HPRD:8278375;LMPID:7957082;LRdb:2645577;LRdb:2828352;LRdb:8278375;Lit-BM-17:1702217;Lit-BM-17:18692472;Lit-BM-17:7957082;connectomeDB2020:2645577;connectomeDB2020:2828352;connectomeDB2020:8278375], IL3 [CellTalkDB:11700046;DIP:7957082;HPMR:11700046;HPRD:9278420;LRdb:11700046;LRdb:93;Lit-BM-17:18692472;Lit-BM-17:7957082;Lit-BM-17:8649415;NetPath:9278420;connectomeDB2020:11700046;connectomeDB2020:9278420], IL5 [Baccin2019:11748263;CellTalkDB:11748263;DIP:7957082;InnateDB:1495999;LMPID:7957082;LRdb:11748263;Lit-BM-17:1495999;Lit-BM-17:7957082;NetPath:1833065;connectomeDB2020:11748263], PTPN6 [HPRD:8246974;HPRD:9162089;HPRD:9254654;NetPath:9162089;ProtMapper:11812650;ProtMapper:9162089;SIGNOR:11812650;SIGNOR:9162089], PTPN11 [HPRD:9162089;HPRD:9254654;InnateDB:18322230;NetPath:9162089;NetPath:9254654;SIGNOR:9162089], LYN [BioGRID:7636265;BioGRID:9973406;HPRD:7636265;HPRD:9973406;NetPath:11823534;NetPath:9973406;PhosphoSite:10329850;PhosphoSite:10672044], JAK2 [BioGRID:7527392;HPRD:10772872;KEA:10362354;KEA:9257712;KEA:9677359;NetPath:7602114;NetPath:7896837], PRKACA [KEA:16437163;ProtMapper:10477722;ProtMapper:10949031;ProtMapper:16437163;ProtMapper:9389692], SRC [KEA:16437163], PIK3CA [iPTMnet:23526884], SOCS1 [BioGRID:24086733], KIT [CancerCellMap:15308671;HPRD:15308671;NetPath:15308671], SYK [HPRD:8666899;NetPath:8666899], HCK [HPRD:9195918;NetPath:11823534;NetPath:9195918], FYN [HPRD:9195918;InnateDB:18322230;NetPath:9195918], FES [HPRD:8631962;NetPath:7896837], PRKCB [HPRD:10490850;NetPath:10490850], JAK1 [HPRD:11557047;NetPath:15988755;NetPath:9516124], KDR [HPRD:16007196], LCK [HPRD:1638019;HPRD:7896837]	granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023]	cellular response to interleukin-3 [GO:0036016]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-5-mediated signaling pathway [GO:0038043]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF2RB&keywords=CSF2RB	0.6983814203	426	NA	NA	0.1239195941	613	0.08661417323	0	0.07411504425	0.01079136691	0	0	0	0	0	6.68E-05	1.93E-04	234	344	342	0.01561641009	0.3903747622	0.3929810833	0.3979153217	339	326	313	427
EPHA6	EPH receptor A6	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000080224	Q9UF33	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43921, P20827, P52797, P52798, P52799, P52803, P98172, Q96T91	EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, EFNB1, EFNB2, GPHA2	EFNA1 [Baccin2019:93308638755474;CellTalkDB:11114742;Cellinker:8755474;Cellinker:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EFNA2 [Baccin2019:9330863;CellTalkDB:11114742;Cellinker:9330863;HPMR:9330863;LRdb:11114742;SIGNOR:10072375;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNA3 [Baccin2019:9330863;CellTalkDB:11114742;Cellinker:9330863;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNA4 [Baccin2019:933086310607706;CellTalkDB:11114742;Cellinker:10607706;Cellinker:9330863;HPRD:10607706;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:9330863], EFNA5 [Baccin2019:9330863;CellTalkDB:11114742;Cellinker:9330863;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:9330863], EFNB1 [CellTalkDB:32196115], EFNB2 [CellTalkDB:10648835;LRdb:10648835;Ramilowski2015:10648835;connectomeDB2020:10648835;talklr:10648835], GPHA2 [CellTalkDB:32103204]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA6&keywords=EPHA6	0.2442206014	525	NA	NA	0.4550450263	383	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	454
EPHB6	EPH receptor B6	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000106123	O15197	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P20827, P52797, P52799, P52803, P54762, P55196, P98172, Q15768	AFDN, EFNA1, EFNA3, EFNA5, EFNB1, EFNB2, EFNB3, EPHB1	AFDN [CellTalkDB:9707552;Cellinker:9707552;DOMINO:9707552;HPRD:9707552;LRdb:9707552;connectomeDB2020:9707552], EFNB1 [Baccin2019:11713248;CellPhoneDB:15114347;Cellinker:11713248;HPMR:11713248;LRdb:11114742;connectomeDB2020:11713248], EFNB3 [CellChatDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347], EFNB2 [Baccin2019:10648835;CellTalkDB:15114347;Cellinker:10648835;HPRD:10648835;LRdb:11114742;connectomeDB2020:10648835], EFNA5 [LRdb:15107857;Ramilowski2015:15107857;connectomeDB2020:15107857;talklr:15107857], EFNA1 [CellTalkDB:32196115], EFNA3 [CellTalkDB:32196115], EPHB1 [HPRD:11713248]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHB6&keywords=EPHB6	2.899596828	275	NA	NA	0.08038668929	674	0.007874015748	0.499500998	0	0.01151079137	0.05723905724	0.03384094755	0.005439709882	0.004893964111	0.03625601184	0.001468820937	0.01684373189	148	302	166	0.06135164078	0.6482823847	0.1607366111	0.3762174436	248	405	322	414
F2RL2	coagulation factor II thrombin receptor like 2	Yes	Yes		ENSG00000164220	O00254	G-protein coupled receptor 1 family	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P00734, P00747, P07477, P07478, P08311, P12544, P12931, P35030	CTSG, F2, GZMA, PLG, PRSS1, PRSS2, PRSS3, SRC	F2 [Baccin2019:1135698512732210;CellTalkDB:11356985;Cellinker:11356985;HPMR:11356985;HPRD:12732212;LRdb:11356985;LRdb:13;SIGNOR:11356985;connectomeDB2020:11356985;connectomeDB2020:12732212], PRSS3 [NA], CTSG [HPRD:11307827], PLG [NA], GZMA [NA], PRSS2 [NA], PRSS1 [NA], SRC [DOMINO:17474147]	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	G protein-coupled receptor activity [GO:0004930]; phosphatidylinositol phospholipase C activity [GO:0004435]; thrombin-activated receptor activity [GO:0015057]	blood coagulation [GO:0007596]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; response to wounding [GO:0009611]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=F2RL2&keywords=F2RL2	5.284626515	225	NA	NA	4.633235209	48	0	4.99E-04	0.003318584071	0.03836930456	0	0	0	0	0	1.34E-04	1.16E-04	234	342	344	0.003857847003	0.721612816	0.7312484525	0.7299761092	217	219	186	209
F2RL3	F2R like thrombin or trypsin receptor 3	Yes	No		ENSG00000127533	Q96RI0	G-protein coupled receptor 1 family	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00254, P00734, P00747, P07477, P07478, P08311, P12544, P35030	CTSG, F2, F2RL2, GZMA, PLG, PRSS1, PRSS2, PRSS3	F2 [Baccin2019:1273221212732210;CellTalkDB:12732212;Cellinker:12732212;HPRD:12732212;LRdb:12732212;SIGNOR:22318735;connectomeDB2020:12732212], PRSS3 [NA], CTSG [NA], GZMA [NA], PLG [NA], PRSS2 [NA], PRSS1 [NA], F2RL2 [HPRD:10766244]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; thrombin-activated receptor activity [GO:0015057]	blood coagulation [GO:0007596]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; response to wounding [GO:0009611]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=F2RL3&keywords=F2RL3	5.059969775	233	NA	NA	1.270010995	189	0	0.00499001996	1.837389381	0.2899280576	0	0.001692047377	0.009066183137	0	0.002219755827	0.001602350113	0.006374348078	228	300	233	0.1957511039	0.0593909612	0.05639022049	0.07958328179	445	440	440	291
GCGR	glucagon receptor	Yes	No		ENSG00000288269, ENSG00000215644	P47871	G-protein coupled receptor 2 family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O95467, P01275, P63092, P84996, Q5JWF2	GCG, GNAS	GCG [CellTalkDB:12529935;Cellinker:12529935;Cellinker:4305077;Cellinker:8382034;Guide2Pharma:4305077;HPMR:12529935;HPRD:8382034;LRdb:12529935;LRdb:4305077;LRdb:8382034;SIGNOR:12529935;SIGNOR:22863277;connectomeDB2020:12529935;connectomeDB2020:4305077;connectomeDB2020:8382034;scConnect:4305077], GNAS [Baccin2019:1908089;CellTalkDB:1908089;Cellinker:1908089;HPRD:1908089;LRdb:1908089;connectomeDB2020:1908089], GNAS [Baccin2019:1908089;CellTalkDB:1908089;Cellinker:1908089;HPRD:1908089;LRdb:1908089;connectomeDB2020:1908089], GNAS [Baccin2019:1908089;CellTalkDB:1908089;Cellinker:1908089;HPRD:1908089;LRdb:1908089;connectomeDB2020:1908089], GNAS [Baccin2019:1908089;CellTalkDB:1908089;Cellinker:1908089;HPRD:1908089;LRdb:1908089;connectomeDB2020:1908089]	endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	glucagon receptor activity [GO:0004967]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucagon stimulus [GO:0071377]; cellular response to starvation [GO:0009267]; exocytosis [GO:0006887]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of glycogen metabolic process [GO:0070873]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GCGR&keywords=GCGR	0.7748167945	419	NA	NA	0.1787587821	542	0.03149606299	0.00748502994	0	0.001918465228	0.01346801347	0.1556683587	0.1631912965	0.01305057096	0.04661487236	0.1620042729	0.002549739231	128	53	273	0.05431333475	0.880297571	2.674472931	0.195134326	151	5	397	255
GFRA1	GDNF family receptor alpha 1	Yes	No		ENSG00000151892	P56159	GDNFR family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, receptor, transmembrane	O60542, P07949, P13591, P39905, Q5T4W7, Q99748	ARTN, GDNF, NCAM1, NRTN, PSPN, RET	RET [BioGRID:9192898;Cellinker:9883723;HPRD:10774729;SIGNOR:10829012;SignaLink3:10829012;SignaLink3:23331499], NRTN [Baccin2019:91828039407096;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9407096;HPRD:9407096;LRdb:9182803;LRdb:941;SIGNOR:9182803;connectomeDB2020:9182803;connectomeDB2020:9407096], GDNF [Baccin2019:14514671;Baccin2019:8674117;Baccin2019:9482105;CellTalkDB:14514671;Cellinker:11544105;Cellinker:14514671;Cellinker:8674117;Cellinker:9482105;DIP:20473317;HPMR:11106404;HPMR:14514671;HPRD:8674117;HPRD:9482105;LRdb:14514671;LRdb:8674117;LRdb:9482105;SIGNOR:9182803;connectomeDB2020:14514671;connectomeDB2020:8674117;connectomeDB2020:9482105], PSPN [CellTalkDB:20350599;Cellinker:20350599;LRdb:20350599;Ramilowski2015:20350599;connectomeDB2020:20350599;talklr:20350599], NCAM1 [CellTalkDB:12837245;Cellinker:12837245;HPRD:12837245;LRdb:12837245;connectomeDB2020:12837245], ARTN [CellTalkDB:9883723;Cellinker:11544105;Cellinker:28937965;Cellinker:9883723;LRdb:9883723;Ramilowski2015:9883723;connectomeDB2020:9883723;talklr:9883723]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]	glial cell-derived neurotrophic factor receptor activity [GO:0016167]; integrin binding [GO:0005178]; neurotrophin receptor activity [GO:0005030]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]	aging [GO:0007568]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; kidney development [GO:0001822]; male gonad development [GO:0008584]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFRA1&keywords=GFRA1	0.7493890753	422	NA	NA	0.07912920968	678	0	4.99E-04	0	0.0103117506	0.006734006734	0.0372250423	0.01178603808	0.01468189233	0.02848686644	0.01331953532	1.55E-04	165	191	343	0.0111998785	1.815428633	1.099984385	0.4789899929	23	99	280	348
GPR151	G protein-coupled receptor 151	Yes	Yes		ENSG00000173250	Q8TDV0	G-protein coupled receptor 1 family	16	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P22466, Q8NHW4	CCL4L1, GAL	GAL [Baccin2019:15111018;CellTalkDB:15111018;Cellinker:15111018;HPRD:15111018;LRdb:15111018;connectomeDB2020:15111018], CCL4L1 [NA]	integral component of plasma membrane [GO:0005887]	G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of immune response [GO:0050778]; response to acidic pH [GO:0010447]; response to ischemia [GO:0002931]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR151&keywords=GPR151	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
IFNGR2	interferon gamma receptor 2	Yes	Yes, No		ENSG00000262795, ENSG00000159128	P38484	Type II cytokine receptor family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O60674, P01579, P23458	IFNG, JAK1, JAK2	IFNG [CellTalkDB:10811850;HPMR:10811850;HPMR:12438563;HPRD:7673114;InnateDB:7673114;LRdb:10811850;LRdb:77;SIGNOR:7673114;SignaLink3:10986460;SignaLink3:12438563;SignaLink3:12915721;SignaLink3:1396683;SignaLink3:15143187;SignaLink3:15530433;SignaLink3:16237089;SignaLink3:16467876;SignaLink3:18591661;SignaLink3:18988627;SignaLink3:20304997;SignaLink3:23331499;SignaLink3:29145629;SignaLink3:7510216;SignaLink3:7514165;SignaLink3:7615558;SignaLink3:7617032;SignaLink3:7673114;SignaLink3:8550631;SignaLink3:8631301;SignaLink3:9111318;connectomeDB2020:10811850;connectomeDB2020:7673114], JAK1 [SIGNOR:19041276], JAK2 [HPRD:7514165;Macrophage:7901766;SIGNOR:23898330]	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interferon-gamma receptor activity [GO:0004906]	cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; microglial cell activation [GO:0001774]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNGR2&keywords=IFNGR2	79.23683445	27	NA	NA	2.112899899	113	0.2598425197	0.5144710579	0.1117256637	0.06282973621	0.1818181818	0.179357022	0.1822302811	0.176182708	0.0825009249	0.1204766992	0.05470349623	96	75	96	0.175103481	0.4997254747	0.7048851728	0.3495531035	305	230	330	111
IGF2R	insulin like growth factor 2 receptor	Yes	TBD		ENSG00000197081	P11717	MRL1/IGF2R family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60664, P00747, P00749, P01344, P05019, P10144, P17612, P29279, P68400, Q7Z6M1, Q8IWJ2	CCN2, CSNK2A1, GCC2, GZMB, IGF1, IGF2, PLAU, PLG, PLIN3, PRKACA, RABEPK, STX10_STX16_VAMP3_VTI1A	IGF2 [Baccin2019:2964083;Baccin2019:7797478;Baccin2019:9722981;CellChatDB:14604834;CellTalkDB:2964083;Cellinker:14604834;Cellinker:2964083;Cellinker:7797478;Cellinker:9722981;DIP:11502794;DIP:17850746;DOMINO:18046459;HPMR:2852162;HPMR:2964083;HPRD:7797478;HPRD:9722981;LRdb:2964083;LRdb:7797478;LRdb:9722981;Lit-BM-17:11502794;Lit-BM-17:17850746;Lit-BM-17:18046459;SIGNOR:11867533;SPIKE:18046459;SPIKE:20980691;connectomeDB2020:2964083;connectomeDB2020:7797478;connectomeDB2020:9722981], RABEPK [SIGNOR:9230071], GCC2 [SIGNOR:18195106], PRKACA [ProtMapper:8318012;SIGNOR:8318012;iPTMnet:8318012], CSNK2A1 [KEA:17081983;KEA:8318012;PhosphoSite:8318012;ProtMapper:8318012;SIGNOR:8318012;iPTMnet:8318012;phosphoELM:8318012], GZMB [CellTalkDB:11081635;HPRD:11081635;LRdb:11081635;SIGNOR:11081635;connectomeDB2020:11081635], PLIN3 [BioGRID:10908666;HPRD:10908666;HPRD:9590177;Lit-BM-17:10908666;Lit-BM-17:9590177;SIGNOR:9590177], IGF1 [CellTalkDB:32196115], PLG [NA], PLAU [CellTalkDB:9566979;Cellinker:9566979;HPRD:9566979;LRdb:9566979;connectomeDB2020:9566979], CCN2 [Baccin2019:22511630;connectomeDB2020:22511630]	cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]	enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor-activated receptor activity [GO:0005010]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]	animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF2R&keywords=IGF2R	31.12016625	70	6933.44	27	1.594393599	153	0.2362204724	0.2754491018	0.08517699115	0.196882494	0.1060606061	0.2504230118	0.228467815	0.1305057096	0.1054384018	0.1245827213	0.08715472281	76	71	71	0.1660329134	0.6557773743	0.7645315793	0.5519122584	243	210	250	106
IL1RAP	interleukin 1 receptor accessory protein	Yes	No		ENSG00000196083	Q9NPH3	Interleukin-1 receptor family	16	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O95760, P01583, P01584, P10586, P14778, P18510, P23468, P51617, Q13332, Q99836, Q9NZH7, Q9NZH8, Q9UBH0, Q9UHA7	IL1A, IL1B, IL1R1, IL1RN, IL33, IL36A, IL36B, IL36G, IL36RN, IRAK1, MYD88, PTPRD, PTPRF, PTPRS	IL1R1 [HPRD:9371760;InnateDB:15044087;InnateDB:15866876;InnateDB:9371760;InnateDB:9430229;NetPath:10854325;NetPath:17507369;NetPath:7775431;NetPath:9430229;SIGNOR:10854325], IL1A [Baccin2019:9820540;CellTalkDB:9820540;HPRD:9820540;LRdb:9820540;NetPath:17507369;NetPath:7775431;NetPath:9862719;connectomeDB2020:9820540], IL1B [Baccin2019:9820540;CellTalkDB:9820540;HPRD:9820540;InnateDB:20802483;LRdb:9820540;NetPath:7775431;SIGNOR:9820540;connectomeDB2020:9820540], IL1RN [NA], IL33 [InnateDB:18450470;InnateDB:19836339], IL36A [NA], IL36B [NA], IL36G [NA], IL36RN [NA], PTPRF [Cellinker:32822567], PTPRD [Cellinker:32822567], PTPRS [Cellinker:32822567], IRAK1 [HPRD:9371760;InnateDB:15044087;InnateDB:9371760;InnateDB:9374458;NetPath:9374458;NetPath:9430229], MYD88 [HPRD:11880380;InnateDB:13679373;InnateDB:15849357;InnateDB:9374458;NetPath:17507369;NetPath:9374458;NetPath:9430229]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]	immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RAP&keywords=IL1RAP	7.375137359	189	NA	NA	2.867042642	80	0.0157480315	0.03493013972	0.01327433628	0.04004796163	0.02693602694	0.04230118443	0.00725294651	0.07993474715	0.03699593045	0.003872346108	0.002820166119	147	252	268	0.02764671062	1.248340949	0.3684876017	0.3405388122	64	335	335	214
IL1RAPL1	interleukin 1 receptor accessory protein like 1	Yes	TBD		ENSG00000169306	Q9NZN1	Interleukin-1 receptor family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43506, P23468, P23470, Q13332, Q14116, Q8WWZ1, Q9BUR5, Q9NZH6	ADAM20, APOO, IL18, IL1F10, IL37, PTPRD, PTPRG, PTPRS	IL1F10 [ICELLNET:22315422;ICELLNET:31387327], IL37 [CellTalkDB:25654981;InnateDB:25654981], IL18 [Baccin2019:9325300;CellTalkDB:9325300;Cellinker:9325300;HPMR:11046021;HPMR:9325300;LRdb:9325300;connectomeDB2020:9325300], PTPRD [Cellinker:32822567], PTPRS [Cellinker:32822567], PTPRG [Cellinker:32589946], ADAM20 [Cellinker:32589946], APOO [Cellinker:32589946]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RAPL1&keywords=IL1RAPL1	0.02573228215	721	NA	NA	0.1271138218	610	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	666
IL1RL2	interleukin 1 receptor like 2	Yes	No		ENSG00000115598	Q9HB29	Interleukin-1 receptor family	16	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P18510, Q14116, Q8WWZ1, Q9NZH7, Q9NZH8, Q9UBH0, Q9UHA7	IL18, IL1F10, IL1RN, IL36A, IL36B, IL36G, IL36RN	IL36A [CellTalkDB:11466363;connectomeDB2020:30452921], IL36B [CellTalkDB:21965679], IL36G [CellTalkDB:25673295], IL36RN [ICELLNET:20959797;ICELLNET:24332029;connectomeDB2020:20081871], IL1F10 [CellTalkDB:22315422;ICELLNET:22315422;ICELLNET:31387327], IL1RN [CellTalkDB:22047735], IL18 [Baccin2019:9325300;CellTalkDB:9325300;Cellinker:9325300;HPRD:9325300;LRdb:9325300]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	interleukin-1, type I, activating receptor activity [GO:0004909]; interleukin-1 receptor activity [GO:0004908]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]	cellular defense response [GO:0006968]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T cell differentiation [GO:0045582]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RL2&keywords=IL1RL2	1.512942497	337	NA	NA	0.8865710272	264	0	0.00499001996	0	0.02134292566	0	0.02030456853	0.01631912965	0.003262642741	0.004439511654	0.006142342102	0.01896851458	221	224	159	0.008706332261	0.7719050133	0.8629346403	1.548594036	201	177	19	251
NPSR1	neuropeptide S receptor 1	Yes	No		ENSG00000187258	Q6W5P4	G-protein coupled receptor 1 family, Vasopressin/oxytocin receptor subfamily	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P0C0P6	NPS	NPS [Baccin2019:1531264815312640;CellChatDB:19732772;CellTalkDB:15312648;Cellinker:15312648;Cellinker:19732772;Guide2Pharma:15312648;HPMR:15312648;LRdb:15312648;connectomeDB2020:15312648;scConnect:15312648]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]	eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPSR1&keywords=NPSR1	0.01809034607	746	NA	NA	1.14308053	208	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	477
NPY5R	neuropeptide Y receptor Y5	Yes	No		ENSG00000164129	Q15761	G-protein coupled receptor 1 family	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01298, P01303, P10082	NPY, PPY, PYY	NPY [CellTalkDB:8824284;Cellinker:12007534;Cellinker:12417094;Cellinker:8824284;Guide2Pharma:8824284;HPMR:12417094;HPRD:12007534;LRdb:12007534;LRdb:12417094;LRdb:8824284;SIGNOR:11825645;connectomeDB2020:12007534;connectomeDB2020:12417094;connectomeDB2020:8824284;scConnect:8824284], PPY [Baccin2019:8824284;CellTalkDB:8824284;Cellinker:8824284;Guide2Pharma:8824284;LRdb:8824284;connectomeDB2020:8824284;scConnect:8824284], PYY [Baccin2019:1182564512665540;CellTalkDB:11825645;Cellinker:11825645;Cellinker:12665544;HPRD:12665544;LRdb:11825645;LRdb:13;SIGNOR:11825645;connectomeDB2020:11825645;connectomeDB2020:12665544]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]	aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; generation of ovulation cycle rhythm [GO:0060112]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; outflow tract morphogenesis [GO:0003151]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of smooth muscle cell proliferation [GO:0048661]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPY5R&keywords=NPY5R	0.2508245222	522	NA	NA	0.2560410393	478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	500
OPRD1	opioid receptor delta 1	Yes	Yes		ENSG00000116329	P41143	G-protein coupled receptor 1 family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, receptor, transmembrane	O43927, P01189, P01210, P01213, P02775, P04899, P17252, P25098, P49841, Q00535, Q02156, Q05655	CDK5, CXCL13, GNAI2, GRK2, GSK3B, PDYN, PENK, POMC, PPBP, PRKCA, PRKCD, PRKCE	POMC [Baccin2019:154641439686407;CellTalkDB:15464143;Cellinker:15464143;Cellinker:9686407;Guide2Pharma:9686407;LRdb:15464143;LRdb:97;SIGNOR:9686407;connectomeDB2020:15464143;connectomeDB2020:9686407;scConnect:9686407], PDYN [Baccin2019:9686407;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:9686407;scConnect:9686407], PENK [Baccin2019:9686407;CA1:15082510;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;connectomeDB2020:9686407;scConnect:9686407], PRKCD [HPRD-phos:11085981;HPRD:11085981;KEA:11085981;ProtMapper:11085981;SIGNOR:11085981;iPTMnet:11085981], PPBP [SIGNOR:9686407], PRKCA [HPRD-phos:11085981;HPRD:11085981;KEA:11085981;KEA:17570479;ProtMapper:11085981;SIGNOR:11085981;iPTMnet:11085981], GRK2 [HPRD-phos:11040053;HPRD:11040053;KEA:11040053;PhosphoSite:10893226;PhosphoSite:16135360;PhosphoSite:17322005;PhosphoSite:18395423;PhosphoSite:19344370;PhosphoSite:32444688;ProtMapper:11040053;SIGNOR:11040053;iPTMnet:11040053;phosphoELM:11040053], PRKCE [HPRD-phos:11085981;HPRD:11085981;KEA:11085981;ProtMapper:11085981;SIGNOR:11085981;iPTMnet:11085981], GNAI2 [Baccin2019:1671672;CellTalkDB:1671672;Cellinker:1671672;HPRD:1671672;LRdb:1671672;connectomeDB2020:1671672], CXCL13 [CellTalkDB:32196115], GSK3B [KEA:17570479], CDK5 [iPTMnet:19295160]	axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuronal dense core vesicle [GO:0098992]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; spine apparatus [GO:0097444]	G protein-coupled enkephalin receptor activity [GO:0038046]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OPRD1&keywords=OPRD1	1.711759112	319	NA	NA	5.322050291	43	0.03149606299	0.01497005988	0.01327433628	0.008872901679	0.0303030303	0.241962775	0.1124206709	0.03425774878	0.1646318905	0.1271865403	0.01251690168	48	70	192	0.07199026529	2.129910055	1.673205225	0.2746289648	11	31	363	116
PLXNA1	plexin A1	Yes	Yes		ENSG00000114554	Q9UIW2	Plexin family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O14786, O94813, O94887, P07332, P31749, P32004, P48745, Q13275, Q13591, Q14563, Q8NFY4, Q9H3T2, Q9P283	AKT1, CCN3, FARP2, FES, L1CAM, NRP1, SEMA3A, SEMA3F, SEMA5A, SEMA5B, SEMA6C, SEMA6D, SLIT2	SEMA3A [Baccin2019:10520994;CellTalkDB:10520994;HPMR:10520994;HPMR:15121181;LRdb:10520994;SIGNOR:25335892;connectomeDB2020:10520994], SEMA3F [CellTalkDB:26156437], CCN3 [CellTalkDB:32196115], FARP2 [CellTalkDB:32196115], SEMA6D [Baccin2019:1497792114977920;CellChatDB:27533782;CellTalkDB:14977921;HPRD:14977921;LRdb:14977921;connectomeDB2020:14977921], SEMA5A [CellChatDB:27533782;Cellinker:26633812;Cellinker:27533782], SEMA5B [CellChatDB:27533782;Cellinker:27533782], SEMA6C [Cellinker:26633812], SLIT2 [Cellinker:29317497], L1CAM [HPMR:10520994;HPMR:15121181], AKT1 [HPRD:15187088;Lit-BM-17:15187088], FES [HPRD:12093729], NRP1 [HPRD:10520994]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNA1&keywords=PLXNA1	4.167382298	243	NA	NA	0.2109839518	515	0.04724409449	0.09481037924	0.04756637168	0.03669064748	0.05050505051	0.01861252115	0.02991840435	0.01468189233	0.006289308176	0.01919481907	0.01989569249	214	176	155	0.03503719827	0.3616856466	0.6482379053	0.6638000061	352	250	206	296
PLXNA3	plexin A3	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000130827	P51805	Plexin family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O94887, Q13275, Q13591, Q14563, Q9P283	FARP2, SEMA3A, SEMA3F, SEMA5A, SEMA5B	SEMA3F [Baccin2019:15721238;CellTalkDB:15721238;HPMR:15721238;LRdb:15721238;connectomeDB2020:15721238], FARP2 [CellTalkDB:32196115], SEMA3A [CellTalkDB:32196115], SEMA5A [CellChatDB:27533782;Cellinker:27533782], SEMA5B [CellChatDB:27533782;Cellinker:27533782]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNA3&keywords=PLXNA3	19.77210533	108	1293.48	75	1.152296867	205	0.02362204724	0.09880239521	0.008849557522	0.01990407674	0.04377104377	0.1049069374	0.1205802357	0.09135399674	0.05031446541	0.08969822406	0.05037666602	124	92	101	0.06383451326	0.8168871541	1.350292968	0.8177295869	185	57	150	107
PLXNA4	plexin A4	Yes	No		ENSG00000221866	Q9HCM2	Plexin family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O94887, Q13214, Q14563, Q8NFY4, Q9H2E6, Q9H3T3	FARP2, SEMA3A, SEMA3B, SEMA6A, SEMA6B, SEMA6D	SEMA3B [SIGNOR:25335892], SEMA3A [Baccin2019:15721238;CellTalkDB:15721238;HPMR:15721238;HPMR:15814794;LRdb:15721238;SIGNOR:25335892;connectomeDB2020:15721238], SEMA6A [CellChatDB:27533782;CellTalkDB:20606624;Cellinker:20606624;Cellinker:26633812;Cellinker:27533782;LRdb:20606624;Ramilowski2015:20606624;connectomeDB2020:20606624;talklr:20606624], FARP2 [CellTalkDB:32196115], SEMA6B [CellChatDB:27533782;Cellinker:26633812;Cellinker:27533782], SEMA6D [Cellinker:26633812]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]	anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNA4&keywords=PLXNA4	0.1173929653	602	NA	NA	0.04608620778	743	0	0	0	0.003836930456	0	0.0152284264	0.00725294651	0	0.009248982612	0.004606756576	3.86E-05	203	242	346	0.003655697724	1.40959349	1.06964557	0.7351240937	45	106	183	423
PLXNB1	plexin B1	Yes			ENSG00000164050	O43157	Plexin family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P04626, P08581, Q92854, Q9C0C4, Q9H3S1	ERBB2, MET, SEMA4A, SEMA4C, SEMA4D	SEMA4D [Baccin2019:10520995;Baccin2019:11937491;Baccin2019:12198496;CellChatDB:27533782;CellTalkDB:10520995;Cellinker:10520995;Cellinker:11937491;Cellinker:12198496;Cellinker:24043639;Cellinker:27533782;DIP:20877282;HPMR:10520995;HPRD:11937491;ICELLNET:11245885;IntAct:20877282;LRdb:10520995;LRdb:11937491;LRdb:12198496;SIGNOR:12198496;connectomeDB2020:10520995;connectomeDB2020:11937491;connectomeDB2020:12198496], SEMA4A [CellChatDB:27533782;CellTalkDB:20043131;Cellinker:24043639;Cellinker:26633812;Cellinker:27533782;ICELLNET:29981480;connectomeDB2020:29981480], MET [Cellinker:28536399;HPRD:12198496;IntAct:12198496;IntAct:15184888;IntAct:22404908], ERBB2 [PhosphoSite:19805522;ProtMapper:20880496], SEMA4C [Cellinker:26633812]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888]	cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNB1&keywords=PLXNB1	23.33691472	90	NA	NA	0.382957735	410	0.007874015748	0.1092814371	0.01659292035	0.0170263789	0.03703703704	0.1133671743	0.06980961015	0.09461663948	0.08694043655	0.04336359995	0.03870967742	87	136	120	0.05769262973	1.432067818	0.788322158	0.7195713568	41	200	190	209
PLXNC1	plexin C1	Yes	Yes		ENSG00000136040	O60486	Plexin family	16	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O75326, Q8NFY4	SEMA6D, SEMA7A	SEMA7A [Baccin2019:1052099510520990;CellChatDB:27533782;CellPhoneDB:22325954;CellTalkDB:10520995;Cellinker:10520995;Cellinker:26633812;Cellinker:27533782;HPMR:10520995;HPRD:10520995;ICELLNET:10520995;ICELLNET:17671519;InnateDB:20727575;IntAct:20727575;LRdb:10520995;Lit-BM-17:20727575;SIGNOR:10520995;connectomeDB2020:10520995], SEMA6D [Cellinker:26633812]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102]	cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNC1&keywords=PLXNC1	8.407608882	173	2165.43	61	1.382866792	172	0.1102362205	0.00748502994	0	0.002877697842	0.01346801347	0.165820643	0.07887579329	0.06362153344	0.09248982612	0.06082253972	0.01989569249	83	118	156	0.05596299907	1.553747215	1.073670705	0.4532191214	32	104	292	126
RYK	receptor like tyrosine kinase	Yes			ENSG00000163785	P34925	Protein kinase superfamily, Tyr protein kinase family	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane	P04628, P29323, P41221, P54753, P56703, P56704, Q86YT6, Q9NZ42, Q9Y5W5	EPHB2, EPHB3, MIB1, PSENEN, WIF1, WNT1, WNT3, WNT3A, WNT5A	WNT3A [Baccin2019:15454084;CellTalkDB:15454084;Cellinker:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:15454084;SignaLink3:15454084;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:15454084], WNT1 [Baccin2019:1545408415454080;CellTalkDB:15454084;Cellinker:15454084;HPMR:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:15454084;SignaLink3:15454084;SignaLink3:23331499;connectomeDB2020:15454084], MIB1 [SIGNOR:21875946], PSENEN [SIGNOR:19000841], WNT5A [Baccin2019:15598975;CellTalkDB:15598975;Cellinker:15598975;HPMR:15598975;LRdb:15598975;SIGNOR:22773843;connectomeDB2020:15598975], WNT3 [Baccin2019:15454084;CellTalkDB:15454084;Cellinker:15454084;LRdb:15454084;connectomeDB2020:15454084], WIF1 [CellTalkDB:28529460], EPHB2 [HPRD:11956217], EPHB3 [HPRD:11956217]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RYK&keywords=RYK	24.47513477	87	NA	NA	0.7973034165	287	0.02362204724	0.2185628743	0.04203539823	0.1071942446	0.1043771044	0.05752961083	0.06708975521	0.044045677	0.03144654088	0.04232874883	0.03314661001	156	138	126	0.07012532832	0.5172714016	0.6530862329	0.538489026	301	245	257	189
SMO	smoothened, frizzled class receptor	Yes	No		ENSG00000128602	Q99835	G-protein coupled receptor Fz/Smo family	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00141, P00450, P12643, P25098, P36873, P43250, P48729, P49407, P49674, P49841, P56705, P62136, P62140, P62714, P67775, Q13635, Q15465, Q9Y6C5	ARRB1, BMP2, CP, CSNK1A1, CSNK1E, GRK2, GRK6, GSK3B, PPP1CA, PPP1CB, PPP1CC, PPP2CA, PPP2CB, PTCH1, PTCH2, SGK1, SHH, WNT4	PTCH1 [BioGRID:9811851;CancerCellMap:9811851;HPRD:9811851;NetPath:8906787;NetPath:9811851;SIGNOR:12192414;SIGNOR:14556242;SPIKE:20076617;SPIKE:20207148;SignaLink3:14556242;SignaLink3:23331499], PTCH2 [CancerCellMap:9811851;HPRD:9811851;NetPath:9811851;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9811851], GSK3B [SignaLink3:15803137;SignaLink3:23331499], GRK6 [SignaLink3:15618519;SignaLink3:23331499], ARRB1 [SignaLink3:15618519;SignaLink3:23331499], CSNK1E [SignaLink3:20708941;SignaLink3:23331499], GRK2 [SIGNOR:15618519;SIGNOR:21695114;SIGNOR:23074268], SGK1 [SIGNOR:25790864], CP [SIGNOR:16885213], CSNK1A1 [SIGNOR:21695114], WNT4 [CellTalkDB:32103204], BMP2 [CellTalkDB:32103204], SHH [Baccin2019:16867986;CellTalkDB:16867986;Cellinker:16867986;HPMR:16867986;LRdb:16867986;NetPath:8906787;connectomeDB2020:16867986], PPP1CA [DEPOD:21730325], PPP1CB [DEPOD:21730325], PPP1CC [DEPOD:21730325], PPP2CA [DEPOD:21730325], PPP2CB [DEPOD:21730325]	9+0 non-motile cilium [GO:0097731]; ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]	anterior/posterior pattern specification [GO:0009952]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of stem cell population maintenance [GO:2000036]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SMO&keywords=SMO	3.383750162	262	NA	NA	0.2132890728	513	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	388
TACR2	tachykinin receptor 2	Yes	No		ENSG00000075073	P21452	G-protein coupled receptor 1 family	16	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P20366, Q86UU9, Q9UHF0	TAC1, TAC3, TAC4	TAC1 [Baccin2019:10189055;Baccin2019:11137709;Baccin2019:11786503;Baccin2019:12954451;Baccin2019:7682062;Baccin2019:7961636;Baccin2019:8925404;Baccin2019:9190866;BioGRID:7961636;CellTalkDB:12954451;Cellinker:10189055;Cellinker:11137709;Cellinker:11786503;Cellinker:12954451;Cellinker:7682062;Cellinker:7961636;Cellinker:9190866;Guide2Pharma:11137709;Guide2Pharma:11786503;Guide2Pharma:7682062;Guide2Pharma:9190866;HPMR:12954451;HPMR:7534932;HPRD:10189055;HPRD:7961636;LRdb:10189055;LRdb:11137709;LRdb:11786503;LRdb:12954451;LRdb:7682062;LRdb:7961636;LRdb:9190866;Lit-BM-17:11786503;Lit-BM-17:23597562;Lit-BM-17:7961636;SIGNOR:8925404;connectomeDB2020:10189055;connectomeDB2020:11137709;connectomeDB2020:11786503;connectomeDB2020:12954451;connectomeDB2020:7682062;connectomeDB2020:7961636;connectomeDB2020:9190866;scConnect:11137709;scConnect:11786503;scConnect:7682062;scConnect:9190866], TAC3 [Baccin2019:10189055;Baccin2019:7682062;Baccin2019:7961636;Baccin2019:8925404;Baccin2019:9190866;Cellinker:10189055;Cellinker:7682062;Cellinker:7961636;Cellinker:8925404;Cellinker:9190866;Guide2Pharma:7682062;Guide2Pharma:9190866;HPRD:10189055;HPRD:7961636;LRdb:10189055;LRdb:7682062;LRdb:7961636;LRdb:8925404;LRdb:9190866;connectomeDB2020:10189055;connectomeDB2020:7682062;connectomeDB2020:7961636;connectomeDB2020:8925404;connectomeDB2020:9190866], TAC4 [CellTalkDB:11786503;Cellinker:11786503;HPRD:11786503;LRdb:11786503;connectomeDB2020:11786503]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]	substance K receptor activity [GO:0016497]; tachykinin receptor activity [GO:0004995]	excretion [GO:0007588]; intestine smooth muscle contraction [GO:0014827]; muscle contraction [GO:0006936]; negative regulation of luteinizing hormone secretion [GO:0033685]; operant conditioning [GO:0035106]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; prolactin secretion [GO:0070459]; response to electrical stimulus [GO:0051602]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TACR2&keywords=TACR2	0.1805668629	554	NA	NA	0.01675742699	830	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	692
TACR3	tachykinin receptor 3	Yes	No		ENSG00000169836	P29371	G-protein coupled receptor 1 family	16	receptor	cell_surface, intracellular, plasma_membrane, receptor, transmembrane	P20366, Q86UU9, Q9UHF0	TAC1, TAC3, TAC4	TAC1 [Baccin2019:10189055;Baccin2019:10866201;Baccin2019:11226387;Baccin2019:1312036;Baccin2019:2176308;Baccin2019:7557266;Baccin2019:8990205;Baccin2019:9190866;Baccin2019:9272936;CellTalkDB:9272936;Cellinker:11226387;Cellinker:1312036;Cellinker:9190866;Cellinker:9272936;Guide2Pharma:11226387;Guide2Pharma:1312036;Guide2Pharma:9190866;HPRD:9272936;LRdb:11226387;LRdb:1312036;LRdb:9190866;LRdb:9272936;connectomeDB2020:11226387;connectomeDB2020:1312036;connectomeDB2020:9190866;connectomeDB2020:9272936;scConnect:11226387;scConnect:1312036;scConnect:9190866], TAC3 [Baccin2019:10189055;Baccin2019:10866201;Baccin2019:11226387;Baccin2019:1312036;Baccin2019:2176308;Baccin2019:7557266;Baccin2019:8990205;Baccin2019:9190866;CellTalkDB:11226387;Cellinker:10189055;Cellinker:10866201;Cellinker:11226387;Cellinker:1312036;Cellinker:2176308;Cellinker:7557266;Cellinker:8990205;Cellinker:9190866;Guide2Pharma:11226387;Guide2Pharma:1312036;Guide2Pharma:2176308;Guide2Pharma:9190866;HPRD:10189055;HPRD:10866201;HPRD:8990205;LRdb:10189055;LRdb:10866201;LRdb:11226387;LRdb:1312036;LRdb:2176308;LRdb:7557266;LRdb:8990205;LRdb:9190866;connectomeDB2020:10189055;connectomeDB2020:10866201;connectomeDB2020:11226387;connectomeDB2020:1312036;connectomeDB2020:2176308;connectomeDB2020:7557266;connectomeDB2020:8990205;connectomeDB2020:9190866], TAC4 [CellTalkDB:11786503;Cellinker:11786503;HPRD:11786503;LRdb:11786503;connectomeDB2020:11786503]	cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]	tachykinin receptor activity [GO:0004995]	aging [GO:0007568]; hyperosmotic salinity response [GO:0042538]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of heart rate [GO:0010460]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to morphine [GO:0043278]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TACR3&keywords=TACR3	0.04901508764	679	NA	NA	0.5357586303	358	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	519
TIE1	tyrosine kinase with immunoglobulin like and EGF like domains 1	Yes	Yes		ENSG00000066056	P35590	Protein kinase superfamily, Tyr protein kinase family, Tie subfamily	16	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane, transmembrane_predicted	O15123, P04629, Q02763, Q15389, Q16653, Q9BY76, Q9UKU9, Q9Y264	ANGPT1, ANGPT2, ANGPT4, ANGPTL2, ANGPTL4, MOG, NTRK1, TEK	ANGPT4 [CellTalkDB:15851516;SignaLink3:10051567;SignaLink3:23331499], ANGPT1 [Baccin2019:11172728;CellTalkDB:11172728;Cellinker:11172728;HPMR:11172728;LRdb:11172728;SIGNOR:11172728;connectomeDB2020:11172728], ANGPTL4 [CellTalkDB:32196115], ANGPT2 [Baccin2019:27548530;CellTalkDB:22342979;connectomeDB2020:27548530], ANGPTL2 [CellTalkDB:32196115], MOG [Cellinker:32822567], TEK [HPRD:10995770], NTRK1 [Cellinker:32822567]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIE1&keywords=TIE1	4.775181218	234	NA	NA	0.3456110112	431	0.007874015748	0.002994011976	0.3473451327	0.04004796163	0	0.006768189509	0.001813236627	0.00163132137	0.001479837218	0.002036319936	0.002511106819	230	283	274	0.03768192123	0.2407586968	0.2524294245	0.2623868018	388	373	368	330
TNFRSF10D	TNF receptor superfamily member 10d	Yes	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000173530	Q9UBN6	NA	16	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P04637, P14174, P50591	MIF, TNFSF10, TP53	TP53 [LRdb:16230375;SPIKE:16230375], TNFSF10 [CellTalkDB:9242610;Cellinker:9242610;Cellinker:9430226;DIP:9382840;HPMR:9242610;HPRD:9430226;ICELLNET:11239407;LRdb:9242610;LRdb:943;Lit-BM-17:20103630;Lit-BM-17:9382840;Lit-BM-17:9430226;SPIKE:9430226;connectomeDB2020:9242610;connectomeDB2020:9430226], MIF [NA]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF10D&keywords=TNFRSF10D	12.29776955	141	NA	NA	1.671936076	144	0.02362204724	0.05439121756	0.08738938053	0.05635491607	0.006734006734	0	0.002719854941	0	7.40E-04	0.001034851115	0.001622561329	232	316	292	0.02132806856	0.3428209623	0.3522352837	0.3709951447	361	341	324	236
TNFRSF25	TNF receptor superfamily member 25	Yes	No		ENSG00000215788	Q93038	NA	16	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	F7VJQ1, O43508, O95150, P04156, P06127, P28482	CD5, MAPK1, PRNP, TNFSF12, TNFSF15	TNFSF15 [CellTalkDB:11911831;Cellinker:11911831;DIP:21300286;HPMR:11911831;HPRD:11911831;ICELLNET:11239407;InnateDB:20403353;LRdb:11911831;SIGNOR:14585074;connectomeDB2020:11911831], TNFSF12 [CellTalkDB:11094155;Cellinker:11094155;HPRD:11094155;LRdb:11094155;NetPath:11094155], CD5 [Cellinker:32589946], PRNP [Cellinker:32589946], PRNP [Cellinker:32589946], MAPK1 [HPRD:11606045]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF25&keywords=TNFRSF25	0.3377275201	492	NA	NA	0.009696170013	851	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	672
MRGPRX2	MAS related GPR family member X2	Yes	Yes		ENSG00000183695	Q96LB1	G-protein coupled receptor 1 family, Mas subfamily	16	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, P20366, P35318, P61278	ADM, CORT, SST, TAC1	ADM [Baccin2019:1611167315823560;Cellinker:15823563;Cellinker:16111673;Guide2Pharma:15823563;LRdb:16;LRdb:16111673;connectomeDB2020:15823563;connectomeDB2020:16111673;scConnect:15823563], CORT [Baccin2019:1291540212915400;CellTalkDB:12915402;Cellinker:12915402;HPMR:12915402;HPRD:12915402;LRdb:12915402;SIGNOR:16111673;connectomeDB2020:12915402], SST [scConnect:23396314], TAC1 [scConnect:25517090;scConnect:28288109]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; mast cell secretagogue receptor activity [GO:1990595]; neuropeptide binding [GO:0042923]	G protein-coupled receptor signaling pathway [GO:0007186]; mast cell activation [GO:0045576]; mast cell degranulation [GO:0043303]; positive regulation of cytokinesis [GO:0032467]; sensory perception of pain [GO:0019233]; sleep [GO:0030431]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MRGPRX2&keywords=MRGPRX2	5.84E-04	850	NA	NA	0.07973369044	677	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	764
DDR2	discoidin domain receptor tyrosine kinase 2	Yes	Yes		ENSG00000162733	Q16832	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	15	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P02452, P02458, P02461, P02462, P05997, P08123, P08572, P12931, P20908, P25940, P29400, P53420, Q01955, Q14031	COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL5A3, SRC	SRC [HPRD:11884411;HPRD:16186108;KEA:11884411;KEA:16186108;PhosphoSite:11884411;PhosphoSite:16186108;ProtMapper:16186108;ProtMapper:28270508;SIGNOR:16186108;dbPTM:18083107;iPTMnet:11884411;iPTMnet:16186108], COL1A1 [Baccin2019:12611880;Baccin2019:9659899;CellTalkDB:12611880;Cellinker:12611880;Cellinker:9659899;HPMR:12611880;HPRD:9659899;LRdb:12611880;LRdb:97;connectomeDB2020:12611880;connectomeDB2020:9659899], COL3A1 [Baccin2019:9659899;CellTalkDB:9659899;Cellinker:9659899;Cellinker:9659900;HPRD:9659899;LRdb:9659899;connectomeDB2020:9659899], COL4A4 [Cellinker:9659900], COL1A2 [Cellinker:9659900], COL5A1 [Cellinker:9659900], COL4A2 [Cellinker:9659900], COL4A3 [Cellinker:9659900], COL2A1 [Cellinker:9659900], COL5A3 [Cellinker:9659900], COL4A5 [Cellinker:9659900], COL4A1 [Cellinker:9659900], COL4A6 [Cellinker:9659900], COL5A2 [Cellinker:9659900]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte proliferation [GO:0035988]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; collagen fibril organization [GO:0030199]; endochondral bone growth [GO:0003416]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DDR2&keywords=DDR2	6.236480524	205	NA	NA	0.2377368129	496	0	0.0124750499	0.01327433628	0.4908872902	0.005050505051	0.05414551607	0.04442429737	0.01141924959	0.01923788383	0.03037788757	0.009658103149	182	153	208	0.06281364718	0.4015440095	0.5545373585	0.2699782789	334	279	364	283
F2RL1	F2R like trypsin receptor 1	Yes	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000164251	P55085	G-protein coupled receptor 1 family	15	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P00734, P00747, P07384, P07477, P07478, P08246, P08311, P12544, P17655, P20231, P24158, P35030, P49407, Q15661, Q92905	ARRB1, CAPN1, CAPN2, COPS5, CTSG, ELANE, F2, GZMA, PLG, PRSS1, PRSS2, PRSS3, PRTN3, TPSAB1, TPSB2	PRSS1 [CA1:9349532;SIGNOR:10978167], ARRB1 [CA1:10725339], CAPN2 [HPRD:10978167;SIGNOR:10978167], PRTN3 [HPRD:10978167;SIGNOR:10978167], F2 [Baccin2019:1135698510978160;CellTalkDB:11356985;Cellinker:11356985;HPMR:11356985;HPRD:10978167;LRdb:11;LRdb:11356985;SIGNOR:11356985;connectomeDB2020:10978167;connectomeDB2020:11356985], CAPN1 [HPRD:10978167;SIGNOR:10978167], PRSS2 [SIGNOR:10978167], ELANE [HPRD:10978167;SIGNOR:10978167], CTSG [HPRD:10978167;SIGNOR:10978167], PRSS3 [SIGNOR:10978167], TPSAB1 [Cellinker:9020112;SIGNOR:21999702], PLG [Baccin2019:10978167;Baccin2019:12604689;Baccin2019:9020112;CellTalkDB:12604689;Cellinker:10978167;Cellinker:12604689;Cellinker:9020112;HPRD-phos:10978167;HPRD-phos:12604689;HPRD-phos:9020112;HPRD:10978167;HPRD:12604689;HPRD:9020112;LRdb:10978167;LRdb:12604689;LRdb:9020112;connectomeDB2020:10978167;connectomeDB2020:12604689;connectomeDB2020:9020112], GZMA [NA], TPSB2 [Cellinker:9020112], COPS5 [HPRD:16410250;IntAct:16410250;Lit-BM-17:16410250]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057]	blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; defense response to virus [GO:0051607]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; leukocyte proliferation [GO:0070661]; mature conventional dendritic cell differentiation [GO:0097029]; negative regulation of chemokine production [GO:0032682]; negative regulation of JNK cascade [GO:0046329]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neutrophil activation [GO:0042119]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070963]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of blood coagulation [GO:0030193]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of JNK cascade [GO:0046328]; T cell activation involved in immune response [GO:0002286]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=F2RL1&keywords=F2RL1	41.6419671	52	NA	NA	7.223522613	29	0	0.3288423154	0.03318584071	0.06450839329	0.1784511785	0.02707275804	0.05439709882	0.05383360522	0.02071772105	0.01528909067	0.04964265018	179	184	102	0.0750855138	0.3610217495	0.2972196974	0.7009730273	353	362	197	157
GFRA2	GDNF family receptor alpha 2	Yes	TBD		ENSG00000168546	O00451	GDNFR family	15	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_peripheral, receptor, transmembrane	O60542, P07949, P39905, Q5T4W7, Q99748	ARTN, GDNF, NRTN, PSPN, RET	GDNF [Baccin2019:91828039407096;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9407096;HPRD:9407096;LRdb:9182803;LRdb:941;SIGNOR:9192898;connectomeDB2020:9182803;connectomeDB2020:9407096], PSPN [CellTalkDB:32196115], NRTN [Baccin2019:918280310829012;CellTalkDB:9182803;Cellinker:10829012;Cellinker:11544105;Cellinker:9182803;HPMR:9182803;HPMR:9192898;HPRD:10829012;LRdb:108;LRdb:9182803;connectomeDB2020:10829012;connectomeDB2020:9182803], ARTN [CellTalkDB:32196115;Cellinker:9883723], RET [Cellinker:9883723]	anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]	nervous system development [GO:0007399]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFRA2&keywords=GFRA2	0.1366237306	584	NA	NA	0.0521058959	731	0.02362204724	0	0	0.009112709832	0	0	0.002719854941	0	0	6.01E-04	0.007378790805	234	326	223	0.003948571283	0.7169193028	0.7599976426	1.245919059	221	212	39	463
IL22RA2	interleukin 22 receptor subunit alpha 2	Yes	TBD		ENSG00000164485	Q969J5	Type II cytokine receptor family	15	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	Q9GZX6	IL22	IL22 [Baccin2019:1139045311390450;CellTalkDB:11390453;Cellinker:11390453;HPMR:11390453;HPRD:11390453;ICELLNET:15032600;InnateDB:19193995;InnateDB:19285080;LRdb:11390453;Lit-BM-17:11390453;Lit-BM-17:15120653;Lit-BM-17:18599299;Lit-BM-17:19285080;SIGNOR:11390453;connectomeDB2020:11390453]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	cytokine receptor activity [GO:0004896]; interleukin-22 binding [GO:0042017]; interleukin-22 receptor activity [GO:0042018]	cytokine-mediated signaling pathway [GO:0019221]; negative regulation of inflammatory response [GO:0050728]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL22RA2&keywords=IL22RA2	4.28E-04	852	NA	NA	0.3608336712	419	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	636
MCHR2	melanin concentrating hormone receptor 2	Yes	TBD		ENSG00000152034	Q969V1	G-protein coupled receptor 1 family	15	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P20382	PMCH	PMCH [CellTalkDB:11416225;Cellinker:10471841;Cellinker:11274220;Cellinker:11404457;Cellinker:11416225;Cellinker:11478907;Cellinker:11839762;Guide2Pharma:11404457;HPMR:10471841;HPRD:11274220;HPRD:11404457;HPRD:11416225;HPRD:11478907;HPRD:11839762;LRdb:10471841;LRdb:11274220;LRdb:11404457;LRdb:11416225;LRdb:11478907;LRdb:11839762;SIGNOR:10471841;connectomeDB2020:10471841;connectomeDB2020:11274220;connectomeDB2020:11404457;connectomeDB2020:11416225;connectomeDB2020:11478907;connectomeDB2020:11839762;scConnect:11404457]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MCHR2&keywords=MCHR2	0.01900812135	743	NA	NA	0.133130572	596	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	670
MLNR	motilin receptor	Yes	TBD		ENSG00000102539	O43193	G-protein coupled receptor 1 family	15	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P12872, Q9UBU3	GHRL, MLN	MLN [CellTalkDB:10381885;Cellinker:10381885;Cellinker:11259768;Cellinker:11461914;Cellinker:11781320;Cellinker:12054506;Cellinker:15677347;Cellinker:16531413;Guide2Pharma:11461914;Guide2Pharma:11781320;Guide2Pharma:15677347;Guide2Pharma:16531413;HPMR:10381885;HPRD:10381885;HPRD:11259768;HPRD:11461914;HPRD:12054506;LRdb:10381885;LRdb:11259768;LRdb:11461914;LRdb:11781320;LRdb:12054506;LRdb:15677347;LRdb:16531413;SIGNOR:10381885;connectomeDB2020:10381885;connectomeDB2020:11259768;connectomeDB2020:11461914;connectomeDB2020:11781320;connectomeDB2020:12054506;connectomeDB2020:15677347;connectomeDB2020:16531413;scConnect:11461914;scConnect:11781320;scConnect:15677347;scConnect:16531413], GHRL [CellTalkDB:12606621;Cellinker:12606621;HPRD:12606621;LRdb:12606621;connectomeDB2020:12606621]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MLNR&keywords=MLNR	0.1293474034	589	NA	NA	1.864150353	131	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	360
NPBWR1	neuropeptides B and W receptor 1	Yes	TBD		ENSG00000288611	P48145	G-protein coupled receptor 1 family	15	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q8N729, Q8NG41	NPB, NPW	NPB [Baccin2019:12118011;Baccin2019:12401809;CellTalkDB:12401809;Guide2Pharma:12118011;Guide2Pharma:12401809;HPMR:12401809;HPRD:12118011;HPRD:12401809;LRdb:12;LRdb:12401809;connectomeDB2020:12118011;connectomeDB2020:12401809;scConnect:12118011;scConnect:12401809], NPW [CellTalkDB:12130646;Guide2Pharma:12130646;HPRD:12130646;HPRD:12401809;LRdb:12130646;LRdb:12401809;connectomeDB2020:12130646;connectomeDB2020:12401809;scConnect:12130646]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]	chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of metabolic process [GO:0019222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPBWR1&keywords=NPBWR1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
NPFFR1	neuropeptide FF receptor 1	Yes	No		ENSG00000148734	Q9GZQ6	G-protein coupled receptor 1 family	15	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15130, Q9HCQ7	NPFF, NPVF	NPFF [CellTalkDB:11024015;Cellinker:11024015;Cellinker:12242085;Cellinker:12421602;Cellinker:17011599;Guide2Pharma:12242085;Guide2Pharma:12421602;Guide2Pharma:17011599;HPRD:11024015;LRdb:11024015;LRdb:12242085;LRdb:12421602;LRdb:17011599;SIGNOR:11024015;connectomeDB2020:11024015;connectomeDB2020:12242085;connectomeDB2020:12421602;connectomeDB2020:17011599;scConnect:12242085;scConnect:12421602;scConnect:17011599], NPVF [CellChatDB:29106375;CellTalkDB:11024015;Cellinker:11024015;Cellinker:12242085;Cellinker:12421602;Cellinker:17337079;Cellinker:29106375;Guide2Pharma:12242085;Guide2Pharma:12421602;Guide2Pharma:17337079;HPMR:11024015;LRdb:11024015;LRdb:12242085;LRdb:12421602;LRdb:17337079;connectomeDB2020:11024015;connectomeDB2020:12242085;connectomeDB2020:12421602;connectomeDB2020:17337079;scConnect:12242085;scConnect:12421602;scConnect:17337079]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPFFR1&keywords=NPFFR1	0.04531871135	684	NA	NA	0.0681473222	695	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	690
NPFFR2	neuropeptide FF receptor 2	Yes	TBD	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000056291	Q9Y5X5	G-protein coupled receptor 1 family	15	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O15130, O43612, P01303, P25098, Q9HCQ7	GRK2, HCRT, NPFF, NPVF, NPY	NPFF [Baccin2019:10851242;Baccin2019:11024015;Baccin2019:11325787;Baccin2019:12421602;Baccin2019:12609745;CellTalkDB:11024015;Cellinker:10851242;Cellinker:11024015;Cellinker:11325787;Cellinker:12421602;Cellinker:12609745;Guide2Pharma:11325787;Guide2Pharma:12421602;HPMR:11024015;HPRD:10851242;HPRD:12609745;LRdb:10851242;LRdb:11024015;LRdb:11325787;LRdb:12421602;LRdb:12609745;SIGNOR:11024015;connectomeDB2020:10851242;connectomeDB2020:11024015;connectomeDB2020:11325787;connectomeDB2020:12421602;connectomeDB2020:12609745;scConnect:11325787;scConnect:12421602], NPVF [Baccin2019:12242085;Baccin2019:12421602;CellChatDB:29106375;CellTalkDB:12242085;Cellinker:12242085;Cellinker:12421602;Cellinker:29106375;LRdb:12;LRdb:12242085;connectomeDB2020:12242085;connectomeDB2020:12421602;scConnect:12242085;scConnect:12421602], HCRT [Baccin2019:12609745;CellTalkDB:12609745;Cellinker:12609745;HPRD:12609745;LRdb:12609745;connectomeDB2020:12609745], NPY [Baccin2019:12609745;CellTalkDB:11325787;Cellinker:12609745;HPRD:12609745;LRdb:12609745;connectomeDB2020:12609745], GRK2 [PhosphoSite:25326382]	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]	detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPFFR2&keywords=NPFFR2	0.3096116515	498	NA	NA	3.572160105	63	0	0.001996007984	0.00110619469	7.19E-04	0	0	0	0.1386623165	0.001479837218	1.34E-04	0.001004442727	230	342	312	0.01319106843	0.4950111398	0.4369582715	0.4745121063	307	311	282	304
NPY4R	neuropeptide Y receptor Y4	Yes	TBD		ENSG00000204174	P50391	G-protein coupled receptor 1 family	15	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01298, P01303, P10082	NPY, PPY, PYY	NPY [CellTalkDB:7592911;Cellinker:7493937;Cellinker:7592911;Guide2Pharma:7493937;HPMR:7592911;HPRD:7493937;LRdb:749;LRdb:7592911;SIGNOR:7592911;connectomeDB2020:7493937;connectomeDB2020:7592911;scConnect:7493937], PPY [CellTalkDB:18767100;Cellinker:16807358;Cellinker:7493937;Cellinker:7592911;Cellinker:8643460;Guide2Pharma:16807358;Guide2Pharma:7493937;Guide2Pharma:7592911;Guide2Pharma:8643460;HPRD:7493937;LRdb:16807358;LRdb:7493937;LRdb:7592911;LRdb:8643460;SIGNOR:7592911;connectomeDB2020:16807358;connectomeDB2020:7493937;connectomeDB2020:7592911;connectomeDB2020:8643460;scConnect:16807358;scConnect:7493937;scConnect:7592911;scConnect:8643460], PYY [CellTalkDB:7592911;Cellinker:7493937;Cellinker:7592911;Guide2Pharma:7493937;HPRD:7493937;LRdb:749;LRdb:7592911;SIGNOR:7592911;connectomeDB2020:7493937;connectomeDB2020:7592911;scConnect:7493937]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; pancreatic polypeptide receptor activity [GO:0001602]; peptide hormone binding [GO:0017046]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPY4R&keywords=NPY4R	0.03590674393	701	NA	NA	0.5169657348	363	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	532
ROBO1	roundabout guidance receptor 1	Yes			ENSG00000169855	Q9Y6N7	Immunoglobulin superfamily, ROBO family	15	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O75093, O75094, O94813, O95866, P00519, P13591	ABL1, MPIG6B, NCAM1, SLIT1, SLIT2, SLIT3	ABL1 [HPRD:10892742;PhosphoSite:10892742;ProtMapper:10892742;SIGNOR:10892742;SPIKE:17618275;SPIKE:20841568;dbPTM:10892742;iPTMnet:10892742], SLIT1 [Baccin2019:1043382210433820;Cellinker:10433822;HPMR:10433822;HPMR:14761655;HPRD:10433822;ICELLNET:21600986;LRdb:10433822;connectomeDB2020:10433822], SLIT3 [CellTalkDB:30288875;connectomeDB2020:19741192], NCAM1 [Baccin2019:16226035;CellTalkDB:16226035;Cellinker:16226035;HPMR:16226035;LRdb:16226035;connectomeDB2020:16226035], SLIT2 [Baccin2019:1010226810102260;CellTalkDB:10102268;Cellinker:10102268;Cellinker:31217826;DIP:17848514;HPRD:10102268;LRdb:10102268;Lit-BM-17:17848514;connectomeDB2020:10102268], MPIG6B [Cellinker:32822567]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROBO1&keywords=ROBO1	21.52555175	97	NA	NA	2.335066055	101	0	0.0244510978	0.06637168142	0.1134292566	0.02693602694	0.1641285956	0.1577515866	0.05546492659	0.04661487236	0.160535452	0.01583928916	129	54	172	0.07559298046	0.6614429368	1.992399973	0.3018856105	240	19	352	68
ROBO2	roundabout guidance receptor 2	Yes	No		ENSG00000185008	Q9HCK4	Immunoglobulin superfamily, ROBO family	15	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O75093, O75094, O94813, O95897	OLFM2, SLIT1, SLIT2, SLIT3	SLIT1 [Cellinker:21600986;ICELLNET:21600986;connectomeDB2020:30547091], OLFM2 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070], SLIT3 [Baccin2019:11754167;CellTalkDB:11754167;Cellinker:11754167;HPRD:11754167;LRdb:11754167;connectomeDB2020:31180321], SLIT2 [Baccin2019:1513049510102260;CellTalkDB:15130495;Cellinker:10102268;Cellinker:15130495;Cellinker:29317497;Cellinker:31217826;HPMR:14761655;HPMR:15130495;HPRD:10102268;LRdb:1;LRdb:15130495;connectomeDB2020:10102268;connectomeDB2020:15130495]	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon guidance receptor activity [GO:0008046]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]	aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROBO2&keywords=ROBO2	19.9455479	106	NA	NA	15.73997019	10	0	0.03592814371	0.00110619469	0.00551558753	0.04208754209	0.4060913706	0.4397098821	0.04078303426	0.01997780244	0.3989851783	0.05837357543	181	19	88	0.1316871192	0.2115774716	2.886537468	0.4825673344	396	3	277	35
TGFBR3	transforming growth factor beta receptor 3	Yes	Yes		ENSG00000069702	Q03167	NA	15	ligand, receptor	cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01137, P05111, P05230, P08476, P10600, P27037, P36897, P37173, P61812	ACVR2A, FGF1, INHA, INHBA, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2	TGFB1 [Baccin2019:7935686;CellTalkDB:7935686;Cellinker:7935686;DIP:10519421;DIP:11323414;DIP:9312157;HPRD:7935686;LRdb:7935686;Lit-BM-17:10519421;Lit-BM-17:11323414;Lit-BM-17:8106553;Lit-BM-17:9312157;NetPath:11278442;NetPath:11323414;SPIKE:11278442;SPIKE:8106553;connectomeDB2020:7935686], TGFB2 [Baccin2019:11157750;Baccin2019:12809600;CellTalkDB:12809600;Cellinker:11157754;Cellinker:12809600;DIP:10519421;DIP:8041735;DIP:9312157;HPMR:12809600;HPRD:11157754;LRdb:11;LRdb:12809600;NetPath:11278442;SIGNOR:10746731;connectomeDB2020:11157754;connectomeDB2020:12809600], TGFB3 [Baccin2019:11382746;CancerCellMap:11382746;CellTalkDB:11382746;Cellinker:11382746;HPRD:11382746;LRdb:11382746;NetPath:11382746;connectomeDB2020:11382746], INHA [Baccin2019:1249374210746730;CellTalkDB:12493742;Cellinker:10746731;Cellinker:12493742;HPRD:10746731;LRdb:11;LRdb:12493742;SIGNOR:10746731;connectomeDB2020:10746731;connectomeDB2020:12493742], FGF1 [CellTalkDB:32103204], INHBA [Baccin2019:10746731;CellTalkDB:10746731;Cellinker:10746731;HPRD:10746731;LRdb:10746731;connectomeDB2020:10746731], TGFBR1 [NetPath:11323414;PhosphoSite:22427868], TGFBR2 [CancerCellMap:11323414;CancerCellMap:12958365;DIP:11323414;HPRD:11323414;Lit-BM-17:11323414;Lit-BM-17:8106553;NetPath:11323414;iPTMnet:11323414;iPTMnet:12958365], ACVR2A [HPRD:10746731]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]	animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFBR3&keywords=TGFBR3	32.28265368	67	4454.92	40	1.141650251	209	0.007874015748	0.05738522954	0.004424778761	0.1007194245	0.1144781145	0.2436548223	0.2429737081	0.01305057096	0.0739918609	0.2237615169	0.003631446784	101	39	254	0.09872231718	0.7725356033	2.150078502	0.1253785528	200	13	421	74
TNFRSF10C	TNF receptor superfamily member 10c	Yes	Yes		ENSG00000173535	O14798	NA	15	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, receptor, transmembrane	P04637, P50591	TNFSF10, TP53	TNFSF10 [CellTalkDB:9314565;Cellinker:9314565;Cellinker:9325248;Cellinker:9613612;HPMR:9325248;HPRD:9314565;HPRD:9325248;HPRD:9613612;ICELLNET:11239407;LRdb:9314565;LRdb:9325248;LRdb:9613612;Lit-BM-17:20103630;Lit-BM-17:9325248;SPIKE:9082980;SPIKE:9314565;connectomeDB2020:9314565;connectomeDB2020:9325248;connectomeDB2020:9613612], TP53 [SPIKE:10435597;SPIKE:10933923;SPIKE:14623878;SPIKE:18431400]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886]	TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]	positive regulation of apoptotic process [GO:0043065]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF10C&keywords=TNFRSF10C	2.494676263	290	NA	NA	0.5011890417	368	0	9.98E-04	0	4.80E-04	0	0.001692047377	9.07E-04	0.004893964111	0.006289308176	0.003104553345	0.004210932973	213	260	248	0.002052276781	1.351554438	1.087309359	1.179107751	50	101	46	255
MRGPRX1	MAS related GPR family member X1	Yes	No		ENSG00000170255	Q96LB2	G-protein coupled receptor 1 family, Mas subfamily	15	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01210	PENK	PENK [CellTalkDB:15163697;Cellinker:11850634;Cellinker:15163697;Cellinker:23396314;Guide2Pharma:11850634;Guide2Pharma:15163697;Guide2Pharma:23396314;LRdb:11850634;LRdb:15163697;LRdb:23396314;connectomeDB2020:11850634;connectomeDB2020:15163697;connectomeDB2020:23396314;scConnect:11850634;scConnect:15163697;scConnect:23396314]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]	acute-phase response [GO:0006953]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; response to chloroquine [GO:1902349]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MRGPRX1&keywords=MRGPRX1	0	862	NA	NA	0.9357088324	252	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	557
TNFRSF21	TNF receptor superfamily member 21	Yes			ENSG00000146072	O75509	NA	15	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O95866, P01375, P05067, Q6UXB8	APP, APP_BACE1, MPIG6B, PI16, TNF	TNF [Baccin2019:9714541;CellTalkDB:9714541;Cellinker:9714541;HPMR:9714541;LRdb:9714541;SIGNOR:9714541;connectomeDB2020:9714541], APP [CellTalkDB:19225519;Cellinker:19225519;DIP:19225519;LRdb:19225519;Lit-BM-17:19225519;Ramilowski2015:19225519;connectomeDB2020:19225519;talklr:19225519], MPIG6B [Cellinker:32822567], PI16 [Cellinker:32589946]	axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	NA	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF21&keywords=TNFRSF21	131.9093169	11	NA	NA	6.094682752	37	0.07086614173	0.5953093812	0.008849557522	0.07913669065	0.1868686869	0.3807106599	0.30643699	0.1843393148	0.2449130596	0.2089731606	0.1875603631	31	43	45	0.2230876369	1.093636123	0.9394456245	0.8475797591	89	151	138	61
NRP1	neuropilin 1	Yes			ENSG00000099250	O14786	Neuropilin family	15	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, secreted, transmembrane	O00300, O15041, O95025, P01024, P01133, P05230, P08581, P08620, P09038, P0C0L4, P11362, P14210, P15692, P17948, P21781, P32004, P35968, P49763, P49765, Q02246, Q13214, Q13275, Q13740, Q14563, Q99985, Q9H3S1	ALCAM, C3, C4A, CNTN2, EGF, FGF1, FGF2, FGF4, FGF7, FGFR1, FLT1, HGF, KDR, L1CAM, MET, PGF, SEMA3A, SEMA3B, SEMA3C, SEMA3D, SEMA3E, SEMA3F, SEMA4A, TNFRSF11B, VEGFA, VEGFB	SEMA3A [Baccin2019:10520994;Baccin2019:15721238;Baccin2019:9331348;CellTalkDB:10520994;DIP:10498602;HPMR:10520994;HPMR:15121181;HPMR:15721238;HPMR:15814794;HPRD:10520994;HPRD:9331348;ICELLNET:29067024;LRdb:10520994;LRdb:15721238;LRdb:9331348;SIGNOR:10196546;SIGNOR:25335892;connectomeDB2020:10520994;connectomeDB2020:15721238;connectomeDB2020:9331348], SEMA3B [Baccin2019:10196540;Baccin2019:10196546;CellTalkDB:10196546;HPRD:10196546;LRdb:10196546;SIGNOR:25335892;connectomeDB2020:10196546], SEMA4A [CellTalkDB:23913274;ICELLNET:23913274], VEGFA [Baccin2019:10409677;Baccin2019:11986311;Baccin2019:15637071;Baccin2019:16763549;Baccin2019:17222790;Baccin2019:9529250;BioGRID:11986311;BioGRID:20363638;CellTalkDB:11986311;Cellinker:10409677;Cellinker:11986311;Cellinker:15637071;Cellinker:16763549;Cellinker:17222790;Cellinker:9529250;DIP:10498602;DIP:11333271;DIP:9712843;HPRD:10409677;HPRD:11986311;HPRD:16763549;HPRD:17222790;HPRD:9529250;ICELLNET:11181169;ICELLNET:21653826;IntAct:16763549;IntAct:17222790;LRdb:10409677;LRdb:11986311;LRdb:15637071;LRdb:16763549;LRdb:17222790;LRdb:9529250;Lit-BM-17:10498602;Lit-BM-17:11333271;Lit-BM-17:11986311;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:17222790;Lit-BM-17:18325345;Lit-BM-17:20363638;Lit-BM-17:21939755;Lit-BM-17:22318724;Lit-BM-17:22897854;Lit-BM-17:9529250;Lit-BM-17:9712843;connectomeDB2020:10409677;connectomeDB2020:11986311;connectomeDB2020:15637071;connectomeDB2020:16763549;connectomeDB2020:17222790;connectomeDB2020:9529250], VEGFB [Baccin2019:40967710409677;CellTalkDB:10409677;Cellinker:10409677;Cellinker:409677;HPRD:10409677;ICELLNET:11181169;LRdb:1041;LRdb:409677;connectomeDB2020:10409677;connectomeDB2020:409677], PGF [Baccin2019:1198631111986310;CellTalkDB:11986311;Cellinker:11986311;HPRD:11986311;ICELLNET:9712843;LRdb:11986311;connectomeDB2020:11986311], SEMA3F [Baccin2019:9883722;CellTalkDB:9883722;Cellinker:26633812;Cellinker:9883722;ELM:20387901;HPRD:9883722;LRdb:9883722;connectomeDB2020:9883722], FGF4 [Baccin2019:15695515;CellTalkDB:16597617;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], HGF [CellTalkDB:18065694], FGF2 [Baccin2019:15695515;CellTalkDB:15695515;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], EGF [CellTalkDB:24556756], SEMA3C [Baccin2019:9331348;CellTalkDB:9331348;HPRD:9331348;LRdb:9331348;connectomeDB2020:9331348], SEMA3D [Baccin2019:27439112;CellTalkDB:15456815;LRdb:15456815;Ramilowski2015:15456815;connectomeDB2020:15456815;talklr:15456815], SEMA3E [Baccin2019:27439112;CellTalkDB:20664165;Cellinker:20664165], FGF1 [Baccin2019:15695515;CellTalkDB:15695515;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], CNTN2 [CellTalkDB:22836270], FGF7 [Baccin2019:15695515;CellTalkDB:16597617;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], ALCAM [connectomeDB2020:31300520], C3 [connectomeDB2020:31572401], C4A [connectomeDB2020:31572401], FLT1 [Cellinker:32589946;HPRD:10842181], MET [Cellinker:28536399], TNFRSF11B [Cellinker:32589946], L1CAM [BioGRID:16377081;HPMR:10520994;HPMR:15121181], KDR [BioGRID:11948691;BioGRID:19857463;BioGRID:26037503;HPRD:11333271;HPRD:16763549;HPRD:17222790], FGFR1 [HPRD:15695515]	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; mitochondrial membrane [GO:0031966]; neurofilament [GO:0005883]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; semaphorin receptor complex [GO:0002116]; sorting endosome [GO:0097443]	coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; GTPase activator activity [GO:0005096]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; artery morphogenesis [GO:0048844]; axonal fasciculation [GO:0007413]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; basal dendrite development [GO:0150018]; branching involved in blood vessel morphogenesis [GO:0001569]; branchiomotor neuron axon guidance [GO:0021785]; cell-cell signaling [GO:0007267]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; dorsal root ganglion morphogenesis [GO:1904835]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; endothelial tip cell fate specification [GO:0097102]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; integrin-mediated signaling pathway [GO:0007229]; motor neuron migration [GO:0097475]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; neuropilin signaling pathway [GO:0038189]; otic placode development [GO:1905040]; outflow tract septum morphogenesis [GO:0003148]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytokine activity [GO:0060301]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynapse organization [GO:0099173]; protein localization to early endosome [GO:1902946]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of vesicle-mediated transport [GO:0060627]; renal artery morphogenesis [GO:0061441]; retinal ganglion cell axon guidance [GO:0031290]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; toxin transport [GO:1901998]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; VEGF-activated neuropilin signaling pathway [GO:0038190]; VEGF-activated neuropilin signaling pathway involved in axon guidance [GO:1902378]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRP1&keywords=NRP1	69.38980403	33	1131.65	77	3.881435021	60	0.4724409449	0.4161676647	0.6061946903	0.6131894484	0.05218855219	0.2165820643	0.274705349	0.1794453507	0.123936367	0.1375350514	0.1337840448	64	65	52	0.2932881389	0.4416142599	0.4864517681	0.4740839696	320	298	283	107
NRP2	neuropilin 2	Yes	No		ENSG00000118257	O60462	Neuropilin family	15	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, secreted, transmembrane, transmembrane_predicted	O14511, O15041, O43915, O95754, P15692, P17948, P35916, P49763, P49767, P49788, Q13214, Q13275, Q14563, Q99985, Q9NS98	FLT1, FLT4, NRG2, PGF, RARRES1, SEMA3A, SEMA3B, SEMA3C, SEMA3E, SEMA3F, SEMA3G, SEMA4F, VEGFA, VEGFC, VEGFD	SEMA3C [Baccin2019:10196546;Baccin2019:9331348;CellTalkDB:10196546;HPMR:10196546;HPRD:9331348;ICELLNET:29067024;LRdb:10196546;LRdb:93;SIGNOR:16816121;connectomeDB2020:10196546;connectomeDB2020:9331348], VEGFC [Baccin2019:8612600;CellTalkDB:8612600;Cellinker:8612600;ELM:25752543;ICELLNET:16621967;LRdb:8612600;SIGNOR:16816121;connectomeDB2020:8612600], SEMA3B [Baccin2019:10196546;CellTalkDB:10196546;HPRD:10196546;LRdb:10196546;SIGNOR:25335892;connectomeDB2020:10196546], SEMA3F [Baccin2019:15721238;Baccin2019:9883722;CellTalkDB:15721238;ELM:20387901;HPMR:15721238;HPRD:9883722;ICELLNET:25068647;ICELLNET:29067024;LRdb:15721238;LRdb:99;SIGNOR:16816121;connectomeDB2020:15721238;connectomeDB2020:9883722], VEGFA [Baccin2019:10748121;CellTalkDB:10748121;Cellinker:10748121;DIP:10748121;ELM:26991001;HPRD:10748121;ICELLNET:11181169;LRdb:10748121;connectomeDB2020:10748121], PGF [CellTalkDB:10748121;Cellinker:10748121;HPRD:10748121;ICELLNET:12613545;LRdb:10748121;connectomeDB2020:10748121], SEMA3G [Baccin2019:27439112;CellTalkDB:19887479;LRdb:19887479;Ramilowski2015:19887479;connectomeDB2020:19887479;talklr:19887479], SEMA3A [CellTalkDB:21059704;Cellinker:26633812;LRdb:21059704;Ramilowski2015:21059704;connectomeDB2020:21059704;talklr:21059704], VEGFD [CellTalkDB:16816121;Cellinker:16816121;Cellinker:9435229;connectomeDB2020:16816121;connectomeDB2020:9435229], SEMA4F [Baccin2019:9856463;CellTalkDB:9856463;Cellinker:9856463;HPRD:9856463;LRdb:9856463], SEMA3E [Cellinker:20664165], FLT4 [Cellinker:32589946], NRG2 [Cellinker:32589946], RARRES1 [Cellinker:32589946], FLT1 [HPRD:11278319]	axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRP2&keywords=NRP2	18.07795388	112	NA	NA	1.294446988	186	0.811023622	0.04341317365	3.013274336	1.657314149	0.01178451178	0.1353637902	0.109700816	0.1680261011	0.1098779134	0.06556282548	0.1028781147	75	110	62	0.5662017594	0.2080485029	0.1311395258	0.1959003299	398	413	396	205
PLAUR	plasminogen activator, urokinase receptor	Yes	Yes		ENSG00000011422	Q03405	NA	15	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P00747, P00749, P01042, P02671, P02751, P04004, P05121, P06241, P07948, P08631, P09769, P23458, P29597, P34820, P39900, Q9HBL7, Q9NZR2	BMP8B, FGA, FGR, FN1, FYN, HCK, JAK1, KNG1, LRP1B, LYN, MMP12, PLAU, PLG, PLGRKT, SERPINE1, TYK2, VTN	PLAU [Baccin2019:11501527;Baccin2019:16456079;Baccin2019:3023326;Baccin2019:3031025;BioGRID:11501527;BioGRID:16879932;BioGRID:19017363;CellTalkDB:16456079;Cellinker:11501527;Cellinker:16456079;Cellinker:3023326;Cellinker:3031025;DIP:18376415;HPMR:16456079;HPRD:11501527;HPRD:3023326;HPRD:3031025;ICELLNET:11501527;LRdb:11501527;LRdb:16456079;LRdb:3023326;LRdb:3031025;SIGNOR:16456079;connectomeDB2020:11501527;connectomeDB2020:16456079;connectomeDB2020:3023326;connectomeDB2020:3031025], LYN [Adhesome:9417082;DIP:9417082;InnateDB:9417082], FYN [Adhesome:9417082;HPRD:9417082], SERPINE1 [CellTalkDB:10896774], VTN [Baccin2019:8830783;CellTalkDB:8830783;Cellinker:8830783;HPRD:8830783;LRdb:8830783;connectomeDB2020:8830783], KNG1 [CellTalkDB:14764580;Cellinker:14764580;HPRD:14764580;LRdb:14764580;connectomeDB2020:14764580], FGA [CellTalkDB:32196115], PLG [CellTalkDB:10092105], MMP12 [Baccin2019:12195704;CellTalkDB:12195704;Cellinker:12195704;HPRD-phos:12195704;HPRD:12195704;LRdb:12195704;connectomeDB2020:12195704], FN1 [CellTalkDB:2413022;Cellinker:2413022;LRdb:2413022;Ramilowski2015:2413022;connectomeDB2020:2413022;talklr:2413022], BMP8B [CellTalkDB:32103204], LRP1B [Baccin2019:11384978;Baccin2019:12194987;Cellinker:11384978;Cellinker:12194987;HPRD:11384978;HPRD:12194987;LRdb:11384978;LRdb:12], PLGRKT [Cellinker:19897580], TYK2 [DIP:9417082;HPRD:9974409;MPPI:9974409], JAK1 [DIP:9417082;HPRD:9417082;MPPI:9974409], HCK [DIP:9417082;HPRD:11097855], FGR [DIP:9417082]	anchored component of membrane [GO:0031225]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579]	enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; urokinase plasminogen activator receptor activity [GO:0030377]	blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of cell adhesion [GO:0030155]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLAUR&keywords=PLAUR	39.60087816	56	NA	NA	4.182386572	52	3.05511811	1.304391218	0.1139380531	1.999040767	0.569023569	0.09644670051	0.06436990027	0.05872756933	0.08620051794	0.01719188143	0.1551864014	90	180	49	0.6836031535	0.1386967713	0.03920380305	0.2381569354	424	449	377	184
DCC	DCC netrin 1 receptor	Yes	Yes		ENSG00000187323	P43146	Immunoglobulin superfamily, DCC family	14	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O60469, O94813, O95631, P05067, P06241, P16333, P27361, P42574, Q00887, Q05397, Q13046, Q8NBI3, Q8WX77, Q9HB63, Q9UKG1	APP, APPL1, CASP3, DRAXIN, DSCAM, FYN, IGFBPL1, MAPK3, NCK1, NTN1, NTN4, PSG7, PSG9, PTK2, SLIT2	NTN1 [Baccin2019:10399920;Baccin2019:12810718;Baccin2019:8861902;Baccin2019:9950216;BioGRID:12810718;BioGRID:9950216;CellTalkDB:8861902;Cellinker:10399920;Cellinker:12810718;Cellinker:8861902;Cellinker:9950216;DIP:19721007;HPMR:11239160;HPMR:12810718;HPMR:8861902;HPRD:12810718;HPRD:9950216;IntAct:19721007;IntAct:26190107;LRdb:10399920;LRdb:12810718;LRdb:8861902;LRdb:9950216;connectomeDB2020:10399920;connectomeDB2020:12810718;connectomeDB2020:8861902;connectomeDB2020:9950216], APP [CellTalkDB:22782894], DRAXIN [CellTalkDB:29503192;Cellinker:29503192], NTN4 [Baccin2019:17174565;CellTalkDB:17174565;Cellinker:17174565;DIP:19721007;LRdb:17174565;connectomeDB2020:17174565], DSCAM [CellTalkDB:19196994], SLIT2 [CellTalkDB:32196115], PSG9 [Cellinker:32822567], IGFBPL1 [Cellinker:32822567], PSG7 [Cellinker:32822567], FYN [ProtMapper:15557120;ProtMapper:21849478;iPTMnet:15557120], MAPK3 [BioGRID:11986622;HPRD:11986622], PTK2 [HPRD:15494733;Lit-BM-17:15494733;Lit-BM-17:20434207], CASP3 [HPRD:11248093;Lit-BM-17:11248093], APPL1 [HPRD:12011067;Lit-BM-17:12011067], NCK1 [HPRD:12149262]	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	netrin receptor activity [GO:0005042]; transmembrane signaling receptor activity [GO:0004888]	anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron projection development [GO:0010977]; neuron migration [GO:0001764]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of neuron death [GO:1901214]; spinal cord ventral commissure morphogenesis [GO:0021965]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DCC&keywords=DCC	3.843435306	249	NA	NA	7.638304565	27	0	0.003493013972	0	0.002637889688	0	0.01015228426	0.03263825929	0.05546492659	0.001109877913	9.35E-04	0.05342862662	231	319	98	0.01453268932	0.4528601723	0.4457197533	2.585473846	318	308	6	226
FPR3	formyl peptide receptor 3	Yes	TBD		ENSG00000187474	P25089	G-protein coupled receptor 1 family	14	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P04083, Q8IVG9, Q9NRV9	ANXA1, HEBP1, MT-RNR2	ANXA1 [CellTalkDB:15187149;Cellinker:15187149;Guide2Pharma:15187149;LRdb:15187149;SIGNOR:15187149;connectomeDB2020:15187149;scConnect:15187149], HEBP1 [CellTalkDB:15623572;Guide2Pharma:15623572;LRdb:15623572;connectomeDB2020:15623572;scConnect:15623572], MT-RNR2 [Guide2Pharma:15465011;scConnect:15465011]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]	chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FPR3&keywords=FPR3	2.92513553	273	NA	NA	1.110095525	215	0.3622047244	0	0	0	0	0	0	0	0	1.67E-04	0	234	341	347	0.03294287599	0.2328674959	0.2367543215	0.2328674959	389	379	378	302
GFRA4	GDNF family receptor alpha 4	Yes	TBD		ENSG00000125861	Q9GZZ7	GDNFR family	14	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O60542, P07949	PSPN, RET	PSPN [Baccin2019:1111614411116140;CellTalkDB:11116144;Cellinker:11116144;Cellinker:11544105;HPMR:11116144;HPRD:11116144;LRdb:11116144;SIGNOR:11116144;connectomeDB2020:11116144], RET [Cellinker:9883723]	anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]	negative regulation of ossification [GO:0030279]; nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFRA4&keywords=GFRA4	0	862	NA	NA	0.1205661249	619	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	741
GPR39	G protein-coupled receptor 39	Yes	No		ENSG00000183840	O43194	G-protein coupled receptor 1 family	14	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q9UBU3	GHRL	GHRL [Baccin2019:16284174;CellTalkDB:16284174;Cellinker:16284174;LRdb:16284174;connectomeDB2020:16284174]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR39&keywords=GPR39	5.961314822	212	1361.55	73	10.08815583	22	0	0.04840319361	0	0.001438848921	0.0202020202	0.005076142132	0.001813236627	0.003262642741	0.001479837218	0.002870877287	0.001506664091	230	265	297	0.007823042076	0.6441008874	0.7221481738	0.6456060667	251	224	219	159
MTNR1B	melatonin receptor 1B	Yes	No		ENSG00000134640	P49286	G-protein coupled receptor 1 family	14	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O14654, P04899, P21333, P46597, P53621, Q16613	AANAT, ASMT, COPA, FLNA, GNAI2, IRS4	AANAT [Baccin2019:12943195;CellTalkDB:12943195;LRdb:12943195;connectomeDB2020:12943195], GNAI2 [Baccin2019:17215244;CellTalkDB:17215244;Cellinker:17215244;HPRD:17215244;LRdb:17215244;connectomeDB2020:17215244], IRS4 [Cellinker:17215244;HPRD:17215244], FLNA [Cellinker:17215244;HPRD:17215244;Lit-BM-17:17215244;Lit-BM-17:26514267], ASMT [NA], COPA [HPRD:17215244]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]	camera-type eye development [GO:0043010]; chemical synaptic transmission [GO:0007268]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MTNR1B&keywords=MTNR1B	0.963224761	387	NA	NA	37.80780584	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	196
PLXNA2	plexin A2	Yes	TBD		ENSG00000076356	O75051	Plexin family	14	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O94887, P06241, P06493, P17252, Q13214, Q13591, Q14563, Q16539, Q99985, Q9H2E6, Q9H3T3	CDK1, FARP2, FYN, MAPK14, PRKCA, SEMA3A, SEMA3B, SEMA3C, SEMA5A, SEMA6A, SEMA6B	SEMA3C [SIGNOR:19666519], SEMA3B [SIGNOR:25335892], SEMA3A [CellTalkDB:10934324;LRdb:10934324;SIGNOR:10679438], SEMA6A [CellChatDB:27533782;CellTalkDB:18327254;Cellinker:18327254;Cellinker:26633812;Cellinker:27533782;LRdb:18327254;Ramilowski2015:18327254;connectomeDB2020:18327254;talklr:18327254], FARP2 [CellTalkDB:32196115], SEMA6B [CellChatDB:27533782;Cellinker:26633812;Cellinker:27533782;connectomeDB2020:25209245], SEMA5A [Cellinker:26633812], FYN [PhosphoSite:29091353], CDK1 [KEA:17570479], MAPK14 [KEA:17570479], PRKCA [KEA:17570479]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNA2&keywords=PLXNA2	11.31149285	151	6152.35	31	1.002450536	237	0.02362204724	0.05289421158	0.4103982301	0.07769784173	0.06734006734	0.2436548223	0.1740707162	0.1092985318	0.1220865705	0.1467151823	0.05698280858	65	60	92	0.1349782754	0.9110783674	1.080956314	0.4620196259	143	103	291	116
PTCH2	patched 2	Yes	No		ENSG00000117425	Q9Y6C5	Patched family	14	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O43323, Q14623, Q15465	DHH, IHH, SHH	SHH [Baccin2019:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SIGNOR:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], IHH [Baccin2019:9811851;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;ICELLNET:29274272;LRdb:9811851;NetPath:9811851;SIGNOR:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], DHH [Baccin2019:98118519811851;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPMR:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]	cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTCH2&keywords=PTCH2	0.3100596242	497	NA	NA	0.04417771928	749	0	0.00499001996	0	0.001918465228	0.001683501684	0.01015228426	0.004533091568	0	0.001109877913	0.005241020163	0.001313502028	231	233	307	0.002812887528	0.8670861965	1.189507059	0.8829783297	162	83	122	391
TNFRSF11B	TNF receptor superfamily member 11b	Yes			ENSG00000164761	O00300	NA	14	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted	O14788, O75487, O75888, P01133, P02751, P02788, P04004, P04275, P07996, P10915, P16871, P35052, P50591, P51654, Q96PX8, Q9Y286, Q9Y336	EGF, FN1, GPC1, GPC3, GPC4, HAPLN1, IL7R, LTF, SIGLEC7, SIGLEC9, SLITRK1, THBS1, TNFSF10, TNFSF11, TNFSF13, VTN, VWF	TNFSF11 [Baccin2019:11733492;Baccin2019:12221720;Baccin2019:9520411;Baccin2019:9568710;CellTalkDB:11733492;Cellinker:11733492;Cellinker:12221720;Cellinker:9520411;Cellinker:9568710;HPMR:9568710;HPRD:12221720;HPRD:9520411;ICELLNET:11239407;IntAct:22664871;LRdb:11733492;LRdb:12221720;LRdb:9520411;LRdb:9568710;NetPath:14741739;NetPath:9568710;SIGNOR:11733492;connectomeDB2020:11733492;connectomeDB2020:12221720;connectomeDB2020:9520411;connectomeDB2020:9568710], TNFSF10 [Baccin2019:12221720;Baccin2019:9520411;CellTalkDB:9520411;Cellinker:12221720;Cellinker:9520411;HPRD:12221720;HPRD:9520411;ICELLNET:11239407;LRdb:122;LRdb:9520411;connectomeDB2020:12221720;connectomeDB2020:9520411], VTN [CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], THBS1 [Baccin2019:15799029;CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], VWF [Baccin2019:15799029;CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], TNFSF13 [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], FN1 [Baccin2019:15799029;CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], SIGLEC7 [Cellinker:32822567], GPC4 [Cellinker:32589946], LTF [Cellinker:32822567], SLITRK1 [Cellinker:32589946], IL7R [Cellinker:32589946], EGF [Cellinker:32589946], HAPLN1 [Cellinker:32822567], GPC1 [Cellinker:32589946], SIGLEC9 [Cellinker:32822567], GPC3 [Cellinker:32589946]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine activity [GO:0005125]; signaling receptor activity [GO:0038023]	apoptotic process [GO:0006915]; extracellular matrix organization [GO:0030198]; negative regulation of bone resorption [GO:0045779]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; negative regulation of osteoclast differentiation [GO:0045671]; response to arsenic-containing substance [GO:0046685]; response to estrogen [GO:0043627]; response to magnesium ion [GO:0032026]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF11B&keywords=TNFRSF11B	24.88235829	85	NA	NA	2.00308108	122	0	0.4271457086	0.01438053097	0.02254196643	0.0101010101	0.1133671743	0.04895738894	0.2446982055	0.2264150943	0.04997329416	0.02847208808	33	129	137	0.107822951	2.006528374	0.5090119848	0.3265245671	14	292	342	157
UNC5C	unc-5 netrin receptor C	Yes	No		ENSG00000182168	O95185	Unc-5 family	14	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O95631, P51654, P53355	DAPK1, GPC3, NTN1	NTN1 [Baccin2019:10399920;Baccin2019:12810718;CellTalkDB:12810718;Cellinker:10399920;Cellinker:12810718;HPMR:12810718;HPRD:12810718;LRdb:1;LRdb:12810718;SIGNOR:10399920;connectomeDB2020:10399920;connectomeDB2020:12810718], GPC3 [Cellinker:32589946], DAPK1 [HPRD:15729359]	cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]	netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]	anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UNC5C&keywords=UNC5C	0.8433125854	401	NA	NA	0.3116219915	453	0	0.002994011976	0	0.007194244604	0	0.008460236887	0.01087941976	0.003262642741	0.004069552349	0.008579249566	0.001004442727	223	211	312	0.004222163692	0.9892694708	1.306358861	0.7737530636	114	64	165	282
BRS3	bombesin receptor subtype 3	Yes	No		ENSG00000102239	P32247	G-protein coupled receptor 1 family	13	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P07492, P08949	GRP, NMB	GRP [CellTalkDB:11112777;LRdb:11112777;Ramilowski2015:11112777;connectomeDB2020:11112777;talklr:11112777], NMB [LRdb:9920658;Ramilowski2015:9920658;connectomeDB2020:9920658;talklr:9920658]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]	adult feeding behavior [GO:0008343]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of blood pressure [GO:0008217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRS3&keywords=BRS3	1.522249006	336	NA	NA	14.63337549	12	0	9.98E-04	0	0.002398081535	0	0.001692047377	0.02538531278	0.03915171289	0.001109877913	8.68E-04	0.04798145644	231	320	104	0.01087131205	0.5323037615	0.5207118564	2.778045592	298	289	5	239
GFRA3	GDNF family receptor alpha 3	Yes	No		ENSG00000146013	O60609	GDNFR family	13	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, receptor, transmembrane, transmembrane_predicted	O60542, P07949, P39905, Q5T4W7, Q99748	ARTN, GDNF, NRTN, PSPN, RET	ARTN [Baccin2019:98837239883723;CellTalkDB:9883723;Cellinker:11544105;Cellinker:9883723;DIP:16765900;HPMR:9883723;HPRD:9883723;IntAct:16765900;LRdb:9883723;Lit-BM-17:16765900;Lit-BM-17:9883723;SIGNOR:9883723;connectomeDB2020:9883723], PSPN [CellTalkDB:32196115], NRTN [CellTalkDB:32196115], GDNF [CellTalkDB:32196115], RET [Cellinker:9883723]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]	nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFRA3&keywords=GFRA3	0.1972904202	547	NA	NA	0.04711519048	740	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	644
GPR182	G protein-coupled receptor 182	Yes	Yes		ENSG00000166856	O15218	G-protein coupled receptor 1 family	13	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P35318	ADM	ADM [CellTalkDB:7592696;Cellinker:7592696;HPMR:7592696;LRdb:7592696]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]	cell surface receptor signaling pathway [GO:0007166]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR182&keywords=GPR182	0.07386733146	650	NA	NA	0.08379162635	667	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	659
MTNR1A	melatonin receptor 1A	Yes	No		ENSG00000168412	P48039	G-protein coupled receptor 1 family	13	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	O00230, O00585, O14625, O14654, O15444, O15467, O43927, P01019, P01024, P01031, P01042, P01189, P01210, P01213, P01298, P01303, P02775, P02776, P02778, P04083, P04899, P05067, P09341, P0DJI8, P10082, P10145, P13501, P19875, P19876, P20382, P21333, P22466, P27797, P42830, P48061, P48645, P55773, P61278, P78556, P80162, Q07325, Q13519, Q16613, Q5H8A3, Q8IVG9, Q8N729, Q8NG41, Q8WXF3, Q99731, Q9H2A7, Q9NRJ3, Q9NRV9, Q9ULZ1, Q9Y4X3, Q9Y5Q6	AANAT, AGT, ANXA1, APLN, APP, C3, C5, CALR, CCL16, CCL19, CCL20, CCL21, CCL23, CCL25, CCL27, CCL28, CCL5, CORT, CXCL1, CXCL10, CXCL11, CXCL12, CXCL13, CXCL16, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8, CXCL9, FLNA, GAL, GNAI2, HEBP1, INSL5, IRS4, KNG1, MT-RNR2, NMS, NMU, NPB, NPW, NPY, PDYN, PENK, PF4, PMCH, PNOC, POMC, PPBP, PPY, PYY, RLN3, SAA1, SST	GNAI2 [Baccin2019:10598579;Baccin2019:17215244;CellTalkDB:10598579;Cellinker:10598579;Cellinker:17215244;HPRD:10598579;HPRD:17215244;LRdb:10598579;LRdb:17;connectomeDB2020:10598579;connectomeDB2020:17215244], HEBP1 [CellTalkDB:32196115], C5 [CellTalkDB:32196115], CXCL6 [CellTalkDB:32196115], C3 [CellTalkDB:32196115], AANAT [Baccin2019:12943195;CellTalkDB:12943195;HPMR:12943195;LRdb:12943195;connectomeDB2020:12943195], CCL21 [CellTalkDB:32196115], CCL27 [CellTalkDB:32196115], NMU [CellTalkDB:32196115], KNG1 [CellTalkDB:32196115], GAL [CellTalkDB:32196115], APP [CellTalkDB:32196115], CXCL13 [CellTalkDB:32196115], SST [CellTalkDB:32196115], CXCL16 [CellTalkDB:32196115], CXCL3 [CellTalkDB:32196115], CXCL5 [CellTalkDB:32196115], PPBP [CellTalkDB:32196115], PF4 [CellTalkDB:32196115], PNOC [CellTalkDB:32196115], INSL5 [CellTalkDB:32196115], PDYN [CellTalkDB:32196115], AGT [CellTalkDB:32196115], CXCL12 [CellTalkDB:32196115], CCL5 [CellTalkDB:32196115], CXCL11 [CellTalkDB:32196115], NMS [CellTalkDB:32196115], APLN [CellTalkDB:32196115], NPY [CellTalkDB:32196115], CCL25 [CellTalkDB:32196115], POMC [CellTalkDB:32196115], SAA1 [CellTalkDB:32196115], CALR [Baccin2019:17215244;CellTalkDB:17215244;HPRD:17215244;IntAct:28298427;LRdb:17215244;connectomeDB2020:17215244], CXCL8 [CellTalkDB:32196115], PYY [CellTalkDB:32196115], CCL16 [CellTalkDB:32196115], CXCL2 [CellTalkDB:32196115], CXCL10 [CellTalkDB:32196115], PMCH [CellTalkDB:32196115], CCL19 [CellTalkDB:32196115], CXCL1 [CellTalkDB:32196115], NPB [CellTalkDB:32196115], PPY [CellTalkDB:32196115], CXCL9 [CellTalkDB:32196115], CCL20 [CellTalkDB:32196115], NPW [CellTalkDB:32196115], PENK [CellTalkDB:32196115], CCL28 [CellTalkDB:32196115], RLN3 [CellTalkDB:32196115], CORT [CellTalkDB:32196115], ANXA1 [CellTalkDB:32196115], FLNA [Cellinker:17215244;HPRD:17215244;Lit-BM-17:17215244;Lit-BM-17:26514267], IRS4 [Cellinker:17215244;HPRD:17215244], CCL23 [NA], MT-RNR2 [NA]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MTNR1A&keywords=MTNR1A	0.5188439101	455	NA	NA	5.131637913	46	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	251
NPBWR2	neuropeptides B and W receptor 2	Yes	No		ENSG00000277339, ENSG00000125522	P48146	G-protein coupled receptor 1 family	13	receptor	cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	Q8N729, Q8NG41	NPB, NPW	NPB [CellTalkDB:12401809;Guide2Pharma:12401809;HPRD:12401809;LRdb:12401809;connectomeDB2020:12401809;scConnect:12401809], NPW [CellTalkDB:12130646;Guide2Pharma:12401809;HPMR:12130646;HPRD:12130646;HPRD:12719537;LRdb:12130646;LRdb:12401809;LRdb:12719537;connectomeDB2020:12130646;connectomeDB2020:12401809;connectomeDB2020:12719537;scConnect:12401809]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPBWR2&keywords=NPBWR2	0	862	NA	NA	0.3073033929	461	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	662
TNFRSF19	TNF receptor superfamily member 19	Yes	Yes		ENSG00000127863	Q9NS68	NA	13	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	Q9NQC3	RTN4	RTN4 [Baccin2019:15694322;CellTalkDB:15694322;LRdb:15694322;connectomeDB2020:15694322]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF19&keywords=TNFRSF19	13.7631197	131	NA	NA	1.872134326	130	0	0.09630738523	0.00110619469	0.01486810552	0.01346801347	0.05752961083	0.1296464189	0.1305057096	0.03699593045	0.04606756576	0.1188719336	146	133	57	0.05866971527	0.6843763697	0.8164816985	1.876692412	234	191	13	146
UNC5A	unc-5 netrin receptor A	Yes	No		ENSG00000113763	Q6ZN44	Unc-5 family	13	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43155, O43300, O95631, O95866, P22455, P53355, Q6UXK5, Q8IZA0, Q9BYE9, Q9HB63, Q9HCJ2, Q9NZU0, Q9NZU1	CDHR2, DAPK1, FGFR4, FLRT1, FLRT2, FLRT3, KIAA0319L, LRRC4C, LRRN1, LRRTM2, MPIG6B, NTN1, NTN4	NTN4 [Baccin2019:17174565;CellTalkDB:17174565;Cellinker:17174565;LRdb:17174565;SIGNOR:12598531;connectomeDB2020:17174565], NTN1 [CellTalkDB:9126742;Cellinker:28710382;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], FLRT1 [Cellinker:32589946], FGFR4 [Cellinker:32822567], FLRT3 [Cellinker:32589946], KIAA0319L [Cellinker:32589946], FLRT2 [Cellinker:32589946], CDHR2 [Cellinker:32589946], LRRTM2 [Cellinker:32822567], MPIG6B [Cellinker:32822567], LRRN1 [Cellinker:32822567], LRRC4C [Cellinker:32589946], DAPK1 [HPRD:15729359]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]	netrin receptor activity [GO:0005042]	anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; netrin-activated signaling pathway [GO:0038007]; neuron projection development [GO:0031175]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UNC5A&keywords=UNC5A	0.2479798508	524	NA	NA	0.02794433263	798	0	4.99E-04	0	0	0	0.001692047377	0.001813236627	0	0	0.002904259581	1.16E-04	234	264	344	6.39E-04	0.9399745673	1.212967582	0.9508686129	128	77	95	416
UNC5D	unc-5 netrin receptor D	Yes	No		ENSG00000156687	Q6UXZ4	Unc-5 family	13	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43155, O75326, O95631, O95866, P14151, P19784, P51654, Q06418, Q6ZMC9, Q9NT99, Q9NZU0, Q9NZU1	CSNK2A2, FLRT1, FLRT2, FLRT3, GPC3, LRRC4B, MPIG6B, NTN1, SELL, SEMA7A, SIGLEC15, TYRO3	NTN1 [CellTalkDB:9126742;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], SEMA7A [Cellinker:32589946], SELL [Cellinker:32589946], LRRC4B [Cellinker:32589946], FLRT2 [Cellinker:32589946], FLRT3 [Cellinker:32589946], FLRT1 [Cellinker:32589946], TYRO3 [Cellinker:32822567], GPC3 [Cellinker:32589946], MPIG6B [Cellinker:32822567], SIGLEC15 [Cellinker:32822567], CSNK2A2 [KEA:17570479]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	netrin receptor activity [GO:0005042]	apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UNC5D&keywords=UNC5D	2.931781678	272	NA	NA	4.119369752	54	0	0.007984031936	0	4.80E-04	0.01178451178	0.1201353638	0.106980961	0.004893964111	0.09507954125	0.118640673	0.001081707553	80	76	310	0.0424600337	2.003039911	2.452165275	0.2112409537	16	7	386	102
CRLF1	cytokine receptor like factor 1	Yes	Yes		ENSG00000006016	O75462	Type I cytokine receptor family, Type 3 subfamily	12	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P26441, Q9UBD9	CLCF1, CNTF	CNTF [HPMR:10966616;SIGNOR:11294841;SignaLink3:11294841;SignaLink3:23331499], CLCF1 [CellTalkDB:10966616;HPMR:10966616;HPRD:10966616;LRdb:10966616;connectomeDB2020:10966616]	CRLF-CLCF1 complex [GO:0097058]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	cytokine-mediated signaling pathway [GO:0019221]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRLF1&keywords=CRLF1	11.97336841	145	NA	NA	0.4990642224	372	0	4.99E-04	0.002212389381	0.5414868106	0	0	0.003626473255	0.00163132137	7.40E-04	0.001869408466	0.00104307514	232	290	311	0.05028258171	0.1781595662	0.1968961536	0.1831884904	410	390	401	299
FGFRL1	fibroblast growth factor receptor like 1	Yes	Yes		ENSG00000127418	Q8N441	NA	12	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O15520, O75487, P05230, P08620, P09038, P11487, P55075, P58401, Q15466, Q9HCT0, Q9HDB5, Q9P2S2, Q9Y4C0, Q9Y625	FGF1, FGF10, FGF2, FGF22, FGF3, FGF4, FGF8, GPC4, GPC6, NR0B2, NRXN2, NRXN3	FGF2 [Baccin2019:11418238;CellTalkDB:11418238;Cellinker:11418238;HPRD:11418238;LRdb:11418238;connectomeDB2020:11418238], FGF10 [CellTalkDB:19920134;connectomeDB2020:19920134], FGF8 [CellTalkDB:23112089;connectomeDB2020:19920134], FGF1 [CellTalkDB:32196115], FGF22 [connectomeDB2020:19920134], FGF3 [connectomeDB2020:19920134], FGF4 [connectomeDB2020:19920134], NRXN3 [Cellinker:32589946], GPC6 [Cellinker:32589946], NR0B2 [Cellinker:23640895], NRXN2 [Cellinker:32589946], GPC4 [Cellinker:32589946], NRXN2 [Cellinker:32589946], NRXN3 [Cellinker:32589946]	cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]	cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFRL1&keywords=FGFRL1	7.658538856	187	NA	NA	0.2906491402	466	0	0.08682634731	0.005530973451	0.0273381295	0.05218855219	0	9.07E-04	0.01141924959	0.001109877913	4.34E-04	0.00224067993	231	330	281	0.01709039982	0.410103874	0.3851537774	0.4518456727	329	330	293	328
ROBO4	roundabout guidance receptor 4	Yes	Yes		ENSG00000154133	Q8WZ75	Immunoglobulin superfamily, ROBO family	12	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	B6A8C7, O75094, O94813, P02751, P07355	ANXA2, FN1, SLIT2, SLIT3, TARM1	SLIT2 [Baccin2019:15894287;CellTalkDB:15894287;Cellinker:15894287;Cellinker:31217826;HPMR:15894287;LRdb:15894287;SIGNOR:12941633;connectomeDB2020:15894287], FN1 [CellTalkDB:1972721], ANXA2 [connectomeDB2020:29786451], SLIT3 [Cellinker:30288875;connectomeDB2020:19741192], TARM1 [Cellinker:32822567]	axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023]	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROBO4&keywords=ROBO4	2.403591192	292	NA	NA	0.1220893114	615	0	0.002994011976	0.5365044248	0.06666666667	0	0.001692047377	0.001813236627	0	0.001109877913	6.01E-04	0.00208615028	231	326	284	0.05576975426	0.1689207758	0.1611817075	0.183764565	416	404	400	409
UNC5B	unc-5 netrin receptor B	Yes	Yes		ENSG00000107731	Q8IZJ1	Unc-5 family	12	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	O43155, O95631, P04899, P53355, Q92896, Q99466, Q9NZU0, Q9NZU1	DAPK1, FLRT1, FLRT2, FLRT3, GLG1, GNAI2, NOTCH4, NTN1	DAPK1 [BioGRID:15729359;HPRD:15729359;Lit-BM-17:15729359;Lit-BM-17:21172653], NTN1 [Baccin2019:23599441;CellTalkDB:9126742;Cellinker:26840727;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], GNAI2 [CellTalkDB:32196115], GLG1 [Cellinker:32589946], FLRT2 [Cellinker:32589946], NOTCH4 [Cellinker:32589946], FLRT3 [Cellinker:32589946], FLRT1 [Cellinker:32589946]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	netrin receptor activity [GO:0005042]	angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UNC5B&keywords=UNC5B	16.27565549	121	NA	NA	1.470844403	162	0.06299212598	0.0878243513	0.3042035398	0.4736211031	0.01851851852	0.4280879865	0.1169537625	0.0277324633	0.4187939327	0.1339631459	0.005563067414	15	67	240	0.1889321815	2.155477959	0.7236795215	0.07823303044	9	223	441	143
TFRC	transferrin receptor	Yes	Yes		ENSG00000072274	P02786	Peptidase M28 family, M28B subfamily	12	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P02787, P02788, P08582, P12931, P17252, P61769, Q9P0V3, Q9Y275	B2M, LTF, MELTF, PRKCA, SH3BP4, SRC, TF, TNFSF13B	SH3BP4 [IntAct:16325581;Lit-BM-17:16325581;SIGNOR:16325581], LTF [CellTalkDB:32196115], MELTF [CellTalkDB:12688510], TNFSF13B [CellTalkDB:32103204], TF [Baccin2019:12210842;Baccin2019:16354665;Baccin2019:6268632;Baccin2019:6270680;CellTalkDB:16354665;Cellinker:12210842;Cellinker:16354665;Cellinker:6268632;Cellinker:6270680;DIP:14691533;DIP:16271884;DIP:20404192;DIP:21788477;DIP:9546397;HPMR:6270680;HPRD:12210842;HPRD:16354665;HPRD:6268632;IntAct:14691533;IntAct:16271884;IntAct:16354665;IntAct:20404192;IntAct:21788477;IntAct:29302006;LRdb:12210842;LRdb:16354665;LRdb:6268632;LRdb:6270680;Lit-BM-17:11027676;Lit-BM-17:14691533;Lit-BM-17:16271884;Lit-BM-17:16354665;Lit-BM-17:9546397;connectomeDB2020:12210842;connectomeDB2020:16354665;connectomeDB2020:6268632;connectomeDB2020:6270680], B2M [CellTalkDB:32196115], PRKCA [KEA:17570479;KEA:3013873;KEA:3119581;KEA:86250833;PhosphoSite:3013873;PhosphoSite:3119581;PhosphoSite:3129437;ProtMapper:15212693;phosphoELM:3013873;phosphoELM:3119581], SRC [PhosphoSite:21859709;ProtMapper:21859709]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; metalloexopeptidase activity [GO:0008235]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]	acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFRC&keywords=TFRC	102.9911706	19	6865.34	28	3.166358249	73	1.149606299	0.4446107784	0.04756637168	0.2724220624	0.196969697	0.192893401	0.199456029	0.1256117455	0.09359970403	0.1055214314	0.0923314661	81	80	68	0.2655080896	0.3760314413	0.4193032284	0.371428172	343	316	323	103
GPR135	G protein-coupled receptor 135	Yes	No		ENSG00000181619	Q8IZ08	G-protein coupled receptor 1 family	11	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P01042	KNG1	KNG1 [Cellinker:1374385;Cellinker:14530218;HPMR:1374385;LRdb:14;LRdb:14530218;connectomeDB2020:1374385;connectomeDB2020:14530218]	endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR135&keywords=GPR135	0.4416934831	470	NA	NA	0.1369198954	590	0	0.01447105788	0.005530973451	0.0170263789	0.006734006734	0.0372250423	0.05258386219	0.0277324633	0.02552719201	0.02620510081	0.01970253042	171	159	157	0.02115805527	1.14022495	1.161982046	0.9532857607	83	90	93	327
IGFLR1	IGF like family receptor 1	Yes	No		ENSG00000126246	Q9H665	NA	11	adhesion, receptor	adhesion, cell_adhesion, cell_surface, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P55899, Q6UW32, Q6UWQ7, Q6UXB1	FCGRT, IGFL1, IGFL2, IGFL3	IGFL2 [CellTalkDB:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693], IGFL1 [CellTalkDB:21454693;IntAct:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693], IGFL3 [CellChatDB:21454693;CellTalkDB:21454693;Cellinker:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693], FCGRT [Cellinker:32589946]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFLR1&keywords=IGFLR1	0.9819103852	382	NA	NA	0.09721121335	646	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	514
OGFR	opioid growth factor receptor	Yes	Yes		ENSG00000060491	Q9NZT2	Opioid growth factor receptor family	11	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor	P01210	PENK	PENK [Baccin2019:16820893;CellTalkDB:16820893;Cellinker:16820893;HPMR:16820893;LRdb:16820893;connectomeDB2020:16820893]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	opioid growth factor receptor activity [GO:0140625]	regulation of cell growth [GO:0001558]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OGFR&keywords=OGFR	5.709952374	217	4819.09	37	0.1793695309	541	0.125984252	0.1482035928	0.1172566372	0.178177458	0.2575757576	0.1285956007	0.1840435177	0.1158238173	0.09137994821	0.1224796368	0.1148927951	84	73	59	0.1440375467	0.6581508886	0.860047694	0.8107944963	241	179	155	209
ROBO3	roundabout guidance receptor 3	Yes	No		ENSG00000154134	Q96MS0	Immunoglobulin superfamily, ROBO family	10	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P13591, P17252, Q99435	NCAM1, NELL2, PRKCA	NCAM1 [Baccin2019:16226035;Cellinker:16226035;HPMR:16226035;LRdb:16226035;connectomeDB2020:16226035], NELL2 [DIP:26586761;connectomeDB2020:26586761], PRKCA [PhosphoSite:25882844]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ROBO3&keywords=ROBO3	0.799382593	407	NA	NA	0.09679931221	647	0	0.008982035928	0.04867256637	0.0175059952	0	0	0.001813236627	0.003262642741	3.70E-04	2.67E-04	0.001468031679	233	338	299	0.007485593292	0.5930573319	0.5871724328	0.6558560231	268	269	210	415
TNFRSF6B	TNF receptor superfamily member 6b	Yes	Yes		ENSG00000243509	O95407	NA	10	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted	O43557, O95150, P48023	FASLG, TNFSF14, TNFSF15	TNFSF15 [CellTalkDB:11911831;Cellinker:11911831;HPMR:14697332;HPRD:11911831;ICELLNET:11239407;LRdb:11911831;connectomeDB2020:11911831], FASLG [BioGRID:9872321;CellTalkDB:14697332;Cellinker:10318773;Cellinker:11994433;Cellinker:14697332;Cellinker:9872321;HPMR:14697332;HPRD:10318773;HPRD:11994433;HPRD:9872321;ICELLNET:11239407;LRdb:10318773;LRdb:11994433;LRdb:14697332;LRdb:9872321;connectomeDB2020:10318773;connectomeDB2020:11994433;connectomeDB2020:14697332;connectomeDB2020:9872321], TNFSF14 [CellTalkDB:11994433;Cellinker:11994433;HPMR:14697332;HPRD:11994433;ICELLNET:11239407;IntAct:21300286;IntAct:25087510;LRdb:11994433;connectomeDB2020:11994433]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	signaling receptor activity [GO:0038023]	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF6B&keywords=TNFRSF6B	0.007426779888	788	NA	NA	5.62E-04	883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	836
TFR2	transferrin receptor 2	Yes	No		ENSG00000106327	Q9UP52	Peptidase M28 family, M28B subfamily	10	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane, transmembrane_predicted	P02787, Q96B86	RGMA, TF	TF [Baccin2019:11027676;CellTalkDB:11027676;Cellinker:11027676;HPRD:11027676;LRdb:11027676;connectomeDB2020:11027676], RGMA [CellTalkDB:22728873]	cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	co-receptor binding [GO:0039706]; metalloexopeptidase activity [GO:0008235]; transferrin receptor activity [GO:0004998]	acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFR2&keywords=TFR2	0.3242955307	495	NA	NA	0.03372508043	780	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	638
TSPAN1	tetraspanin 1	Yes	No		ENSG00000117472	O60635	Tetraspanin (TM4SF) family	10	adhesion, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, intracellular_intercellular_related, plasma_membrane, plasma_membrane_transmembrane, receptor, transmembrane	P21741	MDK	MDK [Baccin2019:18851943;CellTalkDB:18851943;Cellinker:18851943;HPRD:18851943;LRdb:18851943;connectomeDB2020:18851943]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	NA	protein stabilization [GO:0050821]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TSPAN1&keywords=TSPAN1	41.53076885	53	NA	NA	1.722749556	142	0	0.09431137725	0.002212389381	0.005995203837	0.06734006734	0.2859560068	0.2855847688	0.01794453507	0.03625601184	0.3213379623	0.02290902067	149	25	148	0.1036224858	0.4071026217	2.916130202	0.2896347536	332	1	357	55
BAMBI	BMP and activin membrane bound inhibitor	Yes	Yes		ENSG00000095739	Q13145	BAMBI family	9	receptor	cell_surface, extracellular, intracellular, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane, transmembrane_predicted	P08476, P09529	INHBA, INHBB	INHBA [CellTalkDB:10918299;HPMR:10918299;LRdb:10918299;connectomeDB2020:10918299], INHBB [HPMR:10918299]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	frizzled binding [GO:0005109]; type II transforming growth factor beta receptor binding [GO:0005114]	cell migration [GO:0016477]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BAMBI&keywords=BAMBI	14.36591331	128	NA	NA	0.8906545941	262	0.02362204724	0.2265469062	0.01991150442	0.01079136691	0.02356902357	0.05752961083	0.01903898459	0.009787928222	0.08694043655	0.003104553345	0.01487347885	88	260	176	0.04506507643	1.76047039	0.2379830229	0.4517106025	24	376	295	257
IL17RE	interleukin 17 receptor E	Yes			ENSG00000163701	Q8NFR9	NA	9	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	Q9P0M4	IL17C	IL17C [CellTalkDB:21993849;connectomeDB2020:21993848]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	interleukin-17 receptor activity [GO:0030368]	inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RE&keywords=IL17RE	4.44536235	238	NA	NA	0.4376405057	386	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	312
KLB	klotho beta	Yes	No		ENSG00000134962	Q86Z14	Glycosyl hydrolase 1 family, Klotho subfamily	9	receptor	cell_surface, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, transmembrane, transmembrane_predicted	O95750, Q9NSA1	FGF19, FGF21	FGF19 [CellTalkDB:22442730;LRdb:22442730;Ramilowski2015:22442730;connectomeDB2020:22442730;talklr:22442730], FGF21 [CellTalkDB:22442730;HPRD:19059246]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]	carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KLB&keywords=KLB	1.204001854	363	NA	NA	1.557721537	155	0.007874015748	0.008483033932	0.002212389381	0.002877697842	0.02188552189	0.02030456853	0.03717135086	0.02936378467	0.004809470958	0.003838963814	0.04334556693	219	253	111	0.0165605786	0.5575733565	0.5210339739	2.008448978	282	287	9	265
GPR162	G protein-coupled receptor 162	Yes	No		ENSG00000250510	Q16538	G-protein coupled receptor 1 family	7	receptor	cell_surface, plasma_membrane, receptor, transmembrane	P02787, P02788, P07237	LTF, P4HB, TF	LTF [NA], P4HB [NA], TF [NA]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	G protein-coupled receptor activity [GO:0004930]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR162&keywords=GPR162	0.7769275589	418	NA	NA	0.03393325226	778	0.03149606299	9.98E-04	0.00110619469	0.007673860911	0.005050505051	0.01692047377	0.006346328196	0.01141924959	0.01886792453	0.01111630391	0.004210932973	183	199	248	0.01047325824	1.410030792	1.031409054	0.6941217078	44	119	200	379